<?xml version="1.0" encoding="utf-8"?>
<Schedule xmlns:schedule="http://schedule.pharmac.govt.nz/2006/07/Schedule#" xmlns:html="http://www.w3.org/1999/xhtml" xmlns:math="http://www.w3.org/1998/Math/MathML" xmlns="http://schedule.pharmac.govt.nz/2006/07/Schedule#" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nzmt="nzmt.org.nz" xsi:schemaLocation="http://schedule.pharmac.govt.nz/2006/07/Schedule# http://schedule.pharmac.govt.nz/2006/07/Schedule.xsd">
  <Front>
    <Title>Hospital Medicines List</Title>
    <Country>New Zealand</Country>
    <Edition>October 2024</Edition>
    <Volume>12</Volume>
    <Number>3</Number>
    <Published>2024-10-01</Published>
  </Front>
  <Section ID="H2">
    <Name>Preferred Medicines List</Name>
    <ATC1 ID="A01">
      <Name>Alimentary Tract and Metabolism</Name>
      <ATC2 ID="A0104">
        <Name>Antacids and Antiflatulents</Name>
        <ATC3 ID="A010404">
          <Name>Antacids and Reflux Barrier Agents</Name>
          <Chemical ID="C0104048016">
            <Name>Aluminium hydroxide with magnesium hydroxide and simeticone</Name>
            <Formulation ID="F010404801602" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg with magnesium hydroxide 200 mg and simeticone 20 mg</Name>
              <Brand ID="B01040480160200">
                <Name>e.g. Mylanta</Name>
                <Pack ID="P80160200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F010404801625" Rank="3" Units="ml">
              <Name>Oral liq 400 mg with magnesium hydroxide 400 mg and simeticone 30 mg per 5 ml</Name>
              <Brand ID="B01040480162500">
                <Name>e.g. Mylanta Double Strength</Name>
                <Pack ID="P80162500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0104048415">
            <Name>Simeticone</Name>
            <Formulation ID="F010404841501" Rank="3" Units="ml">
              <Name>Oral drops 100 mg per ml</Name>
              <Brand ID="B01040484150100">
                <Name>Any</Name>
                <Pack ID="P84150100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F010404841525" Rank="3" Units="ml">
              <Name>Oral drops 20 mg per 0.3 ml</Name>
              <Brand ID="B01040484152500">
                <Name>Any</Name>
                <Pack ID="P84152500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F010404841526" Rank="3" Units="ml">
              <Name>Oral drops 40 mg per ml</Name>
              <Brand ID="B01040484152600">
                <Name>Any</Name>
                <Pack ID="P84152600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0104048418">
            <Name>Sodium alginate with magnesium alginate</Name>
            <Formulation ID="F010404841801" Rank="3" Units="g">
              <Name>Powder for oral soln 225 mg with magnesium alginate 87.5 mg, sachet</Name>
              <Brand ID="B01040484180100">
                <Name>e.g. Gaviscon Infant</Name>
                <Pack ID="P84180100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0104048424">
            <Name>Sodium citrate</Name>
            <Formulation ID="F010404842401" Rank="3" Units="ml">
              <Name>Oral liq 8.8% (300 mmol/l)</Name>
              <Brand ID="B01040484240125">
                <Name>Biomed</Name>
                <Pack ID="P345865" Specified="true" nzmt:ctpp_id="50075931000117103">
                  <Quantity>90</Quantity>
                  <Price>25.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0104049295">
            <Name>Sodium alginate with sodium bicarbonate and calcium carbonate</Name>
            <Formulation ID="F010404929501" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg with sodium bicarbonate 267 mg and calcium carbonate 160 mg</Name>
              <Brand ID="B01040492950100">
                <Name>e.g. Gaviscon Extra Strength</Name>
                <Pack ID="P92950100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F010404929525" Rank="3" Units="ml">
              <Name>Oral liq 500 mg with sodium bicarbonate 267 mg and calcium carbonate 160 mg per 10 ml</Name>
              <Brand ID="B01040492952525">
                <Name>Acidex</Name>
                <Pack ID="P2196786" Specified="true" nzmt:ctpp_id="50031441000117100">
                  <Quantity>500</Quantity>
                  <Price>7.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A010408">
          <Name>Phosphate Binding Agents</Name>
          <Chemical ID="C0104088015">
            <Name>Aluminium hydroxide</Name>
            <Formulation ID="F010408801501" Rank="1" Units="tab" Weight="600">
              <Name>Tab 600 mg</Name>
              <Brand ID="B01040880150100">
                <Name>Any</Name>
                <Pack ID="P80150100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0104089430">
            <Name>Calcium carbonate</Name>
            <Request Form="RS1698" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Calcium carbonate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Only when prescribed for patients unable to swallow calcium carbonate tablets or where calcium carbonate tablets are inappropriate.</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1698" style="display:none"/>
            <Formulation ID="F010408943001" Rank="3" Units="ml">
              <Name>Oral liq 250 mg per ml (100 mg elemental per ml)</Name>
              <Brand ID="B01040894300125">
                <Name>Roxane</Name>
                <Pack ID="P2428407" Specified="true" nzmt:ctpp_id="50148841000117103">
                  <Quantity>500</Quantity>
                  <Price>39.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B01040894300126">
                <Name>Calcium carbonate PAI</Name>
                <Pack ID="P2652935" Specified="true" nzmt:ctpp_id="50310501000117102">
                  <Quantity>473</Quantity>
                  <Price>47.30</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0108">
        <Name>Antidiarrhoeals and Intestinal Anti-Inflammatory Agents</Name>
        <ATC3 ID="A010804">
          <Name>Antipropulsives</Name>
          <Chemical ID="C0108048147">
            <Name>Diphenoxylate hydrochloride with atropine sulphate</Name>
            <Formulation ID="F010804814701" Rank="1" Units="tab" Weight="2.5">
              <Name>Tab 2.5 mg with atropine sulphate 25 mcg</Name>
              <Brand ID="B01080481470100">
                <Name>Any</Name>
                <Pack ID="P81470100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0108049560">
            <Name>Loperamide hydrochloride</Name>
            <Formulation ID="F010804956001" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Brand ID="B01080495600125">
                <Name>Nodia</Name>
                <Pack ID="P2184427" Specified="true" nzmt:ctpp_id="50030221000117103">
                  <Quantity>400</Quantity>
                  <Price>10.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F010804956025" Rank="2" Units="cap" Weight="2">
              <Name>Cap 2 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B01080495602525" PSS="true">
                <Name>Diamide Relief</Name>
                <Pack ID="P2365545" Specified="true" nzmt:ctpp_id="50119711000117109">
                  <Quantity>400</Quantity>
                  <Price>7.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A010808">
          <Name>Rectal and Colonic Anti-Inflammatories</Name>
          <Chemical ID="C0108088331">
            <Name>Olsalazine</Name>
            <Formulation ID="F010808833101" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Brand ID="B01080883310125">
                <Name>Dipentum</Name>
                <Pack ID="P588679" Specified="true" nzmt:ctpp_id="50097641000117100">
                  <Quantity>100</Quantity>
                  <Price>53.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F010808833102" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Brand ID="B01080883310225">
                <Name>Dipentum</Name>
                <Pack ID="P426342" Specified="true" nzmt:ctpp_id="50084531000117104">
                  <Quantity>100</Quantity>
                  <Price>93.37</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0108088427">
            <Name>Sodium cromoglicate</Name>
            <Formulation ID="F010808842701" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Brand ID="B01080884270100">
                <Name>Any</Name>
                <Pack ID="P84270100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0108088641">
            <Name>Hydrocortisone acetate with pramoxine hydrochloride</Name>
            <Formulation ID="F010808864125" Rank="3" Units="g">
              <Name>Topical Aerosol foam, 1% with pramoxine hydrochloride 1%</Name>
              <Brand ID="B01080886412500">
                <Name>Any</Name>
                <Pack ID="P86412500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0108089137">
            <Name>Budesonide</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1723">
              <Title>
                <range>Budesonide</range>
              </Title>
              <Case When="Initial application" Category="Crohn's disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Mild to moderate ileal, ileocaecal or proximal Crohn's disease</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Diabetes</ci>
                      <ci type="logical">Cushingoid habitus</ci>
                      <ci type="logical">Osteoporosis where there is significant risk of fracture</ci>
                      <ci type="logical">Severe acne following treatment with conventional corticosteroid therapy</ci>
                      <ci type="logical">History of severe psychiatric problems associated with corticosteroid treatment</ci>
                      <ci type="logical">History of major mental illness (such as bipolar affective disorder) where the risk of conventional corticosteroid treatment causing relapse is considered to be
                        high</ci>
                      <ci type="logical">Relapse during pregnancy (where conventional corticosteroids are considered to be contraindicated)</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Collagenous and lymphocytic colitis (microscopic colitis)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has a diagnosis of microscopic colitis (collagenous or lymphocytic colitis) by colonoscopy with biopsies</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Gut Graft versus Host disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has gut Graft versus Host disease following allogenic bone marrow transplantation</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="non-cirrhotic autoimmune hepatitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has autoimmune hepatitis*</ci>
                    <ci type="logical">Patient does not have cirrhosis</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Diabetes</ci>
                      <ci type="logical">Cushingoid habitus</ci>
                      <ci type="logical">Osteoporosis where there is significant risk of fracture</ci>
                      <ci type="logical">Severe acne following treatment with conventional corticosteroid therapy</ci>
                      <ci type="logical">History of severe psychiatric problems associated with corticosteroid treatment</ci>
                      <ci type="logical">History of major mental illness (such as bipolar affective disorder) where the risk of conventional corticosteroid treatment causing relapse is considered to be
                        high</ci>
                      <ci type="logical">Relapse during pregnancy (where conventional corticosteroids are considered to be contraindicated)</ci>
                      <ci type="logical">Adolescents with poor linear growth (where conventional corticosteroid use may limit further growth)</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="non-cirrhotic autoimmune hepatitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Treatment remains appropriate and the patient is benefitting from the treatment</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1723" style="display:none"/>
            <Formulation ID="F010808913701" Rank="2" Units="cap" Weight="3">
              <Name>Cap modified-release 3 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2025" Value="5"/>
              <Brand ID="B01080891370125" PSS="true">
                <Name>Budesonide Te Arai</Name>
                <Pack ID="P2661454" Specified="true" nzmt:ctpp_id="50319351000117101">
                  <Quantity>90</Quantity>
                  <Price>87.60</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0108089216">
            <Name>Mesalazine</Name>
            <Formulation ID="F010808921625" Rank="10" Units="enema" Weight="1">
              <Name>Enema 1 g per 100 ml</Name>
              <Brand ID="B01080892162526">
                <Name>Pentasa</Name>
                <Pack ID="P715867" Specified="true" nzmt:ctpp_id="50105001000117107">
                  <Quantity>7</Quantity>
                  <Price>41.30</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F010808921626" Rank="5" Units="supp" Weight="500">
              <Name>Suppos 500 mg</Name>
              <Brand ID="B01080892162625">
                <Name>Asacol</Name>
                <Pack ID="P462543" nzmt:ctpp_id="50087861000117101">
                  <Quantity>20</Quantity>
                  <Price>22.80</Price>
                </Pack>
                <Pack ID="P2536560" Specified="true">
                  <Quantity>20</Quantity>
                  <Price>22.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F010808921627" Rank="5" Units="supp" Weight="1000">
              <Name>Suppos 1 g</Name>
              <Brand ID="B01080892162725">
                <Name>Pentasa</Name>
                <Pack ID="P2111985" Specified="true" nzmt:ctpp_id="50019841000117108">
                  <Quantity>28</Quantity>
                  <Price>50.96</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F010808921628" Rank="1" Units="tab" Weight="400">
              <Name>Tab EC 400 mg</Name>
              <Brand ID="B01080892162825">
                <Name>Asacol</Name>
                <Pack ID="P241113" nzmt:ctpp_id="50051561000117101">
                  <Quantity>100</Quantity>
                  <Price>49.50</Price>
                </Pack>
                <Pack ID="P2536544" Specified="true">
                  <Quantity>100</Quantity>
                  <Price>49.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F010808921629" Rank="1" Units="tab" Weight="500">
              <Name>Tab long-acting 500 mg</Name>
              <Brand ID="B01080892162925">
                <Name>Pentasa</Name>
                <Pack ID="P768618" Specified="true" nzmt:ctpp_id="50111321000117101">
                  <Quantity>100</Quantity>
                  <Price>56.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F010808921631" Rank="3" Units="g">
              <Name>Modified release granules 1 g</Name>
              <Brand ID="B01080892163125">
                <Name>Pentasa</Name>
                <Pack ID="P2601354" Specified="true" nzmt:ctpp_id="50129091000117106">
                  <Quantity>100</Quantity>
                  <Price>118.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F010808921632" Rank="1" Units="tab" Weight="800">
              <Name>Tab 800 mg</Name>
              <Brand ID="B01080892163225">
                <Name>Asacol</Name>
                <Pack ID="P2470616" nzmt:ctpp_id="50186641000117107">
                  <Quantity>90</Quantity>
                  <Price>85.50</Price>
                </Pack>
                <Pack ID="P2536552" Specified="true">
                  <Quantity>90</Quantity>
                  <Price>85.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0108089343">
            <Name>Hydrocortisone acetate</Name>
            <Formulation ID="F010808934325" Rank="3" Units="g">
              <Name>Rectal foam 10%, CFC free (14 applications)</Name>
              <Brand ID="B01080893432525">
                <Name>Colifoam</Name>
                <Pack ID="P2611120" Specified="true" nzmt:ctpp_id="50290921000117105">
                  <Quantity>15</Quantity>
                  <Price>26.55</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0108089522">
            <Name>Sulfasalazine</Name>
            <Formulation ID="F010808952225" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Brand ID="B01080895222525">
                <Name>Salazopyrin</Name>
                <Pack ID="P251615" Specified="true" nzmt:ctpp_id="50052851000117109">
                  <Quantity>100</Quantity>
                  <Price>16.52</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F010808952226" Rank="1" Units="tab" Weight="500">
              <Name>Tab EC 500 mg</Name>
              <Brand ID="B01080895222625">
                <Name>Salazopyrin EN</Name>
                <Pack ID="P251585" Specified="true" nzmt:ctpp_id="50052831000117104">
                  <Quantity>100</Quantity>
                  <Price>17.86</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0112">
        <Name>Local Preparations for Anal and Rectal Disorders</Name>
        <ATC3 ID="A011204">
          <Name>Antihaemorrhoidal Preparations</Name>
          <Chemical ID="C0112049386">
            <Name>Fluocortolone caproate with fluocortolone pivalate and cinchocaine</Name>
            <Formulation ID="F011204938625" Rank="3" Units="g">
              <Name>Oint 950 mcg with fluocortolone pivalate 920 mcg and cinchocaine hydrochloride 5 mg per g</Name>
              <Brand ID="B01120493862525">
                <Name>Ultraproct</Name>
                <Pack ID="P257451" Specified="true" nzmt:ctpp_id="50055951000117106">
                  <Quantity>30</Quantity>
                  <Price>13.05</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F011204938626" Rank="5" Units="supp">
              <Name>Suppos 630 mcg with fluocortolone pivalate 610 mcg and cinchocaine hydrochloride 1 mg</Name>
              <Brand ID="B01120493862625">
                <Name>Ultraproct</Name>
                <Pack ID="P257478" Specified="true" nzmt:ctpp_id="50055961000117108">
                  <Quantity>12</Quantity>
                  <Price>8.61</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0112049545">
            <Name>Cinchocaine hydrochloride with hydrocortisone</Name>
            <Formulation ID="F011204954525" Rank="3" Units="g">
              <Name>Oint 5 mg with hydrocortisone 5 mg per g</Name>
              <Brand ID="B01120495452525">
                <Name>Proctosedyl</Name>
                <Pack ID="P208388" Specified="true" nzmt:ctpp_id="50013821000117100">
                  <Quantity>30</Quantity>
                  <Price>15.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F011204954526" Rank="5" Units="supp">
              <Name>Suppos 5 mg with hydrocortisone 5 mg per g</Name>
              <Brand ID="B01120495452625">
                <Name>Proctosedyl</Name>
                <Pack ID="P208396" Specified="true" nzmt:ctpp_id="50013861000117109">
                  <Quantity>12</Quantity>
                  <Price>9.90</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A011206">
          <Name>Management of Anal Fissures</Name>
          <Chemical ID="C0112069024">
            <Name>Glyceryl trinitrate</Name>
            <Formulation ID="F011206902428" Rank="3" Units="g">
              <Name>Oint 0.2%</Name>
              <Brand ID="B01120690242825">
                <Name>Rectogesic</Name>
                <Pack ID="P2120313" Specified="true" nzmt:ctpp_id="50021721000117104">
                  <Quantity>30</Quantity>
                  <Price>22.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A011208">
          <Name>Rectal Sclerosants</Name>
          <Chemical ID="C0112088328">
            <Name>Oily phenol [Phenol oily]</Name>
            <Formulation ID="F011208832801" Rank="4" Units="inj">
              <Name>Inj 5%, 5 ml vial</Name>
              <Brand ID="B01120883280100">
                <Name>Any</Name>
                <Pack ID="P83280100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0116">
        <Name>Antispasmodics and Other Agents Altering Gut Motility</Name>
        <ATC3 ID="A011604">
          <Name>Antispasmodics and Other Agents Altering Gut Motility</Name>
          <Chemical ID="C0116048222">
            <Name>Hyoscine butylbromide</Name>
            <Formulation ID="F011604822201" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B01160482220126" PSS="true">
                <Name>Spazmol</Name>
                <Pack ID="P2656027" Specified="true" nzmt:ctpp_id="50315031000117106">
                  <Quantity>1</Quantity>
                  <Price>1.91</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F011604822202" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B01160482220226">
                <Name>Buscopan</Name>
                <Pack ID="P252328" Specified="true" nzmt:ctpp_id="50150341000117107">
                  <Quantity>100</Quantity>
                  <Price>6.35</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0116048519">
            <Name>Glycopyrronium bromide</Name>
            <Formulation ID="F011604851925" Rank="4" Units="inj" Weight="0.2">
              <Name>Inj 200 mcg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Sep-23 to~2025" Value="5"/>
              <Brand ID="B01160485192526" PSS="true">
                <Name>Robinul</Name>
                <Pack ID="P2254484" Specified="true" nzmt:ctpp_id="50040341000117102">
                  <Quantity>5</Quantity>
                  <Price>19.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0116049450">
            <Name>Mebeverine hydrochloride</Name>
            <Formulation ID="F011604945025" Rank="1" Units="tab" Weight="135">
              <Name>Tab 135 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B01160494502525" PSS="true">
                <Name>Colofac</Name>
                <Pack ID="P2535297" Specified="true" nzmt:ctpp_id="50097511000117100">
                  <Quantity>90</Quantity>
                  <Price>8.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0120">
        <Name>Antiulcerants</Name>
        <ATC3 ID="A012004">
          <Name>Antisecretory and Cytoprotective</Name>
          <Chemical ID="C0120048306">
            <Name>Misoprostol</Name>
            <Formulation ID="F012004830601" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mcg</Name>
              <Brand ID="B01200483060125">
                <Name>Cytotec</Name>
                <Pack ID="P561630" Specified="true" nzmt:ctpp_id="50096901000117108">
                  <Quantity>120</Quantity>
                  <Price>47.73</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A012008">
          <Name>H2 Antagonists</Name>
          <Chemical ID="C0120088099">
            <Name>Cimetidine</Name>
            <Formulation ID="F012008809901" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B01200880990100">
                <Name>Any</Name>
                <Pack ID="P80990100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012008809902" Rank="1" Units="tab" Weight="400">
              <Name>Tab 400 mg</Name>
              <Brand ID="B01200880990200">
                <Name>Any</Name>
                <Pack ID="P80990200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0120088646">
            <Name>Famotidine</Name>
            <Formulation ID="F012008864625" Rank="1" Units="tab">
              <Name>Tab 20 mg</Name>
              <Brand ID="B01200886462500">
                <Name>Any</Name>
                <Pack ID="P86462500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012008864626" Rank="1" Units="tab">
              <Name>Tab 40 mg</Name>
              <Brand ID="B01200886462600">
                <Name>Any</Name>
                <Pack ID="P86462600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012008864627" Rank="4" Units="inj">
              <Name>Inj 10 mg per ml, 4 ml vial</Name>
              <Brand ID="B01200886462700">
                <Name>Any</Name>
                <Pack ID="P86462700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012008864628" Rank="4" Units="inj">
              <Name>Inj 10 mg per ml, 2 ml vial</Name>
              <Brand ID="B01200886462800">
                <Name>Any</Name>
                <Pack ID="P86462800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0120089234">
            <Name>Ranitidine</Name>
            <Request Form="RS1703" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ranitidine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">For continuation use</ci>
                    <ci type="logical" class="Indication">Routine prevention of allergic reactions.</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1703" style="display:none"/>
            <Formulation ID="F012008923425" Rank="4" Units="inj" Weight="50">
              <Name>Inj 25 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B01200892342500">
                <Name>Any</Name>
                <Pack ID="P92342500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012008923426" Rank="1" Units="tab" Weight="150">
              <Name>Tab 150 mg</Name>
              <Brand ID="B01200892342600">
                <Name>Any</Name>
                <Pack ID="P92342600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012008923427" Rank="1" Units="tab" Weight="300">
              <Name>Tab 300 mg</Name>
              <Brand ID="B01200892342700">
                <Name>Any</Name>
                <Pack ID="P92342700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A012012">
          <Name>Proton Pump Inhibitors</Name>
          <Chemical ID="C0120129041">
            <Name>Omeprazole</Name>
            <Formulation ID="F012012904101" Rank="2" Units="cap" Weight="10">
              <Name>Cap 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B01201290410128" PSS="true">
                <Name>Omeprazole actavis 10</Name>
                <Pack ID="P2604930" Specified="true" nzmt:ctpp_id="50285801000117102">
                  <Quantity>90</Quantity>
                  <Price>2.06</Price>
                </Pack>
              </Brand>
              <Brand ID="B01201290410129">
                <Name>Omeprazole Teva</Name>
                <Pack ID="P2692155" Specified="true" nzmt:ctpp_id="50304051000117100">
                  <Quantity>90</Quantity>
                  <Price>2.06</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012012904102" Rank="2" Units="cap" Weight="20">
              <Name>Cap 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B01201290410228" PSS="true">
                <Name>Omeprazole actavis 20</Name>
                <Pack ID="P2604949" Specified="true" nzmt:ctpp_id="50285811000117104">
                  <Quantity>90</Quantity>
                  <Price>2.02</Price>
                </Pack>
              </Brand>
              <Brand ID="B01201290410229">
                <Name>Omeprazole Teva</Name>
                <Pack ID="P2692163" Specified="true" nzmt:ctpp_id="50304071000117108">
                  <Quantity>90</Quantity>
                  <Price>2.02</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012012904103" Rank="2" Units="cap" Weight="40">
              <Name>Cap 40 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B01201290410328" PSS="true">
                <Name>Omeprazole actavis 40</Name>
                <Pack ID="P2604957" Specified="true" nzmt:ctpp_id="50285821000117105">
                  <Quantity>90</Quantity>
                  <Price>3.18</Price>
                </Pack>
              </Brand>
              <Brand ID="B01201290410329">
                <Name>Omeprazole Teva</Name>
                <Pack ID="P2692171" Specified="true" nzmt:ctpp_id="50304091000117109">
                  <Quantity>90</Quantity>
                  <Price>3.18</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012012904104" Rank="4" Units="inj" Weight="40">
              <Name>Inj 40 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B01201290410426" PSS="true">
                <Name>Omezol IV</Name>
                <Pack ID="P2503387" Specified="true" nzmt:ctpp_id="50236891000117105">
                  <Quantity>5</Quantity>
                  <Price>11.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012012904105" Rank="4" Units="inj" Weight="40">
              <Name>Inj 40 mg ampoule with diluent</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B01201290410525" PSS="true">
                <Name>Dr Reddy's Omeprazole</Name>
                <Pack ID="P2310201" Specified="true" nzmt:ctpp_id="50046961000117102">
                  <Quantity>5</Quantity>
                  <Price>37.38</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012012904106" Rank="1" Units="tab" Weight="20">
              <Name>Tab dispersible 20 mg</Name>
              <Request Form="RS1027" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Omeprazole - Tab dispersible 20 mg</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">Only for use in tube-fed patients</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1027" style="display:none"/>
              <Brand ID="B01201290410600">
                <Name>Any</Name>
                <Pack ID="P90410600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012012904125" Rank="3" Units="g" Weight="5">
              <Name>Powder for oral liq</Name>
              <Brand ID="B01201290412525">
                <Name>Midwest</Name>
                <Pack ID="P2387085" Specified="true" nzmt:ctpp_id="50123501000117109">
                  <Quantity>5</Quantity>
                  <Price>42.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012012904126" Rank="1" Units="tab" Weight="10">
              <Name>Tab dispersible 10 mg</Name>
              <Request Form="RS1027" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Omeprazole - Tab dispersible 20 mg</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">Only for use in tube-fed patients</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1027" style="display:none"/>
              <Brand ID="B01201290412600">
                <Name>Any</Name>
                <Pack ID="P90412600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0120129301">
            <Name>Lansoprazole</Name>
            <Formulation ID="F012012930125" Rank="2" Units="cap" Weight="30">
              <Name>Cap 30 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B01201293012526" PSS="true">
                <Name>Lanzol Relief</Name>
                <Pack ID="P2482541" Specified="true" nzmt:ctpp_id="50184091000117102">
                  <Quantity>100</Quantity>
                  <Price>5.43</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012012930126" Rank="2" Units="cap" Weight="15">
              <Name>Cap 15 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B01201293012626" PSS="true">
                <Name>Lanzol Relief</Name>
                <Pack ID="P2482533" Specified="true" nzmt:ctpp_id="50183521000117106">
                  <Quantity>100</Quantity>
                  <Price>4.04</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0120129416">
            <Name>Pantoprazole</Name>
            <Formulation ID="F012012941625" Rank="1" Units="tab" Weight="20">
              <Name>Tab EC 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2025" Value="5"/>
              <Brand ID="B01201294162527" PSS="true">
                <Name>Panzop Relief</Name>
                <Pack ID="P2637146" Specified="true" nzmt:ctpp_id="50302351000117108">
                  <Quantity>90</Quantity>
                  <Price>1.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012012941626" Rank="1" Units="tab" Weight="40">
              <Name>Tab EC 40 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2025" Value="5"/>
              <Brand ID="B01201294162627" PSS="true">
                <Name>Panzop Relief</Name>
                <Pack ID="P2637154" Specified="true" nzmt:ctpp_id="50302361000117105">
                  <Quantity>90</Quantity>
                  <Price>2.74</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012012941627" Rank="4" Units="inj" Weight="40">
              <Name>Inj 40 mg vial</Name>
              <Brand ID="B01201294162700">
                <Name>Any</Name>
                <Pack ID="P94162700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A012016">
          <Name>Site Protective Agents</Name>
          <Chemical ID="C0120168448">
            <Name>Sucralfate</Name>
            <Formulation ID="F012016844801" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 g</Name>
              <Brand ID="B01201684480100">
                <Name>Any</Name>
                <Pack ID="P84480100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0120168588">
            <Name>Colloidal bismuth subcitrate</Name>
            <Formulation ID="F012016858825" Rank="1" Units="tab" Weight="120">
              <Name>Tab 120 mg</Name>
              <Brand ID="B01201685882525">
                <Name>Gastrodenol</Name>
                <Pack ID="P2501619" Specified="true" nzmt:ctpp_id="50234111000117102">
                  <Quantity>50</Quantity>
                  <Price>14.51</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0124">
        <Name>Bile and Liver Therapy</Name>
        <ATC3 ID="A012404">
          <Name>Bile and Liver Therapy</Name>
          <Chemical ID="C0124048251">
            <Name>L-ornithine L-aspartate</Name>
            <Request Form="RS1261" To="HealthPAC" For="Subsidy">
              <Title>
                <range>L-ornithine L-aspartate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For patients with chronic hepatic encephalopathy who have not responded to treatment with, or are intolerant to lactulose, or where lactulose is contraindicated</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1261" style="display:none"/>
            <Formulation ID="F012404825101" Rank="2" Units="sach">
              <Name>Grans for oral liquid 3 g</Name>
              <Brand ID="B01240482510100">
                <Name>Any</Name>
                <Pack ID="P82510100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0124048551">
            <Name>Rifaximin</Name>
            <Request Form="RS1416" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Rifaximin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For patients with hepatic encephalopathy despite an adequate trial of maximum tolerated doses of lactulose</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1416" style="display:none"/>
            <Formulation ID="F012404855125" Rank="1" Units="tab">
              <Name>Tab 550 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B01240485512525" PSS="true">
                <Name>Xifaxan</Name>
                <Pack ID="P2449935" Specified="true" nzmt:ctpp_id="50180541000117108">
                  <Quantity>56</Quantity>
                  <Price>625.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0128">
        <Name>Diabetes</Name>
        <ATC3 ID="A012804">
          <Name>Alpha Glucosidase Inhibitors</Name>
          <Chemical ID="C0128049475">
            <Name>Acarbose</Name>
            <Formulation ID="F012804947525" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B01280494752526" PSS="true">
                <Name>Accarb</Name>
                <Pack ID="P2402408" Specified="true" nzmt:ctpp_id="50145021000117105">
                  <Quantity>90</Quantity>
                  <Price>11.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012804947526" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B01280494752626" PSS="true">
                <Name>Accarb</Name>
                <Pack ID="P2402416" Specified="true" nzmt:ctpp_id="50145031000117108">
                  <Quantity>90</Quantity>
                  <Price>17.38</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A012808">
          <Name>Hyperglycaemic Agents</Name>
          <Chemical ID="C0128088203">
            <Name>Glucose with sucrose and fructose</Name>
            <Formulation ID="F012808820301" Rank="3" Units="ml">
              <Name>Gel 19.7% with sucrose 35% and fructose 19.7%, 18 g sachet</Name>
              <Brand ID="B01280882030100">
                <Name>Any</Name>
                <Pack ID="P82030100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0128089321">
            <Name>Glucose [Dextrose]</Name>
            <Formulation ID="F012808932101" Rank="3" Units="ml">
              <Name>Gel 40%</Name>
              <Brand ID="B01280893210100">
                <Name>Any</Name>
                <Pack ID="P93210100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012808932112" Rank="1" Units="tab" Weight="1.5">
              <Name>Tab 1.5 g</Name>
              <Brand ID="B01280893211200">
                <Name>Any</Name>
                <Pack ID="P93211200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012808932113" Rank="1" Units="tab" Weight="3.1">
              <Name>Tab 3.1 g</Name>
              <Brand ID="B01280893211300">
                <Name>Any</Name>
                <Pack ID="P93211300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012808932130" Rank="1" Units="tab" Weight="4">
              <Name>Tab 4 g</Name>
              <Brand ID="B01280893213000">
                <Name>Any</Name>
                <Pack ID="P93213000" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012808932139" Rank="2" Units="sach">
              <Name>Oral soln 15 g per 80 ml sachet</Name>
              <Brand ID="B01280893213925">
                <Name>HypoPak Glucose</Name>
                <Pack ID="P2616394" Specified="true" nzmt:ctpp_id="50289181000117100">
                  <Quantity>50</Quantity>
                  <Price>70.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0128089651">
            <Name>Glucagon hydrochloride</Name>
            <Formulation ID="F012808965125" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg syringe kit</Name>
              <Brand ID="B01280896512525">
                <Name>Glucagen Hypokit</Name>
                <Pack ID="P462519" Specified="true" nzmt:ctpp_id="50087831000117108">
                  <Quantity>1</Quantity>
                  <Price>32.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0128089682">
            <Name>Diazoxide</Name>
            <Request Form="RS1028" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Diazoxide</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For patients with confirmed hypoglycaemia caused by hyperinsulinism</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1028" style="display:none"/>
            <Formulation ID="F012808968225" Rank="2" Units="cap" Weight="25">
              <Name>Cap 25 mg</Name>
              <Brand ID="B01280896822525">
                <Name>Proglicem</Name>
                <Pack ID="P2434628" Specified="true" nzmt:ctpp_id="50164551000117100">
                  <Quantity>100</Quantity>
                  <Price>110.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012808968226" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Brand ID="B01280896822625">
                <Name>Proglicem</Name>
                <Pack ID="P2434601" Specified="true" nzmt:ctpp_id="50164561000117103">
                  <Quantity>100</Quantity>
                  <Price>280.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012808968227" Rank="3" Units="ml">
              <Name>Oral liq 50 mg per ml</Name>
              <Brand ID="B01280896822725">
                <Name>Proglycem</Name>
                <Pack ID="P2457849" Specified="true" nzmt:ctpp_id="50124441000117107">
                  <Quantity>30</Quantity>
                  <Price>620.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A012812">
          <Name>Insulin - Intermediate-Acting Preparations</Name>
          <Chemical ID="C0128128231">
            <Name>Insulin isophane</Name>
            <Formulation ID="F012812823101" Rank="4" Units="inj">
              <Name>Inj insulin human 100 u per ml, 10 ml vial</Name>
              <Brand ID="B01281282310100">
                <Name>Any</Name>
                <Pack ID="P82310100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012812823102" Rank="4" Units="inj">
              <Name>Inj insulin human 100 u per ml, 3 ml cartridge</Name>
              <Brand ID="B01281282310200">
                <Name>Any</Name>
                <Pack ID="P82310200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0128128234">
            <Name>Insulin neutral with insulin isophane</Name>
            <Formulation ID="F012812823401" Rank="4" Units="inj">
              <Name>Inj insulin neutral 30% with insulin isophane 70%, 100 u per ml, 10 ml vial</Name>
              <Brand ID="B01281282340100">
                <Name>Any</Name>
                <Pack ID="P82340100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012812823402" Rank="4" Units="inj">
              <Name>Inj insulin neutral 30% with insulin isophane 70%, 100 u per ml, 3 ml cartridge</Name>
              <Brand ID="B01281282340200">
                <Name>Any</Name>
                <Pack ID="P82340200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012812823403" Rank="4" Units="inj">
              <Name>Inj insulin neutral 40% with insulin isophane 60%, 100 u per ml, 3 ml cartridge</Name>
              <Brand ID="B01281282340300">
                <Name>Any</Name>
                <Pack ID="P82340300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012812823404" Rank="4" Units="inj">
              <Name>Inj insulin neutral 50% with insulin isophane 50%, 100 u per ml, 3 ml cartridge</Name>
              <Brand ID="B01281282340400">
                <Name>Any</Name>
                <Pack ID="P82340400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0128129462">
            <Name>Insulin lispro with insulin lispro protamine</Name>
            <Formulation ID="F012812946225" Rank="4" Units="inj" Weight="300">
              <Name>Inj insulin lispro 50% with insulin lispro protamine 50%, 100 u per ml, 3 ml cartridge</Name>
              <Brand ID="B01281294622525">
                <Name>Humalog Mix 50</Name>
                <Pack ID="P2235854" Specified="true" nzmt:ctpp_id="50037571000117100">
                  <Quantity>5</Quantity>
                  <Price>42.66</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012812946226" Rank="4" Units="inj" Weight="300">
              <Name>Inj insulin lispro 25% with insulin lispro protamine 75%, 100 u per ml, 3 ml cartridge</Name>
              <Brand ID="B01281294622625">
                <Name>Humalog Mix 25</Name>
                <Pack ID="P2011050" Specified="true" nzmt:ctpp_id="50001291000117101">
                  <Quantity>5</Quantity>
                  <Price>42.66</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0128129652">
            <Name>Insulin aspart with insulin aspart protamine</Name>
            <Formulation ID="F012812965225" Rank="4" Units="inj">
              <Name>Inj insulin aspart 30% with insulin aspart protamine 70%, 100 u per ml, 3 ml prefilled pen</Name>
              <Brand ID="B01281296522525">
                <Name>NovoMix 30 FlexPen</Name>
                <Pack ID="P2404303" Specified="true" nzmt:ctpp_id="50134921000117109">
                  <Quantity>5</Quantity>
                  <Price>52.15</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A012816">
          <Name>Insulin - Long-Acting Preparations</Name>
          <Chemical ID="C0128169308">
            <Name>Insulin glargine</Name>
            <Formulation ID="F012816930801" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 u per ml, 3 ml disposable pen</Name>
              <Brand ID="B01281693080125">
                <Name>Lantus SoloStar</Name>
                <Pack ID="P2275406" Specified="true" nzmt:ctpp_id="50043201000117101">
                  <Quantity>5</Quantity>
                  <Price>94.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012816930825" Rank="4" Units="inj" Weight="300">
              <Name>Inj 100 u per ml, 3 ml cartridge</Name>
              <Brand ID="B01281693082525">
                <Name>Lantus</Name>
                <Pack ID="P2146754" Specified="true" nzmt:ctpp_id="50025291000117108">
                  <Quantity>5</Quantity>
                  <Price>94.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012816930826" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 100 u per ml, 10 ml vial</Name>
              <Brand ID="B01281693082625">
                <Name>Lantus</Name>
                <Pack ID="P2146746" Specified="true" nzmt:ctpp_id="50025281000117105">
                  <Quantity>1</Quantity>
                  <Price>63.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A012820">
          <Name>Insulin - Rapid-Acting Preparations</Name>
          <Chemical ID="C0128208230">
            <Name>Insulin aspart</Name>
            <Formulation ID="F012820823001" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 u per ml, 10 ml vial</Name>
              <Brand ID="B01282082300100">
                <Name>Any</Name>
                <Pack ID="P82300100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012820823002" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 u per ml, 3 ml cartridge</Name>
              <Brand ID="B01282082300200">
                <Name>Any</Name>
                <Pack ID="P82300200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012820823025" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 u per ml, 3 ml syringe</Name>
              <Brand ID="B01282082302525">
                <Name>NovoRapid FlexPen</Name>
                <Pack ID="P2469952" Specified="true" nzmt:ctpp_id="50216791000117109">
                  <Quantity>5</Quantity>
                  <Price>51.19</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0128208232">
            <Name>Insulin lispro</Name>
            <Formulation ID="F012820823201" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 u per ml, 10 ml vial</Name>
              <Brand ID="B01282082320100">
                <Name>Any</Name>
                <Pack ID="P82320100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012820823202" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 u per ml, 3 ml cartridge</Name>
              <Brand ID="B01282082320200">
                <Name>Any</Name>
                <Pack ID="P82320200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0128209546">
            <Name>Insulin glulisine</Name>
            <Formulation ID="F012820954601" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 u per ml, 10 ml vial</Name>
              <Brand ID="B01282095460125">
                <Name>Apidra</Name>
                <Pack ID="P2317109" Specified="true" nzmt:ctpp_id="50048271000117103">
                  <Quantity>1</Quantity>
                  <Price>27.03</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012820954602" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 u per ml, 3 ml cartridge</Name>
              <Brand ID="B01282095460225">
                <Name>Apidra</Name>
                <Pack ID="P2361620" Specified="true" nzmt:ctpp_id="50000341000117106">
                  <Quantity>5</Quantity>
                  <Price>46.07</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012820954603" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 u per ml, 3 ml disposable pen</Name>
              <Brand ID="B01282095460325">
                <Name>Apidra Solostar</Name>
                <Pack ID="P2316870" Specified="true" nzmt:ctpp_id="50048231000117101">
                  <Quantity>5</Quantity>
                  <Price>46.07</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A012824">
          <Name>Insulin - Short-Acting Preparations</Name>
          <Chemical ID="C0128248233">
            <Name>Insulin neutral</Name>
            <Formulation ID="F012824823301" Rank="4" Units="inj">
              <Name>Inj human 100 u per ml, 10 ml vial</Name>
              <Brand ID="B01282482330100">
                <Name>Any</Name>
                <Pack ID="P82330100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012824823302" Rank="4" Units="inj">
              <Name>Inj human 100 u per ml, 3 ml cartridge</Name>
              <Brand ID="B01282482330200">
                <Name>Any</Name>
                <Pack ID="P82330200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A012828">
          <Name>Oral Hypoglycaemic Agents</Name>
          <Chemical ID="C0128288202">
            <Name>Glibenclamide</Name>
            <Formulation ID="F012828820201" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B01282882020125">
                <Name>Daonil</Name>
                <Pack ID="P203106" Specified="true" nzmt:ctpp_id="50005871000117103">
                  <Quantity>100</Quantity>
                  <Price>7.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0128288628">
            <Name>Vildagliptin</Name>
            <Formulation ID="F012828862825" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B01282886282525">
                <Name>Galvus</Name>
                <Pack ID="P2455161" Specified="true" nzmt:ctpp_id="50201901000117107">
                  <Quantity>60</Quantity>
                  <Price>35.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0128288629">
            <Name>Vildagliptin with metformin hydrochloride</Name>
            <Formulation ID="F012828862925" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg with 850 mg metformin hydrochloride</Name>
              <Brand ID="B01282886292525">
                <Name>Galvumet</Name>
                <Pack ID="P2554801" Specified="true" nzmt:ctpp_id="50258071000117104">
                  <Quantity>60</Quantity>
                  <Price>35.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012828862926" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg with 1,000 mg metformin hydrochloride</Name>
              <Brand ID="B01282886292625">
                <Name>Galvumet</Name>
                <Pack ID="P2554828" Specified="true" nzmt:ctpp_id="50258011000117106">
                  <Quantity>60</Quantity>
                  <Price>35.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0128289218">
            <Name>Metformin hydrochloride</Name>
            <Formulation ID="F012828921825" Rank="1" Units="tab" Weight="500">
              <Name>Tab immediate-release 500 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2027" Value="1"/>
              <Brand ID="B01282892182530" HSS="true">
                <Name>Metformin Viatris</Name>
                <Pack ID="P2628031" Specified="true" nzmt:ctpp_id="50291171000117103">
                  <Quantity>1000</Quantity>
                  <Price>14.74</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012828921826" Rank="1" Units="tab" Weight="850">
              <Name>Tab immediate-release 850 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-23 to~2027" Value="1"/>
              <Brand ID="B01282892182629" HSS="true">
                <Name>Metformin Viatris</Name>
                <Pack ID="P2628058" Specified="true" nzmt:ctpp_id="50291341000117107">
                  <Quantity>500</Quantity>
                  <Price>11.28</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0128289223">
            <Name>Pioglitazone</Name>
            <Formulation ID="F012828922325" Rank="1" Units="tab" Weight="15">
              <Name>Tab 15 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B01282892232527" PSS="true">
                <Name>Vexazone</Name>
                <Pack ID="P2479435" Specified="true" nzmt:ctpp_id="50224121000117106">
                  <Quantity>90</Quantity>
                  <Price>6.15</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012828922326" Rank="1" Units="tab" Weight="30">
              <Name>Tab 30 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B01282892232627" PSS="true">
                <Name>Vexazone</Name>
                <Pack ID="P2479443" Specified="true" nzmt:ctpp_id="50224131000117109">
                  <Quantity>90</Quantity>
                  <Price>7.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012828922327" Rank="1" Units="tab" Weight="45">
              <Name>Tab 45 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B01282892232727" PSS="true">
                <Name>Vexazone</Name>
                <Pack ID="P2479451" Specified="true" nzmt:ctpp_id="50224141000117101">
                  <Quantity>90</Quantity>
                  <Price>12.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0128289432">
            <Name>Gliclazide</Name>
            <Formulation ID="F012828943225" Rank="1" Units="tab" Weight="80">
              <Name>Tab 80 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B01282894322526" PSS="true">
                <Name>Glizide</Name>
                <Pack ID="P2280647" Specified="true" nzmt:ctpp_id="50209001000117107">
                  <Quantity>500</Quantity>
                  <Price>20.10</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0128289433">
            <Name>Glipizide</Name>
            <Formulation ID="F012828943325" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B01282894332525" PSS="true">
                <Name>Minidiab</Name>
                <Pack ID="P2091755" Specified="true" nzmt:ctpp_id="50017481000117105">
                  <Quantity>100</Quantity>
                  <Price>6.86</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A012830">
          <Name>GLP-1 Agonists</Name>
          <Chemical ID="C0128308677">
            <Name>Dulaglutide</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p><strong>Restricted:</strong> For continuation only. </p>
              <p>Note: Not to be given in combination with a funded SGLT-2 inhibitor or other GLP-1 agonist.</p>
            </div>
            <Formulation ID="F012830867725" Rank="10" Units="dev" Weight="1">
              <Name> Inj 1.5 mg per 0.5 ml prefilled pen</Name>
              <Brand ID="B01283086772525">
                <Name>Trulicity</Name>
                <Pack ID="P2617722" Specified="true" nzmt:ctpp_id="50278501000117100">
                  <Quantity>4</Quantity>
                  <Price>115.23</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0128308711">
            <Name>Liraglutide</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p><strong>Restricted:</strong> For continuation only. </p>
              <p>Note: Not to be given in combination with a funded SGLT-2 inhibitor or other GLP-1 agonist.</p>
            </div>
            <Formulation ID="F012830871125" Rank="4" Units="inj">
              <Name>Inj 6 mg per ml, 3 ml prefilled pen</Name>
              <Brand ID="B01283087112525">
                <Name>Victoza</Name>
                <Pack ID="P2653990" Specified="true" nzmt:ctpp_id="50245461000117105">
                  <Quantity>3</Quantity>
                  <Price>383.72</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A012832">
          <Name>SGLT2 Inhibitors </Name>
          <Request Form="RS1852" To="HealthPAC" For="Subsidy">
            <Title>
              <range>Empagliflozin</range>
              <range>Empagliflozin with metformin hydrochloride</range>
            </Title>
            <Case When="Initial application">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <or/>
                  <ci type="logical" class="Indication">For continuation use</ci>
                  <ci type="logical" class="Indication">Patient has previously had an initial approval for a GLP-1 agonist</ci>
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has type 2 diabetes</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient is Māori or any Pacific
                            ethnicity*</ci>
                      <ci type="logical" class="Indication">Patient has pre-existing
                            cardiovascular disease or risk equivalent (see note a)*</ci>
                      <ci type="logical" class="Indication">Patient has an absolute 5-year
                            cardiovascular disease risk of 15% or greater according to a validated
                            cardiovascular risk assessment calculator*</ci>
                      <ci type="logical" class="Indication">Patient has a high lifetime
                            cardiovascular risk due to being diagnosed with type 2 diabetes during
                            childhood or as a young adult*</ci>
                      <ci type="logical" class="Indication">Patient has diabetic kidney
                            disease (see note b)*</ci>
                    </apply>
                    <ci type="logical" class="Indication">Target HbA1c (of 53 mmol/mol or less) has
                        not been achieved despite the regular use of at least one blood-glucose
                        lowering agent (e.g. metformin, vildagliptin, or insulin) for at least 3
                        months</ci>
                  </apply>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>* Criteria intended to describe patients at high risk of cardiovascular or renal
                complications of diabetes.</p>
                <ol style="list-style-type: lower-alpha">
                  <li>
                    <p>Pre-existing cardiovascular disease or risk equivalent defined as: prior cardiovascular disease event
                        (i.e. angina, myocardial infarction, percutaneous coronary intervention,
                        coronary artery bypass grafting, transient ischaemic attack, ischaemic
                        stroke, peripheral vascular disease), congestive heart failure or familial
                        hypercholesterolaemia.</p>
                  </li>
                  <li>
                    <p>Diabetic kidney disease defined as: persistent albuminuria
                        (albumin:creatinine ratio greater than or equal to 3 mg/mmol, in at least
                        two out of three samples over a 3-6 month period) and/or eGFR less than 60
                        mL/min/1.73m2 in the presence of diabetes, without alternative cause.</p>
                  </li>
                </ol>
              </div>
            </Case>
          </Request>
          <html:div class="Restricted" xlink:href="RS1852" style="display:none"/>
          <Chemical ID="C0128328664">
            <Name>Empagliflozin</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: Not to be given in combination with a funded GLP-1 agonist.</p>
            </div>
            <Formulation ID="F012832866425" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B01283286642525">
                <Name>Jardiance</Name>
                <Pack ID="P2599694" Specified="true" nzmt:ctpp_id="50205351000117105">
                  <Quantity>30</Quantity>
                  <Price>58.56</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012832866426" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Brand ID="B01283286642625">
                <Name>Jardiance</Name>
                <Pack ID="P2599708" Specified="true" nzmt:ctpp_id="50205371000117102">
                  <Quantity>30</Quantity>
                  <Price>58.56</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0128328665">
            <Name>Empagliflozin with metformin hydrochloride</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: Not to be given in combination with a funded GLP-1 agonist.</p>
            </div>
            <Formulation ID="F012832866525" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg with 500 mg metformin hydrochloride</Name>
              <Brand ID="B01283286652525">
                <Name>Jardiamet</Name>
                <Pack ID="P2599716" Specified="true" nzmt:ctpp_id="50225021000117109">
                  <Quantity>60</Quantity>
                  <Price>58.56</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012832866526" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg with 1,000 mg metformin hydrochloride</Name>
              <Brand ID="B01283286652625">
                <Name>Jardiamet</Name>
                <Pack ID="P2599724" Specified="true" nzmt:ctpp_id="50225041000117104">
                  <Quantity>60</Quantity>
                  <Price>58.56</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012832866527" Rank="1" Units="tab" Weight="12">
              <Name>Tab 12.5 mg with 500 mg metformin hydrochloride</Name>
              <Brand ID="B01283286652725">
                <Name>Jardiamet</Name>
                <Pack ID="P2599732" Specified="true" nzmt:ctpp_id="50225051000117102">
                  <Quantity>60</Quantity>
                  <Price>58.56</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F012832866528" Rank="1" Units="tab" Weight="12">
              <Name>Tab 12.5 mg with 1,000 mg metformin hydrochloride</Name>
              <Brand ID="B01283286652825">
                <Name>Jardiamet</Name>
                <Pack ID="P2599740" Specified="true" nzmt:ctpp_id="50225071000117105">
                  <Quantity>60</Quantity>
                  <Price>58.56</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0132">
        <Name>Digestives Including Enzymes</Name>
        <ATC3 ID="A013204">
          <Name>Digestives Including Enzymes</Name>
          <Chemical ID="C0132048340">
            <Name>Pancreatic enzyme</Name>
            <Formulation ID="F013204834001" Rank="2" Units="cap" Weight="25000">
              <Name>Cap pancreatin 150 mg (amylase 8,000 Ph Eur U, lipase 10,000 Ph Eur U, total protease 600 Ph Eur U)</Name>
              <Brand ID="B01320483400125">
                <Name>Creon 10000</Name>
                <Pack ID="P2535300" Specified="true" nzmt:ctpp_id="50119241000117102">
                  <Quantity>100</Quantity>
                  <Price>34.93</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F013204834002" Rank="2" Units="cap" Weight="25000">
              <Name>Cap pancreatin 300 mg (amylase 18,000 Ph Eur U, lipase 25,000 Ph Eur U, total protease 1,000 Ph Eur U) </Name>
              <Brand ID="B01320483400225">
                <Name>Creon 25000</Name>
                <Pack ID="P2535319" Specified="true" nzmt:ctpp_id="50195611000117104">
                  <Quantity>100</Quantity>
                  <Price>94.38</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F013204834003" Rank="2" Units="cap" Weight="25000">
              <Name>Cap pancreatin (175 mg (25,000 U lipase, 22,500 U amylase, 1,250 U protease)) </Name>
              <Brand ID="B01320483400300">
                <Name>Any</Name>
                <Pack ID="P83400300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F013204834004" Rank="3" Units="g" Weight="25000">
              <Name>Powder pancreatin 60.12 mg (3,600 Ph. Eur. u/amylase, 5,000 Ph. Eur. u/lipase and 200 Ph. Eur. u/protease)</Name>
              <Brand ID="B01320483400400">
                <Name>Any</Name>
                <Pack ID="P83400400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F013204834025" Rank="3" Units="g">
              <Name>Modified release granules pancreatin 60.12 mg (amylase 3,600 Ph Eur U, lipase 5,000 Ph Eur U, protease 200 Ph Eur U)</Name>
              <Brand ID="B01320483402525">
                <Name>Creon Micro</Name>
                <Pack ID="P2577550" Specified="true" nzmt:ctpp_id="50201531000117106">
                  <Quantity>20</Quantity>
                  <Price>34.93</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0132049281">
            <Name>Ursodeoxycholic acid</Name>
            <Request Form="RS1824" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ursodeoxycholic acid</range>
              </Title>
              <Case When="Initial application" Category="Alagille syndrome or progressive familial intrahepatic cholestasis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Patient has been diagnosed with Alagille syndrome</ci>
                    <ci type="logical">Patient has progressive familial intrahepatic cholestasis</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Chronic severe drug induced cholestatic liver injury ">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has chronic severe drug induced cholestatic liver injury</ci>
                    <ci type="logical">Cholestatic liver injury not due to Total Parenteral Nutrition (TPN) use in adults</ci>
                    <ci type="logical">Treatment with ursodeoxycholic acid may prevent hospital admission or reduce duration of stay</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Primary biliary cholangitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Primary biliary cholangitis confirmed by antimitochondrial antibody titre (AMA) &gt; 1:80, and raised  cholestatic liver enzymes with or without raised serum IgM or, if AMA is negative by liver biopsy</ci>
                    <ci type="logical">Patient not requiring a liver transplant (bilirubin &gt; 100 umol/l; decompensated cirrhosis</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Pregnancy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient diagnosed with cholestasis of pregnancy</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Haematological transplant">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient at risk of veno-occlusive disease or has hepatic impairment and is undergoing conditioning treatment  prior to allogenic stem cell or bone marrow transplantation</ci>
                    <ci type="logical">Treatment for up to 13 weeks</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Total parenteral nutrition induced cholestasis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Paediatric patient has developed abnormal liver function as indicated on testing which is likely to be  induced by TPN</ci>
                    <ci type="logical">Liver function has not improved with modifying the TPN composition</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="prevention of sinusoidal obstruction syndrome">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient is enrolled in the Children’s Oncology Group AALL1732 trial</ci>
                    <ci type="logical">The patient has leukaemia/lymphoma and is receiving inotuzumab ozogamicin</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1824" style="display:none"/>
            <Formulation ID="F013204928126" Rank="2" Units="cap" Weight="100">
              <Name>Cap 250 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B01320492812625" PSS="true">
                <Name>Ursosan</Name>
                <Pack ID="P2397528" Specified="true" nzmt:ctpp_id="50128171000117100">
                  <Quantity>100</Quantity>
                  <Price>33.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0136">
        <Name>Laxatives</Name>
        <ATC3 ID="A013604">
          <Name>Bowel-Cleansing Preparations</Name>
          <Chemical ID="C0136048101">
            <Name>Citric acid with magnesium carbonate hydrate and sodium picosulfate</Name>
            <Formulation ID="F013604810101" Rank="3" Units="g">
              <Name>Powder for oral soln 12 g with magnesium carbonate hydrate 7.4 g and sodium picosulfate 10 mg per sachet</Name>
              <Brand ID="B01360481010100">
                <Name>e.g. PicoPrep Orange</Name>
                <Pack ID="P81010100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0136048272">
            <Name>Macrogol 3350 with potassium chloride and sodium chloride</Name>
            <Formulation ID="F013604827202" Rank="2" Units="sach">
              <Name>Powder for oral soln 755.68 mg with potassium chloride 10.55 mg, sodium chloride 37.33 mg and sodium sulphate 80.62 mg per g, 70 g sachet</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B01360482720226" PSS="true">
                <Name>Glycoprep Orange</Name>
                <Pack ID="P2637987" Specified="true" nzmt:ctpp_id="50272691000117107">
                  <Quantity>3</Quantity>
                  <Price>16.10</Price>
                </Pack>
                <Pack ID="P2637995" Specified="true" nzmt:ctpp_id="50272701000117107">
                  <Quantity>12</Quantity>
                  <Price>64.32</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F013604827225" Rank="3" Units="g">
              <Name>Powder for oral soln 755.68 mg with potassium chloride 10.55 mg, sodium chloride 37.33 mg and sodium sulphate  80.62 mg per g, 210 g sachet</Name>
              <Brand ID="B01360482722500">
                <Name>e.g. Glycoprep Orange</Name>
                <Pack ID="P82722500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0136048676">
            <Name>Macrogol 3350 with ascorbic acid, potassium chloride, sodium chloride and citric acid with magnesium carbonate hydrate and sodium picosulfate</Name>
            <Formulation ID="F013604867626" Rank="10" Units="each">
              <Name>Powder for oral soln 52.9 g with ascorbic acid 6 g, potassium chloride 740 mg, sodium chloride 2.6 g and sodium sulphate 5.6 g per sachet (1) and powder for oral soln citric acid 12 g with magnesium carbonate hydrate 7.4 g and sodium picosulfate 10 mg per sachet (2)</Name>
              <Brand ID="B01360486762600">
                <Name>e.g. Prepkit Orange</Name>
                <Pack ID="P86762600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0136048715">
            <Name>Macrogol 3350 with potassium chloride and sodium chloride with/without sodium sulfate, sodium ascorbate, ascorbic acid</Name>
            <Formulation ID="F013604871525" Rank="2" Units="sach">
              <Name>Powd for oral soln 100g with potassium chloride 1g, sodium chloride 2g and sodium sulfate 9g per sach(1), powd for oral soln 40g with potassium chloride 1.2g and sodium chloride 3.2g per sach(1) and powd for oral soln ascorbic acid 7.54g and sodium ascorbate 48.11g per sach(1)</Name>
              <Rule Type="DVLimit" Attribute="Oct-23 to~2026" Value="5"/>
              <Brand ID="B01360487152525" PSS="true">
                <Name>Plenvu</Name>
                <Pack ID="P2569671" Specified="true" nzmt:ctpp_id="50238441000117102">
                  <Quantity>3</Quantity>
                  <Price>18.52</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A013608">
          <Name>Bulk-Forming Agents</Name>
          <Chemical ID="C0136088247">
            <Name>Ispaghula (psyllium) husk</Name>
            <Formulation ID="F013608824701" Rank="3" Units="g">
              <Name>Powder for oral soln</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B01360882470125" PSS="true">
                <Name>Konsyl-D</Name>
                <Pack ID="P2358727" Specified="true" nzmt:ctpp_id="50000351000117108">
                  <Quantity>500</Quantity>
                  <Price>20.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0136088446">
            <Name>Sterculia with frangula</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F013608844601" Rank="3" Units="g">
              <Name>Powder for oral soln</Name>
              <Brand ID="B01360884460100">
                <Name>Any</Name>
                <Pack ID="P84460100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A013612">
          <Name>Faecal Softeners</Name>
          <Chemical ID="C0136129182">
            <Name>Docusate sodium with sennosides</Name>
            <Formulation ID="F013612918225" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg with sennosides 8 mg</Name>
              <Rule Type="DVLimit" Attribute="Nov-22 to~2025" Value="5"/>
              <Brand ID="B01361291822525" PSS="true">
                <Name>Laxsol</Name>
                <Pack ID="P2069482" Specified="true" nzmt:ctpp_id="50011761000117100">
                  <Quantity>200</Quantity>
                  <Price>3.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0136129453">
            <Name>Poloxamer</Name>
            <Formulation ID="F013612945325" Rank="3" Units="ml">
              <Name>Oral drops 10%</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B01361294532525" PSS="true">
                <Name>Coloxyl</Name>
                <Pack ID="P252816" Specified="true" nzmt:ctpp_id="50053541000117104">
                  <Quantity>30</Quantity>
                  <Price>4.17</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0136129495">
            <Name>Paraffin</Name>
            <Formulation ID="F013612949501" Rank="10" Units="enema">
              <Name>Enema 133 ml</Name>
              <Brand ID="B01361294950100">
                <Name>Any</Name>
                <Pack ID="P94950100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F013612949504" Rank="3" Units="ml">
              <Name>Oral liquid 1 mg per ml</Name>
              <Brand ID="B01361294950400">
                <Name>Any</Name>
                <Pack ID="P94950400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0136129530">
            <Name>Docusate sodium</Name>
            <Formulation ID="F013612953027" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B01361295302725" PSS="true">
                <Name>Coloxyl</Name>
                <Pack ID="P252832" Specified="true" nzmt:ctpp_id="50053561000117100">
                  <Quantity>100</Quantity>
                  <Price>3.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F013612953028" Rank="1" Units="tab" Weight="120">
              <Name>Tab 120 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B01361295302825" PSS="true">
                <Name>Coloxyl</Name>
                <Pack ID="P252859" Specified="true" nzmt:ctpp_id="50053581000117108">
                  <Quantity>100</Quantity>
                  <Price>4.98</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A013614">
          <Name>Opioid Receptor Antagonists - Peripheral</Name>
          <Chemical ID="C0136148614">
            <Name>Methylnaltrexone bromide</Name>
            <Request Form="RS1601" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Methylnaltrexone bromide</range>
              </Title>
              <Case When="Initial application" Category="Opioid induced constipation">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The patient is receiving palliative care</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Oral and rectal treatments for opioid induced constipation are ineffective</ci>
                      <ci type="logical" class="Indication">Oral and rectal treatments for opioid induced constipation are unable to be tolerated</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1601" style="display:none"/>
            <Formulation ID="F013614861425" Rank="4" Units="inj" Weight="12">
              <Name>Inj 12 mg per 0.6 ml vial</Name>
              <Brand ID="B01361486142525">
                <Name>Relistor</Name>
                <Pack ID="P2536196" Specified="true" nzmt:ctpp_id="50186941000117100">
                  <Quantity>1</Quantity>
                  <Price>36.00</Price>
                </Pack>
                <Pack ID="P2536218" Specified="true" nzmt:ctpp_id="50186961000117101">
                  <Quantity>7</Quantity>
                  <Price>246.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A013616">
          <Name>Osmotic Laxatives</Name>
          <Chemical ID="C0136168434">
            <Name>Sodium phosphate with phosphoric acid</Name>
            <Formulation ID="F013616843401" Rank="10" Units="enema">
              <Name>Enema 10% with phosphoric acid 6.58%</Name>
              <Brand ID="B01361684340125">
                <Name>Fleet Phosphate Enema</Name>
                <Pack ID="P267430" Specified="true" nzmt:ctpp_id="50059401000117104">
                  <Quantity>1</Quantity>
                  <Price>2.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F013616843402" Rank="3" Units="ml">
              <Name>Oral liq 16.4% with phosphoric acid 25.14%</Name>
              <Brand ID="B01361684340200">
                <Name>Any</Name>
                <Pack ID="P84340200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0136169173">
            <Name>Sodium citrate with sodium lauryl sulphoacetate</Name>
            <Formulation ID="F013616917325" Rank="10" Units="enema">
              <Name>Enema 90 mg with sodium lauryl sulphoacetate 9 mg per ml, 5 ml</Name>
              <Rule Type="DVLimit" Attribute="Jun-23 to~2025" Value="5"/>
              <Brand ID="B01361691732526" PSS="true">
                <Name>Micolette</Name>
                <Pack ID="P2262673" Specified="true" nzmt:ctpp_id="50041551000117101">
                  <Quantity>50</Quantity>
                  <Price>35.89</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0136169387">
            <Name>Glycerol</Name>
            <Formulation ID="F013616938727" Rank="5" Units="supp">
              <Name>Suppos 2.8/4.0 g</Name>
              <Rule Type="DVLimit" Attribute="Feb-23 to~2025" Value="5"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to glycerol suppository presentations.</p>
              </div>
              <Brand ID="B01361693872725" PSS="true">
                <Name>Lax-suppositories Glycerol</Name>
                <Pack ID="P2637103" Specified="true" nzmt:ctpp_id="50278581000117107">
                  <Quantity>20</Quantity>
                  <Price>10.39</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0136169408">
            <Name>Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride</Name>
            <Formulation ID="F013616940801" Rank="2" Units="sach" Weight="6563">
              <Name>Powder for oral soln 6.563 g with potassium chloride 23.3 mg, sodium bicarbonate 89.3 mg and sodium chloride 175.4 mg</Name>
              <Brand ID="B01361694080100">
                <Name>Any</Name>
                <Pack ID="P94080100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F013616940825" Rank="2" Units="sach" Weight="13125">
              <Name>Powder for oral soln 13.125 g with potassium chloride 46.6 mg, sodium bicarbonate 178.5 mg and sodium chloride 350.7 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B01361694082527" PSS="true">
                <Name>Molaxole</Name>
                <Pack ID="P2519887" Specified="true" nzmt:ctpp_id="50192031000117106">
                  <Quantity>30</Quantity>
                  <Price>8.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0136169412">
            <Name>Lactulose</Name>
            <Formulation ID="F013616941225" Rank="3" Units="ml">
              <Name>Oral liq 10 g per 15 ml</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B01361694122526" PSS="true">
                <Name>Laevolac</Name>
                <Pack ID="P2440210" Specified="true" nzmt:ctpp_id="50074861000117103">
                  <Quantity>500</Quantity>
                  <Price>3.61</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A013620">
          <Name>Stimulant Laxatives</Name>
          <Chemical ID="C0136208413">
            <Name>Sennosides</Name>
            <Formulation ID="F013620841301" Rank="1" Units="tab" Weight="7.5">
              <Name>Tab 7.5 mg</Name>
              <Brand ID="B01362084130100">
                <Name>Any</Name>
                <Pack ID="P84130100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0136208672">
            <Name>Sodium picosulfate</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1843">
              <Title>
                <range>sodium picosulfate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient is a child with problematic constipation despite an adequate trial of other oral pharmacotherapies including macrogol where practicable</ci>
                    <ci type="logical">The patient would otherwise require a high-volume bowel cleansing preparation</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1843" style="display:none"/>
            <Formulation ID="F013620867225" Rank="3" Units="ml" Weight="7">
              <Name>Oral soln 7.5 mg per ml</Name>
              <Brand ID="B01362086722525">
                <Name>Dulcolax SP Drop</Name>
                <Pack ID="P2555611" Specified="true" nzmt:ctpp_id="50225981000117107">
                  <Quantity>30</Quantity>
                  <Price>7.40</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0136209136">
            <Name>Bisacodyl</Name>
            <Formulation ID="F013620913625" Rank="5" Units="supp" Weight="10">
              <Name>Suppos 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B01362091362527" PSS="true">
                <Name>Lax-Suppositories</Name>
                <Pack ID="P2485397" Specified="true" nzmt:ctpp_id="50278251000117103">
                  <Quantity>10</Quantity>
                  <Price>4.14</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F013620913626" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B01362091362627" PSS="true">
                <Name>Bisacodyl Viatris</Name>
                <Pack ID="P2631881" Specified="true" nzmt:ctpp_id="50299011000117107">
                  <Quantity>200</Quantity>
                  <Price>5.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0140">
        <Name>Metabolic Disorder Agents</Name>
        <ATC3 ID="A014004">
          <Name>Metabolic Disorder Agents</Name>
          <Chemical ID="C0140048036">
            <Name>Arginine</Name>
            <Formulation ID="F014004803603" Rank="4" Units="inj" Weight="600">
              <Name>Inj 600 mg per ml, 25 ml vial</Name>
              <Brand ID="B01400480360300">
                <Name>Any</Name>
                <Pack ID="P80360300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004803604" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B01400480360400">
                <Name>Any</Name>
                <Pack ID="P80360400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004803625" Rank="4" Units="inj">
              <Name>Inj 500 mg per ml, 10 ml vial</Name>
              <Brand ID="B01400480362500">
                <Name>Any</Name>
                <Pack ID="P80362500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004803626" Rank="1" Units="tab" Weight="1000">
              <Name>Tab 1,000 mg</Name>
              <Brand ID="B01400480362600">
                <Name>Any</Name>
                <Pack ID="P80362600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004803627" Rank="2" Units="cap" Weight="500">
              <Name>Cap 500 mg</Name>
              <Brand ID="B01400480362700">
                <Name>Any</Name>
                <Pack ID="P80362700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048050">
            <Name>Betaine</Name>
            <Request Form="RS1794" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Betaine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has a confirmed diagnosis of homocystinuria</ci>
                    <apply>
                      <or/>
                      <ci type="logical">A cystathionine beta-synthase (CBS) deficiency</ci>
                      <ci type="logical">A 5,10-methylene-tetrahydrofolate reductase (MTHFR) deficiency</ci>
                      <ci type="logical">A disorder of intracellular cobalamin metabolism</ci>
                    </apply>
                    <ci type="logical">An appropriate homocysteine level has not been achieved despite a sufficient trial of appropriate vitamin supplementation</ci>
                  </apply>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The treatment remains appropriate and the patient is benefiting from treatment</ci>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1794" style="display:none"/>
            <Formulation ID="F014004805001" Rank="3" Units="g">
              <Name>Powder for oral soln</Name>
              <Brand ID="B01400480500125">
                <Name>Cystadane</Name>
                <Pack ID="P2536587" Specified="true" nzmt:ctpp_id="50119231000117105">
                  <Quantity>180</Quantity>
                  <Price>575.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048209">
            <Name>Haem arginate</Name>
            <Formulation ID="F014004820901" Rank="4" Units="inj" Weight="25">
              <Name>Inj 25 mg per ml, 10 ml ampoule</Name>
              <Brand ID="B01400482090100">
                <Name>Any</Name>
                <Pack ID="P82090100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048255">
            <Name>Levocarnitine</Name>
            <Request Form="RS1035" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Levocarnitine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>neurologist</Applicant>
                <Applicant>metabolic physician</Applicant>
                <Applicant>metabolic disorders dietitian</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1035" style="display:none"/>
            <Formulation ID="F014004825501" Rank="2" Units="cap" Weight="500">
              <Name>Cap 500 mg</Name>
              <Brand ID="B01400482550100">
                <Name>Any</Name>
                <Pack ID="P82550100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004825502" Rank="4" Units="inj" Weight="200">
              <Name>Inj 200 mg per ml, 5 ml vial</Name>
              <Brand ID="B01400482550200">
                <Name>Any</Name>
                <Pack ID="P82550200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004825525" Rank="3" Units="ml" Weight="1100">
              <Name>Oral soln 1,100 mg per 15 ml</Name>
              <Brand ID="B01400482552500">
                <Name>Any</Name>
                <Pack ID="P82552500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004825526" Rank="3" Units="ml" Weight="1000">
              <Name>Oral soln 1,000 mg per 10 ml</Name>
              <Brand ID="B01400482552600">
                <Name>Any</Name>
                <Pack ID="P82552600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004825527" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Brand ID="B01400482552700">
                <Name>Any</Name>
                <Pack ID="P82552700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004825528" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Brand ID="B01400482552800">
                <Name>Any</Name>
                <Pack ID="P82552800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004825529" Rank="3" Units="ml" Weight="500">
              <Name>Oral liq 500 mg per 10 ml</Name>
              <Brand ID="B01400482552900">
                <Name>Any</Name>
                <Pack ID="P82552900" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048420">
            <Name>Sodium benzoate</Name>
            <Formulation ID="F014004842001" Rank="2" Units="cap" Weight="500">
              <Name>Cap 500 mg</Name>
              <Brand ID="B01400484200100">
                <Name>Any</Name>
                <Pack ID="P84200100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004842002" Rank="4" Units="inj">
              <Name>Inj 20%, 10 ml ampoule</Name>
              <Brand ID="B01400484200200">
                <Name>Any</Name>
                <Pack ID="P84200200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004842003" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B01400484200300">
                <Name>Any</Name>
                <Pack ID="P84200300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004842004" Rank="3" Units="ml">
              <Name>Soln 100 mg per ml</Name>
              <Brand ID="B01400484200400">
                <Name>Any</Name>
                <Pack ID="P84200400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048433">
            <Name>Sodium phenylbutyrate</Name>
            <Request Form="RS1797" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Sodium phenylbutyrate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For the chronic management of a urea cycle disorder involving a deficiency of carbamylphosphate synthetase, ornithine transcarbamylase or argininosuccinate synthetase</ci>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The treatment remains appropriate and the patient is benefiting from treatment</ci>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Some items restricted" xlink:href="RS1797" style="display:none"/>
            <Formulation ID="F014004843301" Rank="4" Units="inj" Weight="200">
              <Name>Inj 200 mg per ml, 10 ml ampoule</Name>
              <Brand ID="B01400484330100">
                <Name>Any</Name>
                <Pack ID="P84330100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004843302" Rank="3" Units="ml">
              <Name>Oral liq 250 mg per ml</Name>
              <Brand ID="B01400484330200">
                <Name>Any</Name>
                <Pack ID="P84330200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004843303" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Brand ID="B01400484330300">
                <Name>Any</Name>
                <Pack ID="P84330300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004843325" Rank="3" Units="g">
              <Name>Grans 483 mg per g</Name>
              <html:div class="Restricted item" xlink:href="RS1797" style="display:none"/>
              <Brand ID="B01400484332525">
                <Name>Pheburane</Name>
                <Pack ID="P2503484" Specified="true" nzmt:ctpp_id="50223681000117100">
                  <Quantity>174</Quantity>
                  <Price>2016.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048529">
            <Name>Biotin</Name>
            <Request Form="RS1330" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Biotin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Applicant>metabolic disorders dietitian</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1330" style="display:none"/>
            <Formulation ID="F014004852925" Rank="4" Units="inj">
              <Name>Inj 10 mg per ml, 5 ml vial</Name>
              <Brand ID="B01400485292500">
                <Name>Any</Name>
                <Pack ID="P85292500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004852926" Rank="2" Units="cap" Weight="50">
              <Name>Cap 50 mg</Name>
              <Brand ID="B01400485292600">
                <Name>Any</Name>
                <Pack ID="P85292600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004852927" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Brand ID="B01400485292700">
                <Name>Any</Name>
                <Pack ID="P85292700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048530">
            <Name>Pyridoxal-5-phosphate</Name>
            <Request Form="RS1331" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Pyridoxal-5-phosphate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>neurologist</Applicant>
                <Applicant>metabolic physician</Applicant>
                <Applicant>metabolic disorders dietitian</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1331" style="display:none"/>
            <Formulation ID="F014004853025" Rank="1" Units="tab">
              <Name>Tab 50 mg</Name>
              <Brand ID="B01400485302500">
                <Name>Any</Name>
                <Pack ID="P85302500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048586">
            <Name>Galsulfase</Name>
            <Request Form="RS1795" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Galsulfase</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The patient has been diagnosed with mucopolysaccharidosis VI</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Diagnosis confirmed by demonstration of N-acetyl-galactosamine-4-sulfatase (arylsulfatase B) deficiency confirmed by either enzyme activity assay in leukocytes or skin fibroblasts</ci>
                      <ci type="logical" class="Indication">Detection of two disease causing mutations and patient has a sibling who is known to have mucopolysaccharidosis VI</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The treatment remains appropriate for the patient and the patient is benefiting from treatment</ci>
                    <ci type="logical" class="Indication">Patient has not had severe infusion-related adverse reactions which were not preventable by appropriate pre-medication and/or adjustment of infusion rates</ci>
                    <ci type="logical" class="Indication">Patient has not developed another life threatening or severe disease where the long term prognosis is unlikely to be influenced by Enzyme Replacement Therapy (ERT)</ci>
                    <ci type="logical" class="Indication">Patient has not developed another medical condition that might reasonably be expected to compromise a response to ERT</ci>
                  </apply>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1795" style="display:none"/>
            <Formulation ID="F014004858625" Rank="4" Units="inj" Weight="5">
              <Name>Inj 1 mg per ml, 5 ml vial</Name>
              <Brand ID="B01400485862525">
                <Name>Naglazyme</Name>
                <Pack ID="P2498715" Specified="true" nzmt:ctpp_id="50221641000117108">
                  <Quantity>1</Quantity>
                  <Price>2234.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048601">
            <Name>Alglucosidase alfa</Name>
            <Request Form="RS1793" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Alglucosidase Alfa</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The patient is aged up to 24 months at the time of initial application and has been diagnosed with infantile Pompe disease</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Diagnosis confirmed by documented deficiency of acid alpha-glucosidase by prenatal diagnosis using chorionic villus biopsies and/or cultured amniotic cells</ci>
                      <ci type="logical" class="Indication">Documented deficiency of acid alpha-glucosidase, and urinary tetrasaccharide testing indicating a diagnostic elevation of glucose tetrasaccharides</ci>
                      <ci type="logical" class="Indication">Documented deficiency of acid alpha-glucosidase, and documented molecular genetic testing indicating a disease-causing mutation in the acid alpha-glucosidase gene (GAA gene)</ci>
                      <ci type="logical" class="Indication">Documented urinary tetrasaccharide testing indicating a diagnostic elevation of glucose tetrasaccharides, and molecular genetic testing indicating a disease-causing mutation in the GAA gene</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has not required long-term invasive ventilation for respiratory failure prior to starting enzyme replacement therapy (ERT)</ci>
                    <ci type="logical" class="Indication">Patient does not have another life-threatening or severe disease where the prognosis is unlikely to be influenced by ERT or might be reasonably expected to compromise a response to ERT</ci>
                    <ci type="logical" class="Indication">Alglucosidase alfa to be administered at doses no greater than 20 mg/kg every 2 weeks</ci>
                  </apply>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The treatment remains appropriate for the patient and the patient is benefiting from treatment</ci>
                    <ci type="logical" class="Indication">Alglucosidase alfa to be administered at doses no greater than 20 mg/kg every 2 weeks</ci>
                    <ci type="logical" class="Indication">Patient has not had severe infusion-related adverse reactions which were not preventable by appropriate pre-medication and/or adjustment of infusion rates</ci>
                    <ci type="logical" class="Indication">Patient has not developed another life threatening or severe disease where the long term prognosis is unlikely to be influenced by ERT</ci>
                    <ci type="logical" class="Indication">Patient has not developed another medical condition that might reasonably be expected to compromise a response to ERT</ci>
                    <ci type="logical" class="Indication">There is no evidence of life threatening progression of respiratory disease as evidenced by the needed for &gt;14 days of invasive ventilation</ci>
                    <ci type="logical" class="Indication">There is no evidence of new or progressive cardiomyopathy</ci>
                  </apply>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1793" style="display:none"/>
            <Formulation ID="F014004860125" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg vial</Name>
              <Brand ID="B01400486012525">
                <Name>Myozyme</Name>
                <Pack ID="P2500701" Specified="true" nzmt:ctpp_id="50187701000117103">
                  <Quantity>1</Quantity>
                  <Price>1142.60</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048602">
            <Name>Idursulfase</Name>
            <Request Form="RS1546" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Idursulfase</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The patient has been diagnosed with Hunter Syndrome (mucopolysacchardosis II)</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Diagnosis confirmed by demonstration of iduronate 2-sulfatase deficiency in white blood cells by either enzyme assay in cultured skin fibroblasts</ci>
                      <ci type="logical" class="Indication">Detection of a disease causing mutation in the iduronate 2-sulfatase gene</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient is going to proceed with a haematopoietic stem cell transplant (HSCT) within the next 3 months and treatment with idursulfase would be bridging treatment to transplant</ci>
                    <ci type="logical" class="Indication">Patient has not required long-term invasive ventilation for respiratory failure prior to starting Enzyme Replacement Therapy (ERT)</ci>
                    <ci type="logical" class="Indication">Idursulfase to be administered for a total of 24 weeks (equivalent to 12 weeks pre- and 12 weeks post-HSCT) at doses no greater than 0.5 mg/kg every week</ci>
                  </apply>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="week">24</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1546" style="display:none"/>
            <Formulation ID="F014004860225" Rank="4" Units="inj" Weight="6">
              <Name>Inj 2 mg per ml, 3 ml vial</Name>
              <Brand ID="B01400486022525">
                <Name>Elaprase</Name>
                <Pack ID="P2336359" Specified="true" nzmt:ctpp_id="50181251000117102">
                  <Quantity>1</Quantity>
                  <Price>4608.30</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048615">
            <Name>Laronidase</Name>
            <Request Form="RS1607" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Laronidase</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The patient has been diagnosed with Hurler Syndrome (mucopolysacchardosis I-H)</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Diagnosis confirmed by demonstration of alpha-L-iduronidase deficiency in white blood cells by either enzyme assay in cultured skin
                        fibroblasts</ci>
                      <ci type="logical" class="Indication">Detection of two disease causing mutations in the alpha-L-iduronidase gene and patient has a sibling who is known to have Hurler syndrome</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient is going to proceed with a haematopoietic stem cell transplant (HSCT) within the next 3 months and treatment with laronidase would be
                    bridging treatment to transplant</ci>
                    <ci type="logical" class="Indication">Patient has not required long-term invasive ventilation for respiratory failure prior to starting Enzyme Replacement Therapy (ERT)</ci>
                    <ci type="logical" class="Indication">Laronidase to be administered for a total of 24 weeks (equivalent to 12 weeks pre- and 12 post-HSCT) at doses no greater than 100 units/kg every
                    week</ci>
                  </apply>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="week">24</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1607" style="display:none"/>
            <Formulation ID="F014004861525" Rank="4" Units="inj">
              <Name>Inj 100 U per ml, 5 ml vial</Name>
              <Brand ID="B01400486152525">
                <Name>Aldurazyme</Name>
                <Pack ID="P2398362" Specified="true" nzmt:ctpp_id="50234481000117102">
                  <Quantity>1</Quantity>
                  <Price>1335.16</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048626">
            <Name>Taliglucerase alfa</Name>
            <Request Form="RS1897" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Taliglucerase alfa</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has a diagnosis of symptomatic type 1 or type 3* Gaucher disease confirmed by the demonstration of specific deficiency of glucocerebrosidase in leukocytes or cultured skin fibroblasts, and genotypic analysis</ci>
                    <ci type="logical">Patient does not have another life-threatening or severe disease where the prognosis is unlikely to be influenced by enzyme replacement therapy (ERT) or the disease might be reasonably expected to compromise a response to ERT</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has haematological complications of Gaucher disease</ci>
                      <ci type="logical">Patient has skeletal complications of Gaucher disease</ci>
                      <ci type="logical">Patient has significant liver dysfunction or hepatomegaly attributable
            to Gaucher disease</ci>
                      <ci type="logical">Patient has reduced vital capacity from clinically significant or
            progressive pulmonary disease due to Gaucher disease</ci>
                      <ci type="logical">Patient is a child and has experienced growth failure with significant
            decrease in percentile linear growth over a 6-12 month period</ci>
                    </apply>
                    <ci type="logical">Taliglucerase alfa is to be administered at a dose no greater than 30
          unit/kg every other week rounded to the nearest whole vial (200 units)</ci>
                  </apply>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indication marked with * is an unapproved indication</p>
                </div>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has demonstrated a symptomatic improvement and has maintained improvements in the main symptom or symptoms for which therapy was started</ci>
                    <ci type="logical">Patient has demonstrated a clinically objective improvement or no deterioration in haemoglobin levels, platelet counts and liver and spleen size</ci>
                    <ci type="logical">RRadiological (MRI) signs of bone activity performed at two years since initiation of treatment, and five yearly thereafter, demonstrate no deterioration shown by the MRI, compared with MRI taken immediately prior to commencement of therapy or adjusted dose</ci>
                    <ci type="logical">Patient has not developed another medical condition that might reasonably
          be expected to compromise a response to ERT</ci>
                    <ci type="logical">Patient is adherent with regular treatment and taliglucerase alfa is to
          be administered at a dose no greater than 30 unit/kg every other week rounded to the
          nearest whole vial (200 units)</ci>
                  </apply>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Applicant Referring="metabolic physician">any relevant practitioner</Applicant>
                <Term Measure="year">3</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1897" style="display:none"/>
            <Formulation ID="F014004862625" Rank="4" Units="inj" Weight="200">
              <Name>Inj 200 unit vial</Name>
              <Brand ID="B01400486262525">
                <Name>Elelyso</Name>
                <Pack ID="P2541106" Specified="true" nzmt:ctpp_id="50236221000117107">
                  <Quantity>1</Quantity>
                  <Price>1072.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048634">
            <Name>Sapropterin Dihydrochloride</Name>
            <Request Form="RS1796" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Sapropterin dihydrochloride</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has phenylketonuria (PKU) and is pregnant or actively planning to become pregnant</ci>
                    <ci type="logical">Treatment with sapropterin is required to support management of PKU during pregnancy</ci>
                    <ci type="logical">Sapropterin to be administered at doses no greater than a total daily dose of 20 mg/kg</ci>
                    <ci type="logical">Sapropterin to be used alone or in combination with PKU dietary management</ci>
                    <ci type="logical">Total treatment duration with sapropterin will not exceed 22 months for each pregnancy (includes time for planning and becoming pregnant) and treatment will be stopped after delivery</ci>
                  </apply>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="month">1</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Following the initial one-month approval, the patient has demonstrated an adequate response to a 2 to 4 week trial of sapropterin with a clinically appropriate reduction in phenylalanine levels to support management of PKU during pregnancy</ci>
                      <ci type="logical">On subsequent renewal applications, the patient has previously demonstrated response to treatment with sapropterin and maintained adequate phenylalanine levels to support management of PKU during pregnancy</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical">Patient continues to be pregnant and treatment with sapropterin will not continue after delivery</ci>
                      <ci type="logical">Patient is actively planning a pregnancy and this is the first renewal for treatment with sapropterin</ci>
                      <ci type="logical">Treatment with sapropterin is required for a second or subsequent pregnancy to support management of their PKU during pregnancy</ci>
                    </apply>
                    <ci type="logical">Sapropterin to be administered at doses no greater than a total daily dose of 20 mg/kg</ci>
                    <ci type="logical">Sapropterin to be used alone or in combination with PKU dietary management</ci>
                    <ci type="logical">Total treatment duration with sapropterin will not exceed 22 months for each pregnancy (includes time for planning and becoming pregnant) and treatment will be stopped after delivery</ci>
                  </apply>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1796" style="display:none"/>
            <Formulation ID="F014004863425" Rank="1" Units="tab" Weight="100">
              <Name>Tab soluble 100 mg</Name>
              <Brand ID="B01400486342525">
                <Name>Kuvan</Name>
                <Pack ID="P2351676" Specified="true" nzmt:ctpp_id="50123241000117109">
                  <Quantity>30</Quantity>
                  <Price>1452.70</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048668">
            <Name>Carglumic acid</Name>
            <Request Form="RS1831" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Carglumic Acid</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">For the acute in-patient treatment of organic acidaemias as an alternative to haemofiltration</ci>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1831" style="display:none"/>
            <Formulation ID="F014004866825" Rank="1" Units="tab" Weight="200">
              <Name>Tab disp 200 mg</Name>
              <Brand ID="B01400486682500">
                <Name>Any</Name>
                <Pack ID="P86682500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048669">
            <Name>Coenzyme Q10</Name>
            <Request Form="RS1832" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Coenzyme Q10</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">The patient has a suspected inborn error of
                metabolism that may respond to coenzyme Q10 supplementation</ci>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The patient has a confirmed diagnosis of an
                    inborn error of metabolism that responds to coenzyme Q10 supplementation</ci>
                    <ci type="logical" class="Indication">The treatment remains appropriate and the patient is benefiting from treatment</ci>
                  </apply>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="month">24</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1832" style="display:none"/>
            <Formulation ID="F014004866925" Rank="2" Units="cap" Weight="120">
              <Name>Cap 120 mg</Name>
              <Brand ID="B01400486692500">
                <Name>Any</Name>
                <Pack ID="P86692500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004866926" Rank="2" Units="cap" Weight="160">
              <Name>Cap 160 mg</Name>
              <Brand ID="B01400486692600">
                <Name>Any</Name>
                <Pack ID="P86692600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048670">
            <Name>Riboflavin</Name>
            <Request Form="RS1833" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Riboflavin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">The patient has a suspected inborn error of metabolism that may respond to riboflavin supplementation</ci>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Applicant>neurologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The patient has a confirmed diagnosis of an inborn error of metabolism that responds to riboflavin supplementation</ci>
                    <ci type="logical" class="Indication">The treatment remains appropriate and the patient is benefiting from treatment</ci>
                  </apply>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Applicant>neurologist</Applicant>
                <Term Measure="month">24</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1833" style="display:none"/>
            <Formulation ID="F014004867025" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B01400486702500">
                <Name>Any</Name>
                <Pack ID="P86702500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004867026" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Brand ID="B01400486702600">
                <Name>Any</Name>
                <Pack ID="P86702600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048671">
            <Name>Taurine</Name>
            <Request Form="RS1834" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Taurine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">The patient has a suspected specific mitochondrial disorder that may 
                respond to taurine supplementation</ci>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The patient has a confirmed diagnosis of a specific mitochondrial disorder which responds to taurine supplementation</ci>
                    <ci type="logical" class="Indication">The treatment remains appropriate and the patient is benefiting from treatment</ci>
                  </apply>
                </math>
                <Applicant>metabolic physician</Applicant>
                <Term Measure="month">24</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1834" style="display:none"/>
            <Formulation ID="F014004867125" Rank="2" Units="cap" Weight="1000">
              <Name>Cap 1,000 mg</Name>
              <Brand ID="B01400486712500">
                <Name>Any</Name>
                <Pack ID="P86712500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004867126" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B01400486712600">
                <Name>Any</Name>
                <Pack ID="P86712600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014004867127" Rank="2" Units="cap" Weight="500">
              <Name>Cap 500 mg</Name>
              <Brand ID="B01400486712700">
                <Name>Any</Name>
                <Pack ID="P86712700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0140048735">
            <Name>Trientine</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS2026">
              <Title>
                <range>Trientine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has confirmed Wilson disease</ci>
                    <ci type="logical" class="Indication">Treatment with D-penicillamine has been trialled and discontinued because the person has experienced intolerable side effects or has not received sufficient benefit</ci>
                    <ci type="logical" class="Indication">Treatment with zinc has been trialled and discontinued because the person has experienced intolerable side effects or has not received sufficient benefit, or zinc is considered clinically inappropriate as the person has symptomatic liver disease and requires copper chelation</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2026" style="display:none"/>
            <Formulation ID="F014004873525" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Rule Type="DVLimit" Attribute="Oct-24 to~2025" Value="5"/>
              <Brand ID="B01400487352525" PSS="true">
                <Name>Trientine Waymade</Name>
                <Pack ID="P2621738" Specified="true" nzmt:ctpp_id="50272871000117105">
                  <Quantity>100</Quantity>
                  <Price>2022.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0144">
        <Name>Minerals</Name>
        <ATC3 ID="A014404">
          <Name>Calcium</Name>
          <Chemical ID="C0144049430">
            <Name>Calcium carbonate</Name>
            <Formulation ID="F014404943025" Rank="1" Units="tab" Weight="1000">
              <Name>Tab eff 1.75 g (1 g elemental)</Name>
              <Brand ID="B01440494302500">
                <Name>Any</Name>
                <Pack ID="P94302500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014404943026" Rank="1" Units="tab" Weight="1.25">
              <Name>Tab 1.25 g (500 mg elemental)</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B01440494302626" PSS="true">
                <Name>Calci-Tab 500</Name>
                <Pack ID="P2212269" Specified="true" nzmt:ctpp_id="50033651000117100">
                  <Quantity>250</Quantity>
                  <Price>7.28</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014404943030" Rank="1" Units="tab" Weight="500">
              <Name>Tab eff 1.25 g (500 mg elemental)</Name>
              <Brand ID="B01440494303000">
                <Name>Any</Name>
                <Pack ID="P94303000" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A014406">
          <Name>Copper</Name>
          <Request Form="RS1928" To="HealthPAC" For="Subsidy">
            <Title>
              <range>Copper chloride</range>
            </Title>
            <Case When="Initial application" Category="Moderate to severe burns">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <and/>
                  <ci type="logical">Patient has been hospitalised with moderate to severe burns</ci>
                  <ci type="logical">Treatment is recommended by a National Burns Unit specialist</ci>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="month">3</Term>
            </Case>
          </Request>
          <html:div class="Restricted" xlink:href="RS1928" style="display:none"/>
          <Chemical ID="C0144068696">
            <Name>Copper chloride</Name>
            <Formulation ID="F014406869625" Rank="4" Units="inj">
              <Name>Inj 0.4 mg per ml, 10 ml vial</Name>
              <Brand ID="B01440686962500">
                <Name>Any</Name>
                <Pack ID="P86962500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0144068716">
            <Name>Copper</Name>
            <Formulation ID="F014406871625" Rank="1" Units="tab">
              <Name>Tab 2.5 mg, chelated</Name>
              <Brand ID="B01440687162500">
                <Name>Any</Name>
                <Pack ID="P87162500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A014408">
          <Name>Fluoride</Name>
          <Chemical ID="C0144088428">
            <Name>Sodium fluoride</Name>
            <Formulation ID="F014408842801" Rank="1" Units="tab" Weight="1.1">
              <Name>Tab 1.1 mg (0.5 mg elemental)</Name>
              <Brand ID="B01440884280100">
                <Name>Any</Name>
                <Pack ID="P84280100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A014412">
          <Name>Iodine</Name>
          <Chemical ID="C0144128376">
            <Name>Potassium iodate</Name>
            <Formulation ID="F014412837626" Rank="1" Units="tab" Weight="253">
              <Name>Tab 253 mcg (150 mcg elemental iodine)</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B01441283762625" PSS="true">
                <Name>NeuroTabs</Name>
                <Pack ID="P2439964" Specified="true" nzmt:ctpp_id="50178331000117100">
                  <Quantity>90</Quantity>
                  <Price>5.99</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0144128377">
            <Name>Potassium iodate with iodine</Name>
            <Formulation ID="F014412837701" Rank="3" Units="ml">
              <Name>Oral liq 10% with iodine 5%</Name>
              <Brand ID="B01441283770100">
                <Name>Any</Name>
                <Pack ID="P83770100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A014416">
          <Name>Iron</Name>
          <Chemical ID="C0144168184">
            <Name>Ferrous gluconate with ascorbic acid</Name>
            <Formulation ID="F014416818401" Rank="1" Units="tab" Weight="170">
              <Name>Tab 170 mg (20 mg elemental) with ascorbic acid 40 mg</Name>
              <Brand ID="B01441681840100">
                <Name>Any</Name>
                <Pack ID="P81840100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0144168185">
            <Name>Ferrous sulfate with ascorbic acid</Name>
            <Formulation ID="F014416818501" Rank="1" Units="tab">
              <Name>Tab long-acting 325 mg (105 mg elemental) with ascorbic acid 500 mg</Name>
              <Brand ID="B01441681850100">
                <Name>Any</Name>
                <Pack ID="P81850100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0144168552">
            <Name>Iron (as ferric carboxymaltose)</Name>
            <Request Form="RS1417" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ferric carboxymaltose</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Treatment with oral iron has proven ineffective or is clinically inappropriate</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1417" style="display:none"/>
            <Formulation ID="F014416855225" Rank="4" Units="inj">
              <Name>Inj 50 mg per ml, 10 ml vial</Name>
              <Brand ID="B01441685522525">
                <Name>Ferinject</Name>
                <Pack ID="P2401088" Specified="true" nzmt:ctpp_id="50131001000117104">
                  <Quantity>1</Quantity>
                  <Price>150.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0144169202">
            <Name>Iron polymaltose</Name>
            <Formulation ID="F014416920226" Rank="4" Units="inj" Weight="100">
              <Name>Inj 50 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B01441692022626">
                <Name>Ferrosig</Name>
                <Pack ID="P2135914" Specified="true" nzmt:ctpp_id="50023781000117104">
                  <Quantity>5</Quantity>
                  <Price>34.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0144169222">
            <Name>Ferrous sulfate</Name>
            <Formulation ID="F014416922201" Rank="1" Units="tab">
              <Name>Tab long-acting 325 mg (105 mg elemental)</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B01441692220125" PSS="true">
                <Name>Ferrograd</Name>
                <Pack ID="P2534819" Specified="true" nzmt:ctpp_id="50126231000117106">
                  <Quantity>30</Quantity>
                  <Price>2.55</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014416922225" Rank="3" Units="ml" Weight="150">
              <Name>Oral liq 30 mg (6 mg elemental) per ml</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B01441692222526" PSS="true">
                <Name>Ferodan</Name>
                <Pack ID="P2259087" Specified="true" nzmt:ctpp_id="50040881000117102">
                  <Quantity>500</Quantity>
                  <Price>13.10</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0144169288">
            <Name>Ferrous fumarate</Name>
            <Formulation ID="F014416928825" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg (65 mg elemental)</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B01441692882525" PSS="true">
                <Name>Ferro-tab</Name>
                <Pack ID="P2162156" Specified="true" nzmt:ctpp_id="50027441000117107">
                  <Quantity>100</Quantity>
                  <Price>3.49</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0144169355">
            <Name>Ferrous fumarate with folic acid</Name>
            <Formulation ID="F014416935525" Rank="1" Units="tab" Weight="310">
              <Name>Tab 310 mg (100 mg elemental) with folic acid 350 mcg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B01441693552525" PSS="true">
                <Name>Ferro-F-Tabs</Name>
                <Pack ID="P2615584" Specified="true" nzmt:ctpp_id="50290911000117104">
                  <Quantity>100</Quantity>
                  <Price>5.98</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0144169524">
            <Name>Iron (as sucrose)</Name>
            <Formulation ID="F014416952425" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg per ml, 5 ml ampoule</Name>
              <Brand ID="B01441695242525">
                <Name>Venofer</Name>
                <Pack ID="P2064634" Specified="true" nzmt:ctpp_id="50011291000117103">
                  <Quantity>5</Quantity>
                  <Price>100.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A014420">
          <Name>Magnesium</Name>
          <Chemical ID="C0144208274">
            <Name>Magnesium hydroxide</Name>
            <Formulation ID="F014420827402" Rank="1" Units="tab" Weight="311">
              <Name>Tab 311 mg (130 mg elemental)</Name>
              <Brand ID="B01442082740200">
                <Name>Any</Name>
                <Pack ID="P82740200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014420827425" Rank="3" Units="ml">
              <Name>Suspension 8%</Name>
              <Brand ID="B01442082742500">
                <Name>Any</Name>
                <Pack ID="P82742500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0144208526">
            <Name>Magnesium oxide</Name>
            <Formulation ID="F014420852625" Rank="2" Units="cap" Weight="663">
              <Name>Cap 663 mg (400 mg elemental)</Name>
              <Brand ID="B01442085262500">
                <Name>Any</Name>
                <Pack ID="P85262500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014420852626" Rank="2" Units="cap" Weight="696">
              <Name>Cap 696 mg (420 mg elemental)</Name>
              <Brand ID="B01442085262600">
                <Name>Any</Name>
                <Pack ID="P85262600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0144208627">
            <Name>Magnesium chloride</Name>
            <Formulation ID="F014420862725" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mmol per 1 ml, 100 ml bag</Name>
              <Brand ID="B01442086272500">
                <Name>Any</Name>
                <Pack ID="P86272500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0144208636">
            <Name>Magnesium oxide with magnesium aspartate, magnesium amino acid chelate and magnesium citrate</Name>
            <Formulation ID="F014420863625" Rank="2" Units="cap">
              <Name>Cap 500 mg with magnesium aspartate 100 mg, magnesium amino acid chelate 100 mg and magnesium citrate 100 mg (360 mg elemental magnesium)</Name>
              <Brand ID="B01442086362500">
                <Name>Any</Name>
                <Pack ID="P86362500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0144208637">
            <Name>Magnesium amino acid chelate</Name>
            <Formulation ID="F014420863725" Rank="2" Units="cap" Weight="750">
              <Name>Cap 750 mg (150 mg elemental)</Name>
              <Brand ID="B01442086372500">
                <Name>Any</Name>
                <Pack ID="P86372500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0144209213">
            <Name>Magnesium sulphate</Name>
            <Formulation ID="F014420921301" Rank="4" Units="inj" Weight="0.4">
              <Name>Inj 0.4 mmol per ml, 250 ml bag</Name>
              <Brand ID="B01442092130100">
                <Name>Any</Name>
                <Pack ID="P92130100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014420921325" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2 mmol per ml, 5 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B01442092132526" PSS="true">
                <Name>Martindale</Name>
                <Pack ID="P2406438" Specified="true" nzmt:ctpp_id="50276951000117105">
                  <Quantity>10</Quantity>
                  <Price>37.53</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014420921326" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg per ml, 50 ml bag</Name>
              <Brand ID="B01442092132600">
                <Name>Any</Name>
                <Pack ID="P92132600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014420921327" Rank="4" Units="inj">
              <Name>Inj 100 mg per ml, 40 ml bag</Name>
              <Brand ID="B01442092132700">
                <Name>Any</Name>
                <Pack ID="P92132700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014420921328" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2 mmol per ml, 10 ml ampoule</Name>
              <Brand ID="B01442092132825">
                <Name>Inresa</Name>
                <Pack ID="P2671093" Specified="true" nzmt:ctpp_id="50327411000117107">
                  <Quantity>10</Quantity>
                  <Price>75.06</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A014422">
          <Name>Selenium</Name>
          <Chemical ID="C0144228697">
            <Name>Selenium</Name>
            <Request Form="RS1929" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Selenium</range>
              </Title>
              <Case When="Initial application" Category="Moderate to severe burns">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has been hospitalised with moderate to severe burns</ci>
                    <ci type="logical">Treatment is recommended by a National Burns Unit specialist</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">3</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1929" style="display:none"/>
            <Formulation ID="F014422869725" Rank="3" Units="ml">
              <Name>Oral liq 150 mcg per 3 drops</Name>
              <Brand ID="B01442286972500">
                <Name>e.g. Clinicians selenium oral drops</Name>
                <Pack ID="P86972500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014422869726" Rank="4" Units="inj">
              <Name>Inj 300 mcg per ml, 1 ml ampoule</Name>
              <Brand ID="B01442286972600">
                <Name>Any</Name>
                <Pack ID="P86972600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A014424">
          <Name>Zinc</Name>
          <Chemical ID="C0144248501">
            <Name>Zinc</Name>
            <Formulation ID="F014424850103" Rank="3" Units="ml">
              <Name>Oral liq 5 mg per 5 drops</Name>
              <Brand ID="B01442485010300">
                <Name>Any</Name>
                <Pack ID="P85010300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0144248502">
            <Name>Zinc chloride</Name>
            <Formulation ID="F014424850201" Rank="4" Units="inj" Weight="5.3">
              <Name>Inj 5.3 mg per ml (5.1 mg per ml elemental), 2 ml ampoule</Name>
              <Brand ID="B01442485020100">
                <Name>Any</Name>
                <Pack ID="P85020100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0144249459">
            <Name>Zinc sulphate</Name>
            <Formulation ID="F014424945925" Rank="2" Units="cap" Weight="137.4">
              <Name>Cap 137.4 mg (50 mg elemental)</Name>
              <Brand ID="B01442494592525">
                <Name>Zincaps</Name>
                <Pack ID="P258253" Specified="true" nzmt:ctpp_id="50056211000117108">
                  <Quantity>100</Quantity>
                  <Price>11.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0148">
        <Name>Mouth and Throat</Name>
        <ATC3 ID="A014804">
          <Name>Agents Used in Mouth Ulceration</Name>
          <Chemical ID="C0148048048">
            <Name>Benzydamine hydrochloride</Name>
            <Formulation ID="F014804804801" Rank="3" Units="ml">
              <Name>Soln 0.15%</Name>
              <Brand ID="B01480480480100">
                <Name>Any</Name>
                <Pack ID="P80480100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014804804802" Rank="3" Units="ml">
              <Name>Spray 0.15%</Name>
              <Brand ID="B01480480480200">
                <Name>Any</Name>
                <Pack ID="P80480200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014804804825" Rank="3" Units="ml">
              <Name>Spray 0.3%</Name>
              <Brand ID="B01480480482500">
                <Name>Any</Name>
                <Pack ID="P80482500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0148048049">
            <Name>Benzydamine hydrochloride with cetylpyridinium chloride</Name>
            <Formulation ID="F014804804901" Rank="10" Units="loz">
              <Name>Lozenge 3 mg with cetylpyridinium chloride</Name>
              <Brand ID="B01480480490100">
                <Name>Any</Name>
                <Pack ID="P80490100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0148048081">
            <Name>Carboxymethylcellulose</Name>
            <Formulation ID="F014804808101" Rank="3" Units="ml">
              <Name>Oral spray</Name>
              <Brand ID="B01480480810100">
                <Name>Any</Name>
                <Pack ID="P80810100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0148048082">
            <Name>Carmellose sodium with pectin and gelatine</Name>
            <Formulation ID="F014804808205" Rank="3" Units="g">
              <Name>Paste</Name>
              <Brand ID="B01480480820500">
                <Name>Any</Name>
                <Pack ID="P84220100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F014804808206" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B01480480820600">
                <Name>Any</Name>
                <Pack ID="P84220200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0148048135">
            <Name>Dichlorobenzyl alcohol with amylmetacresol</Name>
            <Formulation ID="F014804813501" Rank="10" Units="loz">
              <Name>Lozenge 1.2 mg with amylmetacresol 0.6 mg</Name>
              <Brand ID="B01480481350100">
                <Name>Any</Name>
                <Pack ID="P81350100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0148049145">
            <Name>Triamcinolone acetonide</Name>
            <Formulation ID="F014804914531" Rank="3" Units="g">
              <Name>Paste 0.1%</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B01480491453126" PSS="true">
                <Name>Kenalog in Orabase</Name>
                <Pack ID="P253790" Specified="true" nzmt:ctpp_id="50054061000117106">
                  <Quantity>5</Quantity>
                  <Price>5.49</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0148049538">
            <Name>Chlorhexidine gluconate</Name>
            <Formulation ID="F014804953826" Rank="3" Units="ml">
              <Name>Mouthwash 0.2%</Name>
              <Rule Type="DVLimit" Attribute="Jan-25 to~2027" Value="5"/>
              <Brand ID="B01480495382625" PSS="true">
                <Name>healthE</Name>
                <Pack ID="P2393840" Specified="true" nzmt:ctpp_id="50145061000117101">
                  <Quantity>200</Quantity>
                  <Price>3.99</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A014808">
          <Name>Oropharyngeal Anti-Infectives</Name>
          <Chemical ID="C0148089032">
            <Name>Amphotericin B</Name>
            <Formulation ID="F014808903203" Rank="10" Units="loz">
              <Name>Lozenge 10 mg</Name>
              <Brand ID="B01480890320325">
                <Name>Fungilin</Name>
                <Pack ID="P201960" Specified="true" nzmt:ctpp_id="50004271000117100">
                  <Quantity>20</Quantity>
                  <Price>5.86</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0148089252">
            <Name>Nystatin</Name>
            <Formulation ID="F014808925225" Rank="3" Units="ml" Weight="100000">
              <Name>Oral liquid 100,000 u per ml</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B01480892522525" PSS="true">
                <Name>Nilstat</Name>
                <Pack ID="P254851" Specified="true" nzmt:ctpp_id="50054691000117108">
                  <Quantity>24</Quantity>
                  <Price>2.22</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0148089672">
            <Name>Miconazole</Name>
            <Formulation ID="F014808967225" Rank="3" Units="g">
              <Name>Oral gel 20 mg per g</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B01480896722525" PSS="true">
                <Name>Decozol</Name>
                <Pack ID="P2405008" Specified="true" nzmt:ctpp_id="50136621000117107">
                  <Quantity>40</Quantity>
                  <Price>5.19</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A014812">
          <Name>Other Oral Agents</Name>
          <Chemical ID="C0148128642">
            <Name>Hyaluronic acid with lidocaine [lignocaine]</Name>
            <Formulation ID="F014812864225" Rank="4" Units="inj">
              <Name>Inj 20 mg per ml</Name>
              <Brand ID="B01481286422500">
                <Name>Any</Name>
                <Pack ID="P86422500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0148129170">
            <Name>Sodium hyaluronate [Hyaluronic acid]</Name>
            <Request Form="RS1175" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Sodium hyaluronate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>otolaryngologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1175" style="display:none"/>
            <Formulation ID="F014812917001" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg per ml, 1 ml syringe</Name>
              <Brand ID="B01481291700100">
                <Name>Any</Name>
                <Pack ID="P91700100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0152">
        <Name>Vitamins</Name>
        <ATC3 ID="A015204">
          <Name>Multivitamin Preparations</Name>
          <Chemical ID="C0152048310">
            <Name>Multivitamins</Name>
            <Formulation ID="F015204831001" Rank="2" Units="cap" Weight="2500">
              <Name>cap vitamin A 2500 u, betacarotene 3 mg, cholecalciferol 11 mcg, alpha tocopherol 150 u, phytomenadione 150 mcg, folic acid 0.2 mg, ascorbic acid 100 mg, thiamine 1.5 mg, pantothenic acid 12 mg, riboflavin 1.7 mg, niacin 20 mg, pyridoxine hydrochloride 1.9 mg, cyanocobalamin 3 mcg, zinc 7.5 mg and biotin 100 mcg</Name>
              <Request To="HealthPAC" For="Subsidy" Form="RS1620">
                <Title>
                  <range>Multivitamins - Cap </range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical">Patient has cystic fibrosis with pancreatic insufficiency</ci>
                      <ci type="logical">Patient is an infant or child with liver disease or short gut syndrome</ci>
                      <ci type="logical">Patient has severe malabsorption syndrome</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1620" style="display:none"/>
              <Brand ID="B01520483100100">
                <Name>e.g. Vitabdeck</Name>
                <Pack ID="P83100100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015204831002" Rank="4" Units="inj">
              <Name>Inj thiamine hydrochloride 250 mg with riboflavin 4 mg and pyridoxine hydrochloride 50 mg, 5 ml ampoule (1) and inj ascorbic acid 500 mg with nicotinamide 160 mg and glucose 1000 mg, 5 ml ampoule (1)</Name>
              <Brand ID="B01520483100200">
                <Name>e.g. Pabrinex IV</Name>
                <Pack ID="P83100200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015204831003" Rank="4" Units="inj">
              <Name>Inj thiamine hydrochloride 250 mg with riboflavin 4 mg and pyridoxine hydrochloride 50 mg, 5 ml ampoule (1) and inj ascorbic acid 500 mg with nicotinamide 160 mg, 2 ml ampoule (1)</Name>
              <Brand ID="B01520483100300">
                <Name>Any</Name>
                <Pack ID="P83100300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015204831004" Rank="4" Units="inj">
              <Name>Inj thiamine hydrochloride 500 mg with riboflavin 8 mg and pyridoxine hydrochloride 100 mg, 10 ml ampoule (1) and inj ascorbic acid 1000 mg with nicotinamide 320 mg and glucose 2000 mg, 10 ml ampoule (1)</Name>
              <Brand ID="B01520483100400">
                <Name>Any</Name>
                <Pack ID="P83100400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015204831006" Rank="1" Units="tab">
              <Name>Tab (BPC cap strength)</Name>
              <Rule Type="DVLimit" Attribute="Feb-23 to~2025" Value="5"/>
              <Brand ID="B01520483100625" PSS="true">
                <Name>Mvite</Name>
                <Pack ID="P2642247" Specified="true" nzmt:ctpp_id="50176641000117104">
                  <Quantity>1000</Quantity>
                  <Price>18.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015204831025" Rank="3" Units="g">
              <Name>Powder vitamin A 3200 mcg with vitamin D 100 mcg, vitamin E 54.2 mg, vitamin C 400 mg, vitamin K1 108 mcg thiamine 3.2 mg, riboflavin 4.4 mg, niacin 41 mg, vitamin B6 3.6 mg, folic acid 600 mcg, vitamin B12 9 mcg, biotin 120 mcg, pantothenic acid 24 mg, choline 1250 mg and inositol 700 mg</Name>
              <Request Form="RS1178" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Multivitamins – Powder</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">Patient has inborn errors of metabolism</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1178" style="display:none"/>
              <Brand ID="B01520483102525">
                <Name>Paediatric Seravit</Name>
                <Pack ID="P2601435" Specified="true" nzmt:ctpp_id="50284571000117107">
                  <Quantity>200</Quantity>
                  <Price>74.88</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0152048570">
            <Name>Multivitamin and mineral supplement</Name>
            <Request Form="RS1498" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Multivitamin and mineral supplement</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient was admitted to hospital with burns</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Burn size is greater than 15% of total body surface area (BSA) for all types of burns</ci>
                      <ci type="logical">Burn size is greater than 10% of BSA for mid-dermal or deep dermal burns</ci>
                      <ci type="logical">Nutritional status prior to admission or dietary intake is poor</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">3</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1498" style="display:none"/>
            <Formulation ID="F015204857025" Rank="2" Units="cap">
              <Name>Cap</Name>
              <Brand ID="B01520485702525">
                <Name>Clinicians Multivit &amp; Mineral Boost</Name>
                <Pack ID="P2343827" Specified="true" nzmt:ctpp_id="50222361000117108">
                  <Quantity>180</Quantity>
                  <Price>23.35</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0152048575">
            <Name>Multivitamin renal</Name>
            <Request Form="RS1499" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Multivitamin renal</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">The patient has chronic kidney disease and is receiving either peritoneal dialysis or haemodialysis</ci>
                    <ci type="logical">The patient has chronic kidney disease grade 5, defined as patient with an estimated glomerular filtration rate of &lt; 15 ml/min/1.73m² body surface area (BSA)</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1499" style="display:none"/>
            <Formulation ID="F015204857525" Rank="2" Units="cap">
              <Name>Cap</Name>
              <Brand ID="B01520485752525">
                <Name>Clinicians Renal Vit</Name>
                <Pack ID="P2479168" Specified="true" nzmt:ctpp_id="50194501000117102">
                  <Quantity>30</Quantity>
                  <Price>7.28</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A015208">
          <Name>Vitamin A</Name>
          <Chemical ID="C0152089555">
            <Name>Retinol</Name>
            <Formulation ID="F015208955501" Rank="2" Units="cap" Weight="25000">
              <Name>Cap 25,000 iu</Name>
              <Brand ID="B01520895550100">
                <Name>Any</Name>
                <Pack ID="P95550100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015208955502" Rank="3" Units="ml">
              <Name>Oral liq 150,000 iu per ml</Name>
              <Brand ID="B01520895550200">
                <Name>Any</Name>
                <Pack ID="P95550200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015208955503" Rank="1" Units="tab" Weight="10000">
              <Name>Tab 10,000 iu</Name>
              <Brand ID="B01520895550300">
                <Name>Any</Name>
                <Pack ID="P95550300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015208955525" Rank="3" Units="ml" Weight="5000">
              <Name>Oral liq 5,000 iu per drop, 30 ml</Name>
              <Brand ID="B01520895552500">
                <Name>Any</Name>
                <Pack ID="P95552500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015208955526" Rank="3" Units="ml">
              <Name>Oral liq 666.7 mcg per 2 drops, 10 ml</Name>
              <Brand ID="B01520895552600">
                <Name>Any</Name>
                <Pack ID="P95552600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A015212">
          <Name>Vitamin B</Name>
          <Chemical ID="C0152128462">
            <Name>Thiamine hydrochloride</Name>
            <Formulation ID="F015212846201" Rank="4" Units="inj" Weight="200">
              <Name>Inj 100 mg per ml, 2 ml vial</Name>
              <Brand ID="B01521284620100">
                <Name>Any</Name>
                <Pack ID="P84620100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015212846202" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B01521284620200">
                <Name>Any</Name>
                <Pack ID="P84620200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015212846203" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B01521284620326" PSS="true">
                <Name>Thiamine multichem</Name>
                <Pack ID="P2646552" Specified="true" nzmt:ctpp_id="50298141000117104">
                  <Quantity>100</Quantity>
                  <Price>4.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015212846225" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg per ml, 1 ml vial</Name>
              <Brand ID="B01521284622500">
                <Name>e.g. Benerva</Name>
                <Pack ID="P84622500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0152128494">
            <Name>Vitamin B complex</Name>
            <Formulation ID="F015212849401" Rank="1" Units="tab">
              <Name>Tab strong, BPC</Name>
              <Brand ID="B01521284940125">
                <Name>Bplex</Name>
                <Pack ID="P2439700" Specified="true" nzmt:ctpp_id="50176651000117102">
                  <Quantity>500</Quantity>
                  <Price>11.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0152129284">
            <Name>Hydroxocobalamin</Name>
            <Formulation ID="F015212928426" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B01521292842627">
                <Name>Hydroxocobalamin Panpharma</Name>
                <Pack ID="P2637391" Specified="true" nzmt:ctpp_id="50251091000117105">
                  <Quantity>3</Quantity>
                  <Price>2.46</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0152129595">
            <Name>Pyridoxine hydrochloride</Name>
            <Formulation ID="F015212959501" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B01521295950100">
                <Name>Any</Name>
                <Pack ID="P95950100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015212959525" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B01521295952526" PSS="true">
                <Name>Vitamin B6 25</Name>
                <Pack ID="P2473534" Specified="true" nzmt:ctpp_id="50320741000117103">
                  <Quantity>90</Quantity>
                  <Price>3.43</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015212959526" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B01521295952626">
                <Name>Pyridoxine multichem</Name>
                <Pack ID="P2610582" Specified="true" nzmt:ctpp_id="50287641000117107">
                  <Quantity>500</Quantity>
                  <Price>23.45</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015212959527" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg per ml, 30 ml vial</Name>
              <Brand ID="B01521295952700">
                <Name>Any</Name>
                <Pack ID="P95952700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015212959528" Rank="4" Units="inj">
              <Name>Inj 100 mg per ml, 2 ml vial</Name>
              <Brand ID="B01521295952800">
                <Name>Any</Name>
                <Pack ID="P95952800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A015216">
          <Name>Vitamin C</Name>
          <Chemical ID="C0152169543">
            <Name>Ascorbic acid</Name>
            <Formulation ID="F015216954302" Rank="1" Units="tab" Weight="250">
              <Name>Tab chewable 250 mg</Name>
              <Brand ID="B01521695430200">
                <Name>Any</Name>
                <Pack ID="P95430200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015216954325" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-23 to~2025" Value="5"/>
              <Brand ID="B01521695432526" PSS="true">
                <Name>Cvite</Name>
                <Pack ID="P2642255" Specified="true" nzmt:ctpp_id="50176661000117100">
                  <Quantity>500</Quantity>
                  <Price>12.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A015220">
          <Name>Vitamin D</Name>
          <Chemical ID="C0152209124">
            <Name>Alfacalcidol</Name>
            <Formulation ID="F015220912401" Rank="3" Units="ml">
              <Name>Oral drops 2 mcg per ml</Name>
              <Brand ID="B01522091240125">
                <Name>One-Alpha</Name>
                <Pack ID="P315761" Specified="true" nzmt:ctpp_id="50070701000117102">
                  <Quantity>20</Quantity>
                  <Price>60.68</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015220912425" Rank="2" Units="cap" Weight="25">
              <Name>Cap 0.25 mcg</Name>
              <Brand ID="B01522091242525">
                <Name>One-Alpha</Name>
                <Pack ID="P203084" Specified="true" nzmt:ctpp_id="50005851000117106">
                  <Quantity>100</Quantity>
                  <Price>26.32</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015220912426" Rank="2" Units="cap" Weight="100">
              <Name>Cap 1 mcg</Name>
              <Brand ID="B01522091242625">
                <Name>One-Alpha</Name>
                <Pack ID="P203092" Specified="true" nzmt:ctpp_id="50005861000117108">
                  <Quantity>100</Quantity>
                  <Price>87.98</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0152209140">
            <Name>Calcitriol</Name>
            <Formulation ID="F015220914001" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mcg per ml, 1 ml ampoule</Name>
              <Brand ID="B01522091400100">
                <Name>Any</Name>
                <Pack ID="P91400100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015220914025" Rank="3" Units="ml" Weight="1">
              <Name>Oral liq 1 mcg per ml</Name>
              <Brand ID="B01522091402500">
                <Name>Any</Name>
                <Pack ID="P91402500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015220914026" Rank="2" Units="cap" Weight="0.25">
              <Name>Cap 0.25 mcg</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B01522091402625" PSS="true">
                <Name>Calcitriol-AFT</Name>
                <Pack ID="P2091038" Specified="true" nzmt:ctpp_id="50017291000117109">
                  <Quantity>100</Quantity>
                  <Price>7.89</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015220914027" Rank="2" Units="cap" Weight="0.5">
              <Name>Cap 0.5 mcg</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B01522091402725" PSS="true">
                <Name>Calcitriol-AFT</Name>
                <Pack ID="P2091011" Specified="true" nzmt:ctpp_id="50017281000117106">
                  <Quantity>100</Quantity>
                  <Price>13.68</Price>
                </Pack>
                <Pack ID="P2691663" nzmt:ctpp_id="50341591000117109">
                  <Quantity>100</Quantity>
                  <Price>13.68</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0152209261">
            <Name>Colecalciferol</Name>
            <Formulation ID="F015220926126" Rank="2" Units="cap" Weight="1">
              <Name>Cap 1.25 mg (50,000 iu)</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B01522092612625" PSS="true">
                <Name>Vit.D3</Name>
                <Pack ID="P2523590" Specified="true" nzmt:ctpp_id="50253791000117108">
                  <Quantity>12</Quantity>
                  <Price>3.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015220926127" Rank="3" Units="ml" Weight="188">
              <Name>Oral liq 188 mcg per ml (7,500 iu per ml)</Name>
              <Brand ID="B01522092612726">
                <Name>Clinicians</Name>
                <Pack ID="P2658429" Specified="true" nzmt:ctpp_id="50320931000117108">
                  <Quantity>5</Quantity>
                  <Price>9.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A015224">
          <Name>Vitamin E</Name>
          <Chemical ID="C0152248011">
            <Name>Alpha tocopheryl acetate</Name>
            <Request Form="RS1176" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Alpha tocopheryl acetate</range>
              </Title>
              <Case When="Initial application" Category="Cystic fibrosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Cystic fibrosis patient</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has tried and failed the other available funded fat soluble vitamin A,D,E,K supplement (Vitabdeck)</ci>
                      <ci type="logical">The other available funded fat soluble vitamin A,D,E,K supplement (Vitabdeck) is contraindicated or clinically inappropriate for the patient</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Osteoradionecrosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For the treatment of osteoradionecrosis</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Other indications">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Infant or child with liver disease or short gut syndrome</ci>
                    <ci type="logical">Requires vitamin supplementation</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has tried and failed the other available funded fat soluble vitamin A,D,E,K supplements (Vitabdeck)</ci>
                      <ci type="logical">The other available funded fat soluble vitamin A,D,E,K supplement (Vitabdeck) is contraindicated or clinically inappropriate for patient</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1176" style="display:none"/>
            <Formulation ID="F015224801101" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 u</Name>
              <Brand ID="B01522480110100">
                <Name>Any</Name>
                <Pack ID="P80110100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015224801102" Rank="2" Units="cap" Weight="500">
              <Name>Cap 500 u</Name>
              <Brand ID="B01522480110200">
                <Name>Any</Name>
                <Pack ID="P80110200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F015224801103" Rank="3" Units="ml">
              <Name>Oral liq 156 u per ml</Name>
              <Brand ID="B01522480110300">
                <Name>Any</Name>
                <Pack ID="P80110300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0152248622">
            <Name>Alpha tocopheryl</Name>
            <Request Form="RS1632" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Alpha tocopheryl</range>
              </Title>
              <Case When="Initial application" Category="Cystic fibrosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Cystic fibrosis patient</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has tried and failed the other available funded fat soluble vitamin A,D,E,K supplement (Vitabdeck)</ci>
                      <ci type="logical">The other available funded fat soluble vitamin A,D,E,K supplement (Vitabdeck) is contraindicated or clinically inappropriate for the patient</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Osteoradionecrosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For the treatment of osteoradionecrosis</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Other indications">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Infant or child with liver disease or short gut syndrome</ci>
                    <ci type="logical">Requires vitamin supplementation</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has tried and failed the other available funded fat soluble vitamin A,D,E,K supplements (Vitabdeck)</ci>
                      <ci type="logical">The other available funded fat soluble vitamin A,D,E,K supplement (Vitabdeck) is contraindicated or clinically inappropriate for patient</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1632" style="display:none"/>
            <Formulation ID="F015224862225" Rank="3" Units="ml" Weight="156">
              <Name>Oral liq 156 u per ml</Name>
              <Brand ID="B01522486222500">
                <Name>Any</Name>
                <Pack ID="P86222500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
    <ATC1 ID="A04">
      <Name>Blood and Blood Forming Organs</Name>
      <ATC2 ID="A0404">
        <Name>Antianaemics</Name>
        <ATC3 ID="A040404">
          <Name>Hypoplastic and Haemolytic</Name>
          <Chemical ID="C0404049019">
            <Name>Epoetin beta</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: Epoetin beta is considered a Discretionary Variance Pharmaceutical for epoetin alfa.</p>
            </div>
            <Request Form="RS1661" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Epoetin beta</range>
              </Title>
              <Case When="Initial application" Category="chronic renal failure">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient in chronic renal failure</ci>
                    <ci type="logical">Haemoglobin is less than or equal to 100g/L</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">Patient does not have diabetes mellitus</ci>
                        <ci type="logical">Glomerular filtration rate is less than or equal to 30ml/min</ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">Patient has diabetes mellitus</ci>
                        <ci type="logical">Glomerular filtration rate is less than or equal to 45ml/min</ci>
                      </apply>
                    </apply>
                    <ci type="logical">Patient is on haemodialysis or peritoneal dialysis</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="myelodysplasia*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has a confirmed diagnosis of myelodysplasia (MDS)</ci>
                    <ci type="logical">Has had symptomatic anaemia with haemoglobin &lt; 100g/L and is red cell transfusion-dependent</ci>
                    <ci type="logical">Patient has very low, low or intermediate risk MDS based on the WHO classification-based prognostic scoring system for myelodysplastic syndrome (WPSS)</ci>
                    <ci type="logical">Other causes of anaemia such as B12 and folate deficiency have been excluded</ci>
                    <ci type="logical">Patient has a serum epoetin level of &lt; 500 IU/L</ci>
                    <ci type="logical">The minimum necessary dose of epoetin would be used and will not exceed 80,000 iu per week</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="myelodysplasia*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient's transfusion requirement continues to be reduced with epoetin treatment</ci>
                    <ci type="logical">Transformation to acute myeloid leukaemia has not occurred</ci>
                    <ci type="logical">The minimum necessary dose of epoetin would be used and will not exceed 80,000 iu per week</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">2</Term>
              </Case>
              <Case When="Initial application" Category="all other indications">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Haematologist</ci>
                    <ci type="logical">For use in patients where blood transfusion is not a viable treatment alternative</ci>
                    <ci type="logical">*Note: Indications marked with * are unapproved indications</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1661" style="display:none"/>
            <Formulation ID="F040404901902" Rank="4" Units="inj" Weight="10000">
              <Name>Inj 10,000 iu in 0.6 ml syringe</Name>
              <Brand ID="B04040490190200">
                <Name>Any</Name>
                <Pack ID="P90190200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040404901903" Rank="4" Units="inj" Weight="2000">
              <Name>Inj 2,000 iu in 0.3 ml syringe</Name>
              <Brand ID="B04040490190300">
                <Name>Any</Name>
                <Pack ID="P90190300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040404901904" Rank="4" Units="inj" Weight="3000">
              <Name>Inj 3,000 iu in 0.3 ml syringe</Name>
              <Brand ID="B04040490190400">
                <Name>Any</Name>
                <Pack ID="P90190400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040404901905" Rank="4" Units="inj" Weight="4000">
              <Name>Inj 4,000 iu in 0.3 ml syringe</Name>
              <Brand ID="B04040490190500">
                <Name>Any</Name>
                <Pack ID="P90190500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040404901906" Rank="4" Units="inj" Weight="5000">
              <Name>Inj 5,000 iu in 0.3 ml syringe</Name>
              <Brand ID="B04040490190600">
                <Name>Any</Name>
                <Pack ID="P90190600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040404901907" Rank="4" Units="inj" Weight="6000">
              <Name>Inj 6,000 iu in 0.3 ml syringe</Name>
              <Brand ID="B04040490190700">
                <Name>Any</Name>
                <Pack ID="P90190700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0404049444">
            <Name>Epoetin alfa</Name>
            <Request Form="RS1660" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Epoetin alfa</range>
              </Title>
              <Case When="Initial application" Category="chronic renal failure">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient in chronic renal failure</ci>
                    <ci type="logical">Haemoglobin is less than or equal to 100g/L</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">Patient does not have diabetes mellitus</ci>
                        <ci type="logical">Glomerular filtration rate is less than or equal to 30ml/min</ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">Patient has diabetes mellitus</ci>
                        <ci type="logical">Glomerular filtration rate is less than or equal to 45ml/min</ci>
                      </apply>
                    </apply>
                    <ci type="logical">Patient is on haemodialysis or peritoneal dialysis</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="myelodysplasia*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has a confirmed diagnosis of myelodysplasia (MDS)</ci>
                    <ci type="logical">Has had symptomatic anaemia with haemoglobin &lt; 100g/L and is red cell transfusion-dependent</ci>
                    <ci type="logical">Patient has very low, low or intermediate risk MDS based on the WHO classification-based prognostic scoring system for myelodysplastic syndrome (WPSS)</ci>
                    <ci type="logical">Other causes of anaemia such as B12 and folate deficiency have been excluded</ci>
                    <ci type="logical">Patient has a serum epoetin level of &lt; 500 IU/L</ci>
                    <ci type="logical">The minimum necessary dose of epoetin would be used and will not exceed 80,000 iu per week</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">2</Term>
              </Case>
              <Case When="Renewal" Category="myelodysplasia*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient's transfusion requirement continues to be reduced with epoetin treatment</ci>
                    <ci type="logical">Transformation to acute myeloid leukaemia has not occurred</ci>
                    <ci type="logical">The minimum necessary dose of epoetin would be used and will not exceed 80,000 iu per week</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="all other indications">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For use in patients where blood transfusion is not a viable treatment alternative</ci>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1660" style="display:none"/>
            <Formulation ID="F040404944425" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1,000 iu in 0.5 ml syringe</Name>
              <Brand ID="B04040494442526">
                <Name>Binocrit</Name>
                <Pack ID="P2559765" Specified="true" nzmt:ctpp_id="50133501000117106">
                  <Quantity>6</Quantity>
                  <Price>250.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040404944427" Rank="4" Units="inj" Weight="3000">
              <Name>Inj 3,000 iu in 0.3 ml syringe</Name>
              <Brand ID="B04040494442726">
                <Name>Binocrit</Name>
                <Pack ID="P2559781" Specified="true" nzmt:ctpp_id="50133511000117109">
                  <Quantity>6</Quantity>
                  <Price>150.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040404944428" Rank="4" Units="inj" Weight="4000">
              <Name>Inj 4,000 iu in 0.4 ml syringe</Name>
              <Brand ID="B04040494442826">
                <Name>Binocrit</Name>
                <Pack ID="P2559803" Specified="true" nzmt:ctpp_id="50133521000117103">
                  <Quantity>6</Quantity>
                  <Price>96.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040404944429" Rank="4" Units="inj" Weight="5000">
              <Name>Inj 5,000 iu in 0.5 ml syringe</Name>
              <Brand ID="B04040494442926">
                <Name>Binocrit</Name>
                <Pack ID="P2559811" Specified="true" nzmt:ctpp_id="50133531000117100">
                  <Quantity>6</Quantity>
                  <Price>125.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040404944430" Rank="4" Units="inj" Weight="6000">
              <Name>Inj 6,000 iu in 0.6 ml syringe</Name>
              <Brand ID="B04040494443026">
                <Name>Binocrit</Name>
                <Pack ID="P2559838" Specified="true" nzmt:ctpp_id="50133541000117108">
                  <Quantity>6</Quantity>
                  <Price>145.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040404944431" Rank="4" Units="inj" Weight="10000">
              <Name>Inj 10,000 iu in 1 ml syringe</Name>
              <Brand ID="B04040494443126">
                <Name>Binocrit</Name>
                <Pack ID="P2559854" Specified="true" nzmt:ctpp_id="50133581000117104">
                  <Quantity>6</Quantity>
                  <Price>197.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040404944432" Rank="4" Units="inj" Weight="8000">
              <Name>Inj 8,000 iu in 0.8 ml syringe</Name>
              <Brand ID="B04040494443226">
                <Name>Binocrit</Name>
                <Pack ID="P2559846" Specified="true" nzmt:ctpp_id="50133561000117107">
                  <Quantity>6</Quantity>
                  <Price>175.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040404944433" Rank="4" Units="inj" Weight="40000">
              <Name>Inj 40,000 iu in 1 ml syringe</Name>
              <Brand ID="B04040494443326">
                <Name>Binocrit</Name>
                <Pack ID="P2559862" Specified="true" nzmt:ctpp_id="50135731000117109">
                  <Quantity>1</Quantity>
                  <Price>250.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040404944434" Rank="4" Units="inj" Weight="2000">
              <Name>inj 2,000 iu in 1 ml syringe</Name>
              <Brand ID="B04040494443425">
                <Name>Binocrit</Name>
                <Pack ID="P2559773" Specified="true" nzmt:ctpp_id="50133491000117100">
                  <Quantity>6</Quantity>
                  <Price>100.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A040408">
          <Name>Megaloblastic</Name>
          <Chemical ID="C0404089244">
            <Name>Folic acid</Name>
            <Formulation ID="F040408924401" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 10 ml vial</Name>
              <Brand ID="B04040892440100">
                <Name>Any</Name>
                <Pack ID="P92440100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040408924402" Rank="1" Units="tab" Weight="0.8">
              <Name>Tab 0.8 mg</Name>
              <Brand ID="B04040892440226">
                <Name>Folic Acid multichem</Name>
                <Pack ID="P2610566" Specified="true" nzmt:ctpp_id="50292241000117108">
                  <Quantity>1000</Quantity>
                  <Price>26.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040408924403" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2027" Value="1"/>
              <Brand ID="B04040892440327" HSS="true">
                <Name>Folic Acid Viatris</Name>
                <Pack ID="P2633450" Specified="true" nzmt:ctpp_id="50292151000117104">
                  <Quantity>100</Quantity>
                  <Price>5.82</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040408924425" Rank="3" Units="ml" Weight="50">
              <Name>Oral liq 50 mcg per ml</Name>
              <Brand ID="B04040892442525">
                <Name>Biomed</Name>
                <Pack ID="P344850" Specified="true" nzmt:ctpp_id="50075821000117108">
                  <Quantity>25</Quantity>
                  <Price>30.26</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0408">
        <Name>Antifibrinolytics, Haemostatics and Local Sclerosants</Name>
        <ATC3 ID="A040804">
          <Name>Antifibrinolytics, Haemostatics and Local Sclerosants</Name>
          <Chemical ID="C0408048183">
            <Name>Ferric subsulfate</Name>
            <Formulation ID="F040804818301" Rank="3" Units="ml">
              <Name>Gel 25.9%</Name>
              <Brand ID="B04080481830100">
                <Name>Any</Name>
                <Pack ID="P81830100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040804818302" Rank="3" Units="ml">
              <Name>Soln 500 ml</Name>
              <Brand ID="B04080481830200">
                <Name>Any</Name>
                <Pack ID="P81830200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0408048371">
            <Name>Polidocanol</Name>
            <Formulation ID="F040804837101" Rank="4" Units="inj">
              <Name>Inj 0.5%, 30 ml vial</Name>
              <Brand ID="B04080483710100">
                <Name>Any</Name>
                <Pack ID="P83710100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0408048437">
            <Name>Sodium tetradecyl sulphate</Name>
            <Formulation ID="F040804843701" Rank="4" Units="inj">
              <Name>Inj 3%, 2 ml ampoule</Name>
              <Brand ID="B04080484370100">
                <Name>Any</Name>
                <Pack ID="P84370100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0408048467">
            <Name>Thrombin</Name>
            <Formulation ID="F040804846701" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B04080484670100">
                <Name>Any</Name>
                <Pack ID="P84670100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0408048531">
            <Name>Aprotinin</Name>
            <Request Form="RS1332" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Aprotinin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Paediatric patient undergoing cardiopulmonary bypass procedure</ci>
                    <ci type="logical">Adult patient undergoing cardiac surgical procedure where the significant risk of massive bleeding outweighs the potential adverse effects of the drug</ci>
                  </apply>
                </math>
                <Applicant>cardiac anaesthetist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1332" style="display:none"/>
            <Formulation ID="F040804853125" Rank="4" Units="inj">
              <Name>Inj 10,000 kIU per ml (equivalent to 200 mg per ml), 50 ml vial</Name>
              <Brand ID="B04080485312500">
                <Name>Any</Name>
                <Pack ID="P85312500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0408048540">
            <Name>Eltrombopag</Name>
            <Request Form="RS1648" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Eltrombopag</range>
              </Title>
              <Case When="Initial application" Category="idiopathic thrombocytopenic purpura - post-splenectomy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has had a splenectomy</ci>
                    <ci type="logical">Two immunosuppressive therapies have been trialled and failed after therapy of 3 months each (or 1 month for rituximab)</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has a platelet count of 20,000 to 30,000 platelets per microlitre and has evidence of significant mucocutaneous bleeding</ci>
                      <ci type="logical">Patient has a platelet count of less than or equal to 20,000 platelets per microlitre and has evidence of active bleeding</ci>
                      <ci type="logical">Patient has a platelet count of less than or equal to 10,000 platelets per microlitre</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="week">6</Term>
              </Case>
              <Case When="Initial application" Category="idiopathic thrombocytopenic purpura - preparation for splenectomy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The patient requires eltrombopag treatment as preparation for splenectomy</ci>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="week">6</Term>
              </Case>
              <Case When="Renewal" Category="idiopathic thrombocytopenic purpura - post-splenectomy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The patient has obtained a response (see Note) from treatment during the initial approval or subsequent renewal periods and further treatment is required</ci>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Response to treatment is defined as a platelet count of &gt; 30,000 platelets per microlitre</p>
                </div>
              </Case>
              <Case When="Initial application" Category="idiopathic thrombocytopenic purpura contraindicated to splenectomy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has a significant and well-documented contraindication to splenectomy for clinical reasons</ci>
                    <ci type="logical">Two immunosuppressive therapies have been trialled and failed after therapy of 3 months each (or 1 month for rituximab)</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has immune thrombocytopenic purpura* with a platelet count of less than or equal to 20,000 platelets per microliter</ci>
                      <ci type="logical">Patient has immune thrombocytopenic purpura* with a platelet count of 20,000 to 30,000 platelets per microlitre and significant mucocutaneous bleeding</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">3</Term>
              </Case>
              <Case When="Renewal" Category="idiopathic thrombocytopenic purpura contraindicated to splenectomy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient’s significant contraindication to splenectomy remains</ci>
                    <ci type="logical">The patient has obtained a response from treatment during the initial approval period</ci>
                    <ci type="logical">Patient has maintained a platelet count of at least 50,000 platelets per microlitre on treatment</ci>
                    <ci type="logical">Further treatment with eltrombopag is required to maintain response</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="severe aplastic anaemia">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Two immunosuppressive therapies have been trialled and failed after therapy of at least 3 months duration</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has severe aplastic anaemia with a platelet count of less than or equal to 20,000 platelets per microliter</ci>
                      <ci type="logical">Patient has severe aplastic anaemia with a platelet count of 20,000 to 30,000 platelets per microlitre and significant mucocutaneous bleeding</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">3</Term>
              </Case>
              <Case When="Renewal" Category="severe aplastic anaemia">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has obtained a response from treatment of at least 20,000 platelets per microlitre above baseline during the initial approval period</ci>
                    <ci type="logical">Platelet transfusion independence for a minimum of 8 weeks during the initial approval period</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1648" style="display:none"/>
            <Formulation ID="F040804854025" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Brand ID="B04080485402525">
                <Name>Revolade</Name>
                <Pack ID="P2391406" Specified="true" nzmt:ctpp_id="50125751000117102">
                  <Quantity>28</Quantity>
                  <Price>1550.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040804854026" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B04080485402625">
                <Name>Revolade</Name>
                <Pack ID="P2391414" Specified="true" nzmt:ctpp_id="50125741000117104">
                  <Quantity>28</Quantity>
                  <Price>3100.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0408048576">
            <Name>Aluminium chloride</Name>
            <Request Form="RS1500" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Aluminium chloride</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For use as a haemostatis agent</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1500" style="display:none"/>
            <Formulation ID="F040804857625" Rank="3" Units="ml">
              <Name>Topical soln 20% w/v</Name>
              <Brand ID="B04080485762500">
                <Name>e.g. Driclor</Name>
                <Pack ID="P85762500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0408048660">
            <Name>Emicizumab</Name>
            <Request Form="RS1998" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Emicizumab</range>
              </Title>
              <Case When="Initial application" Category="Severe Haemophilia A with or without FVIII inhibitors">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has severe congenital haemophilia A with a severe bleeding phenotype (endogenous factor VIII activity less than or equal to 2%)</ci>
                    <ci type="logical">Emicizumab is to be administered at a dose of no greater than 3 mg/kg weekly for 4 weeks followed by the equivalent of 1.5 mg/kg weekly</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1998" style="display:none"/>
            <Formulation ID="F040804866025" Rank="4" Units="inj" Weight="30">
              <Name>Inj 30 mg in 1 ml vial</Name>
              <Brand ID="B04080486602525">
                <Name>Hemlibra</Name>
                <Pack ID="P2553511" Specified="true" nzmt:ctpp_id="50247471000117105">
                  <Quantity>1</Quantity>
                  <Price>3570.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040804866026" Rank="4" Units="inj" Weight="60">
              <Name>Inj 60 mg in 0.4 ml vial</Name>
              <Brand ID="B04080486602625">
                <Name>Hemlibra</Name>
                <Pack ID="P2553546" Specified="true" nzmt:ctpp_id="50247481000117108">
                  <Quantity>1</Quantity>
                  <Price>7138.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040804866027" Rank="4" Units="inj" Weight="105">
              <Name>Inj 105 mg in 0.7 ml vial</Name>
              <Brand ID="B04080486602725">
                <Name>Hemlibra</Name>
                <Pack ID="P2553554" Specified="true" nzmt:ctpp_id="50247491000117106">
                  <Quantity>1</Quantity>
                  <Price>12492.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040804866028" Rank="4" Units="inj" Weight="150">
              <Name>Inj 150 mg in 1 ml vial</Name>
              <Brand ID="B04080486602825">
                <Name>Hemlibra</Name>
                <Pack ID="P2553538" Specified="true" nzmt:ctpp_id="50247501000117100">
                  <Quantity>1</Quantity>
                  <Price>17846.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0408049149">
            <Name>Tranexamic acid</Name>
            <Formulation ID="F040804914925" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-23 to~2025" Value="5"/>
              <Brand ID="B04080491492526" PSS="true">
                <Name>Mercury Pharma</Name>
                <Pack ID="P2574020" Specified="true" nzmt:ctpp_id="50126681000117109">
                  <Quantity>60</Quantity>
                  <Price>10.45</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040804914926" Rank="4" Units="inj" Weight="500">
              <Name>Inj 100 mg per ml, 5 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B04080491492626" PSS="true">
                <Name>Tranexamic-AFT</Name>
                <Pack ID="P2497166" Specified="true" nzmt:ctpp_id="50222371000117103">
                  <Quantity>5</Quantity>
                  <Price>5.39</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040804914927" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 100 mg per ml, 10 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B04080491492725" PSS="true">
                <Name>Tranexamic-AFT</Name>
                <Pack ID="P2497174" Specified="true" nzmt:ctpp_id="50222431000117106">
                  <Quantity>5</Quantity>
                  <Price>7.99</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A040806">
          <Name>Anticoagulant Reversal Agents</Name>
          <Chemical ID="C0408068596">
            <Name>Idarucizumab</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1535">
              <Title>
                <range>Idarucizumab</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For the reversal of the anticoagulant effects of dabigatran when required in situations of life-threatening or uncontrolled bleeding, or for emergency surgery or urgent procedures</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1535" style="display:none"/>
            <Formulation ID="F040806859625" Rank="4" Units="inj" Weight="2500">
              <Name>Inj 50 mg per ml, 50 ml vial</Name>
              <Brand ID="B04080685962525">
                <Name>Praxbind</Name>
                <Pack ID="P2491435" Specified="true" nzmt:ctpp_id="50221401000117109">
                  <Quantity>2</Quantity>
                  <Price>4250.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A040808">
          <Name>Blood Factors</Name>
          <Chemical ID="C0408088309">
            <Name>Moroctocog alfa [Recombinant factor VIII]</Name>
            <Request Form="RS1706" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Moroctocog alfa [Recombinant factor VIII]</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For patients with haemophilia. Rare Clinical Circumstances Brand of short half-life recombinant factor VIII. Access to funded treatment is managed by the Haemophilia Treaters Group in conjunction with the National Haemophilia Management Group, subject to criteria</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1706" style="display:none"/>
            <Formulation ID="F040808830901" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1,000 iu prefilled syringe</Name>
              <Brand ID="B04080883090125">
                <Name>Xyntha</Name>
                <Pack ID="P2424355" Specified="true" nzmt:ctpp_id="50158271000117106">
                  <Quantity>1</Quantity>
                  <Price>1150.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808830902" Rank="4" Units="inj" Weight="2000">
              <Name>Inj 2,000 iu prefilled syringe</Name>
              <Brand ID="B04080883090225">
                <Name>Xyntha</Name>
                <Pack ID="P2424363" Specified="true" nzmt:ctpp_id="50166001000117101">
                  <Quantity>1</Quantity>
                  <Price>2300.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808830903" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 iu prefilled syringe</Name>
              <Brand ID="B04080883090325">
                <Name>Xyntha</Name>
                <Pack ID="P2424339" Specified="true" nzmt:ctpp_id="50158261000117101">
                  <Quantity>1</Quantity>
                  <Price>287.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808830904" Rank="4" Units="inj" Weight="3000">
              <Name>Inj 3,000 iu prefilled syringe</Name>
              <Brand ID="B04080883090425">
                <Name>Xyntha</Name>
                <Pack ID="P2424371" Specified="true" nzmt:ctpp_id="50178631000117108">
                  <Quantity>1</Quantity>
                  <Price>3450.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808830905" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 iu prefilled syringe</Name>
              <Brand ID="B04080883090525">
                <Name>Xyntha</Name>
                <Pack ID="P2424347" Specified="true" nzmt:ctpp_id="50158251000117103">
                  <Quantity>1</Quantity>
                  <Price>575.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0408088321">
            <Name>Octocog alfa [Recombinant factor VIII] (Advate)</Name>
            <Request Form="RS1707" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Octocog alfa [Recombinant factor VIII] (Advate)</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For patients with haemophilia. Preferred Brand of short half-life recombinant factor VIII. Access to funded treatment is managed by the Haemophilia Treaters Group in conjunction with the National Haemophilia Management Group</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1707" style="display:none"/>
            <Formulation ID="F040808832101" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1,000 iu vial</Name>
              <Brand ID="B04080883210125">
                <Name>Advate</Name>
                <Pack ID="P2292726" Specified="true" nzmt:ctpp_id="50044951000117108">
                  <Quantity>1</Quantity>
                  <Price>840.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808832102" Rank="4" Units="inj" Weight="1500">
              <Name>Inj 1,500 iu vial</Name>
              <Brand ID="B04080883210225">
                <Name>Advate</Name>
                <Pack ID="P2292742" Specified="true" nzmt:ctpp_id="50044961000117105">
                  <Quantity>1</Quantity>
                  <Price>1260.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808832103" Rank="4" Units="inj" Weight="2000">
              <Name>Inj 2,000 iu vial</Name>
              <Brand ID="B04080883210325">
                <Name>Advate</Name>
                <Pack ID="P2292750" Specified="true" nzmt:ctpp_id="50044971000117100">
                  <Quantity>1</Quantity>
                  <Price>1680.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808832104" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 iu vial</Name>
              <Brand ID="B04080883210425">
                <Name>Advate</Name>
                <Pack ID="P2292696" Specified="true" nzmt:ctpp_id="50044931000117103">
                  <Quantity>1</Quantity>
                  <Price>210.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808832105" Rank="4" Units="inj" Weight="3000">
              <Name>Inj 3,000 iu vial</Name>
              <Brand ID="B04080883210525">
                <Name>Advate</Name>
                <Pack ID="P2292769" Specified="true" nzmt:ctpp_id="50044981000117102">
                  <Quantity>1</Quantity>
                  <Price>2520.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808832106" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 iu vial</Name>
              <Brand ID="B04080883210625">
                <Name>Advate</Name>
                <Pack ID="P2292718" Specified="true" nzmt:ctpp_id="50044941000117106">
                  <Quantity>1</Quantity>
                  <Price>420.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0408088426">
            <Name>Octocog alfa [Recombinant factor VIII] (Kogenate FS)</Name>
            <Request Form="RS1708" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Octocog alfa [Recombinant factor VIII] (Kogenate FS)</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For patients with haemophilia. Rare Clinical Circumstances Brand of short half-life recombinant factor VIII. Access to funded treatment is managed by the Haemophilia Treaters Group in conjunction with the National Haemophilia Management Group, subject to criteria</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1708" style="display:none"/>
            <Formulation ID="F040808842601" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1,000 iu vial</Name>
              <Brand ID="B04080884260126">
                <Name>Kogenate FS</Name>
                <Pack ID="P2461811" Specified="true" nzmt:ctpp_id="50030571000117104">
                  <Quantity>1</Quantity>
                  <Price>950.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808842603" Rank="4" Units="inj" Weight="2000">
              <Name>Inj 2,000 iu vial</Name>
              <Brand ID="B04080884260326">
                <Name>Kogenate FS</Name>
                <Pack ID="P2328534" Specified="true" nzmt:ctpp_id="50049311000117107">
                  <Quantity>1</Quantity>
                  <Price>1900.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808842604" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 iu vial</Name>
              <Brand ID="B04080884260426">
                <Name>Kogenate FS</Name>
                <Pack ID="P2461366" Specified="true" nzmt:ctpp_id="50030561000117109">
                  <Quantity>1</Quantity>
                  <Price>237.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808842605" Rank="4" Units="inj" Weight="3000">
              <Name>Inj 3,000 iu vial</Name>
              <Brand ID="B04080884260526">
                <Name>Kogenate FS</Name>
                <Pack ID="P2402882" Specified="true" nzmt:ctpp_id="50131741000117104">
                  <Quantity>1</Quantity>
                  <Price>2850.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808842606" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 iu vial</Name>
              <Brand ID="B04080884260626">
                <Name>Kogenate FS</Name>
                <Pack ID="P2461803" Specified="true" nzmt:ctpp_id="50030581000117101">
                  <Quantity>1</Quantity>
                  <Price>475.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0408088580">
            <Name>Nonacog gamma, [Recombinant factor IX]</Name>
            <Request Form="RS1679" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Nonacog gamma</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For patients with haemophilia. Access to funded treatment is managed by the Haemophilia Treaters Group in conjunction with the National Haemophilia Management Group</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1679" style="display:none"/>
            <Formulation ID="F040808858026" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 iu vial</Name>
              <Brand ID="B04080885802625">
                <Name>RIXUBIS</Name>
                <Pack ID="P2487942" Specified="true" nzmt:ctpp_id="50224571000117104">
                  <Quantity>1</Quantity>
                  <Price>435.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808858027" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1,000 iu vial</Name>
              <Brand ID="B04080885802725">
                <Name>RIXUBIS</Name>
                <Pack ID="P2487896" Specified="true" nzmt:ctpp_id="50224581000117101">
                  <Quantity>1</Quantity>
                  <Price>870.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808858028" Rank="4" Units="inj" Weight="2000">
              <Name>Inj 2,000 iu vial</Name>
              <Brand ID="B04080885802825">
                <Name>RIXUBIS</Name>
                <Pack ID="P2487950" Specified="true" nzmt:ctpp_id="50224591000117103">
                  <Quantity>1</Quantity>
                  <Price>1740.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808858029" Rank="4" Units="inj" Weight="3000">
              <Name>Inj 3,000 iu vial</Name>
              <Brand ID="B04080885802925">
                <Name>RIXUBIS</Name>
                <Pack ID="P2487918" Specified="true" nzmt:ctpp_id="50224601000117109">
                  <Quantity>1</Quantity>
                  <Price>2610.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0408088639">
            <Name>Rurioctocog alfa pegol [Recombinant factor VIII]</Name>
            <Request Form="RS1682" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Rurioctocog alfa pegol [Recombinant factor VIII]</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For patients with haemophilia A receiving prophylaxis treatment. Access to funded treatment is managed by the Haemophilia Treaters Group in conjunction with the National Haemophilia Management Group</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1682" style="display:none"/>
            <Formulation ID="F040808863925" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 iu vial</Name>
              <Brand ID="B04080886392525">
                <Name>Adynovate</Name>
                <Pack ID="P2561115" Specified="true" nzmt:ctpp_id="50234041000117102">
                  <Quantity>1</Quantity>
                  <Price>300.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808863926" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 iu vial</Name>
              <Brand ID="B04080886392625">
                <Name>Adynovate</Name>
                <Pack ID="P2561123" Specified="true" nzmt:ctpp_id="50234051000117100">
                  <Quantity>1</Quantity>
                  <Price>600.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808863927" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1,000 iu vial</Name>
              <Brand ID="B04080886392725">
                <Name>Adynovate</Name>
                <Pack ID="P2561131" Specified="true" nzmt:ctpp_id="50234061000117103">
                  <Quantity>1</Quantity>
                  <Price>1200.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808863928" Rank="4" Units="inj" Weight="2000">
              <Name>Inj 2,000 iu vial</Name>
              <Brand ID="B04080886392825">
                <Name>Adynovate</Name>
                <Pack ID="P2561158" Specified="true" nzmt:ctpp_id="50234071000117108">
                  <Quantity>1</Quantity>
                  <Price>2400.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0408088640">
            <Name>Eftrenonacog alfa [Recombinant factor IX]</Name>
            <Request Form="RS1684" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Eftrenonacog alfa</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For patients with haemophilia B receiving prophylaxis treatment. Access to funded treatment is managed by the Haemophilia Treaters Group in conjunction with the National Haemophilia Management Group</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1684" style="display:none"/>
            <Formulation ID="F040808864025" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 iu vial</Name>
              <Brand ID="B04080886402525">
                <Name>Alprolix</Name>
                <Pack ID="P2565846" Specified="true" nzmt:ctpp_id="50213551000117103">
                  <Quantity>1</Quantity>
                  <Price>612.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808864026" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 iu vial</Name>
              <Brand ID="B04080886402625">
                <Name>Alprolix</Name>
                <Pack ID="P2565854" Specified="true" nzmt:ctpp_id="50213561000117101">
                  <Quantity>1</Quantity>
                  <Price>1225.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808864027" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1,000 iu vial</Name>
              <Brand ID="B04080886402725">
                <Name>Alprolix</Name>
                <Pack ID="P2565862" Specified="true" nzmt:ctpp_id="50213571000117106">
                  <Quantity>1</Quantity>
                  <Price>2450.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808864028" Rank="4" Units="inj" Weight="2000">
              <Name>Inj 2,000 iu vial</Name>
              <Brand ID="B04080886402825">
                <Name>Alprolix</Name>
                <Pack ID="P2565870" Specified="true" nzmt:ctpp_id="50213581000117109">
                  <Quantity>1</Quantity>
                  <Price>4900.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808864029" Rank="4" Units="inj" Weight="3000">
              <Name>Inj 3,000 iu vial</Name>
              <Brand ID="B04080886402925">
                <Name>Alprolix</Name>
                <Pack ID="P2565889" Specified="true" nzmt:ctpp_id="50213591000117107">
                  <Quantity>1</Quantity>
                  <Price>7350.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808864030" Rank="4" Units="inj" Weight="4000">
              <Name>Inj 4,000 iu vial</Name>
              <Brand ID="B04080886403025">
                <Name>Alprolix</Name>
                <Pack ID="P2636069" Specified="true" nzmt:ctpp_id="50274791000117108">
                  <Quantity>1</Quantity>
                  <Price>9800.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0408089622">
            <Name>Factor eight inhibitor bypassing fraction</Name>
            <Request Form="RS1705" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Factor eight inhibitor bypassing fraction</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For patients with haemophilia. Preferred Brand of bypassing agent for &gt;14 days predicted use. Access to funded treatment is managed by the Haemophilia Treaters Group in conjunction with the National Haemophilia Management Group</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1705" style="display:none"/>
            <Formulation ID="F040808962225" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 U</Name>
              <Brand ID="B04080896222525">
                <Name>FEIBA NF</Name>
                <Pack ID="P2583992" Specified="true" nzmt:ctpp_id="50268721000117107">
                  <Quantity>1</Quantity>
                  <Price>1315.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808962226" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1,000 U</Name>
              <Brand ID="B04080896222625">
                <Name>FEIBA NF</Name>
                <Pack ID="P2388804" Specified="true" nzmt:ctpp_id="50125351000117103">
                  <Quantity>1</Quantity>
                  <Price>2630.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808962227" Rank="4" Units="inj" Weight="2500">
              <Name>Inj 2,500 U</Name>
              <Brand ID="B04080896222725">
                <Name>FEIBA NF</Name>
                <Pack ID="P2487926" Specified="true" nzmt:ctpp_id="50210621000117103">
                  <Quantity>1</Quantity>
                  <Price>6575.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0408089654">
            <Name>Eptacog alfa [Recombinant factor VIIa]</Name>
            <Request Form="RS1704" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Eptacog alfa</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For patients with haemophilia. Access to funded treatment is managed
                by the Haemophilia Treaters Group in conjunction with the National Haemophilia
                Management Group. Rare Clinical Circumstances Brand of bypassing agent for &gt;14 days
                predicted use. Access to funded treatment for &gt;14 days predicted use is by named
                patient application to the Haemophilia Treaters Group, subject to access
                criteria</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1704" style="display:none"/>
            <Formulation ID="F040808965425" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg syringe</Name>
              <Brand ID="B04080896542525">
                <Name>NovoSeven RT</Name>
                <Pack ID="P2404311" Specified="true" nzmt:ctpp_id="50178411000117101">
                  <Quantity>1</Quantity>
                  <Price>1178.30</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808965426" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2 mg syringe</Name>
              <Brand ID="B04080896542625">
                <Name>NovoSeven RT</Name>
                <Pack ID="P2404338" Specified="true" nzmt:ctpp_id="50178421000117107">
                  <Quantity>1</Quantity>
                  <Price>2356.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808965427" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg syringe</Name>
              <Brand ID="B04080896542725">
                <Name>NovoSeven RT</Name>
                <Pack ID="P2404346" Specified="true" nzmt:ctpp_id="50178431000117105">
                  <Quantity>1</Quantity>
                  <Price>5891.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040808965428" Rank="4" Units="inj" Weight="8">
              <Name>Inj 8 mg syringe</Name>
              <Brand ID="B04080896542825">
                <Name>NovoSeven RT</Name>
                <Pack ID="P2427184" Specified="true" nzmt:ctpp_id="50137201000117104">
                  <Quantity>1</Quantity>
                  <Price>9426.40</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A040812">
          <Name>Vitamin K</Name>
          <Chemical ID="C0408129224">
            <Name>Phytomenadione</Name>
            <Formulation ID="F040812922426" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2 mg in 0.2 ml ampoule</Name>
              <Brand ID="B04081292242625">
                <Name>Konakion MM</Name>
                <Pack ID="P911828" Specified="true" nzmt:ctpp_id="50117821000117103">
                  <Quantity>5</Quantity>
                  <Price>8.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F040812922427" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B04081292242725">
                <Name>Konakion MM</Name>
                <Pack ID="P298204" Specified="true" nzmt:ctpp_id="50066441000117103">
                  <Quantity>5</Quantity>
                  <Price>9.21</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0412">
        <Name>Antithrombotics</Name>
        <ATC3 ID="A041204">
          <Name>Anticoagulants</Name>
          <Chemical ID="C0412048061">
            <Name>Bivalirudin</Name>
            <Request Form="RS1181" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Bivalirudin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">For use in heparin-induced thrombocytopaenia, heparin resistance or heparin intolerance</ci>
                    <ci type="logical">For use in patients undergoing endovascular procedures</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1181" style="display:none"/>
            <Formulation ID="F041204806101" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 mg vial</Name>
              <Brand ID="B04120480610100">
                <Name>Any</Name>
                <Pack ID="P80610100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412048124">
            <Name>Danaparoid</Name>
            <Request Form="RS1182" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Danaparoid</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For use in heparin-induced thrombocytopaenia, heparin resistance or heparin intolerance</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1182" style="display:none"/>
            <Formulation ID="F041204812401" Rank="4" Units="inj" Weight="750">
              <Name>Inj 750 u in 0.6 ml ampoule</Name>
              <Brand ID="B04120481240100">
                <Name>Any</Name>
                <Pack ID="P81240100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412048128">
            <Name>Defibrotide</Name>
            <Request Form="RS1183" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Defibrotide</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has moderate or severe sinusoidal obstruction syndrome as a result of chemotherapy or regimen-related toxicities</ci>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1183" style="display:none"/>
            <Formulation ID="F041204812801" Rank="4" Units="inj" Weight="80">
              <Name>Inj 80 mg per ml, 2.5 ml ampoule</Name>
              <Brand ID="B04120481280100">
                <Name>Any</Name>
                <Pack ID="P81280100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412048134">
            <Name>Dextrose with sodium citrate and citric acid [Acid Citrate Dextrose A]</Name>
            <Formulation ID="F041204813401" Rank="4" Units="inj" Weight="24.5">
              <Name>Inj 24.5 mg with sodium citrate 22 mg and citric acid 7.3 mg per ml, 100 ml bag</Name>
              <Brand ID="B04120481340100">
                <Name>Any</Name>
                <Pack ID="P81340100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412048192">
            <Name>Fondaparinux sodium</Name>
            <Request Form="RS1184" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Fondaparinux sodium</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For use in heparin-induced thrombocytopaenia, heparin resistance or heparin intolerance</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1184" style="display:none"/>
            <Formulation ID="F041204819201" Rank="4" Units="inj" Weight="2.5">
              <Name>Inj 2.5 mg in 0.5 ml syringe</Name>
              <Brand ID="B04120481920100">
                <Name>Any</Name>
                <Pack ID="P81920100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204819202" Rank="4" Units="inj" Weight="7.5">
              <Name>Inj 7.5 mg in 0.6 ml syringe</Name>
              <Brand ID="B04120481920200">
                <Name>Any</Name>
                <Pack ID="P81920200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412048355">
            <Name>Phenindione</Name>
            <Formulation ID="F041204835501" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B04120483550100">
                <Name>Any</Name>
                <Pack ID="P83550100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204835502" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Brand ID="B04120483550200">
                <Name>Any</Name>
                <Pack ID="P83550200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204835503" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B04120483550300">
                <Name>Any</Name>
                <Pack ID="P83550300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412048397">
            <Name>Protamine sulphate</Name>
            <Formulation ID="F041204839701" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 5 ml ampoule</Name>
              <Brand ID="B04120483970100">
                <Name>Any</Name>
                <Pack ID="P83970100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412048425">
            <Name>Sodium citrate with sodium chloride and potassium chloride</Name>
            <Formulation ID="F041204842501" Rank="4" Units="inj" Weight="4.2">
              <Name>Inj 4.2 mg with sodium chloride 5.7 mg and potassium chloride 74.6 mcg per ml, 5,000 ml bag</Name>
              <Brand ID="B04120484250100">
                <Name>Any</Name>
                <Pack ID="P84250100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412048485">
            <Name>Citrate sodium</Name>
            <Formulation ID="F041204848501" Rank="4" Units="inj">
              <Name>Inj 4% (200 mg per 5 ml), 5 ml ampoule</Name>
              <Brand ID="B04120484850100">
                <Name>Any</Name>
                <Pack ID="P84850100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204848502" Rank="4" Units="inj">
              <Name>Inj 46.7% (2.36 g per 5 ml), 5 ml ampoule</Name>
              <Brand ID="B04120484850200">
                <Name>Any</Name>
                <Pack ID="P84850200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204848525" Rank="4" Units="inj">
              <Name>Inj 46.7% (1.4 g per 3 ml), 3 ml syringe</Name>
              <Brand ID="B04120484852500">
                <Name>Any</Name>
                <Pack ID="P84852500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412048496">
            <Name>Warfarin sodium</Name>
            <Formulation ID="F041204849601" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg</Name>
              <Brand ID="B04120484960125">
                <Name>Marevan</Name>
                <Pack ID="P210587" Specified="true" nzmt:ctpp_id="50018991000117103">
                  <Quantity>100</Quantity>
                  <Price>7.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204849602" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Brand ID="B04120484960200">
                <Name>Any</Name>
                <Pack ID="P84960200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204849603" Rank="1" Units="tab" Weight="3">
              <Name>Tab 3 mg</Name>
              <Brand ID="B04120484960325">
                <Name>Marevan</Name>
                <Pack ID="P210595" Specified="true" nzmt:ctpp_id="50019041000117101">
                  <Quantity>100</Quantity>
                  <Price>12.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204849604" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B04120484960425">
                <Name>Marevan</Name>
                <Pack ID="P210609" Specified="true" nzmt:ctpp_id="50019061000117102">
                  <Quantity>100</Quantity>
                  <Price>13.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412049026">
            <Name>Heparinised saline</Name>
            <Formulation ID="F041204902601" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 iu per ml, 2 ml ampoule</Name>
              <Brand ID="B04120490260100">
                <Name>Any</Name>
                <Pack ID="P90260100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204902602" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 iu per ml, 5 ml ampoule</Name>
              <Brand ID="B04120490260200">
                <Name>Any</Name>
                <Pack ID="P90260200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204902626" Rank="4" Units="inj" Weight="50">
              <Name>Inj 10 iu per ml, 5 ml ampoule</Name>
              <Brand ID="B04120490262625">
                <Name>Pfizer</Name>
                <Pack ID="P2339919" Specified="true" nzmt:ctpp_id="50049851000117100">
                  <Quantity>50</Quantity>
                  <Price>96.91</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412049273">
            <Name>Heparin sodium</Name>
            <Formulation ID="F041204927302" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 iu per ml, 250 ml bag</Name>
              <Brand ID="B04120492730200">
                <Name>Any</Name>
                <Pack ID="P92730200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204927303" Rank="4" Units="inj" Weight="5000">
              <Name>Inj 5,000 iu in 0.2 ml ampoule</Name>
              <Brand ID="B04120492730300">
                <Name>Any</Name>
                <Pack ID="P92730300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204927325" Rank="4" Units="inj" Weight="5000">
              <Name>Inj 5,000 iu per ml, 1 ml ampoule</Name>
              <Brand ID="B04120492732525">
                <Name>Hospira</Name>
                <Pack ID="P2034255" Specified="true" nzmt:ctpp_id="50006711000117105">
                  <Quantity>5</Quantity>
                  <Price>70.33</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204927326" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1,000 iu per ml, 1 ml ampoule</Name>
              <Brand ID="B04120492732625">
                <Name>Hospira</Name>
                <Pack ID="P2034247" Specified="true" nzmt:ctpp_id="50006701000117107">
                  <Quantity>50</Quantity>
                  <Price>362.98</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204927327" Rank="4" Units="inj" Weight="5000">
              <Name>Inj 1,000 iu per ml, 5 ml ampoule</Name>
              <Brand ID="B04120492732725">
                <Name>Pfizer</Name>
                <Pack ID="P2339897" Specified="true" nzmt:ctpp_id="50049831000117105">
                  <Quantity>50</Quantity>
                  <Price>127.44</Price>
                </Pack>
              </Brand>
              <Brand ID="B04120492732726">
                <Name>Wockhardt</Name>
                <Pack ID="P2691493" Specified="true" nzmt:ctpp_id="50341231000117107">
                  <Quantity>10</Quantity>
                  <Price>25.49</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204927329" Rank="4" Units="inj">
              <Name>Inj 5,000 iu per ml, 5 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Jul-23 to~2025" Value="5"/>
              <Brand ID="B04120492732925" PSS="true">
                <Name>Heparin Sodium Panpharma</Name>
                <Pack ID="P2651815" Specified="true" nzmt:ctpp_id="50309411000117108">
                  <Quantity>10</Quantity>
                  <Price>83.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204927330" Rank="10" Units="vial">
              <Name>Inj 1,000 iu per ml, 10 ml vial</Name>
              <Brand ID="B04120492733025">
                <Name>Pfizer</Name>
                <Pack ID="P2692392" Specified="true" nzmt:ctpp_id="50341571000117108">
                  <Quantity>25</Quantity>
                  <Price>127.44</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412049491">
            <Name>Enoxaparin sodium</Name>
            <Formulation ID="F041204949125" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg in 0.2 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B04120494912525" PSS="true">
                <Name>Clexane</Name>
                <Pack ID="P2581868" Specified="true" nzmt:ctpp_id="50116511000117109">
                  <Quantity>10</Quantity>
                  <Price>21.90</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204949126" Rank="4" Units="inj" Weight="40">
              <Name>Inj 40 mg in 0.4 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B04120494912625" PSS="true">
                <Name>Clexane</Name>
                <Pack ID="P2581876" Specified="true" nzmt:ctpp_id="50116521000117103">
                  <Quantity>10</Quantity>
                  <Price>29.74</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204949127" Rank="4" Units="inj" Weight="60">
              <Name>Inj 60 mg in 0.6 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B04120494912725" PSS="true">
                <Name>Clexane</Name>
                <Pack ID="P2581884" Specified="true" nzmt:ctpp_id="50083481000117100">
                  <Quantity>10</Quantity>
                  <Price>42.47</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204949128" Rank="4" Units="inj" Weight="80">
              <Name>Inj 80 mg in 0.8 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B04120494912825" PSS="true">
                <Name>Clexane</Name>
                <Pack ID="P2581892" Specified="true" nzmt:ctpp_id="50083491000117102">
                  <Quantity>10</Quantity>
                  <Price>56.62</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204949129" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg in 1 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B04120494912925" PSS="true">
                <Name>Clexane</Name>
                <Pack ID="P2581906" Specified="true" nzmt:ctpp_id="50083501000117108">
                  <Quantity>10</Quantity>
                  <Price>70.91</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204949130" Rank="4" Units="inj" Weight="120">
              <Name>Inj 120 mg in 0.8 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B04120494913026" PSS="true">
                <Name>Clexane Forte</Name>
                <Pack ID="P2581914" Specified="true" nzmt:ctpp_id="50080661000117103">
                  <Quantity>10</Quantity>
                  <Price>88.11</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204949131" Rank="4" Units="inj" Weight="150">
              <Name>Inj 150 mg in 1 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B04120494913126" PSS="true">
                <Name>Clexane Forte</Name>
                <Pack ID="P2581922" Specified="true" nzmt:ctpp_id="50080671000117108">
                  <Quantity>10</Quantity>
                  <Price>100.70</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204949132" Rank="4" Units="inj" Weight="40">
              <Name>Inj 40 mg in 0.4 ml ampoule</Name>
              <Brand ID="B04120494913200">
                <Name>Any</Name>
                <Pack ID="P94913200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412049576">
            <Name>Rivaroxaban</Name>
            <Formulation ID="F041204957625" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B04120495762525" PSS="true">
                <Name>Xarelto</Name>
                <Pack ID="P2545152" Specified="true" nzmt:ctpp_id="50120191000117101">
                  <Quantity>30</Quantity>
                  <Price>15.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204957626" Rank="1" Units="tab" Weight="15">
              <Name>Tab 15 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B04120495762625" PSS="true">
                <Name>Xarelto</Name>
                <Pack ID="P2425920" Specified="true" nzmt:ctpp_id="50147451000117100">
                  <Quantity>28</Quantity>
                  <Price>14.56</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204957627" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B04120495762725" PSS="true">
                <Name>Xarelto</Name>
                <Pack ID="P2425947" Specified="true" nzmt:ctpp_id="50147471000117108">
                  <Quantity>28</Quantity>
                  <Price>14.56</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412049588">
            <Name>Dabigatran</Name>
            <Formulation ID="F041204958825" Rank="2" Units="cap" Weight="75">
              <Name>Cap 75 mg</Name>
              <Rule Type="DVLimit" Attribute="Jul-24 to~2026" Value="5"/>
              <Brand ID="B04120495882525" PSS="true">
                <Name>Pradaxa</Name>
                <Pack ID="P2319586" Specified="true" nzmt:ctpp_id="50048601000117105">
                  <Quantity>60</Quantity>
                  <Price>27.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204958826" Rank="2" Units="cap" Weight="110">
              <Name>Cap 110 mg</Name>
              <Rule Type="DVLimit" Attribute="Jul-24 to~2026" Value="5"/>
              <Brand ID="B04120495882625" PSS="true">
                <Name>Pradaxa</Name>
                <Pack ID="P2319594" Specified="true" nzmt:ctpp_id="50048611000117108">
                  <Quantity>60</Quantity>
                  <Price>27.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041204958827" Rank="2" Units="cap" Weight="150">
              <Name>Cap 150 mg</Name>
              <Rule Type="DVLimit" Attribute="Jul-24 to~2026" Value="5"/>
              <Brand ID="B04120495882725" PSS="true">
                <Name>Pradaxa</Name>
                <Pack ID="P2389673" Specified="true" nzmt:ctpp_id="50125241000117105">
                  <Quantity>60</Quantity>
                  <Price>27.99</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A041208">
          <Name>Antiplatelets</Name>
          <Chemical ID="C0412088041">
            <Name>Aspirin</Name>
            <Formulation ID="F041208804101" Rank="5" Units="supp">
              <Name>Suppos 300 mg</Name>
              <Brand ID="B04120880410100">
                <Name>Any</Name>
                <Pack ID="P80410100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041208804102" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B04120880410225" PSS="true">
                <Name>Ethics Aspirin EC</Name>
                <Pack ID="P2184281" Specified="true" nzmt:ctpp_id="50030141000117101">
                  <Quantity>90</Quantity>
                  <Price>1.95</Price>
                </Pack>
                <Pack ID="P2213621" Specified="true" nzmt:ctpp_id="50034091000117104">
                  <Quantity>990</Quantity>
                  <Price>12.65</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412088471">
            <Name>Ticlopidine</Name>
            <Formulation ID="F041208847101" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B04120884710100">
                <Name>Any</Name>
                <Pack ID="P84710100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412088643">
            <Name>Lysine acetylsalicylate [Lysine asprin]</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1689">
              <Title>
                <range>Lysine acetylsalicylate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">For use when an immediate antiplatelet effect is required prior to an urgent interventional neuro-radiology or interventional cardiology procedure</ci>
                    <ci type="logical">Administration of oral aspirin would delay the procedure</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1689" style="display:none"/>
            <Formulation ID="F041208864325" Rank="4" Units="inj">
              <Name>Inj 500 mg</Name>
              <Brand ID="B04120886432500">
                <Name>e.g. Aspegic</Name>
                <Pack ID="P86432500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412089255">
            <Name>Dipyridamole</Name>
            <Formulation ID="F041208925501" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B04120892550100">
                <Name>Any</Name>
                <Pack ID="P92550100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041208925502" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Brand ID="B04120892550200">
                <Name>Any</Name>
                <Pack ID="P92550200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041208925525" Rank="1" Units="tab" Weight="150">
              <Name>Tab long-acting 150 mg</Name>
              <Brand ID="B04120892552525">
                <Name>Pytazen SR</Name>
                <Pack ID="P750255" Specified="true" nzmt:ctpp_id="50108511000117105">
                  <Quantity>60</Quantity>
                  <Price>13.93</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412089341">
            <Name>Clopidogrel</Name>
            <Formulation ID="F041208934125" Rank="1" Units="tab" Weight="75">
              <Name>Tab 75 mg</Name>
              <Rule Type="DVLimit" Attribute="May-23 to~2025" Value="5"/>
              <Brand ID="B04120893412528" PSS="true">
                <Name>Arrow - Clopid</Name>
                <Pack ID="P2648954" Specified="true" nzmt:ctpp_id="50148141000117109">
                  <Quantity>84</Quantity>
                  <Price>5.07</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412089365">
            <Name>Eptifibatide</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1759">
              <Title>
                <range>Eptifibatide</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">For use in patients with acute coronary syndromes undergoing percutaneous coronary intervention</ci>
                    <ci type="logical">For use in patients with definite or strongly suspected intra-coronary thrombus on coronary angiography</ci>
                    <ci type="logical">For use in patients undergoing intra-cranial intervention</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1759" style="display:none"/>
            <Formulation ID="F041208936525" Rank="4" Units="inj" Weight="20">
              <Name>Inj 2 mg per ml, 10 ml vial</Name>
              <Brand ID="B04120893652527">
                <Name>Eptifibatide Viatris</Name>
                <Pack ID="P2636700" Specified="true" nzmt:ctpp_id="50227541000117100">
                  <Quantity>1</Quantity>
                  <Price>180.38</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041208936526" Rank="4" Units="inj" Weight="75">
              <Name>Inj 750 mcg per ml, 100 ml vial</Name>
              <Brand ID="B04120893652626">
                <Name>Eptifibatide Viatris</Name>
                <Pack ID="P2636719" Specified="true" nzmt:ctpp_id="50227551000117103">
                  <Quantity>1</Quantity>
                  <Price>526.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412089691">
            <Name>Ticagrelor</Name>
            <Request Form="RS1774" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ticagrelor</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Restricted to treatment of acute coronary syndromes specifically for
                patients who have recently (within the last 60 days) been diagnosed with an
                ST-elevation or a non-ST-elevation acute coronary syndrome, and in whom fibrinolytic
                therapy has not been given in the last 24 hours and is not planned</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="thrombosis prevention neurological stenting">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has had a neurological stenting procedure* in the
                        last 60 days</ci>
                      <ci type="logical">Patient is about to have a neurological stenting procedure
                        performed*</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has demonstrated clopidogrel resistance using the
                        P2Y12 (VerifyNow) assay or another appropriate platelet function assay and
                        requires antiplatelet treatment with ticagrelor</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Clopidogrel resistance has been demonstrated by the
                            occurrence of a new cerebral ischemic event</ci>
                        <ci type="logical">Clopidogrel resistance has been demonstrated by the
                            occurrence of transient ischemic attack symptoms referable to the
                            stent.</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="thrombosis prevention neurological stenting">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is continuing to benefit from treatment</ci>
                    <ci type="logical">Treatment continues to be clinically appropriate</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="Percutaneous coronary intervention with stent deployment">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has undergone percutaneous coronary intervention</ci>
                    <ci type="logical">Patient has had a stent deployed in the previous 4 weeks</ci>
                    <ci type="logical">Patient is clopidogrel-allergic**</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="Stent thrombosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has experienced cardiac stent thrombosis whilst on
                clopidogrel</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Myocardial infarction">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For short term use while in hospital following ST-elevated myocardial
                infarction</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="week">1</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Indications marked with * are unapproved indications.</p>
              </div>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: ** Clopidogrel allergy is defined as a history of anaphylaxis, urticaria,
            generalised rash or asthma (in non-asthmatic patients) developing soon after clopidogrel
            is started and is considered unlikely to be caused by any other treatment</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1774" style="display:none"/>
            <Formulation ID="F041208969125" Rank="1" Units="tab" Weight="90">
              <Name>Tab 90 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B04120896912526" PSS="true">
                <Name>Ticagrelor Sandoz</Name>
                <Pack ID="P2638770" Specified="true" nzmt:ctpp_id="50270451000117104">
                  <Quantity>56</Quantity>
                  <Price>20.35</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A041212">
          <Name>Fibrinolytic Agents</Name>
          <Chemical ID="C0412128013">
            <Name>Alteplase</Name>
            <Formulation ID="F041212801301" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg vial</Name>
              <Brand ID="B04121280130100">
                <Name>Any</Name>
                <Pack ID="P80130100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041212801302" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg vial</Name>
              <Brand ID="B04121280130200">
                <Name>Any</Name>
                <Pack ID="P80130200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041212801325" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2 mg vial</Name>
              <Brand ID="B04121280132500">
                <Name>Any</Name>
                <Pack ID="P80132500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412128455">
            <Name>Tenecteplase</Name>
            <Formulation ID="F041212845501" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg vial</Name>
              <Brand ID="B04121284550100">
                <Name>Any</Name>
                <Pack ID="P84550100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0412128489">
            <Name>Urokinase</Name>
            <Formulation ID="F041212848901" Rank="4" Units="inj" Weight="10000">
              <Name>Inj 10,000 iu vial</Name>
              <Brand ID="B04121284890100">
                <Name>Any</Name>
                <Pack ID="P84890100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041212848902" Rank="4" Units="inj" Weight="100000">
              <Name>Inj 100,000 iu vial</Name>
              <Brand ID="B04121284890200">
                <Name>Any</Name>
                <Pack ID="P84890200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041212848903" Rank="4" Units="inj" Weight="50000">
              <Name>Inj 50,000 iu vial</Name>
              <Brand ID="B04121284890300">
                <Name>Any</Name>
                <Pack ID="P84890300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041212848904" Rank="4" Units="inj" Weight="500000">
              <Name>Inj 500,000 iu vial</Name>
              <Brand ID="B04121284890400">
                <Name>Any</Name>
                <Pack ID="P84890400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041212848925" Rank="4" Units="inj">
              <Name>Inj 5,000 iu vial</Name>
              <Brand ID="B04121284892500">
                <Name>Any</Name>
                <Pack ID="P84892500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041212848926" Rank="4" Units="inj" Weight="250000">
              <Name>Inj 250,000 iu vial</Name>
              <Brand ID="B04121284892600">
                <Name>Any</Name>
                <Pack ID="P84892600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0416">
        <Name>Colony-Stimulating Factors</Name>
        <ATC3 ID="A041602">
          <Name>Drugs Used to Mobilise Stem Cells</Name>
          <Chemical ID="C0416028597">
            <Name>Plerixafor</Name>
            <Request Form="RS1536" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Plerixafor</range>
              </Title>
              <Case When="Initial application" Category="Autologous stem cell transplant">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is to undergo stem cell transplantation</ci>
                    <ci type="logical">Patient has not had a previous unsuccessful mobilisation attempt
                    with plerixafor</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">Patient is undergoing G-CSF mobilisation</ci>
                        <apply>
                          <or/>
                          <ci type="logical">Has a suboptimal peripheral blood CD34 count of less
                                than or equal to 10 × <msup><mi>10</mi><mn>6</mn></msup>/L on day 5 after 4 days of G-CSF treatment</ci>
                          <ci type="logical">Efforts to collect &gt; 1 × <msup><mi>10</mi><mn>6</mn></msup> CD34 cells/kg have failed after one apheresis procedure</ci>
                        </apply>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">Patient is undergoing chemotherapy and G-CSF
                            mobilisation</ci>
                        <apply>
                          <or/>
                          <apply>
                            <and/>
                            <ci type="logical">Has rising white blood cell counts of &gt; 5 × <msup><mi>10</mi><mn>9</mn></msup>/L</ci>
                            <ci type="logical">Has a suboptimal peripheral blood CD34 count of
                                    less than or equal to 10 × <msup><mi>10</mi><mn>6</mn></msup>/L</ci>
                          </apply>
                          <ci type="logical">Efforts to collect &gt; 1 × <msup><mi>10</mi><mn>6</mn></msup> CD34 cells/kg have failed after one apheresis procedure</ci>
                          <ci type="logical">The peripheral blood CD34 cell counts are decreasing
                                before the target has been received</ci>
                        </apply>
                      </apply>
                      <ci type="logical">A previous mobilisation attempt with G-CSF or G-CSF plus
                        chemotherapy has failed</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="day">3</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1536" style="display:none"/>
            <Formulation ID="F041602859725" Rank="4" Units="inj" Weight="24">
              <Name>Inj 20 mg per ml, 1.2 ml vial</Name>
              <Brand ID="B04160285972525">
                <Name>Mozobil</Name>
                <Pack ID="P2360993" Specified="true" nzmt:ctpp_id="50121721000117107">
                  <Quantity>1</Quantity>
                  <Price>8740.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A041604">
          <Name>Granulocyte Colony-Stimulating Factors</Name>
          <Chemical ID="C0416048506">
            <Name>Pegfilgrastim</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1743">
              <Title>
                <range>Pegfilgrastim</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For prevention of neutropenia in patients undergoing high risk chemotherapy for cancer (febrile neutropenia risk greater than or equal to 5%*)</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>*Febrile neutropenia risk greater than or equal to 5% after taking into account other risk factors as defined by the European Organisation for Research and Treatment
                of Cancer (EORTC) guidelines</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1743" style="display:none"/>
            <Formulation ID="F041604850625" Rank="4" Units="inj" Weight="6">
              <Name>Inj 6 mg per 0.6 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Jun-23 to~2025" Value="5"/>
              <Brand ID="B04160485062526" PSS="true">
                <Name>Ziextenzo</Name>
                <Pack ID="P2643340" Specified="true" nzmt:ctpp_id="50261371000117103">
                  <Quantity>1</Quantity>
                  <Price>65.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0416049020">
            <Name>Filgrastim</Name>
            <Request Form="RS1188" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Filgrastim</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>haematologist</Applicant>
                <Applicant>oncologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1188" style="display:none"/>
            <Formulation ID="F041604902001" Rank="4" Units="inj" Weight="150">
              <Name>Inj 300 mcg in 0.5 ml prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B04160490200126" PSS="true">
                <Name>Nivestim</Name>
                <Pack ID="P2561956" Specified="true" nzmt:ctpp_id="50132241000117104">
                  <Quantity>10</Quantity>
                  <Price>86.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041604902002" Rank="4" Units="inj" Weight="300">
              <Name>Inj 300 mcg in 1 ml vial</Name>
              <Brand ID="B04160490200201">
                <Name>Neupogen</Name>
                <Pack ID="P2513153" Specified="true" nzmt:ctpp_id="50241001000117102">
                  <Quantity>4</Quantity>
                  <Price>520.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F041604902025" Rank="4" Units="inj" Weight="480">
              <Name>Inj 480 mcg in 0.5 ml prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B04160490202527" PSS="true">
                <Name>Nivestim</Name>
                <Pack ID="P2561964" Specified="true" nzmt:ctpp_id="50132221000117109">
                  <Quantity>10</Quantity>
                  <Price>133.72</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0420">
        <Name>Fluids and Electrolytes</Name>
        <ATC3 ID="A042004">
          <Name>Intravenous Administration</Name>
          <Chemical ID="C0420048073">
            <Name>Calcium chloride</Name>
            <Formulation ID="F042004807301" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg per ml, 10 ml vial</Name>
              <Brand ID="B04200480730100">
                <Name>Any</Name>
                <Pack ID="P80730100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004807325" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg per ml, 50 ml syringe</Name>
              <Brand ID="B04200480732500">
                <Name>e.g. Baxter</Name>
                <Pack ID="P80732500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420048112">
            <Name>Compound electrolytes</Name>
            <Formulation ID="F042004811225" Rank="4" Units="inj" Weight="500">
              <Name>Inj sodium 140 mmol/l, potassium 5 mmol/l, magnesium 1.5 mmol/l, chloride 98 mmol/l, acetate 27 mmol/l, gluconate  23 mmol/l, 500 ml bag</Name>
              <Brand ID="B04200481122525">
                <Name>Plasma-Lyte 148</Name>
                <Pack ID="P2541424" Specified="true" nzmt:ctpp_id="50253041000117104">
                  <Quantity>18</Quantity>
                  <Price>57.06</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004811226" Rank="4" Units="inj" Weight="1000">
              <Name>Inj sodium 140 mmol/l, potassium 5 mmol/l, magnesium 1.5 mmol/l, chloride 98 mmol/l, acetate 27 mmol/l, gluconate  23 mmol/l, 1,000 ml bag</Name>
              <Brand ID="B04200481122625">
                <Name>Plasma-Lyte 148</Name>
                <Pack ID="P2541432" Specified="true" nzmt:ctpp_id="50253051000117102">
                  <Quantity>12</Quantity>
                  <Price>29.28</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420048113">
            <Name>Compound electrolytes with glucose [Dextrose]</Name>
            <Formulation ID="F042004811325" Rank="4" Units="inj">
              <Name>Inj sodium 140 mmol/l, 5 mmol/l potassium, 1.5 mmol/l magnesium, 98 mmol/l chloride, 27 mmol/l acetate and 23 mmol/l gluconate, glucose 23 mmol/l (5%), 1,000 ml bag</Name>
              <Brand ID="B04200481132525">
                <Name>Plasma-Lyte 148 &amp; 5% Glucose</Name>
                <Pack ID="P2541440" Specified="true" nzmt:ctpp_id="50253061000117100">
                  <Quantity>12</Quantity>
                  <Price>227.64</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420048115">
            <Name>Compound sodium lactate [Hartmann's solution]</Name>
            <Formulation ID="F042004811502" Rank="4" Units="inj" Weight="500">
              <Name>Inj sodium 131 mmol/l with potassium 5 mmol/l, calcium 2 mmol/l, bicarbonate 29 mmol/l, chloride 111 mmol/l, 500 ml bag</Name>
              <Brand ID="B04200481150225">
                <Name>Baxter</Name>
                <Pack ID="P2541459" Specified="true" nzmt:ctpp_id="50253071000117105">
                  <Quantity>18</Quantity>
                  <Price>25.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004811525" Rank="4" Units="inj" Weight="1000">
              <Name>Inj sodium 131 mmol/l with potassium 5 mmol/l, calcium 2 mmol/l, bicarbonate 29 mmol/l, chloride 111 mmol/l, 1,000 ml bag</Name>
              <Brand ID="B04200481152525">
                <Name>Baxter</Name>
                <Pack ID="P2541467" Specified="true" nzmt:ctpp_id="50253081000117108">
                  <Quantity>12</Quantity>
                  <Price>16.92</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420048375">
            <Name>Potassium dihydrogen phosphate</Name>
            <Formulation ID="F042004837501" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mmol per ml, 10 ml ampoule</Name>
              <Brand ID="B04200483750125">
                <Name>Hospira</Name>
                <Pack ID="P2213605" Specified="true" nzmt:ctpp_id="50034071000117100">
                  <Quantity>10</Quantity>
                  <Price>174.57</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420048408">
            <Name>Ringer's solution</Name>
            <Formulation ID="F042004840825" Rank="4" Units="inj">
              <Name>Inj sodium 147 mmol/l with potassium 4 mmol/l, calcium 2.2 mmol/l, chloride 156 mmol/l, 1,000 ml bag</Name>
              <Brand ID="B04200484082500">
                <Name>Any</Name>
                <Pack ID="P84082500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420048417">
            <Name>Sodium acetate</Name>
            <Formulation ID="F042004841701" Rank="4" Units="inj" Weight="4">
              <Name>Inj 4 mmol per ml, 20 ml ampoule</Name>
              <Brand ID="B04200484170100">
                <Name>Any</Name>
                <Pack ID="P84170100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420049047">
            <Name>Potassium chloride</Name>
            <Formulation ID="F042004904701" Rank="4" Units="inj" Weight="225">
              <Name>Inj 225 mg (3 mmol) per ml, 20 ml ampoule</Name>
              <Brand ID="B04200490470100">
                <Name>Any</Name>
                <Pack ID="P90470100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004904702" Rank="4" Units="inj" Weight="75">
              <Name>Inj 75 mg (1 mmol) per ml, 10 ml ampoule</Name>
              <Brand ID="B04200490470200">
                <Name>Any</Name>
                <Pack ID="P90470200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420049058">
            <Name>Sodium chloride</Name>
            <Formulation ID="F042004905801" Rank="4" Units="amp" Weight="9.1">
              <Name>Inj 0.9%, 10 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B04200490580127" PSS="true">
                <Name>Fresenius Kabi</Name>
                <Pack ID="P2565757" Specified="true" nzmt:ctpp_id="50181161000117105">
                  <Quantity>50</Quantity>
                  <Price>5.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004905802" Rank="4" Units="amp" Weight="9.05">
              <Name>Inj 0.9%, 5 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B04200490580228" PSS="true">
                <Name>Fresenius Kabi</Name>
                <Pack ID="P2565749" Specified="true" nzmt:ctpp_id="50181141000117106">
                  <Quantity>20</Quantity>
                  <Price>4.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004905808" Rank="10" Units="btl" Weight="0.96">
              <Name>Inj 1.8%, 500 ml bottle</Name>
              <Brand ID="B04200490580800">
                <Name>Any</Name>
                <Pack ID="P90580800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004905832" Rank="4" Units="inj" Weight="234.2">
              <Name>Inj 23.4% (4 mmol/ml), 20 ml ampoule</Name>
              <Brand ID="B04200490583225">
                <Name>Biomed</Name>
                <Pack ID="P2089432" Specified="true" nzmt:ctpp_id="50016361000117109">
                  <Quantity>5</Quantity>
                  <Price>38.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004905833" Rank="4" Units="inj" Weight="9.2">
              <Name>Inj 0.9%, 20 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B04200490583327" PSS="true">
                <Name>Fresenius Kabi</Name>
                <Pack ID="P2565730" Specified="true" nzmt:ctpp_id="50181171000117100">
                  <Quantity>20</Quantity>
                  <Price>5.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004905837" Rank="4" Units="inj" Weight="0.9">
              <Name>Inj 0.9%, 3 ml syringe, non-sterile pack</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2025" Value="5"/>
              <Request Form="RS1297" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Sodium chloride – Inj</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">For use in flushing of in-situ vascular access devices only</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1297" style="display:none"/>
              <Brand ID="B04200490583725" PSS="true">
                <Name>BD PosiFlush</Name>
                <Pack ID="P2476371" Specified="true" nzmt:ctpp_id="50172501000117101">
                  <Quantity>30</Quantity>
                  <Price>12.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004905838" Rank="4" Units="inj" Weight="4">
              <Name>Inj 0.9%, 5 ml syringe, non-sterile pack</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2025" Value="5"/>
              <Request Form="RS1297" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Sodium chloride – Inj</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">For use in flushing of in-situ vascular access devices only</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1297" style="display:none"/>
              <Brand ID="B04200490583825" PSS="true">
                <Name>BD PosiFlush</Name>
                <Pack ID="P2476398" Specified="true" nzmt:ctpp_id="50172511000117103">
                  <Quantity>30</Quantity>
                  <Price>12.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004905839" Rank="4" Units="inj" Weight="9">
              <Name>Inj 0.9%, 10 ml syringe, non-sterile pack</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2025" Value="5"/>
              <Request Form="RS1297" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Sodium chloride – Inj</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">For use in flushing of in-situ vascular access devices only</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1297" style="display:none"/>
              <Brand ID="B04200490583925" PSS="true">
                <Name>BD PosiFlush</Name>
                <Pack ID="P2476401" Specified="true" nzmt:ctpp_id="50172521000117109">
                  <Quantity>30</Quantity>
                  <Price>11.70</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004905840" Rank="10" Units="bag" Weight="0.45">
              <Name>Inj 0.45%, 500 ml bag</Name>
              <Brand ID="B04200490584025">
                <Name>Baxter</Name>
                <Pack ID="P2503832" Specified="true" nzmt:ctpp_id="50234621000117103">
                  <Quantity>18</Quantity>
                  <Price>76.68</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004905841" Rank="10" Units="bag" Weight="50">
              <Name>Inj 0.9%, 50 ml bag</Name>
              <Brand ID="B04200490584125">
                <Name>Baxter</Name>
                <Pack ID="P2503840" Specified="true" nzmt:ctpp_id="50234641000117108">
                  <Quantity>60</Quantity>
                  <Price>118.20</Price>
                </Pack>
              </Brand>
              <Brand ID="B04200490584126">
                <Name>Baxter-Viaflo</Name>
                <Pack ID="P2625857" Specified="true" nzmt:ctpp_id="50292281000117104">
                  <Quantity>75</Quantity>
                  <Price>147.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004905842" Rank="10" Units="bag" Weight="100">
              <Name>Inj 0.9%, 100 ml bag</Name>
              <Brand ID="B04200490584225">
                <Name>Baxter</Name>
                <Pack ID="P2503859" Specified="true" nzmt:ctpp_id="50068611000117101">
                  <Quantity>48</Quantity>
                  <Price>84.48</Price>
                </Pack>
              </Brand>
              <Brand ID="B04200490584226">
                <Name>Baxter-Viaflo</Name>
                <Pack ID="P2625865" Specified="true" nzmt:ctpp_id="50292291000117101">
                  <Quantity>60</Quantity>
                  <Price>105.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004905843" Rank="10" Units="bag" Weight="250">
              <Name>Inj 0.9%, 250 ml bag</Name>
              <Brand ID="B04200490584325">
                <Name>Baxter</Name>
                <Pack ID="P2503867" Specified="true" nzmt:ctpp_id="50234631000117100">
                  <Quantity>24</Quantity>
                  <Price>48.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004905844" Rank="10" Units="bag" Weight="500">
              <Name>Inj 0.9%, 500 ml bag</Name>
              <Brand ID="B04200490584425">
                <Name>Baxter</Name>
                <Pack ID="P2503883" Specified="true" nzmt:ctpp_id="50234651000117105">
                  <Quantity>18</Quantity>
                  <Price>23.94</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004905845" Rank="10" Units="bag" Weight="1000">
              <Name>Inj 0.9%, 1,000 ml bag</Name>
              <Brand ID="B04200490584525">
                <Name>Baxter</Name>
                <Pack ID="P2503891" Specified="true" nzmt:ctpp_id="50234661000117107">
                  <Quantity>12</Quantity>
                  <Price>16.32</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004905846" Rank="10" Units="bag" Weight="3">
              <Name>Inj 3%, 1,000 ml bag</Name>
              <Brand ID="B04200490584625">
                <Name>Baxter</Name>
                <Pack ID="P2503875" Specified="true" nzmt:ctpp_id="50234671000117102">
                  <Quantity>12</Quantity>
                  <Price>150.72</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420049259">
            <Name>Sodium bicarbonate</Name>
            <Formulation ID="F042004925901" Rank="4" Units="inj">
              <Name>Inj 8.4%, 10 ml vial</Name>
              <Brand ID="B04200492590100">
                <Name>Any</Name>
                <Pack ID="P92590100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004925926" Rank="4" Units="inj" Weight="8.4">
              <Name>Inj 8.4%, 100 ml vial</Name>
              <Brand ID="B04200492592626">
                <Name>Biomed</Name>
                <Pack ID="P2244144" Specified="true" nzmt:ctpp_id="50038741000117104">
                  <Quantity>1</Quantity>
                  <Price>24.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004925928" Rank="4" Units="inj">
              <Name>Inj 8.4%, 50 ml vial</Name>
              <Brand ID="B04200492592825">
                <Name>Biomed</Name>
                <Pack ID="P2244152" Specified="true" nzmt:ctpp_id="50038751000117102">
                  <Quantity>1</Quantity>
                  <Price>23.52</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420049270">
            <Name>Calcium gluconate</Name>
            <Formulation ID="F042004927025" Rank="4" Units="inj">
              <Name>Inj 10%, 10 ml ampoule</Name>
              <Brand ID="B04200492702500">
                <Name>e.g. Max Health</Name>
                <Pack ID="P92702500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420049321">
            <Name>Glucose [Dextrose]</Name>
            <Formulation ID="F042004932107" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50%, 10 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B04200493210725" PSS="true">
                <Name>Biomed</Name>
                <Pack ID="P2243296" Specified="true" nzmt:ctpp_id="50038461000117105">
                  <Quantity>5</Quantity>
                  <Price>34.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004932108" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50%, 90 ml bottle</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B04200493210825" PSS="true">
                <Name>Biomed</Name>
                <Pack ID="P2245833" Specified="true" nzmt:ctpp_id="50039251000117100">
                  <Quantity>1</Quantity>
                  <Price>17.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004932131" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5%, 50 ml bag</Name>
              <Brand ID="B04200493213125">
                <Name>Baxter Glucose 5%</Name>
                <Pack ID="P2541475" Specified="true" nzmt:ctpp_id="50253091000117106">
                  <Quantity>60</Quantity>
                  <Price>154.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004932132" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10%, 500 ml bag</Name>
              <Brand ID="B04200493213225">
                <Name>Baxter Glucose 10%</Name>
                <Pack ID="P2541483" Specified="true" nzmt:ctpp_id="50253101000117102">
                  <Quantity>18</Quantity>
                  <Price>118.26</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004932133" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10%, 1,000 ml bag</Name>
              <Brand ID="B04200493213325">
                <Name>Baxter Glucose 10%</Name>
                <Pack ID="P2541491" Specified="true" nzmt:ctpp_id="50253111000117104">
                  <Quantity>12</Quantity>
                  <Price>120.36</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004932134" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50%, 500 ml bag</Name>
              <Brand ID="B04200493213425">
                <Name>Baxter Glucose 50%</Name>
                <Pack ID="P2541505" Specified="true" nzmt:ctpp_id="50253121000117105">
                  <Quantity>18</Quantity>
                  <Price>362.34</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004932135" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5%, 100 ml bag</Name>
              <Brand ID="B04200493213525">
                <Name>Fresenius Kabi</Name>
                <Pack ID="P2541696" Specified="true" nzmt:ctpp_id="50255401000117107">
                  <Quantity>50</Quantity>
                  <Price>95.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004932136" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5%, 250 ml bag</Name>
              <Brand ID="B04200493213625">
                <Name>Fresenius Kabi</Name>
                <Pack ID="P2541270" Specified="true" nzmt:ctpp_id="50255421000117104">
                  <Quantity>30</Quantity>
                  <Price>61.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004932137" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5%, 500 ml bag</Name>
              <Brand ID="B04200493213725">
                <Name>Fresenius Kabi</Name>
                <Pack ID="P2541289" Specified="true" nzmt:ctpp_id="50255431000117101">
                  <Quantity>20</Quantity>
                  <Price>66.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004932138" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5%, 1,000 ml bag</Name>
              <Brand ID="B04200493213825">
                <Name>Fresenius Kabi</Name>
                <Pack ID="P2541718" Specified="true" nzmt:ctpp_id="50255441000117109">
                  <Quantity>10</Quantity>
                  <Price>52.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420049327">
            <Name>Glucose with potassium chloride</Name>
            <Formulation ID="F042004932726" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10% glucose with 20 mmol/l potassium chloride, 500 ml bag</Name>
              <Brand ID="B04200493272600">
                <Name>Any</Name>
                <Pack ID="P93272600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420049328">
            <Name>Glucose with potassium chloride and sodium chloride</Name>
            <Formulation ID="F042004932801" Rank="3" Units="ml" Weight="10">
              <Name>Inj 10% glucose with potassium chloride 10 mmol/l and sodium chloride 15 mmol/l, 500 ml bag</Name>
              <Brand ID="B04200493280100">
                <Name>Any</Name>
                <Pack ID="P93280100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004932802" Rank="3" Units="ml" Weight="2.5">
              <Name>Inj 2.5% glucose with potassium chloride 20 mmol/l and sodium chloride 0.45%, 3,000 ml bag</Name>
              <Brand ID="B04200493280200">
                <Name>Any</Name>
                <Pack ID="P93280200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004932830" Rank="4" Units="inj" Weight="4">
              <Name>Inj 4% glucose with potassium chloride 20 mmol/l and sodium chloride 0.18%, 1,000 ml bag</Name>
              <Brand ID="B04200493283025">
                <Name>Baxter</Name>
                <Pack ID="P2541513" Specified="true" nzmt:ctpp_id="50253131000117108">
                  <Quantity>12</Quantity>
                  <Price>218.52</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004932831" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5% glucose with potassium chloride 20 mmol/l and sodium chloride 0.45%, 1,000 ml bag</Name>
              <Brand ID="B04200493283125">
                <Name>Baxter</Name>
                <Pack ID="P2541521" Specified="true" nzmt:ctpp_id="50253141000117100">
                  <Quantity>12</Quantity>
                  <Price>171.84</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004932832" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5% glucose with potassium chloride 20 mmol/l and sodium chloride 0.9%, 1,000 ml bag</Name>
              <Brand ID="B04200493283225">
                <Name>Baxter</Name>
                <Pack ID="P2541548" Specified="true" nzmt:ctpp_id="50253151000117103">
                  <Quantity>12</Quantity>
                  <Price>303.72</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420049329">
            <Name>Potassium chloride with sodium chloride</Name>
            <Formulation ID="F042004932901" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mmol potassium chloride with 0.29% sodium chloride, 100 ml bag</Name>
              <Brand ID="B04200493290125">
                <Name>Baxter</Name>
                <Pack ID="P2541602" Specified="true" nzmt:ctpp_id="50253191000117107">
                  <Quantity>48</Quantity>
                  <Price>512.16</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004932902" Rank="4" Units="inj" Weight="40">
              <Name>Inj 40 mmol potassium chloride with 0.9% sodium chloride, 100 ml bag</Name>
              <Brand ID="B04200493290225">
                <Name>Baxter</Name>
                <Pack ID="P2541610" Specified="true" nzmt:ctpp_id="50253211000117108">
                  <Quantity>48</Quantity>
                  <Price>829.92</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004932928" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mmol potassium chloride with 0.9% sodium chloride, 1,000 ml bag</Name>
              <Brand ID="B04200493292825">
                <Name>Baxter</Name>
                <Pack ID="P2541580" Specified="true" nzmt:ctpp_id="50253201000117105">
                  <Quantity>12</Quantity>
                  <Price>175.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004932929" Rank="4" Units="inj" Weight="40">
              <Name>Inj 40 mmol potassium chloride with 0.9% sodium chloride, 1,000 ml bag</Name>
              <Brand ID="B04200493292925">
                <Name>Baxter</Name>
                <Pack ID="P2541599" Specified="true" nzmt:ctpp_id="50253221000117102">
                  <Quantity>12</Quantity>
                  <Price>272.16</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420049330">
            <Name>Glucose with sodium chloride</Name>
            <Formulation ID="F042004933029" Rank="4" Units="inj" Weight="4">
              <Name>Inj 4% glucose and sodium chloride 0.18%, 1,000 ml bag</Name>
              <Brand ID="B04200493302925">
                <Name>Baxter</Name>
                <Pack ID="P2541556" Specified="true" nzmt:ctpp_id="50100231000117102">
                  <Quantity>12</Quantity>
                  <Price>175.44</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004933030" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5% glucose and sodium chloride 0.9%, 1,000 ml bag</Name>
              <Brand ID="B04200493303025">
                <Name>Baxter</Name>
                <Pack ID="P2541572" Specified="true" nzmt:ctpp_id="50253171000117106">
                  <Quantity>12</Quantity>
                  <Price>186.24</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004933031" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5% glucose and sodium chloride 0.45%, 1,000 ml bag</Name>
              <Brand ID="B04200493303125">
                <Name>Baxter</Name>
                <Pack ID="P2541564" Specified="true" nzmt:ctpp_id="50253161000117101">
                  <Quantity>12</Quantity>
                  <Price>175.32</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004933032" Rank="4" Units="inj">
              <Name>Inj glucose 2.5% with sodium chloride 0.45%, 500 ml bag</Name>
              <Brand ID="B04200493303200">
                <Name>Any</Name>
                <Pack ID="P93303200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420049331">
            <Name>Water</Name>
            <Formulation ID="F042004933101" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 ml bag</Name>
              <Brand ID="B04200493310100">
                <Name>Any</Name>
                <Pack ID="P93310100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004933102" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 ml bag</Name>
              <Brand ID="B04200493310200">
                <Name>Any</Name>
                <Pack ID="P93310200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004933127" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Sep-23 to~2025" Value="5"/>
              <Brand ID="B04200493312725" PSS="true">
                <Name>Multichem</Name>
                <Pack ID="P2208326" Specified="true" nzmt:ctpp_id="50307331000117101">
                  <Quantity>50</Quantity>
                  <Price>7.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004933128" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B04200493312827" PSS="true">
                <Name>Fresenius Kabi</Name>
                <Pack ID="P2565692" Specified="true" nzmt:ctpp_id="50180201000117109">
                  <Quantity>20</Quantity>
                  <Price>5.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042004933129" Rank="10" Units="bag">
              <Name>Inj, 1,000 ml bag</Name>
              <Brand ID="B04200493312925">
                <Name>Baxter</Name>
                <Pack ID="P2503905" Specified="true" nzmt:ctpp_id="50234681000117104">
                  <Quantity>12</Quantity>
                  <Price>20.52</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420049411">
            <Name>Sodium dihydrogen phosphate [Sodium acid phosphate]</Name>
            <Formulation ID="F042004941101" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mmol per ml, 20 ml ampoule</Name>
              <Brand ID="B04200494110125">
                <Name>Biomed</Name>
                <Pack ID="P2089335" Specified="true" nzmt:ctpp_id="50016301000117108">
                  <Quantity>5</Quantity>
                  <Price>56.30</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A042008">
          <Name>Oral Administration</Name>
          <Chemical ID="C0420088112">
            <Name>Compound electrolytes</Name>
            <Formulation ID="F042008811203" Rank="2" Units="sach">
              <Name>Powder for oral soln</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B04200881120326" PSS="true">
                <Name>Electral</Name>
                <Pack ID="P2576937" Specified="true" nzmt:ctpp_id="50181671000117107">
                  <Quantity>50</Quantity>
                  <Price>9.53</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420088113">
            <Name>Compound electrolytes with glucose [Dextrose]</Name>
            <Formulation ID="F042008811326" Rank="3" Units="ml">
              <Name>Soln with electrolytes</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2025" Value="5"/>
              <Brand ID="B04200881132625" PSS="true">
                <Name>Hydralyte - Lemonade</Name>
                <Pack ID="P2468255" Specified="true" nzmt:ctpp_id="50208671000117101">
                  <Quantity>1000</Quantity>
                  <Price>6.53</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420088363">
            <Name>Phosphorus</Name>
            <Formulation ID="F042008836301" Rank="1" Units="tab">
              <Name>Tab eff 500 mg (16 mmol)</Name>
              <Brand ID="B04200883630100">
                <Name>Any</Name>
                <Pack ID="P83630100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420088435">
            <Name>Sodium polystyrene sulphonate</Name>
            <Formulation ID="F042008843501" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B04200884350125">
                <Name>Resonium A</Name>
                <Pack ID="P251089" Specified="true" nzmt:ctpp_id="50052601000117109">
                  <Quantity>454</Quantity>
                  <Price>84.65</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420089047">
            <Name>Potassium chloride</Name>
            <Formulation ID="F042008904703" Rank="3" Units="ml">
              <Name>Oral liq 2 mmol per ml</Name>
              <Brand ID="B04200890470300">
                <Name>Any</Name>
                <Pack ID="P90470300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042008904704" Rank="1" Units="tab">
              <Name>Tab eff 548 mg (14 mmol) with chloride 285 mg (8 mmol)</Name>
              <Brand ID="B04200890470400">
                <Name>Any</Name>
                <Pack ID="P90470400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042008904725" Rank="1" Units="tab" Weight="600">
              <Name>Tab long-acting 600 mg (8 mmol)</Name>
              <Brand ID="B04200890472525">
                <Name>Span-K</Name>
                <Pack ID="P2144468" Specified="true" nzmt:ctpp_id="50024871000117107">
                  <Quantity>200</Quantity>
                  <Price>15.35</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420089058">
            <Name>Sodium chloride</Name>
            <Formulation ID="F042008905814" Rank="3" Units="ml">
              <Name>Oral liq 2 mmol/ml</Name>
              <Brand ID="B04200890581400">
                <Name>Any</Name>
                <Pack ID="P90581400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F042008905815" Rank="1" Units="tab" Weight="600">
              <Name>Tab 600 mg</Name>
              <Brand ID="B04200890581500">
                <Name>Any</Name>
                <Pack ID="P90581500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420089259">
            <Name>Sodium bicarbonate</Name>
            <Formulation ID="F042008925929" Rank="2" Units="cap" Weight="840">
              <Name>Cap 840 mg</Name>
              <Brand ID="B04200892592925">
                <Name>Sodibic</Name>
                <Pack ID="P2085992" nzmt:ctpp_id="50014371000117109">
                  <Quantity>100</Quantity>
                  <Price>8.52</Price>
                </Pack>
                <Pack ID="P2513447" Specified="true">
                  <Quantity>100</Quantity>
                  <Price>8.52</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0420089380">
            <Name>Calcium polystyrene sulphonate</Name>
            <Formulation ID="F042008938025" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B04200893802525">
                <Name>Calcium Resonium</Name>
                <Pack ID="P201510" Specified="true" nzmt:ctpp_id="50002541000117100">
                  <Quantity>300</Quantity>
                  <Price>169.85</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A042012">
          <Name>Plasma Volume Expanders</Name>
          <Chemical ID="C0420129023">
            <Name>Gelatine, succinylated</Name>
            <Formulation ID="F042012902301" Rank="4" Units="inf" Weight="0.008">
              <Name>Inj 4%, 500 ml bag</Name>
              <Brand ID="B04201290230101">
                <Name>Gelofusine</Name>
                <Pack ID="P2230992" Specified="true" nzmt:ctpp_id="50036871000117104">
                  <Quantity>10</Quantity>
                  <Price>129.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
    <ATC1 ID="A07">
      <Name>Cardiovascular System</Name>
      <ATC2 ID="A0704">
        <Name>Agents Affecting the Renin-Angiotensin System</Name>
        <ATC3 ID="A070404">
          <Name>ACE Inhibitors</Name>
          <Chemical ID="C0704048701">
            <Name>Ramipril</Name>
            <Formulation ID="F070404870125" Rank="2" Units="cap" Weight="1">
              <Name>Cap 1.25 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07040487012525" PSS="true">
                <Name>Tryzan</Name>
                <Pack ID="P2635747" Specified="true" nzmt:ctpp_id="50298761000117101">
                  <Quantity>90</Quantity>
                  <Price>17.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070404870126" Rank="2" Units="cap" Weight="2">
              <Name>Cap 2.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07040487012625" PSS="true">
                <Name>Tryzan</Name>
                <Pack ID="P2635755" Specified="true" nzmt:ctpp_id="50298771000117106">
                  <Quantity>90</Quantity>
                  <Price>16.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070404870127" Rank="2" Units="cap" Weight="5">
              <Name>Cap 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07040487012725" PSS="true">
                <Name>Tryzan</Name>
                <Pack ID="P2635763" Specified="true" nzmt:ctpp_id="50298781000117109">
                  <Quantity>90</Quantity>
                  <Price>16.88</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070404870128" Rank="2" Units="cap" Weight="10">
              <Name>Cap 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07040487012825" PSS="true">
                <Name>Tryzan</Name>
                <Pack ID="P2635771" Specified="true" nzmt:ctpp_id="50298791000117107">
                  <Quantity>90</Quantity>
                  <Price>17.63</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0704049236">
            <Name>Cilazapril</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F070404923625" Rank="1" Units="tab" Weight="0.5">
              <Name>Tab 0.5 mg</Name>
              <Brand ID="B07040492362526">
                <Name>Zapril</Name>
                <Pack ID="P2399059" Specified="true" nzmt:ctpp_id="50134061000117101">
                  <Quantity>90</Quantity>
                  <Price>2.69</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070404923626" Rank="1" Units="tab" Weight="2.5">
              <Name>Tab 2.5 mg</Name>
              <Brand ID="B07040492362626">
                <Name>Zapril</Name>
                <Pack ID="P2379082" Specified="true" nzmt:ctpp_id="50122921000117101">
                  <Quantity>90</Quantity>
                  <Price>5.79</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070404923627" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B07040492362726">
                <Name>Zapril</Name>
                <Pack ID="P2379090" Specified="true" nzmt:ctpp_id="50122931000117103">
                  <Quantity>90</Quantity>
                  <Price>10.05</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0704049237">
            <Name>Quinapril</Name>
            <Formulation ID="F070404923725" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B07040492372526" PSS="true">
                <Name>Arrow-Quinapril 5</Name>
                <Pack ID="P2427877" Specified="true" nzmt:ctpp_id="50157741000117107">
                  <Quantity>90</Quantity>
                  <Price>10.24</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070404923726" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B07040492372626" PSS="true">
                <Name>Arrow-Quinapril 10</Name>
                <Pack ID="P2427885" Specified="true" nzmt:ctpp_id="50157771000117101">
                  <Quantity>90</Quantity>
                  <Price>12.51</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070404923727" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B07040492372726" PSS="true">
                <Name>Arrow-Quinapril 20</Name>
                <Pack ID="P2427893" Specified="true" nzmt:ctpp_id="50157781000117103">
                  <Quantity>90</Quantity>
                  <Price>14.38</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0704049406">
            <Name>Captopril</Name>
            <Formulation ID="F070404940628" Rank="3" Units="ml">
              <Name>Oral liq 5 mg per ml</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2026" Value="5"/>
              <Request Form="RS1263" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Captopril - Oral liq 5 mg per ml</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical">For use in children under 12 years of age</ci>
                      <ci type="logical">For use in tube-fed patients</ci>
                      <ci type="logical">For management of rebound transient hypertension following cardiac surgery</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1263" style="display:none"/>
              <Brand ID="B07040494062826" PSS="true">
                <Name>DP-Captopril</Name>
                <Pack ID="P2657775" Specified="true" nzmt:ctpp_id="50305901000117102">
                  <Quantity>100</Quantity>
                  <Price>86.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0704049487">
            <Name>Lisinopril</Name>
            <Formulation ID="F070404948725" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Oct-22 to~2025" Value="5"/>
              <Brand ID="B07040494872526" PSS="true">
                <Name>Ethics Lisinopril</Name>
                <Pack ID="P2352435" Specified="true" nzmt:ctpp_id="50226071000117102">
                  <Quantity>90</Quantity>
                  <Price>11.07</Price>
                </Pack>
              </Brand>
              <Brand ID="B07040494872527" PSS="true">
                <Name>Teva Lisinopril</Name>
                <Pack ID="P2643669" Specified="true" nzmt:ctpp_id="50304941000117101">
                  <Quantity>90</Quantity>
                  <Price>11.07</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070404948726" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Oct-22 to~2025" Value="5"/>
              <Brand ID="B07040494872626" PSS="true">
                <Name>Ethics Lisinopril</Name>
                <Pack ID="P2352443" Specified="true" nzmt:ctpp_id="50226081000117104">
                  <Quantity>90</Quantity>
                  <Price>11.67</Price>
                </Pack>
              </Brand>
              <Brand ID="B07040494872627" PSS="true">
                <Name>Teva Lisinopril</Name>
                <Pack ID="P2643677" Specified="true" nzmt:ctpp_id="50304951000117104">
                  <Quantity>90</Quantity>
                  <Price>11.67</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070404948727" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Oct-22 to~2025" Value="5"/>
              <Brand ID="B07040494872726" PSS="true">
                <Name>Ethics Lisinopril</Name>
                <Pack ID="P2352451" Specified="true" nzmt:ctpp_id="50226091000117101">
                  <Quantity>90</Quantity>
                  <Price>14.69</Price>
                </Pack>
              </Brand>
              <Brand ID="B07040494872727" PSS="true">
                <Name>Teva Lisinopril</Name>
                <Pack ID="P2643685" Specified="true" nzmt:ctpp_id="50304961000117102">
                  <Quantity>90</Quantity>
                  <Price>14.69</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0704049536">
            <Name>Enalapril maleate</Name>
            <Formulation ID="F070404953625" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2025" Value="5"/>
              <Brand ID="B07040495362528" PSS="true">
                <Name>Acetec</Name>
                <Pack ID="P2636484" Specified="true" nzmt:ctpp_id="50300411000117103">
                  <Quantity>90</Quantity>
                  <Price>1.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070404953626" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2025" Value="5"/>
              <Brand ID="B07040495362628" PSS="true">
                <Name>Acetec</Name>
                <Pack ID="P2636492" Specified="true" nzmt:ctpp_id="50300421000117109">
                  <Quantity>90</Quantity>
                  <Price>1.97</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070404953627" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2025" Value="5"/>
              <Brand ID="B07040495362728" PSS="true">
                <Name>Acetec</Name>
                <Pack ID="P2636506" Specified="true" nzmt:ctpp_id="50300431000117107">
                  <Quantity>90</Quantity>
                  <Price>2.35</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0704049690">
            <Name>Perindopril</Name>
            <Formulation ID="F070404969025" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B07040496902526" PSS="true">
                <Name>Coversyl</Name>
                <Pack ID="P2603942" Specified="true" nzmt:ctpp_id="50075491000117108">
                  <Quantity>30</Quantity>
                  <Price>1.79</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070404969026" Rank="1" Units="tab" Weight="4">
              <Name>Tab 4 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B07040496902626" PSS="true">
                <Name>Coversyl</Name>
                <Pack ID="P2603950" Specified="true" nzmt:ctpp_id="50114111000117106">
                  <Quantity>30</Quantity>
                  <Price>2.44</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070404969027" Rank="1" Units="tab" Weight="8">
              <Name>Tab 8 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B07040496902725" PSS="true">
                <Name>Coversyl</Name>
                <Pack ID="P2643316" Specified="true" nzmt:ctpp_id="50165771000117100">
                  <Quantity>30</Quantity>
                  <Price>3.94</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A070412">
          <Name>Angiotensin II Antagonists</Name>
          <Chemical ID="C0704129141">
            <Name>Candesartan cilexetil</Name>
            <Formulation ID="F070412914125" Rank="1" Units="tab" Weight="4">
              <Name>Tab 4 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07041291412526" PSS="true">
                <Name>Candestar</Name>
                <Pack ID="P2380404" Specified="true" nzmt:ctpp_id="50125421000117101">
                  <Quantity>90</Quantity>
                  <Price>2.68</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070412914126" Rank="1" Units="tab" Weight="8">
              <Name>Tab 8 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07041291412626" PSS="true">
                <Name>Candestar</Name>
                <Pack ID="P2380412" Specified="true" nzmt:ctpp_id="50125431000117103">
                  <Quantity>90</Quantity>
                  <Price>2.67</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070412914127" Rank="1" Units="tab" Weight="16">
              <Name>Tab 16 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07041291412726" PSS="true">
                <Name>Candestar</Name>
                <Pack ID="P2380420" Specified="true" nzmt:ctpp_id="50125441000117106">
                  <Quantity>90</Quantity>
                  <Price>4.22</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070412914128" Rank="1" Units="tab" Weight="32">
              <Name>Tab 32 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07041291412826" PSS="true">
                <Name>Candestar</Name>
                <Pack ID="P2380439" Specified="true" nzmt:ctpp_id="50125451000117108">
                  <Quantity>90</Quantity>
                  <Price>5.24</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0704129625">
            <Name>Losartan potassium</Name>
            <Formulation ID="F070412962525" Rank="1" Units="tab" Weight="12.5">
              <Name>Tab 12.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B07041296252526" PSS="true">
                <Name>Losartan Actavis</Name>
                <Pack ID="P2466856" Specified="true" nzmt:ctpp_id="50211911000117108">
                  <Quantity>84</Quantity>
                  <Price>2.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070412962526" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B07041296252626" PSS="true">
                <Name>Losartan Actavis</Name>
                <Pack ID="P2466864" Specified="true" nzmt:ctpp_id="50211941000117107">
                  <Quantity>84</Quantity>
                  <Price>2.29</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070412962527" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B07041296252726" PSS="true">
                <Name>Losartan Actavis</Name>
                <Pack ID="P2466872" Specified="true" nzmt:ctpp_id="50211971000117101">
                  <Quantity>84</Quantity>
                  <Price>2.86</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070412962529" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B07041296252926" PSS="true">
                <Name>Losartan Actavis</Name>
                <Pack ID="P2466880" Specified="true" nzmt:ctpp_id="50212001000117103">
                  <Quantity>84</Quantity>
                  <Price>4.57</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A070416">
          <Name>Angiotensin II Antagonists with Diuretics</Name>
          <Chemical ID="C0704168269">
            <Name>Losartan potassium with hydrochlorothiazide</Name>
            <Formulation ID="F070416826901" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg with hydrochlorothiazide 12.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B07041682690125" PSS="true">
                <Name>Arrow-Losartan &amp; Hydrochlorothiazide</Name>
                <Pack ID="P2390620" Specified="true" nzmt:ctpp_id="50125521000117102">
                  <Quantity>30</Quantity>
                  <Price>4.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0704168718">
            <Name>Candesartan cilexetil with hydrochlorothiazide</Name>
            <Formulation ID="F070416871825" Rank="1" Units="tab" Weight="32">
              <Name>Tab 32 mg with hydrochlorothiazide 12.5 mg</Name>
              <Brand ID="B07041687182525">
                <Name>APO-Candesartan HCTZ 32/12.5</Name>
                <Pack ID="P2653907" Specified="true" nzmt:ctpp_id="50303121000117106">
                  <Quantity>30</Quantity>
                  <Price>5.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070416871826" Rank="1" Units="tab" Weight="16">
              <Name>Tab 16 mg with hydrochlorothiazide 12.5 mg</Name>
              <Brand ID="B07041687182625">
                <Name>APO-Candesartan HCTZ 16/12.5</Name>
                <Pack ID="P2653893" Specified="true" nzmt:ctpp_id="50303111000117100">
                  <Quantity>30</Quantity>
                  <Price>4.10</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A070420">
          <Name>Angiotensin II Antagonists with Neprilysin Inhibitors</Name>
          <Chemical ID="C0704208630">
            <Name>Sacubitril with valsartan</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS2014">
              <Title>
                <range>Sacubitril with valsartan</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has heart failure</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient is in NYHA/WHO functional class II</ci>
                      <ci type="logical">Patient is in NYHA/WHO functional class III</ci>
                      <ci type="logical">Patient is in NYHA/WHO functional class IV</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has a documented left ventricular ejection fraction (LVEF) of less than or equal to 35%</ci>
                      <ci type="logical">An ECHO is not reasonably practical, and
                        in the opinion of the treating practitioner the patient would benefit from
                        treatment</ci>
                    </apply>
                    <ci type="logical">Patient is receiving concomitant optimal standard chronic heart failure treatments</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2014" style="display:none"/>
            <Formulation ID="F070420863025" Rank="1" Units="tab" Weight="24">
              <Name>Tab 24.3 mg with valsartan 25.7 mg</Name>
              <Brand ID="B07042086302525">
                <Name>Entresto 24/26</Name>
                <Pack ID="P2554720" Specified="true" nzmt:ctpp_id="50257661000117101">
                  <Quantity>56</Quantity>
                  <Price>190.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070420863026" Rank="1" Units="tab" Weight="48">
              <Name>Tab 48.6 mg with valsartan 51.4 mg</Name>
              <Brand ID="B07042086302625">
                <Name>Entresto 49/51</Name>
                <Pack ID="P2554739" Specified="true" nzmt:ctpp_id="50257671000117106">
                  <Quantity>56</Quantity>
                  <Price>190.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070420863027" Rank="1" Units="tab" Weight="97">
              <Name>Tab 97.2 mg with valsartan 102.8 mg</Name>
              <Brand ID="B07042086302725">
                <Name>Entresto 97/103</Name>
                <Pack ID="P2554747" Specified="true" nzmt:ctpp_id="50257681000117109">
                  <Quantity>56</Quantity>
                  <Price>190.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0708">
        <Name>Alpha-Adrenoceptor Blockers</Name>
        <ATC3 ID="A070804">
          <Name>Alpha-Adrenoceptor Blockers</Name>
          <Chemical ID="C0708048359">
            <Name>Phenoxybenzamine hydrochloride</Name>
            <Formulation ID="F070804835901" Rank="2" Units="cap" Weight="10">
              <Name>Cap 10 mg</Name>
              <Brand ID="B07080483590100">
                <Name>Any</Name>
                <Pack ID="P83590100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070804835902" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B07080483590200">
                <Name>Any</Name>
                <Pack ID="P83590200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070804835925" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B07080483592500">
                <Name>Any</Name>
                <Pack ID="P83592500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0708048456">
            <Name>Terazosin</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F070804845601" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg</Name>
              <Brand ID="B07080484560100">
                <Name>Any</Name>
                <Pack ID="P84560100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0708049263">
            <Name>Phentolamine mesylate</Name>
            <Formulation ID="F070804926325" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B07080492632500">
                <Name>Any</Name>
                <Pack ID="P92632500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070804926326" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B07080492632600">
                <Name>Any</Name>
                <Pack ID="P92632600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0708049384">
            <Name>Doxazosin</Name>
            <Formulation ID="F070804938425" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Brand ID="B07080493842527">
                <Name>Doxazosin Clinect</Name>
                <Pack ID="P2608766" Specified="true" nzmt:ctpp_id="50287721000117108">
                  <Quantity>500</Quantity>
                  <Price>17.35</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070804938426" Rank="1" Units="tab" Weight="4">
              <Name>Tab 4 mg</Name>
              <Brand ID="B07080493842627">
                <Name>Doxazosin Clinect</Name>
                <Pack ID="P2608774" Specified="true" nzmt:ctpp_id="50287751000117101">
                  <Quantity>500</Quantity>
                  <Price>20.94</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0708049419">
            <Name>Prazosin</Name>
            <Formulation ID="F070804941925" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg</Name>
              <Brand ID="B07080494192527">
                <Name>Arrotex-Prazosin S29</Name>
                <Pack ID="P2625725" Specified="true" nzmt:ctpp_id="50292251000117105">
                  <Quantity>100</Quantity>
                  <Price>5.53</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070804941926" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Brand ID="B07080494192627">
                <Name>Arrotex-Prazosin S29</Name>
                <Pack ID="P2625733" Specified="true" nzmt:ctpp_id="50292261000117107">
                  <Quantity>100</Quantity>
                  <Price>7.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070804941927" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B07080494192727">
                <Name>Arrotex-Prazosin S29</Name>
                <Pack ID="P2625741" Specified="true" nzmt:ctpp_id="50292271000117102">
                  <Quantity>100</Quantity>
                  <Price>11.70</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070804941928" Rank="2" Units="cap" Weight="1">
              <Name>Cap 1 mg</Name>
              <Brand ID="B07080494192825">
                <Name>Prazosin Mylan</Name>
                <Pack ID="P2673908" Specified="true" nzmt:ctpp_id="50329121000117100">
                  <Quantity>100</Quantity>
                  <Price>15.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070804941929" Rank="2" Units="cap" Weight="2">
              <Name>Cap 2 mg</Name>
              <Brand ID="B07080494192925">
                <Name>Prazosin Mylan</Name>
                <Pack ID="P2673916" Specified="true" nzmt:ctpp_id="50329131000117102">
                  <Quantity>100</Quantity>
                  <Price>15.58</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F070804941930" Rank="2" Units="cap" Weight="5">
              <Name>Cap 5 mg</Name>
              <Brand ID="B07080494193025">
                <Name>Prazosin Mylan</Name>
                <Pack ID="P2673924" Specified="true" nzmt:ctpp_id="50329141000117105">
                  <Quantity>100</Quantity>
                  <Price>23.32</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0712">
        <Name>Antiarrhythmics</Name>
        <ATC3 ID="A071204">
          <Name>Antiarrhythmics</Name>
          <Chemical ID="C0712048007">
            <Name>Adenosine</Name>
            <Formulation ID="F071204800701" Rank="4" Units="inj" Weight="10">
              <Name>Inj 3 mg per ml, 10 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Request Form="RS1266" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Adenosine - Inj 3 mg per ml, 10 ml vial</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">For use in cardiac catheterisation, electrophysiology and MRI</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1266" style="display:none"/>
              <Brand ID="B07120480070125" PSS="true">
                <Name>Adenosine Baxter</Name>
                <Pack ID="P2655780" Specified="true" nzmt:ctpp_id="50312991000117100">
                  <Quantity>5</Quantity>
                  <Price>100.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F071204800702" Rank="4" Units="inj" Weight="2">
              <Name>Inj 3 mg per ml, 2 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B07120480070225" ToBeDelisted="2024-12-01">
                <Name>Adenocor</Name>
                <Pack ID="P282537" Specified="true" nzmt:ctpp_id="50062931000117104">
                  <Quantity>6</Quantity>
                  <Price>62.73</Price>
                </Pack>
              </Brand>
              <Brand ID="B07120480070226" PSS="true">
                <Name>Adsine</Name>
                <Pack ID="P2655799" Specified="true" nzmt:ctpp_id="50313021000117107">
                  <Quantity>5</Quantity>
                  <Price>34.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0712048008">
            <Name>Ajmaline</Name>
            <Request Form="RS1001" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ajmaline</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>cardiologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1001" style="display:none"/>
            <Formulation ID="F071204800801" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 10 ml ampoule</Name>
              <Brand ID="B07120480080100">
                <Name>Any</Name>
                <Pack ID="P80080100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0712048028">
            <Name>Amiodarone hydrochloride</Name>
            <Formulation ID="F071204802801" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 3 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B07120480280127" PSS="true">
                <Name>Max Health</Name>
                <Pack ID="P2565129" Specified="true" nzmt:ctpp_id="50231231000117104">
                  <Quantity>10</Quantity>
                  <Price>15.22</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F071204802802" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B07120480280226" PSS="true">
                <Name>Aratac</Name>
                <Pack ID="P770620" Specified="true" nzmt:ctpp_id="50111671000117109">
                  <Quantity>30</Quantity>
                  <Price>3.49</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F071204802803" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B07120480280326" PSS="true">
                <Name>Aratac</Name>
                <Pack ID="P770639" Specified="true" nzmt:ctpp_id="50111681000117107">
                  <Quantity>30</Quantity>
                  <Price>4.49</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0712048139">
            <Name>Digoxin</Name>
            <Formulation ID="F071204813901" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 mcg per ml, 2 ml vial</Name>
              <Brand ID="B07120481390100">
                <Name>Any</Name>
                <Pack ID="P81390100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F071204813902" Rank="3" Units="ml">
              <Name>Oral liq 50 mcg per ml</Name>
              <Brand ID="B07120481390200">
                <Name>Any</Name>
                <Pack ID="P81390200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F071204813903" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mcg</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B07120481390325" PSS="true">
                <Name>Lanoxin</Name>
                <Pack ID="P2378078" Specified="true" nzmt:ctpp_id="50122551000117103">
                  <Quantity>240</Quantity>
                  <Price>16.90</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F071204813904" Rank="1" Units="tab" Weight="62.5">
              <Name>Tab 62.5 mcg</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B07120481390425" PSS="true">
                <Name>Lanoxin PG</Name>
                <Pack ID="P2377012" Specified="true" nzmt:ctpp_id="50121671000117100">
                  <Quantity>240</Quantity>
                  <Price>7.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0712048155">
            <Name>Disopyramide phosphate</Name>
            <Formulation ID="F071204815501" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Brand ID="B07120481550100">
                <Name>Any</Name>
                <Pack ID="P81550100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0712048395">
            <Name>Propafenone hydrochloride</Name>
            <Formulation ID="F071204839501" Rank="1" Units="tab" Weight="150">
              <Name>Tab 150 mg</Name>
              <Brand ID="B07120483950100">
                <Name>Any</Name>
                <Pack ID="P83950100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0712048609">
            <Name>Ivabradine</Name>
            <Request Form="RS1566" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ivabradine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is indicated for computed tomography coronary
                    angiography</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has a heart rate of greater than 70 beats per minute
                        while taking a maximally tolerated dose of beta blocker</ci>
                      <ci type="logical">Patient is unable to tolerate beta blockers</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1566" style="display:none"/>
            <Formulation ID="F071204860925" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B07120486092500">
                <Name>Any</Name>
                <Pack ID="P86092500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0712049003">
            <Name>Atropine sulphate</Name>
            <Formulation ID="F071204900303" Rank="4" Units="inj" Weight="600">
              <Name>Inj 600 mcg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07120490030326" PSS="true">
                <Name>Martindale</Name>
                <Pack ID="P2528754" Specified="true" nzmt:ctpp_id="50226561000117104">
                  <Quantity>10</Quantity>
                  <Price>16.10</Price>
                </Pack>
              </Brand>
              <Brand ID="B07120490030327">
                <Name>Juno</Name>
                <Pack ID="P2689421" Specified="true" nzmt:ctpp_id="50340291000117104">
                  <Quantity>10</Quantity>
                  <Price>16.10</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0712049523">
            <Name>Flecainide acetate</Name>
            <Formulation ID="F071204952325" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B07120495232526" PSS="true">
                <Name>Flecainide BNM</Name>
                <Pack ID="P2567695" Specified="true" nzmt:ctpp_id="50177531000117105">
                  <Quantity>60</Quantity>
                  <Price>19.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F071204952327" Rank="2" Units="cap" Weight="100">
              <Name>Cap long-acting 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-23 to~2026" Value="5"/>
              <Brand ID="B07120495232726" PSS="true">
                <Name>Flecainide Controlled Release Teva</Name>
                <Pack ID="P2567113" Specified="true" nzmt:ctpp_id="50264311000117107">
                  <Quantity>90</Quantity>
                  <Price>35.78</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F071204952328" Rank="2" Units="cap" Weight="200">
              <Name>Cap long-acting 200 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-23 to~2026" Value="5"/>
              <Brand ID="B07120495232826" PSS="true">
                <Name>Flecainide Controlled Release Teva</Name>
                <Pack ID="P2567121" Specified="true" nzmt:ctpp_id="50264351000117108">
                  <Quantity>90</Quantity>
                  <Price>54.28</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F071204952329" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 15 ml ampoule</Name>
              <Brand ID="B07120495232925">
                <Name>Tambocor</Name>
                <Pack ID="P2447363" Specified="true" nzmt:ctpp_id="50073641000117100">
                  <Quantity>5</Quantity>
                  <Price>108.16</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0712049661">
            <Name>Mexiletine hydrochloride</Name>
            <Formulation ID="F071204966125" Rank="2" Units="cap" Weight="150">
              <Name>Cap 150 mg</Name>
              <Brand ID="B07120496612526">
                <Name>Teva</Name>
                <Pack ID="P2605562" Specified="true" nzmt:ctpp_id="50285941000117108">
                  <Quantity>100</Quantity>
                  <Price>162.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F071204966126" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Brand ID="B07120496612626">
                <Name>Teva</Name>
                <Pack ID="P2607263" Specified="true" nzmt:ctpp_id="50286091000117105">
                  <Quantity>100</Quantity>
                  <Price>202.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0716">
        <Name>Antihypotensives</Name>
        <ATC3 ID="A071604">
          <Name>Antihypotensives</Name>
          <Chemical ID="C0716048302">
            <Name>Midodrine</Name>
            <Request Form="RS1427" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Midodrine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has disabling orthostatic hypotension not due to drugs</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1427" style="display:none"/>
            <Formulation ID="F071604830201" Rank="1" Units="tab" Weight="2.5">
              <Name>Tab 2.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07160483020125" PSS="true">
                <Name>Midodrine Medsurge</Name>
                <Pack ID="P2632063" Specified="true" nzmt:ctpp_id="50277251000117104">
                  <Quantity>100</Quantity>
                  <Price>36.68</Price>
                </Pack>
              </Brand>
              <Brand ID="B07160483020126">
                <Name>MAR-Midodrine</Name>
                <Pack ID="P2667851" Specified="true" nzmt:ctpp_id="50324101000117109">
                  <Quantity>100</Quantity>
                  <Price>36.68</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F071604830202" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07160483020225" PSS="true">
                <Name>Midodrine Medsurge</Name>
                <Pack ID="P2632071" Specified="true" nzmt:ctpp_id="50277131000117100">
                  <Quantity>100</Quantity>
                  <Price>58.88</Price>
                </Pack>
              </Brand>
              <Brand ID="B07160483020226">
                <Name>MAR-Midodrine</Name>
                <Pack ID="P2667878" Specified="true" nzmt:ctpp_id="50336411000117107">
                  <Quantity>100</Quantity>
                  <Price>58.88</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0720">
        <Name>Beta-Adrenoceptor Blockers</Name>
        <ATC3 ID="A072004">
          <Name>Beta-Adrenoceptor Blockers</Name>
          <Chemical ID="C0720048170">
            <Name>Esmolol hydrochloride</Name>
            <Formulation ID="F072004817001" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 10 ml vial</Name>
              <Brand ID="B07200481700100">
                <Name>Any</Name>
                <Pack ID="P81700100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0720049131">
            <Name>Atenolol</Name>
            <Formulation ID="F072004913101" Rank="3" Units="ml">
              <Name>Oral liq 5 mg per ml</Name>
              <Brand ID="B07200491310125">
                <Name>Atenolol-AFT</Name>
                <Pack ID="P2403366" Specified="true" nzmt:ctpp_id="50157821000117107">
                  <Quantity>300</Quantity>
                  <Price>49.85</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004913125" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07200491312528" PSS="true">
                <Name>Viatris</Name>
                <Pack ID="P2627140" Specified="true" nzmt:ctpp_id="50290831000117100">
                  <Quantity>500</Quantity>
                  <Price>11.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004913126" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07200491312628" PSS="true">
                <Name>Atenolol Viatris</Name>
                <Pack ID="P2627159" Specified="true" nzmt:ctpp_id="50290771000117109">
                  <Quantity>500</Quantity>
                  <Price>18.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0720049167">
            <Name>Sotalol</Name>
            <Formulation ID="F072004916725" Rank="1" Units="tab" Weight="80">
              <Name>Tab 80 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B07200491672525" PSS="true">
                <Name>Mylan</Name>
                <Pack ID="P2127903" Specified="true" nzmt:ctpp_id="50022991000117107">
                  <Quantity>500</Quantity>
                  <Price>37.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004916726" Rank="1" Units="tab" Weight="160">
              <Name>Tab 160 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B07200491672625" PSS="true">
                <Name>Mylan</Name>
                <Pack ID="P2127911" Specified="true" nzmt:ctpp_id="50023001000117108">
                  <Quantity>100</Quantity>
                  <Price>14.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0720049205">
            <Name>Labetalol</Name>
            <Formulation ID="F072004920501" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 20 ml ampoule</Name>
              <Brand ID="B07200492050100">
                <Name>Any</Name>
                <Pack ID="P92050100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004920525" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B07200492052500">
                <Name>Any</Name>
                <Pack ID="P92052500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004920526" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B07200492052627">
                <Name>Trandate</Name>
                <Pack ID="P2582155" Specified="true" nzmt:ctpp_id="50025251000117104">
                  <Quantity>100</Quantity>
                  <Price>14.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004920527" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B07200492052727">
                <Name>Trandate</Name>
                <Pack ID="P2582163" Specified="true" nzmt:ctpp_id="50019591000117104">
                  <Quantity>100</Quantity>
                  <Price>27.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0720049235">
            <Name>Carvedilol</Name>
            <Formulation ID="F072004923525" Rank="1" Units="tab" Weight="6.25">
              <Name>Tab 6.25 mg</Name>
              <Brand ID="B07200492352527">
                <Name>Carvedilol Sandoz</Name>
                <Pack ID="P2527332" Specified="true" nzmt:ctpp_id="50192541000117108">
                  <Quantity>60</Quantity>
                  <Price>2.24</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004923526" Rank="1" Units="tab" Weight="12.5">
              <Name>Tab 12.5 mg</Name>
              <Brand ID="B07200492352627">
                <Name>Carvedilol Sandoz</Name>
                <Pack ID="P2527324" Specified="true" nzmt:ctpp_id="50192561000117107">
                  <Quantity>60</Quantity>
                  <Price>2.30</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004923527" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Brand ID="B07200492352727">
                <Name>Carvedilol Sandoz</Name>
                <Pack ID="P2527316" Specified="true" nzmt:ctpp_id="50192581000117104">
                  <Quantity>60</Quantity>
                  <Price>2.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0720049310">
            <Name>Metoprolol tartrate</Name>
            <Formulation ID="F072004931025" Rank="1" Units="tab" Weight="200">
              <Name>Tab long-acting 200 mg</Name>
              <Brand ID="B07200493102525">
                <Name>Slow-Lopresor</Name>
                <Pack ID="P2108682" Specified="true" nzmt:ctpp_id="50019381000117108">
                  <Quantity>28</Quantity>
                  <Price>23.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004931026" Rank="4" Units="inj" Weight="5">
              <Name>Inj 1 mg per ml, 5 ml vial</Name>
              <Brand ID="B07200493102626">
                <Name>Metoprolol IV Mylan</Name>
                <Pack ID="P2550369" Specified="true" nzmt:ctpp_id="50227921000117101">
                  <Quantity>5</Quantity>
                  <Price>26.50</Price>
                </Pack>
              </Brand>
              <Brand ID="B07200493102627">
                <Name>Metoprolol IV Viatris</Name>
                <Pack ID="P2639777" Specified="true" nzmt:ctpp_id="50290851000117105">
                  <Quantity>5</Quantity>
                  <Price>26.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004931027" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-22 to~2027" Value="1"/>
              <Brand ID="B07200493102727" HSS="true">
                <Name>IPCA-Metoprolol</Name>
                <Pack ID="P2618672" Specified="true" nzmt:ctpp_id="50167631000117100">
                  <Quantity>100</Quantity>
                  <Price>5.66</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004931028" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-22 to~2027" Value="1"/>
              <Brand ID="B07200493102827" HSS="true">
                <Name>IPCA-Metoprolol</Name>
                <Pack ID="P2618680" Specified="true" nzmt:ctpp_id="50167641000117108">
                  <Quantity>60</Quantity>
                  <Price>7.55</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0720049381">
            <Name>Celiprolol</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F072004938125" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B07200493812500">
                <Name>Any</Name>
                <Pack ID="P93812500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0720049391">
            <Name>Nadolol</Name>
            <Formulation ID="F072004939125" Rank="1" Units="tab" Weight="40">
              <Name>Tab 40 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-22 to~2027" Value="1"/>
              <Brand ID="B07200493912526" HSS="true">
                <Name>Nadolol BNM</Name>
                <Pack ID="P2621118" nzmt:ctpp_id="50291241000117102">
                  <Quantity>100</Quantity>
                  <Price>19.19</Price>
                </Pack>
                <Pack ID="P2647540" Specified="true" nzmt:ctpp_id="50297151000117101">
                  <Quantity>100</Quantity>
                  <Price>19.19</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004939126" Rank="1" Units="tab" Weight="80">
              <Name>Tab 80 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-22 to~2027" Value="1"/>
              <Brand ID="B07200493912626" HSS="true">
                <Name>Nadolol BNM</Name>
                <Pack ID="P2621126" nzmt:ctpp_id="50291251000117100">
                  <Quantity>100</Quantity>
                  <Price>30.39</Price>
                </Pack>
                <Pack ID="P2647559" Specified="true" nzmt:ctpp_id="50297161000117104">
                  <Quantity>100</Quantity>
                  <Price>30.39</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0720049396">
            <Name>Propranolol</Name>
            <Formulation ID="F072004939601" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B07200493960100">
                <Name>Any</Name>
                <Pack ID="P93960100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004939602" Rank="3" Units="ml">
              <Name>Oral liq 4 mg per ml</Name>
              <Brand ID="B07200493960200">
                <Name>Any</Name>
                <Pack ID="P93960200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004939625" Rank="2" Units="cap" Weight="160">
              <Name>Cap long-acting 160 mg</Name>
              <Brand ID="B07200493962525">
                <Name>Cardinol LA</Name>
                <Pack ID="P326070" Specified="true" nzmt:ctpp_id="50072421000117101">
                  <Quantity>100</Quantity>
                  <Price>18.17</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004939626" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-22 to~2027" Value="1"/>
              <Brand ID="B07200493962626" HSS="true">
                <Name>Drofate</Name>
                <Pack ID="P2611414" Specified="true" nzmt:ctpp_id="50206991000117108">
                  <Quantity>100</Quantity>
                  <Price>7.04</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004939627" Rank="1" Units="tab" Weight="40">
              <Name>Tab 40 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-22 to~2027" Value="1"/>
              <Brand ID="B07200493962726" HSS="true">
                <Name>IPCA-Propranolol</Name>
                <Pack ID="P2618664" Specified="true" nzmt:ctpp_id="50207021000117105">
                  <Quantity>100</Quantity>
                  <Price>8.75</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0720049477">
            <Name>Metoprolol succinate</Name>
            <Formulation ID="F072004947725" Rank="1" Units="tab" Weight="23.75">
              <Name>Tab long-acting 23.75 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2026" Value="5"/>
              <Brand ID="B07200494772527" PSS="true">
                <Name>Myloc CR</Name>
                <Pack ID="P2650681" Specified="true" nzmt:ctpp_id="50309191000117106">
                  <Quantity>90</Quantity>
                  <Price>4.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004947726" Rank="1" Units="tab" Weight="47.5">
              <Name>Tab long-acting 47.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2026" Value="5"/>
              <Brand ID="B07200494772627" PSS="true">
                <Name>Myloc CR</Name>
                <Pack ID="P2650703" Specified="true" nzmt:ctpp_id="50309201000117109">
                  <Quantity>90</Quantity>
                  <Price>3.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004947727" Rank="1" Units="tab" Weight="95">
              <Name>Tab long-acting 95 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2026" Value="5"/>
              <Brand ID="B07200494772727" PSS="true">
                <Name>Myloc CR</Name>
                <Pack ID="P2650711" Specified="true" nzmt:ctpp_id="50309211000117107">
                  <Quantity>90</Quantity>
                  <Price>5.24</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004947728" Rank="1" Units="tab" Weight="190">
              <Name>Tab long-acting 190 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2026" Value="5"/>
              <Brand ID="B07200494772827" PSS="true">
                <Name>Myloc CR</Name>
                <Pack ID="P2650738" Specified="true" nzmt:ctpp_id="50309221000117101">
                  <Quantity>90</Quantity>
                  <Price>9.76</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0720049643">
            <Name>Bisoprolol fumarate</Name>
            <Formulation ID="F072004964325" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2026" Value="5"/>
              <Brand ID="B07200496432528" PSS="true">
                <Name>Ipca-Bisoprolol</Name>
                <Pack ID="P2660369" Specified="true" nzmt:ctpp_id="50319461000117108">
                  <Quantity>90</Quantity>
                  <Price>1.91</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004964326" Rank="1" Units="tab" Weight="2.5">
              <Name>Tab 2.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2026" Value="5"/>
              <Brand ID="B07200496432628" PSS="true">
                <Name>Ipca-Bisoprolol</Name>
                <Pack ID="P2660350" Specified="true" nzmt:ctpp_id="50319451000117106">
                  <Quantity>90</Quantity>
                  <Price>1.36</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072004964327" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2026" Value="5"/>
              <Brand ID="B07200496432728" PSS="true">
                <Name>Ipca-Bisoprolol</Name>
                <Pack ID="P2660377" Specified="true" nzmt:ctpp_id="50319471000117103">
                  <Quantity>90</Quantity>
                  <Price>2.71</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0724">
        <Name>Calcium Channel Blockers</Name>
        <ATC3 ID="A072404">
          <Name>Dihydropyridine Calcium Channel Blockers</Name>
          <Chemical ID="C0724048248">
            <Name>Isradipine</Name>
            <Formulation ID="F072404824803" Rank="1" Units="tab" Weight="2.5">
              <Name>Tab 2.5 mg</Name>
              <Brand ID="B07240482480300">
                <Name>Any</Name>
                <Pack ID="P82480300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072404824825" Rank="2" Units="cap" Weight="2">
              <Name>Cap 2.5 mg</Name>
              <Brand ID="B07240482482500">
                <Name>Any</Name>
                <Pack ID="P82482500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0724048317">
            <Name>Nimodipine</Name>
            <Formulation ID="F072404831701" Rank="4" Units="inj" Weight="200">
              <Name>Inj 0.2 mg per ml, 50 ml vial</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2025" Value="5"/>
              <Brand ID="B07240483170125" PSS="true">
                <Name>Nimotop</Name>
                <Pack ID="P2663937" Specified="true" nzmt:ctpp_id="50321831000117106">
                  <Quantity>5</Quantity>
                  <Price>337.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072404831702" Rank="1" Units="tab" Weight="30">
              <Name>Tab 30 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B07240483170225" PSS="true">
                <Name>Nimotop</Name>
                <Pack ID="P818461" Specified="true" nzmt:ctpp_id="50117561000117105">
                  <Quantity>100</Quantity>
                  <Price>350.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0724048572">
            <Name>Nicardipine hydrochloride</Name>
            <Request Form="RS1699" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Nicardipine hydrochloride</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Patient has hypertension requiring urgent treatment with an intravenous agent</ci>
                    <ci type="logical">Patient has excessive ventricular afterload</ci>
                    <ci type="logical">Patient is awaiting or undergoing cardiac surgery using cardiopulmonary bypass</ci>
                  </apply>
                </math>
                <Applicant>anaesthetist</Applicant>
                <Applicant>intensivist</Applicant>
                <Applicant>cardiologist</Applicant>
                <Applicant>paediatric cardiologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1699" style="display:none"/>
            <Formulation ID="F072404857225" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2.5 mg per ml, 10 ml vial</Name>
              <Brand ID="B07240485722500">
                <Name>Any</Name>
                <Pack ID="P85722500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0724049230">
            <Name>Nifedipine</Name>
            <Formulation ID="F072404923001" Rank="2" Units="cap" Weight="5">
              <Name>Cap 5 mg</Name>
              <Brand ID="B07240492300100">
                <Name>Any</Name>
                <Pack ID="P92300100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072404923002" Rank="1" Units="tab">
              <Name>Tab long-acting 10 mg</Name>
              <Brand ID="B07240492300226">
                <Name>Tensipine MR10</Name>
                <Pack ID="P2603217" Specified="true" nzmt:ctpp_id="50284411000117101">
                  <Quantity>56</Quantity>
                  <Price>19.42</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072404923025" Rank="1" Units="tab" Weight="20">
              <Name>Tab long-acting 20 mg</Name>
              <Brand ID="B07240492302525">
                <Name>Nyefax Retard</Name>
                <Pack ID="P529435" Specified="true" nzmt:ctpp_id="50094481000117101">
                  <Quantity>100</Quantity>
                  <Price>17.72</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072404923026" Rank="1" Units="tab" Weight="30">
              <Name>Tab long-acting 30 mg</Name>
              <Brand ID="B07240492302628">
                <Name>Mylan (24 hr release)</Name>
                <Pack ID="P2602911" Specified="true" nzmt:ctpp_id="50284271000117109">
                  <Quantity>100</Quantity>
                  <Price>34.10</Price>
                </Pack>
              </Brand>
              <Brand ID="B07240492302629">
                <Name>Mylan Italy (24 hr release)</Name>
                <Pack ID="P2618028" Specified="true" nzmt:ctpp_id="50291191000117102">
                  <Quantity>14</Quantity>
                  <Price>4.78</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072404923027" Rank="1" Units="tab" Weight="60">
              <Name>Tab long-acting 60 mg</Name>
              <Brand ID="B07240492302728">
                <Name>Mylan (24 hr release)</Name>
                <Pack ID="P2602938" Specified="true" nzmt:ctpp_id="50284281000117107">
                  <Quantity>100</Quantity>
                  <Price>52.81</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0724049385">
            <Name>Felodipine</Name>
            <Formulation ID="F072404938525" Rank="1" Units="tab" Weight="5">
              <Name>Tab long-acting 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07240493852525" PSS="true">
                <Name>Felo 5 ER</Name>
                <Pack ID="P2041510" Specified="true" nzmt:ctpp_id="50007951000117106">
                  <Quantity>90</Quantity>
                  <Price>6.57</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072404938526" Rank="1" Units="tab" Weight="10">
              <Name>Tab long-acting 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07240493852625" PSS="true">
                <Name>Felo 10 ER</Name>
                <Pack ID="P2041499" Specified="true" nzmt:ctpp_id="50007931000117101">
                  <Quantity>90</Quantity>
                  <Price>6.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072404938527" Rank="1" Units="tab">
              <Name>Tab long-acting 2.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07240493852725" PSS="true">
                <Name>Plendil ER</Name>
                <Pack ID="P353760" Specified="true" nzmt:ctpp_id="50077161000117101">
                  <Quantity>30</Quantity>
                  <Price>2.18</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0724049469">
            <Name>Amlodipine</Name>
            <Formulation ID="F072404946925" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B07240494692527" PSS="true">
                <Name>Vasorex</Name>
                <Pack ID="P2592517" Specified="true" nzmt:ctpp_id="50279001000117102">
                  <Quantity>90</Quantity>
                  <Price>1.21</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072404946926" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B07240494692627" PSS="true">
                <Name>Vasorex</Name>
                <Pack ID="P2592525" Specified="true" nzmt:ctpp_id="50279041000117100">
                  <Quantity>90</Quantity>
                  <Price>1.31</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072404946927" Rank="1" Units="tab" Weight="2.5">
              <Name>Tab 2.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B07240494692726" PSS="true">
                <Name>Vasorex</Name>
                <Pack ID="P2592509" Specified="true" nzmt:ctpp_id="50278961000117108">
                  <Quantity>90</Quantity>
                  <Price>1.45</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A072408">
          <Name>Other Calcium Channel Blockers</Name>
          <Chemical ID="C0724089138">
            <Name>Verapamil hydrochloride</Name>
            <Formulation ID="F072408913825" Rank="1" Units="tab" Weight="40">
              <Name>Tab 40 mg</Name>
              <Brand ID="B07240891382526">
                <Name>Isoptin</Name>
                <Pack ID="P2535327" Specified="true" nzmt:ctpp_id="50053891000117109">
                  <Quantity>100</Quantity>
                  <Price>7.01</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072408913826" Rank="1" Units="tab" Weight="80">
              <Name>Tab 80 mg</Name>
              <Brand ID="B07240891382626">
                <Name>Isoptin</Name>
                <Pack ID="P2535335" Specified="true" nzmt:ctpp_id="50053901000117108">
                  <Quantity>100</Quantity>
                  <Price>11.74</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072408913827" Rank="1" Units="tab" Weight="240">
              <Name>Tab long-acting 240 mg</Name>
              <Brand ID="B07240891382726">
                <Name>Isoptin SR</Name>
                <Pack ID="P2535343" Specified="true" nzmt:ctpp_id="50078791000117109">
                  <Quantity>30</Quantity>
                  <Price>15.12</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072408913828" Rank="4" Units="inj" Weight="5">
              <Name>Inj 2.5 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B07240891382825">
                <Name>Isoptin</Name>
                <Pack ID="P2535351" Specified="true" nzmt:ctpp_id="50053881000117106">
                  <Quantity>5</Quantity>
                  <Price>25.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072408913829" Rank="1" Units="tab" Weight="120">
              <Name>Tab long-acting 120 mg</Name>
              <Brand ID="B07240891382926">
                <Name>Isoptin SR</Name>
                <Pack ID="P2571897" Specified="true" nzmt:ctpp_id="50110821000117102">
                  <Quantity>100</Quantity>
                  <Price>36.02</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0724089226">
            <Name>Perhexiline maleate</Name>
            <Formulation ID="F072408922625" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B07240892262525">
                <Name>Pexsig</Name>
                <Pack ID="P352713" Specified="true" nzmt:ctpp_id="50077101000117102">
                  <Quantity>100</Quantity>
                  <Price>62.90</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0724089466">
            <Name>Diltiazem hydrochloride</Name>
            <Formulation ID="F072408946601" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 5 ml vial</Name>
              <Brand ID="B07240894660100">
                <Name>Any</Name>
                <Pack ID="P94660100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072408946625" Rank="1" Units="tab" Weight="30">
              <Name>Tab 30 mg</Name>
              <Brand ID="B07240894662500">
                <Name>Any</Name>
                <Pack ID="P94662500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072408946626" Rank="2" Units="cap" Weight="120">
              <Name>Cap long-acting 120 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-23 to~2025" Value="5"/>
              <Brand ID="B07240894662627" PSS="true">
                <Name>Diltiazem CD Clinect</Name>
                <Pack ID="P2648172" Specified="true" nzmt:ctpp_id="50299571000117107">
                  <Quantity>500</Quantity>
                  <Price>65.35</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072408946627" Rank="2" Units="cap" Weight="180">
              <Name>Cap long-acting 180 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-22 to~2027" Value="1"/>
              <Brand ID="B07240894662725" HSS="true">
                <Name>Cardizem CD</Name>
                <Pack ID="P254584" Specified="true" nzmt:ctpp_id="50054561000117103">
                  <Quantity>30</Quantity>
                  <Price>7.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072408946628" Rank="2" Units="cap" Weight="240">
              <Name>Cap long-acting 240 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-22 to~2027" Value="1"/>
              <Brand ID="B07240894662825" HSS="true">
                <Name>Cardizem CD</Name>
                <Pack ID="P254592" Specified="true" nzmt:ctpp_id="50054571000117108">
                  <Quantity>30</Quantity>
                  <Price>9.30</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0728">
        <Name>Centrally-Acting Agents</Name>
        <ATC3 ID="A072804">
          <Name>Centrally-Acting Agents</Name>
          <Chemical ID="C0728049271">
            <Name>Clonidine hydrochloride</Name>
            <Formulation ID="F072804927125" Rank="4" Units="inj" Weight="150">
              <Name>Inj 150 mcg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Jan-25 to~2027" Value="5"/>
              <Brand ID="B07280492712525" PSS="true">
                <Name>Catapres</Name>
                <Pack ID="P202266" Specified="true" nzmt:ctpp_id="50004581000117104">
                  <Quantity>5</Quantity>
                  <Price>14.10</Price>
                </Pack>
              </Brand>
              <Brand ID="B07280492712526" ToBeDelisted="2025-01-01">
                <Name>Medsurge</Name>
                <Pack ID="P2548445" Specified="true" nzmt:ctpp_id="50231191000117107">
                  <Quantity>10</Quantity>
                  <Price>29.68</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072804927126" Rank="1" Units="tab" Weight="150">
              <Name>Tab 150 mcg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07280492712625" PSS="true">
                <Name>Catapres</Name>
                <Pack ID="P202274" Specified="true" nzmt:ctpp_id="50004611000117105">
                  <Quantity>100</Quantity>
                  <Price>40.41</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072804927130" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mcg</Name>
              <Rule Type="DVLimit" Attribute="Nov-22 to~2025" Value="5"/>
              <Brand ID="B07280492713027" PSS="true">
                <Name>Clonidine Teva</Name>
                <Pack ID="P2630249" Specified="true" nzmt:ctpp_id="50294351000117106">
                  <Quantity>112</Quantity>
                  <Price>29.32</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0728049451">
            <Name>Methyldopa</Name>
            <Formulation ID="F072804945126" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B07280494512627">
                <Name>Methyldopa Viatris</Name>
                <Pack ID="P2644738" Specified="true" nzmt:ctpp_id="50294411000117102">
                  <Quantity>100</Quantity>
                  <Price>15.10</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0728049521">
            <Name>Clonidine</Name>
            <Formulation ID="F072804952127" Rank="9" Units="patch" Weight="2.5">
              <Name>Patch 2.5 mg, 100 mcg per day</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B07280495212726" PSS="true">
                <Name>Mylan</Name>
                <Pack ID="P2523078" Specified="true" nzmt:ctpp_id="50243581000117102">
                  <Quantity>4</Quantity>
                  <Price>11.70</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072804952128" Rank="9" Units="patch" Weight="5">
              <Name>Patch 5 mg, 200 mcg per day</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B07280495212826" PSS="true">
                <Name>Mylan</Name>
                <Pack ID="P2523086" Specified="true" nzmt:ctpp_id="50243591000117104">
                  <Quantity>4</Quantity>
                  <Price>12.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F072804952129" Rank="9" Units="patch" Weight="7.5">
              <Name>Patch 7.5 mg, 300 mcg per day</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B07280495212926" PSS="true">
                <Name>Mylan</Name>
                <Pack ID="P2523094" Specified="true" nzmt:ctpp_id="50243601000117105">
                  <Quantity>4</Quantity>
                  <Price>17.90</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0732">
        <Name>Diuretics</Name>
        <ATC3 ID="A073204">
          <Name>Loop Diuretics</Name>
          <Chemical ID="C0732049194">
            <Name>Furosemide [Frusemide]</Name>
            <Formulation ID="F073204919401" Rank="4" Units="inj" Weight="25">
              <Name>Inj 10 mg per ml, 25 ml ampoule</Name>
              <Brand ID="B07320491940125">
                <Name>Lasix</Name>
                <Pack ID="P2482800" Specified="true" nzmt:ctpp_id="50218541000117109">
                  <Quantity>6</Quantity>
                  <Price>60.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073204919402" Rank="3" Units="ml" Weight="10">
              <Name>Oral liq 10 mg per ml</Name>
              <Brand ID="B07320491940225">
                <Name>Lasix</Name>
                <Pack ID="P2489341" Specified="true" nzmt:ctpp_id="50018351000117108">
                  <Quantity>30</Quantity>
                  <Price>11.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073204919425" Rank="4" Units="inj" Weight="20">
              <Name>Inj 10 mg per ml, 2 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B07320491942527" PSS="true">
                <Name>Furosemide-Baxter</Name>
                <Pack ID="P2599503" Specified="true" nzmt:ctpp_id="50281561000117100">
                  <Quantity>5</Quantity>
                  <Price>2.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073204919426" Rank="1" Units="tab" Weight="40">
              <Name>Tab 40 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07320491942627" PSS="true">
                <Name>IPCA-Frusemide</Name>
                <Pack ID="P2618699" Specified="true" nzmt:ctpp_id="50164111000117107">
                  <Quantity>1000</Quantity>
                  <Price>12.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073204919427" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Brand ID="B07320491942726">
                <Name>Urex Forte</Name>
                <Pack ID="P2343444" Specified="true" nzmt:ctpp_id="50050091000117108">
                  <Quantity>50</Quantity>
                  <Price>25.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0732049417">
            <Name>Bumetanide</Name>
            <Formulation ID="F073204941701" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mcg per ml, 4 ml vial</Name>
              <Brand ID="B07320494170100">
                <Name>Any</Name>
                <Pack ID="P94170100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073204941725" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg</Name>
              <Brand ID="B07320494172525">
                <Name>Burinex</Name>
                <Pack ID="P210323" Specified="true" nzmt:ctpp_id="50018591000117106">
                  <Quantity>100</Quantity>
                  <Price>16.36</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A073208">
          <Name>Osmotic Diuretics</Name>
          <Chemical ID="C0732089324">
            <Name>Mannitol</Name>
            <Formulation ID="F073208932429" Rank="4" Units="inj">
              <Name>Inj 20%, 500 ml bag</Name>
              <Brand ID="B07320893242925">
                <Name>Baxter</Name>
                <Pack ID="P2541637" Specified="true" nzmt:ctpp_id="50253241000117107">
                  <Quantity>18</Quantity>
                  <Price>1178.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073208932430" Rank="4" Units="inj">
              <Name>Inj 10%, 1,000 ml bag</Name>
              <Brand ID="B07320893243025">
                <Name>Baxter</Name>
                <Pack ID="P2541629" Specified="true" nzmt:ctpp_id="50253251000117109">
                  <Quantity>12</Quantity>
                  <Price>802.56</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A073212">
          <Name>Potassium Sparing Combination Diuretics</Name>
          <Chemical ID="C0732128017">
            <Name>Amiloride hydrochloride with furosemide</Name>
            <Formulation ID="F073212801701" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg with furosemide 40 mg</Name>
              <Brand ID="B07321280170100">
                <Name>Any</Name>
                <Pack ID="P80170100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0732128018">
            <Name>Amiloride hydrochloride with hydrochlorothiazide</Name>
            <Formulation ID="F073212801801" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg with hydrochlorothiazide 50 mg</Name>
              <Brand ID="B07321280180100">
                <Name>Any</Name>
                <Pack ID="P80180100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A073216">
          <Name>Potassium Sparing Diuretics</Name>
          <Chemical ID="C0732168624">
            <Name>Eplerenone</Name>
            <Request Form="RS1640" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Eplerenone</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has heart failure with ejection fraction less than 40%</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient is intolerant to optimal dosing of spironolactone</ci>
                      <ci type="logical">Patient has experienced a clinically significant adverse effect while on optimal dosing of spironolactone</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1640" style="display:none"/>
            <Formulation ID="F073216862425" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B07321686242525" PSS="true">
                <Name>Inspra</Name>
                <Pack ID="P2619512" Specified="true" nzmt:ctpp_id="50048101000117104">
                  <Quantity>30</Quantity>
                  <Price>15.84</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073216862426" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B07321686242625" PSS="true">
                <Name>Inspra</Name>
                <Pack ID="P2619520" Specified="true" nzmt:ctpp_id="50258661000117100">
                  <Quantity>30</Quantity>
                  <Price>25.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0732169166">
            <Name>Spironolactone</Name>
            <Formulation ID="F073216916625" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Sep-22 to~2025" Value="5"/>
              <Brand ID="B07321691662526" PSS="true">
                <Name>Spiractin</Name>
                <Pack ID="P2435179" Specified="true" nzmt:ctpp_id="50166411000117109">
                  <Quantity>100</Quantity>
                  <Price>3.68</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073216916626" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Sep-22 to~2025" Value="5"/>
              <Brand ID="B07321691662626" PSS="true">
                <Name>Spiractin</Name>
                <Pack ID="P2435187" Specified="true" nzmt:ctpp_id="50166421000117103">
                  <Quantity>100</Quantity>
                  <Price>10.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073216916627" Rank="3" Units="ml" Weight="5">
              <Name>Oral liq 5 mg per ml</Name>
              <Brand ID="B07321691662725">
                <Name>Biomed</Name>
                <Pack ID="P344877" Specified="true" nzmt:ctpp_id="50075831000117106">
                  <Quantity>25</Quantity>
                  <Price>34.65</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0732169241">
            <Name>Amiloride hydrochloride</Name>
            <Formulation ID="F073216924101" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B07321692410100">
                <Name>Any</Name>
                <Pack ID="P92410100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073216924125" Rank="3" Units="ml" Weight="1">
              <Name>Oral liq 1 mg per ml</Name>
              <Brand ID="B07321692412525">
                <Name>Biomed</Name>
                <Pack ID="P344710" Specified="true" nzmt:ctpp_id="50075781000117104">
                  <Quantity>25</Quantity>
                  <Price>33.71</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A073220">
          <Name>Thiazide and Related Diuretics</Name>
          <Chemical ID="C0732208299">
            <Name>Metolazone</Name>
            <Formulation ID="F073220829901" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B07322082990100">
                <Name>Any</Name>
                <Pack ID="P82990100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0732209200">
            <Name>Indapamide</Name>
            <Formulation ID="F073220920025" Rank="1" Units="tab" Weight="2.5">
              <Name>Tab 2.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B07322092002526" PSS="true">
                <Name>Dapa-Tabs</Name>
                <Pack ID="P2356406" Specified="true" nzmt:ctpp_id="50050771000117109">
                  <Quantity>90</Quantity>
                  <Price>16.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0732209242">
            <Name>Chlorothiazide</Name>
            <Formulation ID="F073220924225" Rank="3" Units="ml" Weight="50">
              <Name>Oral liq 50 mg per ml</Name>
              <Brand ID="B07322092422525">
                <Name>Biomed</Name>
                <Pack ID="P344818" Specified="true" nzmt:ctpp_id="50075801000117100">
                  <Quantity>25</Quantity>
                  <Price>29.21</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0732209317">
            <Name>Chlortalidone [Chlorthalidone]</Name>
            <Formulation ID="F073220931725" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B07322093172525" PSS="true">
                <Name>Hygroton</Name>
                <Pack ID="P2025779" Specified="true" nzmt:ctpp_id="50005061000117103">
                  <Quantity>50</Quantity>
                  <Price>6.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0732209533">
            <Name>Bendroflumethiazide [Bendrofluazide]</Name>
            <Formulation ID="F073220953325" Rank="1" Units="tab" Weight="2.5">
              <Name>Tab 2.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B07322095332525" PSS="true">
                <Name>Arrow-Bendrofluazide</Name>
                <Pack ID="P2351420" Specified="true" nzmt:ctpp_id="50050591000117104">
                  <Quantity>500</Quantity>
                  <Price>51.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073220953326" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B07322095332625" PSS="true">
                <Name>Arrow-Bendrofluazide</Name>
                <Pack ID="P2351439" Specified="true" nzmt:ctpp_id="50050601000117105">
                  <Quantity>500</Quantity>
                  <Price>61.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A073224">
          <Name>Vasopressin receptor antagonists</Name>
          <Chemical ID="C0732248698">
            <Name>Tolvaptan</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1930">
              <Title>
                <range>Tolvaptan</range>
              </Title>
              <Case When="Initial application" Category="autosomal dominant polycystic kidney disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has a confirmed diagnosis of autosomal
                    dominant polycystic kidney disease</ci>
                    <ci type="logical" class="Indication">Patient has an estimated glomerular filtration
                    rate (eGFR) of greater than or equal to 25 ml/min/1.73 m² at treatment
                    initiation</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient’s disease is rapidly progressing, with a decline in
                        eGFR of greater than or equal to 5 mL/min/1.73 m² within one-year</ci>
                      <ci type="logical">Patient’s disease is rapidly progressing, with an average
                        decline in eGFR of greater than or equal to 2.5 mL/min/1.73 m² per year over
                        a five-year period</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>renal physician</Applicant>
                <Applicant Referring="renal physician">any relevant practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="autosomal dominant polycystic kidney disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has not developed end-stage renal disease, defined as an
                    eGFR of less than 15 mL/min/1.73 m²</ci>
                    <ci type="logical">Patient has not undergone a kidney transplant</ci>
                  </apply>
                </math>
                <Applicant>renal physician</Applicant>
                <Applicant Referring="renal physician">any relevant practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1930" style="display:none"/>
            <Formulation ID="F073224869825" Rank="1" Units="tab" Weight="15">
              <Name>Tab 15 mg</Name>
              <Brand ID="B07322486982525">
                <Name>Jinarc</Name>
                <Pack ID="P2647494" Specified="true" nzmt:ctpp_id="50253291000117100">
                  <Quantity>28</Quantity>
                  <Price>873.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073224869826" Rank="1" Units="tab" Weight="30">
              <Name>Tab 30 mg</Name>
              <Brand ID="B07322486982625">
                <Name>Jinarc</Name>
                <Pack ID="P2647508" Specified="true" nzmt:ctpp_id="50253301000117104">
                  <Quantity>28</Quantity>
                  <Price>873.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073224869827" Rank="1" Units="tab" Weight="45">
              <Name>Tab 45 mg + 15 mg</Name>
              <Brand ID="B07322486982725">
                <Name>Jinarc</Name>
                <Pack ID="P2647451" Specified="true" nzmt:ctpp_id="50253311000117101">
                  <Quantity>56</Quantity>
                  <Price>1747.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073224869828" Rank="1" Units="tab" Weight="60">
              <Name>Tab 60 mg + 30 mg</Name>
              <Brand ID="B07322486982825">
                <Name>Jinarc</Name>
                <Pack ID="P2647478" Specified="true" nzmt:ctpp_id="50253321000117107">
                  <Quantity>56</Quantity>
                  <Price>1747.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073224869829" Rank="1" Units="tab" Weight="90">
              <Name>Tab 90 mg + 30 mg</Name>
              <Brand ID="B07322486982925">
                <Name>Jinarc</Name>
                <Pack ID="P2647486" Specified="true" nzmt:ctpp_id="50253331000117105">
                  <Quantity>56</Quantity>
                  <Price>1747.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0736">
        <Name>Lipid-Modifying Agents</Name>
        <ATC3 ID="A073604">
          <Name>Fibrates</Name>
          <Chemical ID="C0736049268">
            <Name>Bezafibrate</Name>
            <Formulation ID="F073604926825" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B07360492682526" PSS="true">
                <Name>Bezalip</Name>
                <Pack ID="P474223" Specified="true" nzmt:ctpp_id="50089331000117109">
                  <Quantity>90</Quantity>
                  <Price>22.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073604926826" Rank="1" Units="tab" Weight="400">
              <Name>Tab long-acting 400 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B07360492682625" PSS="true">
                <Name>Bezalip Retard</Name>
                <Pack ID="P354333" Specified="true" nzmt:ctpp_id="50077271000117101">
                  <Quantity>30</Quantity>
                  <Price>21.54</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A073608">
          <Name>HMG CoA Reductase Inhibitors (Statins)</Name>
          <Chemical ID="C0736088681">
            <Name>Rosuvastatin</Name>
            <Request Form="RS1868" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Rosuvastatin</range>
              </Title>
              <Case When="Initial application" Category="cardiovascular disease risk">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">Patient is considered to be at risk of cardiovascular disease</ci>
                      <ci type="logical">Patient is Māori or any Pacific ethnicity</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has a calculated risk of cardiovascular disease of at least 15%
            over 5 years</ci>
                      <ci type="logical">LDL cholesterol has not reduced to less than 1.8 mmol/litre with
            treatment with the maximum tolerated dose of atorvastatin and/or simvastatin</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="familial hypercholesterolemia">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has familial hypercholesterolemia (defined as a Dutch Lipid
          Criteria score greater than or equal to 6)</ci>
                    <ci type="logical">LDL cholesterol has not reduced to less than 1.8 mmol/litre with
          treatment with the maximum tolerated dose of atorvastatin and/or simvastatin</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="established cardiovascular disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has proven coronary artery disease (CAD)</ci>
                      <ci type="logical">Patient has proven peripheral artery disease (PAD)</ci>
                      <ci type="logical">Patient has experienced an ischaemic stroke</ci>
                    </apply>
                    <ci type="logical">LDL cholesterol has not reduced to less than 1.4 mmol/litre with
          treatment with the maximum tolerated dose of atorvastatin and/or simvastatin</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="recurrent major cardiovascular events">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has experienced a recurrent major cardiovascular event (defined
          as myocardial infarction, ischaemic stroke, coronary revascularisation, hospitalisation
          for unstable angina) in the last 2 years</ci>
                    <ci type="logical">LDL cholesterol has not reduced to less than 1.0 mmol/litre with
          treatment with the maximum tolerated dose of atorvastatin and/or simvastatin</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1868" style="display:none"/>
            <Formulation ID="F073608868125" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Oct-24 to~2026" Value="5"/>
              <Brand ID="B07360886812525" PSS="true">
                <Name>Rosuvastatin Viatris</Name>
                <Pack ID="P2651130" Specified="true" nzmt:ctpp_id="50294161000117105">
                  <Quantity>30</Quantity>
                  <Price>1.29</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073608868126" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Oct-24 to~2026" Value="5"/>
              <Brand ID="B07360886812625" PSS="true">
                <Name>Rosuvastatin Viatris</Name>
                <Pack ID="P2651149" Specified="true" nzmt:ctpp_id="50294131000117103">
                  <Quantity>30</Quantity>
                  <Price>1.69</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073608868127" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2026" Value="5"/>
              <Brand ID="B07360886812725" PSS="true">
                <Name>Rosuvastatin Viatris</Name>
                <Pack ID="P2651157" Specified="true" nzmt:ctpp_id="50294141000117106">
                  <Quantity>30</Quantity>
                  <Price>2.71</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073608868128" Rank="1" Units="tab" Weight="40">
              <Name>Tab 40 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2026" Value="5"/>
              <Brand ID="B07360886812825" PSS="true">
                <Name>Rosuvastatin Viatris</Name>
                <Pack ID="P2651165" Specified="true" nzmt:ctpp_id="50294151000117108">
                  <Quantity>30</Quantity>
                  <Price>4.55</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0736089413">
            <Name>Simvastatin</Name>
            <Formulation ID="F073608941325" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B07360894132527" PSS="true">
                <Name>Simvastatin Mylan</Name>
                <Pack ID="P2520087" Specified="true" nzmt:ctpp_id="50247601000117104">
                  <Quantity>90</Quantity>
                  <Price>1.68</Price>
                </Pack>
              </Brand>
              <Brand ID="B07360894132528">
                <Name>Simvastatin Viatris</Name>
                <Pack ID="P2643553" Specified="true" nzmt:ctpp_id="50295731000117103">
                  <Quantity>90</Quantity>
                  <Price>1.68</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073608941326" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B07360894132628" PSS="true">
                <Name>Simvastatin Viatris</Name>
                <Pack ID="P2643561" Specified="true" nzmt:ctpp_id="50295861000117102">
                  <Quantity>90</Quantity>
                  <Price>2.54</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073608941327" Rank="1" Units="tab" Weight="40">
              <Name>Tab 40 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B07360894132727" ToBeDelisted="2024-12-01">
                <Name>Simvastatin Mylan</Name>
                <Pack ID="P2520109" Specified="true" nzmt:ctpp_id="50247621000117107">
                  <Quantity>90</Quantity>
                  <Price>4.11</Price>
                </Pack>
              </Brand>
              <Brand ID="B07360894132728" PSS="true">
                <Name>Simvastatin Viatris</Name>
                <Pack ID="P2643588" Specified="true" nzmt:ctpp_id="50295991000117102">
                  <Quantity>90</Quantity>
                  <Price>4.11</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073608941328" Rank="1" Units="tab" Weight="80">
              <Name>Tab 80 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B07360894132828" PSS="true">
                <Name>Simvastatin Viatris</Name>
                <Pack ID="P2643596" Specified="true" nzmt:ctpp_id="50296161000117101">
                  <Quantity>90</Quantity>
                  <Price>8.81</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0736089549">
            <Name>Atorvastatin</Name>
            <Formulation ID="F073608954925" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B07360895492529" PSS="true">
                <Name>Lorstat</Name>
                <Pack ID="P2493586" Specified="true" nzmt:ctpp_id="50230471000117105">
                  <Quantity>500</Quantity>
                  <Price>5.16</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073608954926" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B07360895492629" PSS="true">
                <Name>Lorstat</Name>
                <Pack ID="P2493594" Specified="true" nzmt:ctpp_id="50230501000117100">
                  <Quantity>500</Quantity>
                  <Price>8.12</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073608954927" Rank="1" Units="tab" Weight="40">
              <Name>Tab 40 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B07360895492729" PSS="true">
                <Name>Lorstat</Name>
                <Pack ID="P2493608" Specified="true" nzmt:ctpp_id="50230531000117106">
                  <Quantity>500</Quantity>
                  <Price>13.79</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073608954928" Rank="1" Units="tab" Weight="80">
              <Name>Tab 80 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B07360895492829" PSS="true">
                <Name>Lorstat</Name>
                <Pack ID="P2493616" Specified="true" nzmt:ctpp_id="50230561000117104">
                  <Quantity>500</Quantity>
                  <Price>25.39</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0736089624">
            <Name>Pravastatin</Name>
            <Formulation ID="F073608962401" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B07360896240100">
                <Name>Any</Name>
                <Pack ID="P96240100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073608962425" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2026" Value="5"/>
              <Brand ID="B07360896242529" PSS="true">
                <Name>Clinect</Name>
                <Pack ID="P2665204" Specified="true" nzmt:ctpp_id="50301051000117102">
                  <Quantity>100</Quantity>
                  <Price>7.16</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073608962426" Rank="1" Units="tab" Weight="40">
              <Name>Tab 40 mg</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2026" Value="5"/>
              <Brand ID="B07360896242628" PSS="true">
                <Name>Clinect</Name>
                <Pack ID="P2665212" Specified="true" nzmt:ctpp_id="50301091000117106">
                  <Quantity>100</Quantity>
                  <Price>12.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A073616">
          <Name>Resins</Name>
          <Chemical ID="C0736168094">
            <Name>Cholestyramine</Name>
            <Formulation ID="F073616809401" Rank="3" Units="g">
              <Name>Powder for oral liq 4 g</Name>
              <Brand ID="B07361680940100">
                <Name>Any</Name>
                <Pack ID="P80940100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0736168110">
            <Name>Colestipol hydrochloride</Name>
            <Formulation ID="F073616811001" Rank="2" Units="sach">
              <Name>Grans for oral liq 5 g</Name>
              <Brand ID="B07361681100100">
                <Name>Any</Name>
                <Pack ID="P81100100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0736168720">
            <Name>Colestyramine</Name>
            <Formulation ID="F073616872025" Rank="2" Units="sach">
              <Name>Powder for oral suspension 4 g sachet</Name>
              <Brand ID="B07361687202525">
                <Name>Colestyramine - Mylan</Name>
                <Pack ID="P2662000" Specified="true" nzmt:ctpp_id="50320651000117109">
                  <Quantity>50</Quantity>
                  <Price>61.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A073620">
          <Name>Selective Cholesterol Absorption Inhibitors</Name>
          <Chemical ID="C0736208180">
            <Name>Ezetimibe</Name>
            <Formulation ID="F073620818001" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B07362081800126" PSS="true">
                <Name>Ezetimibe Sandoz</Name>
                <Pack ID="P2545861" Specified="true" nzmt:ctpp_id="50197101000117103">
                  <Quantity>30</Quantity>
                  <Price>1.76</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0736208181">
            <Name>Ezetimibe with simvastatin</Name>
            <Formulation ID="F073620818101" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg with simvastatin 10 mg</Name>
              <Brand ID="B07362081810125">
                <Name>Zimybe</Name>
                <Pack ID="P2470683" Specified="true" nzmt:ctpp_id="50153471000117100">
                  <Quantity>30</Quantity>
                  <Price>5.15</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073620818102" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg with simvastatin 20 mg</Name>
              <Brand ID="B07362081810225">
                <Name>Zimybe</Name>
                <Pack ID="P2470691" Specified="true" nzmt:ctpp_id="50153511000117108">
                  <Quantity>30</Quantity>
                  <Price>6.15</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073620818103" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg with simvastatin 40 mg</Name>
              <Brand ID="B07362081810325">
                <Name>Zimybe</Name>
                <Pack ID="P2470705" Specified="true" nzmt:ctpp_id="50153561000117106">
                  <Quantity>30</Quantity>
                  <Price>7.15</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F073620818104" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg with simvastatin 80 mg</Name>
              <Brand ID="B07362081810425">
                <Name>Zimybe</Name>
                <Pack ID="P2470713" Specified="true" nzmt:ctpp_id="50153591000117100">
                  <Quantity>30</Quantity>
                  <Price>8.15</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A073624">
          <Name>Other Lipid-Modifying Agents</Name>
          <Chemical ID="C0736248005">
            <Name>Acipimox</Name>
            <Formulation ID="F073624800501" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Brand ID="B07362480050100">
                <Name>Any</Name>
                <Pack ID="P80050100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0740">
        <Name>Nitrates</Name>
        <ATC3 ID="A074004">
          <Name>Nitrates</Name>
          <Chemical ID="C0740049024">
            <Name>Glyceryl trinitrate</Name>
            <Formulation ID="F074004902402" Rank="9" Units="patch" Weight="10">
              <Name>Patch 50 mg, 10 mg per day</Name>
              <Brand ID="B07400490240201">
                <Name>Nitroderm TTS 10</Name>
                <Pack ID="P750247" Specified="true" nzmt:ctpp_id="50108501000117107">
                  <Quantity>30</Quantity>
                  <Multiple>30</Multiple>
                  <Price>18.62</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074004902403" Rank="9" Units="patch" Weight="5">
              <Name>Patch 25 mg, 5 mg per day</Name>
              <Brand ID="B07400490240301">
                <Name>Nitroderm TTS 5</Name>
                <Pack ID="P716790" Specified="true" nzmt:ctpp_id="50105141000117108">
                  <Quantity>30</Quantity>
                  <Multiple>30</Multiple>
                  <Price>15.73</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074004902404" Rank="4" Units="inj" Weight="50">
              <Name>Inj 5 mg per ml, 10 ml ampoule</Name>
              <Brand ID="B07400490240401">
                <Name>Hospira</Name>
                <Pack ID="P503681" Specified="true" nzmt:ctpp_id="50093131000117108">
                  <Quantity>5</Quantity>
                  <Price>118.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074004902425" Rank="4" Units="inj" Weight="5">
              <Name>Inj 1 mg per ml, 5 ml ampoule</Name>
              <Brand ID="B07400490242500">
                <Name>Any</Name>
                <Pack ID="P90242500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074004902426" Rank="4" Units="inj" Weight="50">
              <Name>Inj 1 mg per ml, 50 ml vial</Name>
              <Brand ID="B07400490242600">
                <Name>Any</Name>
                <Pack ID="P90242600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074004902430" Rank="6" Units="dose" Weight="400">
              <Name>Oral pump spray, 400 mcg per dose</Name>
              <Brand ID="B07400490243002">
                <Name>Nitrolingual Pump Spray</Name>
                <Pack ID="P2017962" Specified="true" nzmt:ctpp_id="50003521000117101">
                  <Quantity>250</Quantity>
                  <Price>7.48</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074004902431" Rank="4" Units="inj" Weight="10">
              <Name>Inj 1 mg per ml, 10 ml ampoule</Name>
              <Brand ID="B07400490243100">
                <Name>Any</Name>
                <Pack ID="P90243100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0740049203">
            <Name>Isosorbide mononitrate</Name>
            <Formulation ID="F074004920325" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B07400492032525" PSS="true">
                <Name>Ismo 20</Name>
                <Pack ID="P214833" Specified="true" nzmt:ctpp_id="50025581000117108">
                  <Quantity>100</Quantity>
                  <Price>22.49</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074004920326" Rank="1" Units="tab" Weight="60">
              <Name>Tab long-acting 60 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B07400492032625" PSS="true">
                <Name>Duride</Name>
                <Pack ID="P2202964" Specified="true" nzmt:ctpp_id="50032091000117106">
                  <Quantity>90</Quantity>
                  <Price>13.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074004920327" Rank="1" Units="tab" Weight="40">
              <Name>Tab long-acting 40 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B07400492032726" PSS="true">
                <Name>Ismo 40 Retard</Name>
                <Pack ID="P2447355" Specified="true" nzmt:ctpp_id="50196901000117103">
                  <Quantity>30</Quantity>
                  <Price>9.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0744">
        <Name>Other Cardiac Agents</Name>
        <ATC3 ID="A074404">
          <Name>Other Cardiac Agents</Name>
          <Chemical ID="C0744048257">
            <Name>Levosimendan</Name>
            <Request Form="RS1007" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Levosimendan</range>
              </Title>
              <Case When="Initial application" Category="Heart transplant">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">For use as a bridge to heart transplant, in patients who have been accepted for transplant</ci>
                    <ci type="logical">For the treatment of heart failure following heart transplant</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Heart failure">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For the treatment of severe acute decompensated heart failure that is non-responsive to dobutamine</ci>
                </math>
                <Applicant>cardiologist</Applicant>
                <Applicant>intensivist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1007" style="display:none"/>
            <Formulation ID="F074404825701" Rank="4" Units="inj" Weight="10">
              <Name>Inj 2.5 mg per ml, 10 ml vial</Name>
              <Brand ID="B07440482570100">
                <Name>Any</Name>
                <Pack ID="P82570100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074404825702" Rank="4" Units="inj" Weight="5">
              <Name>Inj 2.5 mg per ml, 5 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Nov-24 to~2027" Value="5"/>
              <Brand ID="B07440482570225" PSS="true">
                <Name>Simdax</Name>
                <Pack ID="P2304236" Specified="true" nzmt:ctpp_id="50045811000117103">
                  <Quantity>1</Quantity>
                  <Price>509.60</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0748">
        <Name>Sympathomimetics</Name>
        <ATC3 ID="A074804">
          <Name>Sympathomimetics</Name>
          <Chemical ID="C0748048157">
            <Name>Dobutamine</Name>
            <Formulation ID="F074804815701" Rank="4" Units="inj" Weight="12.5">
              <Name>Inj 12.5 mg per ml, 20 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B07480481570126" PSS="true">
                <Name>Dobutamine-hameln</Name>
                <Pack ID="P2450836" Specified="true" nzmt:ctpp_id="50207901000117101">
                  <Quantity>5</Quantity>
                  <Price>61.13</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0748048246">
            <Name>Isoprenaline [Isoproterenol]</Name>
            <Formulation ID="F074804824601" Rank="4" Units="inj" Weight="200">
              <Name>Inj 200 mcg per ml, 1 ml ampoule</Name>
              <Brand ID="B07480482460100">
                <Name>Any</Name>
                <Pack ID="P82460100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804824602" Rank="4" Units="inj" Weight="200">
              <Name>Inj 200 mcg per ml, 5 ml ampoule</Name>
              <Brand ID="B07480482460200">
                <Name>Any</Name>
                <Pack ID="P82460200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0748048292">
            <Name>Metaraminol</Name>
            <Formulation ID="F074804829201" Rank="4" Units="inj" Weight="0.5">
              <Name>Inj 0.5 mg per ml, 20 ml syringe</Name>
              <Brand ID="B07480482920100">
                <Name>Any</Name>
                <Pack ID="P82920100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804829202" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B07480482920200">
                <Name>Any</Name>
                <Pack ID="P82920200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804829203" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg per ml, 10 ml syringe</Name>
              <Brand ID="B07480482920300">
                <Name>Any</Name>
                <Pack ID="P82920300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804829204" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B07480482920425" PSS="true">
                <Name>Torbay</Name>
                <Pack ID="P2482983" Specified="true" nzmt:ctpp_id="50240731000117104">
                  <Quantity>10</Quantity>
                  <Price>53.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804829225" Rank="4" Units="inj" Weight="0.5">
              <Name>Inj 0.5 mg per ml, 5 ml syringe</Name>
              <Brand ID="B07480482922500">
                <Name>Any</Name>
                <Pack ID="P82922500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804829226" Rank="4" Units="inj" Weight="0.5">
              <Name>Inj 0.5 mg per ml, 10 ml syringe</Name>
              <Brand ID="B07480482922600">
                <Name>Any</Name>
                <Pack ID="P82922600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0748049039">
            <Name>Noradrenaline</Name>
            <Formulation ID="F074804903902" Rank="4" Units="inj" Weight="0.06">
              <Name>Inj 0.06 mg per ml, 100 ml bag</Name>
              <Brand ID="B07480490390200">
                <Name>Any</Name>
                <Pack ID="P90390200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804903903" Rank="4" Units="inj" Weight="0.06">
              <Name>Inj 0.06 mg per ml, 50 ml syringe</Name>
              <Brand ID="B07480490390300">
                <Name>Any</Name>
                <Pack ID="P90390300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804903904" Rank="4" Units="inj" Weight="0.1">
              <Name>Inj 0.1 mg per ml, 100 ml bag</Name>
              <Brand ID="B07480490390400">
                <Name>Any</Name>
                <Pack ID="P90390400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804903905" Rank="4" Units="inj" Weight="0.12">
              <Name>Inj 0.12 mg per ml, 100 ml bag</Name>
              <Brand ID="B07480490390500">
                <Name>Any</Name>
                <Pack ID="P90390500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804903906" Rank="4" Units="inj" Weight="0.12">
              <Name>Inj 0.12 mg per ml, 50 ml syringe</Name>
              <Brand ID="B07480490390600">
                <Name>Any</Name>
                <Pack ID="P90390600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804903907" Rank="4" Units="inj" Weight="0.16">
              <Name>Inj 0.16 mg per ml, 50 ml syringe</Name>
              <Brand ID="B07480490390700">
                <Name>Any</Name>
                <Pack ID="P90390700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804903908" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg per ml, 100 ml bag</Name>
              <Brand ID="B07480490390800">
                <Name>Any</Name>
                <Pack ID="P90390800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804903925" Rank="4" Units="inj" Weight="4">
              <Name>Inj 1 mg per ml, 4 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2025" Value="5"/>
              <Brand ID="B07480490392525" PSS="true">
                <Name>Noradrenaline BNM</Name>
                <Pack ID="P2519879" Specified="true" nzmt:ctpp_id="50225001000117101">
                  <Quantity>10</Quantity>
                  <Price>45.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804903926" Rank="4" Units="inj" Weight="0.1">
              <Name>Inj 0.1 mg per ml, 50 ml syringe</Name>
              <Brand ID="B07480490392600">
                <Name>Any</Name>
                <Pack ID="P90392600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0748049225">
            <Name>Phenylephrine hydrochloride</Name>
            <Formulation ID="F074804922526" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B07480492252625">
                <Name>Neosynephrine HCL</Name>
                <Pack ID="P2341069" Specified="true" nzmt:ctpp_id="50029331000117101">
                  <Quantity>25</Quantity>
                  <Price>163.38</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0748049264">
            <Name>Adrenaline</Name>
            <Formulation ID="F074804926401" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 in 1,000, 30 ml vial</Name>
              <Brand ID="B07480492640100">
                <Name>Any</Name>
                <Pack ID="P92640100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804926402" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 in 10,000, 10 ml syringe</Name>
              <Brand ID="B07480492640200">
                <Name>Any</Name>
                <Pack ID="P92640200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804926425" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 in 1,000, 1 ml ampoule</Name>
              <Brand ID="B07480492642525">
                <Name>DBL Adrenaline</Name>
                <Pack ID="P346659" nzmt:ctpp_id="50076061000117102">
                  <Quantity>50</Quantity>
                  <Price>100.00</Price>
                </Pack>
                <Pack ID="P603341" Specified="true" nzmt:ctpp_id="50098491000117108">
                  <Quantity>5</Quantity>
                  <Price>13.27</Price>
                </Pack>
              </Brand>
              <Brand ID="B07480492642526">
                <Name>Aspen Adrenaline</Name>
                <Pack ID="P2309823" Specified="true" nzmt:ctpp_id="50046931000117109">
                  <Quantity>5</Quantity>
                  <Price>4.98</Price>
                </Pack>
              </Brand>
              <Brand ID="B07480492642527">
                <Name>Hameln</Name>
                <Pack ID="P2685043" Specified="true" nzmt:ctpp_id="50337331000117106">
                  <Quantity>10</Quantity>
                  <Price>25.30</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804926426" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 in 10,000, 10 ml ampoule</Name>
              <Brand ID="B07480492642625">
                <Name>Hospira</Name>
                <Pack ID="P534196" Specified="true" nzmt:ctpp_id="50094741000117103">
                  <Quantity>5</Quantity>
                  <Price>27.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B07480492642626">
                <Name>Aspen Adrenaline</Name>
                <Pack ID="P2390949" Specified="true" nzmt:ctpp_id="50125901000117103">
                  <Quantity>10</Quantity>
                  <Price>49.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0748049313">
            <Name>Dopamine hydrochloride</Name>
            <Formulation ID="F074804931325" Rank="4" Units="inj" Weight="200">
              <Name>Inj 40 mg per ml, 5 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B07480493132526" PSS="true">
                <Name>Max Health Ltd</Name>
                <Pack ID="P2374374" Specified="true" nzmt:ctpp_id="50171911000117102">
                  <Quantity>10</Quantity>
                  <Price>46.38</Price>
                </Pack>
              </Brand>
              <Brand ID="B07480493132527">
                <Name>Dopamine Basi</Name>
                <Pack ID="P2691353" Specified="true" nzmt:ctpp_id="50341411000117102">
                  <Quantity>10</Quantity>
                  <Price>46.38</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0748049664">
            <Name>Ephedrine</Name>
            <Formulation ID="F074804966401" Rank="4" Units="inj" Weight="3">
              <Name>Inj 3 mg per ml, 10 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B07480496640125" PSS="true">
                <Name>Ephedrine Juno</Name>
                <Pack ID="P2544598" Specified="true" nzmt:ctpp_id="50253741000117101">
                  <Quantity>10</Quantity>
                  <Price>142.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F074804966425" Rank="4" Units="inj" Weight="30">
              <Name>Inj 30 mg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B07480496642525" PSS="true">
                <Name>Max Health</Name>
                <Pack ID="P2402874" Specified="true" nzmt:ctpp_id="50129341000117102">
                  <Quantity>10</Quantity>
                  <Price>34.31</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A0752">
        <Name>Vasodilators</Name>
        <ATC3 ID="A075202">
          <Name>Vasodilators</Name>
          <Chemical ID="C0752028304">
            <Name>Milrinone</Name>
            <Formulation ID="F075202830401" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg per ml, 10 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B07520283040127" PSS="true">
                <Name>Milrinone-Baxter</Name>
                <Pack ID="P2603047" Specified="true" nzmt:ctpp_id="50271441000117105">
                  <Quantity>10</Quantity>
                  <Price>68.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0752028350">
            <Name>Pentoxifylline [Oxpentifylline]</Name>
            <Formulation ID="F075202835001" Rank="1" Units="tab" Weight="400">
              <Name>Tab 400 mg</Name>
              <Brand ID="B07520283500100">
                <Name>Any</Name>
                <Pack ID="P83500100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0752028721">
            <Name>Alprostadil</Name>
            <Request Form="RS1992" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Alprostadil</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has erectile dysfunction</ci>
                    <ci type="logical">Patient is to receive a penile Doppler ultrasonography</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1992" style="display:none"/>
            <Formulation ID="F075202872125" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mcg vial</Name>
              <Brand ID="B07520287212500">
                <Name>Any</Name>
                <Pack ID="P87212500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F075202872126" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mcg vial</Name>
              <Brand ID="B07520287212600">
                <Name>Any</Name>
                <Pack ID="P87212600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0752029276">
            <Name>Papaverine hydrochloride</Name>
            <Formulation ID="F075202927601" Rank="4" Units="inj" Weight="30">
              <Name>Inj 30 mg per ml, 1 ml vial</Name>
              <Brand ID="B07520292760100">
                <Name>Any</Name>
                <Pack ID="P92760100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F075202927625" Rank="4" Units="inj" Weight="120">
              <Name>Inj 12 mg per ml, 10 ml ampoule</Name>
              <Brand ID="B07520292762525">
                <Name>Hospira</Name>
                <Pack ID="P333328" Specified="true" nzmt:ctpp_id="50074101000117106">
                  <Quantity>5</Quantity>
                  <Price>257.12</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0752029307">
            <Name>Hydralazine hydrochloride</Name>
            <Formulation ID="F075202930701" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Request Form="RS1008" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Hydralazine hydrochloride - Tab 25 mg</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical">For the treatment of refractory hypertension</ci>
                      <ci type="logical">For the treatment of heart failure, in combination with a nitrate, in patients who are intolerant or have not responded to ACE inhibitors and/or angiotensin receptor blockers</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1008" style="display:none"/>
              <Brand ID="B07520293070100">
                <Name>Any</Name>
                <Pack ID="P93070100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F075202930725" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg ampoule</Name>
              <Brand ID="B07520293072525">
                <Name>Apresoline</Name>
                <Pack ID="P274550" nzmt:ctpp_id="50060901000117109">
                  <Quantity>5</Quantity>
                  <Price>25.90</Price>
                </Pack>
                <Pack ID="P2446227" Specified="true">
                  <Quantity>5</Quantity>
                  <Price>25.90</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0752029340">
            <Name>Alprostadil hydrochloride</Name>
            <Formulation ID="F075202934025" Rank="4" Units="inj" Weight="0.5">
              <Name>Inj 500 mcg per ml, 1 ml ampoule</Name>
              <Brand ID="B07520293402525">
                <Name>Prostin VR</Name>
                <Pack ID="P332593" Specified="true" nzmt:ctpp_id="50073731000117101">
                  <Quantity>5</Quantity>
                  <Price>2030.33</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0752029648">
            <Name>Sodium nitroprusside</Name>
            <Formulation ID="F075202964801" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg vial</Name>
              <Brand ID="B07520296480100">
                <Name>Any</Name>
                <Pack ID="P96480100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0752029662">
            <Name>Nicorandil</Name>
            <Formulation ID="F075202966225" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2025" Value="5"/>
              <Brand ID="B07520296622526" PSS="true">
                <Name>Max Health</Name>
                <Pack ID="P2669242" Specified="true" nzmt:ctpp_id="50298331000117109">
                  <Quantity>60</Quantity>
                  <Price>21.73</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F075202966226" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2025" Value="5"/>
              <Brand ID="B07520296622626" PSS="true">
                <Name>Max Health</Name>
                <Pack ID="P2669250" Specified="true" nzmt:ctpp_id="50298341000117101">
                  <Quantity>60</Quantity>
                  <Price>27.44</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0752029665">
            <Name>Minoxidil</Name>
            <Formulation ID="F075202966525" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B07520296652525">
                <Name>Loniten</Name>
                <Pack ID="P300438" Specified="true" nzmt:ctpp_id="50066681000117105">
                  <Quantity>100</Quantity>
                  <Price>78.40</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0752029682">
            <Name>Diazoxide</Name>
            <Formulation ID="F075202968201" Rank="4" Units="inj" Weight="15">
              <Name>Inj 15 mg per ml, 20 ml ampoule</Name>
              <Brand ID="B07520296820100">
                <Name>Any</Name>
                <Pack ID="P96820100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A075204">
          <Name>Endothelin Receptor Antagonists</Name>
          <Chemical ID="C0752049483">
            <Name>Bosentan</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1982">
              <Title>
                <range>bosentan</range>
              </Title>
              <Case When="Initial application" Category="PAH monotherapy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has pulmonary arterial hypertension (PAH)*</ci>
                    <ci type="logical">PAH is in Group 1, 4 or 5 of the WHO (Venice 2003) clinical classifications</ci>
                    <ci type="logical">PAH is in New York Heart Association/World Health Organization (NYHA/WHO) functional class II, III or IV</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">PAH has been confirmed by right heart catheterisation</ci>
                        <ci type="logical">A mean pulmonary artery pressure (PAPm) greater than 20 mmHg (unless peri Fontan repair)</ci>
                        <ci type="logical">A pulmonary capillary wedge pressure (PCWP) less than or equal to 15 mmHg</ci>
                        <ci type="logical">Pulmonary vascular resistance greater than 2 Wood Units or greater than 160 International Units (dyn s <msup><mi>cm</mi><mn>-5</mn></msup>)</ci>
                        <apply>
                          <or/>
                          <ci type="logical">PAH has been demonstrated to be non-responsive in vasoreactivity assessment using iloprost or nitric oxide, as defined in the 2022 ECS/ERS Guidelines for PAH (see note
                below for link to these guidelines) † </ci>
                          <ci type="logical">Patient has not experienced an acceptable response to calcium antagonist treatment, according to a validated risk stratification tool**</ci>
                          <ci type="logical">Patient has PAH other than idiopathic / heritable or drug-associated type</ci>
                        </apply>
                      </apply>
                      <ci type="logical">Patient is a child with PAH secondary to congenital heart disease or PAH due to idiopathic, congenital or developmental lung disorders including severe chronic neonatal
            lung disease</ci>
                      <ci type="logical">Patient has palliated single ventricle congenital heart disease and elevated pulmonary pressures or a major complication of the Fontan circulation requiring the minimising
            of pulmonary/venous filling pressures</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Bosentan is to be used as PAH monotherapy</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has experienced intolerable side effects on sildenafil</ci>
                        <ci type="logical">Patient has an absolute contraindication to sildenafil</ci>
                        <ci type="logical">Patient is a child with idiopathic PAH or PAH secondary to congenital heart disease</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Applicant>cardiologist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="respiratory specialist, cardiologist or rheumatologist">any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="PAH dual therapy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has pulmonary arterial hypertension (PAH)*</ci>
                    <ci type="logical">PAH is in Group 1, 4 or 5 of the WHO (Venice 2003) clinical classifications</ci>
                    <ci type="logical">PAH is in New York Heart Association/World Health Organization (NYHA/WHO) functional class II, III or IV</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">PAH has been confirmed by right heart catheterisation</ci>
                        <ci type="logical">A mean pulmonary artery pressure (PAPm) greater than 20 mmHg (unless peri Fontan repair)</ci>
                        <ci type="logical">A pulmonary capillary wedge pressure (PCWP) less than or equal to 15 mmHg</ci>
                        <ci type="logical">Pulmonary vascular resistance greater than 2 Wood Units or greater than 160 International Units (dyn s <msup><mi>cm</mi><mn>-5</mn></msup>)</ci>
                        <apply>
                          <or/>
                          <ci type="logical">PAH has been demonstrated to be non-responsive in vasoreactivity assessment using iloprost or nitric oxide, as defined in the 2022 ECS/ERS Guidelines for PAH (see note
                below for link to these guidelines) † </ci>
                          <ci type="logical">Patient has not experienced an acceptable response to calcium antagonist treatment, according to a validated risk stratification tool**</ci>
                          <ci type="logical">Patient has PAH other than idiopathic / heritable or drug-associated type</ci>
                        </apply>
                      </apply>
                      <ci type="logical">Patient is a child with PAH secondary to congenital heart disease or PAH due to idiopathic, congenital or developmental lung disorders including severe chronic neonatal
            lung disease</ci>
                      <ci type="logical">Patient has palliated single ventricle congenital heart disease and elevated pulmonary pressures or a major complication of the Fontan circulation requiring the minimising
            of pulmonary/venous filling pressures</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Bosentan is to be used as part of PAH dual therapy</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has tried a PAH monotherapy (sildenafil) for at least three months and has experienced an inadequate therapeutic response to treatment according to a validated
              risk stratification tool**</ci>
                        <ci type="logical">Patient is presenting in NYHA/WHO functional class III or IV, and in the opinion of the treating clinician would likely benefit from initial dual therapy</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Applicant>cardiologist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="respiratory specialist, cardiologist or rheumatologist">any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="PAH triple therapy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has pulmonary arterial hypertension (PAH)*</ci>
                    <ci type="logical">PAH is in Group 1, 4 or 5 of the WHO (Venice 2003) clinical classifications</ci>
                    <ci type="logical">PAH is in New York Heart Association/World Health Organization (NYHA/WHO) functional class II, III or IV</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">PAH has been confirmed by right heart catheterisation</ci>
                        <ci type="logical">A mean pulmonary artery pressure (PAPm) greater than 20 mmHg (unless peri Fontan repair)</ci>
                        <ci type="logical">A pulmonary capillary wedge pressure (PCWP) less than or equal to 15 mmHg</ci>
                        <ci type="logical">Pulmonary vascular resistance greater than 2 Wood Units or greater than 160 International Units (dyn s <msup><mi>cm</mi><mn>-5</mn></msup>)</ci>
                        <apply>
                          <or/>
                          <ci type="logical">PAH has been demonstrated to be non-responsive in vasoreactivity assessment using iloprost or nitric oxide, as defined in the 2022 ECS/ERS Guidelines for PAH (see note
                below for link to these guidelines) † </ci>
                          <ci type="logical">Patient has not experienced an acceptable response to calcium antagonist treatment, according to a validated risk stratification tool**</ci>
                          <ci type="logical">Patient has PAH other than idiopathic / heritable or drug-associated type</ci>
                        </apply>
                      </apply>
                      <ci type="logical">Patient is a child with PAH secondary to congenital heart disease or PAH due to idiopathic, congenital or developmental lung disorders including severe chronic neonatal
            lung disease</ci>
                      <ci type="logical">Patient has palliated single ventricle congenital heart disease and elevated pulmonary pressures or a major complication of the Fontan circulation requiring the minimising
            of pulmonary/venous filling pressures</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Bosentan is to be used as part of PAH triple therapy</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient is on the lung transplant list</ci>
                        <ci type="logical">Patient is presenting in NYHA/WHO functional class IV</ci>
                        <apply>
                          <and/>
                          <ci type="logical">Patient has tried PAH dual therapy for at least three months and has not experienced an acceptable response to treatment according to a validated risk stratification
                tool**</ci>
                          <ci type="logical">Patient does not have major life-threatening comorbidities and triple therapy is not being used in a palliative scenario</ci>
                        </apply>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Applicant>cardiologist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="respiratory specialist, cardiologist or rheumatologist">any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">Patient is continuing to derive benefit from bosentan treatment according to a validated PAH risk stratification tool**</ci>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Applicant>cardiologist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="respiratory specialist, cardiologist or rheumatologist">any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>† The European Respiratory Journal Guidelines can be found here: <a href="https://erj.ersjournals.com/content/early/2022/08/25/13993003.00879-2022">2022 ECS/ERS Guidelines for the diagnosis and
        treatment of pulmonary hypertension PAH</a></p>
                <p>** the requirement to use a validated risk stratification tool to determine insufficient response applies to adults. Determining insufficient response in children does not require use of a
      validated PAH risk stratification tool, where currently no such validated tools exist for PAH risk stratification in children.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1982" style="display:none"/>
            <Formulation ID="F075204948325" Rank="1" Units="tab" Weight="62.5">
              <Name>Tab 62.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-25 to~2027" Value="5"/>
              <Brand ID="B07520494832529" PSS="true">
                <Name>Bosentan Dr Reddy's</Name>
                <Pack ID="P2550067" Specified="true" nzmt:ctpp_id="50230241000117100">
                  <Quantity>60</Quantity>
                  <Price>100.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F075204948326" Rank="1" Units="tab" Weight="125">
              <Name>Tab 125 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-25 to~2027" Value="5"/>
              <Brand ID="B07520494832629" PSS="true">
                <Name>Bosentan Dr Reddy's</Name>
                <Pack ID="P2550075" Specified="true" nzmt:ctpp_id="50230251000117103">
                  <Quantity>60</Quantity>
                  <Price>100.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0752049528">
            <Name>Ambrisentan</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1981">
              <Title>
                <range>Ambrisentan</range>
              </Title>
              <Case When="Initial application" Category="PAH monotherapy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has pulmonary arterial hypertension (PAH)</ci>
                    <ci type="logical">PAH is in Group 1, 4 or 5 of the WHO (Venice 2003) clinical classifications</ci>
                    <ci type="logical">PAH is in New York Heart Association/World Health Organization (NYHA/WHO) functional class II, III or IV</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">PAH has been confirmed by right heart catheterisation</ci>
                        <ci type="logical">A mean pulmonary artery pressure (PAPm) greater than 20 mmHg (unless peri Fontan repair)</ci>
                        <ci type="logical">A pulmonary capillary wedge pressure (PCWP) less than or equal to 15 mmHg</ci>
                        <ci type="logical">Pulmonary vascular resistance greater than 2 Wood Units or greater than 160 International Units (dyn s <msup><mi>cm</mi><mn>-5</mn></msup>)</ci>
                        <apply>
                          <or/>
                          <ci type="logical">PAH has been demonstrated to be non-responsive in vasoreactivity assessment using iloprost or nitric oxide, as defined in the 2022 ECS/ERS Guidelines for PAH (see note
                below for link to these guidelines) †</ci>
                          <ci type="logical">Patient has not experienced an acceptable response to calcium antagonist treatment, according to a validated risk stratification tool**</ci>
                          <ci type="logical">Patient has PAH other than idiopathic / heritable or drug-associated type</ci>
                        </apply>
                      </apply>
                      <ci type="logical">Patient is a child with PAH secondary to congenital heart disease or PAH due to idiopathic, congenital or developmental lung disorders including chronic neonatal lung
            disease</ci>
                      <ci type="logical">Patient has palliated single ventricle congenital heart disease and elevated pulmonary pressures or a major complication of the Fontan circulation requiring the minimising
            of pulmonary/venous filling pressures</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Ambrisentan is to be used as PAH monotherapy</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has experienced intolerable side effects with both sildenafil and bosentan</ci>
                        <ci type="logical">Patient has an absolute contraindication to sildenafil and an absolute or relative contraindication to bosentan (e.g. due to current use of a combined oral
              contraceptive or liver disease)</ci>
                        <ci type="logical">Patient is a child with idiopathic PAH or PAH secondary to congenital heart disease</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Applicant>cardiologist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="respiratory specialist, cardiologist or rheumatologist">any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="PAH dual therapy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has pulmonary arterial hypertension (PAH)</ci>
                    <ci type="logical">PAH is in Group 1, 4 or 5 of the WHO (Venice 2003) clinical classifications</ci>
                    <ci type="logical">PAH is in New York Heart Association/World Health Organization (NYHA/WHO) functional class II, III or IV</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">PAH has been confirmed by right heart catheterisation</ci>
                        <ci type="logical">A mean pulmonary artery pressure (PAPm) greater than 20 mmHg (unless peri Fontan repair)</ci>
                        <ci type="logical">A pulmonary capillary wedge pressure (PCWP) less than or equal to 15 mmHg</ci>
                        <ci type="logical">Pulmonary vascular resistance greater than 2 Wood Units or greater than 160 International Units (dyn s <msup><mi>cm</mi><mn>-5</mn></msup>)</ci>
                        <apply>
                          <or/>
                          <ci type="logical">PAH has been demonstrated to be non-responsive in vasoreactivity assessment using iloprost or nitric oxide, as defined in the 2022 ECS/ERS Guidelines for PAH (see note
                below for link to these guidelines) †</ci>
                          <ci type="logical">Patient has not experienced an acceptable response to calcium antagonist treatment, according to a validated risk stratification tool**</ci>
                          <ci type="logical">Patient has PAH other than idiopathic / heritable or drug-associated type</ci>
                        </apply>
                      </apply>
                      <ci type="logical">Patient is a child with PAH secondary to congenital heart disease or PAH due to idiopathic, congenital or developmental lung disorders including chronic neonatal lung
            disease</ci>
                      <ci type="logical">Patient has palliated single ventricle congenital heart disease and elevated pulmonary pressures or a major complication of the Fontan circulation requiring the minimising
            of pulmonary/venous filling pressures</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Ambrisentan is to be used as PAH dual therapy</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has tried a PAH monotherapy (sildenafil or bosentan) for at least three months and has not experienced an acceptable response to treatment according to a
              validated risk stratification tool**</ci>
                        <ci type="logical">Patient has tried PAH dual therapy including bosentan and has experienced intolerable side effects on bosentan</ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">Patient is presenting in NYHA/WHO functional class III or IV, and in the opinion of the treating clinician would benefit from initial dual therapy</ci>
                        <ci type="logical">Patient has an absolute or relative contraindication to bosentan (eg due to current use of a combined oral contraceptive or liver disease)</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Applicant>cardiologist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="respiratory specialist, cardiologist or rheumatologist">any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="PAH triple therapy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has pulmonary arterial hypertension (PAH)</ci>
                    <ci type="logical">PAH is in Group 1, 4 or 5 of the WHO (Venice 2003) clinical classifications</ci>
                    <ci type="logical">PAH is in New York Heart Association/World Health Organization (NYHA/WHO) functional class II, III or IV</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">PAH has been confirmed by right heart catheterisation</ci>
                        <ci type="logical">A mean pulmonary artery pressure (PAPm) greater than 20 mmHg (unless peri Fontan repair)</ci>
                        <ci type="logical">A pulmonary capillary wedge pressure (PCWP) less than or equal to 15 mmHg</ci>
                        <ci type="logical">Pulmonary vascular resistance greater than 2 Wood Units or greater than 160 International Units (dyn s <msup><mi>cm</mi><mn>-5</mn></msup>)</ci>
                        <apply>
                          <or/>
                          <ci type="logical">PAH has been demonstrated to be non-responsive in vasoreactivity assessment using iloprost or nitric oxide, as defined in the 2022 ECS/ERS Guidelines for PAH (see note
                below for link to these guidelines) †</ci>
                          <ci type="logical">Patient has not experienced an acceptable response to calcium antagonist treatment, according to a validated risk stratification tool**</ci>
                          <ci type="logical">Patient has PAH other than idiopathic / heritable or drug-associated type</ci>
                        </apply>
                      </apply>
                      <ci type="logical">Patient is a child with PAH secondary to congenital heart disease or PAH due to idiopathic, congenital or developmental lung disorders including chronic neonatal lung
            disease</ci>
                      <ci type="logical">Patient has palliated single ventricle congenital heart disease and elevated pulmonary pressures or a major complication of the Fontan circulation requiring the minimising
            of pulmonary/venous filling pressures</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Ambrisentan is to be used as PAH triple therapy</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient is on the lung transplant list</ci>
                        <apply>
                          <and/>
                          <ci type="logical">Patient is presenting in NYHA/WHO functional class IV</ci>
                          <ci type="logical">Patient has an absolute or relative contraindication to bosentan (e.g. due to current use of a combined oral contraceptive or liver disease)</ci>
                        </apply>
                        <apply>
                          <and/>
                          <ci type="logical">Patient has tried PAH dual therapy for at least three months and remains in an unacceptable risk category according to a validated risk stratification tool**</ci>
                          <ci type="logical">Patient does not have major life-threatening comorbidities and triple therapy is not being used in a palliative scenario</ci>
                        </apply>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Applicant>cardiologist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="respiratory specialist, cardiologist or rheumatologist">any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">The patient is continuing to derive benefit from ambrisentan treatment according to a validated PAH risk stratification tool**</ci>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Applicant>cardiologist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="respiratory specialist, cardiologist or rheumatologist">any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>† The European Respiratory Journal Guidelines can be found here: <a href="https://erj.ersjournals.com/content/early/2022/08/25/13993003.00879-2022">2022 ECS/ERS Guidelines for the diagnosis and
        treatment of pulmonary hypertension PAH</a></p>
                <p>** the requirement to use a validated risk stratification tool to determine insufficient response applies to adults. Determining insufficient response in children does not require use of a
      validated PAH risk stratification tool, where currently no such validated tools exist for PAH risk stratification in children.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1981" style="display:none"/>
            <Formulation ID="F075204952825" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B07520495282527" PSS="true">
                <Name>Ambrisentan Viatris</Name>
                <Pack ID="P2626446" Specified="true" nzmt:ctpp_id="50290651000117109">
                  <Quantity>30</Quantity>
                  <Price>200.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F075204952826" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B07520495282628" PSS="true">
                <Name>Ambrisentan Viatris</Name>
                <Pack ID="P2626454" Specified="true" nzmt:ctpp_id="50290531000117103">
                  <Quantity>30</Quantity>
                  <Price>200.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A075208">
          <Name>Phosphodiesterase Type 5 Inhibitors</Name>
          <Chemical ID="C0752089671">
            <Name>Sildenafil</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1983">
              <Title>
                <range>sildenafil (Vedafil)</range>
              </Title>
              <Case When="Initial application" Category="tablets Raynaud's Phenomenon">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has Raynaud's phenomenon</ci>
                    <ci type="logical">Patient has severe digital ischaemia (defined as severe pain requiring hospital admission or with a high likelihood of digital ulceration; digital ulcers; or
          gangrene)</ci>
                    <ci type="logical">Patient is following lifestyle management (proper body insulation, avoidance of cold exposure, smoking cessation support, avoidance of sympathomimetic
          drugs)</ci>
                    <ci type="logical">Patient has persisting severe symptoms despite treatment with calcium channel blockers and nitrates (unless contraindicated or not tolerated)</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="tablets Pulmonary arterial hypertension">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has pulmonary arterial hypertension (PAH)*</ci>
                    <ci type="logical">PAH is in Group 1, 4 or 5 of the WHO (Venice 2003) clinical classifications</ci>
                    <ci type="logical">PAH is in New York Heart Association/World Health Organization (NYHA/WHO) functional class II, III or IV</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">PAH is confirmed by right heart catheterisation</ci>
                        <ci type="logical">A mean pulmonary artery pressure (PAPm) of greater than 20 mmHg</ci>
                        <ci type="logical">A pulmonary capillary wedge pressure (PCWP) that is less than or equal to 15 mmHg</ci>
                        <ci type="logical">Pulmonary vascular resistance (PVR) of at least 2 Wood Units or at least 160 International Units (dyn s <msup><mi>cm</mi><mn>-5</mn></msup>)</ci>
                        <apply>
                          <or/>
                          <ci type="logical">PAH is non-responsive in vasoreactivity assessment using iloprost or nitric oxide, as defined in the 2022 ECS/ERS Guidelines for PAH (see note below for link to these
                guidelines) †</ci>
                          <ci type="logical">Patient has not experienced an acceptable response to calcium antagonist treatment, according to a validated risk stratification tool**</ci>
                          <ci type="logical">Patient has PAH other than idiopathic / heritable or drug-associated type</ci>
                        </apply>
                      </apply>
                      <ci type="logical">Patient is a child with PAH secondary to congenital heart disease or PAH due to idiopathic, congenital or developmental lung disorders including severe chronic neonatal
            lung disease</ci>
                      <ci type="logical">Patient has palliated single ventricle congenital heart disease and elevated pulmonary pressures or a major complication of the Fontan circulation requiring the minimising
            of pulmonary/venous filling pressures</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Applicant>cardiologist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="respiratory specialist, cardiologist or rheumatologist">any relevant practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="tablets other conditions">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">For use in weaning patients from inhaled nitric oxide</ci>
                    <ci type="logical">For perioperative use in cardiac surgery patients</ci>
                    <ci type="logical">For use in intensive care as an alternative to nitric oxide</ci>
                    <ci type="logical">For use in the treatment of erectile dysfunction secondary to spinal cord injury in patients being treated in a spinal unit</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="injection">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">For use in the treatment of pulmonary hypertension in infants or children being treated in paediatric intensive care units and neonatal intensive care units when the
          enteral route is not accessible</ci>
                    <apply>
                      <or/>
                      <ci type="logical">For perioperative use following cardiac surgery</ci>
                      <ci type="logical">For use in persistent pulmonary hypertension of the newborn (PPHN)</ci>
                      <ci type="logical">For use in congenital diaphragmatic hernia</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>† The European Respiratory Journal Guidelines  can be found here: <a href="https://erj.ersjournals.com/content/early/2022/08/25/13993003.00879-2022">2022 ECS/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension PAH</a></p>
                <p>** the requirement to use a validated risk stratification tool to determine insufficient response applies to adults. Determining insufficient response in children does not require use of a
      validated PAH risk stratification tool, where currently no such validated tools exist for PAH risk stratification in children.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1983" style="display:none"/>
            <Formulation ID="F075208967125" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B07520896712526" PSS="true">
                <Name>Vedafil</Name>
                <Pack ID="P2377810" Specified="true" nzmt:ctpp_id="50123881000117104">
                  <Quantity>12</Quantity>
                  <Price>11.22</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F075208967126" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B07520896712626" PSS="true">
                <Name>Vedafil</Name>
                <Pack ID="P2377764" Specified="true" nzmt:ctpp_id="50123901000117102">
                  <Quantity>4</Quantity>
                  <Price>0.72</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F075208967127" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B07520896712726" PSS="true">
                <Name>Vedafil</Name>
                <Pack ID="P2377780" Specified="true" nzmt:ctpp_id="50123891000117101">
                  <Quantity>4</Quantity>
                  <Price>1.45</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F075208967128" Rank="4" Units="inj" Weight="10">
              <Name>Inj 0.8 mg per ml, 12.5 ml vial</Name>
              <Brand ID="B07520896712800">
                <Name>Any</Name>
                <Pack ID="P96712800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A075212">
          <Name>Prostacyclin Analogues</Name>
          <Chemical ID="C0752128574">
            <Name>Epoprostenol</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1984">
              <Title>
                <range>Epoprostenol</range>
              </Title>
              <Case When="Initial application" Category="PAH dual therapy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has pulmonary arterial hypertension (PAH)</ci>
                    <ci type="logical">PAH is in Group 1, 4 or 5 of the WHO (Venice 2003) clinical classifications</ci>
                    <ci type="logical">PAH is in New York Heart Association/World Health Organization (NYHA/WHO) functional class III or IV</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">PAH has been confirmed by right heart catheterisation</ci>
                        <ci type="logical">A mean pulmonary artery pressure (PAPm) greater than 20 mmHg (unless peri Fontan repair)</ci>
                        <ci type="logical">A pulmonary capillary wedge pressure (PCWP) less than or equal to 15 mmHg</ci>
                        <ci type="logical">A pulmonary vascular resistance greater than 2 Wood Units or greater than 160 International Units (dyn s <msup><mi>cm</mi><mn>-5</mn></msup>)</ci>
                        <apply>
                          <or/>
                          <ci type="logical">PAH has been demonstrated to be non-responsive in vasoreactivity assessment using iloprost or nitric oxide, as defined in the 2022 ECS/ERS Guidelines for PAH (see note
                below for link to these guidelines) † </ci>
                          <ci type="logical">Patient has not experienced an acceptable response to calcium antagonist treatment, according to a validated risk stratification tool**</ci>
                          <ci type="logical">Patient has PAH other than idiopathic / heritable or drug-associated type</ci>
                        </apply>
                      </apply>
                      <ci type="logical">Patient is a child with PAH secondary to congenital heart disease or PAH due to idiopathic, congenital or developmental lung disorders including severe chronic neonatal
            lung disease</ci>
                      <ci type="logical">Patient has palliated single ventricle congenital heart disease and elevated pulmonary pressures or a major complication of the Fontan circulation requiring the minimising
            of pulmonary/venous filling pressures</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Epoprostenol is to be used as part of PAH dual therapy with either sildenafil or an endothelin receptor antagonist</ci>
                      <ci type="logical">Patient is presenting in NYHA/WHO functional class IV</ci>
                      <ci type="logical">Patient has tried a PAH monotherapy for at least three months and remains in an unacceptable risk category according to a validated risk stratification tool</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Applicant>cardiologist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="respiratory specialist, cardiologist or rheumatologist">any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="PAH triple therapy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has pulmonary arterial hypertension (PAH)</ci>
                    <ci type="logical">PAH is in Group 1, 4 or 5 of the WHO (Venice 2003) clinical classifications</ci>
                    <ci type="logical">PAH is in New York Heart Association/World Health Organization (NYHA/WHO) functional class III or IV</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">PAH has been confirmed by right heart catheterisation</ci>
                        <ci type="logical">A mean pulmonary artery pressure (PAPm) greater than 20 mmHg (unless peri Fontan repair)</ci>
                        <ci type="logical">A pulmonary capillary wedge pressure (PCWP) less than or equal to 15 mmHg</ci>
                        <ci type="logical">A pulmonary vascular resistance greater than 2 Wood Units or greater than 160 International Units (dyn s <msup><mi>cm</mi><mn>-5</mn></msup>)</ci>
                        <apply>
                          <or/>
                          <ci type="logical">PAH has been demonstrated to be non-responsive in vasoreactivity assessment using iloprost or nitric oxide, as defined in the 2022 ECS/ERS Guidelines for PAH (see note
                below for link to these guidelines) † </ci>
                          <ci type="logical">Patient has not experienced an acceptable response to calcium antagonist treatment, according to a validated risk stratification tool**</ci>
                          <ci type="logical">Patient has PAH other than idiopathic / heritable or drug-associated type</ci>
                        </apply>
                      </apply>
                      <ci type="logical">Patient is a child with PAH secondary to congenital heart disease or PAH due to idiopathic, congenital or developmental lung disorders including severe chronic neonatal
            lung disease</ci>
                      <ci type="logical">Patient has palliated single ventricle congenital heart disease and elevated pulmonary pressures or a major complication of the Fontan circulation requiring the minimising
            of pulmonary/venous filling pressures</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Epoprostenol is to be used as PAH triple therapy</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient is on the lung transplant list</ci>
                        <ci type="logical">Patient is presenting in NYHA/WHO functional class IV</ci>
                        <apply>
                          <and/>
                          <ci type="logical">Patient has tried PAH dual therapy for at least three months and has not experienced an acceptable response to treatment according to a validated risk stratification
                tool</ci>
                          <ci type="logical">Patient does not have major life-threatening comorbidities and triple therapy is not being used in a palliative scenario</ci>
                        </apply>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Applicant>cardiologist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="respiratory specialist, cardiologist or rheumatologist">any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">Patient is continuing to derive benefit from epoprostenol treatment according to a validated PAH risk stratification tool</ci>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Applicant>cardiologist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="respiratory specialist, cardiologist or rheumatologist">any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>† The European Respiratory Journal Guidelines can be found here: <a href="https://erj.ersjournals.com/content/early/2022/08/25/13993003.00879-2022">2022 ECS/ERS Guidelines for the diagnosis and
        treatment of pulmonary hypertension PAH</a></p>
                <p>** the requirement to use a validated risk stratification tool to determine insufficient response applies to adults. Determining insufficient response in children does not require use of a
      validated PAH risk stratification tool, where currently no such validated tools exist for PAH risk stratification in children.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1984" style="display:none"/>
            <Formulation ID="F075212857425" Rank="4" Units="inj">
              <Name>Inj 500 mcg vial</Name>
              <Brand ID="B07521285742525">
                <Name>Veletri</Name>
                <Pack ID="P2488175" Specified="true" nzmt:ctpp_id="50201321000117100">
                  <Quantity>1</Quantity>
                  <Price>36.61</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F075212857426" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1.5 mg vial</Name>
              <Brand ID="B07521285742625">
                <Name>Veletri</Name>
                <Pack ID="P2488183" Specified="true" nzmt:ctpp_id="50201331000117102">
                  <Quantity>1</Quantity>
                  <Price>73.21</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C0752129485">
            <Name>Iloprost</Name>
            <Formulation ID="F075212948525" Rank="4" Units="inf" Weight="50">
              <Name>Inj 50 mcg in 0.5 ml ampoule</Name>
              <Brand ID="B07521294852525">
                <Name>Ilomedin</Name>
                <Pack ID="P256757" Specified="true" nzmt:ctpp_id="50055631000117105">
                  <Quantity>5</Quantity>
                  <Price>380.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F075212948526" Rank="8" Units="neb" Weight="200">
              <Name>Nebuliser soln 10 mcg per ml, 2 ml</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2025" Value="5"/>
              <Request To="HealthPAC" For="Subsidy" Form="RS1985">
                <Title>
                  <range>Iloprost</range>
                </Title>
                <Case When="Initial application" Category="PAH monotherapy">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <and/>
                      <ci type="logical">Patient has pulmonary arterial hypertension (PAH)</ci>
                      <ci type="logical">PAH is in Group 1, 4 or 5 of the WHO (Venice 2003) clinical classifications</ci>
                      <ci type="logical">PAH is in New York Heart Association/World Health Organization (NYHA/WHO) functional class II, III or IV</ci>
                      <apply>
                        <or/>
                        <apply>
                          <and/>
                          <ci type="logical">PAH has been confirmed by right heart catheterisation</ci>
                          <ci type="logical">A mean pulmonary artery pressure (PAPm) greater than 20 mmHg (unless peri Fontan repair)</ci>
                          <ci type="logical">A pulmonary capillary wedge pressure (PCWP) less than or equal to 15 mmHg</ci>
                          <ci type="logical">A pulmonary vascular resistance greater than 2 Wood Units or greater than 160 International Units (dyn s <msup><mi>cm</mi><mn>-5</mn></msup>)</ci>
                          <apply>
                            <or/>
                            <ci type="logical">PAH has been demonstrated to be non-responsive in vasoreactivity assessment using iloprost or nitric oxide, as defined in the 2022 ECS/ERS Guidelines for PAH (see note
                below for link to these guidelines) † </ci>
                            <ci type="logical">Patient has not experienced an acceptable response to calcium antagonist treatment, according to a validated risk stratification tool**</ci>
                            <ci type="logical">Patient has PAH other than idiopathic / heritable or drug-associated type</ci>
                          </apply>
                        </apply>
                        <ci type="logical">Patient is a child with PAH secondary to congenital heart disease or PAH due to idiopathic, congenital or developmental lung disorders including severe chronic neonatal lung disease</ci>
                        <ci type="logical">Patient has palliated single ventricle congenital heart disease and elevated pulmonary pressures or a major complication of the Fontan circulation requiring the minimising
            of pulmonary/venous filling pressures </ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">Iloprost is to be used as PAH monotherapy</ci>
                        <apply>
                          <or/>
                          <ci type="logical">Patient has experienced intolerable side effects on sildenafil and both the funded endothelin receptor antagonists (i.e. both bosentan and ambrisentan)</ci>
                          <ci type="logical">Patient has an absolute contraindication to sildenafil and an absolute or relative contraindication to endothelin receptor antagonists</ci>
                        </apply>
                      </apply>
                    </apply>
                  </math>
                  <Applicant>respiratory specialist</Applicant>
                  <Applicant>cardiologist</Applicant>
                  <Applicant>rheumatologist</Applicant>
                  <Applicant Referring="respiratory specialist, cardiologist or rheumatologist">any relevant practitioner</Applicant>
                  <Term Measure="month">6</Term>
                </Case>
                <Case When="Initial application" Category="PAH dual therapy">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <and/>
                      <ci type="logical">Patient has pulmonary arterial hypertension (PAH)</ci>
                      <ci type="logical">PAH is in Group 1, 4 or 5 of the WHO (Venice 2003) clinical classifications</ci>
                      <ci type="logical">PAH is in New York Heart Association/World Health Organization (NYHA/WHO) functional class II, III or IV</ci>
                      <apply>
                        <or/>
                        <apply>
                          <and/>
                          <ci type="logical">PAH has been confirmed by right heart catheterisation</ci>
                          <ci type="logical">A mean pulmonary artery pressure (PAPm) greater than 20 mmHg (unless peri Fontan repair)</ci>
                          <ci type="logical">A pulmonary capillary wedge pressure (PCWP) less than or equal to 15 mmHg</ci>
                          <ci type="logical">A pulmonary vascular resistance greater than 2 Wood Units or greater than 160 International Units (dyn s <msup><mi>cm</mi><mn>-5</mn></msup>)</ci>
                          <apply>
                            <or/>
                            <ci type="logical">PAH has been demonstrated to be non-responsive in vasoreactivity assessment using iloprost or nitric oxide, as defined in the 2022 ECS/ERS Guidelines for PAH (see note
                below for link to these guidelines) † </ci>
                            <ci type="logical">Patient has not experienced an acceptable response to calcium antagonist treatment, according to a validated risk stratification tool**</ci>
                            <ci type="logical">Patient has PAH other than idiopathic / heritable or drug-associated type</ci>
                          </apply>
                        </apply>
                        <ci type="logical">Patient is a child with PAH secondary to congenital heart disease or PAH due to idiopathic, congenital or developmental lung disorders including severe chronic neonatal lung disease</ci>
                        <ci type="logical">Patient has palliated single ventricle congenital heart disease and elevated pulmonary pressures or a major complication of the Fontan circulation requiring the minimising
            of pulmonary/venous filling pressures </ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">Iloprost is to be used as PAH dual therapy with either sildenafil or an endothelin receptor antagonist</ci>
                        <apply>
                          <or/>
                          <ci type="logical">Patient has an absolute contraindication to or has experienced intolerable side effects on sildenafil</ci>
                          <ci type="logical">Patient has an absolute or relative contraindication to or experienced intolerable side effects with a funded endothelin receptor antagonist</ci>
                        </apply>
                        <apply>
                          <or/>
                          <ci type="logical">Patient has tried a PAH monotherapy for at least three months and remains in an unacceptable risk category according to a validated risk stratification tool**</ci>
                          <ci type="logical">Patient is presenting in NYHA/WHO functional class III or IV, and in the opinion of the treating clinician would benefit from initial dual therapy</ci>
                        </apply>
                      </apply>
                    </apply>
                  </math>
                  <Applicant>respiratory specialist</Applicant>
                  <Applicant>cardiologist</Applicant>
                  <Applicant>rheumatologist</Applicant>
                  <Applicant Referring="respiratory specialist, cardiologist or rheumatologist">any relevant practitioner</Applicant>
                  <Term Measure="month">6</Term>
                </Case>
                <Case When="Initial application" Category="PAH triple therapy">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <and/>
                      <ci type="logical">Patient has pulmonary arterial hypertension (PAH)</ci>
                      <ci type="logical">PAH is in Group 1, 4 or 5 of the WHO (Venice 2003) clinical classifications</ci>
                      <ci type="logical">PAH is in New York Heart Association/World Health Organization (NYHA/WHO) functional class II, III or IV</ci>
                      <apply>
                        <or/>
                        <apply>
                          <and/>
                          <ci type="logical">PAH has been confirmed by right heart catheterisation</ci>
                          <ci type="logical">A mean pulmonary artery pressure (PAPm) greater than 20 mmHg (unless peri Fontan repair)</ci>
                          <ci type="logical">A pulmonary capillary wedge pressure (PCWP) less than or equal to 15 mmHg</ci>
                          <ci type="logical">A pulmonary vascular resistance greater than 2 Wood Units or greater than 160 International Units (dyn s <msup><mi>cm</mi><mn>-5</mn></msup>)</ci>
                          <apply>
                            <or/>
                            <ci type="logical">PAH has been demonstrated to be non-responsive in vasoreactivity assessment using iloprost or nitric oxide, as defined in the 2022 ECS/ERS Guidelines for PAH (see note
                below for link to these guidelines) † </ci>
                            <ci type="logical">Patient has not experienced an acceptable response to calcium antagonist treatment, according to a validated risk stratification tool**</ci>
                            <ci type="logical">Patient has PAH other than idiopathic / heritable or drug-associated type</ci>
                          </apply>
                        </apply>
                        <ci type="logical">Patient is a child with PAH secondary to congenital heart disease or PAH due to idiopathic, congenital or developmental lung disorders including severe chronic neonatal lung disease</ci>
                        <ci type="logical">Patient has palliated single ventricle congenital heart disease and elevated pulmonary pressures or a major complication of the Fontan circulation requiring the minimising
            of pulmonary/venous filling pressures </ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">Iloprost is to be used as PAH triple therapy</ci>
                        <apply>
                          <or/>
                          <ci type="logical">Patient is on the lung transplant list</ci>
                          <ci type="logical">Patient is presenting in NYHA/WHO functional class IV</ci>
                          <apply>
                            <and/>
                            <ci type="logical">Patient has tried PAH dual therapy for at least three months and has not experienced an acceptable response to treatment according to a validated risk stratification
                tool**</ci>
                            <ci type="logical">Patient does not have major life-threatening comorbidities and triple therapy is not being used in a palliative scenario</ci>
                          </apply>
                        </apply>
                      </apply>
                    </apply>
                  </math>
                  <Applicant>respiratory specialist</Applicant>
                  <Applicant>cardiologist</Applicant>
                  <Applicant>rheumatologist</Applicant>
                  <Applicant Referring="respiratory specialist, cardiologist or rheumatologist">any relevant practitioner</Applicant>
                  <Term Measure="month">6</Term>
                </Case>
                <Case When="Renewal">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical" class="Indication">Patient is continuing to derive benefit from iloprost treatment according to a validated PAH risk stratification tool</ci>
                  </math>
                  <Applicant>respiratory specialist</Applicant>
                  <Applicant>cardiologist</Applicant>
                  <Applicant>rheumatologist</Applicant>
                  <Applicant Referring="respiratory specialist, cardiologist or rheumatologist">any relevant practitioner</Applicant>
                  <Term Measure="year">2</Term>
                </Case>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>† The European Respiratory Journal Guidelines  can be found here: <a href="https://erj.ersjournals.com/content/early/2022/08/25/13993003.00879-2022">2022 ECS/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension PAH</a></p>
                  <p>** the requirement to use a validated risk stratification tool to determine insufficient response applies to adults. Determining insufficient response in children does not require use of a
      validated PAH risk stratification tool, where currently no such validated tools exist for PAH risk stratification in children.</p>
                </div>
              </Request>
              <html:div class="Restricted" xlink:href="RS1985" style="display:none"/>
              <Brand ID="B07521294852626" PSS="true">
                <Name>Vebulis</Name>
                <Pack ID="P2643006" Specified="true" nzmt:ctpp_id="50300961000117108">
                  <Quantity>30</Quantity>
                  <Price>185.03</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
    <ATC1 ID="A10">
      <Name>Dermatologicals</Name>
      <ATC2 ID="A1004">
        <Name>Anti-Infective Preparations</Name>
        <ATC3 ID="A100404">
          <Name>Antibacterials</Name>
          <Chemical ID="C1004048311">
            <Name>Mupirocin</Name>
            <Formulation ID="F100404831101" Rank="3" Units="g">
              <Name>Oint 2%</Name>
              <Brand ID="B10040483110100">
                <Name>Any</Name>
                <Pack ID="P83110100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1004048523">
            <Name>Mafenide acetate</Name>
            <Request Form="RS1299" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Mafenide acetate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For the treatment of burns patients</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1299" style="display:none"/>
            <Formulation ID="F100404852325" Rank="2" Units="sach" Weight="50">
              <Name>Powder 50 g sachet</Name>
              <Brand ID="B10040485232500">
                <Name>Any</Name>
                <Pack ID="P85232500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1004049195">
            <Name>Sodium fusidate  [Fusidic acid]</Name>
            <Formulation ID="F100404919501" Rank="3" Units="g">
              <Name>Crm 2%</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B10040491950125" PSS="true">
                <Name>Foban</Name>
                <Pack ID="P2556170" Specified="true" nzmt:ctpp_id="50162721000117107">
                  <Quantity>5</Quantity>
                  <Price>1.69</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F100404919502" Rank="3" Units="g">
              <Name>Oint 2%</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B10040491950225" PSS="true">
                <Name>Foban</Name>
                <Pack ID="P2556189" Specified="true" nzmt:ctpp_id="50162731000117105">
                  <Quantity>5</Quantity>
                  <Price>1.69</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1004049294">
            <Name>Hydrogen peroxide</Name>
            <Formulation ID="F100404929402" Rank="3" Units="ml">
              <Name>Soln 3% (10 vol)</Name>
              <Brand ID="B10040492940200">
                <Name>Any</Name>
                <Pack ID="P92940200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F100404929425" Rank="3" Units="g">
              <Name>Crm 1%</Name>
              <Brand ID="B10040492942526">
                <Name>Crystaderm</Name>
                <Pack ID="P2399504" Specified="true" nzmt:ctpp_id="50184561000117100">
                  <Quantity>10</Quantity>
                  <Price>8.56</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1004049519">
            <Name>Sulfadiazine silver</Name>
            <Formulation ID="F100404951925" Rank="3" Units="g">
              <Name>Crm 1%</Name>
              <Brand ID="B10040495192525">
                <Name>Flamazine</Name>
                <Pack ID="P2343851" Specified="true" nzmt:ctpp_id="50050131000117105">
                  <Quantity>50</Quantity>
                  <Price>10.80</Price>
                </Pack>
              </Brand>
              <Brand ID="B10040495192526">
                <Name>Ascend</Name>
                <Pack ID="P2682435" Specified="true" nzmt:ctpp_id="50335971000117101">
                  <Quantity>50</Quantity>
                  <Price>15.44</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A100408">
          <Name>Antifungals</Name>
          <Chemical ID="C1004088029">
            <Name>Amorolfine</Name>
            <Formulation ID="F100408802901" Rank="3" Units="ml">
              <Name>Nail soln 5%</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B10040880290125" PSS="true">
                <Name>MycoNail</Name>
                <Pack ID="P2461633" Specified="true" nzmt:ctpp_id="50214811000117100">
                  <Quantity>5</Quantity>
                  <Price>21.87</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1004088097">
            <Name>Ciclopirox olamine</Name>
            <Formulation ID="F100408809701" Rank="3" Units="ml">
              <Name>Nail soln 8%</Name>
              <Brand ID="B10040880970100">
                <Name>Any</Name>
                <Pack ID="P80970100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F100408809702" Rank="3" Units="ml">
              <Name>Soln 1%</Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
                <p>For continuation only</p>
              </div>
              <Brand ID="B10040880970200">
                <Name>Any</Name>
                <Pack ID="P80970200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1004088162">
            <Name>Econazole nitrate</Name>
            <Formulation ID="F100408816201" Rank="3" Units="g">
              <Name>Crm 1%</Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
                <p>For continuation only</p>
              </div>
              <Brand ID="B10040881620100">
                <Name>Any</Name>
                <Pack ID="P81620100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F100408816202" Rank="3" Units="ml">
              <Name>Foaming soln 1%</Name>
              <Brand ID="B10040881620200">
                <Name>Any</Name>
                <Pack ID="P81620200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1004089229">
            <Name>Miconazole nitrate</Name>
            <Formulation ID="F100408922901" Rank="3" Units="ml">
              <Name>Lotn 2%</Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
                <p>For continuation only</p>
              </div>
              <Brand ID="B10040892290100">
                <Name>Any</Name>
                <Pack ID="P92290100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F100408922902" Rank="3" Units="ml">
              <Name>Tinc 2%</Name>
              <Brand ID="B10040892290200">
                <Name>Any</Name>
                <Pack ID="P92290200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F100408922926" Rank="3" Units="g">
              <Name>Crm 2%</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2026" Value="5"/>
              <Brand ID="B10040892292625" PSS="true">
                <Name>Multichem</Name>
                <Pack ID="P2184354" Specified="true" nzmt:ctpp_id="50030171000117107">
                  <Quantity>15</Quantity>
                  <Price>0.90</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1004089252">
            <Name>Nystatin</Name>
            <Formulation ID="F100408925201" Rank="3" Units="g">
              <Name>Crm 100,000 u per g</Name>
              <Brand ID="B10040892520100">
                <Name>Any</Name>
                <Pack ID="P92520100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1004089345">
            <Name>Metronidazole</Name>
            <Formulation ID="F100408934501" Rank="3" Units="ml">
              <Name>Gel 0.75%</Name>
              <Brand ID="B10040893450100">
                <Name>Any</Name>
                <Pack ID="P93450100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1004089382">
            <Name>Clotrimazole</Name>
            <Formulation ID="F100408938201" Rank="3" Units="ml">
              <Name>Soln 1%</Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
                <p>For continuation only</p>
              </div>
              <Brand ID="B10040893820100">
                <Name>Any</Name>
                <Pack ID="P93820100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F100408938226" Rank="3" Units="g" Weight="1">
              <Name>Crm 1%</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B10040893822625" PSS="true">
                <Name>Clomazol</Name>
                <Pack ID="P2184362" Specified="true" nzmt:ctpp_id="50030181000117105">
                  <Quantity>20</Quantity>
                  <Price>1.10</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1004089442">
            <Name>Ketoconazole</Name>
            <Formulation ID="F100408944225" Rank="3" Units="ml">
              <Name>Shampoo 2%</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2026" Value="5"/>
              <Brand ID="B10040894422525" PSS="true">
                <Name>Sebizole</Name>
                <Pack ID="P461504" Specified="true" nzmt:ctpp_id="50087681000117105">
                  <Quantity>100</Quantity>
                  <Price>4.09</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A100412">
          <Name>Antiparasitics</Name>
          <Chemical ID="C1004128144">
            <Name>Dimethicone</Name>
            <Formulation ID="F100412814427" Rank="3" Units="ml" Weight="4">
              <Name>Lotn 4%</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B10041281442725" PSS="true">
                <Name>healthE Dimethicone 4% Lotion</Name>
                <Pack ID="P2351293" Specified="true" nzmt:ctpp_id="50242291000117109">
                  <Quantity>200</Quantity>
                  <Price>4.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1004128276">
            <Name>Malathion [Maldison]</Name>
            <Formulation ID="F100412827601" Rank="3" Units="ml">
              <Name>Lotn 0.5%</Name>
              <Brand ID="B10041282760100">
                <Name>Any</Name>
                <Pack ID="P82760100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F100412827602" Rank="3" Units="ml">
              <Name>Shampoo 1%</Name>
              <Brand ID="B10041282760200">
                <Name>Any</Name>
                <Pack ID="P82760200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1004128595">
            <Name>Phenothrin</Name>
            <Formulation ID="F100412859525" Rank="3" Units="ml">
              <Name>Shampoo 0.5%</Name>
              <Brand ID="B10041285952500">
                <Name>Any</Name>
                <Pack ID="P85952500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1004129393">
            <Name>Permethrin</Name>
            <Formulation ID="F100412939326" Rank="3" Units="ml">
              <Name>Lotn 5%</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B10041293932625" PSS="true">
                <Name>A-Scabies</Name>
                <Pack ID="P2332027" Specified="true" nzmt:ctpp_id="50049481000117109">
                  <Quantity>30</Quantity>
                  <Price>4.28</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1008">
        <Name>Antiacne Preparations</Name>
        <ATC3 ID="A100804">
          <Name>Antiacne Preparations</Name>
          <Chemical ID="C1008048006">
            <Name>Adapalene</Name>
            <Formulation ID="F100804800601" Rank="3" Units="g">
              <Name>Crm 0.1%</Name>
              <Brand ID="B10080480060100">
                <Name>Any</Name>
                <Pack ID="P80060100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F100804800602" Rank="3" Units="ml">
              <Name>Gel 0.1%</Name>
              <Brand ID="B10080480060200">
                <Name>Any</Name>
                <Pack ID="P80060200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1008048047">
            <Name>Benzoyl peroxide</Name>
            <Formulation ID="F100804804701" Rank="3" Units="ml">
              <Name>Soln 5%</Name>
              <Brand ID="B10080480470100">
                <Name>Any</Name>
                <Pack ID="P80470100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1008049204">
            <Name>Isotretinoin</Name>
            <Formulation ID="F100804920425" Rank="2" Units="cap" Weight="10">
              <Name>Cap 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B10080492042526" PSS="true">
                <Name>Oratane</Name>
                <Pack ID="P2400286" Specified="true" nzmt:ctpp_id="50133411000117108">
                  <Quantity>120</Quantity>
                  <Price>18.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F100804920426" Rank="2" Units="cap" Weight="20">
              <Name>Cap 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B10080492042626" PSS="true">
                <Name>Oratane</Name>
                <Pack ID="P2400278" Specified="true" nzmt:ctpp_id="50133421000117102">
                  <Quantity>120</Quantity>
                  <Price>26.73</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F100804920427" Rank="2" Units="cap" Weight="5">
              <Name>Cap 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B10080492042725" PSS="true">
                <Name>Oratane</Name>
                <Pack ID="P2339161" Specified="true" nzmt:ctpp_id="50122151000117106">
                  <Quantity>60</Quantity>
                  <Price>11.26</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1008049291">
            <Name>Tretinoin</Name>
            <Formulation ID="F100804929101" Rank="3" Units="g">
              <Name>Crm 0.05%</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B10080492910125" PSS="true">
                <Name>ReTrieve</Name>
                <Pack ID="P2358751" Specified="true" nzmt:ctpp_id="50050801000117106">
                  <Quantity>50</Quantity>
                  <Price>16.82</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1012">
        <Name>Antipruritic Preparations</Name>
        <ATC3 ID="A101204">
          <Name>Antipruritic Preparations</Name>
          <Chemical ID="C1012049526">
            <Name>Crotamiton</Name>
            <Formulation ID="F101204952625" Rank="3" Units="g">
              <Name>Crm 10%</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B10120495262525" PSS="true">
                <Name>Itch-Soothe</Name>
                <Pack ID="P2343614" Specified="true" nzmt:ctpp_id="50050121000117107">
                  <Quantity>20</Quantity>
                  <Price>3.49</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1012049657">
            <Name>Calamine</Name>
            <Formulation ID="F101204965725" Rank="3" Units="g">
              <Name>Crm, aqueous, BP</Name>
              <Brand ID="B10120496572527">
                <Name>healthE Calamine Aqueous</Name>
                <Pack ID="P2318628" Specified="true" nzmt:ctpp_id="50048441000117105">
                  <Quantity>100</Quantity>
                  <Price>3.45</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1016">
        <Name>Barrier Creams and Emollients</Name>
        <ATC3 ID="A101604">
          <Name>Barrier Creams</Name>
          <Chemical ID="C1016048144">
            <Name>Dimethicone</Name>
            <Formulation ID="F101604814401" Rank="3" Units="g" Weight="5">
              <Name>Crm 5% tube</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B10160481440125" PSS="true">
                <Name>healthE Dimethicone 5%</Name>
                <Pack ID="P2374005" Specified="true" nzmt:ctpp_id="50202711000117104">
                  <Quantity>100</Quantity>
                  <Price>1.47</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F101604814425" Rank="3" Units="ml" Weight="5">
              <Name>Crm 5% pump bottle</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B10160481442525" PSS="true">
                <Name>healthE Dimethicone 5%</Name>
                <Pack ID="P2373319" Specified="true" nzmt:ctpp_id="50196961000117102">
                  <Quantity>500</Quantity>
                  <Price>4.30</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F101604814426" Rank="3" Units="ml" Weight="10">
              <Name>Crm 10% pump bottle</Name>
              <Brand ID="B10160481442625">
                <Name>healthE Dimethicone 10%</Name>
                <Pack ID="P2373289" Specified="true" nzmt:ctpp_id="50226321000117100">
                  <Quantity>500</Quantity>
                  <Price>4.52</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1016048501">
            <Name>Zinc</Name>
            <Formulation ID="F101604850101" Rank="3" Units="g">
              <Name>Crm</Name>
              <Brand ID="B10160485010100">
                <Name>e.g. Zinc Cream (Orion);Zinc Cream (PSM)</Name>
                <Pack ID="P85010100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F101604850102" Rank="3" Units="g">
              <Name>Oint</Name>
              <Brand ID="B10160485010200">
                <Name>e.g. Zinc oxide (PSM)</Name>
                <Pack ID="P85010200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F101604850104" Rank="3" Units="g">
              <Name>Paste</Name>
              <Brand ID="B10160485010400">
                <Name>Any</Name>
                <Pack ID="P85010400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1016048504">
            <Name>Zinc with wool fat</Name>
            <Formulation ID="F101604850401" Rank="3" Units="g">
              <Name>Crm zinc 15.25% with wool fat 4%</Name>
              <Brand ID="B10160485040100">
                <Name>e.g. Sudocrem</Name>
                <Pack ID="P85040100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1016049127">
            <Name>Zinc and castor oil</Name>
            <Formulation ID="F101604912701" Rank="3" Units="g">
              <Name>Oint, BP</Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to the pack sizes of 30 g or less.</p>
              </div>
              <Brand ID="B10160491270125">
                <Name>healthE</Name>
                <Pack ID="P2326701" Specified="true" nzmt:ctpp_id="50222281000117108">
                  <Quantity>20</Quantity>
                  <Price>1.26</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F101604912725" Rank="3" Units="g">
              <Name>Crm</Name>
              <Brand ID="B10160491272525">
                <Name>Orion</Name>
                <Pack ID="P994901" Specified="true" nzmt:ctpp_id="50119681000117108">
                  <Quantity>20</Quantity>
                  <Price>1.63</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F101604912726" Rank="3" Units="g">
              <Name>Oint</Name>
              <Rule Type="DVLimit" Attribute="Nov-23 to~2025" Value="5"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to the pack sizes of greater than 30 g.</p>
              </div>
              <Brand ID="B10160491272626" PSS="true">
                <Name>Evara</Name>
                <Pack ID="P2658399" Specified="true" nzmt:ctpp_id="50297291000117103">
                  <Quantity>500</Quantity>
                  <Price>4.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A101608">
          <Name>Emollients</Name>
          <Chemical ID="C1016088086">
            <Name>Cetomacrogol with glycerol</Name>
            <Formulation ID="F101608808601" Rank="3" Units="g" Weight="100">
              <Name>Crm 90% with glycerol 10%, </Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to the pack sizes of 100 g or less.</p>
              </div>
              <Brand ID="B10160880860127">
                <Name>healthE</Name>
                <Pack ID="P2326698" Specified="true" nzmt:ctpp_id="50190751000117104">
                  <Quantity>100</Quantity>
                  <Price>1.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F101608808602" Rank="3" Units="ml" Weight="100">
              <Name>Crm 90% with glycerol 10%</Name>
              <Rule Type="DVLimit" Attribute="Jul-23 to~2025" Value="5"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to the pack sizes of greater than 100 g.</p>
              </div>
              <Brand ID="B10160880860228" PSS="true">
                <Name>Evara</Name>
                <Pack ID="P2642778" Specified="true" nzmt:ctpp_id="50296641000117105">
                  <Quantity>500</Quantity>
                  <Price>2.13</Price>
                </Pack>
                <Pack ID="P2642786" Specified="true" nzmt:ctpp_id="50296651000117107">
                  <Quantity>1000</Quantity>
                  <Price>3.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1016088206">
            <Name>Glycerol with paraffin</Name>
            <Formulation ID="F101608820601" Rank="3" Units="g">
              <Name>Crm glycerol 10% with white soft paraffin 5% and liquid paraffin 10%</Name>
              <Brand ID="B10160882060100">
                <Name>e.g. QV cream</Name>
                <Pack ID="P82060100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1016088343">
            <Name>Paraffin with wool fat</Name>
            <Formulation ID="F101608834301" Rank="3" Units="ml">
              <Name>Lotn liquid paraffin 15.9% with wool fat 0.6%</Name>
              <Brand ID="B10160883430100">
                <Name>e.g. AlphaKeri;BK ;DP; Hydroderm Lotn</Name>
                <Pack ID="P83430100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F101608834302" Rank="3" Units="ml">
              <Name>Lotn liquid paraffin 91.7% with wool fat 3%</Name>
              <Brand ID="B10160883430200">
                <Name>e.g. Alpha Keri Bath Oil</Name>
                <Pack ID="P83430200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1016088488">
            <Name>Urea</Name>
            <Formulation ID="F101608848801" Rank="3" Units="g">
              <Name>Crm 10%</Name>
              <Brand ID="B10160884880125">
                <Name>healthE Urea Cream</Name>
                <Pack ID="P2444690" Specified="true" nzmt:ctpp_id="50180301000117103">
                  <Quantity>100</Quantity>
                  <Price>1.37</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1016088497">
            <Name>Wool fat</Name>
            <Formulation ID="F101608849701" Rank="3" Units="g">
              <Name>Crm</Name>
              <Brand ID="B10160884970100">
                <Name>Any</Name>
                <Pack ID="P84970100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1016089260">
            <Name>Aqueous cream</Name>
            <Formulation ID="F101608926025" Rank="3" Units="g" Weight="500">
              <Name>Crm 500 g</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to the pack sizes of greater than 100 g.</p>
              </div>
              <Brand ID="B10160892602528" PSS="true">
                <Name>Evara</Name>
                <Pack ID="P2555115" Specified="true" nzmt:ctpp_id="50320251000117106">
                  <Quantity>500</Quantity>
                  <Price>1.65</Price>
                </Pack>
              </Brand>
              <Brand ID="B10160892602529" ToBeDelisted="2025-03-01">
                <Name>GEM Aqueous Cream</Name>
                <Pack ID="P2615592" Specified="true" nzmt:ctpp_id="50289551000117103">
                  <Quantity>500</Quantity>
                  <Price>1.73</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F101608926026" Rank="3" Units="g" Weight="100">
              <Name>Crm 100 g</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to the pack sizes of 100 g or less.</p>
              </div>
              <Brand ID="B10160892602627" PSS="true">
                <Name>Evara</Name>
                <Pack ID="P2682303" Specified="true" nzmt:ctpp_id="50335831000117107">
                  <Quantity>100</Quantity>
                  <Price>1.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1016089431">
            <Name>Emulsifying ointment</Name>
            <Formulation ID="F101608943126" Rank="3" Units="g">
              <Name>Oint BP</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to pack sizes of less than 200 g.</p>
              </div>
              <Brand ID="B10160894312627" PSS="true">
                <Name>Jaychem</Name>
                <Pack ID="P2377675" Specified="true" nzmt:ctpp_id="50151231000117101">
                  <Quantity>100</Quantity>
                  <Price>2.30</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F101608943127" Rank="3" Units="g">
              <Name>Oint BP, 500 g</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2026" Value="5"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to pack sizes of greater than 200 g.</p>
              </div>
              <Brand ID="B10160894312726" PSS="true">
                <Name>Emulsifying Ointment ADE</Name>
                <Pack ID="P2597535" Specified="true" nzmt:ctpp_id="50280561000117109">
                  <Quantity>500</Quantity>
                  <Price>3.13</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1016089493">
            <Name>Oil in water emulsion</Name>
            <Formulation ID="F101608949325" Rank="3" Units="g">
              <Name>Crm, 500 g</Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to the pack sizes of greater than 100 g.</p>
              </div>
              <Brand ID="B10160894932527">
                <Name>Fatty Cream AFT</Name>
                <Pack ID="P2627426" Specified="true" nzmt:ctpp_id="50298701000117102">
                  <Quantity>500</Quantity>
                  <Price>2.04</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F101608949326" Rank="10" Units="pack">
              <Name>Crm, 100 g</Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to the pack sizes of 100 g or less.</p>
              </div>
              <Brand ID="B10160894932625">
                <Name>healthE Fatty Cream</Name>
                <Pack ID="P2341034" Specified="true" nzmt:ctpp_id="50190731000117109">
                  <Quantity>1</Quantity>
                  <Multiple>1</Multiple>
                  <Price>1.59</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1016089495">
            <Name>Paraffin</Name>
            <Formulation ID="F101608949503" Rank="3" Units="g">
              <Name>Oint liquid paraffin 50% with white soft paraffin 50%</Name>
              <Rule Type="DVLimit" Attribute="May-23 to~2025" Value="5"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to the pack sizes of 100 g or less.</p>
              </div>
              <Brand ID="B10160894950326" PSS="true">
                <Name>White Soft Liquid Paraffin AFT</Name>
                <Pack ID="P2639114" Specified="true" nzmt:ctpp_id="50308021000117101">
                  <Quantity>100</Quantity>
                  <Price>1.84</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F101608949525" Rank="3" Units="g">
              <Name>Yellow soft</Name>
              <Brand ID="B10160894952500">
                <Name>Any</Name>
                <Pack ID="P94952500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F101608949526" Rank="3" Units="g">
              <Name>White soft</Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to pack sizes of 30 g or less, and to both white soft paraffin and yellow soft paraffin.</p>
              </div>
              <Brand ID="B10160894952625">
                <Name>healthE</Name>
                <Pack ID="P2318695" Specified="true" nzmt:ctpp_id="50190501000117107">
                  <Quantity>10</Quantity>
                  <Price>0.79</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F101608949527" Rank="3" Units="g">
              <Name>White soft,</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to the pack sizes of 500 g or less and greater than 30 g.</p>
              </div>
              <Brand ID="B10160894952726" PSS="true">
                <Name>EVARA White Soft Paraffin</Name>
                <Pack ID="P2664178" Specified="true" nzmt:ctpp_id="50321911000117107">
                  <Quantity>450</Quantity>
                  <Price>4.74</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F101608949528" Rank="3" Units="ml">
              <Name>Lotn liquid paraffin 85%</Name>
              <Brand ID="B10160894952800">
                <Name>e.g QV Bath Oil</Name>
                <Pack ID="P94952800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1016089554">
            <Name>Cetomacrogol</Name>
            <Formulation ID="F101608955425" Rank="9" Units="tube" Weight="100">
              <Name>Crm BP, 100 g</Name>
              <Brand ID="B10160895542500">
                <Name>Any</Name>
                <Pack ID="P95542500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F101608955426" Rank="3" Units="g" Weight="500">
              <Name>Crm BP, 500 g</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B10160895542627" PSS="true">
                <Name>Cetomacrogol-AFT</Name>
                <Pack ID="P2615509" Specified="true" nzmt:ctpp_id="50293441000117100">
                  <Quantity>500</Quantity>
                  <Price>2.29</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1020">
        <Name>Corticosteroids</Name>
        <ATC3 ID="A102004">
          <Name>Corticosteroids</Name>
          <Chemical ID="C1020048052">
            <Name>Betamethasone dipropionate</Name>
            <Formulation ID="F102004805201" Rank="3" Units="g">
              <Name>Crm 0.05%</Name>
              <Rule Type="DVLimit" Attribute="Jul-24 to~2026" Value="5"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to the pack sizes of greater than 30 g.</p>
              </div>
              <Brand ID="B10200480520125" PSS="true">
                <Name>Diprosone</Name>
                <Pack ID="P210870" Specified="true" nzmt:ctpp_id="50019401000117108">
                  <Quantity>50</Quantity>
                  <Price>36.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102004805202" Rank="3" Units="g">
              <Name>Oint 0.05%</Name>
              <Rule Type="DVLimit" Attribute="Jul-24 to~2026" Value="5"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to the pack sizes of greater than 30 g.</p>
              </div>
              <Brand ID="B10200480520225" PSS="true">
                <Name>Diprosone</Name>
                <Pack ID="P210897" Specified="true" nzmt:ctpp_id="50019501000117109">
                  <Quantity>50</Quantity>
                  <Price>36.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1020048104">
            <Name>Clobetasone butyrate</Name>
            <Formulation ID="F102004810401" Rank="3" Units="g">
              <Name>Crm 0.05%</Name>
              <Brand ID="B10200481040100">
                <Name>Any</Name>
                <Pack ID="P81040100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1020048138">
            <Name>Diflucortolone valerate</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F102004813801" Rank="3" Units="g">
              <Name>Crm 0.1%</Name>
              <Brand ID="B10200481380100">
                <Name>Any</Name>
                <Pack ID="P81380100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102004813802" Rank="3" Units="g">
              <Name>Fatty oint 0.1%</Name>
              <Brand ID="B10200481380200">
                <Name>Any</Name>
                <Pack ID="P81380200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1020048555">
            <Name>Hydrocortisone and paraffin liquid and lanolin</Name>
            <Formulation ID="F102004855525" Rank="3" Units="ml">
              <Name>Lotn 1% with paraffin liquid 15.9% and lanolin 0.6%</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B10200485552525" PSS="true">
                <Name>DP Lotn HC</Name>
                <Pack ID="P716294" Specified="true" nzmt:ctpp_id="50105041000117109">
                  <Quantity>250</Quantity>
                  <Price>12.83</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1020049119">
            <Name>Hydrocortisone</Name>
            <Formulation ID="F102004911926" Rank="3" Units="g" Weight="500">
              <Name>Crm 1%, 500 g</Name>
              <Rule Type="DVLimit" Attribute="Aug-23 to~2025" Value="5"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to the pack sizes of greater than 100 g.</p>
              </div>
              <Brand ID="B10200491192626" PSS="true">
                <Name>Noumed</Name>
                <Pack ID="P2645580" Specified="true" nzmt:ctpp_id="50306641000117104">
                  <Quantity>500</Quantity>
                  <Price>20.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102004911933" Rank="3" Units="g">
              <Name>Crm 1%, 30 g</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: DV limit applies to the pack sizes of less than or equal to 100 g.</p>
              </div>
              <Brand ID="B10200491193326" PSS="true">
                <Name>Ethics</Name>
                <Pack ID="P2646587" Specified="true" nzmt:ctpp_id="50183231000117106">
                  <Quantity>30</Quantity>
                  <Price>1.78</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1020049145">
            <Name>Triamcinolone acetonide</Name>
            <Formulation ID="F102004914529" Rank="3" Units="g">
              <Name>Crm 0.02%</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B10200491452925" PSS="true">
                <Name>Aristocort</Name>
                <Pack ID="P250066" Specified="true" nzmt:ctpp_id="50052201000117106">
                  <Quantity>100</Quantity>
                  <Price>6.49</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102004914530" Rank="3" Units="g">
              <Name>Oint 0.02%</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B10200491453025" PSS="true">
                <Name>Aristocort</Name>
                <Pack ID="P250082" Specified="true" nzmt:ctpp_id="50052221000117103">
                  <Quantity>100</Quantity>
                  <Price>6.54</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1020049154">
            <Name>Clobetasol propionate</Name>
            <Formulation ID="F102004915425" Rank="3" Units="g">
              <Name>Crm 0.05%</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B10200491542525" PSS="true">
                <Name>Dermol</Name>
                <Pack ID="P229059" Specified="true" nzmt:ctpp_id="50044571000117106">
                  <Quantity>30</Quantity>
                  <Price>2.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102004915426" Rank="3" Units="g">
              <Name>Oint 0.05%</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B10200491542625" PSS="true">
                <Name>Dermol</Name>
                <Pack ID="P229040" Specified="true" nzmt:ctpp_id="50044501000117102">
                  <Quantity>30</Quantity>
                  <Price>2.33</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1020049197">
            <Name>Hydrocortisone butyrate</Name>
            <Formulation ID="F102004919725" Rank="3" Units="g">
              <Name>Crm 0.1%</Name>
              <Brand ID="B10200491972526">
                <Name>Locoid Lipocream</Name>
                <Pack ID="P521957" Specified="true" nzmt:ctpp_id="50093981000117107">
                  <Quantity>100</Quantity>
                  <Price>4.85</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102004919727" Rank="3" Units="g">
              <Name>Oint 0.1%</Name>
              <Brand ID="B10200491972725">
                <Name>Locoid</Name>
                <Pack ID="P210382" Specified="true" nzmt:ctpp_id="50018631000117106">
                  <Quantity>100</Quantity>
                  <Price>10.28</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102004919729" Rank="3" Units="ml">
              <Name>Milky emul 0.1%</Name>
              <Brand ID="B10200491972925">
                <Name>Locoid Crelo</Name>
                <Pack ID="P2017458" Specified="true" nzmt:ctpp_id="50003401000117108">
                  <Quantity>100</Quantity>
                  <Price>12.33</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1020049221">
            <Name>Methylprednisolone aceponate</Name>
            <Formulation ID="F102004922125" Rank="3" Units="g">
              <Name>Crm 0.1%</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B10200492212525" PSS="true">
                <Name>Advantan</Name>
                <Pack ID="P389439" Specified="true" nzmt:ctpp_id="50080681000117106">
                  <Quantity>15</Quantity>
                  <Price>4.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102004922126" Rank="3" Units="g">
              <Name>Oint 0.1%</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B10200492212625" PSS="true">
                <Name>Advantan</Name>
                <Pack ID="P388874" Specified="true" nzmt:ctpp_id="50080561000117104">
                  <Quantity>15</Quantity>
                  <Price>4.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1020049346">
            <Name>Betamethasone valerate</Name>
            <Formulation ID="F102004934601" Rank="3" Units="g">
              <Name>Crm 0.1%</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B10200493460125" PSS="true">
                <Name>Beta Cream</Name>
                <Pack ID="P2188740" Specified="true" nzmt:ctpp_id="50030661000117105">
                  <Quantity>50</Quantity>
                  <Price>5.85</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102004934602" Rank="3" Units="ml">
              <Name>Lotn 0.1%</Name>
              <Brand ID="B10200493460225">
                <Name>Betnovate</Name>
                <Pack ID="P210110" Specified="true" nzmt:ctpp_id="50018431000117108">
                  <Quantity>50</Quantity>
                  <Price>25.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102004934603" Rank="3" Units="g">
              <Name>Oint 0.1%</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B10200493460325" PSS="true">
                <Name>Beta Ointment</Name>
                <Pack ID="P2188759" Specified="true" nzmt:ctpp_id="50030671000117100">
                  <Quantity>50</Quantity>
                  <Price>7.90</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1020049512">
            <Name>Mometasone furoate</Name>
            <Formulation ID="F102004951225" Rank="3" Units="g">
              <Name>Crm 0.1%</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B10200495122526" PSS="true">
                <Name>Elocon Alcohol Free</Name>
                <Pack ID="P218375" Specified="true" nzmt:ctpp_id="50029991000117101">
                  <Quantity>15</Quantity>
                  <Price>2.25</Price>
                </Pack>
                <Pack ID="P2395738" Specified="true" nzmt:ctpp_id="50126471000117108">
                  <Quantity>50</Quantity>
                  <Price>3.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102004951226" Rank="3" Units="g">
              <Name>Oint 0.1%</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B10200495122626" PSS="true">
                <Name>Elocon</Name>
                <Pack ID="P218383" Specified="true" nzmt:ctpp_id="50030001000117102">
                  <Quantity>15</Quantity>
                  <Price>2.25</Price>
                </Pack>
                <Pack ID="P2395746" Specified="true" nzmt:ctpp_id="50126521000117106">
                  <Quantity>50</Quantity>
                  <Price>3.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102004951227" Rank="3" Units="ml">
              <Name>Lotn 0.1%</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B10200495122725" PSS="true">
                <Name>Elocon</Name>
                <Pack ID="P2177633" Specified="true" nzmt:ctpp_id="50029201000117101">
                  <Quantity>30</Quantity>
                  <Price>4.99</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A102008">
          <Name>Corticosteroids with Anti-Infective Agents</Name>
          <Chemical ID="C1020088054">
            <Name>Betamethasone valerate with clioquinol</Name>
            <Request Form="RS1125" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Betamethasone valerate with clioquinol</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">For the treatment of intertrigo</ci>
                    <ci type="logical">For continuation use</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1125" style="display:none"/>
            <Formulation ID="F102008805401" Rank="3" Units="g">
              <Name>Crm 0.1% with clioquiniol 3%</Name>
              <Brand ID="B10200880540100">
                <Name>Any</Name>
                <Pack ID="P80540100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1020088055">
            <Name>Betamethasone valerate with sodium fusidate [Fusidic acid]</Name>
            <Formulation ID="F102008805501" Rank="3" Units="g">
              <Name>Crm 0.1% with sodium fusidate (fusidic acid) 2%</Name>
              <Brand ID="B10200880550100">
                <Name>Any</Name>
                <Pack ID="P80550100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1020088478">
            <Name>Triamcinolone acetonide with neomycin  sulphate, gramicidin and nystatin</Name>
            <Formulation ID="F102008847801" Rank="3" Units="g">
              <Name>Crm 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 mcg per g</Name>
              <Brand ID="B10200884780100">
                <Name>Any</Name>
                <Pack ID="P84780100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1020089118">
            <Name>Hydrocortisone with natamycin and neomycin</Name>
            <Formulation ID="F102008911829" Rank="3" Units="g">
              <Name>Oint 1% with natamycin 1% and neomycin sulphate 0.5%</Name>
              <Brand ID="B10200891182925">
                <Name>Pimafucort</Name>
                <Pack ID="P260282" Specified="true" nzmt:ctpp_id="50057061000117103">
                  <Quantity>15</Quantity>
                  <Price>3.35</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1020089388">
            <Name>Hydrocortisone with miconazole</Name>
            <Formulation ID="F102008938825" Rank="3" Units="g">
              <Name>Crm 1% with miconazole nitrate 2%</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B10200893882525" PSS="true">
                <Name>Micreme H</Name>
                <Pack ID="P704733" Specified="true" nzmt:ctpp_id="50103821000117108">
                  <Quantity>15</Quantity>
                  <Price>2.85</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1028">
        <Name>Psoriasis and Eczema Preparations</Name>
        <ATC3 ID="A102804">
          <Name>Psoriasis and Eczema Preparations</Name>
          <Chemical ID="C1028048108">
            <Name>Coal tar with salicylic acid and sulphur</Name>
            <Formulation ID="F102804810801" Rank="3" Units="g">
              <Name>Oint 12% with salicylic acid 2% and sulphur 4%</Name>
              <Brand ID="B10280481080100">
                <Name>Any</Name>
                <Pack ID="P81080100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1028048294">
            <Name>Methoxsalen [8-methoxypsoralen]</Name>
            <Formulation ID="F102804829402" Rank="3" Units="ml">
              <Name>Lotn 1.2%</Name>
              <Brand ID="B10280482940200">
                <Name>Any</Name>
                <Pack ID="P82940200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102804829425" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B10280482942500">
                <Name>Any</Name>
                <Pack ID="P82942500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1028048379">
            <Name>Potassium permanganate</Name>
            <Formulation ID="F102804837901" Rank="1" Units="tab" Weight="400">
              <Name>Tab 400 mg</Name>
              <Brand ID="B10280483790100">
                <Name>Any</Name>
                <Pack ID="P83790100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102804837925" Rank="3" Units="g">
              <Name>Crystals</Name>
              <Brand ID="B10280483792500">
                <Name>Any</Name>
                <Pack ID="P83792500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1028048661">
            <Name>Pimecrolimus</Name>
            <Request Form="RS1781" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Pimecrolimus</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has atopic dermatitis on the eyelid</ci>
                    <ci type="logical">Patient has at least one of the following contraindications to
                    topical corticosteroids: periorificial dermatitis, rosacea, documented epidermal
                    atrophy, documented allergy to topical corticosteroids, cataracts, glaucoma, or
                    raised intraocular pressure</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Applicant>paediatrician</Applicant>
                <Applicant>ophthalmologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1781" style="display:none"/>
            <Formulation ID="F102804866125" Rank="3" Units="g">
              <Name>Crm 1%</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B10280486612525" PSS="true">
                <Name>Elidel</Name>
                <Pack ID="P2098873" Specified="true" nzmt:ctpp_id="50018251000117104">
                  <Quantity>15</Quantity>
                  <Price>33.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1028049163">
            <Name>Tacrolimus</Name>
            <Formulation ID="F102804916329" Rank="3" Units="g">
              <Name>Oint 0.1%</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Request Form="RS1859" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Tacrolimus Ointment</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <and/>
                      <ci type="logical">Patient has atopic dermatitis on the face</ci>
                      <ci type="logical">Patient has at least one of the following contraindications to
                    topical corticosteroids: periorificial dermatitis, rosacea, documented epidermal
                    atrophy or documented allergy to topical corticosteroids</ci>
                    </apply>
                  </math>
                  <Applicant>dermatologist</Applicant>
                  <Applicant>paediatrician</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1859" style="display:none"/>
              <Brand ID="B10280491632925" PSS="true">
                <Name>Zematop</Name>
                <Pack ID="P2607646" Specified="true" nzmt:ctpp_id="50269161000117106">
                  <Quantity>30</Quantity>
                  <Price>33.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1028049240">
            <Name>Calcipotriol</Name>
            <Formulation ID="F102804924026" Rank="3" Units="g" Weight="50">
              <Name>Oint 50 mcg per g</Name>
              <Brand ID="B10280492402625">
                <Name>Daivonex</Name>
                <Pack ID="P2592673" Specified="true" nzmt:ctpp_id="50272331000117100">
                  <Quantity>120</Quantity>
                  <Price>40.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1028049455">
            <Name>Pine tar with trolamine laurilsulfate and fluorescein</Name>
            <Formulation ID="F102804945525" Rank="3" Units="ml">
              <Name>Soln 2.3% with trolamine laurilsulfate and fluorescein sodium</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B10280494552525" PSS="true">
                <Name>Pinetarsol</Name>
                <Pack ID="P307661" Specified="true" nzmt:ctpp_id="50068981000117100">
                  <Quantity>500</Quantity>
                  <Price>5.41</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1028049478">
            <Name>Acitretin</Name>
            <Formulation ID="F102804947825" Rank="2" Units="cap" Weight="10">
              <Name>Cap 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Jul-24 to~2026" Value="5"/>
              <Brand ID="B10280494782526" PSS="true">
                <Name>Novatretin</Name>
                <Pack ID="P2384167" Specified="true" nzmt:ctpp_id="50125951000117104">
                  <Quantity>60</Quantity>
                  <Price>26.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102804947826" Rank="2" Units="cap" Weight="25">
              <Name>Cap 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Jul-24 to~2026" Value="5"/>
              <Brand ID="B10280494782626" PSS="true">
                <Name>Novatretin</Name>
                <Pack ID="P2384175" Specified="true" nzmt:ctpp_id="50125961000117102">
                  <Quantity>60</Quantity>
                  <Price>57.37</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1028049626">
            <Name>Betamethasone dipropionate with calcipotriol</Name>
            <Formulation ID="F102804962625" Rank="3" Units="g">
              <Name>Oint 500 mcg with calcipotriol 50 mcg per g</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B10280496262525" PSS="true">
                <Name>Daivobet</Name>
                <Pack ID="P2170914" Specified="true" nzmt:ctpp_id="50028761000117102">
                  <Quantity>30</Quantity>
                  <Price>14.31</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102804962626" Rank="3" Units="g">
              <Name>Gel 500 mcg with calcipotriol 50 mcg per g</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B10280496262625" PSS="true">
                <Name>Daivobet</Name>
                <Pack ID="P2553015" Specified="true" nzmt:ctpp_id="50179821000117100">
                  <Quantity>60</Quantity>
                  <Price>40.92</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F102804962627" Rank="3" Units="g">
              <Name>Foam spray 500 mcg with calcipotriol 50 mcg per g</Name>
              <Brand ID="B10280496262725">
                <Name>Enstilar</Name>
                <Pack ID="P2582236" Specified="true" nzmt:ctpp_id="50234121000117108">
                  <Quantity>60</Quantity>
                  <Price>59.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1032">
        <Name>Scalp Preparations</Name>
        <ATC3 ID="A103204">
          <Name>Scalp Preparations</Name>
          <Chemical ID="C1032049154">
            <Name>Clobetasol propionate</Name>
            <Formulation ID="F103204915427" Rank="3" Units="ml">
              <Name>Scalp app 0.05%</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B10320491542725" PSS="true">
                <Name>Dermol</Name>
                <Pack ID="P772755" Specified="true" nzmt:ctpp_id="50112111000117104">
                  <Quantity>30</Quantity>
                  <Price>6.26</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1032049197">
            <Name>Hydrocortisone butyrate</Name>
            <Formulation ID="F103204919728" Rank="3" Units="ml">
              <Name>Scalp lotn 0.1%</Name>
              <Brand ID="B10320491972826">
                <Name>Locoid</Name>
                <Pack ID="P210307" Specified="true" nzmt:ctpp_id="50018581000117108">
                  <Quantity>100</Quantity>
                  <Price>6.57</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1032049346">
            <Name>Betamethasone valerate</Name>
            <Formulation ID="F103204934625" Rank="3" Units="ml">
              <Name>Scalp app 0.1%</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B10320493462525" PSS="true">
                <Name>Beta Scalp</Name>
                <Pack ID="P512877" Specified="true" nzmt:ctpp_id="50093721000117106">
                  <Quantity>100</Quantity>
                  <Price>12.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1036">
        <Name>Wart Preparations</Name>
        <ATC3 ID="A103604">
          <Name>Wart Preparations</Name>
          <Chemical ID="C1036048414">
            <Name>Silver nitrate</Name>
            <Formulation ID="F103604841402" Rank="10" Units="pack">
              <Name>Sticks with applicator</Name>
              <Brand ID="B10360484140200">
                <Name>Any</Name>
                <Pack ID="P84140200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1036049219">
            <Name>Podophyllotoxin</Name>
            <Formulation ID="F103604921925" Rank="3" Units="ml">
              <Name>Soln 0.5%</Name>
              <Brand ID="B10360492192525">
                <Name>Condyline</Name>
                <Pack ID="P701610" Specified="true" nzmt:ctpp_id="50103441000117101">
                  <Quantity>3.5</Quantity>
                  <Price>33.60</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1040">
        <Name>Other Skin Preparations</Name>
        <ATC3 ID="A104001">
          <Name>Other Skin Preparations</Name>
          <Chemical ID="C1040018146">
            <Name>Diphemanil metilsulfate</Name>
            <Formulation ID="F104001814601" Rank="3" Units="g">
              <Name>Powder 2%</Name>
              <Brand ID="B10400181460100">
                <Name>Any</Name>
                <Pack ID="P81460100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1040019425">
            <Name>Sunscreen, proprietary</Name>
            <Formulation ID="F104001942525" Rank="3" Units="g" Weight="100">
              <Name>Lotn</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B10400194252526" PSS="true">
                <Name>Marine Blue Lotion SPF 50+</Name>
                <Pack ID="P2454203" Specified="true" nzmt:ctpp_id="50200001000117101">
                  <Quantity>200</Quantity>
                  <Price>6.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1040019445">
            <Name>Imiquimod</Name>
            <Formulation ID="F104001944525" Rank="2" Units="sach">
              <Name>Crm 5%, 250 mg sachet</Name>
              <Brand ID="B10400194452527">
                <Name>Perrigo</Name>
                <Pack ID="P2543907" Specified="true" nzmt:ctpp_id="50195861000117100">
                  <Quantity>24</Quantity>
                  <Price>21.72</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A104004">
          <Name>Antineoplastics</Name>
          <Chemical ID="C1040048295">
            <Name>Methyl aminolevulinate hydrochloride</Name>
            <Request Form="RS1127" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Methyl aminolevulinate hydrochloride</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>dermatologist</Applicant>
                <Applicant>plastic surgeon</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1127" style="display:none"/>
            <Formulation ID="F104004829501" Rank="3" Units="g">
              <Name>Crm 16%</Name>
              <Brand ID="B10400482950100">
                <Name>Any</Name>
                <Pack ID="P82950100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1040049064">
            <Name>Fluorouracil sodium</Name>
            <Formulation ID="F104004906401" Rank="3" Units="g">
              <Name>Crm 5%</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B10400490640101" PSS="true">
                <Name>Efudix</Name>
                <Pack ID="P253065" Specified="true" nzmt:ctpp_id="50053671000117109">
                  <Quantity>20</Quantity>
                  <Price>5.56</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A104012">
          <Name>Wound Management Products</Name>
          <Chemical ID="C1040129270">
            <Name>Calcium gluconate</Name>
            <Formulation ID="F104012927026" Rank="9" Units="tube">
              <Name>Gel 2.5%</Name>
              <Brand ID="B10401292702600">
                <Name>e.g. Orion</Name>
                <Pack ID="P92702600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
    <ATC1 ID="A13">
      <Name>Genito-Urinary System</Name>
      <ATC2 ID="A1304">
        <Name>Anti-Infective Agents</Name>
        <ATC3 ID="A130404">
          <Name>Anti-Infective Agents</Name>
          <Chemical ID="C1304048001">
            <Name>Acetic acid</Name>
            <Formulation ID="F130404800102" Rank="3" Units="ml">
              <Name>Soln 3%</Name>
              <Brand ID="B13040480010200">
                <Name>Any</Name>
                <Pack ID="P80010200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F130404800103" Rank="3" Units="ml">
              <Name>Soln 5%</Name>
              <Brand ID="B13040480010300">
                <Name>Any</Name>
                <Pack ID="P80010300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1304048002">
            <Name>Acetic acid with hydroxyquinoline, glycerol and ricinoleic acid</Name>
            <Formulation ID="F130404800201" Rank="3" Units="g">
              <Name>Jelly 0.94% with hydroxyquinoline sulphate 0.025%, glycerol 5% and ricinoleic acid 0.75% with applicator</Name>
              <Brand ID="B13040480020100">
                <Name>Any</Name>
                <Pack ID="P80020100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1304049229">
            <Name>Miconazole nitrate</Name>
            <Formulation ID="F130404922903" Rank="3" Units="g">
              <Name>Vaginal crm 2% with applicator</Name>
              <Brand ID="B13040492290325">
                <Name>Micreme</Name>
                <Pack ID="P697648" Specified="true" nzmt:ctpp_id="50102721000117108">
                  <Quantity>40</Quantity>
                  <Price>6.89</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1304049252">
            <Name>Nystatin</Name>
            <Formulation ID="F130404925202" Rank="3" Units="g">
              <Name>Vaginal crm 100,000 u per 5 g with applicator(s)</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B13040492520225" PSS="true">
                <Name>Nilstat</Name>
                <Pack ID="P254908" Specified="true" nzmt:ctpp_id="50054711000117106">
                  <Quantity>75</Quantity>
                  <Price>5.70</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1304049382">
            <Name>Clotrimazole</Name>
            <Formulation ID="F130404938225" Rank="3" Units="g" Weight="1">
              <Name>Vaginal crm 1% with applicator</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B13040493822525" PSS="true">
                <Name>Clomazol</Name>
                <Pack ID="P2155656" Specified="true" nzmt:ctpp_id="50026721000117107">
                  <Quantity>35</Quantity>
                  <Price>3.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F130404938227" Rank="3" Units="g" Weight="2">
              <Name>Vaginal crm 2% with applicator</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B13040493822725" PSS="true">
                <Name>Clomazol</Name>
                <Pack ID="P2249634" Specified="true" nzmt:ctpp_id="50039611000117103">
                  <Quantity>20</Quantity>
                  <Price>3.85</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1304049538">
            <Name>Chlorhexidine gluconate</Name>
            <Formulation ID="F130404953829" Rank="3" Units="g">
              <Name>Crm 1%</Name>
              <Brand ID="B13040495382900">
                <Name>Any</Name>
                <Pack ID="P95382900" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F130404953830" Rank="3" Units="ml">
              <Name>Lotn 1%</Name>
              <Brand ID="B13040495383000">
                <Name>Any</Name>
                <Pack ID="P95383000" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1308">
        <Name>Contraceptives</Name>
        <ATC3 ID="A130804">
          <Name>Antiandrogen Oral Contraceptives</Name>
          <Chemical ID="C1308048121">
            <Name>Cyproterone acetate with ethinyloestradiol</Name>
            <Formulation ID="F130804812101" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg with ethinyloestradiol 35 mcg and 7 inert tablets</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B13080481210125" PSS="true">
                <Name>Ginet</Name>
                <Pack ID="P2455455" Specified="true" nzmt:ctpp_id="50198351000117102">
                  <Quantity>168</Quantity>
                  <Price>5.08</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A130808">
          <Name>Combined Oral Contraceptives</Name>
          <Chemical ID="C1308088174">
            <Name>Ethinyloestradiol with desogestrel</Name>
            <Formulation ID="F130808817401" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mcg with desogestrel 150 mcg</Name>
              <Brand ID="B13080881740100">
                <Name>Any</Name>
                <Pack ID="P81740100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F130808817402" Rank="1" Units="tab" Weight="30">
              <Name>Tab 30 mcg with desogestrel 150 mcg</Name>
              <Brand ID="B13080881740200">
                <Name>Any</Name>
                <Pack ID="P81740200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1308088175">
            <Name>Ethinyloestradiol with norethisterone</Name>
            <Formulation ID="F130808817501" Rank="1" Units="tab" Weight="35">
              <Name>Tab 35 mcg with norethisterone 1 mg</Name>
              <Brand ID="B13080881750100">
                <Name>Any</Name>
                <Pack ID="P81750100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F130808817502" Rank="1" Units="tab" Weight="35">
              <Name>Tab 35 mcg with norethisterone 500 mcg</Name>
              <Brand ID="B13080881750200">
                <Name>Any</Name>
                <Pack ID="P81750200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F130808817525" Rank="1" Units="tab" Weight="35">
              <Name>Tab 35 mcg with norethisterone 1 mg and 7 inert tab</Name>
              <Brand ID="B13080881752525">
                <Name>Brevinor 1/28</Name>
                <Pack ID="P303542" Specified="true" nzmt:ctpp_id="50067671000117109">
                  <Quantity>84</Quantity>
                  <Price>12.25</Price>
                </Pack>
              </Brand>
              <Brand ID="B13080881752526">
                <Name>Alyacen</Name>
                <Pack ID="P2688441" Specified="true" nzmt:ctpp_id="50339091000117102">
                  <Quantity>84</Quantity>
                  <Price>12.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1308088320">
            <Name>Norethisterone with mestranol</Name>
            <Formulation ID="F130808832001" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg with mestranol 50 mcg</Name>
              <Brand ID="B13080883200100">
                <Name>Any</Name>
                <Pack ID="P83200100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1308089674">
            <Name>Ethinyloestradiol with levonorgestrel</Name>
            <Formulation ID="F130808967401" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mcg with levonorgestrel 100 mcg</Name>
              <Brand ID="B13080896740100">
                <Name>Any</Name>
                <Pack ID="P96740100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F130808967402" Rank="1" Units="tab" Weight="30">
              <Name>Tab 30 mcg with levonorgestrel 150 mcg</Name>
              <Brand ID="B13080896740200">
                <Name>Any</Name>
                <Pack ID="P96740200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F130808967426" Rank="1" Units="tab">
              <Name>Tab 20 mcg with levonorgestrel 100 mcg and 7 inert tablets</Name>
              <Rule Type="DVLimit" Attribute="Aug-23 to~2025" Value="5"/>
              <Brand ID="B13080896742627" PSS="true">
                <Name>Lo-Oralcon 20 ED</Name>
                <Pack ID="P2637111" Specified="true" nzmt:ctpp_id="50136121000117102">
                  <Quantity>84</Quantity>
                  <Price>1.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F130808967427" Rank="1" Units="tab">
              <Name>Tab 30 mcg with levonorgestrel 150 mcg and 7 inert tablets</Name>
              <Rule Type="DVLimit" Attribute="Aug-23 to~2025" Value="5"/>
              <Brand ID="B13080896742727" PSS="true">
                <Name>Oralcon 30 ED</Name>
                <Pack ID="P2637138" Specified="true" nzmt:ctpp_id="50301271000117101">
                  <Quantity>84</Quantity>
                  <Price>1.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A130810">
          <Name>Contraceptive Devices</Name>
          <Chemical ID="C1308108539">
            <Name>Intra-uterine device</Name>
            <Formulation ID="F130810853926" Rank="10" Units="dev">
              <Name>IUD 29.1 mm length x 23.2 mm width</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B13081085392626" PSS="true">
                <Name>Choice TT380 Short</Name>
                <Pack ID="P2467151" Specified="true" nzmt:ctpp_id="50212771000117109">
                  <Quantity>1</Quantity>
                  <Price>29.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F130810853927" Rank="10" Units="dev">
              <Name>IUD 33.6 mm length x 29.9 mm width</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B13081085392726" PSS="true">
                <Name>Choice TT380 Standard</Name>
                <Pack ID="P2467178" Specified="true" nzmt:ctpp_id="50212761000117104">
                  <Quantity>1</Quantity>
                  <Price>29.80</Price>
                </Pack>
              </Brand>
              <Brand ID="B13081085392727">
                <Name>TCu 380 Plus Normal</Name>
                <Pack ID="P2688484" Specified="true" nzmt:ctpp_id="50339251000117104">
                  <Quantity>1</Quantity>
                  <Price>26.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F130810853928" Rank="10" Units="dev">
              <Name>IUD 35.5 mm length x 19.6 mm width</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B13081085392825" PSS="true">
                <Name>Choice Load 375</Name>
                <Pack ID="P2497999" Specified="true" nzmt:ctpp_id="50232811000117101">
                  <Quantity>1</Quantity>
                  <Price>33.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B13081085392826">
                <Name>Cu 375 Standard</Name>
                <Pack ID="P2688476" Specified="true" nzmt:ctpp_id="50339261000117102">
                  <Quantity>1</Quantity>
                  <Price>33.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A130812">
          <Name>Emergency Contraception</Name>
          <Chemical ID="C1308129547">
            <Name>Levonorgestrel</Name>
            <Formulation ID="F130812954727" Rank="1" Units="tab" Weight="1.5">
              <Name>Tab 1.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-23 to~2025" Value="5"/>
              <Brand ID="B13081295472726" PSS="true">
                <Name>Levonorgestrel BNM</Name>
                <Pack ID="P2645424" Specified="true" nzmt:ctpp_id="50264911000117106">
                  <Quantity>1</Quantity>
                  <Price>1.75</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A130816">
          <Name>Progestogen-Only Contraceptives</Name>
          <Chemical ID="C1308169120">
            <Name>Medroxyprogesterone acetate</Name>
            <Formulation ID="F130816912027" Rank="4" Units="inj" Weight="150">
              <Name>Inj 150 mg per ml, 1 ml syringe</Name>
              <Brand ID="B13081691202725">
                <Name>Depo-Provera</Name>
                <Pack ID="P271691" Specified="true" nzmt:ctpp_id="50060491000117108">
                  <Quantity>1</Quantity>
                  <Price>9.18</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1308169435">
            <Name>Norethisterone</Name>
            <Formulation ID="F130816943501" Rank="1" Units="tab" Weight="350">
              <Name>Tab 350 mcg</Name>
              <Brand ID="B13081694350125">
                <Name>Noriday 28</Name>
                <Pack ID="P398322" Specified="true" nzmt:ctpp_id="50081781000117105">
                  <Quantity>84</Quantity>
                  <Price>12.25</Price>
                </Pack>
              </Brand>
              <Brand ID="B13081694350126">
                <Name>Norethinderone - CDC</Name>
                <Pack ID="P2685051" Specified="true" nzmt:ctpp_id="50337341000117103">
                  <Quantity>84</Quantity>
                  <Price>12.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1308169547">
            <Name>Levonorgestrel</Name>
            <Formulation ID="F130816954701" Rank="10" Units="dev">
              <Name>Intra-uterine device 52 mg</Name>
              <Rule Type="DVLimit" Attribute="Nov-23 to~31~Oct~2024" Value="1"/>
              <Brand ID="B13081695470125" HSS="true">
                <Name>Mirena</Name>
                <Pack ID="P2013908" Specified="true" nzmt:ctpp_id="50002091000117103">
                  <Quantity>1</Quantity>
                  <Price>269.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F130816954702" Rank="1" Units="tab" Weight="30">
              <Name>Tab 30 mcg</Name>
              <Brand ID="B13081695470225">
                <Name>Microlut</Name>
                <Pack ID="P719803" Specified="true" nzmt:ctpp_id="50105531000117107">
                  <Quantity>84</Quantity>
                  <Price>16.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F130816954725" Rank="4" Units="inj">
              <Name>Subdermal implant (2 x 75 mg rods)</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B13081695472525" PSS="true">
                <Name>Jadelle</Name>
                <Pack ID="P2265532" Specified="true" nzmt:ctpp_id="50041821000117106">
                  <Quantity>1</Quantity>
                  <Price>106.92</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F130816954728" Rank="10" Units="dev" Weight="13">
              <Name>Intra-uterine device 13.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Nov-23 to~31~Oct~2024" Value="1"/>
              <Brand ID="B13081695472825" HSS="true">
                <Name>Jaydess</Name>
                <Pack ID="P2474891" Specified="true" nzmt:ctpp_id="50185361000117106">
                  <Quantity>1</Quantity>
                  <Price>215.60</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1312">
        <Name>Obstetric Preparations</Name>
        <ATC3 ID="A131204">
          <Name>Antiprogestogens</Name>
          <Chemical ID="C1312048303">
            <Name>Mifepristone</Name>
            <Formulation ID="F131204830301" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B13120483030100">
                <Name>Any</Name>
                <Pack ID="P83030100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A131208">
          <Name>Oxytocics</Name>
          <Chemical ID="C1312088080">
            <Name>Carboprost trometamol</Name>
            <Formulation ID="F131208808001" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 mcg per ml, 1 ml ampoule</Name>
              <Brand ID="B13120880800100">
                <Name>Any</Name>
                <Pack ID="P80800100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1312088338">
            <Name>Oxytocin with ergometrine maleate</Name>
            <Formulation ID="F131208833801" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 iu with ergometrine maleate 500 mcg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B13120883380125" PSS="true">
                <Name>Syntometrine</Name>
                <Pack ID="P256269" Specified="true" nzmt:ctpp_id="50055381000117101">
                  <Quantity>5</Quantity>
                  <Price>32.40</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1312089043">
            <Name>Oxytocin</Name>
            <Formulation ID="F131208904301" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 iu per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Jun-23 to~2025" Value="5"/>
              <Brand ID="B13120890430125" PSS="true">
                <Name>Oxytocin BNM</Name>
                <Pack ID="P2577046" Specified="true" nzmt:ctpp_id="50128651000117104">
                  <Quantity>5</Quantity>
                  <Price>5.98</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F131208904302" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 iu per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Jun-23 to~2025" Value="5"/>
              <Brand ID="B13120890430225" PSS="true">
                <Name>Oxytocin BNM</Name>
                <Pack ID="P2448211" Specified="true" nzmt:ctpp_id="50128641000117101">
                  <Quantity>5</Quantity>
                  <Price>4.98</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1312089179">
            <Name>Dinoprostone</Name>
            <Formulation ID="F131208917901" Rank="5" Units="pess">
              <Name>Pessaries 10 mg</Name>
              <Brand ID="B13120891790100">
                <Name>Any</Name>
                <Pack ID="P91790100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F131208917925" Rank="10" Units="pack" Weight="1">
              <Name>Vaginal gel 1 mg in 3 g</Name>
              <Brand ID="B13120891792525">
                <Name>Prostin E2</Name>
                <Pack ID="P703869" Specified="true" nzmt:ctpp_id="50103691000117106">
                  <Quantity>1</Quantity>
                  <Price>65.39</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F131208917926" Rank="10" Units="pack" Weight="1">
              <Name>Vaginal gel 2 mg in 3 g</Name>
              <Brand ID="B13120891792625">
                <Name>Prostin E2</Name>
                <Pack ID="P703877" Specified="true" nzmt:ctpp_id="50103701000117106">
                  <Quantity>1</Quantity>
                  <Price>82.33</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1312089306">
            <Name>Ergometrine maleate</Name>
            <Formulation ID="F131208930625" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mcg per ml, 1 ml ampoule</Name>
              <Brand ID="B13120893062525">
                <Name>DBL Ergometrine</Name>
                <Pack ID="P500372" Specified="true" nzmt:ctpp_id="50092921000117104">
                  <Quantity>5</Quantity>
                  <Price>160.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A131212">
          <Name>Tocolytics</Name>
          <Chemical ID="C1312128393">
            <Name>Progesterone</Name>
            <Formulation ID="F131212839301" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Rule Type="DVLimit" Attribute="May-23 to~2025" Value="5"/>
              <Brand ID="B13121283930125" PSS="true">
                <Name>Utrogestan</Name>
                <Pack ID="P2086905" Specified="true" nzmt:ctpp_id="50015211000117108">
                  <Quantity>30</Quantity>
                  <Price>14.85</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1312128457">
            <Name>Terbutaline</Name>
            <Request Form="RS1130" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Terbutaline</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>obstetrician</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1130" style="display:none"/>
            <Formulation ID="F131212845701" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mcg ampoule</Name>
              <Brand ID="B13121284570100">
                <Name>Any</Name>
                <Pack ID="P84570100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1316">
        <Name>Oestrogens</Name>
        <ATC3 ID="A131604">
          <Name>Oestrogens</Name>
          <Chemical ID="C1316048325">
            <Name>Oestriol</Name>
            <Formulation ID="F131604832501" Rank="3" Units="g">
              <Name>Crm 1 mg per g with applicator</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B13160483250125" PSS="true">
                <Name>Ovestin</Name>
                <Pack ID="P767441" Specified="true" nzmt:ctpp_id="50110991000117106">
                  <Quantity>15</Quantity>
                  <Price>6.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F131604832502" Rank="5" Units="pess">
              <Name>Pessaries 500 mcg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B13160483250225" PSS="true">
                <Name>Ovestin</Name>
                <Pack ID="P767468" Specified="true" nzmt:ctpp_id="50216211000117109">
                  <Quantity>15</Quantity>
                  <Price>7.55</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1320">
        <Name>Urologicals</Name>
        <ATC3 ID="A132004">
          <Name>5-Alpha Reductase Inhibitors</Name>
          <Chemical ID="C1320049449">
            <Name>Finasteride</Name>
            <Request Form="RS1131" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Finasteride</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has symptomatic benign prostatic hyperplasia</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient is intolerant of non-selective alpha blockers or these are contraindicated</ci>
                      <ci type="logical">Symptoms are not adequately controlled with non-selective alpha blockers</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1131" style="display:none"/>
            <Formulation ID="F132004944925" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B13200494492528" PSS="true">
                <Name>Ricit</Name>
                <Pack ID="P2522756" Specified="true" nzmt:ctpp_id="50244211000117107">
                  <Quantity>100</Quantity>
                  <Price>4.79</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A132008">
          <Name>Alpha-1A Adrenoceptor Blockers</Name>
          <Chemical ID="C1320089548">
            <Name>Tamsulosin hydrochloride</Name>
            <Request Form="RS1132" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Tamsulosin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has symptomatic benign prostatic hyperplasia</ci>
                    <ci type="logical">The patient is intolerant of non-selective alpha blockers or these are contraindicated</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1132" style="display:none"/>
            <Formulation ID="F132008954825" Rank="2" Units="cap" Weight="400">
              <Name>Cap 400 mcg</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B13200895482525" PSS="true">
                <Name>Tamsulosin-Rex</Name>
                <Pack ID="P2438526" Specified="true" nzmt:ctpp_id="50184831000117105">
                  <Quantity>100</Quantity>
                  <Price>22.31</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A132012">
          <Name>Urinary Alkalisers</Name>
          <Chemical ID="C1320129172">
            <Name>Sodium citro-tartrate</Name>
            <Formulation ID="F132012917225" Rank="2" Units="sach">
              <Name>Grans eff 4 g sachets</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B13201291722525" PSS="true">
                <Name>Ural</Name>
                <Pack ID="P298638" Specified="true" nzmt:ctpp_id="50066491000117105">
                  <Quantity>28</Quantity>
                  <Price>3.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1320129580">
            <Name>Potassium citrate</Name>
            <Request Form="RS1133" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Potassium citrate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has recurrent calcium oxalate urolithiasis</ci>
                    <ci type="logical">The patient has had more than two renal calculi in the two years prior to the application</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1133" style="display:none"/>
            <Formulation ID="F132012958025" Rank="3" Units="ml" Weight="3">
              <Name>Oral liq 3 mmol per ml</Name>
              <Brand ID="B13201295802525">
                <Name>Biomed</Name>
                <Pack ID="P2378728" Specified="true" nzmt:ctpp_id="50121461000117108">
                  <Quantity>200</Quantity>
                  <Price>35.70</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A132016">
          <Name>Urinary Antispasmodics</Name>
          <Chemical ID="C1320169409">
            <Name>Oxybutynin</Name>
            <Formulation ID="F132016940925" Rank="3" Units="ml" Weight="5">
              <Name>Oral liq 5 mg per 5 ml</Name>
              <Brand ID="B13201694092500">
                <Name>Any</Name>
                <Pack ID="P94092500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F132016940926" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B13201694092626">
                <Name>Alchemy Oxybutynin</Name>
                <Pack ID="P2627167" Specified="true" nzmt:ctpp_id="50296311000117101">
                  <Quantity>100</Quantity>
                  <Price>5.42</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1320169520">
            <Name>Solifenacin succinate</Name>
            <Formulation ID="F132016952025" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B13201695202527">
                <Name>Solifenacin Viatris</Name>
                <Pack ID="P2645319" Specified="true" nzmt:ctpp_id="50296261000117106">
                  <Quantity>30</Quantity>
                  <Price>2.05</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F132016952026" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B13201695202627">
                <Name>Solifenacin Viatris</Name>
                <Pack ID="P2645327" Specified="true" nzmt:ctpp_id="50296281000117103">
                  <Quantity>30</Quantity>
                  <Price>3.72</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
    <ATC1 ID="A14">
      <Name>Hormone Preparations</Name>
      <ATC2 ID="A1402">
        <Name>Anabolic Agents</Name>
        <ATC3 ID="A140204">
          <Name>Anabolic Agents</Name>
          <Chemical ID="C1402048520">
            <Name>Oxandrolone</Name>
            <Formulation ID="F140204852025" Rank="1" Units="tab" Weight="2.5">
              <Name>Tab 2.5 mg</Name>
              <Request Form="RS1302" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Oxandroline - Tab 2.5 mg</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">For the treatment of burns patients</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1302" style="display:none"/>
              <Brand ID="B14020485202500">
                <Name>Any</Name>
                <Pack ID="P85202500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1404">
        <Name>Androgen Agonists and Antagonists</Name>
        <ATC3 ID="A140404">
          <Name>Androgen Agonists and Antagonists</Name>
          <Chemical ID="C1404048459">
            <Name>Testosterone esters</Name>
            <Formulation ID="F140404845901" Rank="4" Units="inj">
              <Name>Inj testosterone decanoate 100 mg, testosterone isocarproate 60 mg, testosterone phenylpropionate 60 mg and testosterone propionate 30 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B14040484590100">
                <Name>Any</Name>
                <Pack ID="P84590100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1404049171">
            <Name>Cyproterone acetate</Name>
            <Formulation ID="F140404917125" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B14040491712526">
                <Name>Siterone</Name>
                <Pack ID="P2220482" Specified="true" nzmt:ctpp_id="50035001000117105">
                  <Quantity>50</Quantity>
                  <Price>14.37</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F140404917126" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B14040491712625">
                <Name>Siterone</Name>
                <Pack ID="P2235862" Specified="true" nzmt:ctpp_id="50037581000117102">
                  <Quantity>50</Quantity>
                  <Price>28.03</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1404049370">
            <Name>Testosterone</Name>
            <Formulation ID="F140404937026" Rank="9" Units="patch" Weight="5">
              <Name>Patch 5 mg per day</Name>
              <Brand ID="B14040493702625" ToBeDelisted="2024-11-01">
                <Name>Androderm</Name>
                <Pack ID="P2522403" Specified="true" nzmt:ctpp_id="50242631000117107">
                  <Quantity>30</Quantity>
                  <Price>225.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F140404937027" Rank="3" Units="g" Weight="16">
              <Name>Gel (transdermal) 16.2 mg per g</Name>
              <Rule Type="DVLimit" Attribute="Jul-24 to~2027" Value="5"/>
              <Brand ID="B14040493702725" PSS="true">
                <Name>Testogel</Name>
                <Pack ID="P2676605" Specified="true" nzmt:ctpp_id="50297771000117105">
                  <Quantity>88</Quantity>
                  <Price>52.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1404049440">
            <Name>Testosterone cipionate</Name>
            <Formulation ID="F140404944025" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 100 mg per ml, 10 ml vial</Name>
              <Brand ID="B14040494402525">
                <Name>Depo-Testosterone</Name>
                <Pack ID="P741264" Specified="true" nzmt:ctpp_id="50107601000117107">
                  <Quantity>1</Quantity>
                  <Price>85.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1404049534">
            <Name>Testosterone undecanoate</Name>
            <Formulation ID="F140404953425" Rank="2" Units="cap" Weight="40">
              <Name>Cap 40 mg</Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
                <p>For continuation only</p>
              </div>
              <Brand ID="B14040495342500">
                <Name>Any</Name>
                <Pack ID="P95342500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F140404953427" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 250 mg per ml, 4 ml vial</Name>
              <Brand ID="B14040495342725">
                <Name>Reandron 1000</Name>
                <Pack ID="P2472716" Specified="true" nzmt:ctpp_id="50196911000117100">
                  <Quantity>1</Quantity>
                  <Price>86.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1408">
        <Name>Calcium Homeostasis</Name>
        <ATC3 ID="A140804">
          <Name>Calcium Homeostasis</Name>
          <Chemical ID="C1408048587">
            <Name>Cinacalcet</Name>
            <Request Form="RS1931" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Cinacalcet</range>
              </Title>
              <Case When="Initial application" Category="parathyroid carcinoma or calciphylaxis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">The patient has been diagnosed with a
                        parathyroid carcinoma (see Note)</ci>
                      <ci type="logical" class="Indication">The patient has persistent hypercalcaemia
                        (serum calcium greater than or equal to 3 mmol/L) despite previous
                        first-line treatments including sodium thiosulfate (where appropriate) and
                        bisphosphonates</ci>
                      <ci type="logical" class="Indication">The patient is symptomatic</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">The patient has been diagnosed with
                        calciphylaxis (calcific uraemic arteriolopathy)</ci>
                      <ci type="logical" class="Indication">The patient has symptomatic (e.g. painful
                        skin ulcers) hypercalcaemia (serum calcium greater than or equal to 3
                        mmol/L)</ci>
                      <ci type="logical" class="Indication">The patient's condition has not responded
                        to previous first-line treatments including bisphosphonates and sodium
                        thiosulfate</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>nephrologist</Applicant>
                <Applicant>endocrinologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="parathyroid carcinoma or calciphylaxis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The patient's serum calcium level has fallen
                    to &lt; 3mmol/L</ci>
                    <ci type="logical" class="Indication">The patient has experienced clinically
                    significant symptom improvement</ci>
                  </apply>
                </math>
                <Applicant>nephrologist</Applicant>
                <Applicant>endocrinologist</Applicant>
                <Term Measure="patient's lifetime">1</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>This does not include parathyroid adenomas unless these have become malignant.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="primary hyperparathyroidism">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has primary hyperparathyroidism</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient has hypercalcaemia of more than 3
                        mmol/L with or without symptoms</ci>
                      <ci type="logical" class="Indication">Patient has hypercalcaemia of more than
                        2.85 mmol/L with symptoms</ci>
                    </apply>
                    <ci type="logical" class="Indication">Surgery is not feasible or has failed</ci>
                    <ci type="logical" class="Indication">Patient has other comorbidities, severe bone
                    pain, or calciphylaxis</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime">1</Term>
              </Case>
              <Case When="Initial application" Category="secondary or tertiary hyperparathyroidism">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient has tertiary hyperparathyroidism
                        and markedly elevated parathyroid hormone (PTH) with hypercalcaemia</ci>
                      <ci type="logical" class="Indication">Patient has symptomatic secondary
                        hyperparathyroidism and elevated PTH</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient is on renal replacement therapy</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Residual parathyroid tissue has not been
                        localised despite repeat unsuccessful parathyroid explorations</ci>
                      <ci type="logical" class="Indication">Parathyroid tissue is surgically
                        inaccessible</ci>
                      <ci type="logical" class="Indication">Parathyroid surgery is not feasible</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="secondary or tertiary hyperparathyroidism">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">The patient has had a kidney transplant, and
                    following a treatment free interval of at least 12 weeks a clinically acceptable
                    parathyroid hormone (PTH) level to support ongoing cessation of treatment has
                    not been reached</ci>
                    <ci type="logical" class="Indication">The patient has not received a kidney
                    transplant and trial of withdrawal of cinacalcet is clinically
                    inappropriate</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1931" style="display:none"/>
            <Formulation ID="F140804858725" Rank="1" Units="tab" Weight="30">
              <Name>Tab 30 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B14080485872526" PSS="true">
                <Name>Cinacalet Devatis</Name>
                <Pack ID="P2615517" Specified="true" nzmt:ctpp_id="50268941000117104">
                  <Quantity>28</Quantity>
                  <Price>25.24</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F140804858726" Rank="10" Units="tabs">
              <Name>Tab 60 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B14080485872625" PSS="true">
                <Name>Cinacalet Devatis</Name>
                <Pack ID="P2615525" Specified="true" nzmt:ctpp_id="50268951000117102">
                  <Quantity>28</Quantity>
                  <Price>50.47</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1408049063">
            <Name>Zoledronic acid</Name>
            <Formulation ID="F140804906301" Rank="4" Units="inj" Weight="4">
              <Name>Inj 4 mg per 5 ml, vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B14080490630126" PSS="true">
                <Name>Zoledronic acid Viatris</Name>
                <Pack ID="P2631830" Specified="true" nzmt:ctpp_id="50296231000117104">
                  <Quantity>1</Quantity>
                  <Price>15.65</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1408049448">
            <Name>Calcitonin</Name>
            <Formulation ID="F140804944825" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 iu per ml, 1 ml ampoule</Name>
              <Brand ID="B14080494482525">
                <Name>Miacalcic</Name>
                <Pack ID="P2548356" Specified="true" nzmt:ctpp_id="50056511000117105">
                  <Quantity>5</Quantity>
                  <Price>121.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1412">
        <Name>Corticosteroids</Name>
        <ATC3 ID="A141204">
          <Name>Corticosteroids</Name>
          <Chemical ID="C1412048051">
            <Name>Betamethasone</Name>
            <Formulation ID="F141204805101" Rank="4" Units="inj" Weight="4">
              <Name>Inj 4 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B14120480510100">
                <Name>Any</Name>
                <Pack ID="P80510100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141204805102" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mcg</Name>
              <Brand ID="B14120480510200">
                <Name>Any</Name>
                <Pack ID="P80510200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1412048053">
            <Name>Betamethasone sodium phosphate with betamethasone acetate</Name>
            <Formulation ID="F141204805301" Rank="4" Units="inj" Weight="3.9">
              <Name>Inj 3.9 mg with betamethasone acetate 3 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B14120480530100">
                <Name>Any</Name>
                <Pack ID="P80530100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1412048296">
            <Name>Methylprednisolone (as sodium succinate)</Name>
            <Formulation ID="F141204829601" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1 g vial</Name>
              <Brand ID="B14120482960125">
                <Name>Solu-Medrol</Name>
                <Pack ID="P265357" Specified="true" nzmt:ctpp_id="50059021000117101">
                  <Quantity>1</Quantity>
                  <Price>32.84</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141204829602" Rank="4" Units="inj" Weight="125">
              <Name>Inj 125 mg vial</Name>
              <Brand ID="B14120482960225">
                <Name>Solu-Medrol Act-O-Vial</Name>
                <Pack ID="P2394219" Specified="true" nzmt:ctpp_id="50126631000117108">
                  <Quantity>1</Quantity>
                  <Price>34.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141204829603" Rank="4" Units="inj" Weight="40">
              <Name>Inj 40 mg vial</Name>
              <Brand ID="B14120482960325">
                <Name>Solu-Medrol Act-O-Vial</Name>
                <Pack ID="P2394227" Specified="true" nzmt:ctpp_id="50126641000117100">
                  <Quantity>1</Quantity>
                  <Price>22.30</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141204829604" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg vial</Name>
              <Brand ID="B14120482960425">
                <Name>Solu-Medrol Act-O-Vial</Name>
                <Pack ID="P2394235" Specified="true" nzmt:ctpp_id="50126651000117103">
                  <Quantity>1</Quantity>
                  <Price>26.88</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141204829605" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B14120482960525">
                <Name>Medrol</Name>
                <Pack ID="P681776" Specified="true" nzmt:ctpp_id="50101831000117107">
                  <Quantity>20</Quantity>
                  <Price>223.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141204829606" Rank="1" Units="tab" Weight="4">
              <Name>Tab 4 mg</Name>
              <Brand ID="B14120482960625">
                <Name>Medrol</Name>
                <Pack ID="P210692" Specified="true" nzmt:ctpp_id="50019261000117108">
                  <Quantity>100</Quantity>
                  <Price>112.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1412048384">
            <Name>Prednisolone</Name>
            <Formulation ID="F141204838401" Rank="10" Units="enema">
              <Name>Enema 200 mcg per ml, 100 ml</Name>
              <Brand ID="B14120483840100">
                <Name>Any</Name>
                <Pack ID="P83840100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141204838402" Rank="3" Units="ml">
              <Name>Oral liq 5 mg per ml</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B14120483840225" PSS="true">
                <Name>Redipred</Name>
                <Pack ID="P317659" Specified="true" nzmt:ctpp_id="50071101000117109">
                  <Quantity>30</Quantity>
                  <Price>6.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1412048479">
            <Name>Triamcinolone hexacetonide</Name>
            <Formulation ID="F141204847901" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg per ml, 1 ml vial</Name>
              <Brand ID="B14120484790100">
                <Name>Any</Name>
                <Pack ID="P84790100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1412049119">
            <Name>Hydrocortisone</Name>
            <Formulation ID="F141204911901" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B14120491190101">
                <Name>Douglas</Name>
                <Pack ID="P205621" Specified="true" nzmt:ctpp_id="50010051000117108">
                  <Quantity>100</Quantity>
                  <Multiple>100</Multiple>
                  <Price>8.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141204911902" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Brand ID="B14120491190201">
                <Name>Douglas</Name>
                <Pack ID="P205648" Specified="true" nzmt:ctpp_id="50010111000117106">
                  <Quantity>100</Quantity>
                  <Multiple>100</Multiple>
                  <Price>20.32</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141204911931" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B14120491193125" PSS="true">
                <Name>Solu-Cortef</Name>
                <Pack ID="P265284" Specified="true" nzmt:ctpp_id="50058961000117103">
                  <Quantity>1</Quantity>
                  <Price>3.96</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1412049145">
            <Name>Triamcinolone acetonide</Name>
            <Formulation ID="F141204914525" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="10"/>
              <Brand ID="B14120491452525" PSS="true">
                <Name>Kenacort-A 10</Name>
                <Pack ID="P282499" Specified="true" nzmt:ctpp_id="50062901000117105">
                  <Quantity>5</Quantity>
                  <Price>21.42</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141204914527" Rank="4" Units="inj" Weight="40">
              <Name>Inj 40 mg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B14120491452725" PSS="true">
                <Name>Kenacort-A 40</Name>
                <Pack ID="P253766" Specified="true" nzmt:ctpp_id="50054031000117104">
                  <Quantity>5</Quantity>
                  <Price>52.63</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1412049190">
            <Name>Fludrocortisone acetate</Name>
            <Formulation ID="F141204919025" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mcg</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B14120491902525" PSS="true">
                <Name>Florinef</Name>
                <Pack ID="P204951" Specified="true" nzmt:ctpp_id="50009201000117105">
                  <Quantity>100</Quantity>
                  <Price>11.46</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1412049243">
            <Name>Dexamethasone</Name>
            <Formulation ID="F141204924325" Rank="3" Units="ml" Weight="1">
              <Name>Oral liq 1 mg per ml</Name>
              <Brand ID="B14120492432525">
                <Name>Biomed</Name>
                <Pack ID="P344842" Specified="true" nzmt:ctpp_id="50075811000117102">
                  <Quantity>25</Quantity>
                  <Price>52.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141204924329" Rank="1" Units="tab" Weight="4">
              <Name>Tab 4 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B14120492432926" PSS="true">
                <Name>Dexmethsone</Name>
                <Pack ID="P2490226" Specified="true" nzmt:ctpp_id="50227441000117101">
                  <Quantity>30</Quantity>
                  <Price>3.18</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141204924330" Rank="1" Units="tab">
              <Name>Tab 0.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B14120492433025" PSS="true">
                <Name>Dexmethsone</Name>
                <Pack ID="P2490218" Specified="true" nzmt:ctpp_id="50227431000117109">
                  <Quantity>30</Quantity>
                  <Price>1.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1412049250">
            <Name>Methylprednisolone acetate</Name>
            <Formulation ID="F141204925025" Rank="4" Units="inj" Weight="40">
              <Name>Inj 40 mg per ml, 1 ml vial</Name>
              <Brand ID="B14120492502525">
                <Name>Depo-Medrol</Name>
                <Pack ID="P2454327" Specified="true" nzmt:ctpp_id="50149291000117103">
                  <Quantity>5</Quantity>
                  <Price>47.06</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1412049300">
            <Name>Dexamethasone phosphate</Name>
            <Formulation ID="F141204930025" Rank="4" Units="inj" Weight="4">
              <Name>Inj 4 mg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-23 to~2025" Value="5"/>
              <Brand ID="B14120493002526" PSS="true">
                <Name>Hameln</Name>
                <Pack ID="P2451689" Specified="true" nzmt:ctpp_id="50174641000117108">
                  <Quantity>10</Quantity>
                  <Price>7.86</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141204930027" Rank="4" Units="inj" Weight="8">
              <Name>Inj 4 mg per ml, 2 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-23 to~2025" Value="5"/>
              <Brand ID="B14120493002725" PSS="true">
                <Name>Hameln</Name>
                <Pack ID="P2519143" Specified="true" nzmt:ctpp_id="50240001000117107">
                  <Quantity>10</Quantity>
                  <Price>13.10</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1412049454">
            <Name>Prednisone</Name>
            <Formulation ID="F141204945425" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg</Name>
              <Brand ID="B14120494542527">
                <Name>Prednisone Clinect</Name>
                <Pack ID="P2608715" Specified="true" nzmt:ctpp_id="50287811000117109">
                  <Quantity>500</Quantity>
                  <Price>18.58</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141204945426" Rank="1" Units="tab" Weight="2.5">
              <Name>Tab 2.5 mg</Name>
              <Brand ID="B14120494542626">
                <Name>Prednisone Clinect</Name>
                <Pack ID="P2608723" Specified="true" nzmt:ctpp_id="50287831000117100">
                  <Quantity>500</Quantity>
                  <Price>21.04</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141204945427" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B14120494542726">
                <Name>Prednisone Clinect</Name>
                <Pack ID="P2608731" Specified="true" nzmt:ctpp_id="50287761000117104">
                  <Quantity>500</Quantity>
                  <Price>19.30</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141204945428" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Brand ID="B14120494542826">
                <Name>Prednisone Clinect</Name>
                <Pack ID="P2608758" Specified="true" nzmt:ctpp_id="50287791000117105">
                  <Quantity>500</Quantity>
                  <Price>50.51</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1416">
        <Name>Hormone Replacement Therapy</Name>
        <ATC3 ID="A141604">
          <Name>Oestrogens</Name>
          <Chemical ID="C1416048322">
            <Name>Oestradiol</Name>
            <Formulation ID="F141604832202" Rank="9" Units="patch" Weight="100">
              <Name>Patch 100 mcg per day</Name>
              <Brand ID="B14160483220225">
                <Name>Estradot</Name>
                <Pack ID="P2358883" Specified="true" nzmt:ctpp_id="50121501000117108">
                  <Quantity>8</Quantity>
                  <Price>14.50</Price>
                </Pack>
              </Brand>
              <Brand ID="B14160483220226">
                <Name>Lyllana</Name>
                <Pack ID="P2682397" Specified="true" nzmt:ctpp_id="50335901000117105">
                  <Quantity>8</Quantity>
                  <Price>22.77</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141604832203" Rank="9" Units="patch" Weight="25">
              <Name>Patch 25 mcg per day</Name>
              <Brand ID="B14160483220325">
                <Name>Estradot</Name>
                <Pack ID="P2358840" Specified="true" nzmt:ctpp_id="50121471000117103">
                  <Quantity>8</Quantity>
                  <Price>14.50</Price>
                </Pack>
              </Brand>
              <Brand ID="B14160483220326">
                <Name>Lyllana</Name>
                <Pack ID="P2682362" Specified="true" nzmt:ctpp_id="50335871000117105">
                  <Quantity>8</Quantity>
                  <Price>21.35</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141604832204" Rank="9" Units="patch" Weight="50">
              <Name>Patch 50 mcg per day</Name>
              <Brand ID="B14160483220425">
                <Name>Estradot</Name>
                <Pack ID="P2358867" Specified="true" nzmt:ctpp_id="50050851000117105">
                  <Quantity>8</Quantity>
                  <Price>14.50</Price>
                </Pack>
              </Brand>
              <Brand ID="B14160483220426">
                <Name>Lyllana</Name>
                <Pack ID="P2682370" Specified="true" nzmt:ctpp_id="50335881000117108">
                  <Quantity>8</Quantity>
                  <Price>21.55</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141604832205" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg</Name>
              <Brand ID="B14160483220500">
                <Name>Any</Name>
                <Pack ID="P83220500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141604832225" Rank="9" Units="patch" Weight="75">
              <Name>Patch 75 mcg per day</Name>
              <Brand ID="B14160483222525">
                <Name>Estradot</Name>
                <Pack ID="P2514346" Specified="true" nzmt:ctpp_id="50121491000117102">
                  <Quantity>8</Quantity>
                  <Price>14.50</Price>
                </Pack>
              </Brand>
              <Brand ID="B14160483222526">
                <Name>Lyllana</Name>
                <Pack ID="P2682389" Specified="true" nzmt:ctpp_id="50335891000117106">
                  <Quantity>8</Quantity>
                  <Price>22.37</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1416048323">
            <Name>Oestradiol valerate</Name>
            <Formulation ID="F141604832301" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg</Name>
              <Brand ID="B14160483230125">
                <Name>Progynova</Name>
                <Pack ID="P2450453" Specified="true" nzmt:ctpp_id="50175551000117108">
                  <Quantity>84</Quantity>
                  <Price>12.36</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141604832302" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Brand ID="B14160483230225">
                <Name>Progynova</Name>
                <Pack ID="P2619423" Specified="true" nzmt:ctpp_id="50175561000117105">
                  <Quantity>84</Quantity>
                  <Price>12.36</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1416048326">
            <Name>Oestrogens (conjugated equine)</Name>
            <Formulation ID="F141604832601" Rank="1" Units="tab" Weight="300">
              <Name>Tab 300 mcg</Name>
              <Brand ID="B14160483260100">
                <Name>Any</Name>
                <Pack ID="P83260100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141604832602" Rank="1" Units="tab" Weight="625">
              <Name>Tab 625 mcg</Name>
              <Brand ID="B14160483260200">
                <Name>Any</Name>
                <Pack ID="P83260200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A141608">
          <Name>Progestogen and Oestrogen Combined Preparations</Name>
          <Chemical ID="C1416088324">
            <Name>Oestradiol with norethisterone acetate</Name>
            <Formulation ID="F141608832401" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg with 0.5 mg norethisterone acetate</Name>
              <Brand ID="B14160883240100">
                <Name>Any</Name>
                <Pack ID="P83240100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141608832402" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg with 1 mg norethisterone acetate</Name>
              <Brand ID="B14160883240200">
                <Name>Any</Name>
                <Pack ID="P83240200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141608832403" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg with 1 mg norethisterone acetate (10), and tab 2 mg oestradiol (12) and tab 1 mg oestradiol (6)</Name>
              <Brand ID="B14160883240300">
                <Name>Any</Name>
                <Pack ID="P83240300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1416088327">
            <Name>Oestrogens with medroxyprogesterone acetate</Name>
            <Formulation ID="F141608832701" Rank="1" Units="tab" Weight="625">
              <Name>Tab 625 mcg conjugated equine with 2.5 mg medroxyprogesterone acetate</Name>
              <Brand ID="B14160883270100">
                <Name>Any</Name>
                <Pack ID="P83270100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141608832702" Rank="1" Units="tab" Weight="625">
              <Name>Tab 625 mcg conjugated equine with 5 mg medroxyprogesterone acetate</Name>
              <Brand ID="B14160883270200">
                <Name>Any</Name>
                <Pack ID="P83270200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A141612">
          <Name>Progestogens</Name>
          <Chemical ID="C1416129120">
            <Name>Medroxyprogesterone acetate</Name>
            <Formulation ID="F141612912001" Rank="1" Units="tab" Weight="2.5">
              <Name>Tab 2.5 mg</Name>
              <Brand ID="B14161291200101">
                <Name>Provera</Name>
                <Pack ID="P274186" Specified="true" nzmt:ctpp_id="50060821000117108">
                  <Quantity>30</Quantity>
                  <Multiple>30</Multiple>
                  <Price>6.56</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141612912002" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B14161291200201">
                <Name>Provera</Name>
                <Pack ID="P261130" Specified="true" nzmt:ctpp_id="50057481000117102">
                  <Quantity>100</Quantity>
                  <Multiple>100</Multiple>
                  <Price>20.13</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F141612912003" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B14161291200301">
                <Name>Provera</Name>
                <Pack ID="P274135" Specified="true" nzmt:ctpp_id="50060791000117101">
                  <Quantity>30</Quantity>
                  <Multiple>30</Multiple>
                  <Price>10.28</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1420">
        <Name>Other Endocrine Agents</Name>
        <ATC3 ID="A142004">
          <Name>Other Endocrine Agents</Name>
          <Chemical ID="C1420048200">
            <Name>Gestrinone</Name>
            <Formulation ID="F142004820001" Rank="2" Units="cap" Weight="2.5">
              <Name>Cap 2.5 mg</Name>
              <Brand ID="B14200482000100">
                <Name>Any</Name>
                <Pack ID="P82000100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1420048300">
            <Name>Metyrapone</Name>
            <Formulation ID="F142004830001" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Brand ID="B14200483000100">
                <Name>Any</Name>
                <Pack ID="P83000100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1420048347">
            <Name>Pentagastrin</Name>
            <Formulation ID="F142004834701" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 mcg per ml, 2 ml ampoule</Name>
              <Brand ID="B14200483470100">
                <Name>Any</Name>
                <Pack ID="P83470100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1420049303">
            <Name>Clomifene citrate</Name>
            <Formulation ID="F142004930325" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B14200493032527">
                <Name>Mylan Clomiphen</Name>
                <Pack ID="P2502666" Specified="true" nzmt:ctpp_id="50234241000117105">
                  <Quantity>10</Quantity>
                  <Price>29.84</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1420049650">
            <Name>Cabergoline</Name>
            <Request Form="RS1855" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Cabergoline</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Inhibition of lactation</ci>
                    <ci type="logical">Patient has hyperprolactinemia</ci>
                    <ci type="logical">Patient has acromegaly</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Indication marked with * is an unapproved indication.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1855" style="display:none"/>
            <Formulation ID="F142004965025" Rank="1" Units="tab" Weight="0.5">
              <Name>Tab 0.5 mg</Name>
              <Brand ID="B14200496502525">
                <Name>Dostinex</Name>
                <Pack ID="P275824" Specified="true" nzmt:ctpp_id="50061131000117105">
                  <Quantity>2</Quantity>
                  <Price>4.43</Price>
                </Pack>
                <Pack ID="P275840" Specified="true" nzmt:ctpp_id="50061141000117102">
                  <Quantity>8</Quantity>
                  <Price>17.94</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1424">
        <Name>Other Oestrogen Preparations</Name>
        <ATC3 ID="A142404">
          <Name>Other Oestrogen Preparations</Name>
          <Chemical ID="C1424048322">
            <Name>Oestradiol</Name>
            <Formulation ID="F142404832201" Rank="10" Units="dev">
              <Name>Implant 50 mg</Name>
              <Brand ID="B14240483220100">
                <Name>Any</Name>
                <Pack ID="P83220100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1424048325">
            <Name>Oestriol</Name>
            <Formulation ID="F142404832525" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B14240483252525" PSS="true">
                <Name>Ovestin</Name>
                <Pack ID="P767476" Specified="true" nzmt:ctpp_id="50111011000117105">
                  <Quantity>30</Quantity>
                  <Price>7.70</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1428">
        <Name>Other Progestogen Preparations</Name>
        <ATC3 ID="A142804">
          <Name>Other Progestogen Preparations</Name>
          <Chemical ID="C1428048282">
            <Name>Medroxyprogesterone</Name>
            <Formulation ID="F142804828201" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B14280482820125">
                <Name>Provera HD</Name>
                <Pack ID="P261149" Specified="true" nzmt:ctpp_id="50057491000117104">
                  <Quantity>100</Quantity>
                  <Price>133.57</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1428049435">
            <Name>Norethisterone</Name>
            <Formulation ID="F142804943525" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B14280494352525">
                <Name>Primolut N</Name>
                <Pack ID="P2607441" Specified="true" nzmt:ctpp_id="50151071000117107">
                  <Quantity>30</Quantity>
                  <Price>5.49</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1432">
        <Name>Pituitary and Hypothalamic Hormones and Analogues</Name>
        <ATC3 ID="A143202">
          <Name>Pituitary and Hypothalamic Hormones and Analogues</Name>
          <Chemical ID="C1432028117">
            <Name>Corticorelin (ovine)</Name>
            <Formulation ID="F143202811701" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mcg vial</Name>
              <Brand ID="B14320281170100">
                <Name>Any</Name>
                <Pack ID="P81170100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1432028469">
            <Name>Thyrotropin alfa</Name>
            <Formulation ID="F143202846901" Rank="4" Units="inj" Weight="900">
              <Name>Inj 900 mcg vial</Name>
              <Brand ID="B14320284690100">
                <Name>Any</Name>
                <Pack ID="P84690100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A143204">
          <Name>Adrenocorticotropic Hormones</Name>
          <Chemical ID="C1432049161">
            <Name>Tetracosactide [Tetracosactrin]</Name>
            <Formulation ID="F143204916125" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 mcg per ml, 1 ml ampoule</Name>
              <Brand ID="B14320491612525">
                <Name>Synacthen</Name>
                <Pack ID="P2444836" Specified="true" nzmt:ctpp_id="50179841000117105">
                  <Quantity>1</Quantity>
                  <Price>86.25</Price>
                </Pack>
              </Brand>
              <Brand ID="B14320491612526">
                <Name>UK Synacthen</Name>
                <Pack ID="P2587351" Specified="true" nzmt:ctpp_id="50277571000117105">
                  <Quantity>1</Quantity>
                  <Price>86.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F143204916126" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B14320491612625">
                <Name>Synacthen Depot</Name>
                <Pack ID="P281956" Specified="true" nzmt:ctpp_id="50062571000117107">
                  <Quantity>1</Quantity>
                  <Price>690.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A143208">
          <Name>GnRH Agonists and Antagonists</Name>
          <Chemical ID="C1432088071">
            <Name>Buserelin</Name>
            <Formulation ID="F143208807101" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg per ml, 5.5 ml vial</Name>
              <Brand ID="B14320880710100">
                <Name>Any</Name>
                <Pack ID="P80710100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1432088207">
            <Name>Gonadorelin</Name>
            <Formulation ID="F143208820701" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mcg vial</Name>
              <Brand ID="B14320882070100">
                <Name>Any</Name>
                <Pack ID="P82070100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1432089025">
            <Name>Goserelin</Name>
            <Formulation ID="F143208902501" Rank="4" Units="inj" Weight="10.8">
              <Name>Implant 10.8 mg, syringe</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2026" Value="5"/>
              <Brand ID="B14320890250101" PSS="true">
                <Name>Zoladex</Name>
                <Pack ID="P362107" Specified="true" nzmt:ctpp_id="50078321000117108">
                  <Quantity>1</Quantity>
                  <Price>138.23</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F143208902502" Rank="4" Units="inj" Weight="3.6">
              <Name>Implant 3.6 mg, syringe</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2026" Value="5"/>
              <Brand ID="B14320890250201" PSS="true">
                <Name>Zoladex</Name>
                <Pack ID="P678066" Specified="true" nzmt:ctpp_id="50101681000117109">
                  <Quantity>1</Quantity>
                  <Price>66.48</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1432089207">
            <Name>Leuprorelin acetate</Name>
            <Formulation ID="F143208920731" Rank="4" Units="inj" Weight="3.75">
              <Name>Inj 3.75 mg prefilled dual chamber syringe</Name>
              <Brand ID="B14320892073125">
                <Name>Lucrin Depot 1-month</Name>
                <Pack ID="P2330148" Specified="true" nzmt:ctpp_id="50049431000117108">
                  <Quantity>1</Quantity>
                  <Price>221.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F143208920732" Rank="4" Units="inj" Weight="11.25">
              <Name>Inj 11.25 mg prefilled dual chamber syringe</Name>
              <Brand ID="B14320892073225">
                <Name>Lucrin Depot 3-month</Name>
                <Pack ID="P2330156" Specified="true" nzmt:ctpp_id="50049441000117100">
                  <Quantity>1</Quantity>
                  <Price>591.68</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A143212">
          <Name>Gonadotrophins</Name>
          <Chemical ID="C1432128096">
            <Name>Choriogonadotropin alfa</Name>
            <Formulation ID="F143212809601" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 mcg in 0.5 ml syringe</Name>
              <Brand ID="B14321280960100">
                <Name>Any</Name>
                <Pack ID="P80960100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A143216">
          <Name>Growth Hormone</Name>
          <Chemical ID="C1432168441">
            <Name>Somatropin</Name>
            <Request Form="RS1826" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Somatropin</range>
              </Title>
              <Case When="Initial application" Category="growth hormone deficiency in children">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Growth hormone deficiency causing symptomatic hypoglycaemia, or
                    with other significant growth hormone deficient sequelae (e.g. cardiomyopathy,
                    hepatic dysfunction) and diagnosed with GH &lt; 5 mcg/l on at least two random
                    blood samples in the first 2 weeks of life, or from samples during established
                    hypoglycaemia (whole blood glucose &lt; 2 mmol/l using a laboratory device)</ci>
                    <apply>
                      <and/>
                      <ci type="logical">Height velocity &lt; 25th percentile for age; and adjusted
                        for bone age/pubertal status if appropriate over 6 or 12 months using the
                        standards of Tanner and Davies (1985)</ci>
                      <ci type="logical">A current bone age is &lt; 14 years (female patients) or &lt;
                        16 years (male patients)</ci>
                      <ci type="logical">Peak growth hormone value of &lt; 5.0 mcg per litre in
                        response to two different growth hormone stimulation tests. In children who
                        are 5 years or older, GH testing with sex steroid priming is required</ci>
                      <ci type="logical">If the patient has been treated for a malignancy, they should
                        be disease free for at least one year based upon follow-up laboratory and
                        radiological imaging appropriate for the malignancy, unless there are strong
                        medical reasons why this is either not necessary or appropriate</ci>
                      <ci type="logical">Appropriate imaging of the pituitary gland has been
                        obtained</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>endocrinologist</Applicant>
                <Applicant>paediatric endocrinologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="growth hormone deficiency in children">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">A current bone age is 14 years or under (female patients) or 16
                    years or under (male patients)</ci>
                    <ci type="logical">Height velocity is greater than or equal to 25th percentile for
                    age (adjusted for bone age/pubertal status if appropriate) while on growth
                    hormone treatment, as calculated over six months using the standards of Tanner
                    and Davis (1985)</ci>
                    <ci type="logical">Height velocity is greater than or equal to 2.0 cm per year, as
                    calculated over 6 months</ci>
                    <ci type="logical">No serious adverse effect that the patients specialist considers
                    is likely to be attributable to growth hormone treatment has occurred</ci>
                    <ci type="logical">No malignancy has developed since starting growth hormone</ci>
                  </apply>
                </math>
                <Applicant>endocrinologist</Applicant>
                <Applicant>paediatric endocrinologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="Turner syndrome">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has a post-natal genotype confirming Turner
                    Syndrome</ci>
                    <ci type="logical">Height velocity is &lt; 25th percentile over 6-12 months using
                    the standards of Tanner and Davies (1985)</ci>
                    <ci type="logical">A current bone age is &lt; 14 years</ci>
                  </apply>
                </math>
                <Applicant>endocrinologist</Applicant>
                <Applicant>paediatric endocrinologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="Turner syndrome">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Height velocity greater than or equal to 50th percentile for age
                    (while on growth hormone calculated over 6 to 12 months using the Ranke’s
                    Turner Syndrome growth velocity charts)</ci>
                    <ci type="logical">Height velocity is greater than or equal to 2 cm per year,
                    calculated over six months</ci>
                    <ci type="logical">A current bone age is 14 years or under</ci>
                    <ci type="logical">No serious adverse effect that the specialist considers is likely
                    to be attributable to growth hormone treatment has occurred</ci>
                    <ci type="logical">No malignancy has developed since starting growth hormone</ci>
                  </apply>
                </math>
                <Applicant>endocrinologist</Applicant>
                <Applicant>paediatric endocrinologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="short stature without growth hormone deficiency">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient’s height is more than 3 standard deviations
                    below the mean for age or for bone age if there is marked growth acceleration or
                    delay</ci>
                    <ci type="logical">Height velocity is &lt; 25th percentile for age (adjusted for
                    bone age/pubertal status if appropriate), as calculated over 6 to 12 months
                    using the standards of Tanner and Davies(1985)</ci>
                    <ci type="logical">A current bone age is &lt; 14 years (female patients) or &lt; 16
                    years (male patients)</ci>
                    <ci type="logical">The patient does not have severe chronic disease (including
                    malignancy or recognized severe skeletal dysplasia) and is not receiving
                    medications known to impair height velocity</ci>
                  </apply>
                </math>
                <Applicant>endocrinologist</Applicant>
                <Applicant>paediatric endocrinologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="short stature without growth hormone deficiency">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Height velocity is greater than or equal to 50th percentile
                    (adjusted for bone age/pubertal status if appropriate) as calculated over 6 to
                    12 months using the standards of Tanner and Davies (1985)</ci>
                    <ci type="logical">Height velocity is greater than or equal to 2 cm per year as
                    calculated over six months</ci>
                    <ci type="logical">Current bone age is 14 years or under (female patients) or 16
                    years or under (male patients)</ci>
                    <ci type="logical">No serious adverse effect that the patient’s specialist
                    considers is likely to be attributable to growth hormone treatment has
                    occurred</ci>
                  </apply>
                </math>
                <Applicant>endocrinologist</Applicant>
                <Applicant>paediatric endocrinologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="short stature due to chronic renal insufficiency">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient’s height is more than 2 standard deviations
                    below the mean</ci>
                    <ci type="logical">Height velocity is &lt; 25th percentile (adjusted for bone
                    age/pubertal status if appropriate) as calculated over 6 to 12 months using the
                    standards of Tanner and Davies (1985)</ci>
                    <ci type="logical">A current bone age is to 14 years or under (female patients) or
                    to 16 years or under (male patients)</ci>
                    <ci type="logical">The patient is metabolically stable, has no evidence of metabolic
                    bone disease and absence of any other severe chronic disease</ci>
                    <ci type="logical">The patient is under the supervision of a specialist with
                    expertise in renal medicine</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has a GFR less than or equal to 30 ml/min/1.73
                        m² as measured by the Schwartz method (Height(cm)/plasma creatinine
                        (umol/l x 40 = corrected GFR (ml/min/1.73 m² ) in a child who may or
                        may not be receiving dialysis</ci>
                      <ci type="logical">The patient has received a renal transplant and has received
                        &lt; 5mg/ m² /day of prednisone or equivalent for at least 6
                        months</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>endocrinologist</Applicant>
                <Applicant>paediatric endocrinologist</Applicant>
                <Applicant Referring="endocrinologist or paediatric endocrinologist">renal physician</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="short stature due to chronic renal insufficiency">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Height velocity is greater than or equal to 50th percentile
                    (adjusted for bone age/pubertal status if appropriate) as calculated over 6 to
                    12 months using the standards of Tanner and Davies (1985)</ci>
                    <ci type="logical">Height velocity is greater than or equal to 2 cm per year as
                    calculated over six months</ci>
                    <ci type="logical">A current bone age is 14 years or under (female patients) or 16
                    years or under (male patients)</ci>
                    <ci type="logical">No serious adverse effect that the patients specialist considers
                    is likely to be attributable to growth hormone has occurred</ci>
                    <ci type="logical">No malignancy has developed after growth hormone therapy was
                    commenced</ci>
                    <ci type="logical">The patient has not experienced significant biochemical or
                    metabolic deterioration confirmed by diagnostic results</ci>
                    <ci type="logical">The patient has not received renal transplantation since starting
                    growth hormone treatment</ci>
                    <ci type="logical">If the patient requires transplantation, growth hormone
                    prescription should cease before transplantation and a new application should be
                    made after transplantation based on the above criteria</ci>
                  </apply>
                </math>
                <Applicant>endocrinologist</Applicant>
                <Applicant>paediatric endocrinologist</Applicant>
                <Applicant Referring="endocrinologist or paediatric endocrinologist">renal physician</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="Prader-Willi syndrome">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has a diagnosis of Prader-Willi syndrome that has
                    been confirmed by genetic testing or clinical scoring criteria</ci>
                    <ci type="logical">The patient is aged six months or older</ci>
                    <ci type="logical">A current bone age is &lt; 14 years (female patients) or &lt; 16
                    years (male patients)</ci>
                    <ci type="logical">Sleep studies or overnight oximetry have been performed and there
                    is no obstructive sleep disorder requiring treatment, or if an obstructive sleep
                    disorder is found, it has been adequately treated under the care of a paediatric
                    respiratory physician and/or ENT surgeon</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">The patient is aged two years or older</ci>
                        <ci type="logical">There is no evidence of type II diabetes or uncontrolled
                            obesity defined by BMI that has increased by greater than or equal to
                            0.5 standard deviations in the preceding 12 months</ci>
                      </apply>
                      <ci type="logical">The patient is aged between six months and two years and a
                        thorough upper airway assessment is planned to be undertaken prior to
                        treatment commencement and at six to 12 weeks following treatment
                        initiation</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>endocrinologist</Applicant>
                <Applicant>paediatric endocrinologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="Prader-Willi syndrome">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Height velocity is greater than or equal to 50th percentile
                    (adjusted for bone age/pubertal status if appropriate) as calculated over 6 to
                    12 months using the standards of Tanner and Davies (1985)</ci>
                    <ci type="logical">Height velocity is greater than or equal to 2 cm per year as
                    calculated over six months</ci>
                    <ci type="logical">A current bone age is 14 years or under (female patients) or 16
                    years or under (male patients)</ci>
                    <ci type="logical">No serious adverse effect that the patient’s specialist
                    con siders is likely to be attributable to growth hormone treatment has
                    occurred</ci>
                    <ci type="logical">No malignancy has developed after growth hormone therapy was
                    commenced</ci>
                    <ci type="logical">The patient has not developed type II diabetes or uncontrolled
                    obesity as defined by BMI that has increased by greater than or equal to 0.5
                    standard deviations in the preceding 12 months</ci>
                  </apply>
                </math>
                <Applicant>endocrinologist</Applicant>
                <Applicant>paediatric endocrinologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="adults and adolescents">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has a medical condition that is known to cause growth
                    hormone deficiency (e.g. surgical removal of the pituitary for treatment of a
                    pituitary tumour)</ci>
                    <ci type="logical">The patient has undergone appropriate treatment of other hormonal
                    deficiencies and psychological illnesses</ci>
                    <ci type="logical">The patient has severe growth hormone deficiency (see notes)</ci>
                    <ci type="logical">The patient’s serum IGF-I is more than 1 standard
                    deviation below the mean for age and sex</ci>
                    <ci type="logical">The patient has poor quality of life, as defined by a score of 16
                    or more using the disease-specific quality of life questionnaire for adult
                    growth hormone deficiency (QoL-AGHDA®)</ci>
                  </apply>
                </math>
                <Applicant>endocrinologist</Applicant>
                <Applicant>paediatric endocrinologist</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>For the purposes of adults and adolescents, severe growth hormone deficiency is
                defined as a peak serum growth hormone level of less than or equal to 3 mcg per
                litre during an adequately performed insulin tolerance test (ITT) or glucagon
                stimulation test.</p>
                  <p>Patients with one or more additional anterior pituitary hormone deficiencies and a
                known structural pituitary lesion only require one test. Patients with isolated
                growth hormone deficiency require two growth hormone stimulation tests, of which,
                one should be ITT unless otherwise contraindicated. Where an additional test is
                required, an arginine provocation test can be used with a peak serum growth hormone
                level of less than or equal to 0.4 mcg per litre.</p>
                  <p>The dose of somatropin should be started at 0.2 mg daily and be titrated by 0.1 mg
                monthly until it is within 1 standard deviation of the mean normal value for age and
                sex; and</p>
                  <p>The dose of somatropin not to exceed 0.7 mg per day for male patients, or 1 mg per
                day for female patients.</p>
                  <p>At the commencement of treatment for hypopituitarism, patients must be monitored for
                any required adjustment in replacement doses of corticosteroid and
                levothyroxine.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="adults and adolescents">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has been treated with somatropin for &lt; 12
                        months</ci>
                      <ci type="logical">There has been an improvement in the Quality of Life
                        Assessment defined as a reduction of at least 8 points on the Quality of
                        Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA®)
                        score from baseline</ci>
                      <ci type="logical">Serum IGF-I levels have increased to within ±1SD of the
                        mean of the normal range for age and sex</ci>
                      <ci type="logical">The dose of somatropin does not exceed 0.7 mg per day for
                        male patients, or 1 mg per day for female patients</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has been treated with somatropin for more than 12
                        months</ci>
                      <ci type="logical">The patient has not had a deterioration in Quality of Life
                        defined as a 6 point or greater increase from their lowest QoL-AGHDA®
                        score on treatment (other than due to obvious external factors such as
                        external stressors)</ci>
                      <ci type="logical">Serum IGF-I levels have continued to be maintained within
                        ±1SD of the mean of the normal range for age and sex (other than for
                        obvious external factors)</ci>
                      <ci type="logical">The dose of somatropin has not exceeded 0.7 mg per day for
                        male patients or 1 mg per day for female patients</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has had a Special Authority approval for somatropin for childhood deficiency in children and no longer meets the renewal criteria under this indication</ci>
                      <ci type="logical">The patient has undergone appropriate treatment of other hormonal deficiencies and psychological illnesses</ci>
                      <ci type="logical">The patient has severe growth hormone deficiency (see notes)</ci>
                      <ci type="logical">The patient's serum IGF-I is more than 1 standard deviation below the mean for age and sex</ci>
                      <ci type="logical">The patient has poor quality of life, as defined by a score of 16 or more using the disease-specific quality of life questionnaire for adult growth hormone deficiency (QoL-AGHDA®)</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>endocrinologist</Applicant>
                <Applicant>paediatric endocrinologist</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>For the purposes of adults and adolescents, severe growth hormone deficiency is
                defined as a peak serum growth hormone level of less than or equal to 3 mcg per
                litre during an adequately performed insulin tolerance test (ITT) or glucagon
                stimulation test.</p>
                  <p>Patients with one or more additional anterior pituitary hormone deficiencies and a
                known structural pituitary lesion only require one test. Patients with isolated
                growth hormone deficiency require two growth hormone stimulation tests, of which,
                one should be ITT unless otherwise contraindicated. Where an additional test is
                required, an arginine provocation test can be used with a peak serum growth hormone
                level of less than or equal to 0.4 mcg per litre.</p>
                  <p>The dose of somatropin should be started at 0.2 mg daily and be titrated by 0.1 mg
                monthly until the serum IGF-I is within 1 standard deviation of the mean normal value for age and
                sex; and</p>
                  <p>The dose of somatropin not to exceed 0.7 mg per day for male patients, or 1 mg per
                day for female patients.</p>
                  <p>At the commencement of treatment for hypopituitarism, patients must be monitored for
                any required adjustment in replacement doses of corticosteroid and
                levothyroxine.</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1826" style="display:none"/>
            <Formulation ID="F143216844125" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg cartridge</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B14321684412525" PSS="true">
                <Name>Omnitrope</Name>
                <Pack ID="P2461536" Specified="true" nzmt:ctpp_id="50166511000117105">
                  <Quantity>1</Quantity>
                  <Price>80.21</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F143216844126" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg cartridge</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B14321684412625" PSS="true">
                <Name>Omnitrope</Name>
                <Pack ID="P2461528" Specified="true" nzmt:ctpp_id="50166521000117104">
                  <Quantity>1</Quantity>
                  <Price>80.21</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F143216844127" Rank="4" Units="inj" Weight="15">
              <Name>Inj 15 mg cartridge</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B14321684412725" PSS="true">
                <Name>Omnitrope</Name>
                <Pack ID="P2461501" Specified="true" nzmt:ctpp_id="50166531000117101">
                  <Quantity>1</Quantity>
                  <Price>139.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1436">
        <Name>Thyroid and Antithyroid Preparations</Name>
        <ATC3 ID="A143604">
          <Name>Thyroid and Antithyroid Preparations</Name>
          <Chemical ID="C1436048076">
            <Name>Carbimazole</Name>
            <Formulation ID="F143604807601" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Sep-22 to~2025" Value="5"/>
              <Brand ID="B14360480760125" PSS="true">
                <Name>Neo-Mercazole</Name>
                <Pack ID="P594423" Specified="true" nzmt:ctpp_id="50097891000117106">
                  <Quantity>100</Quantity>
                  <Price>7.56</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1436048240">
            <Name>Iodine</Name>
            <Formulation ID="F143604824001" Rank="3" Units="ml">
              <Name>Soln BP 50 mg per ml</Name>
              <Brand ID="B14360482400100">
                <Name>Any</Name>
                <Pack ID="P82400100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1436048258">
            <Name>Levothyroxine</Name>
            <Formulation ID="F143604825801" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mcg</Name>
              <Brand ID="B14360482580100">
                <Name>Any</Name>
                <Pack ID="P82580100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F143604825802" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mcg</Name>
              <Brand ID="B14360482580200">
                <Name>Any</Name>
                <Pack ID="P82580200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F143604825803" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mcg</Name>
              <Brand ID="B14360482580300">
                <Name>Any</Name>
                <Pack ID="P82580300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1436048264">
            <Name>Liothyronine sodium</Name>
            <Formulation ID="F143604826401" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mcg vial</Name>
              <Brand ID="B14360482640100">
                <Name>Any</Name>
                <Pack ID="P82640100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F143604826425" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mcg</Name>
              <Request Form="RS1301" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Liothyronine sodium - Tab 20 mcg</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">For a maximum of 14 days' treatment in patients with thyroid cancer who are due to receive radioiodine therapy</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1301" style="display:none"/>
              <Brand ID="B14360482642500">
                <Name>Any</Name>
                <Pack ID="P82642500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F143604826426" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mcg vial</Name>
              <Brand ID="B14360482642600">
                <Name>Any</Name>
                <Pack ID="P82642600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1436048376">
            <Name>Potassium iodate</Name>
            <Formulation ID="F143604837625" Rank="1" Units="tab">
              <Name>Tab 170 mg</Name>
              <Brand ID="B14360483762500">
                <Name>Any</Name>
                <Pack ID="P83762500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1436048378">
            <Name>Potassium perchlorate</Name>
            <Formulation ID="F143604837801" Rank="2" Units="cap" Weight="200">
              <Name>Cap 200 mg</Name>
              <Brand ID="B14360483780100">
                <Name>Any</Name>
                <Pack ID="P83780100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1436048398">
            <Name>Protirelin</Name>
            <Formulation ID="F143604839801" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mcg per ml, 2 ml ampoule</Name>
              <Brand ID="B14360483980100">
                <Name>Any</Name>
                <Pack ID="P83980100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1436049644">
            <Name>Propylthiouracil</Name>
            <Request Form="RS1276" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Propylthiouracil</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has hyperthyroidism</ci>
                    <ci type="logical">The patient is intolerant of carbimazole or carbimazole is contraindicated</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1276" style="display:none"/>
            <Formulation ID="F143604964425" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B14360496442525">
                <Name>PTU</Name>
                <Pack ID="P2010526" Specified="true" nzmt:ctpp_id="50130871000117105">
                  <Quantity>100</Quantity>
                  <Price>35.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1440">
        <Name>Vasopressin Agents</Name>
        <ATC3 ID="A144004">
          <Name>Vasopressin Agents</Name>
          <Chemical ID="C1440048037">
            <Name>Argipressin [Vasopressin]</Name>
            <Formulation ID="F144004803701" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 u per ml, 1 ml ampoule</Name>
              <Brand ID="B14400480370100">
                <Name>Any</Name>
                <Pack ID="P80370100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1440048662">
            <Name>Desmopressin</Name>
            <Formulation ID="F144004866225" Rank="1" Units="tab" Weight="120">
              <Name>Wafer 120 mcg</Name>
              <Brand ID="B14400486622525">
                <Name>Minirin Melt</Name>
                <Pack ID="P2603268" Specified="true" nzmt:ctpp_id="50128971000117102">
                  <Quantity>30</Quantity>
                  <Price>47.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1440049248">
            <Name>Desmopressin acetate</Name>
            <Formulation ID="F144004924801" Rank="4" Units="inj" Weight="15">
              <Name>Inj 15 mcg per ml, 1 ml ampoule</Name>
              <Brand ID="B14400492480100">
                <Name>Any</Name>
                <Pack ID="P92480100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F144004924802" Rank="4" Units="inj" Weight="4">
              <Name>Inj 4 mcg per ml, 1 ml ampoule</Name>
              <Brand ID="B14400492480200">
                <Name>Any</Name>
                <Pack ID="P92480200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F144004924803" Rank="6" Units="dose">
              <Name>Nasal drops 100 mcg per ml</Name>
              <Brand ID="B14400492480300">
                <Name>Any</Name>
                <Pack ID="P92480300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F144004924825" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mcg</Name>
              <Brand ID="B14400492482525">
                <Name>Minirin</Name>
                <Pack ID="P492620" Specified="true" nzmt:ctpp_id="50091971000117108">
                  <Quantity>30</Quantity>
                  <Price>25.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F144004924826" Rank="3" Units="ml">
              <Name>Nasal spray 10 mcg per dose</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B14400492482625" PSS="true">
                <Name>Desmopressin-PH&amp;T</Name>
                <Pack ID="P2198231" Specified="true" nzmt:ctpp_id="50031711000117108">
                  <Quantity>6</Quantity>
                  <Price>34.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F144004924827" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mcg</Name>
              <Brand ID="B14400492482725">
                <Name>Minirin</Name>
                <Pack ID="P492639" Specified="true" nzmt:ctpp_id="50091981000117106">
                  <Quantity>30</Quantity>
                  <Price>54.45</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1440049457">
            <Name>Terlipressin</Name>
            <Formulation ID="F144004945727" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg per 8.5 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B14400494572725" ToBeDelisted="2025-02-01">
                <Name>Glypressin</Name>
                <Pack ID="P2468026" Specified="true" nzmt:ctpp_id="50045471000117108">
                  <Quantity>5</Quantity>
                  <Price>215.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B14400494572726" PSS="true">
                <Name>Terlipressin Ever Pharma</Name>
                <Pack ID="P2689359" Specified="true" nzmt:ctpp_id="50267001000117101">
                  <Quantity>5</Quantity>
                  <Price>110.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
    <ATC1 ID="A16">
      <Name>Infections</Name>
      <ATC2 ID="A1604">
        <Name>Antibacterials</Name>
        <ATC3 ID="A160404">
          <Name>Aminoglycosides</Name>
          <Chemical ID="C1604048447">
            <Name>Streptomycin sulphate</Name>
            <Request Form="RS1043" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Streptomycin sulphate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1043" style="display:none"/>
            <Formulation ID="F160404844701" Rank="4" Units="inj" Weight="400">
              <Name>Inj 400 mg per ml, 2.5 ml ampoule</Name>
              <Brand ID="B16040484470100">
                <Name>Any</Name>
                <Pack ID="P84470100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604049117">
            <Name>Gentamicin sulphate</Name>
            <Formulation ID="F160404911701" Rank="4" Units="inj" Weight="80">
              <Name>Inj 40 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B16040491170101">
                <Name>Pfizer</Name>
                <Pack ID="P771740" Specified="true" nzmt:ctpp_id="50111891000117109">
                  <Quantity>10</Quantity>
                  <Price>18.38</Price>
                </Pack>
              </Brand>
              <Brand ID="B16040491170125">
                <Name>Gentamicin Noridem</Name>
                <Pack ID="P2687429" Specified="true" nzmt:ctpp_id="50339001000117107">
                  <Quantity>50</Quantity>
                  <Price>91.90</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160404911725" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B16040491172525">
                <Name>DBL Gentamicin</Name>
                <Pack ID="P619272" Specified="true" nzmt:ctpp_id="50099521000117102">
                  <Quantity>5</Quantity>
                  <Price>95.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604049129">
            <Name>Amikacin</Name>
            <Request Form="RS1041" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Amikacin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1041" style="display:none"/>
            <Formulation ID="F160404912901" Rank="4" Units="inj" Weight="15">
              <Name>Inj 15 mg per ml, 5 ml syringe</Name>
              <Brand ID="B16040491290100">
                <Name>Any</Name>
                <Pack ID="P91290100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160404912902" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 mg per ml, 2 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B16040491290225" PSS="true">
                <Name>DBL Amikacin</Name>
                <Pack ID="P2572214" Specified="true" nzmt:ctpp_id="50087701000117108">
                  <Quantity>5</Quantity>
                  <Price>169.97</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160404912903" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 10 ml syringe</Name>
              <Brand ID="B16040491290300">
                <Name>Any</Name>
                <Pack ID="P91290300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160404912926" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 5 ml syringe</Name>
              <Brand ID="B16040491292625">
                <Name>Biomed</Name>
                <Pack ID="P2161044" Specified="true" nzmt:ctpp_id="50027311000117100">
                  <Quantity>1</Quantity>
                  <Price>21.43</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604049280">
            <Name>Tobramycin</Name>
            <Formulation ID="F160404928001" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg per ml, 5 ml vial</Name>
              <Request Form="RS1044" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Tobramycin</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">No patient criteria</ci>
                  </math>
                  <Applicant>clinical microbiologist</Applicant>
                  <Applicant>infectious disease specialist</Applicant>
                  <Applicant>respiratory specialist</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1044" style="display:none"/>
              <Brand ID="B16040492800100">
                <Name>Any</Name>
                <Pack ID="P92800100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160404928025" Rank="4" Units="inj" Weight="80">
              <Name>Inj 40 mg per ml, 2 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Request Form="RS1044" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Tobramycin</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">No patient criteria</ci>
                  </math>
                  <Applicant>clinical microbiologist</Applicant>
                  <Applicant>infectious disease specialist</Applicant>
                  <Applicant>respiratory specialist</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1044" style="display:none"/>
              <Brand ID="B16040492802527" PSS="true">
                <Name>Tobramycin (Viatris)</Name>
                <Pack ID="P2635690" Specified="true" nzmt:ctpp_id="50290891000117101">
                  <Quantity>5</Quantity>
                  <Price>15.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160404928028" Rank="6" Units="dose">
              <Name>Solution for inhalation 60 mg per ml, 5 ml</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Request Form="RS1435" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Tobramycin Solution for inhalation 60 mg per ml, 5 ml</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">Patient has cystic fibrosis</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1435" style="display:none"/>
              <Brand ID="B16040492802826" PSS="true">
                <Name>Tobramycin BNM</Name>
                <Pack ID="P2601648" Specified="true" nzmt:ctpp_id="50257571000117107">
                  <Quantity>56</Quantity>
                  <Price>395.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160404928029" Rank="3" Units="g">
              <Name>Powder</Name>
              <Request Form="RS1475" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Tobramcyin</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">For addition to orthopaedic bone cement</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1475" style="display:none"/>
              <Brand ID="B16040492802900">
                <Name>Any</Name>
                <Pack ID="P92802900" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604049685">
            <Name>Paromomycin</Name>
            <Request Form="RS1603" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Paromomycin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>gastroenterologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1603" style="display:none"/>
            <Formulation ID="F160404968525" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Brand ID="B16040496852525">
                <Name>Humatin</Name>
                <Pack ID="P2434652" Specified="true" nzmt:ctpp_id="50164581000117106">
                  <Quantity>16</Quantity>
                  <Price>126.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A160408">
          <Name>Carbapenems</Name>
          <Chemical ID="C1604089199">
            <Name>Imipenem with cilastatin</Name>
            <Request Form="RS1046" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Imipenem with cilastatin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1046" style="display:none"/>
            <Formulation ID="F160408919925" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg with 500 mg cilastatin vial</Name>
              <Brand ID="B16040891992526">
                <Name>Imipenem+Cilastatin RBX</Name>
                <Pack ID="P2469553" Specified="true" nzmt:ctpp_id="50137551000117103">
                  <Quantity>1</Quantity>
                  <Price>60.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604089348">
            <Name>Ertapenem</Name>
            <Request Form="RS1045" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ertapenem</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1045" style="display:none"/>
            <Formulation ID="F160408934825" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1 g vial</Name>
              <Brand ID="B16040893482525">
                <Name>Invanz</Name>
                <Pack ID="P2060116" Specified="true" nzmt:ctpp_id="50010701000117107">
                  <Quantity>1</Quantity>
                  <Price>70.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604089434">
            <Name>Meropenem</Name>
            <Request Form="RS1047" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Meropenem</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1047" style="display:none"/>
            <Formulation ID="F160408943425" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B16040894342529" PSS="true">
                <Name>Meropenem-AFT</Name>
                <Pack ID="P2591308" Specified="true" nzmt:ctpp_id="50232151000117105">
                  <Quantity>10</Quantity>
                  <Price>33.48</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160408943426" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1 g vial</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B16040894342629" PSS="true">
                <Name>Meropenem-AFT</Name>
                <Pack ID="P2591316" Specified="true" nzmt:ctpp_id="50232141000117108">
                  <Quantity>10</Quantity>
                  <Price>44.97</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A160412">
          <Name>Cephalosporins and Cephamycins - 1st Generation</Name>
          <Chemical ID="C1604129146">
            <Name>Cefazolin</Name>
            <Formulation ID="F160412914625" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B16041291462528" PSS="true">
                <Name>Cefazolin-AFT</Name>
                <Pack ID="P2391325" Specified="true" nzmt:ctpp_id="50125781000117108">
                  <Quantity>5</Quantity>
                  <Price>3.39</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160412914626" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1 g vial</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B16041291462627" PSS="true">
                <Name>Cefazolin-AFT</Name>
                <Pack ID="P2391317" Specified="true" nzmt:ctpp_id="50125771000117105">
                  <Quantity>5</Quantity>
                  <Price>3.59</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160412914627" Rank="4" Units="inj" Weight="2000">
              <Name>Inj 2 g vial</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B16041291462725" PSS="true">
                <Name>Cefazolin-AFT</Name>
                <Pack ID="P2662876" Specified="true" nzmt:ctpp_id="50228761000117106">
                  <Quantity>5</Quantity>
                  <Price>7.09</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604129513">
            <Name>Cefalexin</Name>
            <Formulation ID="F160412951325" Rank="3" Units="ml" Weight="125">
              <Name>Grans for oral liq 25 mg per ml</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B16041295132526" PSS="true">
                <Name>Flynn</Name>
                <Pack ID="P2640481" Specified="true" nzmt:ctpp_id="50274621000117100">
                  <Quantity>100</Quantity>
                  <Price>7.88</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160412951326" Rank="3" Units="ml" Weight="250">
              <Name>Grans for oral liq 50 mg per ml</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B16041295132625">
                <Name>Cefalexin Sandoz</Name>
                <Pack ID="P2332825" Specified="true" nzmt:ctpp_id="50049531000117107">
                  <Quantity>100</Quantity>
                  <Price>11.75</Price>
                </Pack>
              </Brand>
              <Brand ID="B16041295132626" PSS="true">
                <Name>Flynn</Name>
                <Pack ID="P2640503" Specified="true" nzmt:ctpp_id="50274631000117102">
                  <Quantity>100</Quantity>
                  <Price>10.38</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160412951327" Rank="2" Units="cap" Weight="500">
              <Name>Cap 500 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B16041295132725" PSS="true">
                <Name>Cephalexin ABM</Name>
                <Pack ID="P2361248" Specified="true" nzmt:ctpp_id="50050991000117107">
                  <Quantity>20</Quantity>
                  <Price>5.85</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160412951328" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B16041295132825" PSS="true">
                <Name>Cephalexin ABM</Name>
                <Pack ID="P2498871" Specified="true" nzmt:ctpp_id="50231821000117101">
                  <Quantity>20</Quantity>
                  <Price>3.85</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A160416">
          <Name>Cephalosporins and Cephamycins - 2nd Generation</Name>
          <Chemical ID="C1604168085">
            <Name>Cefuroxime</Name>
            <Formulation ID="F160416808501" Rank="4" Units="inj" Weight="1500">
              <Name>Inj 1.5 g vial</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B16041680850129" PSS="true">
                <Name>Cefuroxime Devatis</Name>
                <Pack ID="P2664909" Specified="true" nzmt:ctpp_id="50322441000117109">
                  <Quantity>10</Quantity>
                  <Price>13.01</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160416808502" Rank="4" Units="inj" Weight="750">
              <Name>Inj 750 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B16041680850229" PSS="true">
                <Name>Cefuroxime Devatis</Name>
                <Pack ID="P2664895" Specified="true" nzmt:ctpp_id="50322311000117102">
                  <Quantity>10</Quantity>
                  <Price>8.16</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160416808503" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B16041680850300">
                <Name>Any</Name>
                <Pack ID="P80850300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604169144">
            <Name>Cefaclor</Name>
            <Formulation ID="F160416914425" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B16041691442525" PSS="true">
                <Name>Ranbaxy-Cefaclor</Name>
                <Pack ID="P2149389" Specified="true" nzmt:ctpp_id="50025801000117104">
                  <Quantity>100</Quantity>
                  <Price>25.85</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160416914426" Rank="3" Units="ml" Weight="125">
              <Name>Grans for oral liq 25 mg per ml</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B16041691442625" PSS="true">
                <Name>Ranbaxy-Cefaclor</Name>
                <Pack ID="P471674" Specified="true" nzmt:ctpp_id="50088741000117109">
                  <Quantity>100</Quantity>
                  <Price>3.75</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604169352">
            <Name>Cefoxitin</Name>
            <Formulation ID="F160416935225" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 g vial</Name>
              <Brand ID="B16041693522500">
                <Name>Any</Name>
                <Pack ID="P93522500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A160420">
          <Name>Cephalosporins and Cephamycins - 3rd Generation</Name>
          <Chemical ID="C1604209010">
            <Name>Cefotaxime</Name>
            <Formulation ID="F160420901001" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1 g vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B16042090100125" PSS="true">
                <Name>DBL Cefotaxime</Name>
                <Pack ID="P2389762" Specified="true" nzmt:ctpp_id="50125261000117109">
                  <Quantity>10</Quantity>
                  <Price>38.98</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160420901003" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg vial</Name>
              <Brand ID="B16042090100325">
                <Name>Cefotaxime Sandoz</Name>
                <Pack ID="P2293269" Specified="true" nzmt:ctpp_id="50045031000117103">
                  <Quantity>1</Quantity>
                  <Price>1.90</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604209011">
            <Name>Ceftazidime</Name>
            <Request Form="RS1048" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ceftazadime</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1048" style="display:none"/>
            <Formulation ID="F160420901104" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1 g vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B16042090110428" PSS="true">
                <Name>Ceftazidime Kabi</Name>
                <Pack ID="P2581183" Specified="true" nzmt:ctpp_id="50251251000117108">
                  <Quantity>10</Quantity>
                  <Price>25.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604209012">
            <Name>Ceftriaxone</Name>
            <Formulation ID="F160420901201" Rank="4" Units="inj" Weight="2000">
              <Name>Inj 2 g vial</Name>
              <Rule Type="DVLimit" Attribute="Aug-23 to~2025" Value="5"/>
              <Brand ID="B16042090120126" PSS="true">
                <Name>Ceftriaxone-AFT</Name>
                <Pack ID="P2653273" Specified="true" nzmt:ctpp_id="50210991000117108">
                  <Quantity>5</Quantity>
                  <Price>7.85</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160420901202" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1 g vial</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B16042090120226" PSS="true">
                <Name>Ceftriaxone-AFT</Name>
                <Pack ID="P2428644" Specified="true" nzmt:ctpp_id="50133641000117109">
                  <Quantity>5</Quantity>
                  <Price>3.59</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160420901205" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B16042090120526" PSS="true">
                <Name>Ceftriaxone-AFT</Name>
                <Pack ID="P2400820" Specified="true" nzmt:ctpp_id="50085571000117100">
                  <Quantity>1</Quantity>
                  <Price>0.79</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A160424">
          <Name>Cephalosporins and Cephamycins - 4th Generation</Name>
          <Chemical ID="C1604249247">
            <Name>Cefepime</Name>
            <Request Form="RS1049" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Cefepime</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1049" style="display:none"/>
            <Formulation ID="F160424924727" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 g vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B16042492472726" PSS="true">
                <Name>Cefepime-AFT</Name>
                <Pack ID="P2437066" Specified="true" nzmt:ctpp_id="50178981000117103">
                  <Quantity>1</Quantity>
                  <Price>3.19</Price>
                </Pack>
              </Brand>
              <Brand ID="B16042492472727" ToBeDelisted="2024-12-01">
                <Name>Cefepime Kabi</Name>
                <Pack ID="P2603381" Specified="true" nzmt:ctpp_id="50250201000117101">
                  <Quantity>10</Quantity>
                  <Price>35.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160424924728" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2 g vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B16042492472826" PSS="true">
                <Name>Cefepime-AFT</Name>
                <Pack ID="P2437074" Specified="true" nzmt:ctpp_id="50179011000117102">
                  <Quantity>1</Quantity>
                  <Price>4.99</Price>
                </Pack>
              </Brand>
              <Brand ID="B16042492472827" ToBeDelisted="2024-12-01">
                <Name>Cefepime Kabi</Name>
                <Pack ID="P2603411" Specified="true" nzmt:ctpp_id="50250211000117103">
                  <Quantity>10</Quantity>
                  <Price>55.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A160425">
          <Name>Cephalosporins and Cephamycins - 5th Generation</Name>
          <Chemical ID="C1604258563">
            <Name>Ceftaroline fosamil</Name>
            <Request Form="RS1446" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ceftaroline</range>
              </Title>
              <Case When="Initial application" Category="multi-resistant organisn salvage therapy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">for patients where alternative therapies have failed</ci>
                    <ci type="logical">for patients who have a contraindication or hypersensitivity to standard current therapies</ci>
                  </apply>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1446" style="display:none"/>
            <Formulation ID="F160425856325" Rank="4" Units="inj" Weight="600">
              <Name>Inj 600 mg vial</Name>
              <Brand ID="B16042585632525">
                <Name>Zinforo</Name>
                <Pack ID="P2469669" Specified="true" nzmt:ctpp_id="50207221000117103">
                  <Quantity>10</Quantity>
                  <Price>1834.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A160428">
          <Name>Macrolides</Name>
          <Chemical ID="C1604288169">
            <Name>Erythromycin (as stearate)</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F160428816901" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B16042881690100">
                <Name>Any</Name>
                <Pack ID="P81690100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160428816902" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Brand ID="B16042881690200">
                <Name>Any</Name>
                <Pack ID="P81690200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604289176">
            <Name>Roxithromycin</Name>
            <Request Form="RS1569" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Roxithromycin tab dispersible 50 mg</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Only for use in patients under 12 years of age</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Some items restricted" xlink:href="RS1569" style="display:none"/>
            <Formulation ID="F160428917625" Rank="1" Units="tab" Weight="150">
              <Name>Tab 150 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-23 to~2026" Value="5"/>
              <Brand ID="B16042891762526" PSS="true">
                <Name>Arrow-Roxithromycin</Name>
                <Pack ID="P2246236" Specified="true" nzmt:ctpp_id="50039301000117105">
                  <Quantity>50</Quantity>
                  <Price>13.19</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160428917626" Rank="1" Units="tab" Weight="300">
              <Name>Tab 300 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-23 to~2026" Value="5"/>
              <Brand ID="B16042891762626" PSS="true">
                <Name>Arrow-Roxithromycin</Name>
                <Pack ID="P2246228" Specified="true" nzmt:ctpp_id="50039291000117109">
                  <Quantity>50</Quantity>
                  <Price>25.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160428917627" Rank="1" Units="tab" Weight="50">
              <Name>Tab dispersible 50 mg</Name>
              <html:div class="Restricted item" xlink:href="RS1569" style="display:none"/>
              <Brand ID="B16042891762700">
                <Name>Any</Name>
                <Pack ID="P91762700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604289184">
            <Name>Erythromycin (as lactobionate)</Name>
            <Formulation ID="F160428918425" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1 g vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B16042891842526" PSS="true">
                <Name>Erythrocin IV</Name>
                <Pack ID="P2270234" Specified="true" nzmt:ctpp_id="50042201000117109">
                  <Quantity>1</Quantity>
                  <Price>10.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604289282">
            <Name>Clarithromycin</Name>
            <Request Form="RS1709" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Clarithromycin</range>
              </Title>
              <Case When="Initial application" Category="Tab 250 mg and oral liquid">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Atypical mycobacterial infection</ci>
                    <ci type="logical">Mycobacterium tuberculosis infection where there is drug resistance or intolerance to standard pharmaceutical agents</ci>
                    <ci type="logical">Helicobacter pylori eradication</ci>
                    <ci type="logical">Prophylaxis of infective endocarditis associated with surgical or dental procedures if amoxicillin is contra-indicated</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Tab 500 mg">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Helicobacter pylori eradication</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Infusion">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Atypical mycobacterial infection</ci>
                    <ci type="logical">Mycobacterium tuberculosis infection where there is drug resistance or intolerance to standard pharmaceutical agents</ci>
                    <ci type="logical">Community-acquired pneumonia</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1709" style="display:none"/>
            <Formulation ID="F160428928225" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-22 to~2027" Value="1"/>
              <Brand ID="B16042892822528" HSS="true">
                <Name>Klacid</Name>
                <Pack ID="P2606038" Specified="true" nzmt:ctpp_id="50122311000117108">
                  <Quantity>14</Quantity>
                  <Price>8.53</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160428928227" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Jul-24 to~2026" Value="5"/>
              <Brand ID="B16042892822727" PSS="true">
                <Name>Klacid IV</Name>
                <Pack ID="P2651904" Specified="true" nzmt:ctpp_id="50070411000117108">
                  <Quantity>1</Quantity>
                  <Price>9.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160428928228" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-22 to~2027" Value="1"/>
              <Brand ID="B16042892822826" HSS="true">
                <Name>Klacid</Name>
                <Pack ID="P2605295" Specified="true" nzmt:ctpp_id="50284701000117107">
                  <Quantity>14</Quantity>
                  <Price>14.58</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160428928229" Rank="3" Units="ml" Weight="50">
              <Name>Grans for oral liq 50 mg per ml</Name>
              <Brand ID="B16042892822925">
                <Name>Klacid</Name>
                <Pack ID="P2535378" Specified="true" nzmt:ctpp_id="50231241000117107">
                  <Quantity>50</Quantity>
                  <Price>192.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604289349">
            <Name>Erythromycin (as ethylsuccinate)</Name>
            <Formulation ID="F160428934925" Rank="1" Units="tab" Weight="400">
              <Name>Tab 400 mg</Name>
              <Brand ID="B16042893492525">
                <Name>E-Mycin</Name>
                <Pack ID="P243094" Specified="true" nzmt:ctpp_id="50051701000117106">
                  <Quantity>100</Quantity>
                  <Price>16.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160428934926" Rank="3" Units="ml">
              <Name>Grans for oral liq 200 mg per 5 ml</Name>
              <Brand ID="B16042893492625">
                <Name>E-Mycin</Name>
                <Pack ID="P2618877" Specified="true" nzmt:ctpp_id="50051681000117108">
                  <Quantity>100</Quantity>
                  <Price>5.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160428934927" Rank="3" Units="ml">
              <Name>Grans for oral liq 400 mg per 5 ml</Name>
              <Brand ID="B16042893492725">
                <Name>E-Mycin</Name>
                <Pack ID="P2618869" Specified="true" nzmt:ctpp_id="50051691000117106">
                  <Quantity>100</Quantity>
                  <Price>6.77</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604289404">
            <Name>Azithromycin</Name>
            <Request Form="RS1598" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Azithromycin</range>
              </Title>
              <Case When="Initial application" Category="bronchiolitis obliterans syndrome, cystic fibrosis and atypical Mycobacterium infections">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Patient has received a lung transplant, stem cell transplant or bone marrow transplant and requires treatment for bronchiolitis obliterans syndrome*</ci>
                    <ci type="logical">Patient has received a lung transplant and requires prophylaxis for bronchiolitis obliterans syndrome*</ci>
                    <ci type="logical">Patient has cystic fibrosis and has chronic infection with Pseudomonas aeruginosa or Pseudomonas related gram negative organisms*</ci>
                    <ci type="logical">Patient has an atypical Mycobacterium infection</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications</p>
                </div>
              </Case>
              <Case When="Initial application" Category="non-cystic fibrosis bronchiectasis*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">For prophylaxis of exacerbations of non-cystic fibrosis bronchiectasis*</ci>
                    <ci type="logical">Patient is aged 18 and under</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has had 3 or more exacerbations of their bronchiectasis, within a 12 month period</ci>
                      <ci type="logical">Patient has had 3 acute admissions to hospital for treatment of infective respiratory exacerbations within a 12 month period</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Applicant>paediatrician</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications. A maximum of 24 months of azithromycin treatment for non-cystic fibrosis will be subsidised in the community.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="non-cystic fibrosis bronchiectasis*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has completed 12 months of azithromycin treatment for non-cystic fibrosis bronchiectasis</ci>
                    <ci type="logical">Following initial 12 months of treatment, the patient has not received any further azithromycin treatment for non-cystic fibrosis bronchiectasis for a further 12 months, unless considered clinically inappropriate to stop treatment</ci>
                    <ci type="logical">The patient will not receive more than a total of 24 months' azithromycin cumulative treatment (see note)</ci>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Applicant>paediatrician</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications. A maximum of 24 months of azithromycin treatment for non-cystic fibrosis will be subsidised in the community.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="other indications">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For any other condition</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="day">5</Term>
              </Case>
              <Case When="Renewal" Category="other indications">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For any other condition</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="day">5</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1598" style="display:none"/>
            <Formulation ID="F160428940425" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Brand ID="B16042894042527">
                <Name>Zithromax</Name>
                <Pack ID="P204218" Specified="true" nzmt:ctpp_id="50008131000117103">
                  <Quantity>2</Quantity>
                  <Price>2.57</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160428940426" Rank="3" Units="ml" Weight="15">
              <Name>Grans for oral liq 200 mg per 5 ml (40 mg per ml)</Name>
              <Brand ID="B16042894042625">
                <Name>Zithromax</Name>
                <Pack ID="P2144042" Specified="true" nzmt:ctpp_id="50024771000117100">
                  <Quantity>15</Quantity>
                  <Price>16.97</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160428940427" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B16042894042700">
                <Name>Any</Name>
                <Pack ID="P94042700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A160436">
          <Name>Penicillins</Name>
          <Chemical ID="C1604368470">
            <Name>Ticarcillin with clavulanic acid</Name>
            <Request Form="RS1054" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ticarcillin with clavulanic acid</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1054" style="display:none"/>
            <Formulation ID="F160436847001" Rank="4" Units="inj" Weight="3">
              <Name>Inj 3 g with clavulanic acid 0.1 mg vial</Name>
              <Brand ID="B16043684700100">
                <Name>Any</Name>
                <Pack ID="P84700100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604369001">
            <Name>Amoxicillin with clavulanic acid</Name>
            <Formulation ID="F160436900105" Rank="1" Units="tab" Weight="600">
              <Name>Tab 500 mg with clavulanic acid 125 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B16043690010526" PSS="true">
                <Name>Curam Duo 500/125</Name>
                <Pack ID="P2602121" Specified="true" nzmt:ctpp_id="50135811000117107">
                  <Quantity>10</Quantity>
                  <Price>1.59</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436900106" Rank="3" Units="ml" Weight="25">
              <Name>Grans for oral liq 25 mg with clavulanic acid 6.25 mg per ml</Name>
              <Brand ID="B16043690010625">
                <Name>Augmentin</Name>
                <Pack ID="P319473" Specified="true" nzmt:ctpp_id="50071531000117105">
                  <Quantity>100</Quantity>
                  <Price>8.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436900107" Rank="3" Units="ml" Weight="50">
              <Name>Grans for oral liq 50 mg with clavulanic acid 12.5 mg per ml</Name>
              <Brand ID="B16043690010726">
                <Name>Curam</Name>
                <Pack ID="P2327945" Specified="true" nzmt:ctpp_id="50049221000117106">
                  <Quantity>100</Quantity>
                  <Price>4.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436900108" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1,000 mg with clavulanic acid 200 mg vial</Name>
              <Brand ID="B16043690010826">
                <Name>Amoxiclav multichem</Name>
                <Pack ID="P2613417" Specified="true" nzmt:ctpp_id="50231851000117108">
                  <Quantity>10</Quantity>
                  <Price>26.90</Price>
                </Pack>
              </Brand>
              <Brand ID="B16043690010827">
                <Name>Cerobact</Name>
                <Pack ID="P2676834" Specified="true" nzmt:ctpp_id="50331561000117104">
                  <Quantity>10</Quantity>
                  <Price>26.90</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436900109" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg with clavulanic acid 100 mg vial</Name>
              <Brand ID="B16043690010926">
                <Name>Amoxiclav multichem</Name>
                <Pack ID="P2613425" Specified="true" nzmt:ctpp_id="50231871000117100">
                  <Quantity>10</Quantity>
                  <Price>17.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604369130">
            <Name>Amoxicillin</Name>
            <Formulation ID="F160436913025" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 mg vial</Name>
              <Brand ID="B16043691302525">
                <Name>Ibiamox</Name>
                <Pack ID="P588296" nzmt:ctpp_id="50097551000117104">
                  <Quantity>5</Quantity>
                  <Price>6.32</Price>
                </Pack>
                <Pack ID="P2272628" Specified="true" nzmt:ctpp_id="50042751000117103">
                  <Quantity>10</Quantity>
                  <Price>15.97</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436913026" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg vial</Name>
              <Brand ID="B16043691302625">
                <Name>Ibiamox</Name>
                <Pack ID="P588318" nzmt:ctpp_id="50097561000117102">
                  <Quantity>5</Quantity>
                  <Price>7.23</Price>
                </Pack>
                <Pack ID="P2272601" Specified="true" nzmt:ctpp_id="50042741000117100">
                  <Quantity>10</Quantity>
                  <Price>17.43</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436913027" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1 g vial</Name>
              <Brand ID="B16043691302725">
                <Name>Ibiamox</Name>
                <Pack ID="P588326" nzmt:ctpp_id="50097571000117107">
                  <Quantity>5</Quantity>
                  <Price>11.00</Price>
                </Pack>
                <Pack ID="P2272636" Specified="true" nzmt:ctpp_id="50042761000117101">
                  <Quantity>10</Quantity>
                  <Price>21.64</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436913028" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Rule Type="DVLimit" Attribute="Sep-24 to~2025" Value="5"/>
              <Brand ID="B16043691302827" PSS="true">
                <Name>Miro-Amoxicillin</Name>
                <Pack ID="P2669617" Specified="true" nzmt:ctpp_id="50309481000117103">
                  <Quantity>500</Quantity>
                  <Price>27.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436913029" Rank="2" Units="cap" Weight="500">
              <Name>Cap 500 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~2025" Value="5"/>
              <Brand ID="B16043691302927" PSS="true">
                <Name>Miro-Amoxicillin</Name>
                <Pack ID="P2669625" Specified="true" nzmt:ctpp_id="50309491000117100">
                  <Quantity>500</Quantity>
                  <Price>41.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436913031" Rank="3" Units="ml" Weight="250">
              <Name>Grans for oral liq 250 mg per 5 ml</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B16043691303127" PSS="true">
                <Name>Alphamox 250</Name>
                <Pack ID="P2503565" Specified="true" nzmt:ctpp_id="50209441000117100">
                  <Quantity>100</Quantity>
                  <Price>2.81</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436913032" Rank="3" Units="ml" Weight="125">
              <Name>Grans for oral liq 125 mg per 5 ml</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B16043691303227" PSS="true">
                <Name>Alphamox 125</Name>
                <Pack ID="P2503557" Specified="true" nzmt:ctpp_id="50209451000117103">
                  <Quantity>100</Quantity>
                  <Price>2.22</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604369134">
            <Name>Benzylpenicillin sodium [Penicillin G]</Name>
            <Formulation ID="F160436913425" Rank="4" Units="inj" Weight="1000000">
              <Name>Inj 600 mg (1 million units) vial</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B16043691342525" PSS="true">
                <Name>Sandoz</Name>
                <Pack ID="P433748" Specified="true" nzmt:ctpp_id="50085141000117102">
                  <Quantity>10</Quantity>
                  <Price>16.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604369189">
            <Name>Flucloxacillin</Name>
            <Formulation ID="F160436918925" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Brand ID="B16043691892526">
                <Name>Flucloxacillin-AFT</Name>
                <Pack ID="P2335573" Specified="true" nzmt:ctpp_id="50049681000117107">
                  <Quantity>250</Quantity>
                  <Price>15.79</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436918926" Rank="2" Units="cap" Weight="500">
              <Name>Cap 500 mg</Name>
              <Brand ID="B16043691892626">
                <Name>Flucloxacillin-AFT</Name>
                <Pack ID="P2224186" Specified="true" nzmt:ctpp_id="50035611000117100">
                  <Quantity>500</Quantity>
                  <Price>52.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436918927" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Jul-24 to~2026" Value="5"/>
              <Brand ID="B16043691892725" PSS="true">
                <Name>Flucloxin</Name>
                <Pack ID="P331848" Specified="true" nzmt:ctpp_id="50073551000117104">
                  <Quantity>10</Quantity>
                  <Price>42.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436918928" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Jul-24 to~2026" Value="5"/>
              <Brand ID="B16043691892825" PSS="true">
                <Name>Flucloxin</Name>
                <Pack ID="P331856" Specified="true" nzmt:ctpp_id="50073561000117102">
                  <Quantity>10</Quantity>
                  <Price>45.63</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436918929" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1 g vial</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B16043691892927" PSS="true">
                <Name>Flucil</Name>
                <Pack ID="P2523108" Specified="true" nzmt:ctpp_id="50197411000117105">
                  <Quantity>5</Quantity>
                  <Price>6.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436918935" Rank="3" Units="ml">
              <Name>Grans for oral liq 25 mg per ml</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B16043691893525" PSS="true">
                <Name>AFT</Name>
                <Pack ID="P2431424" Specified="true" nzmt:ctpp_id="50157801000117104">
                  <Quantity>100</Quantity>
                  <Price>4.89</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436918936" Rank="3" Units="ml" Weight="250">
              <Name>Grans for oral liq 50 mg per ml</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B16043691893625" PSS="true">
                <Name>AFT</Name>
                <Pack ID="P2431432" Specified="true" nzmt:ctpp_id="50157811000117101">
                  <Quantity>100</Quantity>
                  <Price>5.89</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604369253">
            <Name>Procaine penicillin</Name>
            <Formulation ID="F160436925325" Rank="4" Units="inj" Weight="1.5">
              <Name>Inj 1.5 g in 3.4 ml syringe</Name>
              <Brand ID="B16043692532500">
                <Name>Any</Name>
                <Pack ID="P92532500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604369287">
            <Name>Benzathine benzylpenicillin</Name>
            <Formulation ID="F160436928725" Rank="4" Units="inj" Weight="1.2">
              <Name>Inj 900 mg (1.2 million units) in 2.3 ml syringe</Name>
              <Brand ID="B16043692872526">
                <Name>Bicillin LA</Name>
                <Pack ID="P2258072" Specified="true" nzmt:ctpp_id="50040811000117107">
                  <Quantity>10</Quantity>
                  <Price>375.97</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604369394">
            <Name>Phenoxymethylpenicillin [Penicillin V]</Name>
            <Formulation ID="F160436939425" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B16043693942525" PSS="true">
                <Name>Cilicaine VK</Name>
                <Pack ID="P2602865" Specified="true" nzmt:ctpp_id="50009051000117102">
                  <Quantity>50</Quantity>
                  <Price>7.68</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436939426" Rank="2" Units="cap" Weight="500">
              <Name>Cap 500 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B16043693942625" PSS="true">
                <Name>Cilicaine VK</Name>
                <Pack ID="P2602873" Specified="true" nzmt:ctpp_id="50009061000117100">
                  <Quantity>50</Quantity>
                  <Price>13.72</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436939427" Rank="3" Units="ml" Weight="125">
              <Name>Grans for oral liq 125 mg per 5 ml</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B16043693942725" PSS="true">
                <Name>AFT</Name>
                <Pack ID="P2029219" Specified="true" nzmt:ctpp_id="50005731000117107">
                  <Quantity>100</Quantity>
                  <Price>3.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160436939428" Rank="3" Units="ml" Weight="250">
              <Name>Grans for oral liq 250 mg per 5 ml</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B16043693942825" PSS="true">
                <Name>AFT</Name>
                <Pack ID="P2029227" Specified="true" nzmt:ctpp_id="50005741000117104">
                  <Quantity>100</Quantity>
                  <Price>4.24</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604369531">
            <Name>Piperacillin with tazobactam</Name>
            <Request Form="RS1053" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Piperacillin with tazobactam</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1053" style="display:none"/>
            <Formulation ID="F160436953125" Rank="4" Units="inj" Weight="4">
              <Name>Inj 4 g with tazobactam 0.5 g vial</Name>
              <Rule Type="DVLimit" Attribute="Feb-23 to~2025" Value="5"/>
              <Brand ID="B16043695312529" PSS="true">
                <Name>PipTaz-AFT</Name>
                <Pack ID="P2529866" Specified="true" nzmt:ctpp_id="50171051000117102">
                  <Quantity>1</Quantity>
                  <Price>3.59</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A160440">
          <Name>Quinolones</Name>
          <Chemical ID="C1604409151">
            <Name>Ciprofloxacin</Name>
            <Request Form="RS1055" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ciprofloxacin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1055" style="display:none"/>
            <Formulation ID="F160440915102" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2 mg per ml, 100 ml bag</Name>
              <Brand ID="B16044091510200">
                <Name>Any</Name>
                <Pack ID="P91510200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160440915103" Rank="3" Units="ml" Weight="100">
              <Name>Oral liq 100 mg per ml</Name>
              <Brand ID="B16044091510300">
                <Name>Any</Name>
                <Pack ID="P91510300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160440915104" Rank="3" Units="ml" Weight="50">
              <Name>Oral liq 50 mg per ml</Name>
              <Brand ID="B16044091510400">
                <Name>Any</Name>
                <Pack ID="P91510400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160440915125" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Rule Type="DVLimit" Attribute="Nov-24 to~2026" Value="5"/>
              <Brand ID="B16044091512525" ToBeDelisted="2024-11-01">
                <Name>Cipflox</Name>
                <Pack ID="P2104997" Specified="true" nzmt:ctpp_id="50018831000117105">
                  <Quantity>28</Quantity>
                  <Price>2.42</Price>
                </Pack>
              </Brand>
              <Brand ID="B16044091512527" PSS="true">
                <Name>Ipca-Ciprofloxacin</Name>
                <Pack ID="P2676877" Specified="true" nzmt:ctpp_id="50318671000117108">
                  <Quantity>28</Quantity>
                  <Price>1.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160440915126" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Rule Type="DVLimit" Attribute="Nov-24 to~2026" Value="5"/>
              <Brand ID="B16044091512627" ToBeDelisted="2024-11-01">
                <Name>Ciprofloxacin - Torrent</Name>
                <Pack ID="P2664615" Specified="true" nzmt:ctpp_id="50322221000117103">
                  <Quantity>10</Quantity>
                  <Price>4.25</Price>
                </Pack>
              </Brand>
              <Brand ID="B16044091512628" PSS="true">
                <Name>Ipca-Ciprofloxacin</Name>
                <Pack ID="P2676885" Specified="true" nzmt:ctpp_id="50318741000117106">
                  <Quantity>28</Quantity>
                  <Price>3.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160440915127" Rank="1" Units="tab" Weight="750">
              <Name>Tab 750 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2026" Value="5"/>
              <Brand ID="B16044091512725" ToBeDelisted="2024-12-01">
                <Name>Cipflox</Name>
                <Pack ID="P2105012" Specified="true" nzmt:ctpp_id="50018861000117103">
                  <Quantity>28</Quantity>
                  <Price>5.95</Price>
                </Pack>
              </Brand>
              <Brand ID="B16044091512727" PSS="true">
                <Name>Ipca-Ciprofloxacin</Name>
                <Pack ID="P2676893" Specified="true" nzmt:ctpp_id="50318811000117100">
                  <Quantity>28</Quantity>
                  <Price>4.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160440915130" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2 mg per ml, 100 ml bottle</Name>
              <Brand ID="B16044091513028">
                <Name>Ciprofloxacin Kabi</Name>
                <Pack ID="P2654865" Specified="true" nzmt:ctpp_id="50313221000117100">
                  <Quantity>10</Quantity>
                  <Price>125.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604409436">
            <Name>Norfloxacin</Name>
            <Formulation ID="F160440943625" Rank="1" Units="tab" Weight="400">
              <Name>Tab 400 mg</Name>
              <Brand ID="B16044094362525">
                <Name>Arrow-Norfloxacin</Name>
                <Pack ID="P2204398" Specified="true" nzmt:ctpp_id="50032531000117101">
                  <Quantity>100</Quantity>
                  <Price>245.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604409575">
            <Name>Moxifloxacin</Name>
            <Request Form="RS1644" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Moxifloxacin</range>
              </Title>
              <Case When="Initial application" Category="Mycobacterium infection">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">Active tuberculosis</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Documented resistance to one or more first-line medications</ci>
                        <ci type="logical">Suspected resistance to one or more first-line medications (tuberculosis assumed to be contracted in an area with known resistance), as part of regimen containing other
                            second-line agents</ci>
                        <ci type="logical">Impaired visual acuity (considered to preclude ethambutol use)</ci>
                        <ci type="logical">Significant pre-existing liver disease or hepatotoxicity from tuberculosis medications</ci>
                        <ci type="logical">Significant documented intolerance and/or side effects following a reasonable trial of first-line medications</ci>
                      </apply>
                    </apply>
                    <ci type="logical">Mycobacterium avium-intracellulare complex not responding to other therapy or where such therapy is contraindicated</ci>
                    <ci type="logical">Patient is under five years of age and has had close contact with a confirmed multi-drug resistant tuberculosis case</ci>
                  </apply>
                </math>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Pneumonia">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Immunocompromised patient with pneumonia that is unresponsive to first-line treatment</ci>
                    <ci type="logical">Pneumococcal pneumonia or other invasive pneumococcal disease highly resistant to other antibiotics</ci>
                  </apply>
                </math>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>clinical microbiologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Penetrating eye injury">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Five days treatment for patients requiring prophylaxis following a penetrating eye injury</ci>
                </math>
                <Applicant>ophthalmologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Mycoplasma genitalium">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Has nucleic acid amplification test (NAAT) confirmed Mycoplasma genitalium and is symptomatic</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Has tried and failed to clear infection using azithromycin</ci>
                      <ci type="logical">Has laboratory confirmed azithromycin resistance</ci>
                    </apply>
                    <ci type="logical">Treatment is only for 7 days</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1644" style="display:none"/>
            <Formulation ID="F160440957525" Rank="1" Units="tab" Weight="400">
              <Name>Tab 400 mg</Name>
              <Brand ID="B16044095752525">
                <Name>Avelox</Name>
                <Pack ID="P2022362" Specified="true" nzmt:ctpp_id="50004501000117106">
                  <Quantity>5</Quantity>
                  <Price>42.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160440957527" Rank="4" Units="inj" Weight="400">
              <Name>Inj 1.6 mg per ml, 250 ml bottle</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B16044095752726" PSS="true">
                <Name>Moxifloxacin Kabi</Name>
                <Pack ID="P2577062" Specified="true" nzmt:ctpp_id="50236611000117103">
                  <Quantity>10</Quantity>
                  <Price>413.40</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A160444">
          <Name>Tetracyclines</Name>
          <Chemical ID="C1604448129">
            <Name>Demeclocycline hydrochloride</Name>
            <Formulation ID="F160444812901" Rank="2" Units="cap" Weight="150">
              <Name>Cap 150 mg</Name>
              <Brand ID="B16044481290100">
                <Name>Any</Name>
                <Pack ID="P81290100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160444812925" Rank="2" Units="cap" Weight="300">
              <Name>Cap 300 mg</Name>
              <Brand ID="B16044481292500">
                <Name>Any</Name>
                <Pack ID="P81292500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160444812926" Rank="1" Units="tab" Weight="150">
              <Name>Tab 150 mg</Name>
              <Brand ID="B16044481292600">
                <Name>Any</Name>
                <Pack ID="P81292600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604448305">
            <Name>Minocycline</Name>
            <Formulation ID="F160444830501" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
                <p>For continuation only</p>
              </div>
              <Brand ID="B16044483050100">
                <Name>Any</Name>
                <Pack ID="P83050100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160444830502" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B16044483050200">
                <Name>Any</Name>
                <Pack ID="P83050200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604448472">
            <Name>Tigecycline</Name>
            <Request Form="RS1059" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Tigecycline</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1059" style="display:none"/>
            <Formulation ID="F160444847201" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg vial</Name>
              <Brand ID="B16044484720100">
                <Name>Any</Name>
                <Pack ID="P84720100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604449183">
            <Name>Doxycycline</Name>
            <Formulation ID="F160444918301" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 20 ml vial</Name>
              <Brand ID="B16044491830100">
                <Name>Any</Name>
                <Pack ID="P91830100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160444918302" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
                <p>For continuation only</p>
              </div>
              <Brand ID="B16044491830200">
                <Name>Any</Name>
                <Pack ID="P91830200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160444918325" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B16044491832525">
                <Name>Doxine</Name>
                <Pack ID="P2545136" Specified="true" nzmt:ctpp_id="50260471000117101">
                  <Quantity>500</Quantity>
                  <Price>64.43</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604449688">
            <Name>Tetracycline</Name>
            <Formulation ID="F160444968801" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B16044496880125">
                <Name>Accord</Name>
                <Pack ID="P2587106" Specified="true" nzmt:ctpp_id="50275531000117100">
                  <Quantity>28</Quantity>
                  <Price>58.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160444968825" Rank="2" Units="cap" Weight="500">
              <Name>Cap 500 mg</Name>
              <Brand ID="B16044496882500">
                <Name>Any</Name>
                <Pack ID="P96882500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A160448">
          <Name>Other Antibacterials</Name>
          <Chemical ID="C1604488127">
            <Name>Daptomycin</Name>
            <Request Form="RS1063" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Daptomycin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1063" style="display:none"/>
            <Formulation ID="F160448812725" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Jan-24 to~2025" Value="5"/>
              <Brand ID="B16044881272526" PSS="true">
                <Name>Daptomycin Dr Reddy's</Name>
                <Pack ID="P2661616" Specified="true" nzmt:ctpp_id="50299361000117107">
                  <Quantity>1</Quantity>
                  <Price>115.36</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604488213">
            <Name>Methenamine (Hexamine) hippurate</Name>
            <Formulation ID="F160448821301" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 g</Name>
              <Rule Type="DVLimit" Attribute="Feb-23 to~2025" Value="5"/>
              <Brand ID="B16044882130125" PSS="true">
                <Name>Hiprex</Name>
                <Pack ID="P2671077" Specified="true" nzmt:ctpp_id="50017741000117108">
                  <Quantity>100</Quantity>
                  <Price>19.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604488261">
            <Name>Lincomycin</Name>
            <Request Form="RS1065" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Lincomycin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1065" style="display:none"/>
            <Formulation ID="F160448826101" Rank="4" Units="inj" Weight="300">
              <Name>Inj 300 mg per ml, 2 ml vial</Name>
              <Brand ID="B16044882610100">
                <Name>Any</Name>
                <Pack ID="P82610100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604488263">
            <Name>Linezolid</Name>
            <Request Form="RS1066" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Linezolid</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1066" style="display:none"/>
            <Formulation ID="F160448826302" Rank="3" Units="ml">
              <Name>Oral liq 20 mg per ml</Name>
              <Brand ID="B16044882630225">
                <Name>Zyvox</Name>
                <Pack ID="P2058774" Specified="true" nzmt:ctpp_id="50010401000117104">
                  <Quantity>150</Quantity>
                  <Price>1879.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160448826303" Rank="1" Units="tab" Weight="600">
              <Name>Tab 600 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B16044882630325" PSS="true">
                <Name>Zyvox</Name>
                <Pack ID="P2058758" Specified="true" nzmt:ctpp_id="50010381000117104">
                  <Quantity>10</Quantity>
                  <Price>194.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160448826325" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2 mg per ml, 300 ml bottle</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B16044882632525" PSS="true">
                <Name>Linezolid Kabi</Name>
                <Pack ID="P2556766" Specified="true" nzmt:ctpp_id="50244681000117100">
                  <Quantity>10</Quantity>
                  <Price>155.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604488319">
            <Name>Nitrofurantoin</Name>
            <Formulation ID="F160448831901" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B16044883190125">
                <Name>Nifuran</Name>
                <Pack ID="P254754" Specified="true" nzmt:ctpp_id="50054641000117101">
                  <Quantity>100</Quantity>
                  <Price>37.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160448831902" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B16044883190225" PSS="true">
                <Name>Nifuran</Name>
                <Pack ID="P254738" Specified="true" nzmt:ctpp_id="50054631000117109">
                  <Quantity>100</Quantity>
                  <Price>22.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160448831925" Rank="2" Units="cap" Weight="100">
              <Name>Cap modified-release 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B16044883192525" PSS="true">
                <Name>Macrobid</Name>
                <Pack ID="P2493624" Specified="true" nzmt:ctpp_id="50221411000117107">
                  <Quantity>100</Quantity>
                  <Price>81.20</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604488452">
            <Name>Sulfadiazine sodium</Name>
            <Request Form="RS1067" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Sulphadiazine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>maternal-foetal medicine specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1067" style="display:none"/>
            <Formulation ID="F160448845201" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Brand ID="B16044884520100">
                <Name>e.g. Sulfadiazin-Heyl; Wockhardt</Name>
                <Pack ID="P84520100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604488454">
            <Name>Teicoplanin</Name>
            <Request Form="RS1068" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Teicoplanin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1068" style="display:none"/>
            <Formulation ID="F160448845401" Rank="4" Units="inj" Weight="400">
              <Name>Inj 400 mg vial</Name>
              <Brand ID="B16044884540126">
                <Name>Targocid</Name>
                <Pack ID="P280631" Specified="true" nzmt:ctpp_id="50062421000117107">
                  <Quantity>1</Quantity>
                  <Price>49.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604488508">
            <Name>Fosfomycin</Name>
            <Request Form="RS1315" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Fosfomycin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1315" style="display:none"/>
            <Formulation ID="F160448850825" Rank="3" Units="g">
              <Name>Powder for oral solution, 3 g sachet</Name>
              <Brand ID="B16044885082500">
                <Name>e.g. UroFos</Name>
                <Pack ID="P85082500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604488527">
            <Name>Pivmecillinam</Name>
            <Request Form="RS1322" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Pivmecillinam</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1322" style="display:none"/>
            <Formulation ID="F160448852725" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B16044885272500">
                <Name>Any</Name>
                <Pack ID="P85272500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604489143">
            <Name>Vancomycin</Name>
            <Request Form="RS1069" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Vancomycin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1069" style="display:none"/>
            <Formulation ID="F160448914325" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B16044891432526" PSS="true">
                <Name>Mylan</Name>
                <Pack ID="P2195267" Specified="true" nzmt:ctpp_id="50031261000117102">
                  <Quantity>1</Quantity>
                  <Price>3.38</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604489148">
            <Name>Chloramphenicol</Name>
            <Request Form="RS1277" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Aztreonam, Chloramphenicol</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1277" style="display:none"/>
            <Formulation ID="F160448914803" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 g vial</Name>
              <Brand ID="B16044891480300">
                <Name>Any</Name>
                <Pack ID="P91480300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604489153">
            <Name>Clindamycin</Name>
            <Request Form="RS1061" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Clindamycin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1061" style="display:none"/>
            <Formulation ID="F160448915301" Rank="3" Units="ml">
              <Name>Oral liq 15 mg per ml</Name>
              <Brand ID="B16044891530100">
                <Name>Any</Name>
                <Pack ID="P91530100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160448915325" Rank="2" Units="cap" Weight="150">
              <Name>Cap 150 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B16044891532525" PSS="true">
                <Name>Dalacin C</Name>
                <Pack ID="P2576392" Specified="true" nzmt:ctpp_id="50149351000117103">
                  <Quantity>24</Quantity>
                  <Price>4.94</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160448915326" Rank="4" Units="inj" Weight="600">
              <Name>Inj 150 mg per ml, 4 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Aug-23 to~2025" Value="5"/>
              <Brand ID="B16044891532626" PSS="true">
                <Name>Hameln</Name>
                <Pack ID="P2646595" Specified="true" nzmt:ctpp_id="50288101000117100">
                  <Quantity>10</Quantity>
                  <Price>35.10</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604489195">
            <Name>Sodium fusidate  [Fusidic acid]</Name>
            <Request Form="RS1064" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Fusidic acid</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1064" style="display:none"/>
            <Formulation ID="F160448919525" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B16044891952525">
                <Name>Fucidin</Name>
                <Pack ID="P2621053" Specified="true" nzmt:ctpp_id="50053361000117105">
                  <Quantity>36</Quantity>
                  <Price>135.70</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604489407">
            <Name>Colistin sulphomethate [Colestimethate]</Name>
            <Request Form="RS1062" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Colistin sulphomethate [Colestimethate]</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1062" style="display:none"/>
            <Formulation ID="F160448940725" Rank="4" Units="inj" Weight="150">
              <Name>Inj 150 mg per ml, 1 ml vial</Name>
              <Brand ID="B16044894072525">
                <Name>Colistin-Link</Name>
                <Pack ID="P2245418" Specified="true" nzmt:ctpp_id="50039011000117106">
                  <Quantity>1</Quantity>
                  <Price>65.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604489458">
            <Name>Trimethoprim</Name>
            <Formulation ID="F160448945801" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B16044894580100">
                <Name>Any</Name>
                <Pack ID="P94580100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160448945825" Rank="1" Units="tab" Weight="300">
              <Name>Tab 300 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B16044894582525" PSS="true">
                <Name>TMP</Name>
                <Pack ID="P648507" Specified="true" nzmt:ctpp_id="50100371000117106">
                  <Quantity>50</Quantity>
                  <Price>27.83</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604489474">
            <Name>Trimethoprim with sulphamethoxazole [Co-trimoxazole]</Name>
            <Formulation ID="F160448947401" Rank="4" Units="inj" Weight="16">
              <Name>Inj 16 mg with sulphamethoxazole 80 mg per ml, 5 ml ampoule</Name>
              <Brand ID="B16044894740100">
                <Name>Any</Name>
                <Pack ID="P94740100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160448947402" Rank="1" Units="tab" Weight="80">
              <Name>Tab 80 mg with sulphamethoxazole 400 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B16044894740225" PSS="true">
                <Name>Trisul</Name>
                <Pack ID="P283363" Specified="true" nzmt:ctpp_id="50063251000117107">
                  <Quantity>500</Quantity>
                  <Price>115.74</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160448947425" Rank="3" Units="ml" Weight="240">
              <Name>Oral liq 8 mg with sulphamethoxazole 40 mg per ml</Name>
              <Brand ID="B16044894742525">
                <Name>Deprim</Name>
                <Pack ID="P2309718" Specified="true" nzmt:ctpp_id="50046921000117106">
                  <Quantity>100</Quantity>
                  <Price>5.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1604489601">
            <Name>Aztreonam</Name>
            <Request Form="RS1277" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Aztreonam, Chloramphenicol</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1277" style="display:none"/>
            <Formulation ID="F160448960125" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 g vial</Name>
              <Brand ID="B16044896012525">
                <Name>Azactam</Name>
                <Pack ID="P2580179" Specified="true" nzmt:ctpp_id="50273141000117103">
                  <Quantity>10</Quantity>
                  <Price>364.92</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1608">
        <Name>Antifungals</Name>
        <ATC3 ID="A160804">
          <Name>Imidazoles</Name>
          <Chemical ID="C1608049442">
            <Name>Ketoconazole</Name>
            <Formulation ID="F160804944201" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Request Form="RS1410" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Ketoconazole - Tab 200 mg</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">No patient criteria</ci>
                  </math>
                  <Applicant>oncologist</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1410" style="display:none"/>
              <Brand ID="B16080494420100">
                <Name>Any</Name>
                <Pack ID="P94420100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A160812">
          <Name>Polyene Antimycotics</Name>
          <Chemical ID="C1608129032">
            <Name>Amphotericin B</Name>
            <Formulation ID="F160812903201" Rank="4" Units="inj" Weight="50">
              <Name>Inj (liposomal) 50 mg vial</Name>
              <Request Form="RS1071" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Amphotericin B - Inj (liposomal) 50 mg vial</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical">Proven or probable invasive fungal infection, to be prescribed under an established protocol</ci>
                      <apply>
                        <and/>
                        <ci type="logical">Possible invasive fungal infection</ci>
                        <ci type="logical">A multidisciplinary team (including an infectious disease physician or a clinical microbiologist) considers the treatment to be appropriate</ci>
                      </apply>
                    </apply>
                  </math>
                  <Applicant>clinical microbiologist</Applicant>
                  <Applicant>haematologist</Applicant>
                  <Applicant>infectious disease specialist</Applicant>
                  <Applicant>oncologist</Applicant>
                  <Applicant>respiratory specialist</Applicant>
                  <Applicant>transplant specialist</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1071" style="display:none"/>
              <Brand ID="B16081290320101">
                <Name>AmBisome</Name>
                <Pack ID="P231495" nzmt:ctpp_id="50047981000117108">
                  <Quantity>1</Quantity>
                  <Price>345.00</Price>
                </Pack>
                <Pack ID="P2229323" Specified="true" nzmt:ctpp_id="50036731000117108">
                  <Quantity>10</Quantity>
                  <Price>3450.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160812903202" Rank="4" Units="inj" Weight="51">
              <Name>Inj 50 mg vial</Name>
              <Request Form="RS1316" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Amphotericin B - Inj 50 mg vial</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">No patient criteria</ci>
                  </math>
                  <Applicant>clinical microbiologist</Applicant>
                  <Applicant>haematologist</Applicant>
                  <Applicant>infectious disease specialist</Applicant>
                  <Applicant>oncologist</Applicant>
                  <Applicant>respiratory specialist</Applicant>
                  <Applicant>transplant specialist</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1316" style="display:none"/>
              <Brand ID="B16081290320200">
                <Name>Any</Name>
                <Pack ID="P90320200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1608129252">
            <Name>Nystatin</Name>
            <Formulation ID="F160812925226" Rank="1" Units="tab" Weight="500000">
              <Name>Tab 500,000 u</Name>
              <Brand ID="B16081292522625">
                <Name>Nilstat</Name>
                <Pack ID="P770752" Specified="true" nzmt:ctpp_id="50111711000117108">
                  <Quantity>50</Quantity>
                  <Price>17.09</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160812925227" Rank="2" Units="cap" Weight="500000">
              <Name>Cap 500,000 u</Name>
              <Brand ID="B16081292522725">
                <Name>Nilstat</Name>
                <Pack ID="P648345" Specified="true" nzmt:ctpp_id="50100311000117104">
                  <Quantity>50</Quantity>
                  <Price>15.47</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A160816">
          <Name>Triazoles</Name>
          <Chemical ID="C1608169339">
            <Name>Fluconazole</Name>
            <Request Form="RS1072" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Fluconazole</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>consultant</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1072" style="display:none"/>
            <Formulation ID="F160816933925" Rank="3" Units="ml">
              <Name>Oral liquid 50 mg per 5 ml</Name>
              <Brand ID="B16081693392525">
                <Name>Diflucan</Name>
                <Pack ID="P950289" Specified="true" nzmt:ctpp_id="50340451000117109">
                  <Quantity>35</Quantity>
                  <Price>129.02</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160816933926" Rank="4" Units="inj" Weight="100">
              <Name>Inj 2 mg per ml, 50 ml vial</Name>
              <Brand ID="B16081693392627">
                <Name>Fluconazole-Baxter</Name>
                <Pack ID="P2599473" Specified="true" nzmt:ctpp_id="50286861000117109">
                  <Quantity>1</Quantity>
                  <Price>3.11</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160816933927" Rank="2" Units="cap" Weight="50">
              <Name>Cap 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B16081693392725" PSS="true">
                <Name>Mylan</Name>
                <Pack ID="P2149060" Specified="true" nzmt:ctpp_id="50025741000117107">
                  <Quantity>28</Quantity>
                  <Price>4.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160816933928" Rank="2" Units="cap" Weight="150">
              <Name>Cap 150 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B16081693392825" PSS="true">
                <Name>Mylan</Name>
                <Pack ID="P2149079" Specified="true" nzmt:ctpp_id="50025751000117109">
                  <Quantity>1</Quantity>
                  <Price>0.45</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160816933929" Rank="2" Units="cap" Weight="200">
              <Name>Cap 200 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B16081693392925" PSS="true">
                <Name>Mylan</Name>
                <Pack ID="P2149052" Specified="true" nzmt:ctpp_id="50025731000117104">
                  <Quantity>28</Quantity>
                  <Price>8.90</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160816933930" Rank="4" Units="inj" Weight="200">
              <Name>Inj 2 mg per ml, 100 ml vial</Name>
              <Brand ID="B16081693393026">
                <Name>Fluconazole-Baxter</Name>
                <Pack ID="P2599465" Specified="true" nzmt:ctpp_id="50286871000117104">
                  <Quantity>1</Quantity>
                  <Price>3.83</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1608169378">
            <Name>Itraconazole</Name>
            <Request Form="RS1073" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Itraconazole</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical immunologist</Applicant>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>dermatologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1073" style="display:none"/>
            <Formulation ID="F160816937801" Rank="3" Units="ml">
              <Name>Oral liquid 10 mg per ml</Name>
              <Brand ID="B16081693780100">
                <Name>Any</Name>
                <Pack ID="P93780100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160816937825" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Brand ID="B16081693782526">
                <Name>Itrazole</Name>
                <Pack ID="P2354322" Specified="true" nzmt:ctpp_id="50121121000117106">
                  <Quantity>15</Quantity>
                  <Price>6.83</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1608169668">
            <Name>Voriconazole</Name>
            <Request Form="RS2053" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Voriconazole</range>
              </Title>
              <Case When="Initial application" Category="Proven or probable aspergillus infection">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is immunocompromised</ci>
                    <ci type="logical">Patient has proven or probable invasive aspergillus infection</ci>
                  </apply>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>haematologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Possible aspergillus infection">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is immunocompromised</ci>
                    <ci type="logical">Patient has possible invasive aspergillus infection</ci>
                    <ci type="logical">A multidisciplinary team (including an infectious disease physician) considers the treatment to be appropriate</ci>
                  </apply>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>haematologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Resistant candidiasis infections and other moulds">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is immunocompromised</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has fluconazole resistant candidiasis</ci>
                      <ci type="logical">Patient has mould strain such as Fusarium spp. and Scedosporium spp</ci>
                    </apply>
                    <ci type="logical">A multidisciplinary team (including an infectious disease physician or clinical microbiologist) considers the treatment to be appropriate</ci>
                  </apply>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>haematologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Invasive fungal infection prophylaxis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient is at risk of invasive fungal infection</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Voriconazole is prescribed by, or recommended by a haematologist,
            transplant physician, infectious disease specialist, paediatric haematologist or
            paediatric oncologist</ci>
                      <ci type="logical">Prescribing voriconazole is in accordance with a protocol or guideline
            that has been endorsed by the Health New Zealand - Te Whatu Ora Hospital in the specific
            settings where there is a greater than 10% risk of invasive fungal infection (IFI)</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Invasive fungal infection prophylaxis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient is at risk of invasive fungal infection</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Voriconazole is prescribed by, or recommended by a haematologist,
            transplant physician, infectious disease specialist, paediatric haematologist or
            paediatric oncologist</ci>
                      <ci type="logical">Prescribing voriconazole is in accordance with a protocol or guideline
            that has been endorsed by the Health New Zealand - Te Whatu Ora Hospital in the specific
            settings where there is a greater than 10% risk of invasive fungal infection (IFI)</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2053" style="display:none"/>
            <Formulation ID="F160816966801" Rank="4" Units="inj" Weight="200">
              <Name>Inj 200 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Aug-23 to~2025" Value="5"/>
              <Brand ID="B16081696680127" PSS="true">
                <Name>AFT</Name>
                <Pack ID="P2645122" Specified="true" nzmt:ctpp_id="50284991000117100">
                  <Quantity>1</Quantity>
                  <Price>19.85</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160816966802" Rank="3" Units="ml">
              <Name>Powder for oral suspension 40 mg per ml</Name>
              <Brand ID="B16081696680225">
                <Name>Vfend</Name>
                <Pack ID="P2349639" Specified="true" nzmt:ctpp_id="50120351000117108">
                  <Quantity>70</Quantity>
                  <Price>1523.22</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160816966825" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B16081696682526">
                <Name>Vttack</Name>
                <Pack ID="P2474867" Specified="true" nzmt:ctpp_id="50150701000117106">
                  <Quantity>56</Quantity>
                  <Price>91.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160816966826" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B16081696682626">
                <Name>Vttack</Name>
                <Pack ID="P2474875" Specified="true" nzmt:ctpp_id="50150801000117100">
                  <Quantity>56</Quantity>
                  <Price>350.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1608169677">
            <Name>Posaconazole</Name>
            <Request Form="RS2052" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Posaconazole</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has acute myeloid leukaemia</ci>
                      <ci type="logical">Patient is planned to receive a stem cell transplant and is at high
            risk for aspergillus infection</ci>
                    </apply>
                    <ci type="logical">Patient is to be treated with high dose remission induction therapy or
          re-induction therapy</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="week">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has previously received posaconazole prophylaxis during remission
          induction therapy</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient is to be treated with high dose remission re-induction
            therapy</ci>
                      <ci type="logical">Patient is to be treated with high dose consolidation therapy</ci>
                      <ci type="logical">Patient is receiving a high risk stem cell transplant</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="week">6</Term>
              </Case>
              <Case When="Initial application" Category="Invasive fungal infection prophylaxis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient is at risk of invasive fungal infection</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Posaconazole is prescribed by, or recommended by a haematologist,
            transplant physician, infectious disease specialist, paediatric haematologist or
            paediatric oncologist</ci>
                      <ci type="logical">Prescribing posaconazole is in accordance with a protocol or guideline
            that has been endorsed by the Health New Zealand - Te Whatu Ora Hospital in the specific
            settings where there is a greater than 10% risk of invasive fungal infection (IFI)</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Invasive fungal infection prophylaxis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient is at risk of invasive fungal infection</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Posaconazole is prescribed by, or recommended by a haematologist,
            transplant physician, infectious disease specialist, paediatric haematologist or
            paediatric oncologist</ci>
                      <ci type="logical">Prescribing posaconazole is in accordance with a protocol or guideline
            that has been endorsed by the Health New Zealand - Te Whatu Ora Hospital in the specific
            settings where there is a greater than 10% risk of invasive fungal infection (IFI)</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2052" style="display:none"/>
            <Formulation ID="F160816967725" Rank="3" Units="ml" Weight="40">
              <Name>Oral liq 40 mg per ml</Name>
              <Rule Type="DVLimit" Attribute="May-23 to~2025" Value="5"/>
              <Brand ID="B16081696772526" PSS="true">
                <Name>Devatis</Name>
                <Pack ID="P2645181" Specified="true" nzmt:ctpp_id="50276851000117103">
                  <Quantity>105</Quantity>
                  <Price>342.51</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160816967726" Rank="1" Units="tab" Weight="100">
              <Name>Tab modified-release 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B16081696772626" PSS="true">
                <Name>Posaconazole Juno</Name>
                <Pack ID="P2631008" Specified="true" nzmt:ctpp_id="50281921000117100">
                  <Quantity>24</Quantity>
                  <Price>206.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A160820">
          <Name>Other Antifungals</Name>
          <Chemical ID="C1608208188">
            <Name>Flucytosine</Name>
            <Request Form="RS1279" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Flucytosine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1279" style="display:none"/>
            <Formulation ID="F160820818801" Rank="2" Units="cap" Weight="500">
              <Name>Cap 500 mg</Name>
              <Brand ID="B16082081880100">
                <Name>Any</Name>
                <Pack ID="P81880100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160820818825" Rank="1" Units="tab">
              <Name>Tab 500 mg</Name>
              <Brand ID="B16082081882500">
                <Name>Any</Name>
                <Pack ID="P81882500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1608209439">
            <Name>Terbinafine</Name>
            <Formulation ID="F160820943926" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B16082094392626" PSS="true">
                <Name>Deolate</Name>
                <Pack ID="P2597160" Specified="true" nzmt:ctpp_id="50275841000117105">
                  <Quantity>84</Quantity>
                  <Price>8.97</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1608209496">
            <Name>Caspofungin</Name>
            <Request Form="RS1076" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Caspofungin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Proven or probable invasive fungal infection, to be prescribed under an established protocol</ci>
                    <apply>
                      <and/>
                      <ci type="logical">Possible invasive fungal infection</ci>
                      <ci type="logical">A multidisciplinary team (including an infectious disease physician or a clinical microbiologist) considers the treatment to be appropriate</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>haematologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>oncologist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Applicant>transplant specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1076" style="display:none"/>
            <Formulation ID="F160820949625" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B16082094962527" PSS="true">
                <Name>Alchemy Caspofungin</Name>
                <Pack ID="P2647567" Specified="true" nzmt:ctpp_id="50294261000117100">
                  <Quantity>1</Quantity>
                  <Price>110.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F160820949626" Rank="4" Units="inj" Weight="70">
              <Name>Inj 70 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B16082094962627" PSS="true">
                <Name>Alchemy Caspofungin</Name>
                <Pack ID="P2647575" Specified="true" nzmt:ctpp_id="50294271000117105">
                  <Quantity>1</Quantity>
                  <Price>135.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1612">
        <Name>Antimycobacterials</Name>
        <ATC3 ID="A161204">
          <Name>Antileprotics</Name>
          <Chemical ID="C1612048105">
            <Name>Clofazimine</Name>
            <Request Form="RS1077" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Clofazimine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>dermatologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1077" style="display:none"/>
            <Formulation ID="F161204810501" Rank="2" Units="cap" Weight="50">
              <Name>Cap 50 mg</Name>
              <Brand ID="B16120481050100">
                <Name>Any</Name>
                <Pack ID="P81050100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1612048126">
            <Name>Dapsone</Name>
            <Request Form="RS1078" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Dapsone</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>dermatologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1078" style="display:none"/>
            <Formulation ID="F161204812601" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B16120481260125">
                <Name>Dapsone</Name>
                <Pack ID="P712914" Specified="true" nzmt:ctpp_id="50104351000117107">
                  <Quantity>100</Quantity>
                  <Price>329.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F161204812602" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Brand ID="B16120481260225">
                <Name>Dapsone</Name>
                <Pack ID="P2212226" Specified="true" nzmt:ctpp_id="50033621000117107">
                  <Quantity>100</Quantity>
                  <Price>268.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A161208">
          <Name>Antituberculotics</Name>
          <Chemical ID="C1612088119">
            <Name>Cycloserine</Name>
            <Request Form="RS1079" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Cycloserine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1079" style="display:none"/>
            <Formulation ID="F161208811901" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Brand ID="B16120881190100">
                <Name>Any</Name>
                <Pack ID="P81190100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1612088245">
            <Name>Isoniazid with rifampicin</Name>
            <Request Form="RS1282" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Isoniazid with rifampicin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>dermatologist</Applicant>
                <Applicant>paediatrician</Applicant>
                <Applicant>public health physician</Applicant>
                <Applicant>internal medicine physician</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1282" style="display:none"/>
            <Formulation ID="F161208824501" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg with rifampicin 150 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B16120882450125" PSS="true">
                <Name>Rifinah</Name>
                <Pack ID="P251232" Specified="true" nzmt:ctpp_id="50052701000117104">
                  <Quantity>100</Quantity>
                  <Price>89.82</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F161208824502" Rank="1" Units="tab" Weight="150">
              <Name>Tab 150 mg with rifampicin 300 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B16120882450225" PSS="true">
                <Name>Rifinah</Name>
                <Pack ID="P251240" Specified="true" nzmt:ctpp_id="50052711000117101">
                  <Quantity>100</Quantity>
                  <Price>179.13</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1612088400">
            <Name>Pyrazinamide</Name>
            <Request Form="RS1085" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Pyrazinamide</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1085" style="display:none"/>
            <Formulation ID="F161208840001" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Brand ID="B16120884000100">
                <Name>Any</Name>
                <Pack ID="P84000100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1612088407">
            <Name>Rifampicin</Name>
            <Request Form="RS1087" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Rifampicin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>dermatologist</Applicant>
                <Applicant>internal medicine physician</Applicant>
                <Applicant>paediatrician</Applicant>
                <Applicant>public health physician</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1087" style="display:none"/>
            <Formulation ID="F161208840701" Rank="2" Units="cap" Weight="150">
              <Name>Cap 150 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B16120884070125" PSS="true">
                <Name>Rifadin</Name>
                <Pack ID="P251186" Specified="true" nzmt:ctpp_id="50052651000117108">
                  <Quantity>100</Quantity>
                  <Price>58.54</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F161208840702" Rank="2" Units="cap" Weight="300">
              <Name>Cap 300 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B16120884070225" PSS="true">
                <Name>Rifadin</Name>
                <Pack ID="P251194" Specified="true" nzmt:ctpp_id="50052661000117105">
                  <Quantity>100</Quantity>
                  <Price>122.06</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F161208840703" Rank="4" Units="inj" Weight="600">
              <Name>Inj 600 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B16120884070325" PSS="true">
                <Name>Rifadin</Name>
                <Pack ID="P698121" Specified="true" nzmt:ctpp_id="50102851000117105">
                  <Quantity>1</Quantity>
                  <Price>134.98</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F161208840704" Rank="3" Units="ml">
              <Name>Oral liq 100 mg per 5 ml</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B16120884070425" PSS="true">
                <Name>Rifadin</Name>
                <Pack ID="P251208" Specified="true" nzmt:ctpp_id="50052671000117100">
                  <Quantity>60</Quantity>
                  <Price>12.60</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1612088719">
            <Name>Bedaquiline</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1977">
              <Title>
                <range>Bedaquiline</range>
              </Title>
              <Case When="Initial application" Category="multi-drug resistant tuberculosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The person has multi-drug resistant tuberculosis (MDR-TB)</ci>
                    <ci type="logical">Ministry of Health’s Tuberculosis Clinical Network has reviewed the individual case and recommends bedaquiline as part of the treatment regimen</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1977" style="display:none"/>
            <Formulation ID="F161208871925" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B16120887192525">
                <Name>Sirturo</Name>
                <Pack ID="P2659956" Specified="true" nzmt:ctpp_id="50304581000117103">
                  <Quantity>24</Quantity>
                  <Price>3084.51</Price>
                </Pack>
                <Pack ID="P2659972" Specified="true" nzmt:ctpp_id="50222341000117109">
                  <Quantity>188</Quantity>
                  <Price>24162.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1612089367">
            <Name>Isoniazid</Name>
            <Request Form="RS1281" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Isoniazid</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>dermatologist</Applicant>
                <Applicant>paediatrician</Applicant>
                <Applicant>public health physician</Applicant>
                <Applicant>internal medicine physician</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1281" style="display:none"/>
            <Formulation ID="F161208936725" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B16120893672525">
                <Name>PSM</Name>
                <Pack ID="P267473" Specified="true" nzmt:ctpp_id="50059431000117105">
                  <Quantity>100</Quantity>
                  <Price>23.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B16120893672526">
                <Name>Isoniazid Teva</Name>
                <Pack ID="P2689294" Specified="true" nzmt:ctpp_id="50339821000117107">
                  <Quantity>100</Quantity>
                  <Price>94.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1612089397">
            <Name>Rifabutin</Name>
            <Request Form="RS1086" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Rifabutin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>gastroenterologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1086" style="display:none"/>
            <Formulation ID="F161208939725" Rank="2" Units="cap" Weight="150">
              <Name>Cap 150 mg</Name>
              <Brand ID="B16120893972525">
                <Name>Mycobutin</Name>
                <Pack ID="P219924" Specified="true" nzmt:ctpp_id="50031871000117108">
                  <Quantity>30</Quantity>
                  <Price>353.71</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1612089514">
            <Name>Ethambutol hydrochloride</Name>
            <Request Form="RS1080" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ethambutol hydrochloride</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1080" style="display:none"/>
            <Formulation ID="F161208951425" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B16120895142500">
                <Name>Any</Name>
                <Pack ID="P95142500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F161208951426" Rank="1" Units="tab" Weight="400">
              <Name>Tab 400 mg</Name>
              <Brand ID="B16120895142625">
                <Name>Myambutol</Name>
                <Pack ID="P2244969" Specified="true" nzmt:ctpp_id="50038861000117108">
                  <Quantity>56</Quantity>
                  <Price>49.34</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1612089684">
            <Name>Para-aminosalicylic Acid</Name>
            <Request Form="RS1083" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Para-aminosalicylic Acid</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1083" style="display:none"/>
            <Formulation ID="F161208968401" Rank="2" Units="sach">
              <Name>Grans for oral liq 4 g</Name>
              <Brand ID="B16120896840125">
                <Name>Paser</Name>
                <Pack ID="P2254921" Specified="true" nzmt:ctpp_id="50164571000117108">
                  <Quantity>30</Quantity>
                  <Price>280.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1612089687">
            <Name>Protionamide</Name>
            <Request Form="RS1084" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Protionamide</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1084" style="display:none"/>
            <Formulation ID="F161208968725" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B16120896872525">
                <Name>Peteha</Name>
                <Pack ID="P2434695" Specified="true" nzmt:ctpp_id="50164601000117103">
                  <Quantity>100</Quantity>
                  <Price>305.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1616">
        <Name>Antiparasitics</Name>
        <ATC3 ID="A161604">
          <Name>Anthelmintics</Name>
          <Chemical ID="C1616048009">
            <Name>Albendazole</Name>
            <Request Form="RS1088" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Albendazole</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1088" style="display:none"/>
            <Formulation ID="F161604800901" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B16160480090100">
                <Name>Any</Name>
                <Pack ID="P80090100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F161604800925" Rank="1" Units="tab" Weight="400">
              <Name>Tab 400 mg</Name>
              <Brand ID="B16160480092500">
                <Name>Any</Name>
                <Pack ID="P80092500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1616048383">
            <Name>Praziquantel</Name>
            <Formulation ID="F161604838301" Rank="1" Units="tab" Weight="600">
              <Name>Tab 600 mg</Name>
              <Brand ID="B16160483830100">
                <Name>Any</Name>
                <Pack ID="P83830100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1616049441">
            <Name>Ivermectin</Name>
            <Request Form="RS1283" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ivermectin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>dermatologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1283" style="display:none"/>
            <Formulation ID="F161604944125" Rank="1" Units="tab" Weight="3">
              <Name>Tab 3 mg</Name>
              <Brand ID="B16160494412525">
                <Name>Stromectol</Name>
                <Pack ID="P2087057" Specified="true" nzmt:ctpp_id="50015351000117100">
                  <Quantity>4</Quantity>
                  <Price>17.20</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1616049472">
            <Name>Mebendazole</Name>
            <Formulation ID="F161604947201" Rank="3" Units="ml">
              <Name>Oral liq 100 mg per 5 ml</Name>
              <Brand ID="B16160494720100">
                <Name>Any</Name>
                <Pack ID="P94720100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F161604947225" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B16160494722526" PSS="true">
                <Name>Vermox</Name>
                <Pack ID="P258040" Specified="true" nzmt:ctpp_id="50056101000117102">
                  <Quantity>6</Quantity>
                  <Price>5.18</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A161608">
          <Name>Antiprotozoals</Name>
          <Chemical ID="C1616088038">
            <Name>Artemether with lumefantrine</Name>
            <Request Form="RS1090" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Artemether with lumefantrine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1090" style="display:none"/>
            <Formulation ID="F161608803801" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg with lumefantrine 120 mg</Name>
              <Brand ID="B16160880380100">
                <Name>Any</Name>
                <Pack ID="P80380100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1616088039">
            <Name>Artesunate</Name>
            <Request Form="RS1091" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Artesunate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1091" style="display:none"/>
            <Formulation ID="F161608803901" Rank="4" Units="inj" Weight="60">
              <Name>Inj 60 mg vial</Name>
              <Brand ID="B16160880390100">
                <Name>Any</Name>
                <Pack ID="P80390100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1616088042">
            <Name>Atovaquone with proguanil hydrochloride</Name>
            <Request Form="RS1092" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Atovaquone with proguanil hydrochloride</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1092" style="display:none"/>
            <Formulation ID="F161608804201" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg with proguanil hydrochloride 100 mg</Name>
              <Brand ID="B16160880420125">
                <Name>Malarone</Name>
                <Pack ID="P2016370" Specified="true" nzmt:ctpp_id="50003031000117109">
                  <Quantity>12</Quantity>
                  <Price>64.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F161608804225" Rank="1" Units="tab">
              <Name>Tab 62.5 mg with proguanil hydrochloride 25 mg</Name>
              <Brand ID="B16160880422525">
                <Name>Malarone Junior</Name>
                <Pack ID="P2385538" Specified="true" nzmt:ctpp_id="50123651000117109">
                  <Quantity>12</Quantity>
                  <Price>25.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1616088091">
            <Name>Chloroquine phosphate</Name>
            <Request Form="RS1093" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Chloroquine phosphate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>dermatologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1093" style="display:none"/>
            <Formulation ID="F161608809101" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B16160880910100">
                <Name>Any</Name>
                <Pack ID="P80910100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1616088284">
            <Name>Mefloquine</Name>
            <Request Form="RS1094" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Mefloquine hydrochloride</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>dermatologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1094" style="display:none"/>
            <Formulation ID="F161608828401" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B16160882840100">
                <Name>Any</Name>
                <Pack ID="P82840100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1616088348">
            <Name>Pentamidine isethionate</Name>
            <Request Form="RS1096" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Pentamidine isethionate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1096" style="display:none"/>
            <Formulation ID="F161608834801" Rank="4" Units="inj" Weight="300">
              <Name>Inj 300 mg vial</Name>
              <Brand ID="B16160883480125">
                <Name>Pentacarinat</Name>
                <Pack ID="P471933" Specified="true" nzmt:ctpp_id="50088921000117102">
                  <Quantity>5</Quantity>
                  <Price>216.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1616088389">
            <Name>Primaquine</Name>
            <Request Form="RS1097" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Primaquine phosphate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1097" style="display:none"/>
            <Formulation ID="F161608838901" Rank="1" Units="tab" Weight="7.5">
              <Name>Tab 7.5 mg</Name>
              <Brand ID="B16160883890100">
                <Name>Any</Name>
                <Pack ID="P83890100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F161608838925" Rank="1" Units="tab">
              <Name>Tab 15 mg</Name>
              <Brand ID="B16160883892500">
                <Name>Any</Name>
                <Pack ID="P83892500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1616088401">
            <Name>Pyrimethamine</Name>
            <Request Form="RS1098" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Pyrimethamine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>maternal-foetal medicine specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1098" style="display:none"/>
            <Formulation ID="F161608840101" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Brand ID="B16160884010100">
                <Name>Any</Name>
                <Pack ID="P84010100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1616088402">
            <Name>Quinine dihydrochloride</Name>
            <Request Form="RS1099" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Quinine dihydrochloride</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1099" style="display:none"/>
            <Formulation ID="F161608840201" Rank="4" Units="inj" Weight="300">
              <Name>Inj 300 mg per ml, 2 ml vial</Name>
              <Brand ID="B16160884020100">
                <Name>Any</Name>
                <Pack ID="P84020100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F161608840202" Rank="4" Units="inj" Weight="60">
              <Name>Inj 60 mg per ml, 10 ml ampoule</Name>
              <Brand ID="B16160884020200">
                <Name>Any</Name>
                <Pack ID="P84020200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1616088436">
            <Name>Sodium stibogluconate</Name>
            <Request Form="RS1100" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Sodium stibogluconate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1100" style="display:none"/>
            <Formulation ID="F161608843601" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg per ml, 1 ml vial</Name>
              <Brand ID="B16160884360100">
                <Name>Any</Name>
                <Pack ID="P84360100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1616088443">
            <Name>Spiramycin</Name>
            <Request Form="RS1101" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Spiramycin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>maternal-foetal medicine specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1101" style="display:none"/>
            <Formulation ID="F161608844301" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Brand ID="B16160884430100">
                <Name>Any</Name>
                <Pack ID="P84430100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1616089345">
            <Name>Metronidazole</Name>
            <Formulation ID="F161608934525" Rank="4" Units="inj" Weight="500">
              <Name>Inj 5 mg per ml, 100 ml bag</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B16160893452526" PSS="true">
                <Name>Baxter</Name>
                <Pack ID="P2548305" Specified="true" nzmt:ctpp_id="50125721000117109">
                  <Quantity>10</Quantity>
                  <Price>18.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F161608934526" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B16160893452626" ToBeDelisted="2025-03-01">
                <Name>Metrogyl</Name>
                <Pack ID="P2580071" Specified="true" nzmt:ctpp_id="50257541000117101">
                  <Quantity>250</Quantity>
                  <Price>33.15</Price>
                </Pack>
              </Brand>
              <Brand ID="B16160893452627" PSS="true">
                <Name>Metronidamed</Name>
                <Pack ID="P2684446" Specified="true" nzmt:ctpp_id="50312661000117101">
                  <Quantity>250</Quantity>
                  <Price>25.86</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F161608934527" Rank="1" Units="tab" Weight="400">
              <Name>Tab 400 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B16160893452726" ToBeDelisted="2025-03-01">
                <Name>Metrogyl</Name>
                <Pack ID="P2580098" Specified="true" nzmt:ctpp_id="50257551000117104">
                  <Quantity>21</Quantity>
                  <Price>5.23</Price>
                </Pack>
              </Brand>
              <Brand ID="B16160893452727" PSS="true">
                <Name>Metronidamed</Name>
                <Pack ID="P2684454" Specified="true" nzmt:ctpp_id="50312761000117108">
                  <Quantity>21</Quantity>
                  <Price>4.29</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F161608934528" Rank="3" Units="ml" Weight="200">
              <Name>Oral liq benzoate 200 mg per 5 ml</Name>
              <Brand ID="B16160893452825">
                <Name>Flagyl-S</Name>
                <Pack ID="P729426" Specified="true" nzmt:ctpp_id="50106681000117102">
                  <Quantity>100</Quantity>
                  <Price>25.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F161608934529" Rank="5" Units="supp" Weight="500">
              <Name>Suppos 500 mg</Name>
              <Brand ID="B16160893452925">
                <Name>Flagyl</Name>
                <Pack ID="P250511" Specified="true" nzmt:ctpp_id="50052391000117105">
                  <Quantity>10</Quantity>
                  <Price>24.48</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1616089587">
            <Name>Ornidazole</Name>
            <Formulation ID="F161608958725" Rank="1" Units="tab" Weight="5000">
              <Name>Tab 500 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B16160895872525" PSS="true">
                <Name>Arrow-Ornidazole</Name>
                <Pack ID="P2385325" Specified="true" nzmt:ctpp_id="50122911000117107">
                  <Quantity>10</Quantity>
                  <Price>36.52</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1616089683">
            <Name>Nitazoxanide</Name>
            <Request Form="RS1095" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Nitazoxanide</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1095" style="display:none"/>
            <Formulation ID="F161608968301" Rank="3" Units="ml">
              <Name>Oral liq 100 mg per 5 ml</Name>
              <Brand ID="B16160896830100">
                <Name>Any</Name>
                <Pack ID="P96830100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F161608968325" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Brand ID="B16160896832525">
                <Name>Alinia</Name>
                <Pack ID="P2434687" Specified="true" nzmt:ctpp_id="50164651000117104">
                  <Quantity>30</Quantity>
                  <Price>1680.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1620">
        <Name>Antiretrovirals</Name>
        <ATC3 ID="A162008">
          <Name>Non-Nucleoside Reverse Transcriptase Inhibitors</Name>
          <Request Form="RS1898" To="HealthPAC" For="Subsidy">
            <Title>
              <range>Non-Nucleoside Reverse Transcriptase Inhibitors</range>
            </Title>
            <Case When="Initial application" Category="Confirmed HIV">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <ci type="logical">Patient has confirmed HIV infection</ci>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
            <Case When="Initial application" Category="Prevention of maternal transmission">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <or/>
                  <ci type="logical">Prevention of maternal foetal transmission</ci>
                  <ci type="logical">Treatment of the newborn for up to eight weeks</ci>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
            <Case When="Initial application" Category="Post-exposure prophylaxis following exposure to HIV">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <and/>
                  <ci type="logical" class="Treatment">Treatment course to be initiated within 72
                    hours post exposure</ci>
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">Patient has had condomless anal
                        intercourse or receptive vaginal intercourse with a known HIV positive
                        person with an unknown or detectable viral load greater than 200 copies per
                        ml</ci>
                    <ci type="logical" class="Indication">Patient has shared intravenous injecting
                        equipment with a known HIV positive person</ci>
                    <ci type="logical" class="Indication">Patient has had non-consensual intercourse
                        and the clinician considers that the risk assessment indicates prophylaxis
                        is required</ci>
                    <ci type="logical" class="Indication">Patient has had condomless anal
                        intercourse with a person from a high HIV prevalence country or risk group
                        whose HIV status is unknown</ci>
                  </apply>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Refer to local health pathways or the Australasian Society for HIV, Viral Hepatitis and
                Sexual Health Medicine clinical guidelines for PEP
                (https://www.ashm.org.au/hiv/hiv-management/pep/).</p>
              </div>
            </Case>
            <Case When="Initial application" Category="Percutaneous exposure">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <ci type="logical">Patient has percutaneous exposure to blood known to be HIV
                positive</ci>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
          </Request>
          <html:div class="Restricted" xlink:href="RS1898" style="display:none"/>
          <Chemical ID="C1620089326">
            <Name>Nevirapine</Name>
            <Formulation ID="F162008932625" Rank="3" Units="ml">
              <Name>Oral suspension 10 mg per ml</Name>
              <Brand ID="B16200893262525">
                <Name>Viramune Suspension</Name>
                <Pack ID="P2014947" Specified="true" nzmt:ctpp_id="50002451000117104">
                  <Quantity>240</Quantity>
                  <Price>203.55</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162008932626" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B16200893262627" PSS="true">
                <Name>Nevirapine Viatris</Name>
                <Pack ID="P2640023" Specified="true" nzmt:ctpp_id="50290881000117104">
                  <Quantity>60</Quantity>
                  <Price>198.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1620089564">
            <Name>Etravirine</Name>
            <Formulation ID="F162008956426" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B16200895642625">
                <Name>Intelence</Name>
                <Pack ID="P2426900" Specified="true" nzmt:ctpp_id="50147481000117106">
                  <Quantity>60</Quantity>
                  <Price>770.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1620089630">
            <Name>Efavirenz</Name>
            <Formulation ID="F162008963001" Rank="3" Units="ml">
              <Name>Oral liq 30 mg per ml</Name>
              <Brand ID="B16200896300100">
                <Name>Any</Name>
                <Pack ID="P96300100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162008963026" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B16200896302625">
                <Name>Stocrin</Name>
                <Pack ID="P2292483" Specified="true" nzmt:ctpp_id="50044841000117103">
                  <Quantity>90</Quantity>
                  <Price>190.15</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162008963027" Rank="1" Units="tab" Weight="600">
              <Name>Tab 600 mg</Name>
              <Brand ID="B16200896302725">
                <Name>Stocrin</Name>
                <Pack ID="P2060094" Specified="true" nzmt:ctpp_id="50010681000117109">
                  <Quantity>30</Quantity>
                  <Price>63.38</Price>
                </Pack>
              </Brand>
              <Brand ID="B16200896302726">
                <Name>Efavirenz Milpharm</Name>
                <Pack ID="P2676915" Specified="true" nzmt:ctpp_id="50330991000117105">
                  <Quantity>30</Quantity>
                  <Price>65.38</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A162012">
          <Name>Nucleoside Reverse Transcriptase Inhibitors</Name>
          <Request Form="RS1899" To="HealthPAC" For="Subsidy">
            <Title>
              <range>Nucleoside Reverse Transcriptase Inhibitors</range>
            </Title>
            <Case When="Initial application" Category="Confirmed HIV">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <ci type="logical">Patient has confirmed HIV infection</ci>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
            <Case When="Initial application" Category="Prevention of maternal transmission">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <or/>
                  <ci type="logical">Prevention of maternal foetal transmission</ci>
                  <ci type="logical">Treatment of the newborn for up to eight weeks</ci>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
            <Case When="Initial application" Category="Post-exposure prophylaxis following exposure to HIV">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <and/>
                  <ci type="logical" class="Treatment">Treatment course to be initiated within 72
                    hours post exposure</ci>
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">Patient has had condomless anal
                        intercourse or receptive vaginal intercourse with a known HIV positive
                        person with an unknown or detectable viral load greater than 200 copies per
                        ml</ci>
                    <ci type="logical" class="Indication">Patient has shared intravenous injecting
                        equipment with a known HIV positive person</ci>
                    <ci type="logical" class="Indication">Patient has had non-consensual intercourse
                        and the clinician considers that the risk assessment indicates prophylaxis
                        is required</ci>
                    <ci type="logical" class="Indication">Patient has had condomless anal
                        intercourse with a person from a high HIV prevalence country or risk group
                        whose HIV status is unknown</ci>
                  </apply>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Refer to local health pathways or the Australasian Society for HIV, Viral Hepatitis and
                Sexual Health Medicine clinical guidelines for PEP
                (https://www.ashm.org.au/hiv/hiv-management/pep/).</p>
              </div>
            </Case>
            <Case When="Initial application" Category="Percutaneous exposure">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <ci type="logical">Patient has percutaneous exposure to blood known to be HIV
                positive</ci>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
          </Request>
          <html:div class="Restricted" xlink:href="RS1899" style="display:none"/>
          <Chemical ID="C1620128445">
            <Name>Stavudine</Name>
            <Formulation ID="F162012844501" Rank="2" Units="cap" Weight="30">
              <Name>Cap 30 mg</Name>
              <Brand ID="B16201284450100">
                <Name>Any</Name>
                <Pack ID="P84450100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162012844502" Rank="2" Units="cap" Weight="40">
              <Name>Cap 40 mg</Name>
              <Brand ID="B16201284450200">
                <Name>Any</Name>
                <Pack ID="P84450200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162012844503" Rank="3" Units="g">
              <Name>Powder for oral soln 1 mg per ml</Name>
              <Brand ID="B16201284450300">
                <Name>Any</Name>
                <Pack ID="P84450300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1620129353">
            <Name>Abacavir sulphate with lamivudine</Name>
            <Formulation ID="F162012935325" Rank="1" Units="tab" Weight="600">
              <Name>Tab 600 mg with lamivudine 300 mg</Name>
              <Rule Type="DVLimit" Attribute="May-23 to~2025" Value="5"/>
              <Brand ID="B16201293532526" PSS="true">
                <Name>Abacavir/lamivudine Viatris</Name>
                <Pack ID="P2632365" Specified="true" nzmt:ctpp_id="50301251000117109">
                  <Quantity>30</Quantity>
                  <Price>29.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1620129371">
            <Name>Emtricitabine</Name>
            <Formulation ID="F162012937125" Rank="2" Units="cap" Weight="200">
              <Name>Cap 200 mg</Name>
              <Brand ID="B16201293712525">
                <Name>Emtriva</Name>
                <Pack ID="P2250063" Specified="true" nzmt:ctpp_id="50039681000117108">
                  <Quantity>30</Quantity>
                  <Price>307.20</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1620129532">
            <Name>Zidovudine [AZT]</Name>
            <Formulation ID="F162012953201" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 20 ml vial</Name>
              <Brand ID="B16201295320125">
                <Name>Retrovir IV</Name>
                <Pack ID="P2086220" Specified="true" nzmt:ctpp_id="50014581000117101">
                  <Quantity>5</Quantity>
                  <Price>750.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162012953225" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Brand ID="B16201295322525">
                <Name>Retrovir</Name>
                <Pack ID="P552666" Specified="true" nzmt:ctpp_id="50095731000117105">
                  <Quantity>100</Quantity>
                  <Price>152.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162012953226" Rank="3" Units="ml" Weight="10">
              <Name>Oral liq 10 mg per ml</Name>
              <Brand ID="B16201295322625">
                <Name>Retrovir</Name>
                <Pack ID="P818682" Specified="true" nzmt:ctpp_id="50117731000117106">
                  <Quantity>200</Quantity>
                  <Price>30.45</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1620129583">
            <Name>Abacavir sulphate</Name>
            <Formulation ID="F162012958325" Rank="1" Units="tab" Weight="300">
              <Name>Tab 300 mg</Name>
              <Brand ID="B16201295832525">
                <Name>Ziagen</Name>
                <Pack ID="P378038" Specified="true" nzmt:ctpp_id="50079501000117100">
                  <Quantity>60</Quantity>
                  <Price>180.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162012958326" Rank="3" Units="ml" Weight="20">
              <Name>Oral liq 20 mg per ml</Name>
              <Brand ID="B16201295832600">
                <Name>Any</Name>
                <Pack ID="P95832600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1620129660">
            <Name>Lamivudine</Name>
            <Formulation ID="F162012966001" Rank="3" Units="ml">
              <Name>Oral liq 10 mg per ml</Name>
              <Brand ID="B16201296600100">
                <Name>Any</Name>
                <Pack ID="P96600100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162012966003" Rank="1" Units="tab" Weight="150">
              <Name>Tab 150 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B16201296600326" PSS="true">
                <Name>Lamivudine Viatris</Name>
                <Pack ID="P2638045" Specified="true" nzmt:ctpp_id="50293701000117105">
                  <Quantity>60</Quantity>
                  <Price>98.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1620129663">
            <Name>Zidovudine [AZT] with lamivudine</Name>
            <Formulation ID="F162012966325" Rank="1" Units="tab" Weight="300">
              <Name>Tab 300 mg with lamivudine 150 mg</Name>
              <Brand ID="B16201296632526">
                <Name>Lamivudine/Zidovudine Viatris</Name>
                <Pack ID="P2645300" Specified="true" nzmt:ctpp_id="50290701000117100">
                  <Quantity>60</Quantity>
                  <Price>92.40</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1620129669">
            <Name>Efavirenz with emtricitabine and tenofovir disoproxil</Name>
            <Formulation ID="F162012966926" Rank="1" Units="tab">
              <Name>Tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil 245 mg (300 mg as a maleate)</Name>
              <Brand ID="B16201296692626">
                <Name>Viatris</Name>
                <Pack ID="P2644967" Specified="true" nzmt:ctpp_id="50292041000117100">
                  <Quantity>30</Quantity>
                  <Price>106.88</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A162016">
          <Name>Protease Inhibitors</Name>
          <Request Form="RS1900" To="HealthPAC" For="Subsidy">
            <Title>
              <range>Protease Inhibitors</range>
            </Title>
            <Case When="Initial application" Category="Confirmed HIV">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <ci type="logical">Patient has confirmed HIV infection</ci>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
            <Case When="Initial application" Category="Prevention of maternal transmission">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <or/>
                  <ci type="logical">Prevention of maternal foetal transmission</ci>
                  <ci type="logical">Treatment of the newborn for up to eight weeks</ci>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
            <Case When="Initial application" Category="Post-exposure prophylaxis following exposure to HIV">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <and/>
                  <ci type="logical" class="Treatment">Treatment course to be initiated within 72
                    hours post exposure</ci>
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">Patient has had condomless anal
                        intercourse or receptive vaginal intercourse with a known HIV positive
                        person with an unknown or detectable viral load greater than 200 copies per
                        ml</ci>
                    <ci type="logical" class="Indication">Patient has shared intravenous injecting
                        equipment with a known HIV positive person</ci>
                    <ci type="logical" class="Indication">Patient has had non-consensual intercourse
                        and the clinician considers that the risk assessment indicates prophylaxis
                        is required</ci>
                    <ci type="logical" class="Indication">Patient has had condomless anal
                        intercourse with a person from a high HIV prevalence country or risk group
                        whose HIV status is unknown</ci>
                  </apply>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Refer to local health pathways or the Australasian Society for HIV, Viral Hepatitis and
                Sexual Health Medicine clinical guidelines for PEP
                (https://www.ashm.org.au/hiv/hiv-management/pep/).</p>
              </div>
            </Case>
            <Case When="Initial application" Category="Percutaneous exposure">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <ci type="logical">Patient has percutaneous exposure to blood known to be HIV
                positive</ci>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
          </Request>
          <html:div class="Restricted" xlink:href="RS1900" style="display:none"/>
          <Chemical ID="C1620168226">
            <Name>Indinavir</Name>
            <Formulation ID="F162016822601" Rank="2" Units="cap" Weight="200">
              <Name>Cap 200 mg</Name>
              <Brand ID="B16201682260100">
                <Name>Any</Name>
                <Pack ID="P82260100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162016822602" Rank="2" Units="cap" Weight="400">
              <Name>Cap 400 mg</Name>
              <Brand ID="B16201682260200">
                <Name>Any</Name>
                <Pack ID="P82260200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1620169206">
            <Name>Ritonavir</Name>
            <Formulation ID="F162016920626" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B16201692062625">
                <Name>Norvir</Name>
                <Pack ID="P2379317" Specified="true" nzmt:ctpp_id="50122321000117102">
                  <Quantity>30</Quantity>
                  <Price>43.31</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1620169347">
            <Name>Atazanavir sulphate</Name>
            <Formulation ID="F162016934725" Rank="2" Units="cap" Weight="150">
              <Name>Cap 150 mg</Name>
              <Rule Type="DVLimit" Attribute="May-23 to~2025" Value="5"/>
              <Brand ID="B16201693472527" HSS="true">
                <Name>Atazanavir Mylan</Name>
                <Pack ID="P2640015" Specified="true" nzmt:ctpp_id="50239721000117105">
                  <Quantity>60</Quantity>
                  <Price>85.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162016934726" Rank="2" Units="cap" Weight="200">
              <Name>Cap 200 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2025" Value="5"/>
              <Brand ID="B16201693472627" ToBeDelisted="2024-12-01">
                <Name>Atazanavir Mylan</Name>
                <Pack ID="P2642794" Specified="true" nzmt:ctpp_id="50302481000117109">
                  <Quantity>60</Quantity>
                  <Price>110.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B16201693472628" PSS="true">
                <Name>Atazanavir Viatris</Name>
                <Pack ID="P2660024" Specified="true" nzmt:ctpp_id="50319321000117108">
                  <Quantity>60</Quantity>
                  <Price>110.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1620169402">
            <Name>Lopinavir with ritonavir</Name>
            <Formulation ID="F162016940225" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg with ritonavir 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B16201694022526" PSS="true">
                <Name>Lopinavir/Ritonavir Mylan</Name>
                <Pack ID="P2613549" Specified="true" nzmt:ctpp_id="50218941000117103">
                  <Quantity>120</Quantity>
                  <Price>875.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162016940227" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg with ritonavir 25 mg</Name>
              <Brand ID="B16201694022726">
                <Name>Lopinavir/Ritonavir Mylan</Name>
                <Pack ID="P2613530" Specified="true" nzmt:ctpp_id="50218911000117102">
                  <Quantity>60</Quantity>
                  <Price>150.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1620169562">
            <Name>Darunavir</Name>
            <Formulation ID="F162016956226" Rank="1" Units="tab" Weight="400">
              <Name>Tab 400 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B16201695622627" PSS="true">
                <Name>Darunavir Viatris</Name>
                <Pack ID="P2626462" Specified="true" nzmt:ctpp_id="50290581000117102">
                  <Quantity>60</Quantity>
                  <Price>150.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162016956227" Rank="1" Units="tab" Weight="600">
              <Name>Tab 600 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B16201695622727" PSS="true">
                <Name>Darunavir Viatris</Name>
                <Pack ID="P2626470" Specified="true" nzmt:ctpp_id="50290621000117102">
                  <Quantity>60</Quantity>
                  <Price>225.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A162020">
          <Name>Strand Transfer Inhibitors</Name>
          <Request Form="RS1901" To="HealthPAC" For="Subsidy">
            <Title>
              <range>Strand Transfer Inhibitors</range>
            </Title>
            <Case When="Initial application" Category="Confirmed HIV">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <ci type="logical">Patient has confirmed HIV infection</ci>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
            <Case When="Initial application" Category="Prevention of maternal transmission">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <or/>
                  <ci type="logical">Prevention of maternal foetal transmission</ci>
                  <ci type="logical">Treatment of the newborn for up to eight weeks</ci>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
            <Case When="Initial application" Category="Post-exposure prophylaxis following exposure to HIV">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <and/>
                  <ci type="logical" class="Treatment">Treatment course to be initiated within 72
                    hours post exposure</ci>
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">Patient has had condomless anal
                        intercourse or receptive vaginal intercourse with a known HIV positive
                        person with an unknown or detectable viral load greater than 200 copies per
                        ml</ci>
                    <ci type="logical" class="Indication">Patient has shared intravenous injecting
                        equipment with a known HIV positive person</ci>
                    <ci type="logical" class="Indication">Patient has had non-consensual intercourse
                        and the clinician considers that the risk assessment indicates prophylaxis
                        is required</ci>
                    <ci type="logical" class="Indication">Patient has had condomless anal
                        intercourse with a person from a high HIV prevalence country or risk group
                        whose HIV status is unknown</ci>
                  </apply>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Refer to local health pathways or the Australasian Society for HIV, Viral Hepatitis and
                Sexual Health Medicine clinical guidelines for PEP
                (https://www.ashm.org.au/hiv/hiv-management/pep/).</p>
              </div>
            </Case>
            <Case When="Initial application" Category="Percutaneous exposure">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <ci type="logical">Patient has percutaneous exposure to blood known to be HIV
                positive</ci>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
          </Request>
          <html:div class="Restricted" xlink:href="RS1901" style="display:none"/>
          <Chemical ID="C1620208599">
            <Name>Dolutegravir</Name>
            <Formulation ID="F162020859925" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B16202085992525">
                <Name>Tivicay</Name>
                <Pack ID="P2510979" Specified="true" nzmt:ctpp_id="50197421000117104">
                  <Quantity>30</Quantity>
                  <Price>1090.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1620208736">
            <Name>Dolutegravir with lamivudine</Name>
            <Formulation ID="F162020873625" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg with lamivudine 300 mg</Name>
              <Brand ID="B16202087362525">
                <Name>Dovato</Name>
                <Pack ID="P2674335" Specified="true" nzmt:ctpp_id="50276821000117105">
                  <Quantity>30</Quantity>
                  <Price>1090.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1620209506">
            <Name>Raltegravir potassium</Name>
            <Formulation ID="F162020950625" Rank="1" Units="tab" Weight="400">
              <Name>Tab 400 mg</Name>
              <Brand ID="B16202095062525">
                <Name>Isentress</Name>
                <Pack ID="P2324059" Specified="true" nzmt:ctpp_id="50049001000117107">
                  <Quantity>60</Quantity>
                  <Price>1090.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162020950626" Rank="1" Units="tab" Weight="600">
              <Name>Tab 600 mg</Name>
              <Brand ID="B16202095062625">
                <Name>Isentress HD</Name>
                <Pack ID="P2562960" Specified="true" nzmt:ctpp_id="50249791000117108">
                  <Quantity>60</Quantity>
                  <Price>1090.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1624">
        <Name>Antivirals</Name>
        <ATC3 ID="A162404">
          <Name>Hepatitis B</Name>
          <Chemical ID="C1624049375">
            <Name>Tenofovir disoproxil</Name>
            <Formulation ID="F162404937527" Rank="1" Units="tab">
              <Name>Tab 245 mg (300 mg as a maleate)</Name>
              <Rule Type="DVLimit" Attribute="Sep-23 to~2025" Value="5"/>
              <Brand ID="B16240493752726" PSS="true">
                <Name>Tenofovir Disoproxil Viatris</Name>
                <Pack ID="P2638061" Specified="true" nzmt:ctpp_id="50300001000117106">
                  <Quantity>30</Quantity>
                  <Price>15.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1624049492">
            <Name>Entecavir</Name>
            <Formulation ID="F162404949225" Rank="1" Units="tab" Weight="0.5">
              <Name>Tab 0.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B16240494922527" PSS="true">
                <Name>Entecavir (Rex)</Name>
                <Pack ID="P2654431" Specified="true" nzmt:ctpp_id="50255601000117109">
                  <Quantity>30</Quantity>
                  <Price>12.04</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1624049660">
            <Name>Lamivudine</Name>
            <Formulation ID="F162404966002" Rank="3" Units="ml">
              <Name>Oral liq 5 mg per ml</Name>
              <Brand ID="B16240496600225">
                <Name>Zeffix</Name>
                <Pack ID="P307696" Specified="true" nzmt:ctpp_id="50068991000117102">
                  <Quantity>240</Quantity>
                  <Price>270.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162404966025" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B16240496602525" PSS="true">
                <Name>Zetlam</Name>
                <Pack ID="P2399369" Specified="true" nzmt:ctpp_id="50145051000117103">
                  <Quantity>28</Quantity>
                  <Price>12.06</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A162406">
          <Name>Hepatitis C</Name>
          <Chemical ID="C1624068590">
            <Name>Ledipasvir with sofosbuvir</Name>
            <Request Form="RS1528" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ledipasvir with sofosbuvir</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Only for use in patients with approval by the Hepatitis C Treatment Panel (HepCTP). Applications will be considered by HepCTP at its regular meetings and approved subject to eligibility according to the Access Criteria (set out in Section B of the Pharmaceutical Schedule).</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1528" style="display:none"/>
            <Formulation ID="F162406859025" Rank="1" Units="tab">
              <Name>Tab 90 mg with sofosbuvir 400 mg</Name>
              <Brand ID="B16240685902525">
                <Name>Harvoni</Name>
                <Pack ID="P2504111" Specified="true" nzmt:ctpp_id="50203981000117104">
                  <Quantity>28</Quantity>
                  <Price>24363.46</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1624068638">
            <Name>Glecaprevir with pibrentasvir</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: the supply of treatment is via Pharmac’s approved direct distribution supply. Further details can be found on Pharmac’s website https://www.pharmac.govt.nz/maviret.</p>
            </div>
            <Formulation ID="F162406863825" Rank="1" Units="tab">
              <Name>Tab 100 mg with pibrentasvir 40 mg</Name>
              <Brand ID="B16240686382525">
                <Name>Maviret</Name>
                <Pack ID="P2552019" Specified="true" nzmt:ctpp_id="50240831000117105">
                  <Quantity>84</Quantity>
                  <Price>24750.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A162408">
          <Name>Herpesviridae</Name>
          <Chemical ID="C1624088098">
            <Name>Cidofovir</Name>
            <Request Form="RS1108" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Cidofovir</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>otolaryngologist</Applicant>
                <Applicant>oral surgeon</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1108" style="display:none"/>
            <Formulation ID="F162408809801" Rank="4" Units="inj" Weight="75">
              <Name>Inj 75 mg per ml, 5 ml vial</Name>
              <Brand ID="B16240880980100">
                <Name>Any</Name>
                <Pack ID="P80980100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1624088193">
            <Name>Foscarnet sodium</Name>
            <Request Form="RS1109" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Foscarnet sodium</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1109" style="display:none"/>
            <Formulation ID="F162408819301" Rank="4" Units="inj" Weight="24">
              <Name>Inj 24 mg per ml, 250 ml bottle</Name>
              <Brand ID="B16240881930100">
                <Name>Any</Name>
                <Pack ID="P81930100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1624089022">
            <Name>Ganciclovir</Name>
            <Request Form="RS1110" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ganciclovir</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>clinical microbiologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1110" style="display:none"/>
            <Formulation ID="F162408902202" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg vial</Name>
              <Brand ID="B16240890220201">
                <Name>Cymevene</Name>
                <Pack ID="P422037" Specified="true" nzmt:ctpp_id="50083951000117102">
                  <Quantity>5</Quantity>
                  <Price>380.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1624089123">
            <Name>Aciclovir</Name>
            <Formulation ID="F162408912325" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B16240891232529" PSS="true">
                <Name>Aciclovir-Baxter</Name>
                <Pack ID="P2599414" Specified="true" nzmt:ctpp_id="50281541000117104">
                  <Quantity>5</Quantity>
                  <Price>13.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162408912326" Rank="1" Units="tab" Weight="200">
              <Name>Tab dispersible 200 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2025" Value="5"/>
              <Brand ID="B16240891232626" PSS="true">
                <Name>Lovir</Name>
                <Pack ID="P471704" Specified="true" nzmt:ctpp_id="50088761000117108">
                  <Quantity>25</Quantity>
                  <Price>1.78</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162408912327" Rank="1" Units="tab" Weight="400">
              <Name>Tab dispersible 400 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B16240891232726" PSS="true">
                <Name>Lovir</Name>
                <Pack ID="P471690" Specified="true" nzmt:ctpp_id="50088751000117106">
                  <Quantity>56</Quantity>
                  <Price>5.81</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162408912328" Rank="1" Units="tab" Weight="800">
              <Name>Tab dispersible 800 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B16240891232826" PSS="true">
                <Name>Lovir</Name>
                <Pack ID="P471712" Specified="true" nzmt:ctpp_id="50088771000117103">
                  <Quantity>35</Quantity>
                  <Price>6.46</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1624089489">
            <Name>Valaciclovir</Name>
            <Formulation ID="F162408948925" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B16240894892526" PSS="true">
                <Name>Vaclovir</Name>
                <Pack ID="P2483904" Specified="true" nzmt:ctpp_id="50229341000117104">
                  <Quantity>30</Quantity>
                  <Price>9.64</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162408948926" Rank="1" Units="tab" Weight="1000">
              <Name>Tab 1,000 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B16240894892625" PSS="true">
                <Name>Vaclovir</Name>
                <Pack ID="P2483912" Specified="true" nzmt:ctpp_id="50220911000117108">
                  <Quantity>30</Quantity>
                  <Price>17.78</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1624089667">
            <Name>Valganciclovir</Name>
            <Request Form="RS1799" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Valganciclovir</range>
              </Title>
              <Case When="Initial application" Category="Transplant cytomegalovirus prophylaxis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has undergone a solid organ transplant and requires valganciclovir
        for CMV prophylaxis</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">3</Term>
              </Case>
              <Case When="Renewal" Category="Transplant cytomegalovirus prophylaxis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has undergone a solid organ transplant and received
            anti-thymocyte globulin and requires valganciclovir therapy for CMV prophylaxis</ci>
                      <ci type="logical">Patient is to receive a maximum of 90 days of valganciclovir
            prophylaxis following anti-thymocyte globulin</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has received pulse methylprednisolone for acute rejection and
            requires further valganciclovir therapy for CMV prophylaxis</ci>
                      <ci type="logical">Patient is to receive a maximum of 90 days of valganciclovir
            prophylaxis following pulse methylprednisolone</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">3</Term>
              </Case>
              <Case When="Initial application" Category="Lung transplant cytomegalovirus prophylaxis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has undergone a lung transplant</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The donor was cytomegalovirus positive and the patient is
            cytomegalovirus negative</ci>
                      <ci type="logical">The recipient is cytomegalovirus positive</ci>
                    </apply>
                    <ci type="logical">Patient has a high risk of CMV disease</ci>
                  </apply>
                </math>
                <Applicant>relevant specialist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="Cytomegalovirus in immunocompromised patients">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is immunocompromised</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has cytomegalovirus syndrome or tissue invasive disease</ci>
                      <ci type="logical">Patient has rapidly rising plasma CMV DNA in absence of disease</ci>
                      <ci type="logical">Patient has cytomegalovirus retinitis</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1799" style="display:none"/>
            <Formulation ID="F162408966725" Rank="1" Units="tab" Weight="450">
              <Name>Tab 450 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B16240896672527" PSS="true">
                <Name>Valganciclovir Viatris</Name>
                <Pack ID="P2635682" Specified="true" nzmt:ctpp_id="50291401000117103">
                  <Quantity>60</Quantity>
                  <Price>140.89</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A162410">
          <Name>HIV Prophylaxis and Treatment</Name>
          <Chemical ID="C1624109670">
            <Name>Emtricitabine with tenofovir disoproxil</Name>
            <Request Form="RS1902" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Emtricitabine with tenofovir disoproxil</range>
              </Title>
              <Case When="Initial application" Category="Confirmed HIV">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has confirmed HIV infection</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Prevention of maternal transmission">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Prevention of maternal foetal transmission</ci>
                    <ci type="logical">Treatment of the newborn for up to eight weeks</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Post-exposure prophylaxis following non-occupational exposure to HIV">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Treatment course to be initiated within 72 hours post
                    exposure</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has had unprotected receptive anal intercourse with a
                        known HIV positive person</ci>
                      <ci type="logical">Patient has shared intravenous injecting equipment with a
                        known HIV positive person</ci>
                      <ci type="logical">Patient has had non-consensual intercourse and the clinician
                        considers that the risk assessment indicates prophylaxis is required</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Percutaneous exposure">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has percutaneous exposure to blood known to be HIV
                positive</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Pre-exposure prophylaxis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has tested HIV negative, does not have
                    signs or symptoms of acute HIV infection and has been assessed for HIV
                    seroconversion</ci>
                    <ci type="logical" class="Indication">The Practitioner considers the patient is at
                    elevated risk of HIV exposure and use of PrEP is clinically appropriate</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">24</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Refer to local health pathways or the Australasian Society for HIV, Viral Hepatitis
                and Sexual Health Medicine clinical guidelines
                (https://ashm.org.au/HIV/PrEP/)</p>
                </div>
              </Case>
              <Case When="Renewal" Category="Pre-exposure prophylaxis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has tested HIV negative, does not have
                    signs or symptoms of acute HIV infection and has been assessed for HIV
                    seroconversion</ci>
                    <ci type="logical" class="Indication">The Practitioner considers the patient is at
                    elevated risk of HIV exposure and use of PrEP is clinically appropriate</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">24</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Refer to local health pathways or the Australasian Society for HIV, Viral Hepatitis
                and Sexual Health Medicine clinical guidelines
                (https://ashm.org.au/HIV/PrEP/)</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1902" style="display:none"/>
            <Formulation ID="F162410967026" Rank="1" Units="tab">
              <Name>Tab 200 mg with tenofovir disoproxil 245 mg (300.6 mg as a succinate)</Name>
              <Brand ID="B16241096702625">
                <Name>Teva</Name>
                <Pack ID="P2560488" Specified="true" nzmt:ctpp_id="50249931000117106">
                  <Quantity>30</Quantity>
                  <Price>15.45</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162410967027" Rank="1" Units="tab">
              <Name>Tab 200 mg with tenofovir disoproxil 245 mg (300 mg as a maleate)</Name>
              <Rule Type="DVLimit" Attribute="Jun-23 to~2025" Value="5"/>
              <Brand ID="B16241096702726" PSS="true">
                <Name>Tenofovir Disoproxil Emtricitabine Viatr</Name>
                <Pack ID="P2638088" Specified="true" nzmt:ctpp_id="50300051000117105">
                  <Quantity>30</Quantity>
                  <Price>15.45</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A162412">
          <Name>Influenza</Name>
          <Chemical ID="C1624128521">
            <Name>Oseltamivir</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: The restriction on the use of oseltamivir to hospitalised patients means that supply into the community for a new course is not permitted. Supply of a part original pack on discharge where
        initiated as a hospital inpatient is permitted.</p>
            </div>
            <Request Form="RS1307" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Oseltamivir</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Only for hospitalised patient with known or suspected influenza</ci>
                    <ci type="logical">For prophylaxis of influenza in hospitalised patients as part of a Health NZ Hospital approved infections control plan</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1307" style="display:none"/>
            <Formulation ID="F162412852125" Rank="1" Units="tab" Weight="75">
              <Name>Tab 75 mg</Name>
              <Brand ID="B16241285212500">
                <Name>Any</Name>
                <Pack ID="P85212500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162412852127" Rank="3" Units="g">
              <Name>Powder for oral suspension 6 mg per ml</Name>
              <Brand ID="B16241285212700">
                <Name>Any</Name>
                <Pack ID="P85212700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1624128541">
            <Name>Zanamivir</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: The restriction on the use of zanamivir to hospitalised patients means that supply into the community for a new course is not permitted. Supply of a part original pack on discharge where
        initiated as a hospital inpatient is permitted.</p>
            </div>
            <Formulation ID="F162412854125" Rank="6" Units="dose">
              <Name>Powder for inhalation 5 mg</Name>
              <Request Form="RS1369" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Zanamivir - Powder for inhalation 5 mg</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical">Only for hospitalised patient with known or suspected influenza</ci>
                      <ci type="logical">For prophylaxis of influenza in hospitalised patients as part of a Health NZ Hospital approved infections control plan</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1369" style="display:none"/>
              <Brand ID="B16241285412525">
                <Name>Relenza Rotadisk</Name>
                <Pack ID="P353647" Specified="true" nzmt:ctpp_id="50077141000117100">
                  <Quantity>20</Quantity>
                  <Price>37.38</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A162417">
          <Name>COVID-19 Treatments</Name>
          <Chemical ID="C1624178686">
            <Name>Molnupiravir</Name>
            <Request Form="RS1893" To="HealthPAC" For="Subsidy">
              <Title>
                <range>COVID-19 treatments</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">Only if patient meets access criteria (as per 
                    https://pharmac.govt.nz/covid-oral-antivirals).
                Note the supply of treatment is via Pharmac’s approved distribution process. Refer
                to the Pharmac website for more information about this and stock availability</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1893" style="display:none"/>
            <Formulation ID="F162417868625" Rank="10" Units="caps" Weight="200">
              <Name>Cap 200 mg</Name>
              <Brand ID="B16241786862525">
                <Name>Lagevrio</Name>
                <Pack ID="P2635224" Specified="true" nzmt:ctpp_id="50296421000117103">
                  <Quantity>40</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1624178687">
            <Name>Nirmatrelvir with ritonavir</Name>
            <Request Form="RS1894" To="HealthPAC" For="Subsidy">
              <Title>
                <range>COVID-19 treatments</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">Only if patient meets access criteria (as per
                    https://pharmac.govt.nz/covid-oral-antivirals).
                Note the supply of treatment is via Pharmac’s approved distribution process. Refer
                to the Pharmac website for more information about this and stock availability</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1894" style="display:none"/>
            <Formulation ID="F162417868725" Rank="1" Units="tab" Weight="250">
              <Name>Tab 150 mg with ritonavir 100 mg</Name>
              <Brand ID="B16241786872525">
                <Name>Paxlovid</Name>
                <Pack ID="P2635143" Specified="true" nzmt:ctpp_id="50292521000117100">
                  <Quantity>30</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1624178692">
            <Name>Remdesivir</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: Remdesivir to be provided to Health NZ Hospitals at a cost of $0.00 as stock has been
        purchased directly by Pharmac.</p>
            </div>
            <Request Form="RS1912" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Remdesivir</range>
              </Title>
              <Case When="Initial application" Category="Treatment of mild to moderate COVID-19">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Only if patient meets access criteria (as per
                    https://pharmac.govt.nz/covid-oral-antivirals). Note the supply of treatment is
                    via Pharmac’s approved distribution process. Refer to the Pharmac website for
                    more information about this and stock availability</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="COVID-19 in hospitalised patients">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is hospitalised with confirmed (or probable) symptomatic
                    COVID-19</ci>
                    <ci type="logical">Patient is considered to be at high risk of progression to severe
                    disease</ci>
                    <ci type="logical">Patient’s symptoms started within the last 7 days</ci>
                    <ci type="logical">Patient does not require, or is not expected to require,
                    mechanical ventilation</ci>
                    <ci type="logical">Not to be used in conjunction with other funded COVID-19 antiviral
                    treatments</ci>
                    <ci type="logical">Treatment not to exceed five days</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">5</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1912" style="display:none"/>
            <Formulation ID="F162417869225" Rank="4" Units="inj">
              <Name>Inj 100 mg vial</Name>
              <Brand ID="B16241786922525">
                <Name>Veklury</Name>
                <Pack ID="P2640139" Specified="true" nzmt:ctpp_id="50303251000117105">
                  <Quantity>1</Quantity>
                  <Price>760.57</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1628">
        <Name>Immune Modulators</Name>
        <ATC3 ID="A162804">
          <Name>Immune Modulators</Name>
          <Chemical ID="C1628048236">
            <Name>Interferon alfa-2b</Name>
            <Formulation ID="F162804823601" Rank="4" Units="inj" Weight="18">
              <Name>Inj 18 m iu, 1.2 ml multidose pen</Name>
              <Brand ID="B16280482360100">
                <Name>Any</Name>
                <Pack ID="P82360100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162804823602" Rank="4" Units="inj" Weight="30">
              <Name>Inj 30 m iu, 1.2 ml multidose pen</Name>
              <Brand ID="B16280482360200">
                <Name>Any</Name>
                <Pack ID="P82360200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F162804823603" Rank="4" Units="inj" Weight="60">
              <Name>Inj 60 m iu, 1.2 ml multidose pen</Name>
              <Brand ID="B16280482360300">
                <Name>Any</Name>
                <Pack ID="P82360300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1628048239">
            <Name>Interferon gamma</Name>
            <Request Form="RS1113" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Interferon gamma</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has chronic granulomatous disease and requires interferon gamma</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1113" style="display:none"/>
            <Formulation ID="F162804823901" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mcg in 0.5 ml vial</Name>
              <Brand ID="B16280482390100">
                <Name>Any</Name>
                <Pack ID="P82390100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1628048346">
            <Name>Pegylated interferon alfa-2a</Name>
            <Request Form="RS1827" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Pegylated interferon alfa-2a</range>
              </Title>
              <Case When="Initial application" Category="Chronic hepatitis C - genotype 1, 4, 5 or 6 infection or co-infection with HIV or genotype 2 or 3 post liver transplant">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Patient has chronic hepatitis C, genotype 1, 4, 5 or 6 infection</ci>
                    <ci type="logical">Patient has chronic hepatitis C and is co-infected with HIV</ci>
                    <ci type="logical">Patient has chronic hepatitis C genotype 2 or 3 and has received a liver transplant</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="week">48</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Consider stopping treatment if there is absence of a virological response (defined as at least a 2-log reduction in viral load) following 12 weeks of treatment since this is predictive
                of treatment failure.</p>
                  <p>Consider reducing treatment to 24 weeks if serum HCV RNA level at Week 4 is undetectable by sensitive PCR assay (less than 50IU/ml) AND Baseline serum HCV RNA is less than
                400,000IU/ml.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="Chronic hepatitis C - genotype 1 infection">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has chronic hepatitis C, genotype 1</ci>
                    <ci type="logical">Patient has had previous treatment with pegylated interferon and ribavirin</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has responder relapsed</ci>
                      <ci type="logical">Patient was a partial responder</ci>
                    </apply>
                    <ci type="logical">Patient is to be treated in combination with boceprevir</ci>
                  </apply>
                </math>
                <Applicant>gastroenterologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>general physician</Applicant>
                <Term Measure="week">48</Term>
              </Case>
              <Case When="Initial application" Category="Chronic Hepatitis C - genotype 1 infection treatment more than 4 years prior">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has chronic hepatitis C, genotype 1</ci>
                    <ci type="logical">Patient has had previous treatment with pegylated interferon and ribavirin</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has responder relapsed</ci>
                      <ci type="logical">Patient was a partial responder</ci>
                      <ci type="logical">Patient received interferon treatment prior to 2004</ci>
                    </apply>
                    <ci type="logical">Patient is to be treated in combination with boceprevir</ci>
                  </apply>
                </math>
                <Applicant>gastroenterologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>general physician</Applicant>
                <Term Measure="week">48</Term>
              </Case>
              <Case When="Initial application" Category="Chronic hepatitis C - genotype 2 or 3 infection without co-infection with HIV">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has chronic hepatitis C, genotype 2 or 3 infection</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Hepatitis B">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has confirmed Hepatitis B infection (HBsAg positive for more than 6 months)</ci>
                    <ci type="logical">Patient is Hepatitis B treatment-naive</ci>
                    <ci type="logical">ALT &gt; 2 times Upper Limit of Normal</ci>
                    <ci type="logical">HBV DNA &lt; 10 log10 IU/ml</ci>
                    <apply>
                      <or/>
                      <ci type="logical">HBeAg positive</ci>
                      <ci type="logical">Serum HBV DNA greater than or equal to 2,000 units/ml and significant fibrosis (greater than or equal to Metavir Stage F2 or moderate fibrosis)</ci>
                    </apply>
                    <ci type="logical">Compensated liver disease</ci>
                    <ci type="logical">No continuing alcohol abuse or intravenous drug use</ci>
                    <ci type="logical">Not co-infected with HCV, HIV or HDV</ci>
                    <ci type="logical">Neither ALT nor AST &gt; 10 times upper limit of normal</ci>
                    <ci type="logical">No history of hypersensitivity or contraindications to pegylated interferon</ci>
                  </apply>
                </math>
                <Applicant>gastroenterologist</Applicant>
                <Applicant>infectious disease specialist</Applicant>
                <Applicant>general physician</Applicant>
                <Term Measure="week">48</Term>
              </Case>
              <Case When="Initial application" Category="myeloproliferative disorder or cutaneous T cell lymphoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Patient has a cutaneous T cell lymphoma*</ci>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has a myeloproliferative disorder*</ci>
                      <ci type="logical">Patient is intolerant of hydroxyurea</ci>
                      <ci type="logical">Treatment with anagrelide and busulfan is not clinically appropriate</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has a myeloproliferative disorder</ci>
                      <ci type="logical">Patient is pregnant, planning pregnancy or lactating</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="myeloproliferative disorder or cutaneous T cell lymphoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">No evidence of disease progression</ci>
                    <ci type="logical">The treatment remains appropriate and patient is benefitting from treatment</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has a cutaneous T cell lymphoma*</ci>
                      <apply>
                        <and/>
                        <ci type="logical">Patient has a myeloproliferative disorder*</ci>
                        <apply>
                          <or/>
                          <ci type="logical">Remains intolerant of hydroxyurea and treatment with anagrelide and busulfan
                                remains clinically inappropriate</ci>
                          <ci type="logical">Patient is pregnant, planning pregnancy or lactating</ci>
                        </apply>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications</p>
                </div>
              </Case>
              <Case When="Initial application" Category="ocular surface squamous neoplasia">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has ocular surface squamous neoplasia*</ci>
                </math>
                <Applicant>ophthalmologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="ocular surface squamous neoplasia">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The treatment remains appropriate and patient is benefitting from treatment</ci>
                </math>
                <Applicant>ophthalmologist</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications</p>
                </div>
              </Case>
              <Case When="Initial application" Category="post-allogenic bone marrow transplant">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has received an allogeneic bone marrow transplant* and has evidence of disease relapse</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">3</Term>
              </Case>
              <Case When="Renewal" Category="post-allogenic bone marrow transplant">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient is responding and ongoing treatment remains appropriate</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">3</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1827" style="display:none"/>
            <Formulation ID="F162804834604" Rank="4" Units="inj" Weight="180">
              <Name>Inj 180 mcg prefilled syringe</Name>
              <Brand ID="B16280483460425">
                <Name>Pegasys</Name>
                <Pack ID="P2162806" Specified="true" nzmt:ctpp_id="50027531000117100">
                  <Quantity>4</Quantity>
                  <Price>748.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
    <ATC1 ID="A19">
      <Name>Musculoskeletal System</Name>
      <ATC2 ID="A1904">
        <Name>Anticholinesterases</Name>
        <ATC3 ID="A190404">
          <Name>Anticholinesterases</Name>
          <Chemical ID="C1904048163">
            <Name>Edrophonium chloride</Name>
            <Request Form="RS1015" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Edrophonium chloride</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For the diagnosis of myasthenia gravis</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1015" style="display:none"/>
            <Formulation ID="F190404816301" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B19040481630100">
                <Name>Any</Name>
                <Pack ID="P81630100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F190404816325" Rank="4" Units="inj">
              <Name>Inj 10 mg per ml, 15 ml vial</Name>
              <Brand ID="B19040481632500">
                <Name>Any</Name>
                <Pack ID="P81632500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1904048315">
            <Name>Neostigmine metilsulfate with glycopyrronium bromide</Name>
            <Formulation ID="F190404831501" Rank="4" Units="inj" Weight="2.5">
              <Name>Inj 2.5 mg with glycopyrronium bromide 0.5 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B19040483150125">
                <Name>Max Health</Name>
                <Pack ID="P2444097" Specified="true" nzmt:ctpp_id="50126071000117100">
                  <Quantity>10</Quantity>
                  <Price>26.13</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1904049038">
            <Name>Neostigmine metilsulfate</Name>
            <Formulation ID="F190404903801" Rank="4" Units="inj" Weight="2.5">
              <Name>Inj 2.5 mg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B19040490380125" PSS="true">
                <Name>Max Health</Name>
                <Pack ID="P2599996" Specified="true" nzmt:ctpp_id="50183201000117100">
                  <Quantity>10</Quantity>
                  <Price>48.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1904049594">
            <Name>Pyridostigmine bromide</Name>
            <Formulation ID="F190404959425" Rank="1" Units="tab" Weight="60">
              <Name>Tab 60 mg</Name>
              <Brand ID="B19040495942525">
                <Name>Mestinon</Name>
                <Pack ID="P251011" Specified="true" nzmt:ctpp_id="50052591000117103">
                  <Quantity>100</Quantity>
                  <Price>50.28</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1908">
        <Name>Antirheumatoid Agents</Name>
        <ATC3 ID="A190804">
          <Name>Antirheumatoid Agents</Name>
          <Chemical ID="C1908048419">
            <Name>Sodium aurothiomalate</Name>
            <Formulation ID="F190804841901" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg in 0.5 ml ampoule</Name>
              <Brand ID="B19080484190100">
                <Name>Any</Name>
                <Pack ID="P84190100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F190804841902" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg in 0.5 ml ampoule</Name>
              <Brand ID="B19080484190200">
                <Name>Any</Name>
                <Pack ID="P84190200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F190804841903" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg in 0.5 ml ampoule</Name>
              <Brand ID="B19080484190300">
                <Name>Any</Name>
                <Pack ID="P84190300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1908049369">
            <Name>Penicillamine</Name>
            <Formulation ID="F190804936925" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B19080493692525">
                <Name>D-Penamine</Name>
                <Pack ID="P2125382" Specified="true" nzmt:ctpp_id="50022651000117109">
                  <Quantity>100</Quantity>
                  <Price>110.12</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F190804936926" Rank="1" Units="tab" Weight="125">
              <Name>Tab 125 mg</Name>
              <Brand ID="B19080493692625">
                <Name>D-Penamine</Name>
                <Pack ID="P2125374" Specified="true" nzmt:ctpp_id="50022641000117107">
                  <Quantity>100</Quantity>
                  <Price>67.23</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1908049376">
            <Name>Leflunomide</Name>
            <Formulation ID="F190804937625" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B19080493762525" PSS="true">
                <Name>Arava</Name>
                <Pack ID="P306843" Specified="true" nzmt:ctpp_id="50068541000117103">
                  <Quantity>30</Quantity>
                  <Price>6.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F190804937626" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B19080493762625" PSS="true">
                <Name>Arava</Name>
                <Pack ID="P369470" Specified="true" nzmt:ctpp_id="50078741000117102">
                  <Quantity>30</Quantity>
                  <Price>6.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1908049389">
            <Name>Hydroxychloroquine</Name>
            <Request Form="RS1776" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Hydroxychloroquine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Rheumatoid arthritis</ci>
                    <ci type="logical">Systemic or discoid lupus erythematosus</ci>
                    <ci type="logical">Malaria treatment or suppression</ci>
                    <ci type="logical">Relevant dermatological conditions (cutaneous forms of lupus and lichen planus, cutaneous vasculitides and mucosal
                    ulceration)</ci>
                    <ci type="logical">Sarcoidosis (pulmonary and non-pulmonary)</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1776" style="display:none"/>
            <Formulation ID="F190804938925" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B19080493892525">
                <Name>Plaquenil</Name>
                <Pack ID="P208264">
                  <Quantity>100</Quantity>
                  <Price>8.78</Price>
                </Pack>
                <Pack ID="P2689405" Specified="true" nzmt:ctpp_id="50013571000117102">
                  <Quantity>100</Quantity>
                  <Price>8.78</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1912">
        <Name>Drugs Affecting Bone Metabolism</Name>
        <ATC3 ID="A191204">
          <Name>Bisphosphonates</Name>
          <Chemical ID="C1912048532">
            <Name>Risedronate sodium</Name>
            <Formulation ID="F191204853225" Rank="1" Units="tab">
              <Name>Tab 35 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-23 to~2025" Value="5"/>
              <Brand ID="B19120485322525" PSS="true">
                <Name>Risedronate Sandoz</Name>
                <Pack ID="P2440202" Specified="true" nzmt:ctpp_id="50148021000117100">
                  <Quantity>4</Quantity>
                  <Price>2.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1912049018">
            <Name>Pamidronate disodium</Name>
            <Formulation ID="F191204901801" Rank="4" Units="inj" Weight="30">
              <Name>Inj 3 mg per ml, 10 ml vial</Name>
              <Brand ID="B19120490180126">
                <Name>Pamisol</Name>
                <Pack ID="P2034166" Specified="true" nzmt:ctpp_id="50020011000117101">
                  <Quantity>1</Quantity>
                  <Price>32.49</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F191204901802" Rank="4" Units="inj" Weight="60">
              <Name>Inj 6 mg per ml, 10 ml vial</Name>
              <Brand ID="B19120490180226">
                <Name>Pamisol</Name>
                <Pack ID="P2034174" Specified="true" nzmt:ctpp_id="50020031000117105">
                  <Quantity>1</Quantity>
                  <Price>88.11</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F191204901803" Rank="4" Units="inj" Weight="90">
              <Name>Inj 9 mg per ml, 10 ml vial</Name>
              <Brand ID="B19120490180326">
                <Name>Pamisol</Name>
                <Pack ID="P2034190" Specified="true" nzmt:ctpp_id="50006641000117100">
                  <Quantity>1</Quantity>
                  <Price>94.34</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1912049063">
            <Name>Zoledronic acid</Name>
            <Formulation ID="F191204906326" Rank="3" Units="ml">
              <Name>Inj 5 mg per 100 ml, bag</Name>
              <Rule Type="DVLimit" Attribute="Jun-23 to~2025" Value="5"/>
              <Brand ID="B19120490632625" PSS="true">
                <Name>Zoledronic Acid Viatris</Name>
                <Pack ID="P2636743" Specified="true" nzmt:ctpp_id="50300801000117103">
                  <Quantity>100</Quantity>
                  <Price>22.53</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1912049265">
            <Name>Alendronate sodium</Name>
            <Formulation ID="F191204926526" Rank="1" Units="tab" Weight="70">
              <Name>Tab 70 mg</Name>
              <Rule Type="DVLimit" Attribute="Jul-24 to~2026" Value="5"/>
              <Brand ID="B19120492652625" PSS="true">
                <Name>Fosamax</Name>
                <Pack ID="P2022133" Specified="true" nzmt:ctpp_id="50004451000117109">
                  <Quantity>4</Quantity>
                  <Price>3.10</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1912049405">
            <Name>Alendronate sodium with colecalciferol</Name>
            <Formulation ID="F191204940526" Rank="1" Units="tab" Weight="5600">
              <Name>Tab 70 mg with colecalciferol 5,600 iu</Name>
              <Rule Type="DVLimit" Attribute="Jul-24 to~2026" Value="5"/>
              <Brand ID="B19120494052625" PSS="true">
                <Name>Fosamax Plus</Name>
                <Pack ID="P2337053" Specified="true" nzmt:ctpp_id="50049741000117107">
                  <Quantity>4</Quantity>
                  <Price>1.99</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A191208">
          <Name>Other Drugs Affecting Bone Metabolism</Name>
          <Chemical ID="C1912088625">
            <Name>Denosumab</Name>
            <Request Form="RS1665" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Denosumab</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The patient has severe, established osteoporosis</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">The patient is female and postmenopausal</ci>
                      <ci type="logical" class="Indication">The patient is male or non-binary</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">History of one significant osteoporotic
                        fracture demonstrated radiologically and documented bone mineral density
                        (BMD) greater than or equal to 2.5 standard deviations below the mean normal
                        value in young adults (i.e. T-Score less than or equal to -2.5) (see
                        Note)</ci>
                      <ci type="logical" class="Indication">History of one significant osteoporotic
                        fracture demonstrated radiologically, and either the patient is elderly, or
                        densitometry scanning cannot be performed because of major logistical,
                        technical or pathophysiological reasons</ci>
                      <ci type="logical" class="Indication">History of two significant osteoporotic
                        fractures demonstrated radiologically</ci>
                      <ci type="logical" class="Indication">Documented T-Score less than or equal to
                        -3.0 (see Note)</ci>
                      <ci type="logical" class="Indication">A 10-year risk of hip fracture greater
                        than or equal to 3%, calculated using a published risk assessment algorithm
                        (e.g. FRAX or Garvan) which incorporates BMD measurements (see Note)</ci>
                      <ci type="logical" class="Indication">Patient has had a Special Authority approval for alendronate (Underlying cause - Osteoporosis) prior to 1 February 2019 or has had a Special Authority approval for raloxifene</ci>
                    </apply>
                    <ci type="logical" class="Indication">Zoledronic acid is contraindicated because the
                    patient’s creatinine clearance is less than 35 mL/min</ci>
                    <ci type="logical" class="Indication">The patient has experienced at least one
                    symptomatic new fracture after at least 12 months’ continuous therapy with a
                    funded antiresorptive agent at adequate doses (see Notes)</ci>
                    <ci type="logical" class="Indication">The patient must not receive concomitant
                    treatment with any other funded antiresorptive agent for this condition or
                    teriparatide</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <ol style="list-style-type: lower-alpha">
                  <li>
                    <p>BMD (including BMD used to derive T-Score) must be measured using dual-energy
                    x-ray absorptiometry (DXA). Quantitative ultrasound and quantitative computed
                    tomography (QCT) are not acceptable.</p>
                  </li>
                  <li>
                    <p>Evidence suggests that patients aged 75 years and over who have a history of
                    significant osteoporotic fracture demonstrated radiologically are very likely to
                    have a T-Score less than or equal to -2.5 and, therefore, do not require BMD
                    measurement for treatment with denosumab.</p>
                  </li>
                  <li>
                    <p>Osteoporotic fractures are the incident events for severe (established)
                    osteoporosis and can be defined using the WHO definitions of osteoporosis and
                    fragility fracture. The WHO defines severe (established) osteoporosis as a
                    T-score below -2.5 with one or more associated fragility fractures. Fragility
                    fractures are fractures that occur as a result of mechanical forces that would
                    not ordinarily cause fracture (minimal trauma). The WHO has quantified this as
                    forces equivalent to a fall from a standing height or less.</p>
                  </li>
                  <li>
                    <p>A vertebral fracture is defined as a 20% or greater reduction in height of the
                    anterior or mid portion of a vertebral body relative to the posterior height of
                    that body, or a 20% or greater reduction in any of these heights compared to the
                    vertebral body above or below the affected vertebral body.</p>
                  </li>
                  <li>
                    <p>Antiresorptive agents and their adequate doses for the purposes of this Special
                    Authority are defined as: risedronate sodium tab 35 mg once weekly; alendronate
                    sodium tab 70 mg or tab 70 mg with cholecalciferol 5,600 iu once weekly;
                    raloxifene hydrochloride tab 60 mg once daily. If an intolerance of a severity
                    necessitating permanent treatment withdrawal develops during the use of one
                    antiresorptive agent, an alternate antiresorptive agent must be trialled so that
                    the patient achieves the minimum requirement of 12 months’ continuous
                    therapy.</p>
                  </li>
                </ol>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1665" style="display:none"/>
            <Formulation ID="F191208862525" Rank="4" Units="inj" Weight="60">
              <Name>Inj 60 mg prefilled syringe</Name>
              <Brand ID="B19120886252525">
                <Name>Prolia</Name>
                <Pack ID="P2406047" Specified="true" nzmt:ctpp_id="50253831000117103">
                  <Quantity>1</Quantity>
                  <Price>326.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1912089596">
            <Name>Raloxifene</Name>
            <Request Form="RS1666" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Raloxifene</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">History of one significant osteoporotic fracture demonstrated radiologically and documented bone mineral density (BMD) greater than or equal to 2.5 standard deviations below the mean
                    normal value in young adults (i.e. T-Score less than or equal to -2.5) (see Notes)</ci>
                    <ci type="logical">History of one significant osteoporotic fracture demonstrated radiologically, and either the patient is elderly, or densitometry scanning cannot be performed because
                    of major logistical, technical or pathophysiological reasons. It is unlikely that this provision would apply to many patients under 75 years of age</ci>
                    <ci type="logical">History of two significant osteoporotic fractures demonstrated radiologically</ci>
                    <ci type="logical">Documented T-Score greater than or equal to -3.0 (see Notes)</ci>
                    <ci type="logical">A 10-year risk of hip fracture greater than or equal to 3%, calculated using a published risk assessment algorithm (e.g. FRAX or Garvan) which incorporates BMD measurements (see
                    Notes)</ci>
                    <ci type="logical">Patient has had a Special Authority approval for zoledronic acid (Underlying cause - Osteoporosis) or has had a Special Authority approval for alendronate (Underlying cause - Osteoporosis) prior to 1 February 2019</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <ol style="list-style-type: lower-alpha">
                  <li>
                    <p>BMD (including BMD used to derive T-Score) must be measured using dual-energy x-ray absorptiometry (DXA). Quantitative ultrasound and quantitative computed tomography (QCT) are not acceptable.</p>
                  </li>
                  <li>
                    <p>Evidence suggests that patients aged 75 years and over who have a history of significant osteoporotic fracture demonstrated radiologically are very likely to have a T-Score less than or equal to -2.5 and, therefore, do not require BMD measurement for raloxifene funding.</p>
                  </li>
                  <li>
                    <p>Osteoporotic fractures are the incident events for severe (established) osteoporosis, and can be defined using the WHO definitions of osteoporosis and fragility fracture. The WHO defines severe (established) osteoporosis as a T-score below -2.5 with one or more associated fragility fractures. Fragility fractures are fractures that occur as a result of mechanical forces that would not ordinarily cause fracture (minimal trauma). The WHO has quantified this as forces equivalent to a fall from a standing height or less.</p>
                  </li>
                  <li>
                    <p>A vertebral fracture is defined as a 20% or greater reduction in height of the anterior or mid portion of a vertebral body relative to the posterior height of that body, or a 20% or greater reduction in any of these heights compared to the vertebral body above or below the affected vertebral body.</p>
                  </li>
                </ol>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1666" style="display:none"/>
            <Formulation ID="F191208959625" Rank="1" Units="tab" Weight="60">
              <Name>Tab 60 mg</Name>
              <Brand ID="B19120895962525">
                <Name>Evista</Name>
                <Pack ID="P237523" Specified="true" nzmt:ctpp_id="50051191000117102">
                  <Quantity>28</Quantity>
                  <Price>53.76</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1912089597">
            <Name>Teriparatide</Name>
            <Request Form="RS1143" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Teriparatide</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has severe, established osteoporosis</ci>
                    <ci type="logical">The patient has a documented T-score less than or equal to -3.0 (see Notes)</ci>
                    <ci type="logical">The patient has had two or more fractures due to minimal trauma</ci>
                    <ci type="logical">The patient has experienced at least one symptomatic new fracture after at least 12 months' continuous therapy with a funded antiresorptive agent at adequate doses
                    (see Notes)</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">18</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <ol style="list-style-type: lower-alpha">
                  <li>
                    <p>The bone mineral density (BMD) measurement used to derive the T-score must be made using dual-energy x-ray absorptiometry (DXA). Quantitative ultrasound and quantitative computed tomography (QCT) are not acceptable</p>
                  </li>
                  <li>
                    <p>Antiresorptive agents and their adequate doses for the purposes of this restriction are defined as: alendronate sodium tab 70 mg or tab 70 mg with colecalciferol 5,600 iu once weekly; raloxifene hydrochloride tab 60 mg once daily; zoledronic acid 5 mg per year. If an intolerance of a severity necessitating permanent treatment withdrawal develops during the use of one antiresorptive agent, an alternate antiresorptive agent must be trialled so that the patient achieves the minimum requirement of 12 months' continuous therapy.</p>
                  </li>
                  <li>
                    <p>A vertebral fracture is defined as a 20% or greater reduction in height of the anterior or mid portion of a vertebral body relative to the posterior height of that body, or a 20% or greater reduction in any of these heights compared to the vertebral body above or below the affected vertebral body.</p>
                  </li>
                </ol>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1143" style="display:none"/>
            <Formulation ID="F191208959725" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 mcg per ml, 2.4 ml</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2025" Value="5"/>
              <Brand ID="B19120895972526" PSS="true">
                <Name>Teriparatide - Teva</Name>
                <Pack ID="P2670399" Specified="true" nzmt:ctpp_id="50294581000117106">
                  <Quantity>1</Quantity>
                  <Price>195.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1916">
        <Name>Enzymes</Name>
        <ATC3 ID="A191604">
          <Name>Enzymes</Name>
          <Chemical ID="C1916048218">
            <Name>Hyaluronidase</Name>
            <Formulation ID="F191604821801" Rank="4" Units="inj" Weight="1500">
              <Name>Inj 1,500 iu ampoule</Name>
              <Brand ID="B19160482180100">
                <Name>Any</Name>
                <Pack ID="P82180100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1920">
        <Name>Hyperuricaemia and Antigout</Name>
        <ATC3 ID="A192004">
          <Name>Hyperuricaemia and Antigout</Name>
          <Chemical ID="C1920048391">
            <Name>Probenecid</Name>
            <Formulation ID="F192004839101" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Brand ID="B19200483910100">
                <Name>Any</Name>
                <Pack ID="P83910100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1920048405">
            <Name>Rasburicase</Name>
            <Request Form="RS1016" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Rasburicase</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">No patient criteria</ci>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1016" style="display:none"/>
            <Formulation ID="F192004840501" Rank="4" Units="inj" Weight="1.5">
              <Name>Inj 1.5 mg vial</Name>
              <Brand ID="B19200484050100">
                <Name>Any</Name>
                <Pack ID="P84050100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1920048509">
            <Name>Benzbromarone</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F192004850925" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B19200485092525">
                <Name>Benzbromaron AL 100</Name>
                <Pack ID="P2434598" Specified="true" nzmt:ctpp_id="50164541000117102">
                  <Quantity>100</Quantity>
                  <Price>45.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192004850926" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B19200485092600">
                <Name>Any</Name>
                <Pack ID="P85092600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1920048545">
            <Name>Febuxostat</Name>
            <Request Form="RS1844" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Febuxostat</range>
              </Title>
              <Case When="Initial application" Category="Gout">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has been diagnosed with gout</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">The patient has a serum urate level
                        greater than 0.36 mmol/l despite treatment with allopurinol at doses of at
                        least 600 mg/day and addition of probenecid at doses of up to 2 g per day or
                        maximum tolerated dose</ci>
                      <ci type="logical" class="Indication">The patient has experienced intolerable
                        side effects from allopurinol such that treatment discontinuation is
                        required and serum urate remains greater than 0.36 mmol/l despite use of
                        probenecid at doses of up to 2 g per day or maximum tolerated dose</ci>
                      <ci type="logical" class="Indication">The patient has renal impairment such that
                        probenecid is contraindicated or likely to be ineffective and serum urate
                        remains greater than 0.36 mmol/l despite optimal treatment with allopurinol
                        (see Note)</ci>
                      <ci type="logical" class="Indication">The patient has previously had an initial
                        Special Authority approval for benzbromarone for treatment of gout.</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Tumour lysis syndrome">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient is scheduled to receive cancer therapy
                    carrying an intermediate or high risk of tumour lysis syndrome</ci>
                    <ci type="logical" class="Indication">Patient has a documented history of
                    allopurinol intolerance</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Applicant>oncologist</Applicant>
                <Term Measure="week">6</Term>
              </Case>
              <Case When="Renewal" Category="Tumour lysis syndrome">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">The treatment remains appropriate and patient  is benefitting from treatment</ci>
                </math>
                <Applicant>haematologist</Applicant>
                <Applicant>oncologist</Applicant>
                <Term Measure="week">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1844" style="display:none"/>
            <Formulation ID="F192004854525" Rank="1" Units="tab" Weight="80">
              <Name>Tab 80 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B19200485452527" PSS="true">
                <Name>Febuxostat (Teva)</Name>
                <Pack ID="P2670356" Specified="true" nzmt:ctpp_id="50260241000117106">
                  <Quantity>28</Quantity>
                  <Price>4.73</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192004854526" Rank="1" Units="tab" Weight="120">
              <Name>Tab 120 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B19200485452627" PSS="true">
                <Name>Febuxostat (Teva)</Name>
                <Pack ID="P2670364" Specified="true" nzmt:ctpp_id="50260271000117100">
                  <Quantity>28</Quantity>
                  <Price>11.78</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1920049126">
            <Name>Allopurinol</Name>
            <Formulation ID="F192004912625" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B19200491262530" PSS="true">
                <Name>Ipca-Allopurinol</Name>
                <Pack ID="P2666855" Specified="true" nzmt:ctpp_id="50202431000117104">
                  <Quantity>1000</Quantity>
                  <Price>17.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192004912626" Rank="1" Units="tab" Weight="300">
              <Name>Tab 300 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B19200491262630" PSS="true">
                <Name>Ipca-Allopurinol</Name>
                <Pack ID="P2666863" Specified="true" nzmt:ctpp_id="50236381000117103">
                  <Quantity>500</Quantity>
                  <Price>22.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1920049383">
            <Name>Colchicine</Name>
            <Formulation ID="F192004938325" Rank="1" Units="tab" Weight="0.5">
              <Name>Tab 500 mcg</Name>
              <Rule Type="DVLimit" Attribute="Sep-22 to~2025" Value="5"/>
              <Brand ID="B19200493832525" PSS="true">
                <Name>Colgout</Name>
                <Pack ID="P2200503" Specified="true" nzmt:ctpp_id="50031911000117106">
                  <Quantity>100</Quantity>
                  <Price>6.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1924">
        <Name>Muscle Relaxants and Related Agents</Name>
        <ATC3 ID="A192404">
          <Name>Muscle Relaxants and Related Agents</Name>
          <Chemical ID="C1924048125">
            <Name>Dantrolene</Name>
            <Formulation ID="F192404812501" Rank="2" Units="cap" Weight="25">
              <Name>Cap 25 mg</Name>
              <Brand ID="B19240481250125">
                <Name>Dantrium</Name>
                <Pack ID="P252409" Specified="true" nzmt:ctpp_id="50053311000117107">
                  <Quantity>100</Quantity>
                  <Price>112.13</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192404812502" Rank="2" Units="cap" Weight="50">
              <Name>Cap 50 mg</Name>
              <Brand ID="B19240481250225">
                <Name>Dantrium</Name>
                <Pack ID="P252417" Specified="true" nzmt:ctpp_id="50053321000117101">
                  <Quantity>100</Quantity>
                  <Price>77.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192404812503" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg vial</Name>
              <Brand ID="B19240481250325">
                <Name>Dantrium IV</Name>
                <Pack ID="P2395185" Specified="true" nzmt:ctpp_id="50126601000117102">
                  <Quantity>6</Quantity>
                  <Price>994.56</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1924048333">
            <Name>Orphenadrine citrate</Name>
            <Formulation ID="F192404833301" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B19240483330125" PSS="true">
                <Name>Norflex</Name>
                <Pack ID="P2645564" Specified="true" nzmt:ctpp_id="50290901000117102">
                  <Quantity>100</Quantity>
                  <Price>23.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1924048491">
            <Name>Vecuronium bromide</Name>
            <Formulation ID="F192404849101" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Apr-25 to~2027" Value="5"/>
              <Brand ID="B19240484910125" PSS="true">
                <Name>Vecure</Name>
                <Pack ID="P2503379" Specified="true" nzmt:ctpp_id="50235641000117107">
                  <Quantity>10</Quantity>
                  <Price>380.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1924049002">
            <Name>Atracurium besylate</Name>
            <Formulation ID="F192404900201" Rank="4" Units="inj" Weight="25">
              <Name>Inj 10 mg per ml, 2.5 ml ampoule</Name>
              <Brand ID="B19240490020101">
                <Name>Tracrium</Name>
                <Pack ID="P311618" Specified="true" nzmt:ctpp_id="50069711000117101">
                  <Quantity>5</Quantity>
                  <Price>18.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192404900202" Rank="4" Units="inj" Weight="50">
              <Name>Inj 10 mg per ml, 5 ml ampoule</Name>
              <Brand ID="B19240490020201">
                <Name>Tracrium</Name>
                <Pack ID="P311626" Specified="true" nzmt:ctpp_id="50069721000117107">
                  <Quantity>5</Quantity>
                  <Price>20.45</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1924049035">
            <Name>Mivacurium chloride</Name>
            <Formulation ID="F192404903502" Rank="4" Units="inj" Weight="20">
              <Name>Inj 2 mg per ml, 10 ml ampoule</Name>
              <Brand ID="B19240490350200">
                <Name>Any</Name>
                <Pack ID="P90350200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1924049045">
            <Name>Pancuronium bromide</Name>
            <Formulation ID="F192404904501" Rank="4" Units="inj" Weight="4">
              <Name>Inj 2 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B19240490450100">
                <Name>Any</Name>
                <Pack ID="P90450100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1924049059">
            <Name>Suxamethonium chloride</Name>
            <Formulation ID="F192404905901" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 2 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B19240490590125" PSS="true">
                <Name>Martindale</Name>
                <Pack ID="P2442205" Specified="true" nzmt:ctpp_id="50174991000117108">
                  <Quantity>10</Quantity>
                  <Price>35.40</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1924049132">
            <Name>Baclofen</Name>
            <Formulation ID="F192404913201" Rank="4" Units="inj" Weight="0.05">
              <Name>Inj 0.05 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B19240491320125">
                <Name>Lioresal Intrathecal</Name>
                <Pack ID="P2162334" Specified="true" nzmt:ctpp_id="50027491000117100">
                  <Quantity>1</Quantity>
                  <Price>11.55</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192404913202" Rank="3" Units="ml">
              <Name>Oral liq 1 mg per ml</Name>
              <Brand ID="B19240491320200">
                <Name>Any</Name>
                <Pack ID="P91320200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192404913225" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B19240491322525" PSS="true">
                <Name>Pacifen</Name>
                <Pack ID="P403903" Specified="true" nzmt:ctpp_id="50082381000117102">
                  <Quantity>100</Quantity>
                  <Price>3.70</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192404913226" Rank="4" Units="inj" Weight="10">
              <Name>Inj 2 mg per ml, 5 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B19240491322626" ToBeDelisted="2025-03-01">
                <Name>Medsurge</Name>
                <Pack ID="P2560054" Specified="true" nzmt:ctpp_id="50256691000117105">
                  <Quantity>5</Quantity>
                  <Price>306.82</Price>
                </Pack>
              </Brand>
              <Brand ID="B19240491322627" PSS="true">
                <Name>Sintetica Baclofen Intrathecal</Name>
                <Pack ID="P2688417" Specified="true" nzmt:ctpp_id="50341311000117105">
                  <Quantity>10</Quantity>
                  <Price>490.91</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1924049160">
            <Name>Clostridium botulinum type A toxin</Name>
            <Formulation ID="F192404916025" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 u vial</Name>
              <Brand ID="B19240491602525">
                <Name>Botox</Name>
                <Pack ID="P2084155" Specified="true" nzmt:ctpp_id="50013921000117107">
                  <Quantity>1</Quantity>
                  <Price>467.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192404916026" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 u vial</Name>
              <Brand ID="B19240491602625">
                <Name>Dysport</Name>
                <Pack ID="P495530" Specified="true" nzmt:ctpp_id="50092571000117109">
                  <Quantity>2</Quantity>
                  <Price>1295.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192404916027" Rank="4" Units="inj" Weight="300">
              <Name>Inj 300 u vial</Name>
              <Brand ID="B19240491602725">
                <Name>Dysport</Name>
                <Pack ID="P2495708" Specified="true" nzmt:ctpp_id="50177681000117105">
                  <Quantity>1</Quantity>
                  <Price>388.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1924049578">
            <Name>Rocuronium bromide</Name>
            <Formulation ID="F192404957826" Rank="4" Units="inj">
              <Name>Inj 10 mg per ml, 5 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B19240495782625" PSS="true">
                <Name>Hameln</Name>
                <Pack ID="P2577143" Specified="true" nzmt:ctpp_id="50130611000117104">
                  <Quantity>10</Quantity>
                  <Price>37.06</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A192408">
          <Name>Reversers of Neuromuscular Blockade</Name>
          <Chemical ID="C1924088522">
            <Name>Sugammadex</Name>
            <Request Form="RS1370" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Sugammadex</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Patient requires reversal of profound neuromuscular blockade following rapid sequence induction that has been undertaken using rocuronium (i.e. suxamethonium is contraindicated or undesirable)</ci>
                    <ci type="logical">Severe neuromuscular degenerative disease where the use of neuromuscular blockade is required</ci>
                    <ci type="logical">Patient has an unexpectedly difficult airway that cannot be intubated and requires a rapid reversal of anaesthesia and neuromuscular blockade</ci>
                    <ci type="logical">The duration of the patient's surgery is unexpectedly short</ci>
                    <ci type="logical">Neostigmine or a neostigmine/anticholinergic combination is contraindicated (for example the patient has ischaemic heart disease, morbid obesity or COPD)</ci>
                    <ci type="logical">Patient has a partial residual block after conventional reversal</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1370" style="display:none"/>
            <Formulation ID="F192408852225" Rank="4" Units="inj" Weight="200">
              <Name>Inj 100 mg per ml, 2 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B19240885222526" PSS="true">
                <Name>Sugammadex BNM</Name>
                <Pack ID="P2632314" Specified="true" nzmt:ctpp_id="50282211000117108">
                  <Quantity>10</Quantity>
                  <Price>80.64</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192408852226" Rank="4" Units="inj" Weight="500">
              <Name>Inj 100 mg per ml, 5 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B19240885222626" PSS="true">
                <Name>Sugammadex BNM</Name>
                <Pack ID="P2632322" Specified="true" nzmt:ctpp_id="50282201000117105">
                  <Quantity>10</Quantity>
                  <Price>201.60</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1928">
        <Name>Non-Steroidal Anti-Inflammatory Drugs</Name>
        <ATC3 ID="A192804">
          <Name>Non-Steroidal Anti-Inflammatory Drugs</Name>
          <Chemical ID="C1928048228">
            <Name>Indometacin [Indomethacin]</Name>
            <Formulation ID="F192804822801" Rank="2" Units="cap" Weight="25">
              <Name>Cap 25 mg</Name>
              <Brand ID="B19280482280100">
                <Name>Any</Name>
                <Pack ID="P82280100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804822802" Rank="2" Units="cap" Weight="50">
              <Name>Cap 50 mg</Name>
              <Brand ID="B19280482280200">
                <Name>Any</Name>
                <Pack ID="P82280200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804822803" Rank="2" Units="cap" Weight="75">
              <Name>Cap long-acting 75 mg</Name>
              <Brand ID="B19280482280300">
                <Name>Any</Name>
                <Pack ID="P82280300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804822804" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg vial</Name>
              <Brand ID="B19280482280400">
                <Name>Any</Name>
                <Pack ID="P82280400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804822805" Rank="5" Units="supp">
              <Name>Suppos 100 mg</Name>
              <Brand ID="B19280482280500">
                <Name>Any</Name>
                <Pack ID="P82280500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1928048283">
            <Name>Mefenamic acid</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F192804828301" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Brand ID="B19280482830100">
                <Name>Any</Name>
                <Pack ID="P82830100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1928048450">
            <Name>Sulindac</Name>
            <Formulation ID="F192804845001" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B19280484500100">
                <Name>Any</Name>
                <Pack ID="P84500100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804845002" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B19280484500200">
                <Name>Any</Name>
                <Pack ID="P84500200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1928048510">
            <Name>Celecoxib</Name>
            <Formulation ID="F192804851025" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Nov-22 to~2025" Value="5"/>
              <Brand ID="B19280485102525" PSS="true">
                <Name>Celecoxib Pfizer</Name>
                <Pack ID="P2521164" Specified="true" nzmt:ctpp_id="50241081000117109">
                  <Quantity>60</Quantity>
                  <Price>3.45</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804851026" Rank="2" Units="cap" Weight="200">
              <Name>Cap 200 mg</Name>
              <Rule Type="DVLimit" Attribute="Nov-22 to~2025" Value="5"/>
              <Brand ID="B19280485102625" PSS="true">
                <Name>Celecoxib Pfizer</Name>
                <Pack ID="P2521172" Specified="true" nzmt:ctpp_id="50241111000117100">
                  <Quantity>30</Quantity>
                  <Price>3.20</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1928048511">
            <Name>Etoricoxib</Name>
            <Request Form="RS1592" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Etoricoxib</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For in-vivo investigation of allergy only</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1592" style="display:none"/>
            <Formulation ID="F192804851125" Rank="1" Units="tab" Weight="30">
              <Name>Tab 30 mg</Name>
              <Brand ID="B19280485112500">
                <Name>Any</Name>
                <Pack ID="P85112500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804851126" Rank="1" Units="tab" Weight="60">
              <Name>Tab 60 mg</Name>
              <Brand ID="B19280485112600">
                <Name>Any</Name>
                <Pack ID="P85112600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804851127" Rank="1" Units="tab" Weight="90">
              <Name>Tab 90 mg</Name>
              <Brand ID="B19280485112700">
                <Name>Any</Name>
                <Pack ID="P85112700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804851128" Rank="1" Units="tab" Weight="120">
              <Name>Tab 120 mg</Name>
              <Brand ID="B19280485112800">
                <Name>Any</Name>
                <Pack ID="P85112800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1928049177">
            <Name>Diclofenac sodium</Name>
            <Formulation ID="F192804917702" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg dispersible</Name>
              <Brand ID="B19280491770225">
                <Name>Voltaren D</Name>
                <Pack ID="P269905" Specified="true" nzmt:ctpp_id="50059871000117105">
                  <Quantity>20</Quantity>
                  <Price>1.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804917726" Rank="5" Units="supp" Weight="12.5">
              <Name>Suppos 12.5 mg</Name>
              <Brand ID="B19280491772625">
                <Name>Voltaren</Name>
                <Pack ID="P645931" Specified="true" nzmt:ctpp_id="50100171000117109">
                  <Quantity>10</Quantity>
                  <Price>2.04</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804917727" Rank="5" Units="supp" Weight="25">
              <Name>Suppos 25 mg</Name>
              <Brand ID="B19280491772725">
                <Name>Voltaren</Name>
                <Pack ID="P645958" Specified="true" nzmt:ctpp_id="50100181000117107">
                  <Quantity>10</Quantity>
                  <Price>2.44</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804917728" Rank="5" Units="supp" Weight="50">
              <Name>Suppos 50 mg</Name>
              <Brand ID="B19280491772825">
                <Name>Voltaren</Name>
                <Pack ID="P747742" Specified="true" nzmt:ctpp_id="50107991000117109">
                  <Quantity>10</Quantity>
                  <Price>4.22</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804917729" Rank="5" Units="supp" Weight="100">
              <Name>Suppos 100 mg</Name>
              <Brand ID="B19280491772925">
                <Name>Voltaren</Name>
                <Pack ID="P747750" Specified="true" nzmt:ctpp_id="50108001000117101">
                  <Quantity>10</Quantity>
                  <Price>7.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804917730" Rank="1" Units="tab" Weight="75">
              <Name>Tab long-acting 75 mg</Name>
              <Brand ID="B19280491773027">
                <Name>Voltaren SR</Name>
                <Pack ID="P2140276" Specified="true" nzmt:ctpp_id="50024141000117107">
                  <Quantity>100</Quantity>
                  <Price>19.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804917732" Rank="4" Units="inj" Weight="75">
              <Name>Inj 25 mg per ml, 3 ml ampoule</Name>
              <Brand ID="B19280491773225">
                <Name>Voltaren</Name>
                <Pack ID="P263486" Specified="true" nzmt:ctpp_id="50058331000117109">
                  <Quantity>5</Quantity>
                  <Price>13.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804917733" Rank="1" Units="tab" Weight="25">
              <Name>Tab EC 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B19280491773326" PSS="true">
                <Name>Diclofenac Sandoz</Name>
                <Pack ID="P2355981" Specified="true" nzmt:ctpp_id="50050751000117101">
                  <Quantity>50</Quantity>
                  <Price>2.19</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804917734" Rank="1" Units="tab" Weight="50">
              <Name>Tab EC 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B19280491773426" PSS="true">
                <Name>Diclofenac Sandoz</Name>
                <Pack ID="P2356007" Specified="true" nzmt:ctpp_id="50050761000117104">
                  <Quantity>50</Quantity>
                  <Price>2.19</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1928049401">
            <Name>Ibuprofen</Name>
            <Formulation ID="F192804940101" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B19280494010100">
                <Name>Any</Name>
                <Pack ID="P94010100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804940102" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg - 1,000 tablet pack</Name>
              <Rule Type="DVLimit" Attribute="Feb-21 to~2026" Value="1"/>
              <Brand ID="B19280494010225" HSS="true">
                <Name>Relieve</Name>
                <Pack ID="P2526212" Specified="true" nzmt:ctpp_id="50249431000117100">
                  <Quantity>1000</Quantity>
                  <Price>21.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804940103" Rank="1" Units="tab" Weight="400">
              <Name>Tab 400 mg</Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
                <p>For continuation only</p>
              </div>
              <Brand ID="B19280494010300">
                <Name>Any</Name>
                <Pack ID="P94010300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804940104" Rank="1" Units="tab" Weight="600">
              <Name>Tab 600 mg</Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
                <p>For continuation only</p>
              </div>
              <Brand ID="B19280494010400">
                <Name>Any</Name>
                <Pack ID="P94010400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804940125" Rank="3" Units="ml" Weight="100">
              <Name>Oral liq 20 mg per ml</Name>
              <Brand ID="B19280494012526">
                <Name>Ethics</Name>
                <Pack ID="P2551985" Specified="true" nzmt:ctpp_id="50220601000117102">
                  <Quantity>200</Quantity>
                  <Price>2.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804940126" Rank="1" Units="tab" Weight="800">
              <Name>Tab long-acting 800 mg</Name>
              <Brand ID="B19280494012625">
                <Name>Brufen SR</Name>
                <Pack ID="P2534320" Specified="true" nzmt:ctpp_id="50040471000117102">
                  <Quantity>30</Quantity>
                  <Price>3.05</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804940127" Rank="4" Units="inj" Weight="20">
              <Name>Inj 10 mg per ml, 2 ml vial</Name>
              <Brand ID="B19280494012700">
                <Name>Any</Name>
                <Pack ID="P94012700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1928049505">
            <Name>Naproxen</Name>
            <Formulation ID="F192804950501" Rank="1" Units="tab" Weight="1000">
              <Name>Tab long-acting 1 g</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B19280495050125" PSS="true">
                <Name>Naprosyn SR 1000</Name>
                <Pack ID="P2518619" Specified="true" nzmt:ctpp_id="50110931000117107">
                  <Quantity>28</Quantity>
                  <Price>11.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804950502" Rank="1" Units="tab" Weight="750">
              <Name>Tab long-acting 750 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B19280495050225" PSS="true">
                <Name>Naprosyn SR 750</Name>
                <Pack ID="P2518627" Specified="true" nzmt:ctpp_id="50110911000117103">
                  <Quantity>28</Quantity>
                  <Price>10.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804950525" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B19280495052525" PSS="true">
                <Name>Noflam 250</Name>
                <Pack ID="P2654458" Specified="true" nzmt:ctpp_id="50071471000117109">
                  <Quantity>500</Quantity>
                  <Price>39.23</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804950526" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B19280495052625" PSS="true">
                <Name>Noflam 500</Name>
                <Pack ID="P2654466" Specified="true" nzmt:ctpp_id="50072121000117108">
                  <Quantity>250</Quantity>
                  <Price>34.45</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1928049535">
            <Name>Tenoxicam</Name>
            <Formulation ID="F192804953501" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B19280495350126" PSS="true">
                <Name>Tilcotil</Name>
                <Pack ID="P2520559" Specified="true" nzmt:ctpp_id="50106671000117100">
                  <Quantity>100</Quantity>
                  <Price>18.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F192804953525" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg vial</Name>
              <Brand ID="B19280495352525">
                <Name>AFT</Name>
                <Pack ID="P2307022" Specified="true" nzmt:ctpp_id="50046201000117108">
                  <Quantity>1</Quantity>
                  <Price>9.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1928049590">
            <Name>Ketoprofen</Name>
            <Formulation ID="F192804959026" Rank="2" Units="cap" Weight="200">
              <Name>Cap long-acting 200 mg</Name>
              <Brand ID="B19280495902625">
                <Name>Oruvail SR</Name>
                <Pack ID="P397148" Specified="true" nzmt:ctpp_id="50081641000117105">
                  <Quantity>28</Quantity>
                  <Price>12.07</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C1928049647">
            <Name>Parecoxib</Name>
            <Formulation ID="F192804964725" Rank="4" Units="inj" Weight="40">
              <Name>Inj 40 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B19280496472525" PSS="true">
                <Name>Dynastat</Name>
                <Pack ID="P2394804" Specified="true" nzmt:ctpp_id="50126571000117107">
                  <Quantity>10</Quantity>
                  <Price>46.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A1932">
        <Name>Topical Products for Joint and Muscular Pain</Name>
        <ATC3 ID="A193204">
          <Name>Topical Products for Joint and Muscular Pain</Name>
          <Chemical ID="C1932049293">
            <Name>Capsaicin</Name>
            <Request Form="RS1309" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Capsaicin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has osteoarthritis that is not responsive to paracetamol and oral non-steroidal anti-inflammatories are contraindicated</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1309" style="display:none"/>
            <Formulation ID="F193204929326" Rank="3" Units="g" Weight="45">
              <Name>Crm 0.025%</Name>
              <Brand ID="B19320492932625">
                <Name>Zostrix</Name>
                <Pack ID="P472786" Specified="true" nzmt:ctpp_id="50089091000117105">
                  <Quantity>45</Quantity>
                  <Price>9.75</Price>
                </Pack>
              </Brand>
              <Brand ID="B19320492932626">
                <Name>Zo-Rub Osteo</Name>
                <Pack ID="P2682885" Specified="true" nzmt:ctpp_id="50292721000117107">
                  <Quantity>45</Quantity>
                  <Price>9.75</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
    <ATC1 ID="A22">
      <Name>Nervous System</Name>
      <ATC2 ID="A2204">
        <Name>Agents for Parkinsonism and Related Disorders</Name>
        <ATC3 ID="A220404">
          <Name>Agents for Essential Tremor, Chorea and Related Disorders</Name>
          <Chemical ID="C2204048535">
            <Name>Riluzole</Name>
            <Request Form="RS1351" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Riluzole</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has amyotrophic lateral sclerosis with disease duration of 5 years or less</ci>
                    <ci type="logical">The patient has at least 60 percent of predicted forced vital capacity within 2 months prior to the initial application</ci>
                    <ci type="logical">The patient has not undergone a tracheostomy</ci>
                    <ci type="logical">The patient has not experienced respiratory failure</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient is ambulatory</ci>
                      <ci type="logical">The patient is able to use upper limbs</ci>
                      <ci type="logical">The patient is able to swallow</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>neurologist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has not undergone a tracheostomy</ci>
                    <ci type="logical">The patient has not experienced respiratory failure</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient is ambulatory</ci>
                      <ci type="logical">The patient is able to use upper limbs</ci>
                      <ci type="logical">The patient is able to swallow</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">18</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1351" style="display:none"/>
            <Formulation ID="F220404853525" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B22040485352525" PSS="true">
                <Name>Rilutek</Name>
                <Pack ID="P238732" Specified="true" nzmt:ctpp_id="50051311000117108">
                  <Quantity>56</Quantity>
                  <Price>117.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2204049646">
            <Name>Tetrabenazine</Name>
            <Formulation ID="F220404964625" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B22040496462525" PSS="true">
                <Name>Motetis</Name>
                <Pack ID="P2394383" Specified="true" nzmt:ctpp_id="50128441000117103">
                  <Quantity>112</Quantity>
                  <Price>106.59</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A220408">
          <Name>Anticholinergics</Name>
          <Chemical ID="C2204088392">
            <Name>Procyclidine hydrochloride</Name>
            <Formulation ID="F220408839201" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B22040883920100">
                <Name>Any</Name>
                <Pack ID="P83920100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2204089480">
            <Name>Benzatropine mesylate</Name>
            <Formulation ID="F220408948025" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Brand ID="B22040894802525">
                <Name>Benztrop</Name>
                <Pack ID="P2123169" Specified="true" nzmt:ctpp_id="50022361000117100">
                  <Quantity>60</Quantity>
                  <Price>9.59</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220408948026" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B22040894802626">
                <Name>Phebra</Name>
                <Pack ID="P2580454" Specified="true" nzmt:ctpp_id="50269741000117106">
                  <Quantity>5</Quantity>
                  <Price>95.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A220412">
          <Name>Dopamine Agonists and Related Agents</Name>
          <Chemical ID="C2204128068">
            <Name>Bromocriptine</Name>
            <Formulation ID="F220412806801" Rank="2" Units="cap" Weight="5">
              <Name>Cap 5 mg</Name>
              <Brand ID="B22041280680100">
                <Name>Any</Name>
                <Pack ID="P80680100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2204128412">
            <Name>Selegiline hydrochloride</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F220412841201" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B22041284120100">
                <Name>Any</Name>
                <Pack ID="P84120100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2204128675">
            <Name>Rasagiline</Name>
            <Formulation ID="F220412867525" Rank="1" Units="tab">
              <Name>Tab 1 mg</Name>
              <Brand ID="B22041286752525">
                <Name>Azilect</Name>
                <Pack ID="P2611449" Specified="true" nzmt:ctpp_id="50288211000117106">
                  <Quantity>30</Quantity>
                  <Price>53.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2204129128">
            <Name>Amantadine hydrochloride</Name>
            <Formulation ID="F220412912825" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Brand ID="B22041291282525">
                <Name>Symmetrel</Name>
                <Pack ID="P788589" Specified="true" nzmt:ctpp_id="50115041000117107">
                  <Quantity>60</Quantity>
                  <Price>38.24</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2204129283">
            <Name>Entacapone</Name>
            <Formulation ID="F220412928325" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B22041292832525">
                <Name>Comtan</Name>
                <Pack ID="P2536471" Specified="true" nzmt:ctpp_id="50019691000117100">
                  <Quantity>100</Quantity>
                  <Price>18.04</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2204129285">
            <Name>Ropinirole hydrochloride</Name>
            <Formulation ID="F220412928526" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B22041292852626" PSS="true">
                <Name>Ropin</Name>
                <Pack ID="P2310864" Specified="true" nzmt:ctpp_id="50047101000117103">
                  <Quantity>84</Quantity>
                  <Price>4.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220412928527" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B22041292852726" PSS="true">
                <Name>Ropin</Name>
                <Pack ID="P2310872" Specified="true" nzmt:ctpp_id="50047111000117100">
                  <Quantity>84</Quantity>
                  <Price>6.48</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220412928528" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B22041292852826" PSS="true">
                <Name>Ropin</Name>
                <Pack ID="P2310880" Specified="true" nzmt:ctpp_id="50047121000117106">
                  <Quantity>84</Quantity>
                  <Price>14.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220412928531" Rank="1" Units="tab" Weight="0.25">
              <Name>Tab 0.25 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B22041292853125" PSS="true">
                <Name>Ropin</Name>
                <Pack ID="P2310856" Specified="true" nzmt:ctpp_id="50047091000117107">
                  <Quantity>84</Quantity>
                  <Price>4.05</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2204129312">
            <Name>Apomorphine hydrochloride</Name>
            <Formulation ID="F220412931226" Rank="4" Units="inj" Weight="20">
              <Name>Inj 10 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B22041293122626">
                <Name>Movapo</Name>
                <Pack ID="P2498723" Specified="true" nzmt:ctpp_id="50232801000117104">
                  <Quantity>5</Quantity>
                  <Price>59.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220412931227" Rank="4" Units="inj" Weight="50">
              <Name>Inj 10 mg per ml, 5 ml ampoule</Name>
              <Brand ID="B22041293122725">
                <Name>Movapo</Name>
                <Pack ID="P2581159" Specified="true" nzmt:ctpp_id="50232791000117100">
                  <Quantity>5</Quantity>
                  <Price>121.84</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2204129316">
            <Name>Levodopa with benserazide</Name>
            <Formulation ID="F220412931625" Rank="2" Units="cap" Weight="50">
              <Name>Cap 50 mg with benserazide 12.5 mg</Name>
              <Brand ID="B22041293162525">
                <Name>Madopar 62.5</Name>
                <Pack ID="P201413" Specified="true" nzmt:ctpp_id="50002221000117107">
                  <Quantity>100</Quantity>
                  <Price>13.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220412931626" Rank="1" Units="tab" Weight="50">
              <Name>Tab dispersible 50 mg with benserazide 12.5 mg</Name>
              <Brand ID="B22041293162625">
                <Name>Madopar Rapid</Name>
                <Pack ID="P635960" Specified="true" nzmt:ctpp_id="50133141000117104">
                  <Quantity>100</Quantity>
                  <Price>13.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220412931627" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg with benserazide 25 mg</Name>
              <Brand ID="B22041293162725">
                <Name>Madopar 125</Name>
                <Pack ID="P201421" Specified="true" nzmt:ctpp_id="50002261000117103">
                  <Quantity>100</Quantity>
                  <Price>15.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220412931628" Rank="2" Units="cap" Weight="100">
              <Name>Cap long-acting 100 mg with benserazide 25 mg</Name>
              <Brand ID="B22041293162825">
                <Name>Madopar HBS</Name>
                <Pack ID="P693960" Specified="true" nzmt:ctpp_id="50102391000117106">
                  <Quantity>100</Quantity>
                  <Price>22.85</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220412931629" Rank="2" Units="cap" Weight="200">
              <Name>Cap 200 mg with benserazide 50 mg</Name>
              <Brand ID="B22041293162925">
                <Name>Madopar 250</Name>
                <Pack ID="P201448" Specified="true" nzmt:ctpp_id="50002321000117102">
                  <Quantity>100</Quantity>
                  <Price>26.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2204129503">
            <Name>Levodopa with carbidopa</Name>
            <Formulation ID="F220412950325" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg with carbidopa 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B22041295032525" PSS="true">
                <Name>Sinemet</Name>
                <Pack ID="P2429985" Specified="true" nzmt:ctpp_id="50058921000117107">
                  <Quantity>100</Quantity>
                  <Price>26.49</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220412950326" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg with carbidopa 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B22041295032625" PSS="true">
                <Name>Sinemet</Name>
                <Pack ID="P2429993" Specified="true" nzmt:ctpp_id="50008781000117101">
                  <Quantity>100</Quantity>
                  <Price>39.49</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220412950327" Rank="1" Units="tab" Weight="200">
              <Name>Tab long-acting 200 mg with carbidopa 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B22041295032725" PSS="true">
                <Name>Sinemet CR</Name>
                <Pack ID="P2430002" Specified="true" nzmt:ctpp_id="50102931000117108">
                  <Quantity>100</Quantity>
                  <Price>44.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220412950328" Rank="1" Units="tab" Weight="100">
              <Name>Tab long-acting 100 mg with carbipoda 25 mg</Name>
              <Brand ID="B22041295032800">
                <Name>Any</Name>
                <Pack ID="P95032800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2204129599">
            <Name>Tolcapone</Name>
            <Formulation ID="F220412959925" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B22041295992525">
                <Name>Tasmar</Name>
                <Pack ID="P487236" Specified="true" nzmt:ctpp_id="50091491000117100">
                  <Quantity>100</Quantity>
                  <Price>152.38</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2204129639">
            <Name>Pramipexole hydrochloride</Name>
            <Formulation ID="F220412963927" Rank="1" Units="tab" Weight="0.25">
              <Name>Tab 0.25 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B22041296392726" PSS="true">
                <Name>Ramipex</Name>
                <Pack ID="P2450534" Specified="true" nzmt:ctpp_id="50192081000117107">
                  <Quantity>100</Quantity>
                  <Price>5.51</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220412963928" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B22041296392826" PSS="true">
                <Name>Ramipex</Name>
                <Pack ID="P2450542" Specified="true" nzmt:ctpp_id="50192101000117101">
                  <Quantity>100</Quantity>
                  <Price>18.66</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2208">
        <Name>Anaesthetics</Name>
        <ATC3 ID="A220804">
          <Name>General Anaesthetics</Name>
          <Chemical ID="C2208048133">
            <Name>Dexmedetomidine</Name>
            <Formulation ID="F220804813301" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mcg per ml, 2 ml vial</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2026" Value="5"/>
              <Brand ID="B22080481330127" PSS="true">
                <Name>Dexmedetomidine Viatris</Name>
                <Pack ID="P2660008" Specified="true" nzmt:ctpp_id="50318601000117104">
                  <Quantity>5</Quantity>
                  <Price>42.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208048178">
            <Name>Etomidate</Name>
            <Formulation ID="F220804817801" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2 mg per ml, 10 ml ampoule</Name>
              <Brand ID="B22080481780100">
                <Name>Any</Name>
                <Pack ID="P81780100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208048249">
            <Name>Ketamine</Name>
            <Formulation ID="F220804824901" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg per ml, 100 ml bag</Name>
              <Brand ID="B22080482490125">
                <Name>Biomed</Name>
                <Pack ID="P2594145" Specified="true" nzmt:ctpp_id="50279761000117103">
                  <Quantity>5</Quantity>
                  <Price>141.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220804824902" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 10 ml syringe</Name>
              <Brand ID="B22080482490225">
                <Name>Biomed</Name>
                <Pack ID="P2384213" Specified="true" nzmt:ctpp_id="50125591000117100">
                  <Quantity>5</Quantity>
                  <Price>73.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220804824925" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg per ml, 2 ml vial</Name>
              <Brand ID="B22080482492525">
                <Name>Ketalar</Name>
                <Pack ID="P436895" Specified="true" nzmt:ctpp_id="50039201000117104">
                  <Quantity>5</Quantity>
                  <Price>36.23</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208048293">
            <Name>Methohexital sodium</Name>
            <Formulation ID="F220804829301" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 50 ml vial</Name>
              <Brand ID="B22080482930100">
                <Name>Any</Name>
                <Pack ID="P82930100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208048465">
            <Name>Thiopental [Thiopentone] sodium</Name>
            <Formulation ID="F220804846501" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg ampoule</Name>
              <Brand ID="B22080484650100">
                <Name>Any</Name>
                <Pack ID="P84650100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208049028">
            <Name>Isoflurane</Name>
            <Formulation ID="F220804902801" Rank="10" Units="btl" Weight="250">
              <Name>Soln for inhalation 100%, 250 ml bottle</Name>
              <Brand ID="B22080490280102">
                <Name>Aerrane</Name>
                <Pack ID="P2331543" Specified="true" nzmt:ctpp_id="50190841000117106">
                  <Quantity>6</Quantity>
                  <Price>2730.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208049049">
            <Name>Propofol</Name>
            <Formulation ID="F220804904901" Rank="4" Units="inj" Weight="100">
              <Name>Inj 10 mg per ml, 100 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B22080490490128" PSS="true">
                <Name>Fresofol 1% MCT/LCT</Name>
                <Pack ID="P2444038" Specified="true" nzmt:ctpp_id="50177581000117106">
                  <Quantity>10</Quantity>
                  <Price>39.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220804904904" Rank="4" Units="inj" Weight="50">
              <Name>Inj 10 mg per ml, 50 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B22080490490428" PSS="true">
                <Name>Fresofol 1% MCT/LCT</Name>
                <Pack ID="P2444011" Specified="true" nzmt:ctpp_id="50177571000117108">
                  <Quantity>10</Quantity>
                  <Price>19.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220804904905" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 20 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B22080490490526" PSS="true">
                <Name>Fresofol 1% MCT/LCT</Name>
                <Pack ID="P2444003" Specified="true" nzmt:ctpp_id="50177551000117100">
                  <Quantity>5</Quantity>
                  <Price>4.35</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208049057">
            <Name>Sevoflurane</Name>
            <Formulation ID="F220804905701" Rank="10" Units="btl" Weight="250">
              <Name>Soln for inhalation 100%, 250 ml bottle</Name>
              <Brand ID="B22080490570125">
                <Name>Baxter</Name>
                <Pack ID="P2331578" Specified="true" nzmt:ctpp_id="50190861000117105">
                  <Quantity>6</Quantity>
                  <Price>930.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208049494">
            <Name>Desflurane</Name>
            <Formulation ID="F220804949425" Rank="10" Units="btl">
              <Name>Soln for inhalation 100%, 240 ml bottle</Name>
              <Brand ID="B22080494942525">
                <Name>Suprane</Name>
                <Pack ID="P2490293" Specified="true" nzmt:ctpp_id="50190851000117108">
                  <Quantity>6</Quantity>
                  <Price>1350.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A220808">
          <Name>Local Anaesthetics</Name>
          <Chemical ID="C2208088040">
            <Name>Articaine hydrochloride with adrenaline</Name>
            <Formulation ID="F220808804001" Rank="4" Units="inj" Weight="3">
              <Name>Inj 4% with adrenaline 1:100,000, 2.2 ml dental cartridge</Name>
              <Brand ID="B22080880400100">
                <Name>Any</Name>
                <Pack ID="P80400100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808804025" Rank="4" Units="inj" Weight="1">
              <Name>Inj 4% with adrenaline 1:100,000, 1.7 ml dental cartridge</Name>
              <Brand ID="B22080880402500">
                <Name>Any</Name>
                <Pack ID="P80402500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808804026" Rank="4" Units="inj" Weight="4">
              <Name>Inj 4% with adrenaline 1:200,000, 1.7 ml dental cartridge</Name>
              <Brand ID="B22080880402600">
                <Name>Any</Name>
                <Pack ID="P80402600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808804027" Rank="4" Units="inj" Weight="6">
              <Name>Inj 4% with adrenaline 1:200,000, 2.2 ml dental cartridge</Name>
              <Brand ID="B22080880402700">
                <Name>Any</Name>
                <Pack ID="P80402700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808804028" Rank="4" Units="inj" Weight="2">
              <Name>Inj 4% with adrenaline 1:100,000, 1.8 ml dental cartridge</Name>
              <Brand ID="B22080880402800">
                <Name>Any</Name>
                <Pack ID="P80402800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808804029" Rank="4" Units="inj" Weight="5">
              <Name>Inj 4% with adrenaline 1:200,000 1.8 ml dental cartridge</Name>
              <Brand ID="B22080880402900">
                <Name>Any</Name>
                <Pack ID="P80402900" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208088070">
            <Name>Bupivacaine hydrochloride with glucose</Name>
            <Formulation ID="F220808807001" Rank="4" Units="inj">
              <Name>Inj 0.5% with glucose 8%, 4 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Sep-22 to~2025" Value="5"/>
              <Brand ID="B22080880700125" PSS="true">
                <Name>Marcain Heavy</Name>
                <Pack ID="P2184435" Specified="true" nzmt:ctpp_id="50030231000117100">
                  <Quantity>5</Quantity>
                  <Price>26.67</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208088109">
            <Name>Cocaine hydrochloride with adrenaline</Name>
            <Formulation ID="F220808810901" Rank="3" Units="g">
              <Name>Paste 15% with adrenaline 0.06%</Name>
              <Brand ID="B22080881090100">
                <Name>Any</Name>
                <Pack ID="P81090100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808810902" Rank="3" Units="g">
              <Name>Paste 25% with adrenaline 0.06%</Name>
              <Brand ID="B22080881090200">
                <Name>Any</Name>
                <Pack ID="P81090200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208088177">
            <Name>Ethyl chloride</Name>
            <Formulation ID="F220808817701" Rank="3" Units="ml">
              <Name>Spray 100%</Name>
              <Brand ID="B22080881770100">
                <Name>Any</Name>
                <Pack ID="P81770100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208088259">
            <Name>Lidocaine [Lignocaine] hydrochloride with adrenaline and tetracaine hydrochloride</Name>
            <Formulation ID="F220808825901" Rank="4" Units="inj">
              <Name>Soln 4% with adrenaline 0.1% and tetracaine hydrochloride 0.5%, 5 ml syringe</Name>
              <Brand ID="B22080882590125">
                <Name>Topicaine</Name>
                <Pack ID="P2288737" Specified="true" nzmt:ctpp_id="50044261000117103">
                  <Quantity>1</Quantity>
                  <Price>19.70</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208088260">
            <Name>Lidocaine [Lignocaine] hydrochloride with phenylephrine hydrochloride</Name>
            <Formulation ID="F220808826001" Rank="6" Units="dose">
              <Name>Nasal spray 5% with phenylephrine hydrochloride 0.5%</Name>
              <Brand ID="B22080882600100">
                <Name>Any</Name>
                <Pack ID="P82600100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208088291">
            <Name>Mepivacaine hydrochloride</Name>
            <Formulation ID="F220808829101" Rank="4" Units="inj">
              <Name>Inj 3%, 1.8 ml dental cartridge</Name>
              <Brand ID="B22080882910125">
                <Name>Scandonest 3%</Name>
                <Pack ID="P2464217" Specified="true" nzmt:ctpp_id="50208121000117107">
                  <Quantity>50</Quantity>
                  <Price>43.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808829102" Rank="4" Units="inj">
              <Name>Inj 3%, 2.2 ml dental cartridge</Name>
              <Brand ID="B22080882910225">
                <Name>Scandonest 3%</Name>
                <Pack ID="P2464225" Specified="true" nzmt:ctpp_id="50208131000117105">
                  <Quantity>50</Quantity>
                  <Price>43.60</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208088388">
            <Name>Prilocaine hydrochloride with felypressin</Name>
            <Formulation ID="F220808838801" Rank="4" Units="inj">
              <Name>Inj 3% with felypressin 0.03 iu per ml, 1.8 ml dental cartridge</Name>
              <Brand ID="B22080883880100">
                <Name>Any</Name>
                <Pack ID="P83880100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808838802" Rank="4" Units="inj">
              <Name>Inj 3% with felypressin 0.03 iu per ml, 2.2 ml dental cartridge</Name>
              <Brand ID="B22080883880200">
                <Name>Any</Name>
                <Pack ID="P83880200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208088460">
            <Name>Tetracaine [Amethocaine] hydrochloride</Name>
            <Formulation ID="F220808846003" Rank="3" Units="ml">
              <Name>Gel 4%</Name>
              <Brand ID="B22080884600300">
                <Name>Any</Name>
                <Pack ID="P84600300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208088512">
            <Name>Benzocaine</Name>
            <Formulation ID="F220808851225" Rank="3" Units="ml">
              <Name>Gel 20%</Name>
              <Brand ID="B22080885122500">
                <Name>Any</Name>
                <Pack ID="P85122500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208088564">
            <Name>Articaine hydrochloride</Name>
            <Formulation ID="F220808856425" Rank="4" Units="inj">
              <Name>Inj 1%</Name>
              <Brand ID="B22080885642500">
                <Name>Any</Name>
                <Pack ID="P85642500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208088573">
            <Name>Lidocaine [Lignocaine]</Name>
            <Formulation ID="F220808857325" Rank="3" Units="g">
              <Name>Crm 4%</Name>
              <Brand ID="B22080885732525">
                <Name>LMX4</Name>
                <Pack ID="P2396564" Specified="true" nzmt:ctpp_id="50127631000117105">
                  <Quantity>30</Quantity>
                  <Price>27.00</Price>
                </Pack>
                <Pack ID="P2523248" Specified="true" nzmt:ctpp_id="50127621000117107">
                  <Quantity>5</Quantity>
                  <Price>5.40</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208088647">
            <Name>Benzocaine with tetracaine hydrochloride</Name>
            <Formulation ID="F220808864725" Rank="3" Units="ml">
              <Name>Gel 18% with tetracaine hydrochloride 2%</Name>
              <Brand ID="B22080886472500">
                <Name>e.g. ZAP Topical Anaesthetic Gel</Name>
                <Pack ID="P86472500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208088673">
            <Name>Mepivacaine hydrochloride with adrenaline</Name>
            <Formulation ID="F220808867325" Rank="4" Units="inj" Weight="1">
              <Name>Inj 2% with adrenaline 1:100,000, 1.8 ml dental cartridge</Name>
              <Brand ID="B22080886732500">
                <Name>Any</Name>
                <Pack ID="P86732500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808867326" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2% with adrenaline 1:100,000, 2.2 ml dental cartridge</Name>
              <Brand ID="B22080886732600">
                <Name>Any</Name>
                <Pack ID="P86732600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208089006">
            <Name>Bupivacaine hydrochloride</Name>
            <Formulation ID="F220808900604" Rank="4" Units="inj" Weight="50">
              <Name>Inj 2.5 mg per ml, 20 ml ampoule sterile pack</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22080890060401" PSS="true">
                <Name>Marcain</Name>
                <Pack ID="P728071" Specified="true" nzmt:ctpp_id="50106491000117102">
                  <Quantity>5</Quantity>
                  <Price>28.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900606" Rank="4" Units="inj" Weight="50">
              <Name>Inj 5 mg per ml, 10 ml ampoule sterile pack</Name>
              <Brand ID="B22080890060601">
                <Name>Marcain</Name>
                <Pack ID="P728098" Specified="true" nzmt:ctpp_id="50106501000117108">
                  <Quantity>5</Quantity>
                  <Price>16.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900609" Rank="4" Units="inj" Weight="20">
              <Name>Inj 5 mg per ml, 4 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22080890060901" PSS="true">
                <Name>Marcain Isobaric</Name>
                <Pack ID="P2209284" Specified="true" nzmt:ctpp_id="50033231000117108">
                  <Quantity>5</Quantity>
                  <Price>62.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900610" Rank="4" Units="inj" Weight="125">
              <Name>Inj 1.25 mg per ml, 100 ml bag</Name>
              <Brand ID="B22080890061000">
                <Name>Any</Name>
                <Pack ID="P90061000" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900611" Rank="4" Units="inj" Weight="250">
              <Name>Inj 1.25 mg per ml, 200 ml bag</Name>
              <Brand ID="B22080890061100">
                <Name>Any</Name>
                <Pack ID="P90061100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900612" Rank="4" Units="inj" Weight="250">
              <Name>Inj 2.5 mg per ml, 100 ml bag</Name>
              <Brand ID="B22080890061225">
                <Name>Marcain</Name>
                <Pack ID="P2077728" Specified="true" nzmt:ctpp_id="50013261000117105">
                  <Quantity>5</Quantity>
                  <Price>150.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900613" Rank="4" Units="inj" Weight="500">
              <Name>Inj 2.5 mg per ml, 200 ml bag</Name>
              <Brand ID="B22080890061300">
                <Name>Any</Name>
                <Pack ID="P90061300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900625" Rank="4" Units="inj" Weight="100">
              <Name>Inj 5 mg per ml, 20 ml ampoule sterile pack</Name>
              <Brand ID="B22080890062525">
                <Name>Marcain</Name>
                <Pack ID="P728101" Specified="true" nzmt:ctpp_id="50106511000117106">
                  <Quantity>5</Quantity>
                  <Price>16.56</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900626" Rank="4" Units="inj" Weight="50">
              <Name>Inj 2.5 mg per ml, 20 ml ampoule</Name>
              <Brand ID="B22080890062600">
                <Name>Any</Name>
                <Pack ID="P90062600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900627" Rank="4" Units="inj" Weight="100">
              <Name>Inj 5 mg per ml, 20 ml ampoule</Name>
              <Brand ID="B22080890062700">
                <Name>Any</Name>
                <Pack ID="P90062700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900628" Rank="4" Units="inj" Weight="625">
              <Name>Inj 1.25 mg per ml, 500 ml bag</Name>
              <Brand ID="B22080890062800">
                <Name>Any</Name>
                <Pack ID="P90062800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208089007">
            <Name>Bupivacaine hydrochloride with adrenaline</Name>
            <Formulation ID="F220808900703" Rank="4" Units="inj" Weight="0.5">
              <Name>Inj 5 mg per ml with adrenaline 1:200,000, 20 ml vial</Name>
              <Brand ID="B22080890070301">
                <Name>Marcain with Adrenaline</Name>
                <Pack ID="P201405" Specified="true" nzmt:ctpp_id="50002161000117108">
                  <Quantity>5</Quantity>
                  <Price>80.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900725" Rank="4" Units="inj" Weight="0.25">
              <Name>Inj 2.5 mg per ml with adrenaline 1:400,000, 20 ml vial</Name>
              <Brand ID="B22080890072525">
                <Name>Marcain with Adrenaline</Name>
                <Pack ID="P2284189" Specified="true" nzmt:ctpp_id="50043831000117108">
                  <Quantity>5</Quantity>
                  <Price>94.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900726" Rank="4" Units="inj">
              <Name>Inj 2.5 mg per ml with adrenaline 1:200,000, 10 ml ampoule</Name>
              <Brand ID="B22080890072600">
                <Name>Any</Name>
                <Pack ID="P90072600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208089008">
            <Name>Bupivacaine hydrochloride with fentanyl</Name>
            <Formulation ID="F220808900801" Rank="4" Units="inf" Weight="100">
              <Name>Inj 1.25 mg with fentanyl 2 mcg per ml, 100 ml bag</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B22080890080101" PSS="true">
                <Name>Bupafen</Name>
                <Pack ID="P2594242" Specified="true" nzmt:ctpp_id="50279791000117109">
                  <Quantity>5</Quantity>
                  <Price>122.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900802" Rank="4" Units="inf" Weight="200">
              <Name>Inj 1.25 mg with fentanyl 2 mcg per ml, 200 ml bag</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B22080890080201" PSS="true">
                <Name>Bupafen</Name>
                <Pack ID="P2594250" Specified="true" nzmt:ctpp_id="50279781000117106">
                  <Quantity>5</Quantity>
                  <Price>127.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900803" Rank="4" Units="inj" Weight="15">
              <Name>Inj 1.25 mg with fentanyl 2 mcg per ml, 15 ml syringe</Name>
              <Brand ID="B22080890080301">
                <Name>Biomed</Name>
                <Pack ID="P2594226" Specified="true" nzmt:ctpp_id="50279491000117102">
                  <Quantity>5</Quantity>
                  <Price>36.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900804" Rank="4" Units="inj" Weight="20">
              <Name>Inj 1.25 mg with fentanyl 2 mcg per ml, 20 ml syringe</Name>
              <Brand ID="B22080890080401">
                <Name>Biomed</Name>
                <Pack ID="P2594234" Specified="true" nzmt:ctpp_id="50292621000117101">
                  <Quantity>5</Quantity>
                  <Price>54.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900805" Rank="4" Units="inf">
              <Name>Inj 0.625 mg with fentanyl 2 mcg per ml, 100 ml bag</Name>
              <Brand ID="B22080890080500">
                <Name>Any</Name>
                <Pack ID="P90080500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900806" Rank="4" Units="inf">
              <Name>Inj 1.25 mg with fentanyl 2 mcg per ml, 100 ml syringe</Name>
              <Brand ID="B22080890080600">
                <Name>Any</Name>
                <Pack ID="P90080600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900807" Rank="4" Units="inj" Weight="1.25">
              <Name>Inj 1.25 mg with fentanyl 2 mcg per ml, 50 ml syringe</Name>
              <Brand ID="B22080890080700">
                <Name>Any</Name>
                <Pack ID="P90080700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808900825" Rank="4" Units="inf">
              <Name>Inj 0.625 mg with fentanyl 2 mcg per ml, 200 ml bag</Name>
              <Brand ID="B22080890082525">
                <Name>Biomed</Name>
                <Pack ID="P2594188" Specified="true" nzmt:ctpp_id="50279771000117108">
                  <Quantity>5</Quantity>
                  <Price>160.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208089029">
            <Name>Lidocaine [Lignocaine] with prilocaine</Name>
            <Formulation ID="F220808902902" Rank="9" Units="tube" Weight="2.5">
              <Name>Crm 2.5% with prilocaine 2.5%, 5 g</Name>
              <Brand ID="B22080890290201">
                <Name>EMLA</Name>
                <Pack ID="P657697" Specified="true" nzmt:ctpp_id="50100531000117104">
                  <Quantity>5</Quantity>
                  <Price>45.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808902903" Rank="9" Units="patch" Weight="25">
              <Name>Patch 25 mcg with prilocaine 25 mcg</Name>
              <Brand ID="B22080890290301">
                <Name>EMLA</Name>
                <Pack ID="P327093" Specified="true" nzmt:ctpp_id="50072601000117106">
                  <Quantity>20</Quantity>
                  <Price>115.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808902925" Rank="3" Units="g" Weight="2.5">
              <Name>Crm 2.5% with prilocaine 2.5%</Name>
              <Brand ID="B22080890292525">
                <Name>EMLA</Name>
                <Pack ID="P719757" Specified="true" nzmt:ctpp_id="50105491000117107">
                  <Quantity>30</Quantity>
                  <Price>45.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208089030">
            <Name>Lidocaine [Lignocaine] hydrochloride</Name>
            <Formulation ID="F220808903004" Rank="4" Units="inj" Weight="1.05">
              <Name>Inj 1%, 5 ml ampoule</Name>
              <Brand ID="B22080890300426">
                <Name>Lidocaine-Baxter</Name>
                <Pack ID="P2599872" Specified="true" nzmt:ctpp_id="50276461000117104">
                  <Quantity>25</Quantity>
                  <Price>9.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903007" Rank="4" Units="inj" Weight="2.05">
              <Name>Inj 2%, 5 ml ampoule</Name>
              <Brand ID="B22080890300726">
                <Name>Lidocaine-Baxter</Name>
                <Pack ID="P2599848" Specified="true" nzmt:ctpp_id="50276501000117104">
                  <Quantity>25</Quantity>
                  <Price>9.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903008" Rank="3" Units="ml" Weight="0.2">
              <Name>Spray 10%</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B22080890300801" PSS="true">
                <Name>Xylocaine</Name>
                <Pack ID="P761125" Specified="true" nzmt:ctpp_id="50109741000117105">
                  <Quantity>50</Quantity>
                  <Price>78.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903009" Rank="3" Units="g">
              <Name>Gel 2%</Name>
              <Brand ID="B22080890300925">
                <Name>Orion</Name>
                <Pack ID="P777579" Specified="true" nzmt:ctpp_id="50112871000117100">
                  <Quantity>20</Quantity>
                  <Price>4.87</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903011" Rank="3" Units="ml">
              <Name>Soln 4%</Name>
              <Brand ID="B22080890301100">
                <Name>Any</Name>
                <Pack ID="P90301100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903025" Rank="3" Units="ml" Weight="200">
              <Name>Oral (gel) soln 2%</Name>
              <Brand ID="B22080890302526">
                <Name>Mucosoothe</Name>
                <Pack ID="P2513307" Specified="true" nzmt:ctpp_id="50328161000117100">
                  <Quantity>200</Quantity>
                  <Price>44.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903026" Rank="4" Units="inj">
              <Name>Inj 1%, 20 ml ampoule, sterile pack</Name>
              <Brand ID="B22080890302600">
                <Name>Any</Name>
                <Pack ID="P90302600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903027" Rank="4" Units="inj">
              <Name>Inj 2%, 20 ml ampoule, sterile pack</Name>
              <Brand ID="B22080890302700">
                <Name>Any</Name>
                <Pack ID="P90302700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903028" Rank="4" Units="inj" Weight="1.2">
              <Name>Inj 1%, 20 ml vial</Name>
              <Brand ID="B22080890302826">
                <Name>Lidocaine-Baxter</Name>
                <Pack ID="P2599856" Specified="true" nzmt:ctpp_id="50276481000117107">
                  <Quantity>5</Quantity>
                  <Price>6.85</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903029" Rank="4" Units="inj" Weight="2.2">
              <Name>Inj 2%, 20 ml vial</Name>
              <Brand ID="B22080890302926">
                <Name>Lidocaine-Baxter</Name>
                <Pack ID="P2599864" Specified="true" nzmt:ctpp_id="50276521000117107">
                  <Quantity>5</Quantity>
                  <Price>7.15</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903030" Rank="10" Units="ea">
              <Name>Gel 2%, 11 ml urethral syringe</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B22080890303025" PSS="true">
                <Name>Instillagel Lido</Name>
                <Pack ID="P2580497" Specified="true" nzmt:ctpp_id="50246811000117103">
                  <Quantity>10</Quantity>
                  <Price>59.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903031" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10%, 5 ml ampoule</Name>
              <Brand ID="B22080890303100">
                <Name>Any</Name>
                <Pack ID="P90303100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208089031">
            <Name>Lidocaine [Lignocaine] hydrochloride with adrenaline</Name>
            <Formulation ID="F220808903101" Rank="4" Units="inj">
              <Name>Inj 1% with adrenaline 1:100,000, 5 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B22080890310101" PSS="true">
                <Name>Xylocaine</Name>
                <Pack ID="P2120577" Specified="true" nzmt:ctpp_id="50021811000117103">
                  <Quantity>10</Quantity>
                  <Price>32.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903102" Rank="4" Units="inj">
              <Name>Inj 1% with adrenaline 1:200,000, 20 ml vial</Name>
              <Brand ID="B22080890310201">
                <Name>Xylocaine</Name>
                <Pack ID="P251879" Specified="true" nzmt:ctpp_id="50053011000117105">
                  <Quantity>5</Quantity>
                  <Price>50.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903103" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2% with adrenaline 1:200,000, 20 ml vial</Name>
              <Brand ID="B22080890310301">
                <Name>Xylocaine</Name>
                <Pack ID="P693200" Specified="true" nzmt:ctpp_id="50102331000117107">
                  <Quantity>5</Quantity>
                  <Price>60.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903104" Rank="4" Units="inj">
              <Name>Inj 2% with adrenaline 1:80,000, 1.7 ml dental cartridge</Name>
              <Brand ID="B22080890310400">
                <Name>Any</Name>
                <Pack ID="P90310400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903125" Rank="4" Units="inj">
              <Name>Inj 2% with adrenaline 1:80,000, 1.8 ml dental cartridge</Name>
              <Brand ID="B22080890312500">
                <Name>Any</Name>
                <Pack ID="P90312500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903126" Rank="4" Units="inj">
              <Name>Inj 2% with adrenaline 1:80,000, 2.2 ml dental cartridge</Name>
              <Brand ID="B22080890312600">
                <Name>Any</Name>
                <Pack ID="P90312600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903127" Rank="4" Units="inj">
              <Name>Inj 2% with adrenaline 1:100,000, 1.7 ml dental cartridge</Name>
              <Brand ID="B22080890312700">
                <Name>Any</Name>
                <Pack ID="P90312700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808903128" Rank="4" Units="inj">
              <Name>Inj 1% with adreanline 1:100,000, 20 ml vial</Name>
              <Brand ID="B22080890312800">
                <Name>Any</Name>
                <Pack ID="P90312800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208089048">
            <Name>Prilocaine hydrochloride</Name>
            <Formulation ID="F220808904801" Rank="4" Units="inj" Weight="0.01">
              <Name>Inj 0.5%, 50 ml vial</Name>
              <Brand ID="B22080890480101">
                <Name>Citanest</Name>
                <Pack ID="P2089971" Specified="true" nzmt:ctpp_id="50016781000117102">
                  <Quantity>5</Quantity>
                  <Price>100.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808904803" Rank="4" Units="inj" Weight="0.4">
              <Name>Inj 2%, 5 ml ampoule</Name>
              <Brand ID="B22080890480300">
                <Name>Any</Name>
                <Pack ID="P90480300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208089055">
            <Name>Ropivacaine hydrochloride</Name>
            <Formulation ID="F220808905501" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 10 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22080890550125" PSS="true">
                <Name>Ropivacaine Kabi</Name>
                <Pack ID="P2478749" Specified="true" nzmt:ctpp_id="50177041000117107">
                  <Quantity>5</Quantity>
                  <Price>11.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808905504" Rank="4" Units="inj" Weight="2.01">
              <Name>Inj 2 mg per ml, 100 ml bag</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22080890550425" PSS="true">
                <Name>Ropivacaine Kabi</Name>
                <Pack ID="P2479125" Specified="true" nzmt:ctpp_id="50177061000117106">
                  <Quantity>5</Quantity>
                  <Price>32.85</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808905505" Rank="4" Units="inj" Weight="2.002">
              <Name>Inj 2 mg per ml, 20 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22080890550525" PSS="true">
                <Name>Ropivacaine Kabi</Name>
                <Pack ID="P2478714" Specified="true" nzmt:ctpp_id="50177001000117105">
                  <Quantity>5</Quantity>
                  <Price>10.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808905506" Rank="4" Units="inj" Weight="2.02">
              <Name>Inj 2 mg per ml, 200 ml bag</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22080890550625" PSS="true">
                <Name>Ropivacaine Kabi</Name>
                <Pack ID="P2479117" Specified="true" nzmt:ctpp_id="50177071000117101">
                  <Quantity>5</Quantity>
                  <Price>43.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808905507" Rank="4" Units="inj" Weight="7.501">
              <Name>Inj 7.5 mg per ml, 10 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22080890550725" PSS="true">
                <Name>Ropivacaine Kabi</Name>
                <Pack ID="P2478722" Specified="true" nzmt:ctpp_id="50177021000117102">
                  <Quantity>5</Quantity>
                  <Price>11.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808905508" Rank="4" Units="inj" Weight="7.502">
              <Name>Inj 7.5 mg per ml, 20 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22080890550825" PSS="true">
                <Name>Ropivacaine Kabi</Name>
                <Pack ID="P2478730" Specified="true" nzmt:ctpp_id="50177031000117104">
                  <Quantity>5</Quantity>
                  <Price>13.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808905509" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 20 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22080890550925" PSS="true">
                <Name>Ropivacaine Kabi</Name>
                <Pack ID="P2478765" Specified="true" nzmt:ctpp_id="50177051000117109">
                  <Quantity>5</Quantity>
                  <Price>17.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808905510" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2 mg per ml, 10 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22080890551025" PSS="true">
                <Name>Ropivacaine Kabi</Name>
                <Pack ID="P2478757" Specified="true" nzmt:ctpp_id="50176991000117104">
                  <Quantity>5</Quantity>
                  <Price>9.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2208089168">
            <Name>Cocaine hydrochloride</Name>
            <Formulation ID="F220808916801" Rank="3" Units="g">
              <Name>Paste 5%</Name>
              <Brand ID="B22080891680100">
                <Name>Any</Name>
                <Pack ID="P91680100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808916802" Rank="3" Units="ml">
              <Name>Soln 15%, 2 ml syringe</Name>
              <Brand ID="B22080891680200">
                <Name>Any</Name>
                <Pack ID="P91680200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F220808916825" Rank="10" Units="syr">
              <Name>Soln 4%, 2 ml syringe</Name>
              <Brand ID="B22080891682525">
                <Name>Biomed</Name>
                <Pack ID="P461202" Specified="true" nzmt:ctpp_id="50087531000117105">
                  <Quantity>1</Quantity>
                  <Price>28.76</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2212">
        <Name>Analgesics</Name>
        <ATC3 ID="A221204">
          <Name>Non-Opioid Analgesics</Name>
          <Chemical ID="C2212048041">
            <Name>Aspirin</Name>
            <Formulation ID="F221204804103" Rank="1" Units="tab">
              <Name>Tab dispersible 300 mg</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2026" Value="5"/>
              <Brand ID="B22120480410325" PSS="true">
                <Name>Ethics Aspirin</Name>
                <Pack ID="P2184338" Specified="true" nzmt:ctpp_id="50030151000117104">
                  <Quantity>100</Quantity>
                  <Price>5.65</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212048314">
            <Name>Nefopam hydrochloride</Name>
            <Formulation ID="F221204831401" Rank="1" Units="tab" Weight="30">
              <Name>Tab 30 mg</Name>
              <Brand ID="B22120483140100">
                <Name>Any</Name>
                <Pack ID="P83140100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212048449">
            <Name>Sucrose</Name>
            <Formulation ID="F221204844901" Rank="3" Units="ml">
              <Name>Oral liq 25%</Name>
              <Brand ID="B22120484490125">
                <Name>Biomed</Name>
                <Pack ID="P2515148" Specified="true" nzmt:ctpp_id="50267781000117105">
                  <Quantity>25</Quantity>
                  <Price>13.91</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221204844925" Rank="3" Units="ml">
              <Name>Oral liq 66.7% (preservative free)</Name>
              <Request Form="RS1763" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Sucrose</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">For use in neonatal patients only</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1763" style="display:none"/>
              <Brand ID="B22120484492500">
                <Name>Any</Name>
                <Pack ID="P84492500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212048513">
            <Name>Methoxyflurane</Name>
            <Request Form="RS1292" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Methoxyflurane</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is undergoing a painful procedure with an expected duration of less than one hour</ci>
                    <ci type="logical">Only to be used under supervision by a medical practitioner or nurse who is trained in the use of methoxyflurane</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1292" style="display:none"/>
            <Formulation ID="F221204851325" Rank="3" Units="ml">
              <Name>Soln for inhalation 99.9%, 3 ml bottle</Name>
              <Brand ID="B22120485132500">
                <Name>Any</Name>
                <Pack ID="P85132500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212049227">
            <Name>Paracetamol</Name>
            <Request Form="RS1146" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Paracetamol</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Intravenous paracetamol is only to be used where other routes are unavailable or impractical, or where there is reduced absorption. The need for IV paracetamol must be
                re-assessed every 24 hours</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Some items restricted" xlink:href="RS1146" style="display:none"/>
            <Formulation ID="F221204922702" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg - blister pack - 1,000 tablet pack</Name>
              <Rule Type="DVLimit" Attribute="Feb-22 to~2026" Value="1"/>
              <Brand ID="B22120492270225" HSS="true">
                <Name>Pacimol</Name>
                <Pack ID="P2612712" Specified="true" nzmt:ctpp_id="50010991000117100">
                  <Quantity>1000</Quantity>
                  <Price>19.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221204922703" Rank="1" Units="tab">
              <Name>Tab soluble 500 mg</Name>
              <Brand ID="B22120492270300">
                <Name>Any</Name>
                <Pack ID="P92270300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221204922725" Rank="3" Units="ml" Weight="120">
              <Name>Oral liq 120 mg per 5 ml</Name>
              <Rule Type="DVLimit" Attribute="Jun-23 to~2025" Value="20"/>
              <Brand ID="B22120492272529" PSS="true">
                <Name>Paracetamol (Ethics)</Name>
                <Pack ID="P2650665" Specified="true" nzmt:ctpp_id="50207921000117109">
                  <Quantity>200</Quantity>
                  <Price>3.98</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221204922726" Rank="3" Units="ml" Weight="250">
              <Name>Oral liq 250 mg per 5 ml</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="20"/>
              <Brand ID="B22120492272627" PSS="true">
                <Name>Pamol</Name>
                <Pack ID="P2643650" Specified="true" nzmt:ctpp_id="50307141000117106">
                  <Quantity>200</Quantity>
                  <Price>3.35</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221204922727" Rank="5" Units="supp" Weight="125">
              <Name>Suppos 125 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22120492272726" PSS="true">
                <Name>Gacet</Name>
                <Pack ID="P2482711" Specified="true" nzmt:ctpp_id="50206931000117109">
                  <Quantity>10</Quantity>
                  <Price>4.29</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221204922728" Rank="5" Units="supp" Weight="250">
              <Name>Suppos 250 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22120492272826" PSS="true">
                <Name>Gacet</Name>
                <Pack ID="P2482738" Specified="true" nzmt:ctpp_id="50224181000117105">
                  <Quantity>10</Quantity>
                  <Price>5.39</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221204922729" Rank="5" Units="supp" Weight="25">
              <Name>Suppos 25 mg</Name>
              <Brand ID="B22120492272900">
                <Name>Any</Name>
                <Pack ID="P92272900" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221204922730" Rank="5" Units="supp" Weight="50">
              <Name>Suppos 50 mg</Name>
              <Brand ID="B22120492273000">
                <Name>Any</Name>
                <Pack ID="P92273000" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221204922731" Rank="5" Units="supp" Weight="500">
              <Name>Suppos 500 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22120492273126" PSS="true">
                <Name>Gacet</Name>
                <Pack ID="P2552663" Specified="true" nzmt:ctpp_id="50196991000117108">
                  <Quantity>50</Quantity>
                  <Price>16.55</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221204922732" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 10 mg per ml, 100 ml vial</Name>
              <html:div class="Restricted item" xlink:href="RS1146" style="display:none"/>
              <Brand ID="B22120492273227">
                <Name>Paracetamol Kabi</Name>
                <Pack ID="P2523965" Specified="true" nzmt:ctpp_id="50225281000117103">
                  <Quantity>10</Quantity>
                  <Price>15.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221204922733" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg - bottle pack</Name>
              <Rule Type="DVLimit" Attribute="Feb-22 to~2026" Value="1"/>
              <Brand ID="B22120492273325" HSS="true">
                <Name>Noumed Paracetamol</Name>
                <Pack ID="P2611430" Specified="true" nzmt:ctpp_id="50283311000117106">
                  <Quantity>1000</Quantity>
                  <Price>17.92</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221204922734" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg - blister pack - 12 tablet pack</Name>
              <Brand ID="B22120492273400">
                <Name>Any</Name>
                <Pack ID="P92273400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221204922735" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg - blister pack - 20 tablet pack</Name>
              <Brand ID="B22120492273500">
                <Name>Any</Name>
                <Pack ID="P92273500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212049293">
            <Name>Capsaicin</Name>
            <Request Form="RS1145" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Capsaicin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For post-herpetic neuralgia or diabetic peripheral neuropathy</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1145" style="display:none"/>
            <Formulation ID="F221204929325" Rank="3" Units="g">
              <Name>Crm 0.075%</Name>
              <Brand ID="B22120492932525">
                <Name>Zostrix HP</Name>
                <Pack ID="P2022710" Specified="true" nzmt:ctpp_id="50004591000117101">
                  <Quantity>45</Quantity>
                  <Price>11.95</Price>
                </Pack>
              </Brand>
              <Brand ID="B22120492932526">
                <Name>Zo-Rub HP</Name>
                <Pack ID="P2682893" Specified="true" nzmt:ctpp_id="50241511000117106">
                  <Quantity>45</Quantity>
                  <Price>11.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A221208">
          <Name>Opioid Analgesics</Name>
          <Chemical ID="C2212088010">
            <Name>Alfentanil</Name>
            <Formulation ID="F221208801001" Rank="4" Units="inj" Weight="0.5">
              <Name>Inj 0.5 mg per ml, 2 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22120880100126" PSS="true">
                <Name>Medsurge</Name>
                <Pack ID="P2650991" Specified="true" nzmt:ctpp_id="50268611000117107">
                  <Quantity>5</Quantity>
                  <Price>8.99</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212089036">
            <Name>Morphine sulphate</Name>
            <Formulation ID="F221208903601" Rank="4" Units="inj" Weight="1.01">
              <Name>Inj 1 mg per ml, 10 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22120890360101" PSS="true">
                <Name>Biomed</Name>
                <Pack ID="P2526018" Specified="true" nzmt:ctpp_id="50244631000117101">
                  <Quantity>5</Quantity>
                  <Price>27.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903603" Rank="4" Units="inj" Weight="1.05">
              <Name>Inj 1 mg per ml, 50 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22120890360301" PSS="true">
                <Name>Biomed</Name>
                <Pack ID="P2526026" Specified="true" nzmt:ctpp_id="50244641000117109">
                  <Quantity>5</Quantity>
                  <Price>63.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903604" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2 mg per ml, 30 ml syringe</Name>
              <Brand ID="B22120890360401">
                <Name>Biomed</Name>
                <Pack ID="P2308932" Specified="true" nzmt:ctpp_id="50046761000117100">
                  <Quantity>10</Quantity>
                  <Price>135.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903605" Rank="4" Units="inj" Weight="2">
              <Name>Inj 1 mg per ml, 2 ml syringe</Name>
              <Brand ID="B22120890360500">
                <Name>Any</Name>
                <Pack ID="P90360500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903606" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 100 mg cassette</Name>
              <Brand ID="B22120890360600">
                <Name>Any</Name>
                <Pack ID="P90360600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903607" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 100 ml bag</Name>
              <Brand ID="B22120890360700">
                <Name>Any</Name>
                <Pack ID="P90360700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903608" Rank="4" Units="inj" Weight="200">
              <Name>Inj 200 mcg in 0.4 ml syringe</Name>
              <Brand ID="B22120890360800">
                <Name>Any</Name>
                <Pack ID="P90360800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903609" Rank="4" Units="inj" Weight="300">
              <Name>Inj 300 mcg in 0.3 ml syringe</Name>
              <Brand ID="B22120890360900">
                <Name>Any</Name>
                <Pack ID="P90360900" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903625" Rank="2" Units="cap" Weight="10">
              <Name>Cap long-acting 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B22120890362525" PSS="true">
                <Name>m-Eslon</Name>
                <Pack ID="P2106469" Specified="true" nzmt:ctpp_id="50019151000117100">
                  <Quantity>10</Quantity>
                  <Price>3.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903626" Rank="2" Units="cap" Weight="30">
              <Name>Cap long-acting 30 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B22120890362625" PSS="true">
                <Name>m-Eslon</Name>
                <Pack ID="P2106485" Specified="true" nzmt:ctpp_id="50019171000117108">
                  <Quantity>10</Quantity>
                  <Price>4.30</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903627" Rank="2" Units="cap" Weight="60">
              <Name>Cap long-acting 60 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B22120890362725" PSS="true">
                <Name>m-Eslon</Name>
                <Pack ID="P2106493" Specified="true" nzmt:ctpp_id="50019181000117106">
                  <Quantity>10</Quantity>
                  <Price>9.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903628" Rank="2" Units="cap" Weight="100">
              <Name>Cap long-acting 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B22120890362825" PSS="true">
                <Name>m-Eslon</Name>
                <Pack ID="P2106507" Specified="true" nzmt:ctpp_id="50019191000117109">
                  <Quantity>10</Quantity>
                  <Price>10.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903630" Rank="1" Units="tab" Weight="10.1">
              <Name>Tab immediate-release 10 mg</Name>
              <Brand ID="B22120890363025">
                <Name>Sevredol</Name>
                <Pack ID="P2520990" Specified="true" nzmt:ctpp_id="50151981000117109">
                  <Quantity>10</Quantity>
                  <Price>2.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903631" Rank="1" Units="tab" Weight="20">
              <Name>Tab immediate-release 20 mg</Name>
              <Brand ID="B22120890363125">
                <Name>Sevredol</Name>
                <Pack ID="P2521008" Specified="true" nzmt:ctpp_id="50151991000117107">
                  <Quantity>10</Quantity>
                  <Price>5.52</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903632" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2025" Value="5"/>
              <Brand ID="B22120890363226" PSS="true">
                <Name>Medsurge</Name>
                <Pack ID="P2602458" Specified="true" nzmt:ctpp_id="50266771000117109">
                  <Quantity>5</Quantity>
                  <Price>4.68</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903633" Rank="4" Units="inj" Weight="30">
              <Name>Inj 30 mg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2025" Value="5"/>
              <Brand ID="B22120890363326" PSS="true">
                <Name>Medsurge</Name>
                <Pack ID="P2602474" Specified="true" nzmt:ctpp_id="50266831000117100">
                  <Quantity>5</Quantity>
                  <Price>6.28</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903634" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2025" Value="5"/>
              <Brand ID="B22120890363426" PSS="true">
                <Name>Medsurge</Name>
                <Pack ID="P2602431" Specified="true" nzmt:ctpp_id="50266731000117106">
                  <Quantity>5</Quantity>
                  <Price>5.38</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903635" Rank="4" Units="inj" Weight="15">
              <Name>Inj 15 mg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2025" Value="5"/>
              <Brand ID="B22120890363526" PSS="true">
                <Name>Medsurge</Name>
                <Pack ID="P2602466" Specified="true" nzmt:ctpp_id="50266801000117106">
                  <Quantity>5</Quantity>
                  <Price>5.53</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903640" Rank="4" Units="inf" Weight="1">
              <Name>Inj 1 mg per ml, 100 ml bag</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22120890364025" PSS="true">
                <Name>Biomed</Name>
                <Pack ID="P2526034" Specified="true" nzmt:ctpp_id="50244661000117108">
                  <Quantity>5</Quantity>
                  <Price>114.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208903641" Rank="3" Units="ml" Weight="2">
              <Name>Oral liq 2 mg per ml</Name>
              <Brand ID="B22120890364125">
                <Name>Wockhardt</Name>
                <Pack ID="P2670070" Specified="true" nzmt:ctpp_id="50325471000117105">
                  <Quantity>100</Quantity>
                  <Price>16.31</Price>
                </Pack>
              </Brand>
              <Brand ID="B22120890364126">
                <Name>Oramorph</Name>
                <Pack ID="P2677644" Specified="true" nzmt:ctpp_id="50331411000117103">
                  <Quantity>300</Quantity>
                  <Price>42.56</Price>
                </Pack>
              </Brand>
              <Brand ID="B22120890364127">
                <Name>Oramorph CDC S29</Name>
                <Pack ID="P2679361" Specified="true" nzmt:ctpp_id="50333681000117105">
                  <Quantity>100</Quantity>
                  <Price>29.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212089051">
            <Name>Remifentanil</Name>
            <Formulation ID="F221208905101" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22120890510125" PSS="true">
                <Name>Remifentanil-AFT</Name>
                <Pack ID="P2390388" Specified="true" nzmt:ctpp_id="50125291000117103">
                  <Quantity>5</Quantity>
                  <Price>14.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208905102" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22120890510225" PSS="true">
                <Name>Remifentanil-AFT</Name>
                <Pack ID="P2390396" Specified="true" nzmt:ctpp_id="50125301000117102">
                  <Quantity>5</Quantity>
                  <Price>20.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212089152">
            <Name>Tramadol hydrochloride</Name>
            <Formulation ID="F221208915201" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 100 ml bag</Name>
              <Brand ID="B22120891520100">
                <Name>Any</Name>
                <Pack ID="P91520100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208915225" Rank="2" Units="cap" Weight="50">
              <Name>Cap 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-24 to~2026" Value="5"/>
              <Brand ID="B22120891522526" PSS="true">
                <Name>Arrow-Tramadol</Name>
                <Pack ID="P2351889" Specified="true" nzmt:ctpp_id="50050611000117108">
                  <Quantity>100</Quantity>
                  <Price>3.33</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208915226" Rank="1" Units="tab" Weight="100">
              <Name>Tab sustained-release 100 mg</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2026" Value="5"/>
              <Brand ID="B22120891522625" PSS="true">
                <Name>Tramal SR 100</Name>
                <Pack ID="P2149508">
                  <Quantity>20</Quantity>
                  <Price>1.95</Price>
                </Pack>
                <Pack ID="P2650959" Specified="true" nzmt:ctpp_id="50025841000117102">
                  <Quantity>20</Quantity>
                  <Price>1.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208915227" Rank="1" Units="tab" Weight="150">
              <Name>Tab sustained-release 150 mg</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2026" Value="5"/>
              <Brand ID="B22120891522725" PSS="true">
                <Name>Tramal SR 150</Name>
                <Pack ID="P2149532">
                  <Quantity>20</Quantity>
                  <Price>2.95</Price>
                </Pack>
                <Pack ID="P2650967" Specified="true" nzmt:ctpp_id="50025871000117108">
                  <Quantity>20</Quantity>
                  <Price>2.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208915228" Rank="1" Units="tab" Weight="200">
              <Name>Tab sustained-release 200 mg</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2026" Value="5"/>
              <Brand ID="B22120891522825" PSS="true">
                <Name>Tramal SR 200</Name>
                <Pack ID="P2149524">
                  <Quantity>20</Quantity>
                  <Price>3.80</Price>
                </Pack>
                <Pack ID="P2650975" Specified="true" nzmt:ctpp_id="50025861000117103">
                  <Quantity>20</Quantity>
                  <Price>3.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208915229" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2026" Value="5"/>
              <Brand ID="B22120891522925" PSS="true">
                <Name>Tramal 50</Name>
                <Pack ID="P471208" nzmt:ctpp_id="50088651000117103">
                  <Quantity>5</Quantity>
                  <Price>10.00</Price>
                </Pack>
                <Pack ID="P2650940" Specified="true">
                  <Quantity>5</Quantity>
                  <Price>10.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208915230" Rank="4" Units="inj" Weight="100">
              <Name>Inj 50 mg per ml, 2 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2026" Value="5"/>
              <Brand ID="B22120891523025" PSS="true">
                <Name>Tramal 100</Name>
                <Pack ID="P471216" nzmt:ctpp_id="50088661000117101">
                  <Quantity>5</Quantity>
                  <Price>9.00</Price>
                </Pack>
                <Pack ID="P2650932" Specified="true">
                  <Quantity>5</Quantity>
                  <Price>9.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208915231" Rank="3" Units="ml" Weight="10">
              <Name>Oral soln 10 mg per ml</Name>
              <Brand ID="B22120891523100">
                <Name>Any</Name>
                <Pack ID="P91523100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212089169">
            <Name>Codeine phosphate</Name>
            <Formulation ID="F221208916925" Rank="1" Units="tab" Weight="15">
              <Name>Tab 15 mg</Name>
              <Rule Type="DVLimit" Attribute="May-23 to~2025" Value="5"/>
              <Brand ID="B22120891692526" PSS="true">
                <Name>Noumed</Name>
                <Pack ID="P2643200" Specified="true" nzmt:ctpp_id="50302791000117100">
                  <Quantity>100</Quantity>
                  <Price>5.92</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208916926" Rank="1" Units="tab" Weight="30">
              <Name>Tab 30 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B22120891692626">
                <Name>Aspen</Name>
                <Pack ID="P2643308" Specified="true" nzmt:ctpp_id="50304921000117106">
                  <Quantity>100</Quantity>
                  <Price>6.98</Price>
                </Pack>
              </Brand>
              <Brand ID="B22120891692627" PSS="true">
                <Name>Noumed</Name>
                <Pack ID="P2643219" Specified="true" nzmt:ctpp_id="50302821000117107">
                  <Quantity>100</Quantity>
                  <Price>6.98</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208916927" Rank="1" Units="tab" Weight="60">
              <Name>Tab 60 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B22120891692726" PSS="true">
                <Name>Noumed</Name>
                <Pack ID="P2643227" Specified="true" nzmt:ctpp_id="50302851000117100">
                  <Quantity>100</Quantity>
                  <Price>13.89</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212089246">
            <Name>Methadone hydrochloride</Name>
            <Formulation ID="F221208924601" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 1 ml vial</Name>
              <Brand ID="B22120892460125">
                <Name>AFT</Name>
                <Pack ID="P2265710" Specified="true" nzmt:ctpp_id="50041891000117108">
                  <Quantity>10</Quantity>
                  <Price>68.90</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208924625" Rank="3" Units="ml" Weight="2">
              <Name>Oral liq 2 mg per ml</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B22120892462525" PSS="true">
                <Name>Biodone</Name>
                <Pack ID="P361372" Specified="true" nzmt:ctpp_id="50078211000117109">
                  <Quantity>200</Quantity>
                  <Price>7.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208924626" Rank="3" Units="ml" Weight="5">
              <Name>Oral liq 5 mg per ml</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B22120892462625" PSS="true">
                <Name>Biodone Forte</Name>
                <Pack ID="P412341" Specified="true" nzmt:ctpp_id="50083121000117106">
                  <Quantity>200</Quantity>
                  <Price>7.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208924627" Rank="3" Units="ml" Weight="10">
              <Name>Oral liq 10 mg per ml</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B22120892462725" PSS="true">
                <Name>Biodone Extra Forte</Name>
                <Pack ID="P412325" Specified="true" nzmt:ctpp_id="50083111000117100">
                  <Quantity>200</Quantity>
                  <Price>9.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208924630" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-23 to~2025" Value="5"/>
              <Brand ID="B22120892463026" PSS="true">
                <Name>Methadone BNM</Name>
                <Pack ID="P2639823" Specified="true" nzmt:ctpp_id="50256011000117105">
                  <Quantity>10</Quantity>
                  <Price>1.45</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212089257">
            <Name>Morphine tartrate</Name>
            <Formulation ID="F221208925725" Rank="4" Units="inj" Weight="120">
              <Name>Inj 80 mg per ml, 1.5 ml ampoule</Name>
              <Brand ID="B22120892572500">
                <Name>Any</Name>
                <Pack ID="P92572500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212089258">
            <Name>Oxycodone hydrochloride</Name>
            <Formulation ID="F221208925801" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg per ml, 100 ml bag</Name>
              <Brand ID="B22120892580100">
                <Name>Any</Name>
                <Pack ID="P92580100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208925810" Rank="3" Units="ml" Weight="1">
              <Name>Oral liq 1 mg per ml</Name>
              <Brand ID="B22120892581026">
                <Name>Oxycodone Lucis S29</Name>
                <Pack ID="P2678500" Specified="true" nzmt:ctpp_id="50335171000117104">
                  <Quantity>250</Quantity>
                  <Price>37.08</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208925825" Rank="2" Units="cap" Weight="5">
              <Name>Cap immediate-release 5 mg</Name>
              <Brand ID="B22120892582525" ToBeDelisted="2024-12-01">
                <Name>OxyNorm</Name>
                <Pack ID="P2179741" Specified="true" nzmt:ctpp_id="50029531000117105">
                  <Quantity>20</Quantity>
                  <Price>1.88</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208925827" Rank="2" Units="cap" Weight="20">
              <Name>Cap immediate-release 20 mg</Name>
              <Brand ID="B22120892582725" ToBeDelisted="2025-03-01">
                <Name>OxyNorm</Name>
                <Pack ID="P2179776" Specified="true" nzmt:ctpp_id="50029551000117100">
                  <Quantity>20</Quantity>
                  <Price>5.23</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208925828" Rank="1" Units="tab" Weight="10">
              <Name>Tab controlled-release 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22120892582829" PSS="true">
                <Name>Oxycodone Sandoz</Name>
                <Pack ID="P2559722" Specified="true" nzmt:ctpp_id="50223451000117109">
                  <Quantity>20</Quantity>
                  <Price>2.49</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208925829" Rank="1" Units="tab" Weight="20">
              <Name>Tab controlled-release 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22120892582929" PSS="true">
                <Name>Oxycodone Sandoz</Name>
                <Pack ID="P2559730" Specified="true" nzmt:ctpp_id="50223511000117109">
                  <Quantity>20</Quantity>
                  <Price>3.41</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208925830" Rank="1" Units="tab" Weight="40">
              <Name>Tab controlled-release 40 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22120892583029" PSS="true">
                <Name>Oxycodone Sandoz</Name>
                <Pack ID="P2559749" Specified="true" nzmt:ctpp_id="50223571000117102">
                  <Quantity>20</Quantity>
                  <Price>6.67</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208925831" Rank="1" Units="tab" Weight="80">
              <Name>Tab controlled-release 80 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22120892583129" PSS="true">
                <Name>Oxycodone Sandoz</Name>
                <Pack ID="P2559757" Specified="true" nzmt:ctpp_id="50223631000117101">
                  <Quantity>20</Quantity>
                  <Price>12.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208925832" Rank="1" Units="tab" Weight="5">
              <Name>Tab controlled-release 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22120892583227" PSS="true">
                <Name>Oxycodone Sandoz</Name>
                <Pack ID="P2559714" Specified="true" nzmt:ctpp_id="50223391000117108">
                  <Quantity>20</Quantity>
                  <Price>2.49</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208925834" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22120892583427" PSS="true">
                <Name>Hameln</Name>
                <Pack ID="P2631172" Specified="true" nzmt:ctpp_id="50265931000117103">
                  <Quantity>5</Quantity>
                  <Price>4.37</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208925835" Rank="4" Units="inj" Weight="20">
              <Name>Inj 10 mg per ml, 2 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22120892583527" PSS="true">
                <Name>Hameln</Name>
                <Pack ID="P2631180" Specified="true" nzmt:ctpp_id="50265941000117106">
                  <Quantity>5</Quantity>
                  <Price>8.62</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208925836" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22120892583626" PSS="true">
                <Name>Hameln</Name>
                <Pack ID="P2631199" Specified="true" nzmt:ctpp_id="50265951000117108">
                  <Quantity>5</Quantity>
                  <Price>14.90</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208925837" Rank="1" Units="tab" Weight="5">
              <Name>Tab immediate-release 5 mg</Name>
              <Brand ID="B22120892583725">
                <Name>Oxycodone Amneal</Name>
                <Pack ID="P2681919" Specified="true" nzmt:ctpp_id="50335111000117106">
                  <Quantity>100</Quantity>
                  <Price>13.77</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208925838" Rank="1" Units="tab" Weight="10">
              <Name>Tab immediate-release 10 mg</Name>
              <Brand ID="B22120892583825">
                <Name>Oxycodone Amneal</Name>
                <Pack ID="P2681927" Specified="true" nzmt:ctpp_id="50335121000117100">
                  <Quantity>100</Quantity>
                  <Price>18.77</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208925839" Rank="1" Units="tab" Weight="20">
              <Name>Tab immediate-release 20 mg</Name>
              <Brand ID="B22120892583925">
                <Name>Oxycodone Amneal</Name>
                <Pack ID="P2681935" Specified="true" nzmt:ctpp_id="50335131000117102">
                  <Quantity>100</Quantity>
                  <Price>26.77</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212089277">
            <Name>Pethidine hydrochloride</Name>
            <Formulation ID="F221208927701" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 100 ml bag</Name>
              <Brand ID="B22120892770100">
                <Name>Any</Name>
                <Pack ID="P92770100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208927702" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 50 ml syringe</Name>
              <Brand ID="B22120892770200">
                <Name>Any</Name>
                <Pack ID="P92770200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208927703" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 10 ml syringe</Name>
              <Brand ID="B22120892770300">
                <Name>Any</Name>
                <Pack ID="P92770300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208927704" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 100 ml bag</Name>
              <Brand ID="B22120892770400">
                <Name>Any</Name>
                <Pack ID="P92770400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208927725" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B22120892772525">
                <Name>DBL Pethidine Hydrochloride</Name>
                <Pack ID="P500429" Specified="true" nzmt:ctpp_id="50092941000117109">
                  <Quantity>5</Quantity>
                  <Price>29.88</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208927726" Rank="4" Units="inj" Weight="100">
              <Name>Inj 50 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B22120892772625">
                <Name>DBL Pethidine Hydrochloride</Name>
                <Pack ID="P394971" Specified="true" nzmt:ctpp_id="50081381000117106">
                  <Quantity>5</Quantity>
                  <Price>30.72</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208927728" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-23 to~2025" Value="5"/>
              <Brand ID="B22120892772826" PSS="true">
                <Name>Noumed Pethidine</Name>
                <Pack ID="P2645599" Specified="true" nzmt:ctpp_id="50306661000117100">
                  <Quantity>10</Quantity>
                  <Price>8.68</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212089325">
            <Name>Morphine hydrochloride</Name>
            <Formulation ID="F221208932525" Rank="3" Units="ml" Weight="1">
              <Name>Oral liq 1 mg per ml</Name>
              <Brand ID="B22120893252525">
                <Name>RA-Morph</Name>
                <Pack ID="P754285" Specified="true" nzmt:ctpp_id="50108931000117106">
                  <Quantity>200</Quantity>
                  <Price>19.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208932526" Rank="3" Units="ml" Weight="2">
              <Name>Oral liq 2 mg per ml</Name>
              <Brand ID="B22120893252625">
                <Name>RA-Morph</Name>
                <Pack ID="P754293" Specified="true" nzmt:ctpp_id="50108941000117103">
                  <Quantity>200</Quantity>
                  <Price>23.55</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208932527" Rank="3" Units="ml" Weight="5">
              <Name>Oral liq 5 mg per ml</Name>
              <Brand ID="B22120893252725">
                <Name>RA-Morph</Name>
                <Pack ID="P754307" Specified="true" nzmt:ctpp_id="50108951000117101">
                  <Quantity>200</Quantity>
                  <Price>28.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208932528" Rank="3" Units="ml" Weight="10">
              <Name>Oral liq 10 mg per ml</Name>
              <Brand ID="B22120893252825">
                <Name>RA-Morph</Name>
                <Pack ID="P754315" Specified="true" nzmt:ctpp_id="50108961000117104">
                  <Quantity>200</Quantity>
                  <Price>40.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212089529">
            <Name>Dihydrocodeine tartrate</Name>
            <Formulation ID="F221208952925" Rank="1" Units="tab" Weight="60">
              <Name>Tab long-acting 60 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B22120895292525" PSS="true">
                <Name>DHC Continus</Name>
                <Pack ID="P772887" Specified="true" nzmt:ctpp_id="50112121000117105">
                  <Quantity>60</Quantity>
                  <Price>8.60</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212089579">
            <Name>Fentanyl</Name>
            <Formulation ID="F221208957901" Rank="4" Units="inj" Weight="100">
              <Name>Inj 10 mcg per ml, 10 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B22120895790125" PSS="true">
                <Name>Biomed Fentanyl</Name>
                <Pack ID="P2670690" Specified="true" nzmt:ctpp_id="50327201000117108">
                  <Quantity>5</Quantity>
                  <Price>44.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208957902" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 10 mcg per ml, 100 ml bag</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22120895790225" PSS="true">
                <Name>Biomed</Name>
                <Pack ID="P2594137" Specified="true" nzmt:ctpp_id="50279751000117100">
                  <Quantity>5</Quantity>
                  <Price>114.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208957903" Rank="4" Units="inj" Weight="500">
              <Name>Inj 10 mcg per ml, 50 ml bag</Name>
              <Brand ID="B22120895790325">
                <Name>Biomed</Name>
                <Pack ID="P2392089" Specified="true" nzmt:ctpp_id="50228501000117101">
                  <Quantity>10</Quantity>
                  <Price>210.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208957904" Rank="4" Units="inj" Weight="500">
              <Name>Inj 10 mcg per ml, 50 ml syringe</Name>
              <Brand ID="B22120895790425">
                <Name>Biomed</Name>
                <Pack ID="P2392755" Specified="true" nzmt:ctpp_id="50126321000117103">
                  <Quantity>10</Quantity>
                  <Price>165.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208957905" Rank="4" Units="inj" Weight="2000">
              <Name>Inj 20 mcg per ml, 100 ml bag</Name>
              <Brand ID="B22120895790500">
                <Name>Any</Name>
                <Pack ID="P95790500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208957906" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 20 mcg per ml, 50 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B22120895790625" PSS="true">
                <Name>Biomed</Name>
                <Pack ID="P2670704" Specified="true" nzmt:ctpp_id="50327171000117109">
                  <Quantity>5</Quantity>
                  <Price>136.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208957907" Rank="4" Units="inj" Weight="500">
              <Name>Inj 50 mcg per ml, 10 ml ampoule</Name>
              <Brand ID="B22120895790725">
                <Name>Boucher and Muir</Name>
                <Pack ID="P2381168" Specified="true" nzmt:ctpp_id="50122571000117106">
                  <Quantity>10</Quantity>
                  <Price>9.41</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208957908" Rank="4" Units="inj" Weight="100">
              <Name>Inj 50 mcg per ml, 2 ml ampoule</Name>
              <Brand ID="B22120895790825">
                <Name>Boucher and Muir</Name>
                <Pack ID="P2381176" Specified="true" nzmt:ctpp_id="50122561000117101">
                  <Quantity>10</Quantity>
                  <Price>3.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208957909" Rank="9" Units="patch" Weight="75">
              <Name>Patch 75 mcg per hour</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22120895790926" PSS="true">
                <Name>Fentanyl Sandoz</Name>
                <Pack ID="P2472902" Specified="true" nzmt:ctpp_id="50175611000117108">
                  <Quantity>5</Quantity>
                  <Price>15.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208957925" Rank="9" Units="patch" Weight="12.5">
              <Name>Patch 12.5 mcg per hour</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22120895792526" PSS="true">
                <Name>Fentanyl Sandoz</Name>
                <Pack ID="P2472872" Specified="true" nzmt:ctpp_id="50175571000117100">
                  <Quantity>5</Quantity>
                  <Price>6.02</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208957926" Rank="9" Units="patch" Weight="25">
              <Name>Patch 25 mcg per hour</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22120895792626" PSS="true">
                <Name>Fentanyl Sandoz</Name>
                <Pack ID="P2472880" Specified="true" nzmt:ctpp_id="50175581000117102">
                  <Quantity>5</Quantity>
                  <Price>6.91</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208957927" Rank="9" Units="patch" Weight="50">
              <Name>Patch 50 mcg per hour</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22120895792726" PSS="true">
                <Name>Fentanyl Sandoz</Name>
                <Pack ID="P2472899" Specified="true" nzmt:ctpp_id="50175601000117105">
                  <Quantity>5</Quantity>
                  <Price>9.28</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221208957929" Rank="9" Units="patch" Weight="100">
              <Name>Patch 100 mcg per hour</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22120895792926" PSS="true">
                <Name>Fentanyl Sandoz</Name>
                <Pack ID="P2472910" Specified="true" nzmt:ctpp_id="50175621000117102">
                  <Quantity>5</Quantity>
                  <Price>16.37</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2212089593">
            <Name>Paracetamol with codeine</Name>
            <Formulation ID="F221208959325" Rank="1" Units="tab">
              <Name>Tab paracetamol 500 mg with codeine phosphate 8 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B22120895932525" PSS="true">
                <Name>Paracetamol + Codeine (Relieve)</Name>
                <Pack ID="P2461234" Specified="true" nzmt:ctpp_id="50211441000117102">
                  <Quantity>1000</Quantity>
                  <Price>27.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2216">
        <Name>Antidepressants</Name>
        <ATC3 ID="A221604">
          <Name>Cyclic and Related Agents</Name>
          <Chemical ID="C2216048160">
            <Name>Doxepin hydrochloride</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F221604816001" Rank="2" Units="cap" Weight="10">
              <Name>Cap 10 mg</Name>
              <Brand ID="B22160481600100">
                <Name>Any</Name>
                <Pack ID="P81600100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221604816002" Rank="2" Units="cap" Weight="25">
              <Name>Cap 25 mg</Name>
              <Brand ID="B22160481600200">
                <Name>Any</Name>
                <Pack ID="P81600200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221604816003" Rank="2" Units="cap" Weight="50">
              <Name>Cap 50 mg</Name>
              <Brand ID="B22160481600300">
                <Name>Any</Name>
                <Pack ID="P81600300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2216048279">
            <Name>Maprotiline hydrochloride</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F221604827901" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Brand ID="B22160482790100">
                <Name>Any</Name>
                <Pack ID="P82790100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221604827902" Rank="1" Units="tab" Weight="75">
              <Name>Tab 75 mg</Name>
              <Brand ID="B22160482790200">
                <Name>Any</Name>
                <Pack ID="P82790200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2216048301">
            <Name>Mianserin hydrochloride</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F221604830101" Rank="1" Units="tab" Weight="30">
              <Name>Tab 30 mg</Name>
              <Brand ID="B22160483010100">
                <Name>Any</Name>
                <Pack ID="P83010100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2216049155">
            <Name>Clomipramine hydrochloride</Name>
            <Formulation ID="F221604915525" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Brand ID="B22160491552527">
                <Name>Clomipramine Teva</Name>
                <Pack ID="P2611406" Specified="true" nzmt:ctpp_id="50290071000117107">
                  <Quantity>30</Quantity>
                  <Price>11.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221604915526" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B22160491552626">
                <Name>Clomipramine Teva</Name>
                <Pack ID="P2611392" Specified="true" nzmt:ctpp_id="50290061000117102">
                  <Quantity>30</Quantity>
                  <Price>10.17</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221604915527" Rank="2" Units="cap" Weight="25">
              <Name>Cap 25 mg</Name>
              <Brand ID="B22160491552725">
                <Name>Clomipramine Teva</Name>
                <Pack ID="P2666901" Specified="true" nzmt:ctpp_id="50326051000117102">
                  <Quantity>28</Quantity>
                  <Price>11.19</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221604915528" Rank="2" Units="cap" Weight="10">
              <Name>Cap 10 mg</Name>
              <Brand ID="B22160491552825">
                <Name>Clomipramine Teva</Name>
                <Pack ID="P2674149" Specified="true" nzmt:ctpp_id="50329821000117109">
                  <Quantity>28</Quantity>
                  <Price>9.49</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2216049267">
            <Name>Amitriptyline</Name>
            <Formulation ID="F221604926725" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B22160492672527" PSS="true">
                <Name>Arrow-Amitriptyline</Name>
                <Pack ID="P2404451" Specified="true" nzmt:ctpp_id="50136081000117104">
                  <Quantity>100</Quantity>
                  <Price>2.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221604926726" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B22160492672626" PSS="true">
                <Name>Arrow-Amitriptyline</Name>
                <Pack ID="P2461250" Specified="true" nzmt:ctpp_id="50136051000117105">
                  <Quantity>100</Quantity>
                  <Price>1.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221604926727" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B22160492672726" PSS="true">
                <Name>Arrow-Amitriptyline</Name>
                <Pack ID="P2461269" Specified="true" nzmt:ctpp_id="50136011000117109">
                  <Quantity>100</Quantity>
                  <Price>3.14</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2216049344">
            <Name>Imipramine hydrochloride</Name>
            <Formulation ID="F221604934425" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B22160493442525">
                <Name>Tofranil</Name>
                <Pack ID="P2015269" Specified="true" nzmt:ctpp_id="50002621000117109">
                  <Quantity>50</Quantity>
                  <Price>5.48</Price>
                </Pack>
                <Pack ID="P2445468" Specified="true" nzmt:ctpp_id="50180371000117107">
                  <Quantity>60</Quantity>
                  <Price>6.58</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221604934426" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Brand ID="B22160493442625">
                <Name>Tofranil</Name>
                <Pack ID="P2015250" Specified="true" nzmt:ctpp_id="50002611000117103">
                  <Quantity>50</Quantity>
                  <Price>8.80</Price>
                </Pack>
              </Brand>
              <Brand ID="B22160493442626">
                <Name>Imipramine Crescent</Name>
                <Pack ID="P2669692" Specified="true" nzmt:ctpp_id="50325451000117102">
                  <Quantity>28</Quantity>
                  <Price>4.93</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2216049364">
            <Name>Dosulepin [Dothiepin] hydrochloride</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F221604936425" Rank="2" Units="cap" Weight="25">
              <Name>Cap 25 mg</Name>
              <Brand ID="B22160493642527">
                <Name>Dosulepin Viatris</Name>
                <Pack ID="P2636441" Specified="true" nzmt:ctpp_id="50300781000117102">
                  <Quantity>50</Quantity>
                  <Price>7.83</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221604936426" Rank="1" Units="tab" Weight="75">
              <Name>Tab 75 mg</Name>
              <Brand ID="B22160493642626">
                <Name>Dosulepin Viatris</Name>
                <Pack ID="P2630885" Specified="true" nzmt:ctpp_id="50290681000117103">
                  <Quantity>30</Quantity>
                  <Price>3.85</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2216049452">
            <Name>Nortriptyline hydrochloride</Name>
            <Formulation ID="F221604945225" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="May-23 to~2025" Value="5"/>
              <Brand ID="B22160494522525" PSS="true">
                <Name>Norpress</Name>
                <Pack ID="P2090678" Specified="true" nzmt:ctpp_id="50017121000117104">
                  <Quantity>100</Quantity>
                  <Price>2.46</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221604945226" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Rule Type="DVLimit" Attribute="May-23 to~2025" Value="5"/>
              <Brand ID="B22160494522625" PSS="true">
                <Name>Norpress</Name>
                <Pack ID="P2312441" Specified="true" nzmt:ctpp_id="50047841000117107">
                  <Quantity>180</Quantity>
                  <Price>6.29</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A221608">
          <Name>Monoamine-Oxidase Inhibitors - Non-Selective</Name>
          <Chemical ID="C2216088354">
            <Name>Phenelzine sulphate</Name>
            <Formulation ID="F221608835401" Rank="1" Units="tab" Weight="15">
              <Name>Tab 15 mg</Name>
              <Brand ID="B22160883540100">
                <Name>Any</Name>
                <Pack ID="P83540100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2216088475">
            <Name>Tranylcypromine sulphate</Name>
            <Formulation ID="F221608847501" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B22160884750100">
                <Name>Any</Name>
                <Pack ID="P84750100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A221612">
          <Name>Monoamine-Oxidase Type A Inhibitors</Name>
          <Chemical ID="C2216129504">
            <Name>Moclobemide</Name>
            <Formulation ID="F221612950425" Rank="1" Units="tab" Weight="150">
              <Name>Tab 150 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B22161295042527" PSS="true">
                <Name>Aurorix</Name>
                <Pack ID="P2602385" Specified="true" nzmt:ctpp_id="50252531000117106">
                  <Quantity>60</Quantity>
                  <Price>23.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221612950426" Rank="1" Units="tab" Weight="300">
              <Name>Tab 300 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B22161295042627" PSS="true">
                <Name>Aurorix</Name>
                <Pack ID="P2602393" Specified="true" nzmt:ctpp_id="50090581000117106">
                  <Quantity>60</Quantity>
                  <Price>38.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A221616">
          <Name>Other Antidepressants</Name>
          <Chemical ID="C2216169142">
            <Name>Venlafaxine</Name>
            <Formulation ID="F221616914232" Rank="2" Units="cap" Weight="37">
              <Name>Cap 37.5 mg</Name>
              <Brand ID="B22161691423225">
                <Name>Enlafax XR</Name>
                <Pack ID="P2509210" Specified="true" nzmt:ctpp_id="50237561000117103">
                  <Quantity>84</Quantity>
                  <Price>8.29</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221616914233" Rank="2" Units="cap" Weight="75">
              <Name>Cap 75 mg</Name>
              <Brand ID="B22161691423325">
                <Name>Enlafax XR</Name>
                <Pack ID="P2509229" Specified="true" nzmt:ctpp_id="50237581000117106">
                  <Quantity>84</Quantity>
                  <Price>10.32</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221616914234" Rank="2" Units="cap" Weight="150">
              <Name>Cap 150 mg</Name>
              <Brand ID="B22161691423425">
                <Name>Enlafax XR</Name>
                <Pack ID="P2509237" Specified="true" nzmt:ctpp_id="50237601000117103">
                  <Quantity>84</Quantity>
                  <Price>13.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2216169511">
            <Name>Mirtazapine</Name>
            <Formulation ID="F221616951125" Rank="1" Units="tab" Weight="30">
              <Name>Tab 30 mg</Name>
              <Brand ID="B22161695112527">
                <Name>Noumed</Name>
                <Pack ID="P2616084" Specified="true" nzmt:ctpp_id="50289071000117104">
                  <Quantity>28</Quantity>
                  <Price>2.60</Price>
                </Pack>
                <Pack ID="P2678802" Specified="true" nzmt:ctpp_id="50284931000117104">
                  <Quantity>30</Quantity>
                  <Price>2.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221616951126" Rank="1" Units="tab" Weight="45">
              <Name>Tab 45 mg</Name>
              <Brand ID="B22161695112627">
                <Name>Noumed</Name>
                <Pack ID="P2616092" Specified="true" nzmt:ctpp_id="50289081000117101">
                  <Quantity>28</Quantity>
                  <Price>3.45</Price>
                </Pack>
                <Pack ID="P2678810" Specified="true" nzmt:ctpp_id="50284941000117107">
                  <Quantity>30</Quantity>
                  <Price>3.45</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A221620">
          <Name>Selective Serotonin Reuptake Inhibitors</Name>
          <Chemical ID="C2216209122">
            <Name>Citalopram hydrobromide</Name>
            <Formulation ID="F221620912201" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2025" Value="5"/>
              <Brand ID="B22162091220101" PSS="true">
                <Name>Celapram</Name>
                <Pack ID="P2638738" Specified="true" nzmt:ctpp_id="50161501000117102">
                  <Quantity>84</Quantity>
                  <Price>2.86</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2216209192">
            <Name>Fluoxetine hydrochloride</Name>
            <Formulation ID="F221620919225" Rank="2" Units="cap" Weight="20">
              <Name>Cap 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-23 to~2025" Value="5"/>
              <Brand ID="B22162091922526" PSS="true">
                <Name>Arrow-Fluoxetine</Name>
                <Pack ID="P2450860" Specified="true" nzmt:ctpp_id="50134501000117108">
                  <Quantity>90</Quantity>
                  <Price>3.13</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221620919226" Rank="1" Units="tab" Weight="20">
              <Name>Tab dispersible 20 mg, scored</Name>
              <Rule Type="DVLimit" Attribute="Feb-23 to~2025" Value="5"/>
              <Brand ID="B22162091922625" PSS="true">
                <Name>Fluox</Name>
                <Pack ID="P2618575" Specified="true" nzmt:ctpp_id="50292131000117109">
                  <Quantity>28</Quantity>
                  <Price>2.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2216209373">
            <Name>Paroxetine</Name>
            <Formulation ID="F221620937325" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B22162093732525" PSS="true">
                <Name>Loxamine</Name>
                <Pack ID="P2626799" Specified="true" nzmt:ctpp_id="50176921000117101">
                  <Quantity>90</Quantity>
                  <Price>4.11</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2216209569">
            <Name>Escitalopram</Name>
            <Formulation ID="F221620956925" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2026" Value="5"/>
              <Brand ID="B22162095692529" PSS="true">
                <Name>Ipca-Escitalopram</Name>
                <Pack ID="P2661640" Specified="true" nzmt:ctpp_id="50223191000117106">
                  <Quantity>28</Quantity>
                  <Price>0.79</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221620956926" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2026" Value="5"/>
              <Brand ID="B22162095692629" PSS="true">
                <Name>Ipca-Escitalopram</Name>
                <Pack ID="P2661659" Specified="true" nzmt:ctpp_id="50223271000117100">
                  <Quantity>28</Quantity>
                  <Price>1.49</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2216209577">
            <Name>Sertraline</Name>
            <Formulation ID="F221620957725" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B22162095772526" PSS="true">
                <Name>Setrona</Name>
                <Pack ID="P2570831" Specified="true" nzmt:ctpp_id="50168181000117108">
                  <Quantity>30</Quantity>
                  <Price>0.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F221620957726" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B22162095772626" PSS="true">
                <Name>Setrona</Name>
                <Pack ID="P2570858" Specified="true" nzmt:ctpp_id="50168171000117105">
                  <Quantity>30</Quantity>
                  <Price>1.74</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2220">
        <Name>Antiepilepsy Drugs</Name>
        <ATC3 ID="A222004">
          <Name>Agents for the Control of Status Epilepticus</Name>
          <Chemical ID="C2220048344">
            <Name>Paraldehyde</Name>
            <Formulation ID="F222004834401" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 ml ampoule</Name>
              <Brand ID="B22200483440100">
                <Name>Any</Name>
                <Pack ID="P83440100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222004834425" Rank="3" Units="ml">
              <Name>Soln 97%</Name>
              <Brand ID="B22200483442500">
                <Name>Any</Name>
                <Pack ID="P83442500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220048361">
            <Name>Phenytoin sodium</Name>
            <Formulation ID="F222004836103" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B22200483610325">
                <Name>Hospira</Name>
                <Pack ID="P391654" Specified="true" nzmt:ctpp_id="50081081000117108">
                  <Quantity>5</Quantity>
                  <Price>104.58</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222004836104" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 5 ml ampoule</Name>
              <Brand ID="B22200483610425">
                <Name>Hospira</Name>
                <Pack ID="P391646" Specified="true" nzmt:ctpp_id="50081071000117105">
                  <Quantity>5</Quantity>
                  <Price>154.01</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220049156">
            <Name>Clonazepam</Name>
            <Formulation ID="F222004915625" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B22200491562500">
                <Name>Any</Name>
                <Pack ID="P91562500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220049175">
            <Name>Diazepam</Name>
            <Formulation ID="F222004917525" Rank="9" Units="tube" Weight="5">
              <Name>Rectal tubes 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-23 to~2025" Value="5"/>
              <Brand ID="B22200491752525" PSS="true">
                <Name>Stesolid</Name>
                <Pack ID="P425877" Specified="true" nzmt:ctpp_id="50084501000117105">
                  <Quantity>5</Quantity>
                  <Price>54.58</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222004917526" Rank="9" Units="tube" Weight="10">
              <Name>Rectal tubes 10 mg</Name>
              <Brand ID="B22200491752600">
                <Name>Any</Name>
                <Pack ID="P91752600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222004917527" Rank="4" Units="inj" Weight="10">
              <Name>Inj 5 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B22200491752725">
                <Name>Hospira</Name>
                <Pack ID="P399019" Specified="true" nzmt:ctpp_id="50081941000117103">
                  <Quantity>5</Quantity>
                  <Price>27.92</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220049212">
            <Name>Lorazepam</Name>
            <Formulation ID="F222004921201" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2 mg vial</Name>
              <Brand ID="B22200492120100">
                <Name>Any</Name>
                <Pack ID="P92120100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222004921202" Rank="4" Units="inj" Weight="4">
              <Name>Inj 4 mg per ml, 1 ml vial</Name>
              <Brand ID="B22200492120200">
                <Name>Any</Name>
                <Pack ID="P92120200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A222008">
          <Name>Control of Epilepsy</Name>
          <Chemical ID="C2220088075">
            <Name>Carbamazepine</Name>
            <Formulation ID="F222008807501" Rank="3" Units="ml">
              <Name>Oral liq 20 mg per ml</Name>
              <Brand ID="B22200880750125">
                <Name>Tegretol</Name>
                <Pack ID="P503649" Specified="true" nzmt:ctpp_id="50093111000117104">
                  <Quantity>250</Quantity>
                  <Price>26.37</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008807502" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B22200880750225">
                <Name>Tegretol</Name>
                <Pack ID="P2291657" Specified="true" nzmt:ctpp_id="50044721000117103">
                  <Quantity>100</Quantity>
                  <Price>14.53</Price>
                </Pack>
              </Brand>
              <Brand ID="B22200880750226">
                <Name>Tegretol AU</Name>
                <Pack ID="P2681331" Specified="true" nzmt:ctpp_id="50335221000117108">
                  <Quantity>100</Quantity>
                  <Price>14.53</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008807503" Rank="1" Units="tab" Weight="400">
              <Name>Tab 400 mg</Name>
              <Brand ID="B22200880750325">
                <Name>Tegretol</Name>
                <Pack ID="P680931" Specified="true" nzmt:ctpp_id="50101801000117101">
                  <Quantity>100</Quantity>
                  <Price>34.58</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008807504" Rank="1" Units="tab" Weight="200">
              <Name>Tab long-acting 200 mg</Name>
              <Brand ID="B22200880750425">
                <Name>Tegretol CR</Name>
                <Pack ID="P715832" Specified="true" nzmt:ctpp_id="50104971000117103">
                  <Quantity>100</Quantity>
                  <Price>16.98</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008807505" Rank="1" Units="tab" Weight="400">
              <Name>Tab long-acting 400 mg</Name>
              <Brand ID="B22200880750525">
                <Name>Tegretol CR</Name>
                <Pack ID="P715840" Specified="true" nzmt:ctpp_id="50104981000117100">
                  <Quantity>100</Quantity>
                  <Price>39.17</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220088103">
            <Name>Clobazam</Name>
            <Formulation ID="F222008810301" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B22200881030100">
                <Name>Any</Name>
                <Pack ID="P81030100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220088176">
            <Name>Ethosuximide</Name>
            <Formulation ID="F222008817601" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Brand ID="B22200881760125">
                <Name>Zarontin</Name>
                <Pack ID="P2489937" Specified="true" nzmt:ctpp_id="50227311000117108">
                  <Quantity>100</Quantity>
                  <Price>140.88</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008817602" Rank="3" Units="ml">
              <Name>Oral liq 50 mg per ml</Name>
              <Brand ID="B22200881760225">
                <Name>Zarontin</Name>
                <Pack ID="P2106019" Specified="true" nzmt:ctpp_id="50019051000117104">
                  <Quantity>200</Quantity>
                  <Price>56.35</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220088360">
            <Name>Phenytoin</Name>
            <Formulation ID="F222008836001" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B22200883600100">
                <Name>Any</Name>
                <Pack ID="P83600100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220088361">
            <Name>Phenytoin sodium</Name>
            <Formulation ID="F222008836101" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Brand ID="B22200883610100">
                <Name>Any</Name>
                <Pack ID="P83610100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008836102" Rank="2" Units="cap" Weight="30">
              <Name>Cap 30 mg</Name>
              <Brand ID="B22200883610200">
                <Name>Any</Name>
                <Pack ID="P83610200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008836105" Rank="3" Units="ml">
              <Name>Oral liq 6 mg per ml</Name>
              <Brand ID="B22200883610500">
                <Name>Any</Name>
                <Pack ID="P83610500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220088390">
            <Name>Primidone</Name>
            <Formulation ID="F222008839001" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B22200883900100">
                <Name>Any</Name>
                <Pack ID="P83900100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220088439">
            <Name>Sodium valproate</Name>
            <Formulation ID="F222008843901" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg per ml, 4 ml vial</Name>
              <Brand ID="B22200884390125">
                <Name>Epilim IV</Name>
                <Pack ID="P710385" Specified="true" nzmt:ctpp_id="50104041000117108">
                  <Quantity>1</Quantity>
                  <Price>9.98</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008843902" Rank="3" Units="ml">
              <Name>Oral liq 40 mg per ml</Name>
              <Brand ID="B22200884390200">
                <Name>Any</Name>
                <Pack ID="P84390200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008843903" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B22200884390300">
                <Name>Any</Name>
                <Pack ID="P84390300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008843904" Rank="1" Units="tab" Weight="200">
              <Name>Tab EC 200 mg</Name>
              <Brand ID="B22200884390400">
                <Name>Any</Name>
                <Pack ID="P84390400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008843905" Rank="1" Units="tab" Weight="500">
              <Name>Tab EC 500 mg</Name>
              <Brand ID="B22200884390500">
                <Name>Any</Name>
                <Pack ID="P84390500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220088492">
            <Name>Vigabatrin</Name>
            <Request Form="RS1865" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Vigabatrin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has infantile spasms</ci>
                      <apply>
                        <and/>
                        <ci type="logical">Patient has epilepsy</ci>
                        <apply>
                          <or/>
                          <ci type="logical">Seizures are not adequately controlled with optimal treatment with other antiepilepsy agents</ci>
                          <ci type="logical">Seizures are controlled adequately but the patient has experienced unacceptable side effects from optimal treatment with other antiepilepsy agents</ci>
                        </apply>
                      </apply>
                      <ci type="logical">Patient has tuberous sclerosis complex</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical">Patient is, or will be, receiving regular automated visual field testing (ideally before starting therapy and on a 6-monthly basis thereafter)</ci>
                      <ci type="logical">It is impractical or impossible (due to comorbid conditions) to monitor the patient's visual fields</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">15</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has demonstrated a significant and sustained improvement in seizure rate or severity and or quality of life</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient is receiving regular automated visual field testing (ideally every 6 months) on an ongoing basis for duration of treatment with vigabatrin</ci>
                      <ci type="logical">It is impractical or impossible (due to comorbid conditions) to monitor the patient's visual fields</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1865" style="display:none"/>
            <Formulation ID="F222008849201" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Brand ID="B22200884920100">
                <Name>Any</Name>
                <Pack ID="P84920100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008849225" Rank="2" Units="sach" Weight="500">
              <Name>Powder for oral soln 500 mg per sachet</Name>
              <Brand ID="B22200884922525">
                <Name>Sabril</Name>
                <Pack ID="P2661683" Specified="true" nzmt:ctpp_id="50320421000117100">
                  <Quantity>60</Quantity>
                  <Price>71.58</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220088621">
            <Name>Pregabalin</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: Pregabalin not to be given in combination with gabapentin</p>
            </div>
            <Formulation ID="F222008862125" Rank="2" Units="cap" Weight="25">
              <Name>Cap 25 mg</Name>
              <Brand ID="B22200886212525">
                <Name>Pregabalin Pfizer</Name>
                <Pack ID="P2534053" Specified="true" nzmt:ctpp_id="50248261000117100">
                  <Quantity>56</Quantity>
                  <Price>2.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008862126" Rank="2" Units="cap" Weight="75">
              <Name>Cap 75 mg</Name>
              <Brand ID="B22200886212625">
                <Name>Pregabalin Pfizer</Name>
                <Pack ID="P2534088" Specified="true" nzmt:ctpp_id="50248381000117100">
                  <Quantity>56</Quantity>
                  <Price>2.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008862127" Rank="2" Units="cap" Weight="150">
              <Name>Cap 150 mg</Name>
              <Brand ID="B22200886212725">
                <Name>Pregabalin Pfizer</Name>
                <Pack ID="P2534096" Specified="true" nzmt:ctpp_id="50248541000117102">
                  <Quantity>56</Quantity>
                  <Price>4.01</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008862128" Rank="2" Units="cap" Weight="300">
              <Name>Cap 300 mg</Name>
              <Brand ID="B22200886212825">
                <Name>Pregabalin Pfizer</Name>
                <Pack ID="P2534118" Specified="true" nzmt:ctpp_id="50248801000117102">
                  <Quantity>56</Quantity>
                  <Price>7.38</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220089156">
            <Name>Clonazepam</Name>
            <Formulation ID="F222008915601" Rank="3" Units="ml">
              <Name>Oral drops 2.5 mg per ml</Name>
              <Brand ID="B22200891560100">
                <Name>Any</Name>
                <Pack ID="P91560100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220089249">
            <Name>Gabapentin</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: Gabapentin not to be given in combination with pregabalin</p>
            </div>
            <Formulation ID="F222008924925" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-22 to~2027" Value="1"/>
              <Brand ID="B22200892492526" HSS="true">
                <Name>Nupentin</Name>
                <Pack ID="P2422751" Specified="true" nzmt:ctpp_id="50137501000117102">
                  <Quantity>100</Quantity>
                  <Price>6.45</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008924926" Rank="2" Units="cap" Weight="300">
              <Name>Cap 300 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-22 to~2027" Value="1"/>
              <Brand ID="B22200892492626" HSS="true">
                <Name>Nupentin</Name>
                <Pack ID="P2422778" Specified="true" nzmt:ctpp_id="50137511000117104">
                  <Quantity>100</Quantity>
                  <Price>8.45</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008924927" Rank="2" Units="cap" Weight="400">
              <Name>Cap 400 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-22 to~2027" Value="1"/>
              <Brand ID="B22200892492726" HSS="true">
                <Name>Nupentin</Name>
                <Pack ID="P2422786" Specified="true" nzmt:ctpp_id="50137521000117105">
                  <Quantity>100</Quantity>
                  <Price>10.26</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220089368">
            <Name>Lamotrigine</Name>
            <Formulation ID="F222008936825" Rank="1" Units="tab" Weight="5">
              <Name>Tab dispersible 5 mg</Name>
              <Brand ID="B22200893682526">
                <Name>Lamictal</Name>
                <Pack ID="P2056143" Specified="true" nzmt:ctpp_id="50010041000117106">
                  <Quantity>30</Quantity>
                  <Price>50.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008936826" Rank="1" Units="tab" Weight="25">
              <Name>Tab dispersible 25 mg</Name>
              <Brand ID="B22200893682628">
                <Name>Logem</Name>
                <Pack ID="P2553376" Specified="true" nzmt:ctpp_id="50042601000117107">
                  <Quantity>56</Quantity>
                  <Price>4.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008936827" Rank="1" Units="tab" Weight="50">
              <Name>Tab dispersible 50 mg</Name>
              <Brand ID="B22200893682728">
                <Name>Logem</Name>
                <Pack ID="P2553384" Specified="true" nzmt:ctpp_id="50042611000117105">
                  <Quantity>56</Quantity>
                  <Price>5.11</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008936828" Rank="1" Units="tab" Weight="100">
              <Name>Tab dispersible 100 mg</Name>
              <Brand ID="B22200893682828">
                <Name>Logem</Name>
                <Pack ID="P2553392" Specified="true" nzmt:ctpp_id="50042621000117104">
                  <Quantity>56</Quantity>
                  <Price>6.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008936830" Rank="1" Units="tab" Weight="2">
              <Name>Tab dispersible 2 mg</Name>
              <Brand ID="B22200893683025">
                <Name>Lamictal</Name>
                <Pack ID="P2040034" Specified="true" nzmt:ctpp_id="50007681000117106">
                  <Quantity>30</Quantity>
                  <Price>55.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220089446">
            <Name>Topiramate</Name>
            <Formulation ID="F222008944625" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Brand ID="B22200894462525">
                <Name>Topamax</Name>
                <Pack ID="P470988" Specified="true" nzmt:ctpp_id="50088551000117104">
                  <Quantity>60</Quantity>
                  <Price>26.04</Price>
                </Pack>
              </Brand>
              <Brand ID="B22200894462526">
                <Name>Arrow-Topiramate</Name>
                <Pack ID="P2350408" Specified="true" nzmt:ctpp_id="50050461000117109">
                  <Quantity>60</Quantity>
                  <Price>11.07</Price>
                </Pack>
              </Brand>
              <Brand ID="B22200894462527">
                <Name>Topiramate Actavis</Name>
                <Pack ID="P2465825" Specified="true" nzmt:ctpp_id="50203041000117107">
                  <Quantity>60</Quantity>
                  <Price>11.07</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008944626" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B22200894462625">
                <Name>Topamax</Name>
                <Pack ID="P470996" Specified="true" nzmt:ctpp_id="50088561000117102">
                  <Quantity>60</Quantity>
                  <Price>44.26</Price>
                </Pack>
              </Brand>
              <Brand ID="B22200894462626">
                <Name>Arrow-Topiramate</Name>
                <Pack ID="P2350416" Specified="true" nzmt:ctpp_id="50050471000117104">
                  <Quantity>60</Quantity>
                  <Price>18.81</Price>
                </Pack>
              </Brand>
              <Brand ID="B22200894462627">
                <Name>Topiramate Actavis</Name>
                <Pack ID="P2465833" Specified="true" nzmt:ctpp_id="50203101000117109">
                  <Quantity>60</Quantity>
                  <Price>18.81</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008944627" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B22200894462725">
                <Name>Topamax</Name>
                <Pack ID="P471003" Specified="true" nzmt:ctpp_id="50088571000117107">
                  <Quantity>60</Quantity>
                  <Price>75.25</Price>
                </Pack>
              </Brand>
              <Brand ID="B22200894462726">
                <Name>Arrow-Topiramate</Name>
                <Pack ID="P2350424" Specified="true" nzmt:ctpp_id="50050481000117101">
                  <Quantity>60</Quantity>
                  <Price>31.99</Price>
                </Pack>
              </Brand>
              <Brand ID="B22200894462727">
                <Name>Topiramate Actavis</Name>
                <Pack ID="P2465841" Specified="true" nzmt:ctpp_id="50202991000117109">
                  <Quantity>60</Quantity>
                  <Price>31.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008944628" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B22200894462825">
                <Name>Topamax</Name>
                <Pack ID="P471011" Specified="true" nzmt:ctpp_id="50088581000117105">
                  <Quantity>60</Quantity>
                  <Price>129.85</Price>
                </Pack>
              </Brand>
              <Brand ID="B22200894462826">
                <Name>Arrow-Topiramate</Name>
                <Pack ID="P2350432" Specified="true" nzmt:ctpp_id="50050491000117103">
                  <Quantity>60</Quantity>
                  <Price>55.19</Price>
                </Pack>
              </Brand>
              <Brand ID="B22200894462827">
                <Name>Topiramate Actavis</Name>
                <Pack ID="P2465868" Specified="true" nzmt:ctpp_id="50203151000117108">
                  <Quantity>60</Quantity>
                  <Price>55.19</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008944629" Rank="2" Units="cap" Weight="15">
              <Name>Cap sprinkle 15 mg</Name>
              <Brand ID="B22200894462925">
                <Name>Topamax</Name>
                <Pack ID="P437212" Specified="true" nzmt:ctpp_id="50085741000117103">
                  <Quantity>60</Quantity>
                  <Price>20.84</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008944630" Rank="2" Units="cap" Weight="25">
              <Name>Cap sprinkle 25 mg</Name>
              <Brand ID="B22200894463025">
                <Name>Topamax</Name>
                <Pack ID="P437239" Specified="true" nzmt:ctpp_id="50085751000117101">
                  <Quantity>60</Quantity>
                  <Price>26.04</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220089517">
            <Name>Phenobarbitone</Name>
            <Formulation ID="F222008951725" Rank="1" Units="tab" Weight="15">
              <Name>Tab 15 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~2025" Value="5"/>
              <Brand ID="B22200895172526" PSS="true">
                <Name>Noumed Phenobarbitone</Name>
                <Pack ID="P2647524" Specified="true" nzmt:ctpp_id="50307081000117103">
                  <Quantity>500</Quantity>
                  <Price>248.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008951726" Rank="1" Units="tab" Weight="30">
              <Name>Tab 30 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2025" Value="5"/>
              <Brand ID="B22200895172626" PSS="true">
                <Name>Noumed Phenobarbitone</Name>
                <Pack ID="P2647532" Specified="true" nzmt:ctpp_id="50307091000117100">
                  <Quantity>500</Quantity>
                  <Price>398.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220089566">
            <Name>Levetiracetam</Name>
            <Formulation ID="F222008956601" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg per ml, 5 ml vial</Name>
              <Brand ID="B22200895660125">
                <Name>Levetiracetam-AFT</Name>
                <Pack ID="P2472414" Specified="true" nzmt:ctpp_id="50228671000117109">
                  <Quantity>10</Quantity>
                  <Price>38.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008956625" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B22200895662526">
                <Name>Everet</Name>
                <Pack ID="P2479532" Specified="true" nzmt:ctpp_id="50229981000117109">
                  <Quantity>60</Quantity>
                  <Price>5.84</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008956626" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Brand ID="B22200895662626">
                <Name>Everet</Name>
                <Pack ID="P2479540" Specified="true" nzmt:ctpp_id="50229991000117107">
                  <Quantity>60</Quantity>
                  <Price>10.51</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008956627" Rank="1" Units="tab" Weight="750">
              <Name>Tab 750 mg</Name>
              <Brand ID="B22200895662726">
                <Name>Everet</Name>
                <Pack ID="P2479559" Specified="true" nzmt:ctpp_id="50230001000117106">
                  <Quantity>60</Quantity>
                  <Price>16.71</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008956628" Rank="1" Units="tab" Weight="1000">
              <Name>Tab 1,000 mg</Name>
              <Brand ID="B22200895662825">
                <Name>Everet</Name>
                <Pack ID="P2479567" Specified="true" nzmt:ctpp_id="50230011000117109">
                  <Quantity>60</Quantity>
                  <Price>21.82</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008956629" Rank="3" Units="ml">
              <Name>Oral liq 100 mg per ml</Name>
              <Brand ID="B22200895662925">
                <Name>Levetiracetam-AFT</Name>
                <Pack ID="P2472406" Specified="true" nzmt:ctpp_id="50227941000117106">
                  <Quantity>300</Quantity>
                  <Price>44.78</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220089585">
            <Name>Lacosamide</Name>
            <Request Form="RS1988" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Lacosamide</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has focal epilepsy</ci>
                    <ci type="logical">Seizures are not adequately controlled by, or patient has experienced
          unacceptable side effects from, optimal treatment with all of the following: sodium
          valproate, topiramate, levetiracetam, and any two of carbamazepine, lamotrigine, and
          phenytoin sodium (see Note)</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">15</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Those of childbearing potential are not required to trial phenytoin sodium, sodium
        valproate, or topiramate. Those who can father children are not required to trial sodium valproate.</p>
                </div>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has demonstrated a significant and sustained improvement in seizure
        rate or severity and/or quality of life compared with that prior to starting lacosamide
        treatment</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1988" style="display:none"/>
            <Formulation ID="F222008958501" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 20 ml vial</Name>
              <Brand ID="B22200895850100">
                <Name>Any</Name>
                <Pack ID="P95850100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008958525" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B22200895852525">
                <Name>Vimpat</Name>
                <Pack ID="P2378353" Specified="true" nzmt:ctpp_id="50122581000117109">
                  <Quantity>14</Quantity>
                  <Price>25.04</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008958526" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B22200895852625">
                <Name>Vimpat</Name>
                <Pack ID="P2378388" Specified="true" nzmt:ctpp_id="50122591000117107">
                  <Quantity>14</Quantity>
                  <Price>50.06</Price>
                </Pack>
                <Pack ID="P2378396" Specified="true" nzmt:ctpp_id="50122601000117101">
                  <Quantity>56</Quantity>
                  <Price>200.24</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008958527" Rank="1" Units="tab" Weight="150">
              <Name>Tab 150 mg</Name>
              <Brand ID="B22200895852725">
                <Name>Vimpat</Name>
                <Pack ID="P2378418" Specified="true" nzmt:ctpp_id="50122611000117103">
                  <Quantity>14</Quantity>
                  <Price>75.10</Price>
                </Pack>
                <Pack ID="P2378426" Specified="true" nzmt:ctpp_id="50122621000117109">
                  <Quantity>56</Quantity>
                  <Price>300.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008958528" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B22200895852825">
                <Name>Vimpat</Name>
                <Pack ID="P2378442" Specified="true" nzmt:ctpp_id="50122631000117107">
                  <Quantity>56</Quantity>
                  <Price>400.55</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2220089689">
            <Name>Stiripentol</Name>
            <Request Form="RS1989" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Stiripentol</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has confirmed diagnosis of Dravet syndrome</ci>
                    <ci type="logical">Seizures have been inadequately controlled by appropriate courses of
          sodium valproate, clobazam and at least two of the following: topiramate, levetiracetam,
          ketogenic diet</ci>
                  </apply>
                </math>
                <Applicant>paediatric neurologist</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Those of childbearing potential are not required to trial sodium valproate or
        topiramate. Those who can father children are not required to trial sodium valproate.</p>
                </div>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient continues to benefit from treatment as measured by reduced seizure
        frequency from baseline</ci>
                </math>
                <Applicant>paediatric neurologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1989" style="display:none"/>
            <Formulation ID="F222008968925" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Brand ID="B22200896892525">
                <Name>Diacomit</Name>
                <Pack ID="P2434636" Specified="true" nzmt:ctpp_id="50164631000117109">
                  <Quantity>60</Quantity>
                  <Price>509.29</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222008968926" Rank="2" Units="sach">
              <Name>Powder for oral liq 250 mg sachet</Name>
              <Brand ID="B22200896892625">
                <Name>Diacomit</Name>
                <Pack ID="P2434644" Specified="true" nzmt:ctpp_id="50164641000117101">
                  <Quantity>60</Quantity>
                  <Price>509.29</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2224">
        <Name>Antimigraine Preparations</Name>
        <ATC3 ID="A222404">
          <Name>Acute Migraine Treatment</Name>
          <Chemical ID="C2224048141">
            <Name>Dihydroergotamine mesylate</Name>
            <Formulation ID="F222404814101" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B22240481410100">
                <Name>Any</Name>
                <Pack ID="P81410100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2224048298">
            <Name>Metoclopramide hydrochloride with paracetamol</Name>
            <Formulation ID="F222404829801" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg with paracetamol 500 mg</Name>
              <Brand ID="B22240482980100">
                <Name>Any</Name>
                <Pack ID="P82980100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2224049374">
            <Name>Sumatriptan</Name>
            <Formulation ID="F222404937425" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-22 to~2027" Value="1"/>
              <Brand ID="B22240493742526" HSS="true">
                <Name>Sumagran</Name>
                <Pack ID="P2605848" Specified="true" nzmt:ctpp_id="50235041000117101">
                  <Quantity>90</Quantity>
                  <Price>14.41</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222404937426" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-22 to~2027" Value="1"/>
              <Brand ID="B22240493742626" HSS="true">
                <Name>Sumagran</Name>
                <Pack ID="P2605856" Specified="true" nzmt:ctpp_id="50235061000117102">
                  <Quantity>90</Quantity>
                  <Price>22.68</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222404937428" Rank="4" Units="inj" Weight="6">
              <Name>Inj 12 mg per ml, 0.5 ml prefilled pen</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2025" Value="5"/>
              <Brand ID="B22240493742825" PSS="true">
                <Name>Clustran</Name>
                <Pack ID="P2647958" Specified="true" nzmt:ctpp_id="50318621000117107">
                  <Quantity>2</Quantity>
                  <Price>29.30</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2224049428">
            <Name>Rizatriptan</Name>
            <Formulation ID="F222404942826" Rank="1" Units="tab" Weight="10">
              <Name>Tab orodispersible 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22240494282625" PSS="true">
                <Name>Rizamelt</Name>
                <Pack ID="P2394634" Specified="true" nzmt:ctpp_id="50128451000117101">
                  <Quantity>30</Quantity>
                  <Price>4.84</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A222408">
          <Name>Prophylaxis of Migraine</Name>
          <Chemical ID="C2224089525">
            <Name>Pizotifen</Name>
            <Formulation ID="F222408952525" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mcg</Name>
              <Brand ID="B22240895252525">
                <Name>Sandomigran</Name>
                <Pack ID="P2492954" Specified="true" nzmt:ctpp_id="50228651000117101">
                  <Quantity>100</Quantity>
                  <Price>23.21</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2228">
        <Name>Antinausea and Vertigo Agents</Name>
        <ATC3 ID="A222804">
          <Name>Antinausea and Vertigo Agents</Name>
          <Chemical ID="C2228048161">
            <Name>Droperidol</Name>
            <Formulation ID="F222804816101" Rank="4" Units="inj" Weight="2.5">
              <Name>Inj 2.5 mg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2025" Value="5"/>
              <Brand ID="B22280481610125" PSS="true">
                <Name>Droperidol Panpharma</Name>
                <Pack ID="P2527138" Specified="true" nzmt:ctpp_id="50245391000117107">
                  <Quantity>10</Quantity>
                  <Price>43.85</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2228048568">
            <Name>Granisetron</Name>
            <Formulation ID="F222804856826" Rank="4" Units="inj" Weight="3">
              <Name>Inj 1 mg per ml, 3 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22280485682625" PSS="true">
                <Name>Deva</Name>
                <Pack ID="P2554186" Specified="true" nzmt:ctpp_id="50236351000117109">
                  <Quantity>1</Quantity>
                  <Price>1.20</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2228049033">
            <Name>Metoclopramide hydrochloride</Name>
            <Formulation ID="F222804903301" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 2 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B22280490330125" PSS="true">
                <Name>Baxter</Name>
                <Pack ID="P2625873" Specified="true" nzmt:ctpp_id="50273251000117107">
                  <Quantity>10</Quantity>
                  <Price>7.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222804903302" Rank="3" Units="ml">
              <Name>Oral liq 5 mg per 5 ml</Name>
              <Brand ID="B22280490330200">
                <Name>Any</Name>
                <Pack ID="P90330200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222804903325" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B22280490332526" PSS="true">
                <Name>Metoclopramide Actavis 10</Name>
                <Pack ID="P2528878" Specified="true" nzmt:ctpp_id="50206281000117101">
                  <Quantity>100</Quantity>
                  <Price>1.57</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2228049042">
            <Name>Ondansetron</Name>
            <Formulation ID="F222804904201" Rank="4" Units="inj" Weight="4">
              <Name>Inj 2 mg per ml, 2 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2025" Value="5"/>
              <Brand ID="B22280490420129" PSS="true">
                <Name>Ondansetron-AFT</Name>
                <Pack ID="P2604752" Specified="true" nzmt:ctpp_id="50272081000117102">
                  <Quantity>5</Quantity>
                  <Price>1.42</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222804904202" Rank="4" Units="inj" Weight="8">
              <Name>Inj 2 mg per ml, 4 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2025" Value="5"/>
              <Brand ID="B22280490420228" PSS="true">
                <Name>Ondansetron-AFT</Name>
                <Pack ID="P2604760" Specified="true" nzmt:ctpp_id="50272111000117106">
                  <Quantity>5</Quantity>
                  <Price>1.89</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222804904203" Rank="1" Units="tab" Weight="4">
              <Name>Tab 4 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-23 to~2025" Value="5"/>
              <Brand ID="B22280490420328" PSS="true">
                <Name>Periset</Name>
                <Pack ID="P2648024" Specified="true" nzmt:ctpp_id="50303721000117107">
                  <Quantity>50</Quantity>
                  <Price>2.27</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222804904204" Rank="1" Units="tab" Weight="8">
              <Name>Tab 8 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-23 to~2025" Value="5"/>
              <Brand ID="B22280490420428" PSS="true">
                <Name>Periset</Name>
                <Pack ID="P2648032" Specified="true" nzmt:ctpp_id="50303761000117103">
                  <Quantity>50</Quantity>
                  <Price>4.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222804904205" Rank="1" Units="tab" Weight="4">
              <Name>Tab dispersible 4 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B22280490420526" PSS="true">
                <Name>Periset ODT</Name>
                <Pack ID="P2656868" Specified="true" nzmt:ctpp_id="50264581000117108">
                  <Quantity>10</Quantity>
                  <Price>0.56</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222804904206" Rank="1" Units="tab" Weight="8">
              <Name>Tab dispersible 8 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B22280490420626" PSS="true">
                <Name>Periset ODT</Name>
                <Pack ID="P2656876" Specified="true" nzmt:ctpp_id="50264601000117100">
                  <Quantity>10</Quantity>
                  <Price>0.90</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2228049061">
            <Name>Tropisetron</Name>
            <Formulation ID="F222804906102" Rank="4" Units="inj" Weight="2">
              <Name>Inj 1 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B22280490610200">
                <Name>Any</Name>
                <Pack ID="P90610200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222804906103" Rank="4" Units="inj" Weight="5">
              <Name>Inj 1 mg per ml, 5 ml ampoule</Name>
              <Brand ID="B22280490610300">
                <Name>Any</Name>
                <Pack ID="P90610300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2228049135">
            <Name>Betahistine dihydrochloride</Name>
            <Formulation ID="F222804913525" Rank="1" Units="tab" Weight="16">
              <Name>Tab 16 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B22280491352526" PSS="true">
                <Name>Serc</Name>
                <Pack ID="P2611376" Specified="true" nzmt:ctpp_id="50157851000117100">
                  <Quantity>100</Quantity>
                  <Price>3.70</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2228049272">
            <Name>Cyclizine lactate</Name>
            <Formulation ID="F222804927225" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B22280492722527" PSS="true">
                <Name>Hameln</Name>
                <Pack ID="P2595877" Specified="true" nzmt:ctpp_id="50260751000117103">
                  <Quantity>10</Quantity>
                  <Price>16.36</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2228049274">
            <Name>Hyoscine hydrobromide</Name>
            <Formulation ID="F222804927401" Rank="9" Units="patch">
              <Name>Patch 1 mg per 72 hours</Name>
              <Request Form="RS1155" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Hyoscine hydrobromide - Patch 1.5 mg</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical">Control of intractable nausea, vomiting, or inability to swallow saliva in the treatment of malignancy or chronic disease where the patient cannot tolerate or does not adequately respond to oral anti-nausea agents</ci>
                      <ci type="logical">Control of clozapine-induced hypersalivation where trials of at least two other alternative treatments have proven ineffective</ci>
                      <ci type="logical">For treatment of post-operative nausea and vomiting where cyclizine, droperidol and a 5HT3 antagonist have proven ineffective, are not tolerated or are contraindicated</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1155" style="display:none"/>
              <Brand ID="B22280492740125" ToBeDelisted="2025-01-01">
                <Name>Scopoderm TTS</Name>
                <Pack ID="P311472" Specified="true" nzmt:ctpp_id="50069661000117105">
                  <Quantity>2</Quantity>
                  <Price>17.70</Price>
                </Pack>
              </Brand>
              <Brand ID="B22280492740126">
                <Name>Scopolamine - Mylan</Name>
                <Pack ID="P2666391" Specified="true" nzmt:ctpp_id="50324281000117108">
                  <Quantity>10</Quantity>
                  <Price>88.50</Price>
                </Pack>
                <Pack ID="P2674181" nzmt:ctpp_id="50329881000117108">
                  <Quantity>10</Quantity>
                  <Price>88.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222804927425" Rank="4" Units="inj" Weight="400">
              <Name>Inj 400 mcg per ml, 1 ml ampoule</Name>
              <Brand ID="B22280492742500">
                <Name>Any</Name>
                <Pack ID="P92742500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2228049350">
            <Name>Cyclizine hydrochloride</Name>
            <Formulation ID="F222804935025" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B22280493502525" PSS="true">
                <Name>Nausicalm</Name>
                <Pack ID="P2231220" Specified="true" nzmt:ctpp_id="50036891000117103">
                  <Quantity>10</Quantity>
                  <Price>0.66</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2228049395">
            <Name>Prochlorperazine</Name>
            <Formulation ID="F222804939501" Rank="4" Units="inj" Weight="12.5">
              <Name>Inj 12.5 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B22280493950100">
                <Name>Any</Name>
                <Pack ID="P93950100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222804939502" Rank="5" Units="supp">
              <Name>Suppos 25 mg</Name>
              <Brand ID="B22280493950200">
                <Name>Any</Name>
                <Pack ID="P93950200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222804939503" Rank="1" Units="tab" Weight="3">
              <Name>Tab buccal 3 mg</Name>
              <Brand ID="B22280493950300">
                <Name>Any</Name>
                <Pack ID="P93950300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F222804939525" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B22280493952526" PSS="true">
                <Name>Nausafix</Name>
                <Pack ID="P2528886" Specified="true" nzmt:ctpp_id="50205771000117103">
                  <Quantity>250</Quantity>
                  <Price>25.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2228049500">
            <Name>Aprepitant</Name>
            <Request Form="RS1154" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Aprepitant</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient is undergoing highly emetogenic chemotherapy and/or anthracycline-based chemotherapy for the treatment of malignancy</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1154" style="display:none"/>
            <Formulation ID="F222804950025" Rank="2" Units="cap" Weight="2">
              <Name>Cap 2 x 80 mg and 1 x 125 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-25 to~2027" Value="5"/>
              <Brand ID="B22280495002525" PSS="true">
                <Name>Emend Tri-Pack</Name>
                <Pack ID="P2244098" Specified="true" nzmt:ctpp_id="50038731000117107">
                  <Quantity>3</Quantity>
                  <Price>21.90</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2228049673">
            <Name>Domperidone</Name>
            <Formulation ID="F222804967325" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-23 to~2025" Value="5"/>
              <Brand ID="B22280496732527" PSS="true">
                <Name>Domperidone Viatris</Name>
                <Pack ID="P2631903" Specified="true" nzmt:ctpp_id="50301571000117103">
                  <Quantity>100</Quantity>
                  <Price>4.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2232">
        <Name>Antipsychotic Agents</Name>
        <ATC3 ID="A223208">
          <Name>General</Name>
          <Chemical ID="C2232088093">
            <Name>Chlorpromazine hydrochloride</Name>
            <Formulation ID="F223208809301" Rank="4" Units="inj" Weight="25">
              <Name>Inj 25 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B22320880930125">
                <Name>Largactil</Name>
                <Pack ID="P202525" Specified="true" nzmt:ctpp_id="50004951000117100">
                  <Quantity>10</Quantity>
                  <Price>30.79</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208809302" Rank="3" Units="ml">
              <Name>Oral liq 10 mg per ml</Name>
              <Brand ID="B22320880930200">
                <Name>Any</Name>
                <Pack ID="P80930200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208809304" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B22320880930425">
                <Name>Largactil</Name>
                <Pack ID="P202592" Specified="true" nzmt:ctpp_id="50005121000117108">
                  <Quantity>100</Quantity>
                  <Price>36.73</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208809305" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Brand ID="B22320880930525">
                <Name>Largactil</Name>
                <Pack ID="P202576" Specified="true" nzmt:ctpp_id="50005051000117100">
                  <Quantity>100</Quantity>
                  <Price>15.62</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208809325" Rank="3" Units="ml" Weight="20">
              <Name>Oral liq 20 mg per ml</Name>
              <Brand ID="B22320880932500">
                <Name>Any</Name>
                <Pack ID="P80932500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232088256">
            <Name>Levomepromazine</Name>
            <Formulation ID="F223208825602" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B22320882560225">
                <Name>Nozinan</Name>
                <Pack ID="P258032" Specified="true" nzmt:ctpp_id="50056091000117106">
                  <Quantity>100</Quantity>
                  <Price>41.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208825603" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Brand ID="B22320882560325">
                <Name>Nozinan</Name>
                <Pack ID="P258024" Specified="true" nzmt:ctpp_id="50056081000117108">
                  <Quantity>100</Quantity>
                  <Price>16.10</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232088353">
            <Name>Pericyazine</Name>
            <Formulation ID="F223208835301" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B22320883530100">
                <Name>Any</Name>
                <Pack ID="P83530100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208835302" Rank="1" Units="tab" Weight="2.5">
              <Name>Tab 2.5 mg</Name>
              <Brand ID="B22320883530200">
                <Name>Any</Name>
                <Pack ID="P83530200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232088505">
            <Name>Zuclopenthixol acetate</Name>
            <Formulation ID="F223208850501" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B22320885050100">
                <Name>Any</Name>
                <Pack ID="P85050100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208850502" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B22320885050200">
                <Name>Any</Name>
                <Pack ID="P85050200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232088593">
            <Name>Levomepromazine hydrochloride</Name>
            <Formulation ID="F223208859325" Rank="4" Units="inj" Weight="25">
              <Name>Inj 25 mg per ml, 1 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B22320885932525" PSS="true">
                <Name>Wockhardt</Name>
                <Pack ID="P2501902" Specified="true" nzmt:ctpp_id="50213121000117104">
                  <Quantity>10</Quantity>
                  <Price>24.48</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232089015">
            <Name>Clozapine</Name>
            <Formulation ID="F223208901501" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B22320890150101">
                <Name>Clozaril</Name>
                <Pack ID="P2534878" nzmt:ctpp_id="50086781000117104">
                  <Quantity>50</Quantity>
                  <Price>17.33</Price>
                </Pack>
                <Pack ID="P2534886" Specified="true" nzmt:ctpp_id="50048281000117100">
                  <Quantity>100</Quantity>
                  <Price>34.65</Price>
                </Pack>
                <Pack ID="P2633361" Specified="true">
                  <Quantity>50</Quantity>
                  <Price>17.33</Price>
                </Pack>
              </Brand>
              <Brand ID="B22320890150125">
                <Name>Clopine</Name>
                <Pack ID="P2229161" Specified="true" nzmt:ctpp_id="50036721000117105">
                  <Quantity>100</Quantity>
                  <Price>34.65</Price>
                </Pack>
                <Pack ID="P2229811" Specified="true" nzmt:ctpp_id="50036781000117109">
                  <Quantity>50</Quantity>
                  <Price>17.33</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208901502" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Brand ID="B22320890150201">
                <Name>Clozaril</Name>
                <Pack ID="P2534843" nzmt:ctpp_id="50086771000117102">
                  <Quantity>50</Quantity>
                  <Price>6.69</Price>
                </Pack>
                <Pack ID="P2534851" Specified="true" nzmt:ctpp_id="50048291000117102">
                  <Quantity>100</Quantity>
                  <Price>13.37</Price>
                </Pack>
                <Pack ID="P2633353" Specified="true">
                  <Quantity>50</Quantity>
                  <Price>6.69</Price>
                </Pack>
              </Brand>
              <Brand ID="B22320890150225">
                <Name>Clopine</Name>
                <Pack ID="P2229153" Specified="true" nzmt:ctpp_id="50036711000117104">
                  <Quantity>100</Quantity>
                  <Price>13.37</Price>
                </Pack>
                <Pack ID="P2229773" Specified="true" nzmt:ctpp_id="50036761000117101">
                  <Quantity>50</Quantity>
                  <Price>6.69</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208901525" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B22320890152525">
                <Name>Clopine</Name>
                <Pack ID="P2229137" Specified="true" nzmt:ctpp_id="50036691000117102">
                  <Quantity>100</Quantity>
                  <Price>17.33</Price>
                </Pack>
                <Pack ID="P2229781" Specified="true" nzmt:ctpp_id="50036771000117106">
                  <Quantity>50</Quantity>
                  <Price>8.67</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208901526" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B22320890152625">
                <Name>Clopine</Name>
                <Pack ID="P2229110" Specified="true" nzmt:ctpp_id="50036671000117103">
                  <Quantity>100</Quantity>
                  <Price>69.30</Price>
                </Pack>
                <Pack ID="P2229854" Specified="true" nzmt:ctpp_id="50036791000117107">
                  <Quantity>50</Quantity>
                  <Price>34.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208901527" Rank="3" Units="ml" Weight="50">
              <Name>Oral liq 50 mg per ml</Name>
              <Brand ID="B22320890152726">
                <Name>Versacloz</Name>
                <Pack ID="P2604965" Specified="true" nzmt:ctpp_id="50269121000117102">
                  <Quantity>100</Quantity>
                  <Price>67.62</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232089050">
            <Name>Quetiapine</Name>
            <Formulation ID="F223208905001" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22320890500125" PSS="true">
                <Name>Quetapel</Name>
                <Pack ID="P2252880" Specified="true" nzmt:ctpp_id="50040151000117103">
                  <Quantity>90</Quantity>
                  <Price>6.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208905003" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22320890500325" PSS="true">
                <Name>Quetapel</Name>
                <Pack ID="P2252902" Specified="true" nzmt:ctpp_id="50040171000117106">
                  <Quantity>90</Quantity>
                  <Price>10.97</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208905004" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22320890500425" PSS="true">
                <Name>Quetapel</Name>
                <Pack ID="P2476266" Specified="true" nzmt:ctpp_id="50040161000117101">
                  <Quantity>90</Quantity>
                  <Price>2.36</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208905025" Rank="1" Units="tab" Weight="300">
              <Name>Tab 300 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22320890502526" PSS="true">
                <Name>Quetapel</Name>
                <Pack ID="P2476274" Specified="true" nzmt:ctpp_id="50040181000117109">
                  <Quantity>90</Quantity>
                  <Price>15.83</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232089196">
            <Name>Haloperidol</Name>
            <Formulation ID="F223208919625" Rank="1" Units="tab" Weight="0.5">
              <Name>Tab 500 mcg</Name>
              <Brand ID="B22320891962525">
                <Name>Serenace</Name>
                <Pack ID="P254320" Specified="true" nzmt:ctpp_id="50054391000117102">
                  <Quantity>100</Quantity>
                  <Price>6.23</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208919626" Rank="1" Units="tab" Weight="1.5">
              <Name>Tab 1.5 mg</Name>
              <Brand ID="B22320891962625">
                <Name>Serenace</Name>
                <Pack ID="P2143046" Specified="true" nzmt:ctpp_id="50024641000117102">
                  <Quantity>100</Quantity>
                  <Price>9.43</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208919627" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B22320891962725">
                <Name>Serenace</Name>
                <Pack ID="P254355" Specified="true" nzmt:ctpp_id="50054421000117108">
                  <Quantity>100</Quantity>
                  <Price>29.72</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208919628" Rank="3" Units="ml" Weight="2">
              <Name>Oral liq 2 mg per ml</Name>
              <Brand ID="B22320891962825">
                <Name>Serenace</Name>
                <Pack ID="P254290" Specified="true" nzmt:ctpp_id="50054381000117100">
                  <Quantity>100</Quantity>
                  <Price>23.84</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208919629" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 1ml ampoule</Name>
              <Brand ID="B22320891962925">
                <Name>Serenace</Name>
                <Pack ID="P254258" Specified="true" nzmt:ctpp_id="50054351000117106">
                  <Quantity>10</Quantity>
                  <Price>21.55</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232089228">
            <Name>Olanzapine</Name>
            <Formulation ID="F223208922801" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg vial</Name>
              <Brand ID="B22320892280100">
                <Name>Any</Name>
                <Pack ID="P92280100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208922825" Rank="1" Units="tab" Weight="2.5">
              <Name>Tab 2.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~2026" Value="5"/>
              <Brand ID="B22320892282527" PSS="true">
                <Name>Zypine</Name>
                <Pack ID="P2439859" nzmt:ctpp_id="50183661000117101">
                  <Quantity>28</Quantity>
                  <Price>1.35</Price>
                </Pack>
                <Pack ID="P2651076" Specified="true" nzmt:ctpp_id="50312961000117106">
                  <Quantity>30</Quantity>
                  <Price>1.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208922826" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~2026" Value="5"/>
              <Brand ID="B22320892282627" PSS="true">
                <Name>Zypine</Name>
                <Pack ID="P2439867" nzmt:ctpp_id="50183651000117103">
                  <Quantity>28</Quantity>
                  <Price>1.58</Price>
                </Pack>
                <Pack ID="P2651084" Specified="true" nzmt:ctpp_id="50312971000117101">
                  <Quantity>30</Quantity>
                  <Price>1.93</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208922827" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~2026" Value="5"/>
              <Brand ID="B22320892282727" PSS="true">
                <Name>Zypine</Name>
                <Pack ID="P2439875" nzmt:ctpp_id="50183671000117106">
                  <Quantity>28</Quantity>
                  <Price>2.01</Price>
                </Pack>
                <Pack ID="P2651092" Specified="true" nzmt:ctpp_id="50312981000117103">
                  <Quantity>30</Quantity>
                  <Price>1.93</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208922830" Rank="1" Units="tab" Weight="10">
              <Name>Tab orodispersible 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22320892283026" PSS="true">
                <Name>Zypine ODT</Name>
                <Pack ID="P2439840" Specified="true" nzmt:ctpp_id="50183621000117105">
                  <Quantity>28</Quantity>
                  <Price>2.89</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208922831" Rank="1" Units="tab" Weight="5">
              <Name>Tab orodispersible 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22320892283126" PSS="true">
                <Name>Zypine ODT</Name>
                <Pack ID="P2439832" Specified="true" nzmt:ctpp_id="50183641000117100">
                  <Quantity>28</Quantity>
                  <Price>2.42</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232089279">
            <Name>Risperidone</Name>
            <Formulation ID="F223208927931" Rank="3" Units="ml" Weight="1">
              <Name>Oral liq 1 mg per ml</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B22320892793126" PSS="true">
                <Name>Risperon</Name>
                <Pack ID="P2325640" Specified="true" nzmt:ctpp_id="50049071000117103">
                  <Quantity>30</Quantity>
                  <Price>10.29</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208927932" Rank="1" Units="tab" Weight="0.5">
              <Name>Tab 0.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B22320892793225">
                <Name>Risperdal</Name>
                <Pack ID="P2015765" Specified="true" nzmt:ctpp_id="50002851000117101">
                  <Quantity>20</Quantity>
                  <Price>0.72</Price>
                </Pack>
              </Brand>
              <Brand ID="B22320892793229" PSS="true">
                <Name>Risperidone (Teva)</Name>
                <Pack ID="P2466899" Specified="true" nzmt:ctpp_id="50280921000117109">
                  <Quantity>60</Quantity>
                  <Price>2.17</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208927933" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B22320892793325">
                <Name>Risperdal</Name>
                <Pack ID="P245364" Specified="true" nzmt:ctpp_id="50051851000117101">
                  <Quantity>60</Quantity>
                  <Price>2.44</Price>
                </Pack>
              </Brand>
              <Brand ID="B22320892793329" PSS="true">
                <Name>Risperidone (Teva)</Name>
                <Pack ID="P2466902" Specified="true" nzmt:ctpp_id="50280931000117107">
                  <Quantity>60</Quantity>
                  <Price>2.44</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208927934" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B22320892793425">
                <Name>Risperdal</Name>
                <Pack ID="P245372" Specified="true" nzmt:ctpp_id="50051861000117104">
                  <Quantity>60</Quantity>
                  <Price>2.72</Price>
                </Pack>
              </Brand>
              <Brand ID="B22320892793429" PSS="true">
                <Name>Risperidone (Teva)</Name>
                <Pack ID="P2466910" Specified="true" nzmt:ctpp_id="50280941000117104">
                  <Quantity>60</Quantity>
                  <Price>2.72</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208927935" Rank="1" Units="tab" Weight="3">
              <Name>Tab 3 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B22320892793525">
                <Name>Risperdal</Name>
                <Pack ID="P245380" Specified="true" nzmt:ctpp_id="50051871000117109">
                  <Quantity>60</Quantity>
                  <Price>4.50</Price>
                </Pack>
              </Brand>
              <Brand ID="B22320892793529" PSS="true">
                <Name>Risperidone (Teva)</Name>
                <Pack ID="P2466929" Specified="true" nzmt:ctpp_id="50280951000117102">
                  <Quantity>60</Quantity>
                  <Price>4.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208927936" Rank="1" Units="tab" Weight="4">
              <Name>Tab 4 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B22320892793629" PSS="true">
                <Name>Risperidone (Teva)</Name>
                <Pack ID="P2466937" Specified="true" nzmt:ctpp_id="50280961000117100">
                  <Quantity>60</Quantity>
                  <Price>6.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232089403">
            <Name>Ziprasidone</Name>
            <Formulation ID="F223208940325" Rank="2" Units="cap" Weight="20">
              <Name>Cap 20 mg</Name>
              <Brand ID="B22320894032526">
                <Name>Zusdone</Name>
                <Pack ID="P2479575" Specified="true" nzmt:ctpp_id="50224261000117107">
                  <Quantity>60</Quantity>
                  <Price>17.90</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208940326" Rank="2" Units="cap" Weight="40">
              <Name>Cap 40 mg</Name>
              <Brand ID="B22320894032626">
                <Name>Zusdone</Name>
                <Pack ID="P2479583" Specified="true" nzmt:ctpp_id="50224271000117102">
                  <Quantity>60</Quantity>
                  <Price>27.41</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208940327" Rank="2" Units="cap" Weight="60">
              <Name>Cap 60 mg</Name>
              <Brand ID="B22320894032726">
                <Name>Zusdone</Name>
                <Pack ID="P2479591" Specified="true" nzmt:ctpp_id="50224281000117104">
                  <Quantity>60</Quantity>
                  <Price>38.39</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208940328" Rank="2" Units="cap" Weight="80">
              <Name>Cap 80 mg</Name>
              <Brand ID="B22320894032826">
                <Name>Zusdone</Name>
                <Pack ID="P2479605" Specified="true" nzmt:ctpp_id="50224291000117101">
                  <Quantity>60</Quantity>
                  <Price>46.55</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232089460">
            <Name>Aripiprazole</Name>
            <Formulation ID="F223208946025" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Oct-22 to~2025" Value="5"/>
              <Brand ID="B22320894602526" PSS="true">
                <Name>Aripiprazole Sandoz</Name>
                <Pack ID="P2544539" Specified="true" nzmt:ctpp_id="50242531000117108">
                  <Quantity>30</Quantity>
                  <Price>10.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208946026" Rank="1" Units="tab" Weight="30">
              <Name>Tab 30 mg</Name>
              <Rule Type="DVLimit" Attribute="Oct-22 to~2025" Value="5"/>
              <Brand ID="B22320894602626" PSS="true">
                <Name>Aripiprazole Sandoz</Name>
                <Pack ID="P2544563" Specified="true" nzmt:ctpp_id="50242561000117101">
                  <Quantity>30</Quantity>
                  <Price>10.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208946027" Rank="1" Units="tab" Weight="15">
              <Name>Tab 15 mg</Name>
              <Rule Type="DVLimit" Attribute="Oct-22 to~2025" Value="5"/>
              <Brand ID="B22320894602726" PSS="true">
                <Name>Aripiprazole Sandoz</Name>
                <Pack ID="P2544547" Specified="true" nzmt:ctpp_id="50242541000117100">
                  <Quantity>30</Quantity>
                  <Price>10.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208946028" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Oct-22 to~2025" Value="5"/>
              <Brand ID="B22320894602826" PSS="true">
                <Name>Aripiprazole Sandoz</Name>
                <Pack ID="P2544555" Specified="true" nzmt:ctpp_id="50242551000117103">
                  <Quantity>30</Quantity>
                  <Price>10.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208946029" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Oct-22 to~2025" Value="5"/>
              <Brand ID="B22320894602926" PSS="true">
                <Name>Aripiprazole Sandoz</Name>
                <Pack ID="P2544520" Specified="true" nzmt:ctpp_id="50242521000117105">
                  <Quantity>30</Quantity>
                  <Price>10.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232089468">
            <Name>Amisulpride</Name>
            <Formulation ID="F223208946825" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22320894682526" PSS="true">
                <Name>Sulprix</Name>
                <Pack ID="P2609401" Specified="true" nzmt:ctpp_id="50176361000117106">
                  <Quantity>30</Quantity>
                  <Price>5.84</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208946826" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22320894682626" PSS="true">
                <Name>Sulprix</Name>
                <Pack ID="P2609398" Specified="true" nzmt:ctpp_id="50176481000117105">
                  <Quantity>60</Quantity>
                  <Price>14.47</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208946827" Rank="3" Units="ml" Weight="100">
              <Name>Oral liq 100 mg per ml</Name>
              <Brand ID="B22320894682700">
                <Name>Any</Name>
                <Pack ID="P94682700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208946828" Rank="1" Units="tab" Weight="400">
              <Name>Tab 400 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22320894682826" PSS="true">
                <Name>Sulprix</Name>
                <Pack ID="P2609428" Specified="true" nzmt:ctpp_id="50176551000117103">
                  <Quantity>60</Quantity>
                  <Price>35.06</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232089498">
            <Name>Zuclopenthixol hydrochloride</Name>
            <Formulation ID="F223208949825" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B22320894982525">
                <Name>Clopixol</Name>
                <Pack ID="P390372" Specified="true" nzmt:ctpp_id="50080941000117109">
                  <Quantity>100</Quantity>
                  <Price>31.45</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232089623">
            <Name>Lithium carbonate</Name>
            <Formulation ID="F223208962301" Rank="1" Units="tab">
              <Name>Tab long-acting 400 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B22320896230125" PSS="true">
                <Name>Priadel</Name>
                <Pack ID="P260851" Specified="true" nzmt:ctpp_id="50057341000117100">
                  <Quantity>100</Quantity>
                  <Price>82.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223208962325" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Brand ID="B22320896232525">
                <Name>Douglas</Name>
                <Pack ID="P733393" Specified="true" nzmt:ctpp_id="50107021000117108">
                  <Quantity>100</Quantity>
                  <Price>22.36</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A223210">
          <Name>Depot Injections</Name>
          <Chemical ID="C2232108367">
            <Name>Pipothiazine palmitate</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F223210836701" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B22321083670100">
                <Name>Any</Name>
                <Pack ID="P83670100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210836702" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B22321083670200">
                <Name>Any</Name>
                <Pack ID="P83670200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232108544">
            <Name>Paliperidone</Name>
            <Request Form="RS1381" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Paliperidone</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">The patient has had an initial Special Authority approval for risperidone depot injection or olanzapine depot injection</ci>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has schizophrenia or other psychotic disorder</ci>
                      <ci type="logical">The patient has tried but failed to comply with treatment using oral atypical antipsychotic agents</ci>
                      <ci type="logical">The patient has been admitted to hospital or treated in respite care, or intensive outpatient or home-based treatment for 30 days or more in the last 12 months</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The initiation of paliperidone depot injection has been associated with fewer days of intensive intervention than was the case during a corresponding period of time prior to
        the initiation of an atypical antipsychotic depot injection</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1381" style="display:none"/>
            <Formulation ID="F223210854425" Rank="4" Units="inj" Weight="25">
              <Name>Inj 25 mg syringe</Name>
              <Brand ID="B22321085442525">
                <Name>Invega Sustenna</Name>
                <Pack ID="P2426919" Specified="true" nzmt:ctpp_id="50134611000117107">
                  <Quantity>1</Quantity>
                  <Price>194.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210854426" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg syringe</Name>
              <Brand ID="B22321085442625">
                <Name>Invega Sustenna</Name>
                <Pack ID="P2426927" Specified="true" nzmt:ctpp_id="50134631000117103">
                  <Quantity>1</Quantity>
                  <Price>271.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210854427" Rank="4" Units="inj" Weight="75">
              <Name>Inj 75 mg syringe</Name>
              <Brand ID="B22321085442725">
                <Name>Invega Sustenna</Name>
                <Pack ID="P2426935" Specified="true" nzmt:ctpp_id="50134671000117100">
                  <Quantity>1</Quantity>
                  <Price>357.42</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210854428" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg syringe</Name>
              <Brand ID="B22321085442825">
                <Name>Invega Sustenna</Name>
                <Pack ID="P2426943" Specified="true" nzmt:ctpp_id="50131131000117106">
                  <Quantity>1</Quantity>
                  <Price>435.12</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210854429" Rank="4" Units="inj" Weight="150">
              <Name>Inj 150 mg syringe</Name>
              <Brand ID="B22321085442925">
                <Name>Invega Sustenna</Name>
                <Pack ID="P2426951" Specified="true" nzmt:ctpp_id="50134811000117108">
                  <Quantity>1</Quantity>
                  <Price>435.12</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232108699">
            <Name>Paliperidone palmitate</Name>
            <Request Form="RS1932" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Paliperidone palmitate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has schizophrenia</ci>
                    <ci type="logical">The patient has had an initial Special Authority approval for
          paliperidone once-monthly depot injection</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The initiation of paliperidone depot injection has been associated with
        fewer days of intensive intervention than was the case during a corresponding period of time
        prior to the initiation of an atypical antipsychotic depot injection</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1932" style="display:none"/>
            <Formulation ID="F223210869925" Rank="4" Units="inj" Weight="175">
              <Name>Inj 175 mg syringe</Name>
              <Brand ID="B22321086992525">
                <Name>Invega Trinza</Name>
                <Pack ID="P2515202" Specified="true" nzmt:ctpp_id="50221911000117100">
                  <Quantity>1</Quantity>
                  <Price>815.85</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210869926" Rank="4" Units="inj" Weight="263">
              <Name>Inj 263 mg syringe</Name>
              <Brand ID="B22321086992625">
                <Name>Invega Trinza</Name>
                <Pack ID="P2515210" Specified="true" nzmt:ctpp_id="50221921000117106">
                  <Quantity>1</Quantity>
                  <Price>1072.26</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210869927" Rank="4" Units="inj" Weight="350">
              <Name>Inj 350 mg syringe</Name>
              <Brand ID="B22321086992725">
                <Name>Invega Trinza</Name>
                <Pack ID="P2515229" Specified="true" nzmt:ctpp_id="50221931000117109">
                  <Quantity>1</Quantity>
                  <Price>1305.36</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210869928" Rank="4" Units="inj" Weight="525">
              <Name>Inj 525 mg syringe</Name>
              <Brand ID="B22321086992825">
                <Name>Invega Trinza</Name>
                <Pack ID="P2515237" Specified="true" nzmt:ctpp_id="50221941000117101">
                  <Quantity>1</Quantity>
                  <Price>1305.36</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232109125">
            <Name>Zuclopenthixol decanoate</Name>
            <Formulation ID="F223210912525" Rank="4" Units="inj" Weight="200">
              <Name>Inj 200 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B22321091252525">
                <Name>Clopixol</Name>
                <Pack ID="P496189" Specified="true" nzmt:ctpp_id="50092801000117103">
                  <Quantity>5</Quantity>
                  <Price>19.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210912526" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B22321091252600">
                <Name>e.g. Clopixol Conc</Name>
                <Pack ID="P91252600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232109193">
            <Name>Flupenthixol decanoate</Name>
            <Formulation ID="F223210919301" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B22321091930125">
                <Name>Fluanxol</Name>
                <Pack ID="P437301" Specified="true" nzmt:ctpp_id="50085781000117107">
                  <Quantity>5</Quantity>
                  <Price>20.90</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210919325" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B22321091932525">
                <Name>Fluanxol</Name>
                <Pack ID="P437298" Specified="true" nzmt:ctpp_id="50085771000117109">
                  <Quantity>5</Quantity>
                  <Price>13.14</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210919327" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B22321091932725">
                <Name>Fluanxol</Name>
                <Pack ID="P437271" Specified="true" nzmt:ctpp_id="50085761000117104">
                  <Quantity>5</Quantity>
                  <Price>40.87</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232109228">
            <Name>Olanzapine</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Request Form="RS2018" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Olanzapine</range>
              </Title>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The initiation of olanzapine depot injection has been associated with fewer days of intensive intervention than was the case during a corresponding period of time prior to the
        initiation of an atypical antipsychotic depot injection</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2018" style="display:none"/>
            <Formulation ID="F223210922802" Rank="4" Units="inj" Weight="210">
              <Name>Inj 210 mg vial</Name>
              <Brand ID="B22321092280225">
                <Name>Zyprexa Relprevv</Name>
                <Pack ID="P2337339" Specified="true" nzmt:ctpp_id="50122191000117102">
                  <Quantity>1</Quantity>
                  <Price>252.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210922803" Rank="4" Units="inj" Weight="300">
              <Name>Inj 300 mg vial</Name>
              <Brand ID="B22321092280325">
                <Name>Zyprexa Relprevv</Name>
                <Pack ID="P2337347" Specified="true" nzmt:ctpp_id="50122181000117100">
                  <Quantity>1</Quantity>
                  <Price>414.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210922804" Rank="4" Units="inj" Weight="405">
              <Name>Inj 405 mg vial</Name>
              <Brand ID="B22321092280425">
                <Name>Zyprexa Relprevv</Name>
                <Pack ID="P2337355" Specified="true" nzmt:ctpp_id="50122171000117103">
                  <Quantity>1</Quantity>
                  <Price>504.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232109262">
            <Name>Haloperidol decanoate</Name>
            <Formulation ID="F223210926225" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B22321092622525">
                <Name>Haldol Concentrate</Name>
                <Pack ID="P768596" Specified="true" nzmt:ctpp_id="50111311000117107">
                  <Quantity>5</Quantity>
                  <Price>55.90</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210926226" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B22321092622625">
                <Name>Haldol</Name>
                <Pack ID="P714615" Specified="true" nzmt:ctpp_id="50104811000117100">
                  <Quantity>5</Quantity>
                  <Price>28.39</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232109279">
            <Name>Risperidone</Name>
            <Request Form="RS1380" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Risperidone</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">The patient has had an initial Special Authority approval for paliperidone depot injection or olanzapine depot injection</ci>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has schizophrenia or other psychotic disorder</ci>
                      <ci type="logical">The patient has tried but failed to comply with treatment using oral atypical antipsychotic agents</ci>
                      <ci type="logical">The patient has been admitted to hospital or treated in respite care, or intensive outpatient or home-based treatment for 30 days or more in the last 12 months</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The initiation of risperidone depot injection has been associated with fewer days of intensive intervention than was the case during a corresponding period of time prior to
        the initiation of an atypical antipsychotic depot injection</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1380" style="display:none"/>
            <Formulation ID="F223210927925" Rank="4" Units="inj" Weight="25">
              <Name>Inj 25 mg vial</Name>
              <Brand ID="B22321092792525">
                <Name>Risperdal Consta</Name>
                <Pack ID="P2347652" Specified="true" nzmt:ctpp_id="50050331000117107">
                  <Quantity>1</Quantity>
                  <Price>135.98</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210927926" Rank="4" Units="inj" Weight="37.5">
              <Name>Inj 37.5 mg vial</Name>
              <Brand ID="B22321092792625">
                <Name>Risperdal Consta</Name>
                <Pack ID="P2347644" Specified="true" nzmt:ctpp_id="50050321000117109">
                  <Quantity>1</Quantity>
                  <Price>178.71</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210927927" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg vial</Name>
              <Brand ID="B22321092792725">
                <Name>Risperdal Consta</Name>
                <Pack ID="P2347660" Specified="true" nzmt:ctpp_id="50050341000117104">
                  <Quantity>1</Quantity>
                  <Price>217.56</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2232109460">
            <Name>Aripiprazole</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS2017">
              <Title>
                <range>Aripiprazole</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">Patient has a current Special Authority approval for olanzapine depot injection, risperidone depot injection or paliperidone depot injection</ci>
                      <ci type="logical" class="Indication">Patient has tried but has experienced an inadequate response to, or intolerable side effects from, prior therapy with olanzapine depot injection,
            risperidone depot injection or paliperidone depot injection</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has been unable to access olanzapine depot injection due to supply issues with olanzapine depot injection, or otherwise would have been initiated on olanzapine depot injection but has been unable to due to supply issues with olanzapine depot injection.  (see Note below for the olanzapine Special Authority criteria for new olanzapine depot injection patients prior to 1 April 2024)</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>The Olanzapine depot injection Special Authority criteria that apply to criterion 2 in this Aripiprazole Special Authority application are as follows:</p>
                  <ul>
                    <li>
                      <p>The patient has had an initial Special Authority approval for paliperidone depot injection or risperidone depot injection; or</p>
                    </li>
                    <li>
                      <p>All of the following:</p>
                      <ul>
                        <li>
                          <p>The patient has schizophrenia; and</p>
                        </li>
                        <li>
                          <p>The patient has tried but failed to comply with treatment using oral atypical antipsychotic agents; and</p>
                        </li>
                        <li>
                          <p>The patient has been admitted to hospital or treated in respite care, or intensive outpatient or home-based treatment for 30 days or more in the last 12 months.</p>
                        </li>
                      </ul>
                    </li>
                  </ul>
                </div>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">The initiation of aripiprazole depot injection has been associated with fewer days of intensive intervention than prior to the initiation of an atypical
        antipsychotic depot injection</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2017" style="display:none"/>
            <Formulation ID="F223210946040" Rank="4" Units="inj" Weight="300">
              <Name>Inj 300 mg vial</Name>
              <Brand ID="B22321094604025">
                <Name>Abilify Maintena</Name>
                <Pack ID="P2670976" nzmt:ctpp_id="50212371000117105">
                  <Quantity>1</Quantity>
                  <Price>273.56</Price>
                </Pack>
                <Pack ID="P2680394" Specified="true" nzmt:ctpp_id="50334091000117103">
                  <Quantity>1</Quantity>
                  <Price>273.56</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223210946041" Rank="4" Units="inj" Weight="400">
              <Name>Inj 400 mg vial</Name>
              <Brand ID="B22321094604125">
                <Name>Abilify Maintena</Name>
                <Pack ID="P2670984" nzmt:ctpp_id="50212381000117108">
                  <Quantity>1</Quantity>
                  <Price>341.96</Price>
                </Pack>
                <Pack ID="P2680408" Specified="true" nzmt:ctpp_id="50334101000117107">
                  <Quantity>1</Quantity>
                  <Price>341.96</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2236">
        <Name>Anxiolytics</Name>
        <ATC3 ID="A223604">
          <Name>Anxiolytics</Name>
          <Chemical ID="C2236048335">
            <Name>Oxazepam</Name>
            <Formulation ID="F223604833501" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B22360483350100">
                <Name>Any</Name>
                <Pack ID="P83350100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223604833502" Rank="1" Units="tab" Weight="15">
              <Name>Tab 15 mg</Name>
              <Brand ID="B22360483350200">
                <Name>Any</Name>
                <Pack ID="P83350200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2236049156">
            <Name>Clonazepam</Name>
            <Formulation ID="F223604915626" Rank="1" Units="tab" Weight="0.5">
              <Name>Tab 500 mcg</Name>
              <Brand ID="B22360491562625">
                <Name>Paxam</Name>
                <Pack ID="P2095483" Specified="true" nzmt:ctpp_id="50017781000117104">
                  <Quantity>100</Quantity>
                  <Price>5.64</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223604915627" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Brand ID="B22360491562725">
                <Name>Paxam</Name>
                <Pack ID="P2095491" Specified="true" nzmt:ctpp_id="50017791000117101">
                  <Quantity>100</Quantity>
                  <Price>10.78</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2236049175">
            <Name>Diazepam</Name>
            <Formulation ID="F223604917528" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B22360491752826" PSS="true">
                <Name>Arrow-Diazepam</Name>
                <Pack ID="P2327996" Specified="true" nzmt:ctpp_id="50049241000117101">
                  <Quantity>500</Quantity>
                  <Price>95.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223604917529" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B22360491752926" PSS="true">
                <Name>Arrow-Diazepam</Name>
                <Pack ID="P2328003" Specified="true" nzmt:ctpp_id="50049251000117104">
                  <Quantity>500</Quantity>
                  <Price>115.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223604917530" Rank="3" Units="ml">
              <Name>Oral liq 10 mg per 10 ml</Name>
              <Request Form="RS2054" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Diazepam</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">Only for use in children where diazepam tablets are not appropriate</ci>
                  </math>
                  <Applicant>relevant specialist</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS2054" style="display:none"/>
              <Brand ID="B22360491753000">
                <Name>Any</Name>
                <Pack ID="P91753000" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2236049212">
            <Name>Lorazepam</Name>
            <Formulation ID="F223604921225" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B22360492122525" PSS="true">
                <Name>Ativan</Name>
                <Pack ID="P2139022" Specified="true" nzmt:ctpp_id="50023961000117105">
                  <Quantity>250</Quantity>
                  <Price>10.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223604921226" Rank="1" Units="tab" Weight="2.5">
              <Name>Tab 2.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B22360492122625" PSS="true">
                <Name>Ativan</Name>
                <Pack ID="P250120" Specified="true" nzmt:ctpp_id="50052251000117105">
                  <Quantity>100</Quantity>
                  <Price>13.13</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2236049379">
            <Name>Buspirone hydrochloride</Name>
            <Formulation ID="F223604937925" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22360493792527" PSS="true">
                <Name>Buspirone Viatris</Name>
                <Pack ID="P2615355" Specified="true" nzmt:ctpp_id="50289641000117104">
                  <Quantity>100</Quantity>
                  <Price>13.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F223604937926" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22360493792627" PSS="true">
                <Name>Buspirone Viatris</Name>
                <Pack ID="P2615363" Specified="true" nzmt:ctpp_id="50289651000117102">
                  <Quantity>100</Quantity>
                  <Price>12.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2240">
        <Name>Multiple Sclerosis Treatments</Name>
        <ATC3 ID="A224004">
          <Name>Multiple Sclerosis Treatments</Name>
          <Request To="HealthPAC" For="Subsidy" Form="RS1993">
            <Title>
              <range>Multiple Sclerosis</range>
            </Title>
            <Case When="Initial application" Category="Multiple Sclerosis - dimethyl fumarate, fingolimod, glatiramer acetate, interferon beta-1-alpha, interferon beta-1-beta, natalizumab and teriflunomide">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <or/>
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Diagnosis of multiple sclerosis (MS) meets the
                    McDonald 2017 diagnostic criteria for MS and has been confirmed by a
                    neurologist</ci>
                    <ci type="logical" class="Indication">Patient has an EDSS score between 0 –
                    6.0</ci>
                    <ci type="logical" class="Indication">Patient has had at least one significant
                    attack of MS in the previous 12 months or two significant attacks in the past 24
                    months</ci>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">Each significant attack must be confirmed
                        by the applying neurologist or general physician (the patient may not
                        necessarily have been seen by them during the attack, but the
                        neurologist/physician must be satisfied that the clinical features were
                        characteristic)</ci>
                      <ci type="logical" class="Indication">Each significant attack is associated with
                        characteristic new symptom(s)/sign(s) or substantially worsening of
                        previously experienced symptoms(s)/sign(s)</ci>
                      <ci type="logical" class="Indication">Each significant attack has lasted at
                        least one week and has started at least one month after the onset of a
                        previous attack (where relevant)</ci>
                      <ci type="logical" class="Indication">Each significant attack can be
                        distinguished from the effects of general fatigue; and is not associated
                        with a fever (T&gt; 37.5°C)</ci>
                      <apply>
                        <or/>
                        <ci type="logical" class="Indication">Each significant attack is severe
                            enough to change either the EDSS or at least one of the Kurtze
                            Functional System scores by at least 1 point</ci>
                        <ci type="logical" class="Indication">Each significant attack is a recurrent
                            paroxysmal symptom of multiple sclerosis (tonic seizures/spasms,
                            trigeminal neuralgia, Lhermitte’s symptom)</ci>
                      </apply>
                    </apply>
                    <ci type="logical" class="Indication">Evidence of new inflammatory activity on an
                    MRI scan within the past 24 months</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">A sign of that new inflammatory activity
                        on MRI scanning (in criterion 5 immediately above) is a gadolinium enhancing
                        lesion</ci>
                      <ci type="logical" class="Indication">A sign of that new inflammatory activity
                        is a lesion showing diffusion restriction</ci>
                      <ci type="logical" class="Indication">A sign of that new inflammatory is a T2
                        lesion with associated local swelling</ci>
                      <ci type="logical" class="Indication">A sign of that new inflammatory activity
                        is a prominent T2 lesion that clearly is responsible for the clinical
                        features of a recent attack that occurred within the last 2 years</ci>
                      <ci type="logical" class="Indication">A sign of that new inflammatory activity
                        is new T2 lesions compared with a previous MRI scan</ci>
                    </apply>
                  </apply>
                  <ci type="logical" class="Indication">Patient has an active approval for ocrelizumab and does not have primary progressive MS</ci>
                </apply>
              </math>
              <Applicant>any relevant practitioner</Applicant>
              <Term Measure="month">12</Term>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Treatment on two or more funded multiple sclerosis treatments simultaneously is not permitted.</p>
              </div>
            </Case>
            <Case When="Renewal" Category="Multiple Sclerosis - dimethyl fumarate, fingolimod, glatiramer acetate, interferon beta-1-alpha, interferon beta-1-beta, natalizumab and teriflunomide">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <ci type="logical">Patient has had an EDSS score of 0 to 6.0 (inclusive) with or without
                the use unilateral or bilateral aids at any time in the last six months (ie the
                patient has walked 100 metres or more with or without aids in the last six
                months)</ci>
              </math>
              <Applicant>any relevant practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Treatment on two or more funded multiple sclerosis treatments simultaneously is not permitted.</p>
              </div>
            </Case>
          </Request>
          <html:div class="Restricted" xlink:href="RS1993" style="display:none"/>
          <Chemical ID="C2240048201">
            <Name>Glatiramer acetate</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: Treatment on two or more funded multiple sclerosis treatments simultaneously is not permitted.</p>
            </div>
            <Formulation ID="F224004820125" Rank="4" Units="inj" Weight="40">
              <Name>Inj 40 mg prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Oct-22 to~2025" Value="5"/>
              <Brand ID="B22400482012525" PSS="true">
                <Name>Copaxone</Name>
                <Pack ID="P2545349" Specified="true" nzmt:ctpp_id="50226651000117100">
                  <Quantity>12</Quantity>
                  <Price>1137.48</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2240048237">
            <Name>Interferon beta-1-alpha</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: Treatment on two or more funded multiple sclerosis treatments simultaneously is not permitted.</p>
            </div>
            <Formulation ID="F224004823701" Rank="4" Units="inj" Weight="6">
              <Name>Inj 6 million iu in 0.5 ml pen injector</Name>
              <Brand ID="B22400482370125">
                <Name>Avonex Pen</Name>
                <Pack ID="P2431440" Specified="true" nzmt:ctpp_id="50155651000117106">
                  <Quantity>4</Quantity>
                  <Price>1170.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224004823702" Rank="4" Units="inj" Weight="6">
              <Name>Inj 6 million iu in 0.5 ml syringe</Name>
              <Brand ID="B22400482370225">
                <Name>Avonex</Name>
                <Pack ID="P2261421" Specified="true" nzmt:ctpp_id="50041341000117105">
                  <Quantity>4</Quantity>
                  <Price>1170.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2240048238">
            <Name>Interferon beta-1-beta</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: Treatment on two or more funded multiple sclerosis treatments simultaneously is not permitted.</p>
            </div>
            <Formulation ID="F224004823801" Rank="4" Units="inj" Weight="8">
              <Name>Inj 8 million iu per ml, 1 ml vial</Name>
              <Brand ID="B22400482380100">
                <Name>Any</Name>
                <Pack ID="P82380100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2240048556">
            <Name>Fingolimod</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: Treatment on two or more funded multiple sclerosis treatments simultaneously is not permitted.</p>
            </div>
            <Formulation ID="F224004855625" Rank="2" Units="cap">
              <Name>Cap 0.5 mg</Name>
              <Brand ID="B22400485562525">
                <Name>Gilenya</Name>
                <Pack ID="P2455153" Specified="true" nzmt:ctpp_id="50141011000117102">
                  <Quantity>28</Quantity>
                  <Price>2200.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2240048569">
            <Name>Natalizumab</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: Treatment on two or more funded multiple sclerosis treatments simultaneously is not permitted.</p>
            </div>
            <Formulation ID="F224004856925" Rank="4" Units="inj">
              <Name>Inj 20 mg per ml, 15 ml vial</Name>
              <Brand ID="B22400485692525">
                <Name>Tysabri</Name>
                <Pack ID="P2467062" Specified="true" nzmt:ctpp_id="50130411000117101">
                  <Quantity>1</Quantity>
                  <Price>1750.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2240048578">
            <Name>Dimethyl fumarate</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: Treatment on two or more funded multiple sclerosis treatments simultaneously is not permitted.</p>
            </div>
            <Formulation ID="F224004857825" Rank="2" Units="cap" Weight="120">
              <Name>Cap 120 mg</Name>
              <Brand ID="B22400485782525">
                <Name>Tecfidera</Name>
                <Pack ID="P2493004" Specified="true" nzmt:ctpp_id="50181461000117104">
                  <Quantity>14</Quantity>
                  <Price>520.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224004857826" Rank="2" Units="cap" Weight="240">
              <Name>Cap 240 mg</Name>
              <Brand ID="B22400485782625">
                <Name>Tecfidera</Name>
                <Pack ID="P2493012" Specified="true" nzmt:ctpp_id="50181491000117105">
                  <Quantity>56</Quantity>
                  <Price>2000.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2240048579">
            <Name>Teriflunomide</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: Treatment on two or more funded multiple sclerosis treatments simultaneously is not permitted.</p>
            </div>
            <Formulation ID="F224004857925" Rank="1" Units="tab" Weight="14">
              <Name>Tab 14 mg</Name>
              <Brand ID="B22400485792525">
                <Name>Aubagio</Name>
                <Pack ID="P2494418" Specified="true" nzmt:ctpp_id="50154071000117105">
                  <Quantity>28</Quantity>
                  <Price>659.90</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A224008">
          <Name>Multiple Sclerosis Treatments - Other</Name>
          <Chemical ID="C2240088648">
            <Name>Ocrelizumab</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: Treatment on two or more funded multiple sclerosis treatments simultaneously is not permitted.</p>
            </div>
            <Request To="HealthPAC" For="Subsidy" Form="RS1997">
              <Title>
                <range>Multiple Sclerosis</range>
              </Title>
              <Case When="Initial application" Category="Multiple Sclerosis - ocrelizumab">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">Diagnosis of multiple sclerosis (MS) meets the
                    McDonald 2017 diagnostic criteria for MS and has been confirmed by a
                    neurologist</ci>
                      <ci type="logical" class="Indication">Patient has an EDSS score between 0 –
                    6.0</ci>
                      <ci type="logical" class="Indication">Patient has had at least one significant
                    attack of MS in the previous 12 months or two significant attacks in the past 24
                    months</ci>
                      <apply>
                        <and/>
                        <ci type="logical" class="Indication">Each significant attack must be confirmed
                        by the applying neurologist or general physician (the patient may not
                        necessarily have been seen by them during the attack, but the
                        neurologist/physician must be satisfied that the clinical features were
                        characteristic)</ci>
                        <ci type="logical" class="Indication">Each significant attack is associated with
                        characteristic new symptom(s)/sign(s) or substantially worsening of
                        previously experienced symptoms(s)/sign(s)</ci>
                        <ci type="logical" class="Indication">Each significant attack has lasted at
                        least one week and has started at least one month after the onset of a
                        previous attack (where relevant)</ci>
                        <ci type="logical" class="Indication">Each significant attack can be
                        distinguished from the effects of general fatigue; and is not associated
                        with a fever (T&gt; 37.5°C)</ci>
                        <apply>
                          <or/>
                          <ci type="logical" class="Indication">Each significant attack is severe
                            enough to change either the EDSS or at least one of the Kurtze
                            Functional System scores by at least 1 point</ci>
                          <ci type="logical" class="Indication">Each significant attack is a recurrent
                            paroxysmal symptom of multiple sclerosis (tonic seizures/spasms,
                            trigeminal neuralgia, Lhermitte’s symptom)</ci>
                        </apply>
                      </apply>
                      <ci type="logical" class="Indication">Evidence of new inflammatory activity on an
                    MRI scan within the past 24 months</ci>
                      <apply>
                        <or/>
                        <ci type="logical" class="Indication">A sign of that new inflammatory activity
                        on MRI scanning (in criterion 5 immediately above) is a gadolinium enhancing
                        lesion</ci>
                        <ci type="logical" class="Indication">A sign of that new inflammatory activity
                        is a lesion showing diffusion restriction</ci>
                        <ci type="logical" class="Indication">A sign of that new inflammatory is a T2
                        lesion with associated local swelling</ci>
                        <ci type="logical" class="Indication">A sign of that new inflammatory activity
                        is a prominent T2 lesion that clearly is responsible for the clinical
                        features of a recent attack that occurred within the last 2 years</ci>
                        <ci type="logical" class="Indication">A sign of that new inflammatory activity
                        is new T2 lesions compared with a previous MRI scan</ci>
                      </apply>
                    </apply>
                    <ci type="logical" class="Indication">Patient has an active Special Authority approval for either dimethyl fumarate, fingolimod, glatiramer acetate, interferon beta-1-alpha, interferon beta-1-beta, natalizumab or teriflunomide</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Treatment on two or more funded multiple sclerosis treatments simultaneously is not permitted.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="Multiple Sclerosis - ocrelizumab">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has had an EDSS score of 0 to 6.0 (inclusive) with or without
                the use unilateral or bilateral aids at any time in the last six months (ie the
                patient has walked 100 metres or more with or without aids in the last six
                months)</ci>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Treatment on two or more funded multiple sclerosis treatments simultaneously is not permitted.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="Primary Progressive Multiple Sclerosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Diagnosis of primary progressive multiple sclerosis (PPMS) meets the 2017 McDonald criteria and has been confirmed by a neurologist</ci>
                    <ci type="logical" class="Indication">Patient has an EDSS 2.0 (score equal to or greater than 2 on pyramidal functions) to EDSS 6.5</ci>
                    <ci type="logical" class="Indication">Patient has no history of relapsing remitting multiple sclerosis</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="Primary Progressive Multiple Sclerosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">Patient has had an EDSS score of less than or equal to 6.5 at any time in the last six months (ie patient has walked 20 metres with bilateral assistance/aids, without rest in the last six months)</ci>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1997" style="display:none"/>
            <Formulation ID="F224008864825" Rank="4" Units="inj" Weight="30">
              <Name>Inj 30 mg per ml, 10 ml vial</Name>
              <Brand ID="B22400886482525">
                <Name>Ocrevus</Name>
                <Pack ID="P2540789" Specified="true" nzmt:ctpp_id="50235631000117104">
                  <Quantity>1</Quantity>
                  <Price>9346.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2244">
        <Name>Sedatives and Hypnotics</Name>
        <ATC3 ID="A224404">
          <Name>Sedatives and Hypnotics</Name>
          <Chemical ID="C2244048088">
            <Name>Chloral hydrate</Name>
            <Formulation ID="F224404808801" Rank="3" Units="ml">
              <Name>Oral liq 100 mg per ml</Name>
              <Brand ID="B22440480880100">
                <Name>Any</Name>
                <Pack ID="P80880100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224404808802" Rank="3" Units="ml">
              <Name>Oral liq 200 mg per ml</Name>
              <Brand ID="B22440480880200">
                <Name>Any</Name>
                <Pack ID="P80880200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2244048268">
            <Name>Lormetazepam</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F224404826801" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg</Name>
              <Brand ID="B22440482680100">
                <Name>Any</Name>
                <Pack ID="P82680100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2244048480">
            <Name>Triazolam</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F224404848001" Rank="1" Units="tab" Weight="125">
              <Name>Tab 125 mcg</Name>
              <Brand ID="B22440484800100">
                <Name>Any</Name>
                <Pack ID="P84800100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224404848002" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mcg</Name>
              <Brand ID="B22440484800200">
                <Name>Any</Name>
                <Pack ID="P84800200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2244048514">
            <Name>Melatonin</Name>
            <Request Form="RS1576" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Melatonin</range>
              </Title>
              <Case When="Initial application" Category="insomnia secondary to neurodevelopmental disorder">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has been diagnosed with persistent and distressing insomnia secondary to a neurodevelopmental disorder (including, but not limited to, autism spectrum disorder or attention deficit hyperactivity disorder)</ci>
                    <ci type="logical">Behavioural and environmental approaches have been tried or are inappropriate</ci>
                    <ci type="logical">Funded modified-release melatonin is to be given at doses no greater than 10 mg per day</ci>
                    <ci type="logical">Patient is aged 18 years or under</ci>
                  </apply>
                </math>
                <Applicant>psychiatrist</Applicant>
                <Applicant>paediatrician</Applicant>
                <Applicant>neurologist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="insomnia secondary to neurodevelopmental disorder">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is aged 18 years or under</ci>
                    <ci type="logical">Patient has demonstrated clinically meaningful benefit from funded modified-release melatonin (clinician determined)</ci>
                    <ci type="logical">Patient has had a trial of funded modified-release melatonin discontinuation within the past 12 months and has had a recurrence of persistent and distressing insomnia</ci>
                    <ci type="logical">Funded modified-release melatonin is to be given at doses no greater than 10 mg per day</ci>
                  </apply>
                </math>
                <Applicant>psychiatrist</Applicant>
                <Applicant>paediatrician</Applicant>
                <Applicant>neurologist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="insomnia where benzodiazepines and zopiclone are contraindicated">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has insomnia and benzodiazepines and zopiclone are contraindicated</ci>
                    <ci type="logical">For in-hospital use only</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1576" style="display:none"/>
            <Formulation ID="F224404851429" Rank="1" Units="tab" Weight="3">
              <Name>Tab 3 mg</Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: Only for use in compounding an oral liquid formulation, for in-hospital use only.</p>
              </div>
              <Brand ID="B22440485142900">
                <Name>Any</Name>
                <Pack ID="P85142900" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224404851430" Rank="1" Units="tab">
              <Name>Tab modified-release 2 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B22440485143026" PSS="true">
                <Name>Vigisom</Name>
                <Pack ID="P2612593" Specified="true" nzmt:ctpp_id="50281501000117101">
                  <Quantity>30</Quantity>
                  <Price>5.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2244049034">
            <Name>Midazolam</Name>
            <Formulation ID="F224404903401" Rank="4" Units="inj" Weight="5">
              <Name>Inj 1 mg per ml, 5 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Jan-25 to~2027" Value="5"/>
              <Brand ID="B22440490340127" ToBeDelisted="2025-01-01">
                <Name>Mylan Midazolam</Name>
                <Pack ID="P2474468" Specified="true" nzmt:ctpp_id="50259041000117102">
                  <Quantity>10</Quantity>
                  <Price>3.95</Price>
                </Pack>
              </Brand>
              <Brand ID="B22440490340128" ToBeDelisted="2025-01-01">
                <Name>Midazolam Viatris</Name>
                <Pack ID="P2634945" Specified="true" nzmt:ctpp_id="50292031000117108">
                  <Quantity>10</Quantity>
                  <Price>3.95</Price>
                </Pack>
              </Brand>
              <Brand ID="B22440490340129" PSS="true">
                <Name>Midazolam-Baxter</Name>
                <Pack ID="P2599279" Specified="true" nzmt:ctpp_id="50281291000117108">
                  <Quantity>10</Quantity>
                  <Price>7.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224404903402" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 3 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Jan-25 to~2027" Value="5"/>
              <Brand ID="B22440490340227" ToBeDelisted="2025-01-01">
                <Name>Mylan Midazolam</Name>
                <Pack ID="P2474476" Specified="true" nzmt:ctpp_id="50259061000117103">
                  <Quantity>5</Quantity>
                  <Price>3.52</Price>
                </Pack>
              </Brand>
              <Brand ID="B22440490340228" ToBeDelisted="2025-01-01">
                <Name>Midazolam Viatris</Name>
                <Pack ID="P2634953" Specified="true" nzmt:ctpp_id="50293821000117107">
                  <Quantity>5</Quantity>
                  <Price>3.52</Price>
                </Pack>
              </Brand>
              <Brand ID="B22440490340229" PSS="true">
                <Name>Midazolam-Baxter</Name>
                <Pack ID="P2599260" Specified="true" nzmt:ctpp_id="50281301000117109">
                  <Quantity>5</Quantity>
                  <Price>4.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224404903403" Rank="3" Units="ml">
              <Name>Oral liq 2 mg per ml</Name>
              <Brand ID="B22440490340300">
                <Name>Any</Name>
                <Pack ID="P90340300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224404903404" Rank="1" Units="tab" Weight="7.5">
              <Name>Tab 7.5 mg</Name>
              <Brand ID="B22440490340400">
                <Name>Any</Name>
                <Pack ID="P90340400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224404903425" Rank="4" Units="amp">
              <Name>Inj 5 mg per ml, 1 ml plastic ampoule</Name>
              <Brand ID="B22440490342525">
                <Name>Midazolam-Pfizer</Name>
                <Pack ID="P2692406" Specified="true" nzmt:ctpp_id="50158411000117103">
                  <Quantity>10</Quantity>
                  <Price>22.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2244049456">
            <Name>Temazepam</Name>
            <Formulation ID="F224404945625" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B22440494562525" PSS="true">
                <Name>Normison</Name>
                <Pack ID="P2184877" Specified="true" nzmt:ctpp_id="50030301000117100">
                  <Quantity>25</Quantity>
                  <Price>1.40</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2244049463">
            <Name>Zopiclone</Name>
            <Formulation ID="F224404946325" Rank="1" Units="tab" Weight="7.5">
              <Name>Tab 7.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B22440494632526" PSS="true">
                <Name>Zopiclone Actavis</Name>
                <Pack ID="P2480662" Specified="true" nzmt:ctpp_id="50220441000117102">
                  <Quantity>500</Quantity>
                  <Price>21.85</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2244049517">
            <Name>Phenobarbitone</Name>
            <Formulation ID="F224404951701" Rank="4" Units="inj" Weight="200">
              <Name>Inj 200 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B22440495170100">
                <Name>Any</Name>
                <Pack ID="P95170100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224404951727" Rank="4" Units="inj">
              <Name>Inj 130 mg per ml, 1 ml vial</Name>
              <Brand ID="B22440495172700">
                <Name>Any</Name>
                <Pack ID="P95172700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2246">
        <Name>Spinal Muscular Atrophy</Name>
        <ATC3 ID="A224601">
          <Name>Spinal Muscular Atrophy</Name>
          <Chemical ID="C2246018702">
            <Name>Nusinersen</Name>
            <Request Form="RS1938" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Nusinersen</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has genetic documentation of homozygous SMN1 gene deletion, homozygous SMN1 point mutation, or compound heterozygous mutation</ci>
                    <ci type="logical">Patient is 18 years of age or under</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has experienced the defined signs and symptoms of SMA type I, II or IIIa prior to three years of age</ci>
                      <apply>
                        <and/>
                        <ci type="logical">Patient is pre-symptomatic</ci>
                        <ci type="logical">Patient has three or less copies of SMN2</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">There has been demonstrated maintenance of motor milestone function since treatment initiation</ci>
                    <ci type="logical">Patient does not require invasive permanent ventilation (at least 16 hours per day), in the absence of a potentially reversible cause while being treated with nusinersen</ci>
                    <ci type="logical">Nusinersen not to be administered in combination other SMA disease modifying treatments or gene therapy</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1938" style="display:none"/>
            <Formulation ID="F224601870225" Rank="4" Units="inj">
              <Name>Inj 12 mg per 5 ml vial</Name>
              <Brand ID="B22460187022525">
                <Name>Spinraza</Name>
                <Pack ID="P2648040" Specified="true" nzmt:ctpp_id="50249481000117104">
                  <Quantity>1</Quantity>
                  <Price>120000.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2246018714">
            <Name>Risdiplam</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: the supply of risdiplam is via Pharmac's approved direct distribution supply. Further details can be found on Pharmac's website https://pharmac.govt.nz/risdiplam</p>
            </div>
            <Request Form="RS1954" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Risdiplam</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has genetic documentation of homozygous SMN1 gene deletion,
          homozygous SMN1 point mutation, or compound heterozygous mutation</ci>
                    <ci type="logical">Patient is 18 years of age or under</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has experienced the defined signs and symptoms of SMA type I,
            II or IIIa prior to three years of age</ci>
                      <apply>
                        <and/>
                        <ci type="logical">Patient is pre-symptomatic</ci>
                        <ci type="logical">Patient has three or less copies of SMN2</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">There has been demonstrated maintenance of motor milestone function since treatment initiation</ci>
                    <ci type="logical">Patient does not require invasive permanent ventilation (at least 16 hours per day), in the absence of a potentially reversible cause while being treated with risdiplam</ci>
                    <ci type="logical">Risdiplam not to be administered in combination other SMA disease modifying treatments or gene therapy</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1954" style="display:none"/>
            <Formulation ID="F224601871425" Rank="3" Units="ml">
              <Name>Powder for oral soln 750 mcg per ml, 60 mg per bottle</Name>
              <Brand ID="B22460187142525">
                <Name>Evrysdi</Name>
                <Pack ID="P2649403" Specified="true" nzmt:ctpp_id="50282411000117109">
                  <Quantity>80</Quantity>
                  <Price>14100.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2248">
        <Name>Stimulants / ADHD Treatments</Name>
        <ATC3 ID="A224804">
          <Name>Stimulants / ADHD Treatments</Name>
          <Chemical ID="C2248048072">
            <Name>Caffeine</Name>
            <Formulation ID="F224804807201" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B22480480720100">
                <Name>Any</Name>
                <Pack ID="P80720100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2248048307">
            <Name>Modafinil</Name>
            <Request Form="RS1803" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Modafinil</range>
              </Title>
              <Case When="Initial application" Category="Narcolepsy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has a diagnosis of narcolepsy and has excessive daytime sleepiness associated with narcolepsy occurring almost daily for three months or more</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has a multiple sleep latency test with a mean sleep latency of less than or equal to 10 minutes and 2 or more sleep onset rapid eye movement periods</ci>
                      <ci type="logical">The patient has at least one of: cataplexy, sleep paralysis or hypnagogic hallucinations</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical">An effective dose of a listed formulation of methylphenidate or dexamphetamine has been trialled and discontinued because of intolerable side effects</ci>
                      <ci type="logical">Methylphenidate and dexamphetamine are contraindicated</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>neurologist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="month">24</Term>
              </Case>
              <Case When="Renewal" Category="Narcolepsy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The treatment remains appropriate and the patient is benefiting from treatment</ci>
                </math>
                <Applicant>neurologist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="month">24</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1803" style="display:none"/>
            <Formulation ID="F224804830701" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B22480483070125">
                <Name>Modavigil</Name>
                <Pack ID="P2560615" Specified="true" nzmt:ctpp_id="50018651000117101">
                  <Quantity>60</Quantity>
                  <Price>29.13</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2248049220">
            <Name>Methylphenidate hydrochloride</Name>
            <Request Form="RS1294" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Methylphenidate hydrochloride</range>
              </Title>
              <Case When="Initial application" Category="ADHD (immediate-release and sustained-release formulations)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has ADHD (Attention Deficit and Hyperactivity Disorder), diagnosed according to DSM-IV or ICD 10 criteria</ci>
                </math>
                <Applicant>paediatrician</Applicant>
                <Applicant>psychiatrist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Narcolepsy (immediate-release and sustained-release formulations)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient suffers from narcolepsy</ci>
                </math>
                <Applicant>neurologist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="month">24</Term>
              </Case>
              <Case When="Renewal" Category="Narcolepsy (immediate-release and sustained-release formulations)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The treatment remains appropriate and the patient is benefiting from treatment</ci>
                </math>
                <Applicant>neurologist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="month">24</Term>
              </Case>
              <Case When="Initial application" Category="Extended-release and modified-release formulations">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has ADHD (Attention Deficit and Hyperactivity Disorder), diagnosed according to DSM-IV or ICD 10 criteria</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient is taking a currently listed formulation of methylphenidate hydrochloride (immediate-release or sustained-release) which has not been effective due to
                        significant administration and/or compliance difficulties</ci>
                      <ci type="logical">There is significant concern regarding the risk of diversion or abuse of immediate-release methylphenidate hydrochloride</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>paediatrician</Applicant>
                <Applicant>psychiatrist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1294" style="display:none"/>
            <Formulation ID="F224804922001" Rank="2" Units="cap" Weight="10">
              <Name>Cap modified-release 10 mg</Name>
              <Brand ID="B22480492200125">
                <Name>Ritalin LA</Name>
                <Pack ID="P2346370" Specified="true" nzmt:ctpp_id="50050231000117101">
                  <Quantity>30</Quantity>
                  <Price>15.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804922002" Rank="2" Units="cap" Weight="20">
              <Name>Cap modified-release 20 mg</Name>
              <Brand ID="B22480492200225">
                <Name>Ritalin LA</Name>
                <Pack ID="P2274892" Specified="true" nzmt:ctpp_id="50043041000117107">
                  <Quantity>30</Quantity>
                  <Price>20.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804922003" Rank="2" Units="cap" Weight="30">
              <Name>Cap modified-release 30 mg</Name>
              <Brand ID="B22480492200325">
                <Name>Ritalin LA</Name>
                <Pack ID="P2274906" Specified="true" nzmt:ctpp_id="50043051000117109">
                  <Quantity>30</Quantity>
                  <Price>25.52</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804922004" Rank="2" Units="cap" Weight="40">
              <Name>Cap modified-release 40 mg</Name>
              <Brand ID="B22480492200425">
                <Name>Ritalin LA</Name>
                <Pack ID="P2274884" Specified="true" nzmt:ctpp_id="50043031000117104">
                  <Quantity>30</Quantity>
                  <Price>30.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804922005" Rank="1" Units="tab">
              <Name>Tab extended-release 18 mg</Name>
              <Brand ID="B22480492200525">
                <Name>Concerta</Name>
                <Pack ID="P2145065" Specified="true" nzmt:ctpp_id="50025041000117109">
                  <Quantity>30</Quantity>
                  <Price>58.96</Price>
                </Pack>
              </Brand>
              <Brand ID="B22480492200526">
                <Name>Methylphenidate ER - Teva</Name>
                <Pack ID="P2567091" Specified="true" nzmt:ctpp_id="50250351000117106">
                  <Quantity>30</Quantity>
                  <Price>7.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804922006" Rank="1" Units="tab">
              <Name>Tab extended-release 27 mg</Name>
              <Brand ID="B22480492200625">
                <Name>Concerta</Name>
                <Pack ID="P2294524" Specified="true" nzmt:ctpp_id="50045281000117107">
                  <Quantity>30</Quantity>
                  <Price>65.44</Price>
                </Pack>
              </Brand>
              <Brand ID="B22480492200626">
                <Name>Methylphenidate ER - Teva</Name>
                <Pack ID="P2562774" Specified="true" nzmt:ctpp_id="50250341000117109">
                  <Quantity>30</Quantity>
                  <Price>11.45</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804922007" Rank="1" Units="tab">
              <Name>Tab extended-release 36 mg</Name>
              <Brand ID="B22480492200725">
                <Name>Concerta</Name>
                <Pack ID="P2145073" Specified="true" nzmt:ctpp_id="50025061000117108">
                  <Quantity>30</Quantity>
                  <Price>71.93</Price>
                </Pack>
              </Brand>
              <Brand ID="B22480492200726">
                <Name>Methylphenidate ER - Teva</Name>
                <Pack ID="P2562782" Specified="true" nzmt:ctpp_id="50250331000117101">
                  <Quantity>30</Quantity>
                  <Price>15.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804922008" Rank="1" Units="tab">
              <Name>Tab extended-release 54 mg</Name>
              <Brand ID="B22480492200825">
                <Name>Concerta</Name>
                <Pack ID="P2145081" Specified="true" nzmt:ctpp_id="50025071000117103">
                  <Quantity>30</Quantity>
                  <Price>86.24</Price>
                </Pack>
              </Brand>
              <Brand ID="B22480492200826">
                <Name>Methylphenidate ER - Teva</Name>
                <Pack ID="P2562790" Specified="true" nzmt:ctpp_id="50250321000117104">
                  <Quantity>30</Quantity>
                  <Price>22.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804922026" Rank="1" Units="tab" Weight="5">
              <Name>Tab immediate-release 5 mg</Name>
              <Brand ID="B22480492202625">
                <Name>Rubifen</Name>
                <Pack ID="P2227371" Specified="true" nzmt:ctpp_id="50036641000117109">
                  <Quantity>30</Quantity>
                  <Price>3.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804922027" Rank="1" Units="tab" Weight="20">
              <Name>Tab immediate-release 20 mg</Name>
              <Brand ID="B22480492202725">
                <Name>Rubifen</Name>
                <Pack ID="P2227320" Specified="true" nzmt:ctpp_id="50036631000117101">
                  <Quantity>30</Quantity>
                  <Price>7.85</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804922029" Rank="1" Units="tab" Weight="20">
              <Name>Tab sustained-release 20 mg</Name>
              <Brand ID="B22480492202926">
                <Name>Rubifen SR</Name>
                <Pack ID="P2116782" Specified="true" nzmt:ctpp_id="50020531000117104">
                  <Quantity>30</Quantity>
                  <Price>10.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804922030" Rank="1" Units="tab" Weight="10">
              <Name>Tab immediate-release 10 mg</Name>
              <Brand ID="B22480492203025">
                <Name>Ritalin</Name>
                <Pack ID="P2349329" Specified="true" nzmt:ctpp_id="50120341000117106">
                  <Quantity>30</Quantity>
                  <Price>3.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B22480492203026">
                <Name>Rubifen</Name>
                <Pack ID="P437204" Specified="true" nzmt:ctpp_id="50085731000117106">
                  <Quantity>30</Quantity>
                  <Price>3.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2248049363">
            <Name>Dexamfetamine sulfate</Name>
            <Request Form="RS1169" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Dexamphetamine sulphate</range>
              </Title>
              <Case When="Initial application" Category="ADHD">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has ADHD (Attention Deficit and Hyperactivity Disorder), diagnosed according to DSM-IV or ICD 10 criteria</ci>
                </math>
                <Applicant>paediatrician</Applicant>
                <Applicant>psychiatrist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Narcolepsy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient suffers from narcolepsy</ci>
                </math>
                <Applicant>neurologist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="month">24</Term>
              </Case>
              <Case When="Renewal" Category="Narcolepsy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The treatment remains appropriate and the patient is benefiting from treatment</ci>
                </math>
                <Applicant>neurologist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="month">24</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1169" style="display:none"/>
            <Formulation ID="F224804936325" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2025" Value="5"/>
              <Brand ID="B22480493632527" PSS="true">
                <Name>Noumed Dexamfetamine</Name>
                <Pack ID="P2647516" Specified="true" nzmt:ctpp_id="50307061000117106">
                  <Quantity>100</Quantity>
                  <Price>29.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2248049473">
            <Name>Atomoxetine</Name>
            <Formulation ID="F224804947325" Rank="2" Units="cap" Weight="10">
              <Name>Cap 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~2026" Value="5"/>
              <Brand ID="B22480494732527" PSS="true">
                <Name>APO-Atomoxetine</Name>
                <Pack ID="P2638517" Specified="true" nzmt:ctpp_id="50297781000117108">
                  <Quantity>28</Quantity>
                  <Price>43.02</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804947326" Rank="2" Units="cap" Weight="18">
              <Name>Cap 18 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~2026" Value="5"/>
              <Brand ID="B22480494732627" PSS="true">
                <Name>APO-Atomoxetine</Name>
                <Pack ID="P2637065" Specified="true" nzmt:ctpp_id="50301411000117109">
                  <Quantity>28</Quantity>
                  <Price>45.57</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804947327" Rank="2" Units="cap" Weight="25">
              <Name>Cap 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~2026" Value="5"/>
              <Brand ID="B22480494732727" PSS="true">
                <Name>APO-Atomoxetine</Name>
                <Pack ID="P2637073" Specified="true" nzmt:ctpp_id="50301421000117103">
                  <Quantity>28</Quantity>
                  <Price>44.30</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804947328" Rank="2" Units="cap" Weight="40">
              <Name>Cap 40 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~2026" Value="5"/>
              <Brand ID="B22480494732827" PSS="true">
                <Name>APO-Atomoxetine</Name>
                <Pack ID="P2637081" Specified="true" nzmt:ctpp_id="50301431000117100">
                  <Quantity>28</Quantity>
                  <Price>46.21</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804947329" Rank="2" Units="cap" Weight="60">
              <Name>Cap 60 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~2026" Value="5"/>
              <Brand ID="B22480494732927" PSS="true">
                <Name>APO-Atomoxetine</Name>
                <Pack ID="P2638525" Specified="true" nzmt:ctpp_id="50300341000117105">
                  <Quantity>28</Quantity>
                  <Price>51.31</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804947330" Rank="2" Units="cap" Weight="80">
              <Name>Cap 80 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~2026" Value="5"/>
              <Brand ID="B22480494733027" PSS="true">
                <Name>APO-Atomoxetine</Name>
                <Pack ID="P2638533" Specified="true" nzmt:ctpp_id="50297791000117106">
                  <Quantity>28</Quantity>
                  <Price>65.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F224804947331" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~2026" Value="5"/>
              <Brand ID="B22480494733127" PSS="true">
                <Name>APO-Atomoxetine</Name>
                <Pack ID="P2638541" Specified="true" nzmt:ctpp_id="50297801000117107">
                  <Quantity>28</Quantity>
                  <Price>65.71</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2252">
        <Name>Treatments for Dementia</Name>
        <ATC3 ID="A225204">
          <Name>Treatments for Dementia</Name>
          <Chemical ID="C2252048557">
            <Name>Rivastigmine</Name>
            <Request Form="RS1436" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Rivastigmine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has been diagnosed with dementia</ci>
                    <ci type="logical">The patient has experienced intolerable nausea and/or vomiting from donepezil tablets</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The treatment remains appropriate</ci>
                    <ci type="logical">The patient has demonstrated a significant and sustained benefit from treatment</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1436" style="display:none"/>
            <Formulation ID="F225204855725" Rank="9" Units="patch" Weight="4">
              <Name>Patch 4.6 mg per 24 hour</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B22520485572527" PSS="true">
                <Name>Rivastigmine Patch BNM 5</Name>
                <Pack ID="P2611570" Specified="true" nzmt:ctpp_id="50258711000117109">
                  <Quantity>30</Quantity>
                  <Price>49.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F225204855726" Rank="9" Units="patch" Weight="9">
              <Name>Patch 9.5 mg per 24 hour</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B22520485572627" PSS="true">
                <Name>Rivastigmine Patch BNM 10</Name>
                <Pack ID="P2611589" Specified="true" nzmt:ctpp_id="50258721000117103">
                  <Quantity>30</Quantity>
                  <Price>49.40</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2252049565">
            <Name>Donepezil hydrochloride</Name>
            <Formulation ID="F225204956525" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B22520495652526" PSS="true">
                <Name>Ipca-Donepezil</Name>
                <Pack ID="P2666871" Specified="true" nzmt:ctpp_id="50321231000117105">
                  <Quantity>84</Quantity>
                  <Price>3.70</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F225204956526" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B22520495652626" PSS="true">
                <Name>Ipca-Donepezil</Name>
                <Pack ID="P2666898" Specified="true" nzmt:ctpp_id="50321261000117103">
                  <Quantity>84</Quantity>
                  <Price>5.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2256">
        <Name>Treatments for Substance Dependence</Name>
        <ATC3 ID="A225604">
          <Name>Treatments for Substance Dependence</Name>
          <Chemical ID="C2256049181">
            <Name>Disulfiram</Name>
            <Formulation ID="F225604918125" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B22560491812525">
                <Name>Antabuse</Name>
                <Pack ID="P524492" Specified="true" nzmt:ctpp_id="50094221000117104">
                  <Quantity>100</Quantity>
                  <Price>236.40</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2256049231">
            <Name>Naltrexone hydrochloride</Name>
            <Request Form="RS1173" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Naltrexone hydrochloride</range>
              </Title>
              <Case When="Initial application" Category="Alcohol dependence">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is currently enrolled, or is planned to be enrolled, in a recognised comprehensive treatment programme for alcohol dependence</ci>
                    <ci type="logical">Naltrexone is to be prescribed by, or on the recommendation of, a physician working in an Alcohol and Drug Service</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Constipation">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For the treatment of opioid-induced constipation</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1173" style="display:none"/>
            <Formulation ID="F225604923125" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B22560492312525">
                <Name>Revia</Name>
                <Pack ID="P2689049" Specified="true" nzmt:ctpp_id="50339321000117101">
                  <Quantity>50</Quantity>
                  <Price>138.88</Price>
                </Pack>
              </Brand>
              <Brand ID="B22560492312526" PSS="true">
                <Name>Naltraccord</Name>
                <Pack ID="P2380374" Specified="true" nzmt:ctpp_id="50122441000117101">
                  <Quantity>30</Quantity>
                  <Price>83.33</Price>
                </Pack>
              </Brand>
              <Brand ID="B22560492312527">
                <Name>Naltrexone AOP</Name>
                <Pack ID="P2664941" Specified="true" nzmt:ctpp_id="50322261000117107">
                  <Quantity>28</Quantity>
                  <Price>77.77</Price>
                </Pack>
              </Brand>
              <Brand ID="B22560492312528">
                <Name>Naltrexone Max Health</Name>
                <Pack ID="P2692961" Specified="true">
                  <Quantity>30</Quantity>
                  <Price>102.60</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2256049239">
            <Name>Nicotine</Name>
            <Request Form="RS1873" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Nicotine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">For perioperative use in patients who have a 'nil by mouth'
          instruction</ci>
                    <ci type="logical"> For use within mental health inpatient units</ci>
                    <ci type="logical">Patient would be admitted to a mental health inpatient unit, but is
          unable to due to COVID-19 self-isolation requirement</ci>
                    <ci type="logical">For acute use in agitated patients who are unable to leave the hospital
          facilities</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Some items restricted" xlink:href="RS1873" style="display:none"/>
            <Formulation ID="F225604923901" Rank="10" Units="piece">
              <Name>Gum 2 mg</Name>
              <Brand ID="B22560492390126">
                <Name>Habitrol (Fruit)</Name>
                <Pack ID="P2640589" Specified="true" nzmt:ctpp_id="50315211000117107">
                  <Quantity>204</Quantity>
                  <Price>23.02</Price>
                </Pack>
              </Brand>
              <Brand ID="B22560492390127">
                <Name>Habitrol (Mint)</Name>
                <Pack ID="P2640562" Specified="true" nzmt:ctpp_id="50189591000117105">
                  <Quantity>204</Quantity>
                  <Price>23.02</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F225604923902" Rank="10" Units="piece">
              <Name>Gum 4 mg</Name>
              <Brand ID="B22560492390226">
                <Name>Habitrol (Fruit)</Name>
                <Pack ID="P2640597" Specified="true" nzmt:ctpp_id="50309181000117108">
                  <Quantity>204</Quantity>
                  <Price>25.98</Price>
                </Pack>
              </Brand>
              <Brand ID="B22560492390227">
                <Name>Habitrol (Mint)</Name>
                <Pack ID="P2640570" Specified="true" nzmt:ctpp_id="50189491000117106">
                  <Quantity>204</Quantity>
                  <Price>25.98</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F225604923929" Rank="9" Units="patch" Weight="7">
              <Name>Patch 7 mg per 24 hours</Name>
              <Brand ID="B22560492392925">
                <Name>Habitrol</Name>
                <Pack ID="P2381389" Specified="true" nzmt:ctpp_id="50122471000117107">
                  <Quantity>28</Quantity>
                  <Price>19.62</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F225604923930" Rank="9" Units="patch" Weight="14">
              <Name>Patch 14 mg per 24 hours</Name>
              <Brand ID="B22560492393025">
                <Name>Habitrol</Name>
                <Pack ID="P2381397" Specified="true" nzmt:ctpp_id="50122481000117105">
                  <Quantity>28</Quantity>
                  <Price>21.57</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F225604923931" Rank="9" Units="patch" Weight="21">
              <Name>Patch 21 mg per 24 hours</Name>
              <Brand ID="B22560492393125">
                <Name>Habitrol</Name>
                <Pack ID="P2381400" Specified="true" nzmt:ctpp_id="50122491000117108">
                  <Quantity>28</Quantity>
                  <Price>24.72</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F225604923932" Rank="10" Units="loz" Weight="2">
              <Name>Lozenge 2 mg</Name>
              <Brand ID="B22560492393225">
                <Name>Habitrol</Name>
                <Pack ID="P2381362" Specified="true" nzmt:ctpp_id="50122461000117102">
                  <Quantity>216</Quantity>
                  <Price>24.68</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F225604923933" Rank="10" Units="loz" Weight="1">
              <Name>Lozenge 1 mg</Name>
              <Brand ID="B22560492393325">
                <Name>Habitrol</Name>
                <Pack ID="P2381370" Specified="true" nzmt:ctpp_id="50122451000117104">
                  <Quantity>216</Quantity>
                  <Price>22.53</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F225604923934" Rank="10" Units="pack">
              <Name>Soln for inhalation 15 mg cartridge</Name>
              <html:div class="Restricted item" xlink:href="RS1873" style="display:none"/>
              <Brand ID="B22560492393400">
                <Name>e.g. Nicorette Inhalator</Name>
                <Pack ID="P92393400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F225604923935" Rank="10" Units="each">
              <Name>Oral spray 1 mg per dose</Name>
              <html:div class="Restricted item" xlink:href="RS1873" style="display:none"/>
              <Brand ID="B22560492393500">
                <Name>e.g. Nicorette QuickMist Mouth Spray</Name>
                <Pack ID="P92393500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2256049484">
            <Name>Bupropion hydrochloride</Name>
            <Formulation ID="F225604948425" Rank="1" Units="tab" Weight="150">
              <Name>Tab modified-release 150 mg</Name>
              <Rule Type="DVLimit" Attribute="May-24 to~2026" Value="5"/>
              <Brand ID="B22560494842525" PSS="true">
                <Name>Zyban</Name>
                <Pack ID="P2439743" Specified="true" nzmt:ctpp_id="50080021000117103">
                  <Quantity>30</Quantity>
                  <Price>15.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2256049568">
            <Name>Varenicline</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1702">
              <Title>
                <range>Varenicline</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Short-term therapy as an aid to achieving abstinence in a patient who has indicated that they are ready to cease smoking</ci>
                    <ci type="logical">The patient is part of, or is about to enrol in, a comprehensive support and counselling smoking cessation programme, which includes prescriber or nurse monitoring</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has tried but failed to quit smoking after at least two separate trials of nicotine replacement therapy, at least one of which included the patient receiving comprehensive advice on the optimal use of nicotine replacement therapy</ci>
                      <ci type="logical">The patient has tried but failed to quit smoking using bupropion or nortriptyline</ci>
                    </apply>
                    <ci type="logical">The patient has not had a Special Authority for varenicline approved in the last 6 months</ci>
                    <ci type="logical">Varenicline is not to be used in combination with other pharmacological smoking cessation treatments and the patient has agreed to this</ci>
                    <ci type="logical">The patient is not pregnant</ci>
                    <ci type="logical">The patient will not be prescribed more than 12 weeks' funded varenicline in a 12 month period</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1702" style="display:none"/>
            <Formulation ID="F225604956826" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg</Name>
              <Brand ID="B22560495682626">
                <Name>Varenicline Pfizer</Name>
                <Pack ID="P2553163" Specified="true" nzmt:ctpp_id="50255041000117100">
                  <Quantity>56</Quantity>
                  <Price>17.62</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F225604956827" Rank="1" Units="tab">
              <Name>Tab 0.5 mg x 11 and 1 mg x 42</Name>
              <Brand ID="B22560495682725">
                <Name>Varenicline Pfizer</Name>
                <Pack ID="P2553155" Specified="true" nzmt:ctpp_id="50255031000117108">
                  <Quantity>53</Quantity>
                  <Price>16.67</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2256049649">
            <Name>Buprenorphine with naloxone</Name>
            <Request Form="RS1172" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Buprenorphine with naloxone</range>
              </Title>
              <Case When="Initial application" Category="Detoxification">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is opioid dependent</ci>
                    <ci type="logical">Patient is currently engaged with an opioid treatment service approved by the Ministry of Health</ci>
                    <ci type="logical">Prescriber works in an opioid treatment service approved by the Ministry of Health</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Maintenance treatment">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is opioid dependent</ci>
                    <ci type="logical">Patient will not be receiving methadone</ci>
                    <ci type="logical">Patient is currently enrolled in an opioid substitution treatment program in a service approved by the Ministry of Health</ci>
                    <ci type="logical">Prescriber works in an opioid treatment service approved by the Ministry of Health</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1172" style="display:none"/>
            <Formulation ID="F225604964925" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg with naloxone 0.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B22560496492526" PSS="true">
                <Name>Buprenorphine Naloxone BNM</Name>
                <Pack ID="P2574004" Specified="true" nzmt:ctpp_id="50244061000117104">
                  <Quantity>28</Quantity>
                  <Price>11.76</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F225604964926" Rank="1" Units="tab" Weight="8">
              <Name>Tab 8 mg with naloxone 2 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B22560496492626" PSS="true">
                <Name>Buprenorphine Naloxone BNM</Name>
                <Pack ID="P2574012" Specified="true" nzmt:ctpp_id="50244071000117109">
                  <Quantity>28</Quantity>
                  <Price>34.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
    <ATC1 ID="A25">
      <Name>Oncology Agents and Immunosuppressants</Name>
      <ATC2 ID="A2504">
        <Name>Chemotherapeutic Agents</Name>
        <ATC3 ID="A250404">
          <Name>Alkylating Agents</Name>
          <Chemical ID="C2504048083">
            <Name>Carmustine</Name>
            <Formulation ID="F250404808301" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Sep-22 to~2025" Value="5"/>
              <Brand ID="B25040480830125" PSS="true">
                <Name>BiCNU</Name>
                <Pack ID="P2571234" Specified="true" nzmt:ctpp_id="50073841000117104">
                  <Quantity>1</Quantity>
                  <Price>710.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B25040480830128">
                <Name>BiCNU S29</Name>
                <Pack ID="P2680556" Specified="true" nzmt:ctpp_id="50334801000117100">
                  <Quantity>1</Quantity>
                  <Price>710.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B25040480830129">
                <Name>Novadoz</Name>
                <Pack ID="P2689375" Specified="true" nzmt:ctpp_id="50339911000117106">
                  <Quantity>1</Quantity>
                  <Price>710.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504048089">
            <Name>Chlorambucil</Name>
            <Formulation ID="F250404808901" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Brand ID="B25040480890100">
                <Name>Any</Name>
                <Pack ID="P80890100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504048286">
            <Name>Melphalan</Name>
            <Formulation ID="F250404828601" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B25040482860125" PSS="true">
                <Name>Melpha</Name>
                <Pack ID="P2647699" Specified="true" nzmt:ctpp_id="50280261000117107">
                  <Quantity>1</Quantity>
                  <Price>48.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250404828602" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Brand ID="B25040482860200">
                <Name>Any</Name>
                <Pack ID="P82860200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504048466">
            <Name>Thiotepa</Name>
            <Formulation ID="F250404846601" Rank="4" Units="inj" Weight="15">
              <Name>Inj 15 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2026" Value="5"/>
              <Brand ID="B25040484660125" PSS="true">
                <Name>Tepadina</Name>
                <Pack ID="P2487985" Specified="true" nzmt:ctpp_id="50180611000117105">
                  <Quantity>1</Quantity>
                  <Price>398.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250404846625" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Apr-24 to~2026" Value="5"/>
              <Brand ID="B25040484662525" PSS="true">
                <Name>Tepadina</Name>
                <Pack ID="P2487977" Specified="true" nzmt:ctpp_id="50125231000117102">
                  <Quantity>1</Quantity>
                  <Price>1800.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504048610">
            <Name>Bendamustine hydrochloride</Name>
            <Request Form="RS1917" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Bendamustine hydrochloride</range>
              </Title>
              <Case When="Initial application" Category="treatment naive CLL">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has Binet stage B or C, or progressive stage A
                    chronic lymphocytic leukaemia requiring treatment</ci>
                    <ci type="logical">The patient is chemotherapy treatment naive</ci>
                    <ci type="logical">The patient is unable to tolerate toxicity of full-dose FCR</ci>
                    <ci type="logical">Patient has ECOG performance status 0-2</ci>
                    <ci type="logical">Patient has a Cumulative Illness Rating Scale (CIRS) score of
                    &lt;6</ci>
                    <ci type="logical">Bendamustine is to be administered at a maximum dose of 100 mg/m²
                    on days 1 and 2 every 4 weeks for a maximum of 6 cycles</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>'Chronic lymphocytic leukaemia (CLL)' includes small lymphocytic lymphoma (SLL).
                Chemotherapy treatment is considered to comprise a known standard therapeutic
                chemotherapy regimen and supportive treatments.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="Indolent, Low-grade lymphomas">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has indolent low grade NHL requiring treatment</ci>
                    <ci type="logical">Patient has a WHO performance status of 0-2</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">Patient is treatment naive</ci>
                        <ci type="logical">Bendamustine is to be administered for a maximum of 6
                            cycles (in combination with rituximab when CD20+)</ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">Patient is refractory to or has relapsed within 12 months of a rituximab containing combined chemo-immunotherapy regimen</ci>
                        <ci type="logical">Bendamustine is to be administered in combination with obinutuzumab for a maximum of 6 cycles</ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">The patient has not received prior bendamustine therapy</ci>
                        <ci type="logical">Bendamustine is to be administered for a maximum of 6 cycles in relapsed patients (in combination with rituximab when CD20+)</ci>
                        <ci type="logical">Patient has had a rituximab treatment-free interval of 12 months or more</ci>
                      </apply>
                      <ci type="logical">Bendamustine is to be administered as monotherapy for a maximum of 6 cycles in rituximab refractory patients</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">9</Term>
              </Case>
              <Case When="Renewal" Category="Indolent, Low-grade lymphomas">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">Patient is refractory to or has relapsed within 12 months of rituximab in combination with bendamustine</ci>
                      <ci type="logical">Bendamustine is to be administered in combination with obinutuzumab for a maximum of 6 cycles</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patients have not received a bendamustine regimen within the last 12 months</ci>
                      <apply>
                        <or/>
                        <apply>
                          <and/>
                          <ci type="logical">Bendamustine is to be administered for a maximum of 6
                                          cycles in relapsed patients (in combination with rituximab when
                                             CD20+)</ci>
                          <ci type="logical">Patient has had a rituximab treatment-free interval of 12
                                        months or more</ci>
                        </apply>
                        <ci type="logical">Bendamustine is to be administered as a monotherapy for a
                              maximum of 6 cycles in rituximab refractory patients</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">9</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>'indolent, low-grade lymphomas' includes follicular, mantle cell, marginal zone and
                lymphoplasmacytic/ Waldenström's macroglobulinaemia.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="Hodgkin's lymphoma*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has Hodgkin's lymphoma requiring
                    treatment</ci>
                    <ci type="logical" class="Indication">Patient has a ECOG performance status of
                    0-2</ci>
                    <ci type="logical" class="Indication">Patient has received one prior line of
                    chemotherapy</ci>
                    <ci type="logical" class="Indication">Patient's disease relapsed or was refractory
                    following prior chemotherapy</ci>
                    <ci type="logical" class="Indication">Bendamustine is to be administered in
                    combination with gemcitabine and vinorelbine (BeGeV) at a maximum dose of no
                    greater than 90 mg/m2 twice per cycle, for a maximum of four cycles</ci>
                  </apply>
                </math>
                <Applicant>relevant specialist</Applicant>
                <Applicant Referring="relevant specialist">medical practitioner</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1917" style="display:none"/>
            <Formulation ID="F250404861025" Rank="4" Units="inj" Weight="25">
              <Name>Inj 25 mg vial</Name>
              <Brand ID="B25040486102525">
                <Name>Ribomustin</Name>
                <Pack ID="P2483807" Specified="true" nzmt:ctpp_id="50176951000117108">
                  <Quantity>1</Quantity>
                  <Price>77.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250404861026" Rank="4" Units="inj" Weight="100">
              <Name>inj 100 mg vial</Name>
              <Brand ID="B25040486102625">
                <Name>Ribomustin</Name>
                <Pack ID="P2483793" Specified="true" nzmt:ctpp_id="50126201000117100">
                  <Quantity>1</Quantity>
                  <Price>308.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504049074">
            <Name>Cyclophosphamide</Name>
            <Formulation ID="F250404907401" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B25040490740127" PSS="true">
                <Name>Cyclonex</Name>
                <Pack ID="P2611597" Specified="true" nzmt:ctpp_id="50286921000117107">
                  <Quantity>50</Quantity>
                  <Price>145.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250404907404" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 1 g vial</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B25040490740401" PSS="true">
                <Name>Endoxan</Name>
                <Pack ID="P2034212" Specified="true" nzmt:ctpp_id="50006661000117101">
                  <Quantity>1</Quantity>
                  <Price>47.46</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250404907405" Rank="4" Units="inj" Weight="2000">
              <Name>Inj 2 g vial</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B25040490740501" PSS="true">
                <Name>Endoxan</Name>
                <Pack ID="P2034220" Specified="true" nzmt:ctpp_id="50006671000117106">
                  <Quantity>1</Quantity>
                  <Price>95.06</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504049092">
            <Name>Ifosfamide</Name>
            <Formulation ID="F250404909201" Rank="4" Units="inj" Weight="100">
              <Name>Inj 1 g vial</Name>
              <Brand ID="B25040490920101">
                <Name>Holoxan</Name>
                <Pack ID="P712736" Specified="true" nzmt:ctpp_id="50104251000117103">
                  <Quantity>1</Quantity>
                  <Price>96.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250404909202" Rank="4" Units="inj" Weight="200">
              <Name>Inj 2 g vial</Name>
              <Brand ID="B25040490920201">
                <Name>Holoxan</Name>
                <Pack ID="P712760" Specified="true" nzmt:ctpp_id="50104281000117109">
                  <Quantity>1</Quantity>
                  <Price>180.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504049581">
            <Name>Busulfan</Name>
            <Formulation ID="F250404958101" Rank="4" Units="inj" Weight="6">
              <Name>Inj 6 mg per ml, 10 ml ampoule</Name>
              <Brand ID="B25040495810100">
                <Name>Any</Name>
                <Pack ID="P95810100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250404958125" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Brand ID="B25040495812525">
                <Name>Myleran</Name>
                <Pack ID="P201472" Specified="true" nzmt:ctpp_id="50002411000117100">
                  <Quantity>100</Quantity>
                  <Price>89.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504049591">
            <Name>Lomustine</Name>
            <Formulation ID="F250404959125" Rank="2" Units="cap" Weight="10">
              <Name>Cap 10 mg</Name>
              <Brand ID="B25040495912525" ToBeDelisted="2025-01-01">
                <Name>Ceenu</Name>
                <Pack ID="P332771" Specified="true" nzmt:ctpp_id="50073821000117109">
                  <Quantity>20</Quantity>
                  <Price>132.59</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250404959126" Rank="2" Units="cap" Weight="40">
              <Name>Cap 40 mg</Name>
              <Brand ID="B25040495912625" ToBeDelisted="2025-01-01">
                <Name>Ceenu</Name>
                <Pack ID="P332798" Specified="true" nzmt:ctpp_id="50073831000117107">
                  <Quantity>20</Quantity>
                  <Price>399.15</Price>
                </Pack>
              </Brand>
              <Brand ID="B25040495912626">
                <Name>Medac</Name>
                <Pack ID="P2681137" Specified="true" nzmt:ctpp_id="50335281000117107">
                  <Quantity>20</Quantity>
                  <Price>880.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A250408">
          <Name>Anthracyclines and Other Cytotoxic Antibiotics</Name>
          <Chemical ID="C2504088123">
            <Name>Dactinomycin [Actinomycin D]</Name>
            <Formulation ID="F250408812301" Rank="4" Units="inj" Weight="0.5">
              <Name>Inj 0.5 mg vial</Name>
              <Brand ID="B25040881230125">
                <Name>Cosmegen</Name>
                <Pack ID="P203343" Specified="true" nzmt:ctpp_id="50006341000117108">
                  <Quantity>1</Quantity>
                  <Price>255.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504089068">
            <Name>Bleomycin sulphate</Name>
            <Formulation ID="F250408906801" Rank="4" Units="inj" Weight="15000">
              <Name>Inj 15,000 iu vial</Name>
              <Brand ID="B25040890680125">
                <Name>DBL Bleomycin Sulfate</Name>
                <Pack ID="P2343207" Specified="true" nzmt:ctpp_id="50050051000117104">
                  <Quantity>1</Quantity>
                  <Price>185.16</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504089077">
            <Name>Daunorubicin</Name>
            <Formulation ID="F250408907725" Rank="4" Units="inj" Weight="20">
              <Name>Inj 2 mg per ml, 10 ml vial</Name>
              <Brand ID="B25040890772525">
                <Name>Pfizer</Name>
                <Pack ID="P2325500" Specified="true" nzmt:ctpp_id="50049051000117106">
                  <Quantity>1</Quantity>
                  <Price>171.93</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504089081">
            <Name>Doxorubicin hydrochloride</Name>
            <Formulation ID="F250408908106" Rank="4" Units="inj" Weight="50">
              <Name>Inj 2 mg per ml, 25 ml vial</Name>
              <Brand ID="B25040890810625">
                <Name>Doxorubicin Ebewe</Name>
                <Pack ID="P2224089" Specified="true" nzmt:ctpp_id="50035541000117102">
                  <Quantity>1</Quantity>
                  <Price>11.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250408908107" Rank="4" Units="inj" Weight="10">
              <Name>Inj 2 mg per ml, 5 ml vial</Name>
              <Brand ID="B25040890810700">
                <Name>Any</Name>
                <Pack ID="P90810700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250408908108" Rank="4" Units="inj" Weight="100">
              <Name>Inj 2 mg per ml, 50 ml vial</Name>
              <Brand ID="B25040890810825">
                <Name>Doxorubicin Ebewe</Name>
                <Pack ID="P2224097" Specified="true" nzmt:ctpp_id="50035551000117100">
                  <Quantity>1</Quantity>
                  <Price>23.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250408908125" Rank="4" Units="inj" Weight="200">
              <Name>Inj 2 mg per ml, 100 ml vial</Name>
              <Brand ID="B25040890812525">
                <Name>Doxorubicin Ebewe</Name>
                <Pack ID="P2224100" Specified="true" nzmt:ctpp_id="50035561000117103">
                  <Quantity>1</Quantity>
                  <Price>69.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250408908126" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg vial</Name>
              <Brand ID="B25040890812600">
                <Name>Any</Name>
                <Pack ID="P90812600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504089082">
            <Name>Epirubicin hydrochloride</Name>
            <Formulation ID="F250408908201" Rank="4" Units="inj" Weight="10">
              <Name>Inj 2 mg per ml, 5 ml vial</Name>
              <Brand ID="B25040890820125">
                <Name>Epirubicin Ebewe</Name>
                <Pack ID="P2224119" Specified="true" nzmt:ctpp_id="50035571000117108">
                  <Quantity>1</Quantity>
                  <Price>25.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250408908202" Rank="4" Units="inj" Weight="50">
              <Name>Inj 2 mg per ml, 25 ml vial</Name>
              <Brand ID="B25040890820225">
                <Name>Epirubicin Ebewe</Name>
                <Pack ID="P2224127" Specified="true" nzmt:ctpp_id="50035581000117106">
                  <Quantity>1</Quantity>
                  <Price>30.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250408908226" Rank="4" Units="inj" Weight="200">
              <Name>Inj 2 mg per ml, 100 ml vial</Name>
              <Brand ID="B25040890822625">
                <Name>Epirubicin Ebewe</Name>
                <Pack ID="P2224143" Specified="true" nzmt:ctpp_id="50035601000117103">
                  <Quantity>1</Quantity>
                  <Price>99.99</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504089091">
            <Name>Idarubicin hydrochloride</Name>
            <Formulation ID="F250408909104" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg vial</Name>
              <Brand ID="B25040890910401">
                <Name>Zavedos</Name>
                <Pack ID="P784443" Specified="true" nzmt:ctpp_id="50113921000117104">
                  <Quantity>1</Quantity>
                  <Price>109.74</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250408909105" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg vial</Name>
              <Brand ID="B25040890910501">
                <Name>Zavedos</Name>
                <Pack ID="P784451" Specified="true" nzmt:ctpp_id="50113931000117101">
                  <Quantity>1</Quantity>
                  <Price>233.64</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504089102">
            <Name>Mitozantrone</Name>
            <Formulation ID="F250408910201" Rank="4" Units="inj" Weight="20">
              <Name>Inj 2 mg per ml, 10 ml vial</Name>
              <Brand ID="B25040891020126">
                <Name>Mitozantrone Ebewe</Name>
                <Pack ID="P2270463" Specified="true" nzmt:ctpp_id="50042391000117108">
                  <Quantity>1</Quantity>
                  <Price>97.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504089552">
            <Name>Mitomycin C</Name>
            <Formulation ID="F250408955225" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg vial</Name>
              <Brand ID="B25040895522500">
                <Name>Any</Name>
                <Pack ID="P95522500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250408955226" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg vial</Name>
              <Brand ID="B25040895522626">
                <Name>Teva</Name>
                <Pack ID="P2601761" Specified="true" nzmt:ctpp_id="50264951000117107">
                  <Quantity>1</Quantity>
                  <Price>1250.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A250412">
          <Name>Antimetabolites</Name>
          <Chemical ID="C2504128191">
            <Name>Fluorouracil</Name>
            <Formulation ID="F250412819103" Rank="4" Units="inj" Weight="5000">
              <Name>Inj 50 mg per ml, 100 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B25041281910326" PSS="true">
                <Name>Fluorouracil Accord</Name>
                <Pack ID="P2618427" Specified="true" nzmt:ctpp_id="50261301000117107">
                  <Quantity>1</Quantity>
                  <Price>19.36</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412819104" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 20 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B25041281910426" PSS="true">
                <Name>Fluorouracil Accord</Name>
                <Pack ID="P2618435" Specified="true" nzmt:ctpp_id="50261271000117105">
                  <Quantity>1</Quantity>
                  <Price>10.51</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412819105" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 50 ml vial</Name>
              <Brand ID="B25041281910526">
                <Name>Fluorouracil Accord</Name>
                <Pack ID="P2674092" Specified="true" nzmt:ctpp_id="50261281000117108">
                  <Quantity>1</Quantity>
                  <Price>14.72</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504128464">
            <Name>Thioguanine</Name>
            <Formulation ID="F250412846401" Rank="1" Units="tab" Weight="40">
              <Name>Tab 40 mg</Name>
              <Brand ID="B25041284640100">
                <Name>Any</Name>
                <Pack ID="P84640100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504128553">
            <Name>Azacitidine</Name>
            <Request Form="RS1904" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Azacitidine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has International Prognostic Scoring System (IPSS) intermediate-2 or high risk myelodysplastic syndrome</ci>
                      <ci type="logical">The patient has chronic myelomonocytic leukaemia (10%-29% marrow blasts without myeloproliferative disorder)</ci>
                      <ci type="logical">The patient has acute myeloid leukaemia with 20-30% blasts and multi-lineage dysplasia, according to World Health Organisation Classification (WHO)</ci>
                    </apply>
                    <ci type="logical">The patient has performance status (WHO/ECOG) grade 0-2</ci>
                    <ci type="logical">The patient has an estimated life expectancy of at least 3 months</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">No evidence of disease progression</ci>
                    <ci type="logical">The treatment remains appropriate and patient is benefitting from treatment</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Applicant Referring="haematologist">medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1904" style="display:none"/>
            <Formulation ID="F250412855325" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B25041285532526" PSS="true">
                <Name>Azacitidine Dr Reddy's</Name>
                <Pack ID="P2550083" Specified="true" nzmt:ctpp_id="50232011000117105">
                  <Quantity>1</Quantity>
                  <Price>50.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504128613">
            <Name>Pemetrexed</Name>
            <Request Form="RS1596" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Pemetrexed</range>
              </Title>
              <Case When="Initial application" Category="Mesothelioma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has been diagnosed with mesothelioma</ci>
                    <ci type="logical" class="Indication">Pemetrexed to be administered at a dose of 500 mg/m² every 21 days in combination with cisplatin or carboplatin for a maximum of 6 cycles</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">8</Term>
              </Case>
              <Case When="Renewal" Category="Mesothelioma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">No evidence of disease progression</ci>
                    <ci type="logical" class="Indication">The treatment remains appropriate and the patient is benefitting from treatment</ci>
                    <ci type="logical" class="Indication">Pemetrexed to be administered at a dose of 500mg/m² every 21 days for a maximum of 6 cycles</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">8</Term>
              </Case>
              <Case When="Initial application" Category="Non small cell lung cancer">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has locally advanced or metastatic non-squamous non-small cell lung carcinoma</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical" class="Indication">Patient has chemotherapy-naïve disease</ci>
                        <ci type="logical" class="Indication">Pemetrexed is to be administered at a dose of 500 mg/m² every 21 days in combination with cisplatin or carboplatin for a maximum of 6 cycles</ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical" class="Indication">Patient has had first-line treatment with platinum based chemotherapy</ci>
                        <ci type="logical" class="Indication">Patient has not received prior funded treatment with pemetrexed</ci>
                        <ci type="logical" class="Indication">Pemetrexed is to be administered at a dose of 500 mg/m² every 21 days for a maximum of 6 cycles</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">8</Term>
              </Case>
              <Case When="Renewal" Category="Non small cell lung cancer">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">No evidence of disease progression</ci>
                    <ci type="logical" class="Indication">The treatment remains appropriate and the patient is benefitting from treatment</ci>
                    <ci type="logical" class="Indication">Pemetrexed is to be administered at a dose of 500mg/m² every 21 days</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">8</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1596" style="display:none"/>
            <Formulation ID="F250412861325" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg vial</Name>
              <Brand ID="B25041286132525">
                <Name>Juno Pemetrexed</Name>
                <Pack ID="P2524619" Specified="true" nzmt:ctpp_id="50229141000117102">
                  <Quantity>1</Quantity>
                  <Price>60.89</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412861326" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg vial</Name>
              <Brand ID="B25041286132625">
                <Name>Juno Pemetrexed</Name>
                <Pack ID="P2524627" Specified="true" nzmt:ctpp_id="50229131000117105">
                  <Quantity>1</Quantity>
                  <Price>217.77</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504129009">
            <Name>Capecitabine</Name>
            <Formulation ID="F250412900901" Rank="1" Units="tab" Weight="150">
              <Name>Tab 150 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-24 to~2025" Value="5"/>
              <Brand ID="B25041290090128" PSS="true">
                <Name>Capecitabine Viatris</Name>
                <Pack ID="P2634929" Specified="true" nzmt:ctpp_id="50302761000117106">
                  <Quantity>60</Quantity>
                  <Price>9.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412900902" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Rule Type="DVLimit" Attribute="Jan-24 to~2025" Value="5"/>
              <Brand ID="B25041290090228" PSS="true">
                <Name>Capecitabine Viatris</Name>
                <Pack ID="P2634937" Specified="true" nzmt:ctpp_id="50302771000117101">
                  <Quantity>120</Quantity>
                  <Price>46.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504129072">
            <Name>Cladribine</Name>
            <Formulation ID="F250412907201" Rank="4" Units="inj" Weight="10">
              <Name>Inj 1 mg per ml, 10 ml vial</Name>
              <Brand ID="B25041290720101">
                <Name>Leustatin</Name>
                <Pack ID="P2595788" Specified="true" nzmt:ctpp_id="50278241000117100">
                  <Quantity>1</Quantity>
                  <Price>749.96</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412907202" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2 mg per ml, 5 ml vial</Name>
              <Brand ID="B25041290720200">
                <Name>Any</Name>
                <Pack ID="P90720200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504129075">
            <Name>Cytarabine</Name>
            <Formulation ID="F250412907509" Rank="4" Units="inj" Weight="2000">
              <Name>Inj 100 mg per ml, 20 ml vial</Name>
              <Brand ID="B25041290750901">
                <Name>Cytarabine DBL</Name>
                <Pack ID="P341711" Specified="true" nzmt:ctpp_id="50075311000117108">
                  <Quantity>1</Quantity>
                  <Price>48.80</Price>
                </Pack>
              </Brand>
              <Brand ID="B25041290750925">
                <Name>Pfizer</Name>
                <Pack ID="P2359537" Specified="true" nzmt:ctpp_id="50050901000117102">
                  <Quantity>1</Quantity>
                  <Price>48.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412907525" Rank="4" Units="inj" Weight="100">
              <Name>Inj 20 mg per ml, 5 ml vial</Name>
              <Brand ID="B25041290752525">
                <Name>Pfizer</Name>
                <Pack ID="P786365" Specified="true" nzmt:ctpp_id="50114251000117101">
                  <Quantity>5</Quantity>
                  <Price>472.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504129088">
            <Name>Fludarabine phosphate</Name>
            <Formulation ID="F250412908801" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B25041290880125">
                <Name>Fludara Oral</Name>
                <Pack ID="P2327988" Specified="true" nzmt:ctpp_id="50120021000117104">
                  <Quantity>20</Quantity>
                  <Price>412.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412908802" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Jan-23 to~2025" Value="5"/>
              <Brand ID="B25041290880225" PSS="true">
                <Name>Fludarabine Ebewe</Name>
                <Pack ID="P2386933" Specified="true" nzmt:ctpp_id="50123471000117104">
                  <Quantity>5</Quantity>
                  <Price>634.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B25041290880226">
                <Name>Fludarabine Sagent</Name>
                <Pack ID="P2680793" Specified="true" nzmt:ctpp_id="50334761000117107">
                  <Quantity>1</Quantity>
                  <Price>126.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504129090">
            <Name>Gemcitabine Hydrochloride</Name>
            <Formulation ID="F250412909025" Rank="4" Units="inj">
              <Name>Inj 43.3 mg per ml (equivalent to 38 mg per ml gemcitabine), 26.3 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~2026" Value="5"/>
              <Brand ID="B25041290902525" PSS="true">
                <Name>DBL Gemcitabine</Name>
                <Pack ID="P2521423" Specified="true" nzmt:ctpp_id="50146891000117109">
                  <Quantity>1</Quantity>
                  <Price>18.94</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504129100">
            <Name>Methotrexate</Name>
            <Formulation ID="F250412910001" Rank="1" Units="tab" Weight="2.5">
              <Name>Tab 2.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B25041291000125" PSS="true">
                <Name>Trexate</Name>
                <Pack ID="P2537060" Specified="true" nzmt:ctpp_id="50252481000117108">
                  <Quantity>90</Quantity>
                  <Price>7.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412910002" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B25041291000225" PSS="true">
                <Name>Trexate</Name>
                <Pack ID="P2537079" Specified="true" nzmt:ctpp_id="50252491000117106">
                  <Quantity>90</Quantity>
                  <Price>26.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412910014" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 100 mg per ml, 10 ml vial</Name>
              <Brand ID="B25041291001425">
                <Name>Methotrexate Ebewe</Name>
                <Pack ID="P2215675" Specified="true" nzmt:ctpp_id="50034311000117109">
                  <Quantity>1</Quantity>
                  <Price>25.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412910015" Rank="4" Units="inj" Weight="5000">
              <Name>Inj 100 mg per ml, 50 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B25041291001525" PSS="true">
                <Name>Methotrexate Ebewe</Name>
                <Pack ID="P2215683" Specified="true" nzmt:ctpp_id="50034321000117103">
                  <Quantity>1</Quantity>
                  <Price>67.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412910016" Rank="4" Units="inj" Weight="2.5">
              <Name>Inj 2.5 mg per ml, 2 ml vial</Name>
              <Brand ID="B25041291001600">
                <Name>Any</Name>
                <Pack ID="P91001600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412910026" Rank="4" Units="inj" Weight="50">
              <Name>Inj 25 mg per ml, 2 ml vial</Name>
              <Brand ID="B25041291002626">
                <Name>Methotrexate DBL Onco-Vial</Name>
                <Pack ID="P2599686" Specified="true" nzmt:ctpp_id="50281681000117107">
                  <Quantity>5</Quantity>
                  <Price>30.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412910027" Rank="4" Units="inj" Weight="500">
              <Name>Inj 25 mg per ml, 20 ml vial</Name>
              <Brand ID="B25041291002725">
                <Name>DBL Methotrexate Onco-Vial</Name>
                <Pack ID="P333263" Specified="true" nzmt:ctpp_id="50074071000117103">
                  <Quantity>1</Quantity>
                  <Price>45.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412910028" Rank="4" Units="inj" Weight="7">
              <Name>Inj 7.5 mg prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B25041291002825" PSS="true">
                <Name>Methotrexate Sandoz</Name>
                <Pack ID="P2445832" Specified="true" nzmt:ctpp_id="50167731000117107">
                  <Quantity>1</Quantity>
                  <Price>29.17</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412910029" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B25041291002925" PSS="true">
                <Name>Methotrexate Sandoz</Name>
                <Pack ID="P2445840" Specified="true" nzmt:ctpp_id="50167761000117100">
                  <Quantity>1</Quantity>
                  <Price>19.09</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412910030" Rank="4" Units="inj" Weight="15">
              <Name>Inj 15 mg prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B25041291003025" PSS="true">
                <Name>Methotrexate Sandoz</Name>
                <Pack ID="P2445859" Specified="true" nzmt:ctpp_id="50167791000117106">
                  <Quantity>1</Quantity>
                  <Price>24.53</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412910031" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B25041291003125" PSS="true">
                <Name>Methotrexate Sandoz</Name>
                <Pack ID="P2445867" Specified="true" nzmt:ctpp_id="50141461000117106">
                  <Quantity>1</Quantity>
                  <Price>16.64</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412910032" Rank="4" Units="inj" Weight="25">
              <Name>Inj 25 mg prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B25041291003225" PSS="true">
                <Name>Methotrexate Sandoz</Name>
                <Pack ID="P2445875" Specified="true" nzmt:ctpp_id="50141451000117109">
                  <Quantity>1</Quantity>
                  <Price>20.72</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412910033" Rank="4" Units="inj" Weight="30">
              <Name>Inj 30 mg prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B25041291003325" PSS="true">
                <Name>Methotrexate Sandoz</Name>
                <Pack ID="P2445883" Specified="true" nzmt:ctpp_id="50141441000117107">
                  <Quantity>1</Quantity>
                  <Price>55.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504129559">
            <Name>Mercaptopurine</Name>
            <Formulation ID="F250412955925" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B25041295592525" PSS="true">
                <Name>Puri-nethol</Name>
                <Pack ID="P261270" Specified="true" nzmt:ctpp_id="50057571000117101">
                  <Quantity>25</Quantity>
                  <Price>25.90</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250412955926" Rank="3" Units="ml" Weight="20">
              <Name>Oral suspension 20 mg per ml</Name>
              <Request Form="RS1635" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Mercaptopurine</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">The patient requires a total dose of less than one full 50 mg tablet per day</ci>
                  </math>
                  <Applicant>paediatric haematologist</Applicant>
                  <Applicant>paediatric oncologist</Applicant>
                  <Term Measure="month">12</Term>
                </Case>
                <Case When="Renewal">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">The patient requires a total dose of less than one full 50 mg tablet per day</ci>
                  </math>
                  <Applicant>paediatric haematologist</Applicant>
                  <Applicant>paediatric oncologist</Applicant>
                  <Term Measure="month">12</Term>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1635" style="display:none"/>
              <Brand ID="B25041295592625">
                <Name>Allmercap</Name>
                <Pack ID="P2545551" Specified="true" nzmt:ctpp_id="50221241000117105">
                  <Quantity>100</Quantity>
                  <Price>428.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B25041295592626">
                <Name> Xaluprine</Name>
                <Pack ID="P2682257" Specified="true" nzmt:ctpp_id="50335821000117109">
                  <Quantity>100</Quantity>
                  <Price>428.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A250416">
          <Name>Other Cytotoxic Agents</Name>
          <Chemical ID="C2504168030">
            <Name>Amsacrine</Name>
            <Formulation ID="F250416803001" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 1.5 ml ampoule</Name>
              <Brand ID="B25041680300100">
                <Name>Any</Name>
                <Pack ID="P80300100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416803025" Rank="4" Units="inj" Weight="75">
              <Name>Inj 75 mg</Name>
              <Brand ID="B25041680302500">
                <Name>Any</Name>
                <Pack ID="P80302500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504168032">
            <Name>Anagrelide hydrochloride</Name>
            <Formulation ID="F250416803201" Rank="2" Units="cap" Weight="0.5">
              <Name>Cap 0.5 mg</Name>
              <Brand ID="B25041680320100">
                <Name>Any</Name>
                <Pack ID="P80320100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504168349">
            <Name>Pentostatin [Deoxycoformycin]</Name>
            <Formulation ID="F250416834901" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg vial</Name>
              <Brand ID="B25041683490100">
                <Name>Any</Name>
                <Pack ID="P83490100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504168554">
            <Name>Lenalidomide (Revlimid)</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1836">
              <Title>
                <range>Lenalidomide</range>
              </Title>
              <Case When="Initial application" Category="Relapsed/refractory disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has relapsed or refractory multiple myeloma with progressive disease</ci>
                    <ci type="logical">Patient has not previously been treated with lenalidomide</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Lenalidomide to be used as third line* treatment for multiple myeloma</ci>
                      <apply>
                        <and/>
                        <ci type="logical">Lenalidomide to be used as second line treatment for multiple myeloma</ci>
                        <ci type="logical">The patient has experienced severe (grade 3 or higher), dose limiting, peripheral neuropathy with either bortezomib or thalidomide that precludes further treatment
                            with either of these treatments</ci>
                      </apply>
                    </apply>
                    <ci type="logical">Lenalidomide to be administered at a maximum dose of 25 mg/day in combination with dexamethasone</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Relapsed/refractory disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">No evidence of disease progression</ci>
                    <ci type="logical">The treatment remains appropriate and patient is benefitting from treatment</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Maintenance following first-line autologous stem cell transplant (SCT)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has newly diagnosed symptomatic multiple myeloma and has undergone first-line treatment that included an autologous stem cell transplantation</ci>
                    <ci type="logical">Patient has at least a stable disease response in the first 100 days after transplantation</ci>
                    <ci type="logical">Lenalidomide maintenance is to be commenced within 6 months of transplantation</ci>
                    <ci type="logical">Lenalidomide to be administered at a maximum dose of 15 mg/day</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Maintenance following first-line autologous stem cell transplant (SCT)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">No evidence of disease progression</ci>
                    <ci type="logical">The treatment remains appropriate and patient is benefitting from treatment</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Indication marked with * is an unapproved indication. A line of treatment is considered to comprise either: a) a known therapeutic
            chemotherapy regimen and supportive treatments or b) a transplant induction chemotherapy regimen, stem cell transplantation and supportive treatments. Prescriptions must be written by a
            registered prescriber in the lenalidomide risk management programme operated by the supplier.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1836" style="display:none"/>
            <Formulation ID="F250416855425" Rank="2" Units="cap" Weight="10">
              <Name>Cap 10 mg</Name>
              <Brand ID="B25041685542525" ToBeDelisted="2025-02-01">
                <Name>Revlimid</Name>
                <Pack ID="P2293390" nzmt:ctpp_id="50045051000117108">
                  <Quantity>21</Quantity>
                  <Price>4655.25</Price>
                </Pack>
                <Pack ID="P2586312" Specified="true" nzmt:ctpp_id="50259661000117107">
                  <Quantity>28</Quantity>
                  <Price>6207.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416855426" Rank="2" Units="cap" Weight="25">
              <Name>Cap 25 mg</Name>
              <Brand ID="B25041685542625" ToBeDelisted="2025-02-01">
                <Name>Revlimid</Name>
                <Pack ID="P2331209" Specified="true" nzmt:ctpp_id="50126541000117101">
                  <Quantity>21</Quantity>
                  <Price>7627.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416855427" Rank="2" Units="cap" Weight="15">
              <Name>Cap 15 mg</Name>
              <Brand ID="B25041685542725" ToBeDelisted="2025-02-01">
                <Name>Revlimid</Name>
                <Pack ID="P2369478" nzmt:ctpp_id="50124471000117101">
                  <Quantity>21</Quantity>
                  <Price>5429.39</Price>
                </Pack>
                <Pack ID="P2586320" Specified="true" nzmt:ctpp_id="50259671000117102">
                  <Quantity>28</Quantity>
                  <Price>7239.18</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416855428" Rank="2" Units="cap" Weight="5">
              <Name>Cap 5 mg</Name>
              <Brand ID="B25041685542825" ToBeDelisted="2025-02-01">
                <Name>Revlimid</Name>
                <Pack ID="P2586339" Specified="true" nzmt:ctpp_id="50259651000117105">
                  <Quantity>28</Quantity>
                  <Price>5122.76</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504168650">
            <Name>Venetoclax</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1713">
              <Title>
                <range>Venetoclax</range>
              </Title>
              <Case When="Initial application" Category="relapsed/refractory chronic lymphocytic leukaemia">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has chronic lymphocytic leukaemia requiring treatment</ci>
                    <ci type="logical" class="Indication">Patient has received at least one prior therapy for chronic lymphocytic leukaemia</ci>
                    <ci type="logical" class="Indication">Patient has not previously received funded venetoclax</ci>
                    <ci type="logical" class="Indication">The patient’s disease has relapsed within 36 months of previous treatment</ci>
                    <ci type="logical" class="Indication">Venetoclax to be used in combination with six 28-day cycles of rituximab commencing after the 5-week dose titration schedule with venetoclax</ci>
                    <ci type="logical" class="Indication">Patient has an ECOG performance status of 0-2</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">7</Term>
              </Case>
              <Case When="Renewal" Category="relapsed/refractory chronic lymphocytic leukaemia">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Treatment remains clinically appropriate and the patient is benefitting from and tolerating treatment</ci>
                    <ci type="logical" class="Indication">Venetoclax is to be discontinued after a maximum of 24 months of treatment following the titration schedule unless earlier discontinuation is
                    required due to disease progression or unacceptable toxicity</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="previously untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has previously untreated chronic lymphocytic leukaemia</ci>
                    <ci type="logical" class="Indication">There is documentation confirming that patient has 17p deletion by FISH testing or TP53 mutation by sequencing</ci>
                    <ci type="logical" class="Indication">Patient has an ECOG performance status of 0-2</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="previously untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">The treatment remains clinically appropriate and the patient is benefitting from and tolerating treatment</ci>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>‘Chronic lymphocytic leukaemia (CLL)’ includes small lymphocytic lymphoma (SLL)* and B-cell prolymphocytic leukaemia (B-PLL)*. Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1713" style="display:none"/>
            <Formulation ID="F250416865025" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B25041686502525">
                <Name>Venclexta</Name>
                <Pack ID="P2635054" Specified="true" nzmt:ctpp_id="50285391000117102">
                  <Quantity>2</Quantity>
                  <Price>13.68</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416865026" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Brand ID="B25041686502625">
                <Name>Venclexta</Name>
                <Pack ID="P2555654" Specified="true" nzmt:ctpp_id="50240861000117103">
                  <Quantity>7</Quantity>
                  <Price>239.44</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416865027" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B25041686502725">
                <Name>Venclexta</Name>
                <Pack ID="P2555662" Specified="true" nzmt:ctpp_id="50240901000117108">
                  <Quantity>120</Quantity>
                  <Price>8209.41</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416865028" Rank="1" Units="tab">
              <Name>Tab 14 x 10 mg, 7 x 50 mg, 21 x 100 mg</Name>
              <Brand ID="B25041686502825">
                <Name>Venclexta</Name>
                <Pack ID="P2555638" Specified="true" nzmt:ctpp_id="50240911000117106">
                  <Quantity>42</Quantity>
                  <Price>1771.86</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504168652">
            <Name>Olaparib</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1925">
              <Title>
                <range>Olaparib</range>
              </Title>
              <Case When="Initial application" Category="Ovarian cancer">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has a high-grade serous* epithelial ovarian, fallopian tube, or primary peritoneal cancer</ci>
                    <ci type="logical" class="Indication">There is documentation confirming pathogenic germline BRCA1 or BRCA2 gene mutation</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical" class="Indication">Patient has newly diagnosed, advanced disease</ci>
                        <ci type="logical" class="Indication">Patient has received one line** of previous treatment with platinum-based chemotherapy</ci>
                        <ci type="logical" class="Indication">Patient’s disease must have experienced a partial or complete response to the first-line platinum-based regimen</ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical" class="Indication">Patient has received at least two lines** of previous treatment with platinum-based chemotherapy</ci>
                        <ci type="logical" class="Indication">Patient has platinum sensitive disease defined as disease progression occurring at least 6 months after the last dose of the penultimate line** of platinum-based chemotherapy</ci>
                        <ci type="logical" class="Indication">Patient’s disease must have experienced a partial or complete response to treatment with the immediately preceding platinum-based regimen</ci>
                        <ci type="logical" class="Indication">Patient has not previously received funded olaparib treatment</ci>
                      </apply>
                    </apply>
                    <ci type="logical" class="Indication">Treatment will be commenced within 12 weeks of the patient’s last dose of the immediately preceding platinum-based regimen</ci>
                    <ci type="logical" class="Indication">Treatment to be administered as maintenance treatment</ci>
                    <ci type="logical" class="Indication">Treatment not to be administered in combination with other chemotherapy</ci>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="Ovarian cancer">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Treatment remains clinically appropriate and patient is benefitting from treatment</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">No evidence of progressive disease</ci>
                      <ci type="logical" class="Indication">Evidence of residual (not progressive) disease and the patient would continue to benefit from treatment in the clinician’s opinion</ci>
                    </apply>
                    <ci type="logical" class="Indication">Treatment to be administered as maintenance treatment</ci>
                    <ci type="logical" class="Indication">Treatment not to be administered in combination with other chemotherapy</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical" class="Indication">Patient has received one line** of previous treatment with platinum-based chemotherapy</ci>
                        <ci type="logical" class="Indication">Documentation confirming that the patient has been informed and acknowledges that the funded treatment period of olaparib will not be continued beyond 2 years if the patient experiences a complete response to treatment and there is no radiological evidence of disease at 2 years</ci>
                      </apply>
                      <ci type="logical" class="Indication">Patient has received at least two lines** of previous treatment with platinum-based chemotherapy</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>*Note “high-grade serous” includes tumours with high-grade serous features or a high-grade serous component.</p>
                <p>**A line of chemotherapy treatment is considered to comprise a known standard therapeutic chemotherapy regimen and supportive treatments.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1925" style="display:none"/>
            <Formulation ID="F250416865226" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B25041686522625">
                <Name>Lynparza</Name>
                <Pack ID="P2578441" Specified="true" nzmt:ctpp_id="50249561000117108">
                  <Quantity>56</Quantity>
                  <Price>3701.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416865227" Rank="1" Units="tab" Weight="150">
              <Name>Tab 150 mg</Name>
              <Brand ID="B25041686522725">
                <Name>Lynparza</Name>
                <Pack ID="P2578468" Specified="true" nzmt:ctpp_id="50249551000117106">
                  <Quantity>56</Quantity>
                  <Price>3701.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504168700">
            <Name>Ibrutinib</Name>
            <Request Form="RS1933" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ibrutinib</range>
              </Title>
              <Case When="Initial application" Category="chronic lymphocytic leukaemia (CLL)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has chronic lymphocytic leukaemia
                    (CLL) requiring therapy</ci>
                    <ci type="logical" class="Indication">Patient has not previously received funded
                    ibrutinib</ci>
                    <ci type="logical" class="Indication">Ibrutinib is to be used as monotherapy</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">There is documentation confirming that patient has 17p
                            deletion or TP53 mutation</ci>
                        <ci type="logical">Patient has experienced intolerable side effects with
                            venetoclax monotherapy</ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">Patient has received at least one prior
                            immunochemotherapy for CLL</ci>
                        <ci type="logical">Patient’s CLL has relapsed within 36 months of previous
                            treatment</ci>
                        <ci type="logical">Patient has experienced intolerable side effects with
                            venetoclax in combination with rituximab regimen</ci>
                      </apply>
                      <ci type="logical">Patient’s CLL is refractory to or has relapsed within 36
                        months of a venetoclax regimen</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="chronic lymphocytic leukaemia (CLL)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">No evidence of clinical disease progression</ci>
                    <ci type="logical">The treatment remains appropriate and the patient is benefitting
                    from treatment</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>‘Chronic lymphocytic leukaemia (CLL)’ includes small lymphocytic lymphoma (SLL) and
            B-cell prolymphocytic leukaemia (B-PLL)*. Indications marked with * are Unapproved
            indications.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1933" style="display:none"/>
            <Formulation ID="F250416870025" Rank="1" Units="tab" Weight="140">
              <Name>Tab 140 mg</Name>
              <Brand ID="B25041687002525">
                <Name>Imbruvica</Name>
                <Pack ID="P2606402" Specified="true" nzmt:ctpp_id="50257041000117106">
                  <Quantity>30</Quantity>
                  <Price>3217.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416870026" Rank="1" Units="tab" Weight="420">
              <Name>Tab 420 mg</Name>
              <Brand ID="B25041687002625">
                <Name>Imbruvica</Name>
                <Pack ID="P2606410" Specified="true" nzmt:ctpp_id="50257061000117105">
                  <Quantity>30</Quantity>
                  <Price>9652.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504168737">
            <Name>Niraparib</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS2027">
              <Title>
                <range>Niraparib</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has advanced high-grade serous* epithelial ovarian, fallopian tube, or primary peritoneal cancer</ci>
                    <ci type="logical" class="Indication">Patient has received at least one line** of treatment with platinum-based chemotherapy</ci>
                    <ci type="logical" class="Indication">Patient has experienced a partial or complete response to the preceding treatment with platinum-based chemotherapy</ci>
                    <ci type="logical" class="Indication">Patient has not previously received funded treatment with a PARP inhibitor</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Treatment will be commenced within 12 weeks of the patient's last dose of the preceding platinum-based regimen</ci>
                      <ci type="logical" class="Indication">Patient commenced treatment with niraparib prior to 1 May 2024</ci>
                    </apply>
                    <ci type="logical" class="Indication">Treatment to be administered as maintenance treatment</ci>
                    <ci type="logical" class="Indication">Treatment not to be administered in combination with other chemotherapy</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">No evidence of progressive disease</ci>
                    <ci type="logical" class="Indication">Treatment to be administered as maintenance treatment</ci>
                    <ci type="logical" class="Indication">Treatment not to be administered in combination with other chemotherapy</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Treatment with niraparib to cease after a total duration of 36 months from commencement</ci>
                      <ci type="logical" class="Indication">Treatment with niraparib is being used in the second-line or later maintenance setting</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>* "high-grade serous" includes tumours with high-grade serous features or a high-grade serous component.</p>
                <p>**A line of chemotherapy treatment is considered to comprise a known standard therapeutic chemotherapy regimen and supportive treatments</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS2027" style="display:none"/>
            <Formulation ID="F250416873725" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Brand ID="B25041687372525">
                <Name>Zejula</Name>
                <Pack ID="P2635232" Specified="true" nzmt:ctpp_id="50281941000117105">
                  <Quantity>56</Quantity>
                  <Price>8929.84</Price>
                </Pack>
                <Pack ID="P2635240" Specified="true" nzmt:ctpp_id="50281951000117107">
                  <Quantity>84</Quantity>
                  <Price>13393.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504168743">
            <Name>Lenalidomide (Viatris)</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS2044">
              <Title>
                <range>Lenalidomide</range>
              </Title>
              <Case When="Initial application" Category="Plasma cell dyscrasia">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has plasma cell dyscrasia, not including Waldenström macroglobulinaemia, requiring treatment</ci>
                    <ci type="logical" class="Indication">Patient is not refractory to prior lenalidomide use</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Myelodysplastic syndrome">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has low or intermediate-1 risk myelodysplastic syndrome (based on IPSS or an IPSS-R score of less than 3.5) associated with a deletion 5q cytogenetic abnormality</ci>
                    <ci type="logical" class="Indication">Patient has transfusion-dependent anaemia</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Myelodysplastic syndrome">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has not needed a transfusion in the last 4 months</ci>
                    <ci type="logical" class="Indication">No evidence of disease progression</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2044" style="display:none"/>
            <Formulation ID="F250416874325" Rank="2" Units="cap" Weight="5">
              <Name>Cap 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~31~Jan~2028" Value="5"/>
              <Brand ID="B25041687432525" PSS="true">
                <Name>Lenalidomide Viatris</Name>
                <Pack ID="P2673525" Specified="true" nzmt:ctpp_id="50293081000117100">
                  <Quantity>21</Quantity>
                  <Price>76.92</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416874326" Rank="2" Units="cap" Weight="10">
              <Name>Cap 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~31~Jan~2028" Value="5"/>
              <Brand ID="B25041687432625" PSS="true">
                <Name>Lenalidomide Viatris</Name>
                <Pack ID="P2673533" Specified="true" nzmt:ctpp_id="50293101000117106">
                  <Quantity>21</Quantity>
                  <Price>50.30</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416874327" Rank="2" Units="cap" Weight="15">
              <Name>Cap 15 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~31~Jan~2028" Value="5"/>
              <Brand ID="B25041687432725" PSS="true">
                <Name>Lenalidomide Viatris</Name>
                <Pack ID="P2673541" Specified="true" nzmt:ctpp_id="50293111000117109">
                  <Quantity>21</Quantity>
                  <Price>62.13</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416874328" Rank="2" Units="cap" Weight="25">
              <Name>Cap 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~31~Jan~2028" Value="5"/>
              <Brand ID="B25041687432825" PSS="true">
                <Name>Lenalidomide Viatris</Name>
                <Pack ID="P2673568" Specified="true" nzmt:ctpp_id="50293131000117100">
                  <Quantity>21</Quantity>
                  <Price>65.09</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504168744">
            <Name>Pomalidomide</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS2045">
              <Title>
                <range>Pomalidomide</range>
              </Title>
              <Case When="Initial application" Category="Relapsed/refractory plasma cell dyscrasia">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has relapsed or refractory plasma cell
                    dyscrasia, not including Waldenström macroglobulinaemia, requiring
                    treatment</ci>
                    <ci type="logical" class="Indication">Patient has not received prior funded
                    pomalidomide</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Relapsed/refractory plasma cell dyscrasia">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">Patient has no evidence of disease progression</ci>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2045" style="display:none"/>
            <Formulation ID="F250416874425" Rank="2" Units="cap" Weight="1">
              <Name>Cap 1 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~31~Jul~2027" Value="5"/>
              <Brand ID="B25041687442525" PSS="true">
                <Name>Pomolide</Name>
                <Pack ID="P2680297" Specified="true" nzmt:ctpp_id="50299721000117104">
                  <Quantity>14</Quantity>
                  <Price>47.45</Price>
                </Pack>
                <Pack ID="P2680300" Specified="true" nzmt:ctpp_id="50299731000117101">
                  <Quantity>21</Quantity>
                  <Price>71.18</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416874426" Rank="2" Units="cap" Weight="2">
              <Name>Cap 2 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~31~Jul~2027" Value="5"/>
              <Brand ID="B25041687442625" PSS="true">
                <Name>Pomolide</Name>
                <Pack ID="P2680319" Specified="true" nzmt:ctpp_id="50299751000117106">
                  <Quantity>14</Quantity>
                  <Price>94.90</Price>
                </Pack>
                <Pack ID="P2680327" Specified="true" nzmt:ctpp_id="50299761000117108">
                  <Quantity>21</Quantity>
                  <Price>142.35</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416874427" Rank="2" Units="cap" Weight="3">
              <Name>Cap 3 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~31~Jul~2027" Value="5"/>
              <Brand ID="B25041687442725" PSS="true">
                <Name>Pomolide</Name>
                <Pack ID="P2680335" Specified="true" nzmt:ctpp_id="50299781000117100">
                  <Quantity>14</Quantity>
                  <Price>142.35</Price>
                </Pack>
                <Pack ID="P2680343" Specified="true" nzmt:ctpp_id="50299791000117102">
                  <Quantity>21</Quantity>
                  <Price>213.53</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416874428" Rank="2" Units="cap" Weight="4">
              <Name>Cap 4 mg</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~31~Jul~2027" Value="5"/>
              <Brand ID="B25041687442825" PSS="true">
                <Name>Pomolide</Name>
                <Pack ID="P2680351" Specified="true" nzmt:ctpp_id="50299811000117103">
                  <Quantity>14</Quantity>
                  <Price>189.81</Price>
                </Pack>
                <Pack ID="P2680378" Specified="true" nzmt:ctpp_id="50299821000117109">
                  <Quantity>21</Quantity>
                  <Price>284.71</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504169076">
            <Name>Dacarbazine</Name>
            <Formulation ID="F250416907602" Rank="4" Units="inj" Weight="200">
              <Name>Inj 200 mg vial</Name>
              <Brand ID="B25041690760201">
                <Name>DBL Dacarbazine</Name>
                <Pack ID="P299308" Specified="true" nzmt:ctpp_id="50066551000117100">
                  <Quantity>1</Quantity>
                  <Price>72.11</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504169085">
            <Name>Etoposide</Name>
            <Formulation ID="F250416908501" Rank="2" Units="cap" Weight="50">
              <Name>Cap 50 mg</Name>
              <Brand ID="B25041690850101">
                <Name>Vepesid</Name>
                <Pack ID="P332690" Specified="true" nzmt:ctpp_id="50073781000117100">
                  <Quantity>20</Quantity>
                  <Price>340.73</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416908502" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Brand ID="B25041690850201">
                <Name>Vepesid</Name>
                <Pack ID="P332704" Specified="true" nzmt:ctpp_id="50073791000117102">
                  <Quantity>10</Quantity>
                  <Price>340.73</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416908503" Rank="4" Units="inj" Weight="100">
              <Name>Inj 20 mg per ml, 5 ml vial</Name>
              <Brand ID="B25041690850325">
                <Name>Rex Medical</Name>
                <Pack ID="P2480913" Specified="true" nzmt:ctpp_id="50225401000117106">
                  <Quantity>1</Quantity>
                  <Price>7.90</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504169096">
            <Name>Irinotecan hydrochloride</Name>
            <Formulation ID="F250416909602" Rank="4" Units="inj" Weight="100">
              <Name>Inj 20 mg per ml, 5 ml vial</Name>
              <Brand ID="B25041690960227">
                <Name>Accord</Name>
                <Pack ID="P2621177" Specified="true" nzmt:ctpp_id="50265431000117109">
                  <Quantity>1</Quantity>
                  <Price>52.57</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504169105">
            <Name>Procarbazine hydrochloride</Name>
            <Formulation ID="F250416910501" Rank="2" Units="cap" Weight="50">
              <Name>Cap 50 mg</Name>
              <Brand ID="B25041691050101">
                <Name>Natulan</Name>
                <Pack ID="P336548" Specified="true" nzmt:ctpp_id="50074521000117109">
                  <Quantity>50</Quantity>
                  <Price>980.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504169198">
            <Name>Hydroxyurea [hydroxycarbamide]</Name>
            <Formulation ID="F250416919825" Rank="2" Units="cap" Weight="500">
              <Name>Cap 500 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B25041691982526" PSS="true">
                <Name>Devatis</Name>
                <Pack ID="P2593246" Specified="true" nzmt:ctpp_id="50265131000117101">
                  <Quantity>100</Quantity>
                  <Price>20.72</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504169291">
            <Name>Tretinoin</Name>
            <Formulation ID="F250416929125" Rank="2" Units="cap" Weight="10">
              <Name>Cap 10 mg</Name>
              <Brand ID="B25041692912525">
                <Name>Vesanoid</Name>
                <Pack ID="P235229" Specified="true" nzmt:ctpp_id="50050631000117104">
                  <Quantity>100</Quantity>
                  <Price>479.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504169298">
            <Name>Temozolomide</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1994">
              <Title>
                <range>Temozolomide</range>
              </Title>
              <Case When="Initial application" Category="gliomas">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has a glioma</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="gliomas">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Treatment remains appropriate and patient is benefitting from treatment</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="Neuroendocrine tumours">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has been diagnosed with metastatic or unresectable well-differentiated neuroendocrine tumour*</ci>
                    <ci type="logical">Temozolomide is to be given in combination with capecitabine</ci>
                    <ci type="logical">Temozolomide is to be used in 28 day treatment cycles for a maximum of 5 days treatment per cycle at a maximum dose of 200 mg/m² per day</ci>
                    <ci type="logical">Temozolomide to be discontinued at disease progression</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">9</Term>
              </Case>
              <Case When="Renewal" Category="Neuroendocrine tumours">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">No evidence of disease progression</ci>
                    <ci type="logical" class="Indication">The treatment remains appropriate and the patient is benefitting from treatment</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="ewing's sarcoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has relapse or refractory Ewing’s sarcoma</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">9</Term>
              </Case>
              <Case When="Renewal" Category="ewing's sarcoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">No evidence of disease progression</ci>
                    <ci type="logical" class="Indication">The treatment remains appropriate and the patient is benefitting from treatment</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Indication marked with a * is an unapproved indication. Temozolomide is not funded for the treatment of relapsed high grade glioma.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1994" style="display:none"/>
            <Formulation ID="F250416929825" Rank="2" Units="cap" Weight="5">
              <Name>Cap 5 mg</Name>
              <Brand ID="B25041692982526">
                <Name>Temaccord</Name>
                <Pack ID="P2388278" Specified="true" nzmt:ctpp_id="50127391000117103">
                  <Quantity>5</Quantity>
                  <Price>9.13</Price>
                </Pack>
              </Brand>
              <Brand ID="B25041692982528">
                <Name>Temozolomide Taro</Name>
                <Pack ID="P2689413" Specified="true" nzmt:ctpp_id="50339921000117100">
                  <Quantity>5</Quantity>
                  <Price>9.13</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416929826" Rank="2" Units="cap" Weight="20">
              <Name>Cap 20 mg</Name>
              <Brand ID="B25041692982626">
                <Name>Temaccord</Name>
                <Pack ID="P2388251" Specified="true" nzmt:ctpp_id="50127411000117103">
                  <Quantity>5</Quantity>
                  <Price>16.38</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416929827" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Brand ID="B25041692982726">
                <Name>Temaccord</Name>
                <Pack ID="P2388243" Specified="true" nzmt:ctpp_id="50127421000117109">
                  <Quantity>5</Quantity>
                  <Price>35.98</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416929828" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Brand ID="B25041692982826">
                <Name>Temaccord</Name>
                <Pack ID="P2388235" Specified="true" nzmt:ctpp_id="50127441000117104">
                  <Quantity>5</Quantity>
                  <Price>86.34</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416929829" Rank="2" Units="cap" Weight="140">
              <Name>Cap 140 mg</Name>
              <Brand ID="B25041692982925">
                <Name>Temaccord</Name>
                <Pack ID="P2566044" Specified="true" nzmt:ctpp_id="50182161000117104">
                  <Quantity>5</Quantity>
                  <Price>50.12</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504169479">
            <Name>Arsenic trioxide</Name>
            <Formulation ID="F250416947925" Rank="4" Units="inj" Weight="10">
              <Name>Inj 1 mg per ml, 10 ml vial</Name>
              <Brand ID="B25041694792526">
                <Name>Phenasen</Name>
                <Pack ID="P2560518" Specified="true" nzmt:ctpp_id="50262111000117102">
                  <Quantity>10</Quantity>
                  <Price>4817.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504169582">
            <Name>Thalidomide</Name>
            <Request Form="RS2046" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Thalidomide</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">The patient has plasma cell dyscrasia, not including Waldenström macroglobulinaemia, requiring treatment</ci>
                    <ci type="logical">The patient has erythema nodosum leprosum</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has obtained a response from treatment during the initial approval period</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Prescription must be written by a registered prescriber in the thalidomide risk management programme operated by the supplier</p>
                  <p>Maximum dose of 400 mg daily as monotherapy or in a combination therapy regimen</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2046" style="display:none"/>
            <Formulation ID="F250416958225" Rank="2" Units="cap" Weight="50">
              <Name>Cap 50 mg</Name>
              <Brand ID="B25041695822525">
                <Name>Thalomid</Name>
                <Pack ID="P2381125" Specified="true" nzmt:ctpp_id="50122501000117102">
                  <Quantity>28</Quantity>
                  <Price>378.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250416958226" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Brand ID="B25041695822625">
                <Name>Thalomid</Name>
                <Pack ID="P2381133" Specified="true" nzmt:ctpp_id="50122651000117102">
                  <Quantity>28</Quantity>
                  <Price>756.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504169584">
            <Name>Bortezomib</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS2043">
              <Title>
                <range>Bortezomib</range>
              </Title>
              <Case When="Initial application" Category="plasma cell dyscrasia">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The patient has plasma cell dyscrasia, not including Waldenström macroglobulinaemia, requiring treatment</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2043" style="display:none"/>
            <Formulation ID="F250416958425" Rank="4" Units="inj" Weight="3.5">
              <Name>Inj 3.5 mg vial</Name>
              <Rule Type="DVLimit" Attribute="May-23 to~2025" Value="5"/>
              <Brand ID="B25041695842527" PSS="true">
                <Name>DBL Bortezomib</Name>
                <Pack ID="P2647583" Specified="true" nzmt:ctpp_id="50249241000117107">
                  <Quantity>1</Quantity>
                  <Price>74.93</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504169589">
            <Name>Etoposide (as phosphate)</Name>
            <Formulation ID="F250416958925" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg vial</Name>
              <Brand ID="B25041695892525">
                <Name>Etopophos</Name>
                <Pack ID="P493953" Specified="true" nzmt:ctpp_id="50092311000117106">
                  <Quantity>1</Quantity>
                  <Price>40.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504169686">
            <Name>Pegaspargase</Name>
            <Request Form="RS1788" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Pegaspargase</range>
              </Title>
              <Case When="Initial application" Category="Newly diagnosed ALL">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has newly diagnosed acute lymphoblastic leukaemia</ci>
                    <ci type="logical">Pegaspargase to be used with a contemporary intensive multi-agent chemotherapy treatment protocol</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="Relapsed ALL">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has relapsed acute lymphoblastic leukaemia</ci>
                    <ci type="logical">Pegaspargase to be used with a contemporary intensive multi-agent chemotherapy treatment protocol</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="Lymphoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has lymphoma requiring L-asparaginase containing protocol (e.g. SMILE)</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1788" style="display:none"/>
            <Formulation ID="F250416968625" Rank="4" Units="inj" Weight="750">
              <Name>Inj 750 iu per ml, 5 ml vial</Name>
              <Brand ID="B25041696862526">
                <Name>Oncaspar LYO</Name>
                <Pack ID="P2578158" Specified="true" nzmt:ctpp_id="50339521000117109">
                  <Quantity>1</Quantity>
                  <Price>3973.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A250420">
          <Name>Platinum Compounds</Name>
          <Chemical ID="C2504209069">
            <Name>Carboplatin</Name>
            <Formulation ID="F250420906903" Rank="4" Units="inj" Weight="450">
              <Name>Inj 10 mg per ml, 45 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B25042090690325" ToBeDelisted="2024-12-01">
                <Name>Carboplatin Ebewe</Name>
                <Pack ID="P2236524" Specified="true" nzmt:ctpp_id="50037621000117102">
                  <Quantity>1</Quantity>
                  <Price>45.20</Price>
                </Pack>
              </Brand>
              <Brand ID="B25042090690328" PSS="true">
                <Name>Carboplatin Accord</Name>
                <Pack ID="P2678926" Specified="true" nzmt:ctpp_id="50289301000117105">
                  <Quantity>1</Quantity>
                  <Price>25.73</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504209071">
            <Name>Cisplatin</Name>
            <Formulation ID="F250420907106" Rank="4" Units="inj" Weight="100">
              <Name>Inj 1 mg per ml, 100 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B25042090710601" ToBeDelisted="2024-12-01">
                <Name>DBL Cisplatin</Name>
                <Pack ID="P528048" Specified="true" nzmt:ctpp_id="50094411000117106">
                  <Quantity>1</Quantity>
                  <Price>29.66</Price>
                </Pack>
              </Brand>
              <Brand ID="B25042090710626" PSS="true">
                <Name>Cisplatin Accord</Name>
                <Pack ID="P2682648" Specified="true" nzmt:ctpp_id="50287871000117102">
                  <Quantity>1</Quantity>
                  <Price>18.90</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504209104">
            <Name>Oxaliplatin</Name>
            <Formulation ID="F250420910426" Rank="4" Units="inj" Weight="100">
              <Name>Inj 5 mg per ml, 20 ml vial</Name>
              <Brand ID="B25042091042627">
                <Name>Alchemy Oxaliplatin</Name>
                <Pack ID="P2654830" Specified="true" nzmt:ctpp_id="50291781000117104">
                  <Quantity>1</Quantity>
                  <Price>33.35</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A250424">
          <Name>Protein-Tyrosine Kinase Inhibitors</Name>
          <Chemical ID="C2504248558">
            <Name>Nilotinib</Name>
            <Request Form="RS2010" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Nilotinib</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has a diagnosis of chronic myeloid leukaemia (CML) in blast crisis, high risk chronic phase, or in chronic phase</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has documented CML treatment failure* with a tyrosine kinase inhibitor (TKI)</ci>
                      <ci type="logical">Patient has experienced treatment limiting toxicity with a tyrosine kinase inhibitor (TKI) precluding further treatment</ci>
                    </apply>
                    <ci type="logical">Maximum nilotinib dose of 800 mg/day</ci>
                    <ci type="logical">Subsidised for use as monotherapy only</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>*treatment failure as defined by Leukaemia Net Guidelines.</p>
                </div>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Lack of treatment failure while on nilotinib as defined by Leukaemia Net Guidelines</ci>
                    <ci type="logical">Nilotinib treatment remains appropriate and the patient is benefiting from treatment</ci>
                    <ci type="logical">Maximum nilotinib dose of 800 mg/day</ci>
                    <ci type="logical">Subsidised for use as monotherapy only</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2010" style="display:none"/>
            <Formulation ID="F250424855825" Rank="2" Units="cap" Weight="150">
              <Name>Cap 150 mg</Name>
              <Brand ID="B25042485582525">
                <Name>Tasigna</Name>
                <Pack ID="P2468115" Specified="true" nzmt:ctpp_id="50214821000117106">
                  <Quantity>120</Quantity>
                  <Price>4680.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250424855826" Rank="2" Units="cap" Weight="200">
              <Name>Cap 200 mg</Name>
              <Brand ID="B25042485582625">
                <Name>Tasigna</Name>
                <Pack ID="P2439360" Specified="true" nzmt:ctpp_id="50141131000117107">
                  <Quantity>120</Quantity>
                  <Price>6532.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504248631">
            <Name>Ruxolitinib</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1726">
              <Title>
                <range>Ruxolitinib</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has primary myelofibrosis or post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis</ci>
                    <apply>
                      <or/>
                      <ci type="logical">A classification of risk of intermediate-2 or high-risk myelofibrosis according to either the International Prognostic Scoring System (IPSS), Dynamic
                        International Prognostic Scoring System (DIPSS), or the Age-Adjusted DIPSS</ci>
                      <apply>
                        <and/>
                        <ci type="logical">A classification of risk of intermediate-1 myelofibrosis according to either the International Prognostic Scoring System (IPSS), Dynamic International
                            Prognostic Scoring System (DIPSS), or the Age-Adjusted DIPSS</ci>
                        <ci type="logical">Patient has severe disease-related symptoms that are resistant, refractory or intolerant to available therapy</ci>
                      </apply>
                    </apply>
                    <ci type="logical">A maximum dose of 20 mg twice daily is to be given</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The treatment remains appropriate and the patient is benefiting from treatment</ci>
                    <ci type="logical">A maximum dose of 20 mg twice daily is to be given</ci>
                  </apply>
                </math>
                <Applicant>relevant specialist</Applicant>
                <Applicant Referring="Relevant specialist">medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1726" style="display:none"/>
            <Formulation ID="F250424863125" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B25042486312525">
                <Name>Jakavi</Name>
                <Pack ID="P2554763" Specified="true" nzmt:ctpp_id="50219001000117105">
                  <Quantity>56</Quantity>
                  <Price>2500.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250424863126" Rank="1" Units="tab" Weight="15">
              <Name>Tab 15 mg</Name>
              <Brand ID="B25042486312625">
                <Name>Jakavi</Name>
                <Pack ID="P2554771" Specified="true" nzmt:ctpp_id="50219071000117101">
                  <Quantity>56</Quantity>
                  <Price>5000.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250424863127" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Brand ID="B25042486312725">
                <Name>Jakavi</Name>
                <Pack ID="P2554798" Specified="true" nzmt:ctpp_id="50219141000117106">
                  <Quantity>56</Quantity>
                  <Price>5000.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250424863128" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B25042486312825">
                <Name>Jakavi</Name>
                <Pack ID="P2627817" Specified="true" nzmt:ctpp_id="50244541000117108">
                  <Quantity>56</Quantity>
                  <Price>5000.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504248649">
            <Name>Alectinib</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1712">
              <Title>
                <range>Alectinib</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has locally advanced, or metastatic, unresectable, non-small cell lung cancer</ci>
                    <ci type="logical">There is documentation confirming that the patient has an ALK tyrosine kinase gene rearrangement using an appropriate ALK test</ci>
                    <ci type="logical">Patient has an ECOG performance score of 0-2</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">No evidence of progressive disease according to RECIST criteria</ci>
                    <ci type="logical">The patient is benefitting from and tolerating treatment</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1712" style="display:none"/>
            <Formulation ID="F250424864925" Rank="2" Units="cap" Weight="150">
              <Name>Cap 150 mg</Name>
              <Brand ID="B25042486492525">
                <Name>Alecensa</Name>
                <Pack ID="P2574152" Specified="true" nzmt:ctpp_id="50242371000117101">
                  <Quantity>224</Quantity>
                  <Price>7935.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504248654">
            <Name>Palbociclib</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS2034">
              <Title>
                <range>Palbociclib (Ibrance)</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has unresectable locally advanced or metastatic
                        breast cancer</ci>
                      <ci type="logical">There is documentation confirming disease is hormone-receptor
                        positive and HER2-negative</ci>
                      <ci type="logical">Patient has an ECOG performance score of 0-2</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Disease has relapsed or progressed during prior endocrine
                            therapy</ci>
                        <apply>
                          <and/>
                          <ci type="logical">Patient is amenorrhoeic, either naturally or induced,
                                with endocrine levels consistent with a postmenopausal or without
                                menstrual-potential state</ci>
                          <ci type="logical">Patient has not received prior systemic treatment
                                    for metastatic disease</ci>
                        </apply>
                      </apply>
                      <ci type="logical">Treatment must be used in combination with an endocrine
                        partner</ci>
                      <ci type="logical">Patient has not received prior funded treatment with a CDK4/6
                        inhibitor</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has an active Special Authority approval for
                        ribociclib</ci>
                      <ci type="logical">Patient has experienced a grade 3 or 4 adverse reaction to
                        ribociclib that cannot be managed by dose reductions and requires treatment
                        discontinuation</ci>
                      <ci type="logical">Treatment must be used in combination with an endocrine
                        partner</ci>
                      <ci type="logical">There is no evidence of progressive disease since initiation
                        of ribociclib</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Treatment must be used in combination with an endocrine partner</ci>
                    <ci type="logical">There is no evidence of progressive disease since initiation of palbociclib</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2034" style="display:none"/>
            <Formulation ID="F250424865428" Rank="1" Units="tab" Weight="75">
              <Name>Tab 75 mg</Name>
              <Brand ID="B25042486542825">
                <Name>Ibrance</Name>
                <Pack ID="P2611635" Specified="true" nzmt:ctpp_id="50280071000117106">
                  <Quantity>21</Quantity>
                  <Price>4000.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250424865429" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Brand ID="B25042486542925">
                <Name>Ibrance</Name>
                <Pack ID="P2611643" Specified="true" nzmt:ctpp_id="50280081000117109">
                  <Quantity>21</Quantity>
                  <Price>4000.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250424865430" Rank="1" Units="tab" Weight="125">
              <Name>Tab 125 mg</Name>
              <Brand ID="B25042486543025">
                <Name>Ibrance</Name>
                <Pack ID="P2611651" Specified="true" nzmt:ctpp_id="50280091000117107">
                  <Quantity>21</Quantity>
                  <Price>4000.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504248739">
            <Name>Midostaurin</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS2033">
              <Title>
                <range>Midostaurin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has a diagnosis of acute myeloid leukaemia</ci>
                    <ci type="logical">Condition must be FMS tyrosine kinase 3 (FLT3) mutation
                    positive</ci>
                    <ci type="logical">Patient must not have received a prior line of intensive
                    chemotherapy for acute myeloid leukaemia</ci>
                    <ci type="logical">Patient is to receive standard intensive chemotherapy in
                    combination with midostaurin only</ci>
                    <ci type="logical">Midostaurin to be funded for a maximum of 4 cycles</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2033" style="display:none"/>
            <Formulation ID="F250424873925" Rank="2" Units="cap" Weight="25">
              <Name>Cap 25 mg</Name>
              <Brand ID="B25042487392525">
                <Name>Rydapt</Name>
                <Pack ID="P2608650" Specified="true" nzmt:ctpp_id="50262461000117105">
                  <Quantity>56</Quantity>
                  <Price>10981.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504248740">
            <Name>Ribociclib</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS2035">
              <Title>
                <range>Ribociclib</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has unresectable locally advanced or metastatic
                        breast cancer</ci>
                      <ci type="logical">There is documentation confirming disease is hormone-receptor
                        positive and HER2-negative</ci>
                      <ci type="logical">Patient has an ECOG performance score of 0-2</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Disease has relapsed or progressed during prior endocrine
                            therapy</ci>
                        <apply>
                          <and/>
                          <ci type="logical">Patient is amenorrhoeic, either naturally or induced,
                                with endocrine levels consistent with a postmenopausal or without
                                menstrual-potential state</ci>
                          <ci type="logical">Patient has not received prior systemic endocrine
                                treatment for metastatic disease</ci>
                        </apply>
                        <apply>
                          <and/>
                          <ci type="logical">Patient commenced treatment with ribociclib in
                                combination with an endocrine partner prior to 1 July 2024</ci>
                          <ci type="logical">There is no evidence of progressive disease</ci>
                        </apply>
                      </apply>
                      <ci type="logical">Treatment to be used in combination with an endocrine
                        partner</ci>
                      <ci type="logical">Patient has not received prior funded treatment with a CDK4/6
                        inhibitor</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has an active Special Authority approval for
                        palbociclib</ci>
                      <ci type="logical">Patient has experienced a grade 3 or 4 adverse reaction to
                        palbociclib that cannot be managed by dose reductions and requires treatment
                        discontinuation</ci>
                      <ci type="logical">Treatment must be used in combination with an endocrine
                        partner</ci>
                      <ci type="logical">There is no evidence of progressive disease since initiation
                        of palbociclib</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Treatment must be used in combination with an endocrine
                    partner</ci>
                    <ci type="logical">There is no evidence of progressive disease since initiation of
                    ribociclib</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2035" style="display:none"/>
            <Formulation ID="F250424874025" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B25042487402525">
                <Name>Kisqali</Name>
                <Pack ID="P2678772" Specified="true" nzmt:ctpp_id="50251951000117100">
                  <Quantity>21</Quantity>
                  <Price>1883.00</Price>
                </Pack>
                <Pack ID="P2678780" Specified="true" nzmt:ctpp_id="50251961000117103">
                  <Quantity>42</Quantity>
                  <Price>3767.00</Price>
                </Pack>
                <Pack ID="P2678799" Specified="true" nzmt:ctpp_id="50251971000117108">
                  <Quantity>63</Quantity>
                  <Price>5650.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504249027">
            <Name>Imatinib mesilate</Name>
            <Formulation ID="F250424902726" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B25042490272626" PSS="true">
                <Name>Imatinib-Rex</Name>
                <Pack ID="P2594315" Specified="true" nzmt:ctpp_id="50245691000117101">
                  <Quantity>60</Quantity>
                  <Price>44.93</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250424902727" Rank="2" Units="cap" Weight="400">
              <Name>Cap 400 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B25042490272726" PSS="true">
                <Name>Imatinib-Rex</Name>
                <Pack ID="P2594323" Specified="true" nzmt:ctpp_id="50245701000117101">
                  <Quantity>30</Quantity>
                  <Price>69.76</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504249490">
            <Name>Dasatinib</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS2055">
              <Title>
                <range>Dasatinib</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">The patient has a diagnosis of chronic myeloid leukaemia
                        (CML) in blast crisis or accelerated phase</ci>
                    <ci type="logical">The patient has a diagnosis of Philadelphia
                        chromosome-positive acute lymphoid leukaemia (Ph+ ALL)</ci>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has a diagnosis of CML in chronic phase</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has documented treatment failure* with
                            imatinib</ci>
                        <ci type="logical">Patient has experienced treatment-limiting toxicity with
                            imatinib precluding further treatment with imatinib</ci>
                        <ci type="logical">Patient has high-risk chronic-phase CML defined by the
                            Sokal or EURO scoring system</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Applicant Referring="haematologist">any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Lack of treatment failure while on dasatinib*</ci>
                    <ci type="logical">Dasatinib treatment remains appropriate and the patient is
                    benefiting from treatment</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Applicant Referring="haematologist ">any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>*treatment failure for CML as defined by Leukaemia Net Guidelines.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS2055" style="display:none"/>
            <Formulation ID="F250424949025" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B25042494902525" ToBeDelisted="2025-03-01">
                <Name>Sprycel</Name>
                <Pack ID="P2258048" Specified="true" nzmt:ctpp_id="50040781000117105">
                  <Quantity>60</Quantity>
                  <Price>3774.06</Price>
                </Pack>
              </Brand>
              <Brand ID="B25042494902526" PSS="true">
                <Name>Dasatinib-Teva</Name>
                <Pack ID="P2679612" Specified="true" nzmt:ctpp_id="50275441000117107">
                  <Quantity>60</Quantity>
                  <Price>132.88</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250424949026" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B25042494902625" ToBeDelisted="2025-03-01">
                <Name>Sprycel</Name>
                <Pack ID="P2258056" Specified="true" nzmt:ctpp_id="50040791000117108">
                  <Quantity>60</Quantity>
                  <Price>6214.20</Price>
                </Pack>
              </Brand>
              <Brand ID="B25042494902626" PSS="true">
                <Name>Dasatinib-Teva</Name>
                <Pack ID="P2679620" Specified="true" nzmt:ctpp_id="50275461000117106">
                  <Quantity>60</Quantity>
                  <Price>304.13</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250424949027" Rank="1" Units="tab" Weight="70">
              <Name>Tab 70 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B25042494902725" ToBeDelisted="2025-03-01">
                <Name>Sprycel</Name>
                <Pack ID="P2258064" Specified="true" nzmt:ctpp_id="50040801000117109">
                  <Quantity>60</Quantity>
                  <Price>7692.58</Price>
                </Pack>
              </Brand>
              <Brand ID="B25042494902726" PSS="true">
                <Name>Dasatinib-Teva</Name>
                <Pack ID="P2679639" Specified="true" nzmt:ctpp_id="50275481000117103">
                  <Quantity>60</Quantity>
                  <Price>415.75</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504249558">
            <Name>Erlotinib</Name>
            <Request Form="RS1885" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Erlotinib</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has locally advanced or metastatic, unresectable, non-squamous Non Small Cell Lung Cancer (NSCLC)</ci>
                    <ci type="logical">There is documentation confirming that the disease expresses activating mutations of EGFR tyrosine kinase</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient is treatment naive</ci>
                      <apply>
                        <and/>
                        <ci type="logical">The patient has discontinued getitinib due to intolerance</ci>
                        <ci type="logical">The cancer did not progress while on gefitinib</ci>
                      </apply>
                    </apply>
                    <ci type="logical">Erlotinib is to be given for a maximum of 3 months</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Radiological assessment (preferably including CT scan) indicates NSCLC has not progressed</ci>
                    <ci type="logical">Erlotinib is to be given for a maximum of 3 months</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="pandemic circumstances">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient is clinically benefiting from treatment and continued treatment remains appropriate</ci>
                    <ci type="logical">Erlotinib to be discontinued at progression</ci>
                    <ci type="logical">The regular renewal requirements cannot be met due to COVID-19 constraints on the health sector</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1885" style="display:none"/>
            <Formulation ID="F250424955825" Rank="1" Units="tab" Weight="100">
              <Name>Tab 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Oct-24 to~2027" Value="5"/>
              <Brand ID="B25042495582526" PSS="true">
                <Name>Alchemy</Name>
                <Pack ID="P2641569" Specified="true" nzmt:ctpp_id="50280501000117108">
                  <Quantity>30</Quantity>
                  <Price>280.84</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250424955826" Rank="1" Units="tab" Weight="150">
              <Name>Tab 150 mg</Name>
              <Rule Type="DVLimit" Attribute="Oct-24 to~2027" Value="5"/>
              <Brand ID="B25042495582626" PSS="true">
                <Name>Alchemy</Name>
                <Pack ID="P2641550" Specified="true" nzmt:ctpp_id="50280511000117106">
                  <Quantity>30</Quantity>
                  <Price>484.24</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504249567">
            <Name>Sunitinib</Name>
            <Request Form="RS1886" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Sunitinib</range>
              </Title>
              <Case When="Initial application" Category="RCC">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has metastatic renal cell carcinoma</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient is treatment naive</ci>
                      <ci type="logical">The patient has only received prior cytokine treatment</ci>
                      <ci type="logical">The patient has only received prior treatment with an investigational agent within the confines of a bona fide clinical trial which has Ethics Committee
                        approval</ci>
                      <apply>
                        <and/>
                        <ci type="logical">The patient has discontinued pazopanib within 3 months of starting treatment due to intolerance</ci>
                        <ci type="logical">The cancer did not progress whilst on pazopanib</ci>
                      </apply>
                    </apply>
                    <ci type="logical">The patient has good performance status (WHO/ECOG grade 0-2)</ci>
                    <ci type="logical">The disease is of predominant clear cell histology</ci>
                    <apply>
                      <and/>
                      <ci type="logical">Lactate dehydrogenase level &gt; 1.5 times upper limit of normal</ci>
                      <ci type="logical">Haemoglobin level &lt; lower limit of normal</ci>
                      <ci type="logical">Corrected serum calcium level &gt; 10 mg/dL (2.5 mmol/L)</ci>
                      <ci type="logical">Interval of &lt; 1 year from original diagnosis to the start of systemic therapy</ci>
                      <ci type="logical">Karnofsky performance score of less than or equal to 70</ci>
                      <ci type="logical">2 or more sites of organ metastasis</ci>
                    </apply>
                    <ci type="logical">Sunitinib to be used for a maximum of 2 cycles</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">3</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>RCC - Sunitinib treatment should be stopped if disease progresses.</p>
                  <p>Poor prognosis patients are defined as having at least 3 of criteria 5.1-5.6. Intermediate prognosis patients are defined as having 1 or 2 of criteria 5.1-5.6.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="RCC">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">No evidence of disease progression</ci>
                    <ci type="logical">The treatment remains appropriate and the patient is benefiting from treatment</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">3</Term>
              </Case>
              <Case When="Initial application" Category="GIST">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has unresectable or metastatic malignant gastrointestinal stromal tumour (GIST)</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient's disease has progressed following treatment with imatinib</ci>
                      <ci type="logical">The patient has documented treatment-limiting intolerance, or toxicity to, imatinib</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">3</Term>
              </Case>
              <Case When="Renewal" Category="GIST">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <mi class="heading">The patient has responded to treatment or has stable disease as determined by Choi's modified CT response evaluation criteria as follows:</mi>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has had a complete response (disappearance of all lesions and no new lesions)</ci>
                      <ci type="logical">The patient has had a partial response (a decrease in size of 10% or more or decrease in tumour density in Hounsfield Units (HU) of 15% or more on CT and no new lesions and
                        no obvious progression of non-measurable disease)</ci>
                      <ci type="logical">The patient has stable disease (does not meet criteria the two above) and does not have progressive disease and no symptomatic deterioration attributed to tumour
                        progression</ci>
                    </apply>
                    <ci type="logical">The treatment remains appropriate and the patient is benefiting from treatment</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="GIST pandemic circumstances">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has unresectable or metastatic malignant gastrointestinal stromal tumour (GIST)</ci>
                    <ci type="logical">The patient is clinically benefiting from treatment and continued treatment remains appropriate</ci>
                    <ci type="logical">Sunitinib is to be discontinued at progression</ci>
                    <ci type="logical">The regular renewal requirements cannot be met due to COVID-19 constraints on the health sector</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>GIST - It is recommended that response to treatment be assessed using Choi's modified CT response evaluation criteria (J Clin Oncol, 2007, 25:1753-1759). Progressive disease is defined as either: an increase in tumour size of 10% or more and not meeting criteria of partial response (PR) by tumour density (HU) on CT; or: new lesions, or new intratumoral nodules, or increase in the size of the existing intratumoral nodules.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1886" style="display:none"/>
            <Formulation ID="F250424956725" Rank="2" Units="cap" Weight="12.5">
              <Name>Cap 12.5 mg</Name>
              <Brand ID="B25042495672526">
                <Name>Sunitinib Pfizer</Name>
                <Pack ID="P2630303" Specified="true" nzmt:ctpp_id="50282531000117101">
                  <Quantity>28</Quantity>
                  <Price>208.38</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250424956726" Rank="2" Units="cap" Weight="25">
              <Name>Cap 25 mg</Name>
              <Brand ID="B25042495672626">
                <Name>Sunitinib Pfizer</Name>
                <Pack ID="P2630311" Specified="true" nzmt:ctpp_id="50282541000117109">
                  <Quantity>28</Quantity>
                  <Price>416.77</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250424956727" Rank="2" Units="cap" Weight="50">
              <Name>Cap 50 mg</Name>
              <Brand ID="B25042495672726">
                <Name>Sunitinib Pfizer</Name>
                <Pack ID="P2630338" Specified="true" nzmt:ctpp_id="50282561000117108">
                  <Quantity>28</Quantity>
                  <Price>694.62</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504249635">
            <Name>Lapatinib</Name>
            <Request Form="RS1828" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Lapatinib</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For continuation use only</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has metastatic breast cancer expressing HER-2 IHC 3+ or ISH+ (including FISH or other current technology)</ci>
                    <ci type="logical">The cancer has not progressed at any time point during the previous 12 months whilst on lapatinib</ci>
                    <ci type="logical">Lapatinib not to be given in combination with trastuzumab</ci>
                    <ci type="logical">Lapatinib to be discontinued at disease progression</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1828" style="display:none"/>
            <Formulation ID="F250424963525" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B25042496352500">
                <Name>Any</Name>
                <Pack ID="P96352500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504249638">
            <Name>Pazopanib</Name>
            <Request Form="RS1198" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Pazopanib</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has metastatic renal cell carcinoma</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient is treatment naive</ci>
                      <ci type="logical">The patient has only received prior cytokine treatment</ci>
                      <apply>
                        <and/>
                        <ci type="logical">The patient has discontinued sunitinib within 3 months of starting treatment due to intolerance</ci>
                        <ci type="logical">The cancer did not progress whilst on sunitinib</ci>
                      </apply>
                    </apply>
                    <ci type="logical">The patient has good performance status (WHO/ECOG grade 0-2)</ci>
                    <ci type="logical">The disease is of predominant clear cell histology</ci>
                    <apply>
                      <and/>
                      <ci type="logical">Lactate dehydrogenase level &gt; 1.5 times upper limit of normal</ci>
                      <ci type="logical">Haemoglobin level &lt; lower limit of normal</ci>
                      <ci type="logical">Corrected serum calcium level &gt; 10 mg/dL (2.5 mmol/L)</ci>
                      <ci type="logical">Interval of &lt; 1 year from original diagnosis to the start of systemic therapy</ci>
                      <ci type="logical">Karnofsky performance score of less than or equal to 70</ci>
                      <ci type="logical">2 or more sites of organ metastasis</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">3</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">No evidence of disease progression</ci>
                    <ci type="logical">The treatment remains appropriate and the patient is benefiting from treatment</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">3</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Pazopanib treatment should be stopped if disease progresses.</p>
                <p>Poor prognosis patients are defined as having at least 3 of criteria 5.1-5.6. Intermediate prognosis patients are defined as having 1 or 2 of criteria 5.1-5.6.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1198" style="display:none"/>
            <Formulation ID="F250424963825" Rank="1" Units="tab" Weight="200">
              <Name>Tab 200 mg</Name>
              <Brand ID="B25042496382525">
                <Name>Votrient</Name>
                <Pack ID="P2386127" Specified="true" nzmt:ctpp_id="50123631000117104">
                  <Quantity>30</Quantity>
                  <Price>1334.70</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250424963826" Rank="1" Units="tab" Weight="400">
              <Name>Tab 400 mg</Name>
              <Brand ID="B25042496382625">
                <Name>Votrient</Name>
                <Pack ID="P2386135" Specified="true" nzmt:ctpp_id="50123641000117107">
                  <Quantity>30</Quantity>
                  <Price>2669.40</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504249655">
            <Name>Gefitinib</Name>
            <Request Form="RS1887" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Gefitinib</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has locally advanced, or metastatic, unresectable, non-squamous Non Small Cell Lung Cancer (NSCLC)</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient is treatment naive</ci>
                      <apply>
                        <and/>
                        <ci type="logical">The patient has discontinued erlotinib due to intolerance</ci>
                        <ci type="logical">The cancer did not progress whilst on erlotinib</ci>
                      </apply>
                    </apply>
                    <ci type="logical">There is documentation confirming that disease expresses activating mutations of EGFR tyrosine kinase</ci>
                    <ci type="logical">Gefitinib is to be given for a maximum of 3 months</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Radiological assessment (preferably including CT scan) indicates NSCLC has not progressed</ci>
                    <ci type="logical">Gefitinib is to be given for a maximum of 3 months</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="pandemic circumstances">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient is clinically benefiting from treatment and continued treatment remains appropriate</ci>
                    <ci type="logical">Gefitinib to be discontinued at progression</ci>
                    <ci type="logical">The regular renewal requirements cannot be met due to COVID-19 constraints on the health sector</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1887" style="display:none"/>
            <Formulation ID="F250424965525" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B25042496552525">
                <Name>Iressa</Name>
                <Pack ID="P2146541" Specified="true" nzmt:ctpp_id="50025241000117101">
                  <Quantity>30</Quantity>
                  <Price>918.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A250428">
          <Name>Taxanes</Name>
          <Chemical ID="C2504289080">
            <Name>Docetaxel</Name>
            <Formulation ID="F250428908004" Rank="4" Units="inj" Weight="80">
              <Name>Inj 10 mg per ml, 8 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B25042890800427" PSS="true">
                <Name>DBL Docetaxel</Name>
                <Pack ID="P2440830" Specified="true" nzmt:ctpp_id="50142051000117105">
                  <Quantity>1</Quantity>
                  <Price>24.91</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504289103">
            <Name>Paclitaxel</Name>
            <Formulation ID="F250428910302" Rank="4" Units="inj" Weight="100">
              <Name>Inj 6 mg per ml, 16.7 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~2026" Value="5"/>
              <Brand ID="B25042891030227" PSS="true">
                <Name>Anzatax</Name>
                <Pack ID="P2271834" Specified="true" nzmt:ctpp_id="50042651000117106">
                  <Quantity>1</Quantity>
                  <Price>19.59</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250428910326" Rank="4" Units="inj" Weight="300">
              <Name>Inj 6 mg per ml, 50 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Aug-24 to~2026" Value="5"/>
              <Brand ID="B25042891032626" PSS="true">
                <Name>Anzatax</Name>
                <Pack ID="P2271818" Specified="true" nzmt:ctpp_id="50042631000117101">
                  <Quantity>1</Quantity>
                  <Price>37.89</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A250432">
          <Name>Treatment of Cytotoxic-Induced Side Effects</Name>
          <Chemical ID="C2504328644">
            <Name>Dexrazoxane</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1695">
              <Title>
                <range>Dexrazoxane</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is to receive treatment with high dose anthracycline given with curative intent</ci>
                    <ci type="logical">Based on current treatment plan, patient’s cumulative lifetime dose of anthracycline will exceed 250mg/m2 doxorubicin equivalent or greater</ci>
                    <ci type="logical">Dexrazoxane to be administered only whilst on anthracycline treatment</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Treatment to be used as a cardioprotectant for a child or young adult</ci>
                      <ci type="logical">Treatment to be used as a cardioprotectant for secondary malignancy</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Applicant>paediatric oncologist</Applicant>
                <Applicant>haematologist</Applicant>
                <Applicant>paediatric haematologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1695" style="display:none"/>
            <Formulation ID="F250432864425" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg</Name>
              <Brand ID="B25043286442500">
                <Name>e.g. Cardioxane</Name>
                <Pack ID="P86442500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504329109">
            <Name>Mesna</Name>
            <Formulation ID="F250432910901" Rank="1" Units="tab" Weight="400">
              <Name>Tab 400 mg</Name>
              <Brand ID="B25043291090101">
                <Name>Uromitexan</Name>
                <Pack ID="P2085887" Specified="true" nzmt:ctpp_id="50014261000117107">
                  <Quantity>50</Quantity>
                  <Price>314.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250432910902" Rank="1" Units="tab" Weight="600">
              <Name>Tab 600 mg</Name>
              <Brand ID="B25043291090201">
                <Name>Uromitexan</Name>
                <Pack ID="P2087189" Specified="true" nzmt:ctpp_id="50015441000117108">
                  <Quantity>50</Quantity>
                  <Price>448.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250432910903" Rank="4" Units="inj" Weight="400">
              <Name>Inj 100 mg per ml, 4 ml ampoule</Name>
              <Brand ID="B25043291090301">
                <Name>Uromitexan</Name>
                <Pack ID="P712744" Specified="true" nzmt:ctpp_id="50123281000117100">
                  <Quantity>15</Quantity>
                  <Price>177.45</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250432910904" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 100 mg per ml, 10 ml ampoule</Name>
              <Brand ID="B25043291090402">
                <Name>Uromitexan</Name>
                <Pack ID="P712752" Specified="true" nzmt:ctpp_id="50104271000117106">
                  <Quantity>15</Quantity>
                  <Price>407.40</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504329269">
            <Name>Calcium folinate</Name>
            <Formulation ID="F250432926901" Rank="4" Units="inj" Weight="3">
              <Name>Inj 3 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B25043292690100">
                <Name>Any</Name>
                <Pack ID="P92690100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250432926926" Rank="4" Units="inj" Weight="300">
              <Name>Inj 10 mg per ml, 30 ml vial</Name>
              <Brand ID="B25043292692626">
                <Name>Calcium Folinate Ebewe</Name>
                <Pack ID="P2216086" Specified="true" nzmt:ctpp_id="50034381000117104">
                  <Quantity>1</Quantity>
                  <Price>22.51</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250432926928" Rank="1" Units="tab" Weight="15">
              <Name>Tab 15 mg</Name>
              <Brand ID="B25043292692825">
                <Name>DBL Leucovorin Calcium</Name>
                <Pack ID="P701300" Specified="true" nzmt:ctpp_id="50125481000117102">
                  <Quantity>10</Quantity>
                  <Price>135.33</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250432926929" Rank="4" Units="inj" Weight="50">
              <Name>Inj 10 mg per ml, 5 ml ampoule</Name>
              <Brand ID="B25043292692925">
                <Name>Calcium Folinate Ebewe</Name>
                <Pack ID="P2216051" Specified="true" nzmt:ctpp_id="50034361000117107">
                  <Quantity>5</Quantity>
                  <Price>18.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250432926930" Rank="4" Units="inj" Weight="100">
              <Name>Inj 10 mg per ml, 10 ml vial</Name>
              <Brand ID="B25043292693026">
                <Name>Calcium Folinate Sandoz</Name>
                <Pack ID="P2539209" Specified="true" nzmt:ctpp_id="50235731000117106">
                  <Quantity>1</Quantity>
                  <Price>9.49</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250432926931" Rank="4" Units="inj" Weight="1000">
              <Name>Inj 10 mg per ml, 100 ml vial</Name>
              <Brand ID="B25043292693126">
                <Name>Calcium Folinate Sandoz</Name>
                <Pack ID="P2539225" Specified="true" nzmt:ctpp_id="50235771000117109">
                  <Quantity>1</Quantity>
                  <Price>72.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B25043292693127">
                <Name>Eurofolic</Name>
                <Pack ID="P2687364" Specified="true" nzmt:ctpp_id="50338061000117102">
                  <Quantity>1</Quantity>
                  <Price>72.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250432926932" Rank="4" Units="inj" Weight="50">
              <Name>Inj 10 mg per ml, 5 ml vial</Name>
              <Brand ID="B25043292693225">
                <Name>Calcium Folinate Sandoz</Name>
                <Pack ID="P2539195" Specified="true" nzmt:ctpp_id="50235721000117108">
                  <Quantity>1</Quantity>
                  <Price>7.28</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250432926933" Rank="4" Units="inj" Weight="350">
              <Name>Inj 10 mg per ml, 35 ml vial</Name>
              <Brand ID="B25043292693325">
                <Name>Calcium Folinate Sandoz</Name>
                <Pack ID="P2539217" Specified="true" nzmt:ctpp_id="50235751000117101">
                  <Quantity>1</Quantity>
                  <Price>25.14</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A250436">
          <Name>Vinca Alkaloids</Name>
          <Chemical ID="C2504369110">
            <Name>Vinblastine sulphate</Name>
            <Formulation ID="F250436911001" Rank="4" Units="inj" Weight="10">
              <Name>Inj 1 mg per ml, 10 ml vial</Name>
              <Brand ID="B25043691100102">
                <Name>Hospira</Name>
                <Pack ID="P779989" Specified="true" nzmt:ctpp_id="50113271000117106">
                  <Quantity>5</Quantity>
                  <Price>270.37</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504369111">
            <Name>Vincristine sulphate</Name>
            <Formulation ID="F250436911102" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mg per ml, 1 ml vial</Name>
              <Brand ID="B25043691110201">
                <Name>DBL Vincristine Sulfate</Name>
                <Pack ID="P604585" Specified="true" nzmt:ctpp_id="50098581000117109">
                  <Quantity>5</Quantity>
                  <Price>74.52</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250436911104" Rank="4" Units="inj" Weight="2">
              <Name>Inj 1 mg per ml, 2 ml vial</Name>
              <Brand ID="B25043691110402">
                <Name>DBL Vincristine Sulfate</Name>
                <Pack ID="P604593" Specified="true" nzmt:ctpp_id="50098591000117107">
                  <Quantity>5</Quantity>
                  <Price>102.73</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2504369113">
            <Name>Vinorelbine</Name>
            <Formulation ID="F250436911301" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 1 ml vial</Name>
              <Brand ID="B25043691130100">
                <Name>Any</Name>
                <Pack ID="P91130100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250436911302" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 5 ml vial</Name>
              <Brand ID="B25043691130200">
                <Name>Any</Name>
                <Pack ID="P91130200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250436911325" Rank="2" Units="cap" Weight="20">
              <Name>Cap 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Oct-23 to~2025" Value="5"/>
              <Brand ID="B25043691132525" PSS="true">
                <Name>Vinorelbine Te Arai</Name>
                <Pack ID="P2651912" Specified="true" nzmt:ctpp_id="50255711000117101">
                  <Quantity>1</Quantity>
                  <Price>30.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250436911326" Rank="2" Units="cap" Weight="30">
              <Name>Cap 30 mg</Name>
              <Rule Type="DVLimit" Attribute="Oct-23 to~2025" Value="5"/>
              <Brand ID="B25043691132625" PSS="true">
                <Name>Vinorelbine Te Arai</Name>
                <Pack ID="P2547880" Specified="true" nzmt:ctpp_id="50255721000117107">
                  <Quantity>1</Quantity>
                  <Price>40.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250436911327" Rank="2" Units="cap" Weight="80">
              <Name>Cap 80 mg</Name>
              <Rule Type="DVLimit" Attribute="Oct-23 to~2025" Value="5"/>
              <Brand ID="B25043691132725" PSS="true">
                <Name>Vinorelbine Te Arai</Name>
                <Pack ID="P2651920" Specified="true" nzmt:ctpp_id="50255731000117105">
                  <Quantity>1</Quantity>
                  <Price>60.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2508">
        <Name>Endocrine Therapy</Name>
        <ATC3 ID="A250802">
          <Name>Endocrine Therapy</Name>
          <Chemical ID="C2508028571">
            <Name>Abiraterone acetate</Name>
            <Request Form="RS1888" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Abiraterone acetate</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has prostate cancer</ci>
                    <ci type="logical">Patient has metastases</ci>
                    <ci type="logical">Patient's disease is castration resistant</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">Patient is symptomatic</ci>
                        <ci type="logical">Patient has disease progression (rising serum PSA) after second line anti-androgen therapy</ci>
                        <ci type="logical">Patient has ECOG performance score of 0-1</ci>
                        <ci type="logical">Patient has not had prior treatment with taxane chemotherapy</ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">Patient's disease has progressed following prior chemotherapy containing a taxane</ci>
                        <ci type="logical">Patient has ECOG performance score of 0-2</ci>
                        <ci type="logical">Patient has not had prior treatment with abiraterone</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Applicant>radiation oncologist</Applicant>
                <Applicant>urologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Significant decrease in serum PSA from baseline</ci>
                    <ci type="logical">No evidence of clinical disease progression</ci>
                    <ci type="logical">No initiation of taxane chemotherapy with abiraterone</ci>
                    <ci type="logical">The treatment remains appropriate and the patient is benefiting from treatment</ci>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Applicant>radiation oncologist</Applicant>
                <Applicant>urologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="pandemic circumstances">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient is clinically benefiting from treatment and continued treatment remains appropriate</ci>
                    <ci type="logical">Abiraterone acetate to be discontinued at progression</ci>
                    <ci type="logical">No initiation of taxane chemotherapy with abiraterone</ci>
                    <ci type="logical">The regular renewal requirements cannot be met due to COVID-19 constraints on the health sector</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1888" style="display:none"/>
            <Formulation ID="F250802857125" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B25080285712525">
                <Name>Zytiga</Name>
                <Pack ID="P2453517" Specified="true" nzmt:ctpp_id="50143741000117101">
                  <Quantity>120</Quantity>
                  <Price>4276.19</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2508028655">
            <Name>Fulvestrant</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1732">
              <Title>
                <range>Fulvestrant</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has oestrogen-receptor positive locally advanced or metastatic breast cancer</ci>
                    <ci type="logical">Patient has disease progression following prior treatment with an aromatase inhibitor or tamoxifen for their locally advanced or metastatic disease</ci>
                    <ci type="logical">Treatment to be given at a dose of 500 mg monthly following loading doses</ci>
                    <ci type="logical">Treatment to be discontinued at disease progression</ci>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Treatment remains appropriate and patient is benefitting from treatment</ci>
                    <ci type="logical">Treatment to be given at a dose of 500 mg monthly</ci>
                    <ci type="logical">No evidence of disease progression</ci>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1732" style="display:none"/>
            <Formulation ID="F250802865525" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 5 ml prefilled syringe</Name>
              <Brand ID="B25080286552525">
                <Name>Faslodex</Name>
                <Pack ID="P2586371" Specified="true" nzmt:ctpp_id="50260581000117104">
                  <Quantity>2</Quantity>
                  <Price>1068.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2508029040">
            <Name>Octreotide</Name>
            <Request Form="RS1889" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Octreotide</range>
              </Title>
              <Case When="Initial application" Category="Malignant bowel obstruction">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has nausea* and vomiting* due to malignant bowel obstruction*</ci>
                    <ci type="logical">Treatment with antiemetics, rehydration, antimuscarinic agents, corticosteroids and analgesics for at least 48 hours has failed</ci>
                    <ci type="logical">Octreotide to be given at a maximum dose 1500 mcg daily for up to 4 weeks</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications</p>
                </div>
              </Case>
              <Case When="Initial application" Category="acromegaly">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has acromegaly</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Treatment with surgery, radiotherapy and a dopamine agonist has failed</ci>
                      <ci type="logical">Treatment with octreotide is for an interim period while awaiting the effects of radiotherapy and a dopamine agonist has failed</ci>
                      <ci type="logical">The patient is unwilling, or unable, to undergo surgery and/or radiotherapy</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">3</Term>
              </Case>
              <Case When="Renewal" Category="acromegaly">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">IGF1 levels have decreased since starting octreotide</ci>
                    <ci type="logical">The treatment remains appropriate and the patient is benefiting from treatment</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>In patients with acromegaly octreotide treatment should be discontinued if IGF1 levels have not decreased after 3 months treatment. In patients treated with radiotherapy octreotide treatment should be withdrawn every 2 years, for 1 month, for assessment of remission. Octreotide treatment should be stopped where there is biochemical evidence of remission (normal IGF1 levels) following octreotide treatment withdrawal for at least 4 weeks.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="Other indications">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">VIPomas and glucagonomas - for patients who are seriously ill in order to improve their clinical state prior to definitive surgery</ci>
                    <apply>
                      <and/>
                      <ci type="logical">Gastrinoma</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has failed surgery</ci>
                        <ci type="logical">Patient in metastatic disease after H2 antagonists (or proton pump inhibitors) have failed</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Insulinomas</ci>
                      <ci type="logical">Surgery is contraindicated or has failed</ci>
                    </apply>
                    <ci type="logical">For pre-operative control of hypoglycaemia and for maintenance therapy</ci>
                    <apply>
                      <and/>
                      <ci type="logical">Carcinoid syndrome (diagnosed by tissue pathology and/or urinary 5HIAA analysis)</ci>
                      <ci type="logical">Disabling symptoms not controlled by maximal medical therapy</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>restriction applies only to the long-acting formulations of octreotide</p>
                </div>
              </Case>
              <Case When="Initial application" Category="pre-operative acromegaly">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has acromegaly</ci>
                    <ci type="logical">Patient has a large pituitary tumour, greater than 10 mm at its widest</ci>
                    <ci type="logical">Patient is scheduled to undergo pituitary surgery in the next six months</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications</p>
                </div>
              </Case>
              <Case When="Renewal" Category="Acromegaly - pandemic circumstances">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has acromegaly</ci>
                    <ci type="logical">The patient is clinically benefiting from treatment and continued treatment remains appropriate</ci>
                    <ci type="logical">The regular renewal requirements cannot be met due to COVID-19 constraints on the health sector</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Some items restricted" xlink:href="RS1889" style="display:none"/>
            <Formulation ID="F250802904001" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mcg per ml, 1 ml ampoule</Name>
              <Brand ID="B25080290400127">
                <Name>Max Health</Name>
                <Pack ID="P2629518" Specified="true" nzmt:ctpp_id="50275161000117100">
                  <Quantity>5</Quantity>
                  <Price>32.71</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250802904002" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mcg per ml, 1 ml ampoule</Name>
              <Brand ID="B25080290400227">
                <Name>Max Health</Name>
                <Pack ID="P2629534" Specified="true" nzmt:ctpp_id="50275151000117102">
                  <Quantity>5</Quantity>
                  <Price>27.58</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250802904003" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mcg per ml, 1 ml ampoule</Name>
              <Brand ID="B25080290400327">
                <Name>Max Health</Name>
                <Pack ID="P2629526" Specified="true" nzmt:ctpp_id="50275171000117105">
                  <Quantity>5</Quantity>
                  <Price>113.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250802904025" Rank="4" Units="inj" Weight="10000">
              <Name>Inj depot 10 mg prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <html:div class="Restricted item" xlink:href="RS1889" style="display:none"/>
              <Brand ID="B25080290402525" PSS="true">
                <Name>Sandostatin LAR</Name>
                <Pack ID="P2150832" Specified="true" nzmt:ctpp_id="50026161000117102">
                  <Quantity>1</Quantity>
                  <Price>438.40</Price>
                </Pack>
              </Brand>
              <Brand ID="B25080290402526" ToBeDelisted="2024-12-01">
                <Name>Octreotide Depot Teva</Name>
                <Pack ID="P2615320" Specified="true" nzmt:ctpp_id="50265481000117105">
                  <Quantity>1</Quantity>
                  <Price>439.97</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250802904026" Rank="4" Units="inj" Weight="20000">
              <Name>Inj depot 20 mg prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <html:div class="Restricted item" xlink:href="RS1889" style="display:none"/>
              <Brand ID="B25080290402625" PSS="true">
                <Name>Sandostatin LAR</Name>
                <Pack ID="P2150840" Specified="true" nzmt:ctpp_id="50026171000117107">
                  <Quantity>1</Quantity>
                  <Price>583.70</Price>
                </Pack>
              </Brand>
              <Brand ID="B25080290402626" ToBeDelisted="2024-12-01">
                <Name>Octreotide Depot Teva</Name>
                <Pack ID="P2615339" Specified="true" nzmt:ctpp_id="50265491000117108">
                  <Quantity>1</Quantity>
                  <Price>647.03</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250802904027" Rank="4" Units="inj" Weight="30000">
              <Name>Inj depot 30 mg prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <html:div class="Restricted item" xlink:href="RS1889" style="display:none"/>
              <Brand ID="B25080290402725" PSS="true">
                <Name>Sandostatin LAR</Name>
                <Pack ID="P2150859" Specified="true" nzmt:ctpp_id="50026181000117105">
                  <Quantity>1</Quantity>
                  <Price>670.80</Price>
                </Pack>
              </Brand>
              <Brand ID="B25080290402726" ToBeDelisted="2024-12-01">
                <Name>Octreotide Depot Teva</Name>
                <Pack ID="P2615347" Specified="true" nzmt:ctpp_id="50265501000117102">
                  <Quantity>1</Quantity>
                  <Price>718.55</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250802904028" Rank="4" Units="inj">
              <Name>Inj 100 mcg per ml, 1 ml vial</Name>
              <Brand ID="B25080290402825">
                <Name>Omega</Name>
                <Pack ID="P2687275" Specified="true" nzmt:ctpp_id="50338121000117107">
                  <Quantity>5</Quantity>
                  <Price>48.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2508029116">
            <Name>Flutamide</Name>
            <Formulation ID="F250802911601" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B25080291160101">
                <Name>Flutamin</Name>
                <Pack ID="P259985" Specified="true" nzmt:ctpp_id="50056921000117108">
                  <Quantity>100</Quantity>
                  <Multiple>100</Multiple>
                  <Price>119.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2508029162">
            <Name>Tamoxifen citrate</Name>
            <Formulation ID="F250802916225" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B25080291622526" PSS="true">
                <Name>Tamoxifen Sandoz</Name>
                <Pack ID="P2556944" Specified="true" nzmt:ctpp_id="50255141000117101">
                  <Quantity>60</Quantity>
                  <Price>15.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F250802916226" Rank="1" Units="tab" Weight="20">
              <Name>Tab 20 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B25080291622626" PSS="true">
                <Name>Tamoxifen Sandoz</Name>
                <Pack ID="P2556952" Specified="true" nzmt:ctpp_id="50048541000117106">
                  <Quantity>60</Quantity>
                  <Price>5.32</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2508029461">
            <Name>Bicalutamide</Name>
            <Formulation ID="F250802946125" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B25080294612527" PSS="true">
                <Name>Binarex</Name>
                <Pack ID="P2523655" Specified="true" nzmt:ctpp_id="50198471000117104">
                  <Quantity>28</Quantity>
                  <Price>4.18</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A250804">
          <Name>Aromatase Inhibitors</Name>
          <Chemical ID="C2508049245">
            <Name>Letrozole</Name>
            <Formulation ID="F250804924525" Rank="1" Units="tab" Weight="2.5">
              <Name>Tab 2.5 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B25080492452528" PSS="true">
                <Name>Letrole</Name>
                <Pack ID="P2656655" Specified="true" nzmt:ctpp_id="50227451000117104">
                  <Quantity>30</Quantity>
                  <Price>4.67</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2508049400">
            <Name>Exemestane</Name>
            <Formulation ID="F250804940025" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Nov-23 to~2026" Value="5"/>
              <Brand ID="B25080494002526" PSS="true">
                <Name>Pfizer Exemestane</Name>
                <Pack ID="P2500647" Specified="true" nzmt:ctpp_id="50228741000117107">
                  <Quantity>30</Quantity>
                  <Price>9.86</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2508049467">
            <Name>Anastrozole</Name>
            <Formulation ID="F250804946725" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg</Name>
              <Rule Type="DVLimit" Attribute="Dec-23 to~2026" Value="5"/>
              <Brand ID="B25080494672528" PSS="true">
                <Name>Anatrole</Name>
                <Pack ID="P2520079" Specified="true" nzmt:ctpp_id="50281611000117102">
                  <Quantity>30</Quantity>
                  <Price>4.39</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2510">
        <Name>Imaging Agents</Name>
        <ATC3 ID="A251004">
          <Name>Imaging Agents</Name>
          <Chemical ID="C2510048607">
            <Name>Aminolevulinic acid hydrochloride</Name>
            <Request Form="RS1565" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Aminolevulinic acid hydrochloride</range>
              </Title>
              <Case When="Initial application" Category="high grade malignant glioma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has newly diagnosed, untreated, glioblastoma multiforme</ci>
                    <ci type="logical">Treatment to be used as adjuvant to fluorescence-guided resection</ci>
                    <ci type="logical">Patient's tumour is amenable to complete resection</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1565" style="display:none"/>
            <Formulation ID="F251004860725" Rank="4" Units="inj" Weight="30">
              <Name>Powder for oral soln, 30 mg per ml, 1.5 g vial</Name>
              <Brand ID="B25100486072525">
                <Name>Gliolan</Name>
                <Pack ID="P2523302" Specified="true" nzmt:ctpp_id="50212361000117100">
                  <Quantity>1</Quantity>
                  <Price>4400.00</Price>
                </Pack>
                <Pack ID="P2523310" Specified="true" nzmt:ctpp_id="50212341000117104">
                  <Quantity>10</Quantity>
                  <Price>44000.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2512">
        <Name>Immunosuppressants</Name>
        <ATC3 ID="A251204">
          <Name>Calcineurin Inhibitors</Name>
          <Chemical ID="C2512049016">
            <Name>Ciclosporin</Name>
            <Formulation ID="F251204901601" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Brand ID="B25120490160101">
                <Name>Neoral</Name>
                <Pack ID="P455598" Specified="true" nzmt:ctpp_id="50086851000117101">
                  <Quantity>50</Quantity>
                  <Price>177.81</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251204901602" Rank="2" Units="cap" Weight="25">
              <Name>Cap 25 mg</Name>
              <Brand ID="B25120490160201">
                <Name>Neoral</Name>
                <Pack ID="P455571" Specified="true" nzmt:ctpp_id="50086841000117103">
                  <Quantity>50</Quantity>
                  <Price>44.63</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251204901603" Rank="2" Units="cap" Weight="50">
              <Name>Cap 50 mg</Name>
              <Brand ID="B25120490160301">
                <Name>Neoral</Name>
                <Pack ID="P2011344" Specified="true" nzmt:ctpp_id="50001411000117105">
                  <Quantity>50</Quantity>
                  <Price>88.91</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251204901604" Rank="3" Units="ml" Weight="100">
              <Name>Oral liq 100 mg per ml</Name>
              <Brand ID="B25120490160401">
                <Name>Neoral</Name>
                <Pack ID="P455563" Specified="true" nzmt:ctpp_id="50086831000117106">
                  <Quantity>50</Quantity>
                  <Price>198.13</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251204901625" Rank="4" Units="inj" Weight="250">
              <Name>Inj 50 mg per ml, 5 ml ampoule</Name>
              <Brand ID="B25120490162525">
                <Name>Sandimmun</Name>
                <Pack ID="P327921" Specified="true" nzmt:ctpp_id="50072751000117102">
                  <Quantity>10</Quantity>
                  <Price>276.30</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512049163">
            <Name>Tacrolimus</Name>
            <Request Form="RS1990" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Tacrolimus</range>
              </Title>
              <Case When="Initial application" Category="organ transplant recipients">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">For use in organ transplant recipients</ci>
                </math>
                <Applicant>any specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="non-transplant indications*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient requires long-term systemic immunosuppression</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Ciclosporin has been trialled and discontinued treatment because of unacceptable side effects or inadequate clinical response</ci>
                      <ci type="logical" class="Indication">Patient is a child with nephrotic syndrome*</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>any specialist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Indications marked with * are unapproved indications</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1990" style="display:none"/>
            <Formulation ID="F251204916301" Rank="4" Units="inj" Weight="5">
              <Name>Inj 5 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B25120491630100">
                <Name>Any</Name>
                <Pack ID="P91630100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251204916325" Rank="2" Units="cap" Weight="0.5">
              <Name>Cap 0.5 mg</Name>
              <Brand ID="B25120491632526">
                <Name>Tacrolimus Sandoz</Name>
                <Pack ID="P2431238" Specified="true" nzmt:ctpp_id="50179411000117108">
                  <Quantity>100</Quantity>
                  <Price>49.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251204916326" Rank="2" Units="cap" Weight="1">
              <Name>Cap 1 mg</Name>
              <Brand ID="B25120491632626">
                <Name>Tacrolimus Sandoz</Name>
                <Pack ID="P2431246" Specified="true" nzmt:ctpp_id="50179421000117102">
                  <Quantity>100</Quantity>
                  <Price>84.30</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251204916327" Rank="2" Units="cap" Weight="5">
              <Name>Cap 5 mg</Name>
              <Brand ID="B25120491632726">
                <Name>Tacrolimus Sandoz</Name>
                <Pack ID="P2431254" Specified="true" nzmt:ctpp_id="50179431000117104">
                  <Quantity>50</Quantity>
                  <Price>248.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251204916328" Rank="2" Units="cap" Weight="0.75">
              <Name>Cap 0.75 mg</Name>
              <Brand ID="B25120491632825">
                <Name>Tacrolimus Sandoz</Name>
                <Pack ID="P2573938" Specified="true" nzmt:ctpp_id="50257171000117104">
                  <Quantity>100</Quantity>
                  <Price>99.30</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A251208">
          <Name>Fusion Proteins</Name>
          <Chemical ID="C2512089185">
            <Name>Etanercept</Name>
            <Request Form="RS1879" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Etanercept</range>
              </Title>
              <Case When="Initial application" Category="polyarticular course juvenile idiopathic arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has had an initial Special Authority approval for
                        adalimumab for polyarticular course juvenile idiopathic arthritis (JIA)</ci>
                      <apply>
                        <or/>
                        <ci type="logical">The patient has experienced intolerable side effects from
                            adalimumab</ci>
                        <ci type="logical">The patient has received insufficient benefit from
                            adalimumab to meet the renewal criteria for adalimumab for polyarticular
                            course JIA</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">To be used as an adjunct to methotrexate therapy or
                        monotherapy where use of methotrexate is limited by toxicity or
                        intolerance</ci>
                      <ci type="logical">Patient has had polyarticular course JIA for 6 months
                        duration or longer</ci>
                      <apply>
                        <or/>
                        <ci type="logical">At least 5 active joints and at least 3 joints with
                            limited range of motion, pain or tenderness after a 3-month trial of
                            methotrexate (at the maximum tolerated dose)</ci>
                        <ci type="logical">Moderate or high disease activity (cJADAS10 score of at
                            least 2.5) after a 3-month trial of methotrexate (at the maximum
                            tolerated dose)</ci>
                        <ci type="logical">Low disease activity (cJADAS10 score between 1.1 and 2.5)
                            after a 6-month trial of methotrexate</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant>named specialist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="polyarticular course juvenile idiopathic arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Treatment is to be used as an adjunct to methotrexate therapy or
                    monotherapy where use of methotrexate is limited by toxicity or intolerance</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Following 3 to 4 months' initial treatment, the patient has
                        at least a 50% decrease in active joint count and an improvement in
                        physician's global assessment from baseline</ci>
                      <ci type="logical">On subsequent reapplications, the patient demonstrates at
                        least a continuing 30% improvement in active joint count and continued
                        improvement in physician's global assessment from baseline</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant>named specialist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="oligoarticular course juvenile idiopathic arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has had an initial Special Authority approval for
                        adalimumab for oligoarticular course juvenile idiopathic arthritis
                        (JIA)</ci>
                      <apply>
                        <or/>
                        <ci type="logical">The patient has experienced intolerable side effects from
                            adalimumab</ci>
                        <ci type="logical">The patient has received insufficient benefit from
                            adalimumab to meet the renewal criteria for adalimumab for
                            oligoarticular course JIA</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">To be used as an adjunct to methotrexate therapy or
                        monotherapy where use of methotrexate is limited by toxicity or
                        intolerance</ci>
                      <ci type="logical">Patient has had oligoarticular course JIA for 6 months
                        duration or longer</ci>
                      <apply>
                        <or/>
                        <ci type="logical">At least 2 active joints with limited range of motion,
                            pain or tenderness after a 3-month trial of methotrexate (at the maximum
                            tolerated dose)</ci>
                        <ci type="logical">Moderate or high disease activity (cJADAS10 score greater
                            than 1.5) with poor prognostic features after a 3-month trial of
                            methotrexate (at the maximum tolerated dose)</ci>
                        <ci type="logical">High disease activity (cJADAS10 score greater than 4)
                            after a 6-month trial of methotrexate</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant>named specialist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="oligoarticular course juvenile idiopathic arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Subsidised as an adjunct to methotrexate therapy or monotherapy
                    where use of methotrexate is limited by toxicity or intolerance</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Following 3 to 4 months' initial treatment, the patient has
                        at least a 50% decrease in active joint count and an improvement in
                        physician's global assessment from baselinee</ci>
                      <ci type="logical">On subsequent reapplications, the patient demonstrates at
                        least a continuing 30% improvement in active joint count and continued
                        improvement in physician's global assessment from baseline</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant>named specialist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Arthritis - rheumatoid">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has had an initial Special Authority approval for
                        adalimumab for rheumatoid arthritis</ci>
                      <apply>
                        <or/>
                        <ci type="logical">The patient has experienced intolerable side effects</ci>
                        <ci type="logical">The patient has received insufficient benefit to meet the
                            renewal criteria for rheumatoid arthritis</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has had rheumatoid arthritis (either confirmed by
                        radiology imaging, or the patient is cyclic citrullinated peptide (CCP)
                        antibody positive) for six months duration or longer</ci>
                      <ci type="logical">Treatment is to be used as an adjunct to methotrexate therapy
                        or monotherapy where use of methotrexate is limited by toxicity or
                        intolerance</ci>
                      <ci type="logical">Patient has tried and not responded to at least three months
                        of methotrexate at a maximum tolerated dose (unless contraindicated)</ci>
                      <ci type="logical">Patient has tried and not responded to at least three months
                        of methotrexate in combination with sulfasalazine and hydroxychloroquine
                        sulphate at maximum tolerated doses (unless contraindicated)</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has tried and not responded to at least three
                            months of methotrexate in combination with the maximum tolerated dose of
                            ciclosporin</ci>
                        <ci type="logical">Patient has tried and not responded to at least three
                            months of therapy at the maximum tolerated dose of leflunomide alone or
                            in combination with methotrexate</ci>
                      </apply>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has persistent symptoms of poorly controlled and
                            active disease in at least 15 swollen joints</ci>
                        <ci type="logical">Patient has persistent symptoms of poorly controlled and
                            active disease in at least four joints from the following: wrist, elbow,
                            knee, ankle, and either shoulder or hip</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Arthritis - rheumatoid">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Treatment is to be used as an adjunct to methotrexate therapy or
                    monotherapy where use of methotrexate is limited by toxicity or intolerance</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Following initial treatment, the patient has at least a 50%
                        decrease in active joint count from baseline and a clinically significant
                        response to treatment in the opinion of the physician</ci>
                      <ci type="logical">On subsequent reapplications, the patient demonstrates at
                        least a continuing 30% improvement in active joint count from baseline and a
                        clinically significant response to treatment in the opinion of the
                        physician</ci>
                    </apply>
                    <ci type="logical">Etanercept to be administered at doses no greater than 50 mg
                    every 7 days</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="ankylosing spondylitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has had an initial Special Authority approval for
                        adalimumab for ankylosing spondylitis</ci>
                      <apply>
                        <or/>
                        <ci type="logical">The patient has experienced intolerable side effects from
                            adalimumab</ci>
                        <ci type="logical">The patient has received insufficient benefit from
                            adalimumab to meet the renewal criteria for adalimumab for ankylosing
                            spondylitis</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has a confirmed diagnosis of ankylosing spondylitis
                        present for more than six months</ci>
                      <ci type="logical">Patient has low back pain and stiffness that is relieved by
                        exercise but not by rest</ci>
                      <ci type="logical">Patient has bilateral sacroiliitis demonstrated by plain
                        radiographs, CT or MRI scan</ci>
                      <ci type="logical">Patient's ankylosing spondylitis has not responded adequately
                        to treatment with two or more non-steroidal anti-inflammatory drugs
                        (NSAIDs), in combination with anti-ulcer therapy if indicated, while patient
                        was undergoing at least 3 months of a regular exercise regimen for
                        ankylosing spondylitis</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has limitation of motion of the lumbar spine in
                            the sagittal and the frontal planes as determined by the following Bath
                            Ankylosing Spondylitis Metrology Index (BASMI) measures: a modified
                            Schober's test of less than or equal to 4 cm and lumbar side flexion
                            measurement of less than or equal to 10 cm (mean of left and right)</ci>
                        <ci type="logical">Patient has limitation of chest expansion by at least 2.5
                            cm below the average normal values corrected for age and gender (see
                            Notes)</ci>
                      </apply>
                      <ci type="logical">Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
                        of at least 6 on a 0-10 scale</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>The BASDAI must have been determined at the completion of the 3 month exercise trial,
                but prior to ceasing NSAID treatment. The BASDAI measure must be no more than 1
                month old at the time of starting treatment.</p>
                  <p>Average normal chest expansion corrected for age and gender:</p>
                  <table>
                    <tr>
                      <th>Age</th>
                      <th>Male</th>
                      <th>Female</th>
                    </tr>
                    <tr>
                      <td>18-24</td>
                      <td>7.0 cm</td>
                      <td>5.5 cm</td>
                    </tr>
                    <tr>
                      <td>25-34</td>
                      <td>7.5 cm</td>
                      <td>5.5 cm</td>
                    </tr>
                    <tr>
                      <td>35-44</td>
                      <td>6.5 cm</td>
                      <td>4.5 cm</td>
                    </tr>
                    <tr>
                      <td>45-54</td>
                      <td>6.0 cm</td>
                      <td>5.0 cm</td>
                    </tr>
                    <tr>
                      <td>55-64</td>
                      <td>5.5 cm</td>
                      <td>4.0 cm</td>
                    </tr>
                    <tr>
                      <td>65-74</td>
                      <td>4.0 cm</td>
                      <td>4.0 cm</td>
                    </tr>
                    <tr>
                      <td>75+ </td>
                      <td>3.0 cm</td>
                      <td>2.5 cm</td>
                    </tr>
                  </table>
                </div>
              </Case>
              <Case When="Renewal" Category="ankylosing spondylitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Following 12 weeks' initial treatment and for subsequent
                    renewals, treatment has resulted in an improvement in BASDAI of 4 or more points
                    from pre-treatment baseline on a 10 point scale, or an improvement in BASDAI of
                    50%, whichever is less</ci>
                    <ci type="logical">Physician considers that the patient has benefited from treatment
                    and that continued treatment is appropriate</ci>
                    <ci type="logical">Etanercept to be administered at doses no greater than 50 mg
                    every 7 days</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="psoriatic arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has had an initial Special Authority approval for
                        adalimumab or secukinumab for psoriatic arthritis</ci>
                      <apply>
                        <or/>
                        <ci type="logical">The patient has experienced intolerable side effects from
                            adalimumab or secukinumab</ci>
                        <ci type="logical">The patient has received insufficient benefit from
                            adalimumab or secukinumab to meet the renewal criteria for adalimumab or
                            secukinumab for psoriatic arthritis</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has had severe active psoriatic arthritis for six
                        months duration or longer</ci>
                      <ci type="logical">Patient has tried and not responded to at least three months
                        of oral or parenteral methotrexate at a dose of at least 20 mg weekly or a
                        maximum tolerated dose</ci>
                      <ci type="logical">Patient has tried and not responded to at least three months
                        of sulfasalazine at a dose of at least 2 g per day or leflunomide at a dose
                        of up to 20 mg daily (or maximum tolerated doses)</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has persistent symptoms of poorly controlled and
                            active disease in at least 15 swollen, tender joints</ci>
                        <ci type="logical">Patient has persistent symptoms of poorly controlled and
                            active disease in at least four joints from the following: wrist, elbow,
                            knee, ankle, and either shoulder or hip</ci>
                      </apply>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has a C-reactive protein level greater than 15
                            mg/L measured no more than one month prior to the date of this
                            application</ci>
                        <ci type="logical">Patient has an elevated erythrocyte sedimentation rate
                            (ESR) greater than 25 mm per hour</ci>
                        <ci type="logical">ESR and CRP not measured as patient is currently
                            receiving prednisone therapy at a dose of greater than 5 mg per day and
                            has done so for more than three months</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="psoriatic arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Following 3 to 4 months' initial treatment, the patient has
                        at least a 50% decrease in active joint count from baseline and a clinically
                        significant response to treatment in the opinion of the physician</ci>
                      <ci type="logical">The patient demonstrates at least a continuing 30%
                        improvement in active joint count from baseline and a clinically significant
                        response to prior etanercept treatment in the opinion of the treating
                        physician</ci>
                    </apply>
                    <ci type="logical">Etanercept to be administered at doses no greater than 50 mg
                    every 7 days</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="severe chronic plaque psoriasis, prior TNF use">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has had an initial Special Authority approval for
                    adalimumab for severe chronic plaque psoriasis</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from
                        adalimumab</ci>
                      <ci type="logical">The patient has received insufficient benefit from adalimumab
                        to meet the renewal criteria for adalimumab for severe chronic plaque
                        psoriasis</ci>
                    </apply>
                    <ci type="logical">Patient must be reassessed for continuation after 3 doses</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Initial application" Category="severe chronic plaque psoriasis, treatment-naive">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has "whole body" severe chronic plaque psoriasis with
                        a Psoriasis Area and Severity Index (PASI) score of greater than 10, where
                        lesions have been present for at least 6 months from the time of initial
                        diagnosis</ci>
                      <ci type="logical">Patient has severe chronic plaque psoriasis of the face, or
                        palm of a hand or sole of a foot, where the plaque or plaques have been
                        present for at least 6 months from the time of initial diagnosis</ci>
                    </apply>
                    <ci type="logical">Patient has tried, but had an inadequate response (see Note) to,
                    or has experienced intolerable side effects from, at least three of the
                    following (at maximum tolerated doses unless contraindicated): phototherapy,
                    methotrexate, ciclosporin, or acitretin</ci>
                    <ci type="logical">A PASI assessment or Dermatology Quality of Life Index (DLQI)
                    assessment has been completed for at least the most recent prior treatment
                    course (but preferably all prior treatment courses), preferably while still on
                    treatment but no longer than 1 month following cessation of each prior treatment
                    course</ci>
                    <ci type="logical">The most recent PASI or DLQI assessment is no more than 1 month
                    old at the time of initiation</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="month">4</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>"Inadequate response" is defined as: for whole body severe chronic plaque psoriasis,
                a PASI score of greater than 10, as assessed preferably while still on treatment but
                no longer than 1 month following cessation of the most recent prior treatment; for
                severe chronic plaque psoriasis of the face, hand or foot, at least 2 of the 3 PASI
                symptom subscores for erythema, thickness and scaling are rated as severe or very
                severe, and the skin area affected is 30% or more of the face, palm of a hand or
                sole of a foot, as assessed preferably while still on treatment but no longer than 1
                month following cessation of the most recent prior treatment.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="severe chronic plaque psoriasis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">Patient had "whole body" severe chronic plaque psoriasis
                            at the start of treatment</ci>
                        <apply>
                          <or/>
                          <ci type="logical">Following each prior etanercept treatment course the
                                patient has a PASI score which is reduced by 75% or more, or is
                                sustained at this level, when compared with the pre-etanercept
                                treatment baseline value</ci>
                          <ci type="logical">Following each prior etanercept treatment course the
                                patient has a Dermatology Quality of Life Index (DLQI) improvement
                                of 5 or more, when compared with the pre-treatment baseline
                                value</ci>
                        </apply>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">Patient had severe chronic plaque psoriasis of the face,
                            or palm of a hand or sole of a foot at the start of treatment</ci>
                        <apply>
                          <or/>
                          <ci type="logical">Following each prior etanercept treatment course the
                                patient has a reduction in the PASI symptom subscores for all 3 of
                                erythema, thickness and scaling, to slight or better, or sustained
                                at this level, as compared to the treatment course baseline
                                values</ci>
                          <ci type="logical">Following each prior etanercept treatment course the
                                patient has a reduction of 75% or more in the skin area affected, or
                                sustained at this level, as compared to the pre-etanercept treatment
                                baseline value</ci>
                        </apply>
                      </apply>
                    </apply>
                    <ci type="logical">Etanercept to be administered at doses no greater than 50 mg
                    every 7 days</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="pyoderma gangrenosum">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has pyoderma gangrenosum*</ci>
                    <ci type="logical">Patient has received three months of conventional therapy
                    including a minimum of three pharmaceuticals (e.g. prednisone, ciclosporin,
                    azathioprine, or methotrexate) and not received an adequate response</ci>
                    <ci type="logical">A maximum of 8 doses</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="pyoderma gangrenosum">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has shown clinical improvement</ci>
                    <ci type="logical">Patient continues to require treatment</ci>
                    <ci type="logical">A maximum of 8 doses</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="adult-onset Still's disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <apply>
                        <or/>
                        <ci type="logical">The patient has had an initial Special Authority approval
                            for etanercept for adult-onset Still's disease (AOSD)</ci>
                        <ci type="logical">The patient has been started on tocilizumab for AOSD in a
                            Health NZ Hospital</ci>
                      </apply>
                      <apply>
                        <or/>
                        <ci type="logical">The patient has experienced intolerable side effects from
                            etanercept and/or tocilizumab</ci>
                        <ci type="logical">The patient has received insufficient benefit from at
                            least a three-month trial of adalimumab and/or tocilizumab such that
                            they do not meet the renewal criteria for AOSD</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient diagnosed with AOSD according to the Yamaguchi
                        criteria (J Rheumatol 1992;19:424-430)</ci>
                      <ci type="logical">Patient has tried and not responded to at least 6 months of
                        glucocorticosteroids at a dose of at least 0.5 mg/kg, non-steroidal
                        antiinflammatory drugs (NSAIDs) and methotrexate</ci>
                      <ci type="logical">Patient has persistent symptoms of disabling poorly
                        controlled and active disease</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="adult-onset Still's disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The patient has a sustained improvement in inflammatory markers and
                functional status</ci>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="undifferentiated spondyloarthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has undifferentiated peripheral spondyloarthritis* with
                    active peripheral joint arthritis in at least four joints from the following:
                    wrist, elbow, knee, ankle, and either shoulder or hip</ci>
                    <ci type="logical">Patient has tried and not responded to at least three months of
                    oral or parenteral methotrexate at a dose of at least 20 mg weekly or a maximum
                    tolerated dose</ci>
                    <ci type="logical">Patient has tried and not responded to at least three months of
                    sulfasalazine at a dose of at least 2 g per day (or maximum tolerated dose)</ci>
                    <ci type="logical">Patient has tried and not responded to at least three months of
                    leflunomide at a dose of up to 20 mg daily (or maximum tolerated dose)</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has a C-reactive protein level greater than 15 mg/L
                        measured no more than one month prior to the date of this application</ci>
                      <ci type="logical">Patient has an elevated erythrocyte sedimentation rate (ESR)
                        greater than 25 mm per hour measured no more than one month prior to the
                        date of this application</ci>
                      <ci type="logical">ESR and CRP not measured as patient is currently receiving
                        prednisone therapy at a dose of greater than 5 mg per day and has done so
                        for more than three months</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="undifferentiated spondyloarthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Applicant is a rheumatologist</ci>
                      <ci type="logical">Applicant is a Practitioner and confirms that a
                        rheumatologist has provided a letter, email or fax recommending that the
                        patient continues with etanercept treatment</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical">Following 3 to 4 months’ initial treatment, the patient has
                        at least a 50% decrease in active joint count from baseline and a clinically
                        significant response to treatment in the opinion of the physician</ci>
                      <ci type="logical">The patient demonstrates at least a continuing 30%
                        improvement in active joint count from baseline and a clinically significant
                        response to prior etanercept treatment in the opinion of the treating
                        physician</ci>
                    </apply>
                    <ci type="logical">Etanercept to be administered at doses no greater than 50 mg dose
                    every 7 days</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="Rheumatologist">medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1879" style="display:none"/>
            <Formulation ID="F251208918525" Rank="4" Units="inj" Weight="25">
              <Name>Inj 25 mg vial</Name>
              <Brand ID="B25120891852525">
                <Name>Enbrel</Name>
                <Pack ID="P2006561" Specified="true" nzmt:ctpp_id="50000651000117101">
                  <Quantity>4</Quantity>
                  <Price>690.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251208918526" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg autoinjector</Name>
              <Brand ID="B25120891852625">
                <Name>Enbrel</Name>
                <Pack ID="P2510456" Specified="true" nzmt:ctpp_id="50120621000117108">
                  <Quantity>4</Quantity>
                  <Price>1050.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251208918527" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg syringe</Name>
              <Brand ID="B25120891852725">
                <Name>Enbrel</Name>
                <Pack ID="P2382113" Specified="true" nzmt:ctpp_id="50122421000117106">
                  <Quantity>4</Quantity>
                  <Price>1050.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251208918528" Rank="4" Units="inj" Weight="25">
              <Name>Inj 25 mg autoinjector</Name>
              <Brand ID="B25120891852825">
                <Name>Enbrel</Name>
                <Pack ID="P2602113" Specified="true" nzmt:ctpp_id="50305921000117105">
                  <Quantity>4</Quantity>
                  <Price>690.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A251212">
          <Name>Monoclonal Antibodies</Name>
          <Chemical ID="C2512128057">
            <Name>Bevacizumab</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1691">
              <Title>
                <range>Bevacizumab</range>
              </Title>
              <Case When="Initial application" Category="Recurrent Respiratory Papillomatosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Maximum of 6 doses</ci>
                    <ci type="logical">The patient has recurrent respiratory papillomatosis</ci>
                    <ci type="logical">The treatment is for intra-lesional administration</ci>
                  </apply>
                </math>
                <Applicant>otolaryngologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="Recurrent Respiratory Papillomatosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Maximum of 6 doses</ci>
                    <ci type="logical">The treatment is for intra-lesional administration</ci>
                    <ci type="logical">There has been a reduction in surgical treatments or disease regrowth as a result of treatment</ci>
                  </apply>
                </math>
                <Applicant>otolaryngologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="ocular conditions">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Ocular neovascularisation</ci>
                    <ci type="logical">Exudative ocular angiopathy</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1691" style="display:none"/>
            <Formulation ID="F251212805701" Rank="4" Units="inj" Weight="400">
              <Name>Inj 25 mg per ml, 16 ml vial</Name>
              <Brand ID="B25121280570100">
                <Name>Any</Name>
                <Pack ID="P80570100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212805702" Rank="4" Units="inj" Weight="100">
              <Name>Inj 25 mg per ml, 4 ml vial</Name>
              <Brand ID="B25121280570200">
                <Name>Any</Name>
                <Pack ID="P80570200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128404">
            <Name>Ranibizumab</Name>
            <Request Form="RS1870" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ranibizumab</range>
              </Title>
              <Case When="Initial application" Category="Wet Age Related Macular Degeneration">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <apply>
                        <or/>
                        <ci type="logical">Wet age-related macular degeneration (wet AMD)</ci>
                        <ci type="logical">Polypoidal choroidal vasculopathy</ci>
                        <ci type="logical">Choroidal neovascular membrane from causes other than wet AMD</ci>
                      </apply>
                      <apply>
                        <or/>
                        <ci type="logical">The patient has developed severe endophthalmitis or severe posterior uveitis following treatment with bevacizumab</ci>
                        <ci type="logical">There is worsening of vision or failure of retina to dry despite three intraocular injections of bevacizumab four weeks apart</ci>
                      </apply>
                      <ci type="logical">There is no structural damage to the central fovea of the treated eye</ci>
                      <ci type="logical">Patient has not previously been treated with aflibercept for longer than 3 months</ci>
                    </apply>
                    <ci type="logical">Patient has current approval to use aflibercept for treatment of wAMD and was found to be intolerant to aflibercept within 3 months</ci>
                  </apply>
                </math>
                <Applicant>ophthalmologist</Applicant>
                <Applicant>nurse practitioner</Applicant>
                <Term Measure="month">3</Term>
              </Case>
              <Case When="Renewal" Category="Wet Age Related Macular Degeneration">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Documented benefit must be demonstrated to continue</ci>
                    <ci type="logical">Patient’s vision is 6/36 or better on the Snellen visual acuity score</ci>
                    <ci type="logical">There is no structural damage to the central fovea of the treated eye</ci>
                  </apply>
                </math>
                <Applicant>ophthalmologist</Applicant>
                <Applicant>nurse practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1870" style="display:none"/>
            <Formulation ID="F251212840401" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 0.23 ml vial</Name>
              <Brand ID="B25121284040100">
                <Name>Any</Name>
                <Pack ID="P84040100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212840402" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 0.3 ml vial</Name>
              <Brand ID="B25121284040200">
                <Name>Any</Name>
                <Pack ID="P84040200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128515">
            <Name>Infliximab</Name>
            <Request Form="RS1941" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Infliximab</range>
              </Title>
              <Case When="Initial application" Category="Graft vs host disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has steroid-refractory acute graft vs. host disease of the gut</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="rheumatoid arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has had an initial Special Authority approval for adalimumab
          and/or etanercept for rheumatoid arthritis</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from a reasonable
            trial of adalimumab and/or etanercept</ci>
                      <ci type="logical">Following at least a four month trial of adalimumab and/or etanercept,
            the patient did not meet the renewal criteria for adalimumab and/or etanercept</ci>
                    </apply>
                    <ci type="logical">Treatment is to be used as an adjunct to methotrexate therapy or
          monotherapy where use of methotrexate is limited by toxicity or intolerance</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="rheumatoid arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Treatment is to be used as an adjunct to methotrexate therapy or
          monotherapy where use of methotrexate is limited by toxicity or intolerance</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Following 3 to 4 months' initial treatment, the patient has at least a
            50% decrease in active joint count from baseline and a clinically significant response
            to treatment in the opinion of the physician</ci>
                      <ci type="logical">The patient demonstrates at least a continuing 30% improvement in
            active joint count from baseline and a clinically significant response to treatment in
            the opinion of the physician</ci>
                    </apply>
                    <ci type="logical">Infliximab to be administered at doses no greater than 3 mg/kg every 8
          weeks</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="ankylosing spondylitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has had an initial Special Authority approval for adalimumab
          and/or etanercept for ankylosing spondylitis</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from a reasonable
            trial of adalimumab and/or etanercept</ci>
                      <ci type="logical">Following 12 weeks of adalimumab and/or etanercept treatment, the
            patient did not meet the renewal criteria for adalimumab and/or etanercept for
            ankylosing spondylitis</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">3</Term>
              </Case>
              <Case When="Renewal" Category="ankylosing spondylitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Following 12 weeks of infliximab treatment, BASDAI has improved by 4 or
          more points from pre-infliximab baseline on a 10 point scale, or by 50%, whichever is
          less</ci>
                    <ci type="logical">Physician considers that the patient has benefited from treatment and
          that continued treatment is appropriate</ci>
                    <ci type="logical">Infliximab to be administered at doses no greater than 5 mg/kg every 6-8
          weeks</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="psoriatic arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has had an initial Special Authority approval for adalimumab
          and/or etanercept and/or secukinumab for psoriatic arthritis</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from a reasonable
            trial of adalimumab and/or etanercept and/or secukinumab</ci>
                      <ci type="logical">Following 3-4 months' initial treatment with adalimumab and/or
            etanercept and/or secukinumab, the patient did not meet the renewal criteria for
            adalimumab and/or etanercept and/or secukinumab for psoriatic arthritis. </ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="psoriatic arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Following 3 to 4 months' initial treatment, the patient has at least a
            50% decrease in active joint count from baseline and a clinically significant response
            to treatment in the opinion of the physician</ci>
                      <ci type="logical">The patient demonstrates at least a continuing 30% improvement in
            active joint count from baseline and a clinically significant response to prior
            infliximab treatment in the opinion of the treating physician</ci>
                    </apply>
                    <ci type="logical">Infliximab to be administered at doses no greater than 5 mg/kg every 8
          weeks</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="severe ocular inflammation">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has had an initial Special Authority approval for
            adalimumab for severe ocular inflammation</ci>
                      <apply>
                        <or/>
                        <ci type="logical">The patient has experienced intolerable side effects from
              adalimumab</ci>
                        <ci type="logical">The patient has received insufficient benefit from adalimumab to meet
              the renewal criteria for adalimumab for severe ocular inflammation</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has severe, vision-threatening ocular inflammation requiring
            rapid control</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Treatment with high-dose steroids (intravenous methylprednisolone)
              followed by high dose oral steroids has proven ineffective at controlling
              symptoms</ci>
                        <ci type="logical">Patient developed new inflammatory symptoms while receiving high dose
              steroids</ci>
                        <ci type="logical">Patient is aged under 8 years and treatment with high dose oral
              steroids and other immunosuppressants has proven ineffective at controlling
              symptoms</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="severe ocular inflammation">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">The patient has had a good clinical response following 3 initial
          doses</ci>
                    <ci type="logical">Following each 12-month treatment period, the patient has had a sustained
          reduction in inflammation (Standardisation of Uveitis Nomenclature (SUN) criteria &lt; ½+
          anterior chamber or vitreous cells, absence of active vitreous or retinal lesions, or
          resolution of uveitic cystoid macular oedema)</ci>
                    <ci type="logical">Following each 12-month treatment period, the patient has a sustained
          steroid sparing effect, allowing reduction in prednisone to &lt;10mg daily, or steroid
          drops less than twice daily if under 18 years old</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>A trial withdrawal should be considered after every 24 months of stability, unless the
        patient is deemed to have extremely high risk of irreversible vision loss if infliximab is
        withdrawn.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="chronic ocular inflammation">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has had an initial Special Authority approval for
            adalimumab for chronic ocular inflammation</ci>
                      <apply>
                        <or/>
                        <ci type="logical">The patient has experienced intolerable side effects from
              adalimumab</ci>
                        <ci type="logical">The patient has received insufficient benefit from adalimumab to meet
              the renewal criteria for adalimumab for chronic ocular inflammation</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has severe uveitis uncontrolled with treatment of steroids and
            other immunosuppressants with a severe risk of vision loss</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient is 18 years or older and treatment with at least two other
              immunomodulatory agents has proven ineffective</ci>
                        <ci type="logical">Patient is under 18 years and treatment with methotrexate has proven
              ineffective or is not tolerated at therapeutic dose</ci>
                        <ci type="logical">Patient is under 8 years and treatment with steroids or methotrexate
              has proven ineffective or is not tolerated at a therapeutic dose; or disease requires
              control to prevent irreversible vision loss prior to achieving a therapeutic dose of
              methotrexate</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="chronic ocular inflammation">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">The patient has had a good clinical response following 3 initial
          doses</ci>
                    <ci type="logical">Following each 12-month treatment period, the patient has had a sustained
          reduction in inflammation (Standardisation of Uveitis Nomenclature (SUN) criteria &lt; ½+
          anterior chamber or vitreous cells, absence of active vitreous or retinal lesions, or
          resolution of uveitic cystoid macular oedema)</ci>
                    <ci type="logical">Following each 12-month treatment period, the patient has a sustained
          steroid sparing effect, allowing reduction in prednisone to &lt;10mg daily, or steroid
          drops less than twice daily if under 18 years old</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>A trial withdrawal should be considered after every 24 months of stability, unless the
        patient is deemed to have extremely high risk of irreversible vision loss if infliximab is
        withdrawn.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="Pulmonary sarcoidosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has life-threatening pulmonary sarcoidosis that is refractory to
          other treatments</ci>
                    <ci type="logical">Treatment is to be prescribed by, or has been recommended by, a physician
          with expertise in the treatment of pulmonary sarcoidosis</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Crohn's disease (adults)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has active Crohn's disease</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has a CDAI score of greater than or equal to 300, or HBI score
            of greater than or equal to 10</ci>
                      <ci type="logical">Patient has extensive small intestine disease affecting more than 50 cm
            of the small intestine</ci>
                      <ci type="logical">Patient has evidence of short gut syndrome or would be at risk of short
            gut syndrome with further bowel resection</ci>
                      <ci type="logical">Patient has an ileostomy or colostomy, and has intestinal
            inflammation</ci>
                    </apply>
                    <ci type="logical">Patient has tried but had an inadequate response to, or has experienced
          intolerable side effects from, prior therapy with immunomodulators and
          corticosteroids</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Crohn's disease (adults)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">CDAI score has reduced by 100 points from the CDAI score, or HBI score
            has reduced by 3 points, from when the patient was initiated on infliximab</ci>
                      <ci type="logical">CDAI score is 150 or less, or HBI is 4 or less</ci>
                      <ci type="logical">The patient has demonstrated an adequate response to treatment but CDAI
            score and/or HBI score cannot be assessed</ci>
                    </apply>
                    <ci type="logical">Infliximab to be administered at doses up to 5 mg/kg every 8 weeks. Up to
          10 mg/kg every 8 weeks (or equivalent) can be used for up to 3 doses if required for
          secondary non-response to treatment for re-induction. Another re-induction may be
          considered sixteen weeks after completing the last re-induction cycle</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="Crohn's disease (children)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Paediatric patient has active Crohn's disease</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has a PCDAI score of greater than or equal to 30</ci>
                      <ci type="logical">Patient has extensive small intestine disease</ci>
                    </apply>
                    <ci type="logical">Patient has tried but experienced an inadequate response to, or
          intolerable side effects from, prior therapy with immunomodulators and
          corticosteroids</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Crohn's disease (children)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">PCDAI score has reduced by 10 points from the PCDAI score when the
            patient was initiated on infliximab</ci>
                      <ci type="logical">PCDAI score is 15 or less</ci>
                      <ci type="logical">The patient has demonstrated an adequate response to treatment but
            PCDAI score cannot be assessed</ci>
                    </apply>
                    <ci type="logical">Infliximab to be administered at doses up to 5 mg/kg every 8 weeks. Up to
          10 mg/kg every 8 weeks (or equivalent) can be used for up to 3 doses if required for
          secondary non-response to treatment for re-induction. Another re-induction may be
          considered sixteen weeks after completing the last re-induction cycle</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="fistulising Crohn's disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has confirmed Crohn's disease</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has one or more complex externally draining enterocutaneous
            fistula(e)</ci>
                      <ci type="logical">Patient has one or more rectovaginal fistula(e)</ci>
                      <ci type="logical">Patient has complete peri-anal fistula</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>gastroenterologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="fistulising Crohn's disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The number of open draining fistulae have decreased from baseline by at
            least 50%</ci>
                      <ci type="logical">There has been a marked reduction in drainage of all fistula(e) from
            baseline (in the case of adult patients, as demonstrated by a reduction in the Fistula
            Assessment score), together with less induration and patient reported pain</ci>
                    </apply>
                    <ci type="logical">Infliximab to be administered at doses up to 5 mg/kg every 8 weeks. Up to
          10 mg/kg every 8 weeks (or equivalent) can be used for up to 3 doses if required for
          secondary non-response to treatment for re-induction. Another re-induction may be
          considered sixteen weeks after completing the last re-induction cycle</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="acute fulminant ulcerative colitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has acute, fulminant ulcerative colitis</ci>
                    <ci type="logical">Treatment with intravenous or high dose oral corticosteroids has not been
          successful</ci>
                  </apply>
                </math>
                <Applicant>gastroenterologist</Applicant>
                <Term Measure="week">6</Term>
              </Case>
              <Case When="Renewal" Category="fulminant ulcerative colitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Where maintenance treatment is considered appropriate, infliximab should
          be used in combination with immunomodulators and reassessed every 6 months</ci>
                    <ci type="logical">Infliximab to be administered at doses up to 5 mg/kg every 8 weeks. Up to
          10 mg/kg every 8 weeks (or equivalent) can be used for up to 3 doses if required for
          secondary non-response to treatment for re-induction. Another re-induction may be
          considered sixteen weeks after completing the last re-induction cycle</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="ulcerative colitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has active ulcerative colitis</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patients SCCAI is greater than or equal to 4</ci>
                      <ci type="logical">Patients PUCAI score is greater than or equal to 20</ci>
                    </apply>
                    <ci type="logical">Patient has experienced an inadequate response to, or intolerable side
          effects from, prior therapy with immunomodulators and systemic corticosteroids</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="ulcerative colitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The SCCAI score has reduced by 2
            points or more from the SCCAI score when the patient was initiated on infliximab</ci>
                      <ci type="logical">The PUCAI score has reduced by 30 points
            or more from the PUCAI score when the patient was initiated on infliximab</ci>
                    </apply>
                    <ci type="logical">Infliximab to be administered at doses up to 5 mg/kg every 8 weeks. Up to
          10 mg/kg every 8 weeks (or equivalent) can be used for up to 3 doses if required for
          secondary non-response to treatment for re-induction. Another re-induction may be
          considered sixteen weeks after completing the last re-induction cycle</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="plaque psoriasis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has had an initial Special Authority approval for adalimumab,
            etanercept or secukinumab for severe chronic plaque psoriasis</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has experienced intolerable side effects from adalimumab,
              etanercept or secukinumab</ci>
                        <ci type="logical">Patient has received insufficient benefit from adalimumab, etanercept
              or secukinumab to meet the renewal criteria for adalimumab, etanercept or secukinumab
              for severe chronic plaque psoriasis</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has "whole body" severe chronic plaque psoriasis with a
              Psoriasis Area and Severity Index (PASI) score of greater than 10, where lesions have
              been present for at least 6 months from the time of initial diagnosis</ci>
                        <ci type="logical">Patient has severe chronic plaque psoriasis of the face, or palm of a
              hand or sole of a foot, where the plaque or plaques have been present for at least 6
              months from the time of initial diagnosis</ci>
                      </apply>
                      <ci type="logical">Patient has tried, but had an inadequate response (see Note) to, or has
            experienced intolerable side effects from, at least three of the following (at maximum
            tolerated doses unless contraindicated): phototherapy, methotrexate, cyclosporin, or
            acitretin</ci>
                      <ci type="logical">A PASI assessment has been completed for at least the most recent prior
            treatment course (but preferably all prior treatment courses), preferably while still on
            treatment but no longer than 1 month following cessation of each prior treatment
            course</ci>
                      <ci type="logical">The most recent PASI assessment is no more than 1 month old at the time
            of initiation</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="dose">3</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>"Inadequate response" is defined as: for whole body severe chronic plaque psoriasis, a PASI
        score of greater than 10, as assessed preferably while still on treatment but no longer than
        1 month following cessation of the most recent prior treatment; for severe chronic plaque
        psoriasis of the face, hand or foot, at least 2 of the 3 PASI symptom subscores for
        erythema, thickness and scaling are rated as severe or very severe, and the skin area
        affected is 30% or more of the face, palm of a hand or sole of a foot, as assessed
        preferably while still on treatment but no longer than 1 month following cessation of the
        most recent prior treatment.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="plaque psoriasis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">Patient had "whole body" severe chronic plaque psoriasis at the start
              of treatment</ci>
                        <ci type="logical">Following each prior infliximab treatment course the patient has a
              PASI score which is reduced by 75% or more, or is sustained at this level, when
              compared with the pre-infliximab treatment baseline value</ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">Patient had severe chronic plaque psoriasis of the face, or palm of a
              hand or sole of a foot at the start of treatment</ci>
                        <apply>
                          <or/>
                          <ci type="logical">Following each prior infliximab treatment course the patient has a
                reduction in the PASI symptom subscores for all 3 of erythema, thickness and
                scaling, to slight or better, or sustained at this level, as compared to the
                treatment course baseline values</ci>
                          <ci type="logical">Following each prior infliximab treatment course the patient has a
                reduction of 75% or more in the skin area affected, or sustained at this level, as
                compared to the pre-infliximab treatment baseline value</ci>
                        </apply>
                      </apply>
                    </apply>
                    <ci type="logical">Infliximab to be administered at doses no greater than 5 mg/kg every 8
          weeks</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="dose">3</Term>
              </Case>
              <Case When="Initial application" Category="neurosarcoidosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Biopsy consistent with diagnosis of neurosarcoidosis</ci>
                    <ci type="logical">Patient has CNS involvement</ci>
                    <ci type="logical">Patient has steroid-refractory disease</ci>
                    <apply>
                      <or/>
                      <ci type="logical">IV cyclophosphamide has been tried</ci>
                      <ci type="logical">Treatment with IV cyclophosphamide is clinically inappropriate</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>neurologist</Applicant>
                <Term Measure="month">18</Term>
              </Case>
              <Case When="Renewal" Category="neurosarcoidosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">A withdrawal period has been tried and the patient has relapsed</ci>
                    <apply>
                      <and/>
                      <ci type="logical">A withdrawal period has been considered but would not be clinically
            appropriate</ci>
                      <ci type="logical">There has been a marked reduction in prednisone dose</ci>
                      <apply>
                        <or/>
                        <ci type="logical">There has been an improvement in MRI appearances</ci>
                        <ci type="logical">Marked improvement in other symptomology</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>neurologist</Applicant>
                <Term Measure="month">18</Term>
              </Case>
              <Case When="Initial application" Category="severe Behcet's disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has severe Behcet's disease which is significantly impacting
          the patient’s quality of life (see Notes)</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has severe ocular, neurological and/or vasculitic symptoms
            and has not responded adequately to one or more treatment(s) appropriate for the
            particular symptom(s) (see Notes)</ci>
                      <ci type="logical">The patient has severe gastrointestinal, rheumatologic and/or
            mucocutaneous symptoms and has not responded adequately to two or more treatment
            appropriate for the particular symptom(s) (see Notes)</ci>
                    </apply>
                    <ci type="logical">The patient is experiencing significant loss of quality of life</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">4</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <ol style="list-style-type: lower-alpha">
                    <li>
                      <p>Behcet’s disease diagnosed according to the International Study Group for Behcet’s
            Disease. Lancet 1990;335(8697):1078-80. Quality of life measured using an appropriate
            quality of life scale such as that published in Gilworth et al J Rheumatol.
            2004;31:931-7.</p>
                    </li>
                    <li>
                      <p>Treatments appropriate for the particular symptoms are those that are considered
            standard conventional treatments for these symptoms, for example intravenous/oral
            steroids and other immunosuppressants for ocular symptoms; azathioprine, steroids,
            thalidomide, interferon alpha and ciclosporin for mucocutaneous symptoms; and
            colchicine, steroids and methotrexate for rheumatological symptoms.</p>
                    </li>
                  </ol>
                </div>
              </Case>
              <Case When="Renewal" Category="severe Behcet's disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has had a good clinical response to initial treatment with
          measurably improved quality of life</ci>
                    <ci type="logical">Infliximab to be administered at doses no greater than 5 mg/kg every 8
          weeks</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="pyoderma gangrenosum">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has pyoderma gangrenosum*</ci>
                    <ci type="logical">Patient has received three months of conventional therapy including a
          minimum of three pharmaceuticals (e.g. prednisone, ciclosporin, azathioprine, or
          methotrexate) and not received an adequate response</ci>
                    <ci type="logical">A maximum of 8 doses</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="pyoderma gangrenosum">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has shown clinical improvement</ci>
                    <ci type="logical">Patient continues to require treatment</ci>
                    <ci type="logical">A maximum of 8 doses</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Inflammatory bowel arthritis (axial)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has a diagnosis of active ulcerative
          colitis or active Crohn's disease</ci>
                    <ci type="logical" class="Indication">Patient has had axial inflammatory pain for
          six months or more</ci>
                    <ci type="logical" class="Indication">Patient is unable to take NSAIDs</ci>
                    <ci type="logical" class="Indication">Patient has unequivocal sacroiliitis
          demonstrated by radiological imaging or MRI</ci>
                    <ci type="logical" class="Indication">Patient has not experienced an adequate response to prior treatment consisting of at least 3 months of an exercise regime supervised by a physiotherapist</ci>
                    <ci type="logical" class="Indication">Patient has a BASDAI of at least 6 on a 0-10
          scale completed after the 3 month exercise trial, but prior to ceasing any
          previous pharmacological treatment </ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Inflammatory bowel arthritis (axial)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">Where treatment has resulted in an improvement in
          BASDAI of 4 or more points from pre-treatment baseline on a 10-point scale, or
          an improvement in BASDAI of 50%, whichever is less</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="Inflammatory bowel arthritis (peripheral)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has a diagnosis of active ulcerative
          colitis or active Crohn’s disease</ci>
                    <ci type="logical" class="Indication">Patient has active arthritis in at least four
          joints from the following: hip, knee, ankle, subtalar, tarsus, forefoot, wrist,
          elbow, shoulder, sternoclavicular</ci>
                    <ci type="logical" class="Indication">Patient has tried and not experienced a
          response to at least three months of methotrexate or azathioprine at a maximum
          tolerated dose (unless contraindicated)</ci>
                    <ci type="logical" class="Indication">Patient has tried and not experienced a
          response to at least three months of sulfasalazine at a maximum tolerated dose
          (unless contraindicated)</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient has a CRP level greater than 15
            mg/L measured no more than one month prior to the date of this
            application</ci>
                      <ci type="logical" class="Indication">Patient has an ESR greater than 25 mm per
            hour measured no more than one month prior to the date of this
            application</ci>
                      <ci type="logical" class="Indication">ESR and CRP not measured as patient is
            currently receiving prednisone therapy at a dose of greater than 5 mg per
            day and has done so for more than three months</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Inflammatory bowel arthritis (peripheral)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">Following initial treatment, patient has
          experienced at least a 50% decrease in active joint count from baseline and a
          clinically significant response to treatment in the opinion of the
          physician</ci>
                    <ci type="logical" class="Indication">Patient has experienced at least a continuing
          30% improvement in active joint count from baseline in the opinion of the
          treating physician</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1941" style="display:none"/>
            <Formulation ID="F251212851525" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg</Name>
              <Rule Type="DVLimit" Attribute="Sep-20 to~2025" Value="5"/>
              <Brand ID="B25121285152525" HSS="true">
                <Name>Remicade</Name>
                <Pack ID="P2016710" Specified="true" nzmt:ctpp_id="50003171000117108">
                  <Quantity>1</Quantity>
                  <Price>428.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128516">
            <Name>Tocilizumab</Name>
            <Request Form="RS2025" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Tocilizumab</range>
              </Title>
              <Case When="Initial application" Category="cytokine release syndrome">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical" class="Use">The patient is enrolled in the Children's
                        Oncology Group AALL1731 trial</ci>
                      <ci type="logical" class="Use">The patient has developed grade 3 or 4 cytokine
                        release syndrome associated with the administration of blinatumomab for the
                        treatment of acute lymphoblastic leukaemia</ci>
                      <ci type="logical" class="Use">Tocilizumab is to be administered at doses no
                        greater than 8 mg/kg IV for a maximum of 3 doses (if less than 30kg, maximum
                        of 12 mg/kg)</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">The patient is enrolled in the Malaghan
                        Institute of Medical Research ENABLE trial programme</ci>
                      <ci type="logical" class="Indication">The patient has developed CRS or Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) following CAR T-Cell therapy for the treatment of relapsed or refractory B-cell non-Hodgkin lymphoma</ci>
                      <ci type="logical" class="Indication">Tocilizumab is to be administered according to the consensus guidelines for CRS or ICANS for CAR T-cell therapy at doses no greater than 8 mg/kg IV for a maximum of 3 doses</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">3</Term>
              </Case>
              <Case When="Initial application" Category="previous use">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Use">Patient was being treated with tocilizumab prior to 1
                    February 2019</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">rheumatoid arthritis</ci>
                      <ci type="logical" class="Use">systemic juvenile idiopathic arthritis</ci>
                      <ci type="logical" class="Use">adult-onset Still's disease</ci>
                      <ci type="logical" class="Use">polyarticular juvenile idiopathic arthritis</ci>
                      <ci type="logical" class="Use">idiopathic multicentric Castleman's disease</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Rheumatoid Arthritis (patients previously treated with adalimumab or etanercept)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Use">The patient has had an initial Special Authority
                    approval for adalimumab and/or etanercept for rheumatoid arthritis</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">The patient has experienced intolerable
                        side effects from adalimumab and/or etanercept</ci>
                      <ci type="logical" class="Use">The patient has received insufficient benefit
                        from at least a three-month trial of adalimumab and/or etanercept such that
                        they do not meet the renewal criteria for rheumatoid arthritis</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">The patient is seronegative for both
                        anti-cyclic citrullinated peptide (CCP) antibodies and rheumatoid
                        factor</ci>
                      <apply>
                        <and/>
                        <ci type="logical" class="Indication">The patient has been started on
                            rituximab for rheumatoid arthritis in a Health NZ Hospital</ci>
                        <apply>
                          <or/>
                          <ci type="logical" class="Indication">The patient has experienced
                                intolerable side effects from rituximab</ci>
                          <ci type="logical" class="Use">At four months following the initial
                                course of rituximab the patient has received insufficient benefit
                                such that they do not meet the renewal criteria for rheumatoid
                                arthritis</ci>
                        </apply>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="rheumatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Rheumatoid Arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has had severe and active erosive
                    rheumatoid arthritis (either confirmed by radiology imaging, or the patient is
                    cyclic citrullinated peptide (CCP) antibody positive) for six months duration or
                    longer</ci>
                    <ci type="logical" class="Indication">Tocilizumab is to be used as monotherapy</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Treatment with methotrexate is
                        contraindicated</ci>
                      <ci type="logical" class="Use">Patient has tried and did not tolerate oral
                        and/or parenteral methotrexate</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient has tried and not responded to at
                        least three months therapy at the maximum tolerated dose of ciclosporin
                        alone or in combination with another agent</ci>
                      <ci type="logical" class="Use">Patient has tried and not responded to at least
                        three months therapy at the maximum tolerated dose of leflunomide alone or
                        in combination with another agent</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient has persistent symptoms of poorly
                        controlled and active disease in at least 20 active, swollen, tender
                        joints</ci>
                      <ci type="logical" class="Use">Patient has persistent symptoms of poorly
                        controlled and active disease in at least four active joints from the
                        following: wrist, elbow, knee, ankle, and either shoulder or hip</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient has a C-reactive protein level
                        greater than 15 mg/L measured no more than one month prior to the date of
                        this application</ci>
                      <ci type="logical" class="Use">C-reactive protein levels not measured as patient
                        is currently receiving prednisone therapy at a dose of greater than 5 mg per
                        day and has done so for more than three months</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="rheumatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="systemic juvenile idiopathic arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient diagnosed with systemic juvenile
                    idiopathic arthritis</ci>
                    <ci type="logical" class="Indication">Patient has tried and not responded to a
                    reasonable trial of all of the following, either alone or in combination: oral
                    or parenteral methotrexate; non-steroidal anti-inflammatory drugs (NSAIDs); and
                    systemic corticosteroids</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="rheumatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="adult-onset Still's disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <apply>
                        <or/>
                        <ci type="logical" class="Indication">The patient has had an initial Special
                            Authority approval for adalimumab and/or etanercept for adult-onset
                            Still's disease (AOSD)</ci>
                        <ci type="logical" class="Indication">The patient has been started on
                            tocilizumab for AOSD in a Health NZ Hospital</ci>
                      </apply>
                      <apply>
                        <or/>
                        <ci type="logical" class="Indication">The patient has experienced
                            intolerable side effects from adalimumab and/or etanercept</ci>
                        <ci type="logical" class="Indication">The patient has received insufficient
                            benefit from at least a three-month trial of adalimumab and/or
                            etanercept such that they do not meet the renewal criteria for AOSD</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">Patient diagnosed with AOSD according to
                        the Yamaguchi criteria (J Rheumatol 1992;19:424-430)</ci>
                      <ci type="logical" class="Indication">Patient has tried and not responded to at
                        least 6 months of glucocorticosteroids at a dose of at least 0.5 mg/kg,
                        non-steroidal antiinflammatory drugs (NSAIDs) and methotrexate</ci>
                      <ci type="logical" class="Indication">Patient has persistent symptoms of
                        disabling poorly controlled and active disease</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="rheumatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="polyarticular juvenile idiopathic arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">The patient has had an initial Special
                        Authority approval for both etanercept and adalimumab for polyarticular
                        course juvenile idiopathic arthritis (JIA)</ci>
                      <ci type="logical" class="Indication">The patient has experienced intolerable
                        side effects, or has received insufficient benefit from, both etanercept and
                        adalimumab</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">Treatment with a tumour necrosis factor
                        alpha inhibitor is contraindicated</ci>
                      <ci type="logical" class="Indication">Patient has had polyarticular course JIA
                        for 6 months duration or longer</ci>
                      <ci type="logical" class="Indication">To be used as an adjunct to methotrexate
                        therapy or monotherapy where use of methotrexate is limited by toxicity or
                        intolerance</ci>
                      <apply>
                        <or/>
                        <ci type="logical" class="Indication">At least 5 active joints and at least
                            3 joints with limited range of motion, pain or tenderness after a
                            3-month trial of methotrexate (at the maximum tolerated dose)</ci>
                        <ci type="logical" class="Indication">Moderate or high disease activity
                            (cJADAS10 score of at least 2.5) after a 3-month trial of methotrexate
                            (at the maximum tolerated dose)</ci>
                        <ci type="logical" class="Indication">Low disease activity (cJADAS10 score
                            between 1.1 and 2.5) after a 6-month trial of methotrexate</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="rheumatologist">Practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Initial application" Category="idiopathic multicentric Castleman's disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has severe HHV-8 negative idiopathic
                    multicentric Castleman's disease</ci>
                    <ci type="logical" class="Indication">Treatment with an adequate trial of
                    corticosteroids has proven ineffective</ci>
                    <ci type="logical" class="Indication">Tocilizumab to be administered at doses no
                    greater than 8 mg/kg IV every 3-4 weeks</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="haematologist or rheumatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="moderate to severe COVID-19">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has confirmed (or probable)
                    COVID-19</ci>
                    <ci type="logical" class="Indication">Oxygen saturation of &lt;92% on room air, or
                    requiring supplemental oxygen</ci>
                    <ci type="logical" class="Indication">Patient is receiving adjunct systemic
                    corticosteroids, or systemic corticosteroids are contraindicated</ci>
                    <ci type="logical" class="Indication">Tocilizumab is to be administered at doses no
                    greater than 8mg/kg IV for a maximum of one dose</ci>
                    <ci type="logical" class="Indication">Tocilizumab is not to be administered in
                    combination with barcitinib</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">1</Term>
              </Case>
              <Case When="Renewal" Category="Rheumatoid Arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">Following 6 months' initial treatment, the
                    patient has at least a 50% decrease in active joint count from baseline and a
                    clinically significant response to treatment in the opinion of the
                    physician</ci>
                    <ci type="logical" class="Indication">On subsequent reapplications, the patient
                    demonstrates at least a continuing 30% improvement in active joint count from
                    baseline and a clinically significant response to treatment in the opinion of
                    the physician</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="rheumatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="systemic juvenile idiopathic arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">Following up to 6 months' initial treatment,
                    the patient has achieved at least an American College of Rheumatology paediatric
                    30% improvement criteria (ACR Pedi 30) response from baseline</ci>
                    <ci type="logical" class="Indication">On subsequent reapplications, the patient
                    demonstrates at least a continuing ACR Pedi 30 response from baseline</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="rheumatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="adult-onset Still's disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">the patient has a sustained improvement in
                inflammatory markers and functional status</ci>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="rheumatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="polyarticular juvenile idiopathic arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Treatment is to be used as an adjunct to
                    methotrexate therapy or monotherapy where use of methotrexate is limited by
                    toxicity or intolerance</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Following 3 to 4 months' initial
                        treatment, the patient has at least a 50% decrease in active joint count and
                        an improvement in physician's global assessment from baseline</ci>
                      <ci type="logical" class="Indication">On subsequent reapplications, the patient
                        demonstrates at least a continuing 30% improvement in active joint count and
                        continued improvement in physician's global assessment from baseline</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="rheumatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="idiopathic multicentric Castleman's disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">the treatment remains appropriate and the patient
                has a sustained improvement in inflammatory markers and functional status</ci>
                </math>
                <Applicant>haematologist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="haematologist or rheumatologist">Practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2025" style="display:none"/>
            <Formulation ID="F251212851625" Rank="4" Units="inj" Weight="200">
              <Name>Inj 20 mg per ml, 10 ml vial</Name>
              <Brand ID="B25121285162525">
                <Name>Actemra</Name>
                <Pack ID="P2337991" Specified="true" nzmt:ctpp_id="50120261000117102">
                  <Quantity>1</Quantity>
                  <Price>550.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212851626" Rank="4" Units="inj" Weight="400">
              <Name>Inj 20 mg per ml, 20 ml vial</Name>
              <Brand ID="B25121285162625">
                <Name>Actemra</Name>
                <Pack ID="P2440571" Specified="true" nzmt:ctpp_id="50176811000117102">
                  <Quantity>1</Quantity>
                  <Price>1100.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212851627" Rank="4" Units="inj" Weight="80">
              <Name>Inj 20 mg per ml, 4 ml vial</Name>
              <Brand ID="B25121285162725">
                <Name>Actemra</Name>
                <Pack ID="P2337983" Specified="true" nzmt:ctpp_id="50120251000117104">
                  <Quantity>1</Quantity>
                  <Price>220.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128559">
            <Name>Omalizumab</Name>
            <Request Form="RS1652" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Omalizumab</range>
              </Title>
              <Case When="Initial application" Category="severe asthma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient must be aged 6 years or older </ci>
                    <ci type="logical">Patient has a diagnosis of severe asthma</ci>
                    <ci type="logical">Past or current evidence of atopy, documented by skin prick
                    testing or RAST</ci>
                    <ci type="logical">Total serum human immunoglobulin E (IgE) between 76 IU/mL and
                    1300 IU/ml at baseline</ci>
                    <ci type="logical">Proven adherence with optimal inhaled therapy including high dose
                    inhaled corticosteroid (budesonide 1,600 mcg per day or fluticasone propionate
                    1,000 mcg per day or equivalent), plus long-acting beta-2 agonist therapy (at
                    least salmeterol 50 mcg bd or eformoterol 12 mcg bd) for at least 12 months,
                    unless contraindicated or not tolerated</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has received courses of systemic corticosteroids
                        equivalent to at least 28 days treatment in the past 12 months, unless
                        contraindicated or not tolerated</ci>
                      <ci type="logical">Patient has had at least 4 exacerbations needing systemic
                        corticosteroids in the previous 12 months, where an exacerbation is defined
                        as either documented use of oral corticosteroids for at least 3 days or
                        parenteral steroids</ci>
                    </apply>
                    <ci type="logical">Patient has an Asthma Control Test (ACT) score of 10 or less</ci>
                    <ci type="logical">Baseline measurements of the patient’s asthma control using the
                    ACT and oral corticosteroid dose must be made at the time of application, and
                    again at around 26 weeks after the first dose to assess response to
                    treatment</ci>
                  </apply>
                </math>
                <Applicant>clinical immunologist</Applicant>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="severe asthma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">An increase in the Asthma Control Test (ACT) score of at least 5
                    from baseline</ci>
                    <ci type="logical">A reduction in the maintenance oral corticosteroid dose or number
                    of exacerbations of at least 50% from baseline</ci>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="severe chronic spontaneous urticaria">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient must be aged 12 years or older</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">Patient is symptomatic with Urticaria Activity Score 7
                            (UAS7) of 20 or above</ci>
                        <ci type="logical">Patient has a Dermatology life quality index (DLQI) of 10
                            or greater</ci>
                      </apply>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has been taking high dose antihistamines (e.g. 4
                        times standard dose) and ciclosporin (&gt;3 mg/kg day) for at least 6
                        weeks</ci>
                      <ci type="logical">Patient has been taking high dose antihistamines (e.g. 4
                        times standard dose) and at least 3 courses of systemic corticosteroids (&gt;20
                        mg prednisone per day for at least 5 days) in the previous 6 months</ci>
                      <ci type="logical">Patient has developed significant adverse effects whilst on
                        corticosteroids or ciclosporin</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical">Treatment to be stopped if inadequate response* following 4
                        doses</ci>
                      <ci type="logical">Complete response* to 6 doses of omalizumab</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>clinical immunologist</Applicant>
                <Applicant>dermatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="severe chronic spontaneous urticaria">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Patient has previously had a complete response* to 6 doses of
                    omalizumab</ci>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has previously had a complete response* to 6 doses of
                        omalizumab</ci>
                      <ci type="logical">Patient has relapsed after cessation of omalizumab
                        therapy</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>clinical immunologist</Applicant>
                <Applicant>dermatologist</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>*Inadequate response defined as less than 50% reduction in baseline UAS7 and DLQI
                score, or an increase in Urticaria Control Test (UCT) score of less than 4 from
                baseline. Patient is to be reassessed for response after 4 doses of omalizumab.
                Complete response is defined as UAS7 less than or equal to 6 and DLQI less than or
                equal to 5; or UCT of 16. Relapse of chronic urticaria on stopping
                prednisone/ciclosporin does not justify the funding of omalizumab.</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1652" style="display:none"/>
            <Formulation ID="F251212855925" Rank="4" Units="inj" Weight="150">
              <Name>Inj 150 mg vial</Name>
              <Brand ID="B25121285592525">
                <Name>Xolair</Name>
                <Pack ID="P2243369" Specified="true" nzmt:ctpp_id="50038491000117104">
                  <Quantity>1</Quantity>
                  <Price>450.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212855926" Rank="4" Units="inj" Weight="150">
              <Name>Inj 150 mg prefilled syringe</Name>
              <Brand ID="B25121285592625">
                <Name>Xolair</Name>
                <Pack ID="P2555042" Specified="true" nzmt:ctpp_id="50246061000117105">
                  <Quantity>1</Quantity>
                  <Price>450.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128589">
            <Name>Siltuximab</Name>
            <Request Form="RS1525" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Siltuximab</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has severe HHV-8 negative idiopathic multicentric Castleman's Disease</ci>
                    <ci type="logical">Treatment with an adequate trial of corticosteroids has proven ineffective</ci>
                    <ci type="logical">Siltuximab is to be administered at doses no greater than 11 mg/kg every 3 weeks</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The treatment remains appropriate and the patient has sustained improvement in inflammatory markers and functional status</ci>
                </math>
                <Applicant>haematologist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1525" style="display:none"/>
            <Formulation ID="F251212858925" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg vial</Name>
              <Brand ID="B25121285892525">
                <Name>Sylvant</Name>
                <Pack ID="P2500663" Specified="true" nzmt:ctpp_id="50206061000117103">
                  <Quantity>1</Quantity>
                  <Price>770.57</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212858926" Rank="4" Units="inj" Weight="400">
              <Name>Inj 400 mg vial</Name>
              <Brand ID="B25121285892625">
                <Name>Sylvant</Name>
                <Pack ID="P2500655" Specified="true" nzmt:ctpp_id="50206071000117108">
                  <Quantity>1</Quantity>
                  <Price>3082.33</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128603">
            <Name>Obinutuzumab</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1919">
              <Title>
                <range>Obinutuzumab </range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has progressive Binet stage A, B or C CD20+ chronic lymphocytic leukaemia requiring treatment</ci>
                    <ci type="logical">The patient is obinutuzumab treatment naive</ci>
                    <ci type="logical">The patient is not eligible for full dose FCR due to comorbidities with a score &gt; 6 on the Cumulative Illness Rating Scale (CIRS) or reduced renal function (creatinine clearance &lt;70mL/min)</ci>
                    <ci type="logical">Patient has adequate neutrophil and platelet counts* unless the cytopenias are a consequence of marrow infiltration by CLL</ci>
                    <ci type="logical">Patient has good performance status</ci>
                    <ci type="logical">Obinutuzumab to be administered at a maximum cumulative dose of 8,000 mg and in combination with chlorambucil for a maximum of 6 cycles</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Chronic lymphocytic leukaemia includes small lymphocytic lymphoma. Comorbidity refers only to illness/impairment other than CLL induced illness/impairment in the patient. ’Good performance status’ means ECOG score of 0-1, however, in patients temporarily debilitated by their CLL disease symptoms a higher ECOG (2 or 3) is acceptable where treatment with obinutuzumab is expected to improve symptoms and improve ECOG score to &lt;2.</p>
                  <p>* greater than or equal to 1.5 x 10<sup>9</sup>/L and platelets greater than or equal to 75 x 10<sup>9</sup>/L</p>
                </div>
              </Case>
              <Case When="Initial application" Category="follicular / marginal zone lymphoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient has follicular lymphoma</ci>
                      <ci type="logical" class="Indication">Patient has marginal zone lymphoma</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient is refractory to or has relapsed within 12 months of a rituximab containing combined chemo-immunotherapy regimen*</ci>
                    <ci type="logical" class="Indication">Patient has an ECOG performance status of 0-2</ci>
                    <ci type="logical" class="Indication">Patient has been previously treated with no more than four chemotherapy regimens</ci>
                    <ci type="logical" class="Indication">Obinutuzumab to be administered at a maximum dose of 1000 mg for a maximum of 6 cycles in combination with chemotherapy*</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">9</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>* includes unapproved indications</p>
                </div>
              </Case>
              <Case When="Renewal" Category="follicular / marginal zone lymphoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has no evidence of disease progression following obinutuzumab induction therapy</ci>
                    <ci type="logical">Obinutuzumab to be administered at a maximum of 1000 mg every 2 months for a maximum of 2 years</ci>
                    <ci type="logical">Obinutuzumab to be discontinued at disease progression</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">24</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1919" style="display:none"/>
            <Formulation ID="F251212860325" Rank="4" Units="inj" Weight="25">
              <Name>Inj 25 mg per ml, 40 ml vial</Name>
              <Brand ID="B25121286032525">
                <Name>Gazyva</Name>
                <Pack ID="P2471981" Specified="true" nzmt:ctpp_id="50184011000117105">
                  <Quantity>1</Quantity>
                  <Price>5910.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128604">
            <Name>Pertuzumab</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1995">
              <Title>
                <range>Pertuzumab </range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has metastatic breast cancer expressing HER-2 IHC 3+ or ISH+ (including FISH or other current technology)</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient is chemotherapy treatment naive</ci>
                      <ci type="logical">Patient has not received prior treatment for their metastatic disease and has had a treatment free interval of at least 12 months between prior (neo)adjuvant chemotherapy treatment and diagnosis of metastatic breast cancer</ci>
                    </apply>
                    <ci type="logical">The patient has good performance status (ECOG grade 0-1)</ci>
                    <ci type="logical">Pertuzumab to be administered in combination with trastuzumab</ci>
                    <ci type="logical">Pertuzumab maximum first dose of 840 mg, followed by maximum of 420 mg every 3 weeks</ci>
                    <ci type="logical">Pertuzumab to be discontinued at disease progression</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has metastatic breast cancer expressing HER-2 IHC 3+ or ISH+ (including FISH or other current technology)</ci>
                      <ci type="logical">The cancer has not progressed at any time point during the previous 12 months whilst on pertuzumab and trastuzumab</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has previously discontinued treatment with pertuzumab and trastuzumab for reasons other than severe toxicity or disease progression</ci>
                      <ci type="logical">Patient has signs of disease progression</ci>
                      <ci type="logical">Disease has not progressed during previous treatment with pertuzumab and trastuzumab</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1995" style="display:none"/>
            <Formulation ID="F251212860425" Rank="4" Units="inj" Weight="30">
              <Name>Inj 30 mg per ml, 14 ml vial</Name>
              <Brand ID="B25121286042525">
                <Name>Perjeta</Name>
                <Pack ID="P2444208" Specified="true" nzmt:ctpp_id="50149421000117101">
                  <Quantity>1</Quantity>
                  <Price>3927.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128616">
            <Name>Cetuximab</Name>
            <Request Form="RS1613" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Cetuximab</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has locally advanced, non-metastatic, squamous cell cancer of the head and neck</ci>
                    <ci type="logical">Patient is contraindicated to, or is intolerant of, cisplatin</ci>
                    <ci type="logical">Patient has good performance status</ci>
                    <ci type="logical">To be administered in combination with radiation therapy</ci>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1613" style="display:none"/>
            <Formulation ID="F251212861625" Rank="4" Units="inj" Weight="100">
              <Name>Inj 5 mg per ml, 20 ml vial</Name>
              <Brand ID="B25121286162525">
                <Name>Erbitux</Name>
                <Pack ID="P2304457" Specified="true" nzmt:ctpp_id="50045981000117103">
                  <Quantity>1</Quantity>
                  <Price>364.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212861626" Rank="4" Units="inj" Weight="500">
              <Name>Inj 5 mg per ml, 100 ml vial</Name>
              <Brand ID="B25121286162625">
                <Name>Erbitux</Name>
                <Pack ID="P2304465" Specified="true" nzmt:ctpp_id="50045991000117100">
                  <Quantity>1</Quantity>
                  <Price>1820.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128623">
            <Name>Aflibercept</Name>
            <Request Form="RS1872" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Aflibercept</range>
              </Title>
              <Case When="Initial application" Category="Wet Age Related Macular Degeneration">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <apply>
                        <or/>
                        <ci type="logical">Wet age-related macular degeneration (wet AMD)</ci>
                        <ci type="logical">Polypoidal choroidal vasculopathy</ci>
                        <ci type="logical">Choroidal neovascular membrane from causes other than wet AMD</ci>
                      </apply>
                      <apply>
                        <or/>
                        <ci type="logical">The patient has developed severe endophthalmitis or severe posterior uveitis following treatment with bevacizumab</ci>
                        <ci type="logical">There is worsening of vision or failure of retina to dry despite three intraocular injections of bevacizumab four weeks apart</ci>
                      </apply>
                      <ci type="logical">There is no structural damage to the central fovea of the treated eye</ci>
                      <ci type="logical">Patient has not previously been treated with ranibizumab for longer than 3 months</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has current approval to use ranibizumab for treatment of wAMD and was found to be intolerant to ranibizumab within 3 months</ci>
                      <ci type="logical">Patient has previously* (*before June 2018) received treatment with ranibizumab for wAMD and disease was stable while on treatment</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>ophthalmologist</Applicant>
                <Applicant>nurse practitioner</Applicant>
                <Term Measure="month">3</Term>
              </Case>
              <Case When="Renewal" Category="Wet Age Related Macular Degeneration">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Documented benefit must be demonstrated to continue</ci>
                    <ci type="logical">Patient’s vision is 6/36 or better on the Snellen visual acuity score</ci>
                    <ci type="logical">There is no structural damage to the central fovea of the treated eye</ci>
                  </apply>
                </math>
                <Applicant>ophthalmologist</Applicant>
                <Applicant>nurse practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="Diabetic Macular Oedema">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has centre involving diabetic macular oedema (DMO)</ci>
                    <ci type="logical">Patient’s disease is non responsive to 4 doses of intravitreal bevacizumab when administered 4-6 weekly</ci>
                    <ci type="logical">Patient has reduced visual acuity between 6/9 – 6/36 with functional awareness of reduction in vision</ci>
                    <ci type="logical">Patient has DMO within central OCT (ocular coherence tomography) subfield &gt;350 micrometers</ci>
                    <ci type="logical">There is no centre-involving sub-retinal fibrosis or foveal atrophy</ci>
                  </apply>
                </math>
                <Applicant>ophthalmologist</Applicant>
                <Applicant>nurse practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="Diabetic Macular Oedema">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">There is stability or two lines of Snellen visual acuity gain</ci>
                    <ci type="logical">There is structural improvement on OCT scan (with reduction in intra-retinal cysts, central retinal thickness, and sub-retinal fluid)</ci>
                    <ci type="logical">Patient’s vision is 6/36 or better on the Snellen visual acuity score</ci>
                    <ci type="logical">There is no centre-involving sub-retinal fibrosis or foveal atrophy</ci>
                    <ci type="logical">After each consecutive 12 months treatment with aflibercept, patient has retrialled with at least one injection of bevacizumab and had no response</ci>
                  </apply>
                </math>
                <Applicant>ophthalmologist</Applicant>
                <Applicant>nurse practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1872" style="display:none"/>
            <Formulation ID="F251212862325" Rank="4" Units="inj" Weight="4">
              <Name>Inj 40 mg per ml, 0.1 ml vial</Name>
              <Brand ID="B25121286232525">
                <Name>Eylea</Name>
                <Pack ID="P2441195" Specified="true" nzmt:ctpp_id="50140231000117107">
                  <Quantity>1</Quantity>
                  <Price>1250.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128632">
            <Name>Secukinumab</Name>
            <Request Form="RS1863" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Secukinumab</range>
              </Title>
              <Case When="Initial application" Category="severe chronic plaque psoriasis, second-line biologic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has had an initial Special Authority approval for adalimumab
          or etanercept, or has trialled infliximab in a Health NZ Hospital, for severe chronic plaque psoriasis</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from adalimumab,
            etanercept or infliximab</ci>
                      <ci type="logical">The patient has received insufficient benefit from adalimumab,
            etanercept or infliximab</ci>
                    </apply>
                    <ci type="logical">A Psoriasis Area and Severity Index (PASI) assessment or Dermatology
          Quality of Life Index (DLQI) assessment has been completed for at least the most recent
          prior treatment course, preferably while still on treatment but no longer than 1 month
          following cessation of each prior treatment course</ci>
                    <ci type="logical">The most recent PASI or DQLI assessment is no more than 1 month old at
          the time of application</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="severe chronic plaque psoriasis, second-line biologic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Patient’s PASI score has reduced by 75% or more (PASI 75) as compared
            to baseline PASI prior to commencing secukinumab</ci>
                      <ci type="logical">Patient has a Dermatology Quality of Life Index (DLQI) improvement of 5
            or more, as compared to baseline DLQI prior to commencing secukinumab</ci>
                    </apply>
                    <ci type="logical">Secukinumab to be administered at a maximum dose of 300 mg monthly</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="severe chronic plaque psoriasis, first-line biologic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has "whole body" severe chronic plaque psoriasis with a
            Psoriasis Area and Severity Index (PASI) score of greater than 10, where lesions have
            been present for at least 6 months from the time of initial diagnosis</ci>
                      <ci type="logical">Patient has severe chronic plaque psoriasis of the face, or palm of a
            hand or sole of a foot, where the plaque or plaques have been present for at least 6
            months from the time of initial diagnosis</ci>
                    </apply>
                    <ci type="logical">Patient has tried, but had an inadequate response (see Note) to, or has
          experienced intolerable side effects from, at least three of the following (at maximum
          tolerated doses unless contraindicated): phototherapy, methotrexate, ciclosporin, or
          acitretin</ci>
                    <ci type="logical">A PASI assessment or Dermatology Quality of Life Index (DLQI) assessment
          has been completed for at least the most recent prior treatment course, preferably while
          still on treatment but no longer than 1 month following cessation of each prior treatment
          course</ci>
                    <ci type="logical">The most recent PASI or DQLI assessment is no more than 1 month old at
          the time of application</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="month">4</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>A treatment course is defined as a minimum of 12 weeks of treatment. "Inadequate response"
        is defined as: for whole body severe chronic plaque psoriasis, a PASI score of greater than
        10, as assessed preferably while still on treatment but no longer than 1 month following
        cessation of the most recent prior treatment; for severe chronic plaque psoriasis of the
        face, hand or foot, at least 2 of the 3 PASI symptom sub scores for erythema, thickness and
        scaling are rated as severe or very severe, and the skin area affected is 30% or more of the
        face, palm of a hand or sole of a foot, as assessed preferably while still on treatment but
        no longer than 1 month following cessation of the most recent prior treatment.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="severe chronic plaque psoriasis, first-line biologic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Patient’s PASI score has reduced by 75% or more (PASI 75) as compared
            to baseline PASI prior to commencing secukinumab</ci>
                      <ci type="logical">Patient has a Dermatology Quality of Life Index (DLQI) improvement of 5
            or more, as compared to baseline DLQI prior to commencing secukinumab</ci>
                    </apply>
                    <ci type="logical">Secukinumab to be administered at a maximum dose of 300 mg monthly</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="ankylosing spondylitis, second-line biologic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The patient has had an initial Special Authority
          approval for adalimumab and/or etanercept for ankylosing spondylitis</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">The patient has experienced intolerable side effects
            from a reasonable trial of adalimumab and/or etanercept</ci>
                      <ci type="logical" class="Indication">Following 12 weeks of adalimumab and/or etanercept
            treatment, the patient did not meet the renewal criteria for adalimumab and/or
            etanercept for ankylosing spondylitis</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">3</Term>
              </Case>
              <Case When="Renewal" Category="ankylosing spondylitis, second-line biologic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Following 12 weeks initial treatment of secukinumab
          treatment, BASDAI has improved by 4 or more points from pre-secukinumab baseline on a 10
          point scale, or by 50%, whichever is less</ci>
                    <ci type="logical" class="Indication">Physician considers that the patient has benefitted
          from treatment and that continued treatment is appropriate</ci>
                    <ci type="logical" class="Indication">Secukinumab to be administered at doses no greater
          than 150 mg monthly</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="psoriatic arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">Patient has had an initial Special Authority
            approval for adalimumab, etanercept or infliximab for psoriatic arthritis</ci>
                      <apply>
                        <or/>
                        <ci type="logical" class="Indication">Patient has experienced intolerable side effects
              from adalimumab, etanercept or infliximab</ci>
                        <ci type="logical" class="Indication">Patient has received insufficient benefit from
              adalimumab, etanercept or infliximab to meet the renewal criteria for adalimumab, 
              etanercept or infliximab for psoriatic arthritis</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">Patient has had severe active psoriatic arthritis
            for six months duration or longer</ci>
                      <ci type="logical" class="Indication">Patient has tried and not responded to at least
            three months of oral or parenteral methotrexate at a dose of at least 20 mg weekly or a
            maximum tolerated dose</ci>
                      <ci type="logical" class="Indication">Patient has tried and not responded to at least
            three months of sulfasalazine at a dose of at least 2 g per day or leflunomide at a dose
            of up to 20 mg daily (or maximum tolerated doses)</ci>
                      <apply>
                        <or/>
                        <ci type="logical" class="Indication">Patient has persistent symptoms of poorly
              controlled and active disease in at least 15 swollen, tender joints</ci>
                        <ci type="logical" class="Indication">Patient has persistent symptoms of poorly
              controlled and active disease in at least four joints from the following: wrist,
              elbow, knee, ankle, and either shoulder or hip</ci>
                      </apply>
                      <apply>
                        <or/>
                        <ci type="logical" class="Indication">Patient has a C-reactive protein level greater
              than 15 mg/L measured no more than one month prior to the date of this
              application</ci>
                        <ci type="logical" class="Indication">Patient has an elevated erythrocyte sedimentation
              rate (ESR) greater than 25 mm per hour</ci>
                        <ci type="logical" class="Indication">ESR and CRP not measured as patient is currently
              receiving prednisone therapy at a dose of greater than 5 mg per day and has done so
              for more than three months</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="psoriatic arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Following 3 to 4 months' initial treatment, the
            patient has at least a 50% decrease in active joint count from baseline and a clinically
            significant response to treatment in the opinion of the physician</ci>
                      <ci type="logical" class="Indication">The patient demonstrates at least a continuing 30%
            improvement in active joint count from baseline and a clinically significant response to
            prior secukinumab treatment in the opinion of the treating physician</ci>
                    </apply>
                    <ci type="logical" class="Indication">Secukinumab to be administered at doses no greater
          than 300 mg monthly</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1863" style="display:none"/>
            <Formulation ID="F251212863225" Rank="4" Units="inj" Weight="150">
              <Name>Inj 150 mg per ml, 1 ml prefilled syringe</Name>
              <Brand ID="B25121286322525">
                <Name>Cosentyx</Name>
                <Pack ID="P2554712" Specified="true" nzmt:ctpp_id="50230961000117108">
                  <Quantity>2</Quantity>
                  <Price>1599.00</Price>
                </Pack>
                <Pack ID="P2609665" Specified="true" nzmt:ctpp_id="50230971000117103">
                  <Quantity>1</Quantity>
                  <Price>799.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128651">
            <Name>Trastuzumab emtansine</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1908">
              <Title>
                <range>Trastuzumab emtansine</range>
              </Title>
              <Case When="Initial application" Category="early breast cancer">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has early breast cancer expressing
                    HER2 IHC3+ or ISH+</ci>
                    <ci type="logical" class="Indication">Documentation of pathological invasive
                    residual disease in the breast and/or auxiliary lymph nodes following completion
                    of surgery</ci>
                    <ci type="logical" class="Indication">Patient has completed systemic neoadjuvant therapy with trastuzumab and chemotherapy prior to surgery</ci>
                    <ci type="logical" class="Indication">Disease has not progressed during neoadjuvant therapy</ci>
                    <ci type="logical" class="Indication">Patient has left ventricular ejection fraction of 45% or greater</ci>
                    <ci type="logical" class="Indication">Adjuvant treatment with trastuzumab emtansine to be commenced within 12 weeks of surgery</ci>
                    <ci type="logical" class="Indication">Trastuzumab emtansine to be discontinued at disease progression</ci>
                    <ci type="logical" class="Indication">Total adjuvant treatment duration must not exceed 42 weeks (14 cycles)</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="metastatic breast cancer">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has metastatic breast cancer expressing HER-2 IHC 3+ or ISH+ (including FISH or other current technology)</ci>
                    <ci type="logical">Patient has previously received trastuzumab and chemotherapy, separately or in combination</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has received prior therapy for metastatic disease*</ci>
                      <ci type="logical">The patient developed disease recurrence during, or within six months of completing adjuvant therapy*</ci>
                    </apply>
                    <ci type="logical">Patient has a good performance status (ECOG 0-1)</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient does not have symptomatic brain metastases</ci>
                      <ci type="logical">Patient has brain metastases and has received prior local CNS therapy</ci>
                    </apply>
                    <ci type="logical">Patient has not received prior funded trastuzumab emtansine treatment</ci>
                    <ci type="logical">Treatment to be discontinued at disease progression</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="metastatic breast cancer">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The cancer has not progressed at any time point during the previous approval period whilst on trastuzumab emtansine</ci>
                    <ci type="logical">Treatment to be discontinued at disease progression</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>*Note: Prior or adjuvant therapy includes anthracycline, other chemotherapy, biological drugs, or endocrine therapy.</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1908" style="display:none"/>
            <Formulation ID="F251212865125" Rank="4" Units="inj">
              <Name>Inj 100 mg vial</Name>
              <Brand ID="B25121286512525">
                <Name>Kadcyla</Name>
                <Pack ID="P2444186" Specified="true" nzmt:ctpp_id="50149361000117101">
                  <Quantity>1</Quantity>
                  <Price>2320.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212865126" Rank="4" Units="inj">
              <Name>Inj 160 mg vial</Name>
              <Brand ID="B25121286512625">
                <Name>Kadcyla</Name>
                <Pack ID="P2444194" Specified="true" nzmt:ctpp_id="50149481000117102">
                  <Quantity>1</Quantity>
                  <Price>3712.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128653">
            <Name>Rituximab (riximyo)</Name>
            <Request Form="RS1973" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Rituximab<instance>Riximyo</instance></range>
              </Title>
              <Case When="Initial application" Category="haemophilia with inhibitors">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Patient has mild congenital haemophilia complicated by inhibitors</ci>
                    <ci type="logical">Patient has severe congenital haemophilia complicated by inhibitors and
          has failed immune tolerance therapy</ci>
                    <ci type="logical">Patient has acquired haemophilia</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Renewal" Category="haemophilia with inhibitors">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient was previously treated with rituximab for haemophilia with
          inhibitors</ci>
                    <ci type="logical">An initial response lasting at least 12 months was demonstrated</ci>
                    <ci type="logical">Patient now requires repeat treatment</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="post-transplant">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has B-cell post-transplant lymphoproliferative disorder*</ci>
                    <ci type="logical">To be used for a maximum of 8 treatment cycles</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="post-transplant">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has had a rituximab treatment-free interval of 12 months or
          more</ci>
                    <ci type="logical">The patient has B-cell post-transplant lymphoproliferative disorder*</ci>
                    <ci type="logical">To be used for no more than 6 treatment cycles</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="indolent, low-grade lymphomas or hairy cell leukaemia*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has indolent low grade NHL or hairy cell leukaemia* with
            relapsed disease following prior chemotherapy</ci>
                      <ci type="logical">To be used for a maximum of 6 treatment cycles</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has indolent, low grade lymphoma or hairy cell leukaemia*
            requiring first-line systemic chemotherapy</ci>
                      <ci type="logical">To be used for a maximum of 6 treatment cycles</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">9</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>'Indolent, low-grade lymphomas' includes follicular, mantle, marginal zone and
        lymphoplasmacytic/Waldenstrom macroglobulinaemia. *Unapproved indication. 'Hairy cell
        leukaemia' also includes hairy cell leukaemia variant.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="indolent, low-grade lymphomas or hairy cell leukaemia*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has had a rituximab treatment-free interval of 12 months or
          more</ci>
                    <ci type="logical">The patient has indolent, low-grade NHL or hairy cell leukaemia* with
          relapsed disease following prior chemotherapy</ci>
                    <ci type="logical">To be used for no more than 6 treatment cycles</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>'Indolent, low-grade lymphomas' includes follicular, mantle, marginal zone and
        lymphoplasmacytic/Waldenstrom macroglobulinaemia. *Unapproved indication. 'Hairy cell
        leukaemia' also includes hairy cell leukaemia variant.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="aggressive CD20 positive NHL">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has treatment naive aggressive CD20 positive NHL</ci>
                      <ci type="logical">To be used with a multi-agent chemotherapy regimen given with curative
            intent</ci>
                      <ci type="logical">To be used for a maximum of 8 treatment cycles</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has aggressive CD20 positive NHL with relapsed disease
            following prior chemotherapy</ci>
                      <ci type="logical">To be used for a maximum of 6 treatment cycles</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>'Aggressive CD20 positive NHL' includes large B-cell lymphoma and Burkitt's
        lymphoma/leukaemia.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="aggressive CD20 positive NHL">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has had a rituximab treatment-free interval of 12 months or
          more</ci>
                    <ci type="logical">The patient has relapsed refractory/aggressive CD20 positive NHL</ci>
                    <ci type="logical">To be used with a multi-agent chemotherapy regimen given with curative
          intent</ci>
                    <ci type="logical">To be used for a maximum of 4 treatment cycles</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>'Aggressive CD20 positive NHL' includes large B-cell lymphoma and Burkitt's
        lymphoma/leukaemia.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="Chronic lymphocytic leukaemia">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has progressive Binet stage A, B or C chronic lymphocytic
          leukaemia (CLL) requiring treatment</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient is rituximab treatment naive</ci>
                      <apply>
                        <or/>
                        <ci type="logical">The patient is chemotherapy treatment naive</ci>
                        <apply>
                          <and/>
                          <ci type="logical">The patient's disease has relapsed following no more than three
                prior lines of chemotherapy treatment</ci>
                          <ci type="logical">The patient has had a treatment-free interval of 12 months or more
                if previously treated with fludarabine and cyclophosphamide chemotherapy</ci>
                        </apply>
                      </apply>
                      <ci type="logical">The patient’s disease has relapsed within 36 months of previous
            treatment and rituximab treatment is to be used in combination with funded
            venetoclax</ci>
                    </apply>
                    <ci type="logical">The patient has good performance status</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient does not have chromosome 17p deletion CLL</ci>
                      <ci type="logical">Rituximab treatment is to be used in combination with funded venetoclax
            for relapsed/refractory chronic lymphocytic leukaemia</ci>
                    </apply>
                    <ci type="logical">Rituximab to be administered in combination with fludarabine and
          cyclophosphamide, bendamustine or venetoclax for a maximum of 6 treatment cycles</ci>
                    <ci type="logical">It is planned that the patient receives full dose fludarabine and
          cyclophosphamide (orally or dose equivalent intravenous administration), bendamustine or
          venetoclax</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>'Chronic lymphocytic leukaemia (CLL)' includes small lymphocytic lymphoma. A line of
        chemotherapy treatment is considered to comprise a known standard therapeutic chemotherapy
        regimen and supportive treatments. 'Good performance status' means ECOG score of 0-1,
        however, in patients temporarily debilitated by their CLL disease symptoms a higher ECOG (2
        or 3) is acceptable where treatment with rituximab is expected to improve symptoms and
        improve ECOG score to &lt;2.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="Chronic lymphocytic leukaemia">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient’s disease has relapsed within 36 months of previous
            treatment and rituximab treatment is to be used in combination with funded
            venetoclax</ci>
                      <apply>
                        <and/>
                        <ci type="logical">The patient's disease has relapsed following no more than one prior
              line of treatment with rituximab for CLL</ci>
                        <ci type="logical">The patient has had an interval of 36 months or more since
              commencement of initial rituximab treatment</ci>
                        <ci type="logical">The patient does not have chromosome 17p deletion CLL</ci>
                        <ci type="logical">It is planned that the patient receives full dose fludarabine and
              cyclophosphamide (orally or dose equivalent intravenous administration) or
              bendamustin</ci>
                      </apply>
                    </apply>
                    <ci type="logical">Rituximab to be administered in combination with fludarabine and
          cyclophosphamide, bendamustine or venetoclax for a maximum of 6 treatment cycles</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>'Chronic lymphocytic leukaemia (CLL)' includes small lymphocytic lymphoma. A line of
        chemotherapy treatment is considered to comprise a known standard therapeutic chemotherapy
        regimen and supportive treatments.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="severe cold haemagglutinin disease (CHAD)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has cold haemagglutinin disease*</ci>
                    <ci type="logical">Patient has severe disease which is characterized by symptomatic anaemia,
          transfusion dependence or disabling circulatory symptoms</ci>
                    <ci type="logical">The total rituximab dose used would not exceed the equivalent of 375
          mg/m2 of body surface area per week for a total of 4 weeks</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="week">8</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="severe cold haemagglutinin disease (CHAD)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Previous treatment with lower doses of rituximab (100 mg weekly for 4
          weeks) have proven ineffective and treatment with higher doses (375 mg/m² weekly for 4
          weeks) is now planned</ci>
                    <apply>
                      <and/>
                      <ci type="logical">Patient was previously treated with rituximab for severe cold
            haemagglutinin disease*</ci>
                      <ci type="logical">An initial response lasting at least 12 months was demonstrated</ci>
                      <ci type="logical">Patient now requires repeat treatment</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="week">8</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="warm autoimmune haemolytic anaemia (warm AIHA)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has warm autoimmune haemolytic anaemia*</ci>
                    <ci type="logical">One of the following treatments has been ineffective: steroids (including
          if patient requires ongoing steroids at doses equivalent to &gt;5 mg prednisone daily),
          cytotoxic agents (e.g. cyclophosphamide monotherapy or in combination), intravenous
          immunoglobulin</ci>
                    <ci type="logical">The total rituximab dose used would not exceed the equivalent of 375
          mg/m2 of body surface area per week for a total of 4 weeks</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="week">8</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="warm autoimmune haemolytic anaemia (warm AIHA)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Previous treatment with lower doses of rituximab (100 mg weekly for 4
          weeks) have proven ineffective and treatment with higher doses (375 mg/m² weekly for 4
          weeks) is now planned</ci>
                    <apply>
                      <and/>
                      <ci type="logical">Patient was previously treated with rituximab for warm autoimmune
            haemolytic anaemia*</ci>
                      <ci type="logical">An initial response lasting at least 12 months was demonstrated</ci>
                      <ci type="logical">Patient now requires repeat treatment</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="week">8</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="immune thrombocytopenic purpura (ITP)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has immune thrombocytopenic purpura* with a platelet count of
            less than or equal to 20,000 platelets per microlitre</ci>
                      <ci type="logical">Patient has immune thrombocytopenic purpura* with a platelet count of
            20,000 to 30,000 platelets per microlitre and significant mucocutaneous bleeding</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical">Treatment with steroids and splenectomy have been ineffective</ci>
                      <ci type="logical">Treatment with steroids has been ineffective and splenectomy is an
            absolute contraindication</ci>
                      <ci type="logical">Other treatments including steroids have been ineffective and patient
            is being prepared for elective surgery (e.g. splenectomy)</ci>
                    </apply>
                    <ci type="logical">The total rituximab dose used would not exceed the equivalent of 375
          mg/m2 of body surface area per week for a total of 4 weeks</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="week">8</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="immune thrombocytopenic purpura (ITP)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Previous treatment with lower doses of rituximab (100 mg weekly for 4
          weeks) have proven ineffective and treatment with higher doses (375 mg/m² weekly for 4
          weeks) is now planned</ci>
                    <apply>
                      <and/>
                      <ci type="logical">Patient was previously treated with rituximab for immune
            thrombocytopenic purpura*</ci>
                      <ci type="logical">An initial response lasting at least 12 months was demonstrated</ci>
                      <ci type="logical">Patient now requires repeat treatment</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="week">8</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="thrombotic thrombocytopenic purpura (TTP)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The total rituximab dose used would not exceed the equivalent of 375
          mg/m2 of body surface area per week for a total of 4 weeks</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has thrombotic thrombocytopenic purpura* and has experienced
            progression of clinical symptoms or persistent thrombocytopenia despite plasma
            exchange</ci>
                      <ci type="logical">Patient has acute idiopathic thrombotic thrombocytopenic purpura* with
            neurological or cardiovascular pathology</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="week">8</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="thrombotic thrombocytopenic purpura (TTP)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient was previously treated with rituximab for thrombotic
          thrombocytopenic purpura*</ci>
                    <ci type="logical">An initial response lasting at least 12 months was demonstrated</ci>
                    <ci type="logical">Patient now requires repeat treatment</ci>
                    <ci type="logical">The total rituximab dose used would not exceed the equivalent of 375
          mg/m2 of body surface area per week for a total of 4 weeks</ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="week">8</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="pure red cell aplasia (PRCA)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has autoimmune pure red cell aplasia* associated with a
        demonstrable B-cell lymphoproliferative disorder</ci>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="week">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="pure red cell aplasia (PRCA)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient was previously treated with rituximab for pure red cell aplasia*
        associated with a demonstrable B-cell lymphoproliferative disorder and demonstrated an
        initial response lasting at least 12 months</ci>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="week">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="ANCA associated vasculitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has been diagnosed with ANCA associated vasculitis*</ci>
                    <ci type="logical">The total rituximab dose would not exceed the equivalent of 375 mg/m² of
          body-surface area per week for a total of 4 weeks</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Induction therapy with daily oral or pulse intravenous cyclophosphamide
            has failed to achieve significant improvement of disease after at least 3 months</ci>
                      <ci type="logical">Patient has previously had a cumulative dose of cyclophosphamide &gt;15
            g or a further repeat 3 month induction course of cyclophosphamide would result in a
            cumulative dose &gt;15 g</ci>
                      <ci type="logical">Cyclophosphamide and methotrexate are contraindicated</ci>
                      <ci type="logical">Patient is a female of child-bearing potential</ci>
                      <ci type="logical">Patient has a previous history of haemorrhagic cystitis, urological
            malignancy or haematological malignancy</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="week">8</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="ANCA associated vasculitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has been diagnosed with ANCA associated vasculitis*</ci>
                    <ci type="logical">Patient has previously responded to treatment with rituximab but is now
          experiencing an acute flare of vasculitis</ci>
                    <ci type="logical">The total rituximab dose would not exceed the equivalent of 375 mg/m² of
          body-surface area per week for a total of 4 weeks</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="week">8</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="treatment refractory systemic lupus erythematosus (SLE)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has severe, immediately life- or organ-threatening SLE*</ci>
                    <ci type="logical">The disease has proved refractory to treatment with steroids at a dose of
          at least 1 mg/kg</ci>
                    <ci type="logical">The disease has relapsed following prior treatment for at least 6 months
          with maximal tolerated doses of azathioprine, mycophenolate mofetil and high dose
          cyclophosphamide, or cyclophosphamide is contraindicated</ci>
                    <ci type="logical">Maximum of four 1000 mg infusions of rituximab</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant>nephrologist</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="treatment refractory systemic lupus erythematosus (SLE)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient’s SLE* achieved at least a partial response to the previous round
          of prior rituximab treatment</ci>
                    <ci type="logical">The disease has subsequently relapsed</ci>
                    <ci type="logical">Maximum of two 1000 mg infusions of rituximab</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant>nephrologist</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="Antibody-mediated organ transplant rejection">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has been diagnosed with antibody-mediated organ transplant
        rejection*</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="ABO-incompatible organ transplant">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient is to undergo an ABO-incompatible solid organ transplant*</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="Steroid dependent nephrotic syndrome (SDNS) or frequently relapsing nephrotic syndrome (FRNS)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is a child with SDNS* or FRNS*</ci>
                    <ci type="logical">Treatment with steroids for at least a period of 3 months has been
          ineffective or associated with evidence of steroid toxicity</ci>
                    <ci type="logical">Treatment with ciclosporin for at least a period of 3 months has been
          ineffective and/or discontinued due to unacceptable side effects</ci>
                    <ci type="logical">Treatment with mycophenolate for at least a period of 3 months with no
          reduction in disease relapses</ci>
                    <ci type="logical">The total rituximab dose used would not exceed the equivalent of 375
          mg/m² of body surface area per week for a total of 4 weeks</ci>
                  </apply>
                </math>
                <Applicant>nephrologist</Applicant>
                <Term Measure="week">8</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with a * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="Steroid dependent nephrotic syndrome (SDNS) or frequently relapsing nephrotic syndrome (FRNS)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient who was previously treated with rituximab for nephrotic
          syndrome*</ci>
                    <ci type="logical">Treatment with rituximab was previously successful and has demonstrated
          sustained response for &gt;6 months, but the condition has relapsed and the patient now
          requires repeat treatment</ci>
                    <ci type="logical">The total rituximab dose used would not exceed the equivalent of 375
          mg/m² of body surface area per week for a total of 4 weeks</ci>
                  </apply>
                </math>
                <Applicant>nephrologist</Applicant>
                <Term Measure="week">8</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with a * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="Steroid resistant nephrotic syndrome (SRNS)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is a child with SRNS* where treatment with steroids and
          ciclosporin for at least 3 months have been ineffective</ci>
                    <ci type="logical">Treatment with tacrolimus for at least 3 months has been ineffective</ci>
                    <ci type="logical">Genetic causes of nephrotic syndrome have been excluded</ci>
                    <ci type="logical">The total rituximab dose used would not exceed the equivalent of 375
          mg/m² of body surface area per week for a total of 4 weeks</ci>
                  </apply>
                </math>
                <Applicant>nephrologist</Applicant>
                <Term Measure="week">8</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with a * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="Steroid resistant nephrotic syndrome (SRNS)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient who was previously treated with rituximab for nephrotic
          syndrome*</ci>
                    <ci type="logical">Treatment with rituximab was previously successful and has demonstrated
          sustained response for greater than 6 months, but the condition has relapsed and the
          patient now requires repeat treatment</ci>
                    <ci type="logical">The total rituximab dose used would not exceed the equivalent of 375
          mg/m² of body surface area per week for a total of 4 weeks</ci>
                  </apply>
                </math>
                <Applicant>nephrologist</Applicant>
                <Term Measure="week">8</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with a * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="Neuromyelitis Optica Spectrum Disorder (NMOSD)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">One of the following dose regimens is to be used: 2 doses of 1,000 mg
          rituximab administered fortnightly, or 4 doses of 375 mg/m2 administered weekly for four
          weeks</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced a severe episode or attack of NMOSD
            (rapidly progressing symptoms and clinical investigations supportive of a severe attack
            of NMOSD)</ci>
                      <apply>
                        <and/>
                        <ci type="logical">The patient has experienced a breakthrough attack of NMOSD</ci>
                        <ci type="logical">The patient is receiving treatment with mycophenolate</ci>
                        <ci type="logical">The patients is receiving treatment with corticosteroids</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Neuromyelitis Optica Spectrum Disorder (NMOSD)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">One of the following dose regimens is to be used: 2 doses of 1,000 mg
          rituximab administered fortnightly, or 4 doses of 375 mg/m2 administered weekly for four
          weeks</ci>
                    <ci type="logical">The patients has responded to the most recent course of rituximab</ci>
                    <ci type="logical">The patient has not received rituximab in the previous 6 months</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="Severe Refractory Myasthenia Gravis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">One of the following dose regimens is to be used: 375 mg/m2 of body
          surface area per week for a total of four weeks, or 500 mg once weekly for four weeks, or
          two 1,000 mg doses given two weeks apart</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Treatment with corticosteroids and at least one other immunosuppressant
            for at least a period of 12 months has been ineffective</ci>
                      <apply>
                        <and/>
                        <ci type="logical">Treatment with at least one other immunosuppressant for a period of
              at least 12 months</ci>
                        <ci type="logical">Corticosteroids have been trialed for at least 12 months and have
              been discontinued due to unacceptable side effects</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>neurologist</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Renewal" Category="Severe Refractory Myasthenia Gravis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">One of the following dose regimens is to be used: 375 mg/m2 of body
          surface area per week for a total of four weeks, or 500 mg once weekly for four weeks, or
          two 1,000 mg doses given two weeks apart</ci>
                    <ci type="logical">An initial response lasting at least 12 months was demonstrated</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has relapsed despite treatment with corticosteroids and at
            least one other immunosuppressant for a period of at least 12 months</ci>
                      <apply>
                        <and/>
                        <ci type="logical">The patient’s myasthenia gravis has relapsed despite treatment with
              at least one immunosuppressant for a period of at least 12 months</ci>
                        <ci type="logical">Corticosteroids have been trialed for at least 12 months and have
              been discontinued due to unacceptable side effects</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>neurologist</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="Severe antisynthetase syndrome">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has confirmed antisynthetase syndrome</ci>
                    <ci type="logical">Patient has severe, immediately life or organ threatening disease,
          including interstitial lung disease</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Treatment with at least 3 immunosuppressants (oral steroids,
            cyclophosphamide, methotrexate, mycophenolate, ciclosporin, azathioprine) has not be
            effective at controlling active disease</ci>
                      <ci type="logical">Rapid treatment is required due to life threatening complications</ci>
                    </apply>
                    <ci type="logical">Maximum of four 1,000 mg infusions of rituximab</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="Severe antisynthetase syndrome">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient’s disease has responded to the previous rituximab treatment with
          demonstrated improvement in inflammatory markers, muscle strength and pulmonary
          function</ci>
                    <ci type="logical">The patient has not received rituximab in the previous 6 months</ci>
                    <ci type="logical">Maximum of two cycles of 2 x 1,000 mg infusions of rituximab given two
          weeks apart</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="graft versus host disease">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has refractory graft versus host disease following
          transplant</ci>
                    <ci type="logical">Treatment with at least 3 immunosuppressants (oral steroids, ciclosporin,
          tacrolimus, mycophenolate, sirolimus) has not be effective at controlling active
          disease</ci>
                    <ci type="logical">The total rituximab dose used would not exceed the equivalent of 375
          mg/m² of body surface area per week for a total of 4 weeks</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="severe chronic inflammatory demyelinating polyneuropathy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has severe chronic inflammatory demyelinating polyneuropathy
          (CIPD)</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">Treatment with steroids and intravenous immunoglobulin and/or plasma
              exchange has not been effective at controlling active disease</ci>
                        <ci type="logical">At least one other immunosuppressant (cyclophosphamide, ciclosporin,
              tacrolimus, mycophenolate) has not been effective at controlling active disease</ci>
                      </apply>
                      <ci type="logical">Rapid treatment is required due to life threatening complications</ci>
                    </apply>
                    <ci type="logical">One of the following dose regimens is to be used: 375 mg/m2 of body
          surface area per week for a total of four weeks, or 500 mg once weekly for four weeks, or
          two 1,000 mg doses given two weeks apart</ci>
                  </apply>
                </math>
                <Applicant>neurologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="severe chronic inflammatory demyelinating polyneuropathy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient’s disease has responded to the previous rituximab treatment with
          demonstrated improvement in neurological function compared to baseline</ci>
                    <ci type="logical">The patient has not received rituximab in the previous 6 months</ci>
                    <ci type="logical">One of the following dose regimens is to be used: 375 mg/m2 of body
          surface area per week for a total of four weeks, or 500 mg once weekly for four weeks, or
          two 1,000 mg doses given two weeks apart</ci>
                  </apply>
                </math>
                <Applicant>neurologist</Applicant>
                <Applicant Referring="Neurologist">medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="anti-NMDA receptor autoimmune encephalitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has severe anti-NMDA receptor autoimmune encephalitis</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">Treatment with steroids and intravenous immunoglobulin and/or plasma
              exchange has not been effective at controlling active disease</ci>
                        <ci type="logical">At least one other immunosuppressant (cyclophosphamide, ciclosporin,
              tacrolimus, mycophenolate) has not been effective at controlling active disease</ci>
                      </apply>
                      <ci type="logical">Rapid treatment is required due to life threatening complications</ci>
                    </apply>
                    <ci type="logical">One of the following dose regimens is to be used: 375 mg/m2 of body
          surface area per week for a total of four weeks, or 500 mg once weekly for four weeks, or
          two 1,000 mg doses given two weeks apart</ci>
                  </apply>
                </math>
                <Applicant>neurologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="anti-NMDA receptor autoimmune encephalitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient’s disease has responded to the previous rituximab treatment with
          demonstrated improvement in neurological function</ci>
                    <ci type="logical">The patient has not received rituximab in the previous 6 months</ci>
                    <ci type="logical">The patient has experienced a relapse and now requires further
          treatment</ci>
                    <ci type="logical">One of the following dose regimens is to be used: 375 mg/m2 of body
          surface area per week for a total of four weeks, or 500 mg once weekly for four weeks, or
          two 1,000 mg doses given two weeks apart</ci>
                  </apply>
                </math>
                <Applicant>neurologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="CD20+ low grade or follicular B-cell NHL">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has CD20+ low grade or follicular B-cell NHL with relapsed
            disease following prior chemotherapy</ci>
                      <ci type="logical">To be used for a maximum of 6 treatment cycles</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has CD20+ low grade or follicular B-cell NHL requiring
            first-line systemic chemotherapy</ci>
                      <ci type="logical">To be used for a maximum of 6 treatment cycles</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">9</Term>
              </Case>
              <Case When="Renewal" Category="CD20+ low grade or follicular B-cell NHL">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Rituximab is to be used for maintenance in CD20+ low grade or follicular
          B-cell NHL following induction with first-line systemic chemotherapy</ci>
                    <ci type="logical">Patient is intended to receive rituximab maintenance therapy for 2 years
          at a dose of 375 mg/m2 every 8 weeks (maximum of 12 cycles)</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">24</Term>
              </Case>
              <Case When="Initial application" Category="Membranous nephropathy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has biopsy-proven primary/idiopathic membranous
            nephropathy*</ci>
                      <ci type="logical">Patient has PLA2 antibodies with no evidence of secondary cause, and an
            eGFR of &gt;60ml/min/1.73m2</ci>
                    </apply>
                    <ci type="logical">Patient remains at high risk of progression to end-stage kidney disease
          despite more than 3 months of treatment with conservative measures (see Note)</ci>
                    <ci type="logical">The total rituximab dose would not exceed the equivalent of 375mg/m2 of
          body surface area per week for a total of 4 weeks</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="week">6</Term>
              </Case>
              <Case When="Renewal" Category="Membranous nephropathy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient was previously treated with rituximab for membranous
          nephropathy*</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Treatment with rituximab was previously successful, but the condition
            has relapsed, and the patient now requires repeat treatment</ci>
                      <ci type="logical">Patient achieved partial response to treatment and requires repeat
            treatment (see Note)</ci>
                    </apply>
                    <ci type="logical">The total rituximab dose used would not exceed the equivalent of 375
          mg/m2 of body surface area per week for a total of 4 weeks</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="week">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <ol style="list-style-type: lower-alpha">
                    <li>
                      <p>Indications marked with * are unapproved indications.</p>
                    </li>
                    <li>
                      <p>High risk of progression to end-stage kidney disease defined as &gt;5g/day
            proteinuria.</p>
                    </li>
                    <li>
                      <p>Conservative measures include renin-angiotensin system blockade, blood-pressure
            management, dietary sodium and protein restriction, treatment of dyslipidaemia, and
            anticoagulation agents unless contraindicated or the patient has experienced intolerable
            side effects.</p>
                    </li>
                    <li>
                      <p>Partial response defined as a reduction of proteinuria of at least 50% from baseline,
            and between 0.3 grams and 3.5 grams per 24 hours.</p>
                    </li>
                  </ol>
                </div>
              </Case>
              <Case When="Initial application" Category="B-cell acute lymphoblastic leukaemia/lymphoma*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has newly diagnosed B-cell acute lymphoblastic
          leukaemia/lymphoma*</ci>
                    <ci type="logical">Treatment must be in combination with an intensive chemotherapy protocol
          with curative intent</ci>
                    <ci type="logical">The total rituximab dose would not exceed the equivalent of 375 mg/m2 per
          dose for a maximum of 18 doses</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="year">2</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="desensitisation prior to transplant">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient requires desensitisation prior to mismatched allogenic stem cell
          transplant*</ci>
                    <ci type="logical">Patient would receive no more than two doses at 375 mg/m2 of body-surface
          area</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="week">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="pemiphigus*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has severe rapidly progressive pemphigus</ci>
                      <ci type="logical">Is used in combination with systemic corticosteroids (20 mg/day)</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Skin involvement is at least 5% body surface area</ci>
                        <ci type="logical">Significant mucosal involvement (10 or more mucosal erosions) or
              diffuse gingivitis or confluent large erosions</ci>
                        <ci type="logical">Involvement of two or more mucosal sites</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has pemphigus</ci>
                      <ci type="logical">Patient has not experienced adequate clinical benefit from systemic
            corticosteroids (20 mg/day) in combination with a steroid sparing agent, unless
            contraindicated</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Applicant>relevant specialist</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="pemiphigus*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has experienced adequate clinical benefit from rituximab
          treatment, with improvement in symptoms and healing of skin ulceration and reduction in
          corticosteroid requirement</ci>
                    <ci type="logical">Patient has not received rituximab in the previous 6 months</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Applicant>relevant specialist</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="immunoglobulin G4-related disease (IgG4-RD*)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has confirmed diagnosis of IgG4-RD*</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Treatment with corticosteroids and/or disease modifying anti-rheumatic drugs for at least 3 months has been ineffective in lowering corticosteroid dose below 5 mg per day (prednisone equivalent) without relapse</ci>
                      <ci type="logical">Treatment with corticosteroids and/or disease modifying anti-rheumatic drugs is contraindicated or associated with evidence of toxicity or intolerance</ci>
                    </apply>
                    <ci type="logical">Total rituximab dose used should not exceed a maximum of two 1000 mg infusions of rituximab given two weeks apart</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="week">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="immunoglobulin G4-related disease (IgG4-RD*)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Treatment with rituximab for IgG4-RD* was previously successful and patient’s disease has demonstrated sustained response, but the condition has relapsed</ci>
                      <ci type="logical">Patient is receiving maintenance treatment for IgG4-RD*</ci>
                    </apply>
                    <ci type="logical">Rituximab re-treatment not to be given within 6 months of previous course of treatment</ci>
                    <ci type="logical">Maximum of two 1000 mg infusions of rituximab given two weeks apart</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1973" style="display:none"/>
            <Formulation ID="F251212865325" Rank="4" Units="inj" Weight="100">
              <Name>Inj 10 mg per ml, 10 ml vial</Name>
              <Brand ID="B25121286532525">
                <Name>Riximyo</Name>
                <Pack ID="P2583917" Specified="true" nzmt:ctpp_id="50250031000117104">
                  <Quantity>2</Quantity>
                  <Price>275.33</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212865326" Rank="4" Units="inj" Weight="500">
              <Name>Inj 10 mg per ml, 50 ml vial</Name>
              <Brand ID="B25121286532625">
                <Name>Riximyo</Name>
                <Pack ID="P2583909" Specified="true" nzmt:ctpp_id="50250041000117107">
                  <Quantity>1</Quantity>
                  <Price>688.20</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128656">
            <Name>Mepolizumab</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS2024">
              <Title>
                <range>Mepolizumab</range>
              </Title>
              <Case When="Initial application" Category="Severe eosinophilic asthma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient must be aged 12 years or older</ci>
                    <ci type="logical">Patient must have a diagnosis of severe eosinophilic asthma
                    documented by a respiratory physician or clinical immunologist</ci>
                    <ci type="logical">Conditions that mimic asthma eg. vocal cord dysfunction, central
                    airway obstruction, bronchiolitis etc. have been excluded</ci>
                    <ci type="logical">Patient has a blood eosinophil count of greater than 0.5 x 10^9
                    cells/L in the last 12 months</ci>
                    <ci type="logical">Patient must be adherent to optimised asthma therapy including
                    inhaled corticosteroids (equivalent to at least 1000 mcg per day of fluticasone
                    propionate) plus long acting beta-2 agonist, or budesonide/formoterol as part of
                    the single maintenance and reliever therapy regimen, unless contraindicated or
                    not tolerated</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has had at least 4 exacerbations needing systemic
                        corticosteroids in the previous 12 months, where an exacerbation is defined
                        as either documented use of oral corticosteroids for at least 3 days or
                        parenteral corticosteroids</ci>
                      <ci type="logical">Patient has received continuous oral corticosteroids of at
                        least the equivalent of 10 mg per day over the previous 3 months</ci>
                    </apply>
                    <ci type="logical">Treatment is not to be used in combination with subsidised
                    benralizumab</ci>
                    <ci type="logical">Patient has an Asthma Control Test (ACT) score of 10 or less.
                    Baseline measurements of the patient’s asthma control using the ACT and oral
                    corticosteroid dose must be made at the time of application, and again at around
                    52 weeks after the first dose to assess response to treatment</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient has not previously received an
                        anti-IL5 biological therapy for their severe eosinophilic asthma</ci>
                      <apply>
                        <and/>
                        <ci type="logical" class="Indication">Patient was refractory or intolerant
                            to previous anti-IL5 biological therapy</ci>
                        <ci type="logical" class="Indication">Patient was not eligible to continue
                            treatment with previous anti-IL5 biological therapy and discontinued
                            within 12 months of commencing treatment</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory physician</Applicant>
                <Applicant>clinical immunologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="Severe eosinophilic asthma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">An increase in the Asthma Control Test (ACT) score of at least 5
                    from baseline</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Exacerbations have been reduced from baseline by 50% as a
                        result of treatment with mepolizumab</ci>
                      <ci type="logical">Reduction in continuous oral corticosteroid use by 50% or by
                        10 mg/day while maintaining or improving asthma control</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory physician</Applicant>
                <Applicant>clinical immunologist</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="eosinophilic granulomatosis with polyangiitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has eosinophilic granulomatosis with polyangiitis</ci>
                    <ci type="logical">The patient has trialled and not received adequate benefit from at least one of the following for at least three months (unless contraindicated to all): azathioprine, cyclophosphamide, leflunomide, methotrexate, mycophenolate, or rituximab</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has trialled prednisone for a minimum of three months and is unable to maintain disease control at doses below 7.5 mg per day</ci>
                      <ci type="logical">Corticosteroids are contraindicated</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="eosinophilic granulomatosis with polyangiitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has no evidence of clinical disease progression</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2024" style="display:none"/>
            <Formulation ID="F251212865625" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg vial</Name>
              <Brand ID="B25121286562500">
                <Name>Any</Name>
                <Pack ID="P86562500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212865626" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg prefilled pen</Name>
              <Brand ID="B25121286562625">
                <Name>Nucala</Name>
                <Pack ID="P2606836" Specified="true" nzmt:ctpp_id="50276021000117102">
                  <Quantity>1</Quantity>
                  <Price>1638.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128682">
            <Name>Casirivimab and imdevimab</Name>
            <Request Form="RS1874" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Casirivimab and imdevimab</range>
              </Title>
              <Case When="Initial application" Category="Treatment of profoundly immunocompromised patients">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has confirmed (or probable)
                    COVID-19</ci>
                    <ci type="logical" class="Indication">The patient is in the community (treated as an
                    outpatient) with mild to moderate disease severity*</ci>
                    <ci type="logical" class="Indication">Patient is profoundly immunocompromised** and
                    is at risk of not having mounted an adequate response to vaccination against
                    COVID-19 or is unvaccinated</ci>
                    <ci type="logical" class="Indication">Patient’s symptoms started within the last 10
                    days</ci>
                    <ci type="logical" class="Indication">Patient is not receiving high flow oxygen or
                    assisted/mechanical ventilation</ci>
                    <ci type="logical" class="Indication">Casirivimab and imdevimab is to be
                    administered at a maximum dose of no greater than 2,400 mg</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="week">2</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>* Mild to moderate disease severity as described on the <a href="https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-information-health-professionals/covid-19-advice-all-health-professionals#adult-management">Ministry of Health Website</a></p>
                  <p>** Examples include B-cell depletive illnesses or patients receiving treatment that
                is B-Cell depleting.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="mild to moderate COVID-19-hospitalised patients">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has confirmed (or probable)
                    COVID-19</ci>
                    <ci type="logical" class="Indication">Patient is an in-patient in hospital with mild
                    to moderate disease severity*</ci>
                    <ci type="logical" class="Indication">Patient’s symptoms started within the last 10
                    days</ci>
                    <ci type="logical" class="Indication">Patient is not receiving high flow oxygen or
                    assisted/mechanical ventilation</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Age &gt;50</ci>
                      <ci type="logical" class="Indication">BMI &gt;30</ci>
                      <ci type="logical" class="Indication">Patient is Māori or Pacific ethnicity</ci>
                      <ci type="logical" class="Indication">Patient is at increased risk of severe
                        illness from COVID-19, excluding pregnancy, as described on the Ministry of
                        Health website (see Notes)</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient is unvaccinated</ci>
                      <ci type="logical" class="Indication">Patient is seronegative where serology
                        testing is readily available or strongly suspected to be seronegative where serology testing is not available</ci>
                    </apply>
                    <ci type="logical" class="Indication">Casirivimab and imdevimab is to be
                    administered at a maximum dose of no greater than 2,400 mg</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="week">2</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>* Mild to moderate disease severity as described on the <a href="https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-information-health-professionals/covid-19-advice-all-health-professionals#adult-management">Ministry of Health Website</a></p>
                  <p>**(<a href="https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-information-specific-audiences/covid-19-advice-higher-risk-people">https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-information-specific-audiences/covid-19-advice-higher-risk-people</a>)</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1874" style="display:none"/>
            <Formulation ID="F251212868225" Rank="10" Units="pack">
              <Name>Inj 120 mg per ml casirivimab, 11.1 ml vial (1) and inj 120 mg per ml imdevimab, 11.1 ml vial (1)</Name>
              <Brand ID="B25121286822525">
                <Name>Ronapreve</Name>
                <Pack ID="P2630923" Specified="true" nzmt:ctpp_id="50290861000117107">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128684">
            <Name>Adalimumab (Amgevita)</Name>
            <Request Form="RS1940" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Adalimumab (Amgevita)</range>
              </Title>
              <Case When="Initial application" Category="Behcet's disease - severe">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has severe Behcet's disease* that is significantly
                    impacting the patient's quality of life</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has severe ocular, neurological, and/or
                        vasculitic symptoms and has not responded adequately to one or more
                        treatment(s) appropriate for the particular symptom(s)</ci>
                      <ci type="logical">The patient has severe gastrointestinal, rheumatological
                        and/or mucocutaneous symptoms and has not responded adequately to two or
                        more treatments appropriate for the particular symptom(s)</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="Hidradenitis suppurativa">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has hidradenitis suppurativa Hurley Stage II or Hurley
                    Stage III lesions in distinct anatomic areas</ci>
                    <ci type="logical">Patient has tried, but had an inadequate response to at least a
                    90 day trial of systemic antibiotics or patient has demonstrated intolerance to
                    or has contraindications for systemic antibiotics</ci>
                    <ci type="logical">Patient has 3 or more active lesions</ci>
                    <ci type="logical">The patient has a DLQI of 10 or more and the assessment is no
                    more than 1 month old at time of application</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="Hidradenitis suppurativa">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has a reduction in active lesions (e.g. inflammatory
                    nodules, abscesses, draining fistulae) of 25% or more from baseline</ci>
                    <ci type="logical">The patient has a DLQI improvement of 4 or more from
                    baseline</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="Plaque psoriasis - severe chronic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has had an initial Special Authority approval for
                        etanercept for severe chronic plaque psoriasis</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has experienced intolerable side effects</ci>
                        <ci type="logical">Patient has received insufficient benefit to meet the
                            renewal criteria for etanercept for severe chronic plaque psoriasis</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has "whole body" severe chronic plaque psoriasis
                            with a (PASI) score of greater than 10, where lesions have been present
                            for at least 6 months from the time of initial diagnosis</ci>
                        <ci type="logical">Patient has severe chronic plaque psoriasis of the face,
                            or palm of a hand or sole of a foot, where the plaque or plaques have
                            been present for at least 6 months from the time of initial
                            diagnosis</ci>
                      </apply>
                      <ci type="logical">Patient has tried, but had an inadequate response to, or has
                        experienced intolerable side effects from, at least three of the following
                        (at maximum tolerated doses unless contraindicated): phototherapy,
                        methotrexate, ciclosporin, or acitretin</ci>
                      <ci type="logical">A PASI assessment or (DLQI) assessment has been completed for
                        at least the most recent prior treatment course but no longer than 1 month
                        following cessation of each prior treatment course and is no more than 1
                        month old at the time of application</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="Plaque psoriasis - severe chronic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">Patient had "whole body" severe chronic plaque psoriasis at
                        the start of treatment</ci>
                      <apply>
                        <or/>
                        <ci type="logical">The patient has a PASI score which is reduced by 75% or
                            more, or is sustained at this level, when compared with the
                            pre-adalimumab treatment baseline value</ci>
                        <ci type="logical">The patient has a DLQI improvement of 5 or more, when
                            compared with the pre-treatment baseline value</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient had severe chronic plaque psoriasis of the face, or
                        palm of a hand or sole of a foot at the start of treatment</ci>
                      <apply>
                        <or/>
                        <ci type="logical">The patient has a reduction in the PASI symptom subscores
                            for all 3 of erythema, thickness and scaling, to slight or better, or
                            sustained at this level, as compared to the treatment course baseline
                            values</ci>
                        <ci type="logical">The patient has a reduction of 75% or more in the skin
                            area affected, or sustained at this level, as compared to the
                            pre-adalimumab treatment baseline value</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="pyoderma gangrenosum">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has pyoderma gangrenosum*</ci>
                    <ci type="logical">Patient has received three months of conventional therapy
                    including a minimum of three pharmaceuticals (e.g. prednisone, ciclosporin,
                    azathioprine, or methotrexate) and not received an adequate response</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="Crohn's disease - adults">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has severe active Crohn's disease</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has a CDAI score of greater than or equal to 300 or
                        HBI score of greater than or equal to 10</ci>
                      <ci type="logical">Patient has extensive small intestine disease affecting more
                        than 50 cm of the small intestine</ci>
                      <ci type="logical">Patient has evidence of short gut syndrome or would be at
                        risk of short gut syndrome with further bowel resection</ci>
                      <ci type="logical">Patient has an ileostomy or colostomy and has intestinal
                        inflammation</ci>
                    </apply>
                    <ci type="logical">Patient has tried but had an inadequate response to, or has
                    experienced intolerable side effects from, prior therapy with immunomodulators
                    and corticosteroids</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Crohn's disease - adults">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">CDAI score has reduced by 100 points from the CDAI score, or HBI
                    score has reduced 3 points, from when the patient was initiated on
                    adalimumab</ci>
                    <ci type="logical">CDAI score is 150 or less, or HBI is 4 or less</ci>
                    <ci type="logical">The patient has demonstrated an adequate response to treatment,
                    but CDAI score and/or HBI score cannot be assessed</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="Crohn's disease - children">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Paediatric patient has active Crohn's disease</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has a PCDAI score of greater than or equal to 30</ci>
                      <ci type="logical">Patient has extensive small intestine disease</ci>
                    </apply>
                    <ci type="logical">Patient has tried but had an inadequate response to, or has
                    experienced intolerable side effects from, prior therapy with immunomodulators
                    and corticosteroids</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Crohn's disease - children">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">PCDAI score has reduced by 10 points from the PCDAI score when
                    the patient was initiated on adalimumab</ci>
                    <ci type="logical">PCDAI score is 15 or less</ci>
                    <ci type="logical">The patient has demonstrated an adequate response to treatment
                    but PCDAI score cannot be assessed</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="Crohn's disease - fistulising">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has confirmed Crohn's disease</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has one or more complex externally draining
                        enterocutaneous fistula(e)</ci>
                      <ci type="logical">Patient has one or more rectovaginal fistula(e)</ci>
                      <ci type="logical">Patient has complex peri-anal fistula</ci>
                    </apply>
                    <ci type="logical">A Baseline Fistula Assessment has been completed and is no more
                    than 1 month old at the time of application</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Crohn's disease - fistulising">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">The number of open draining fistulae have decreased from baseline
                    by at least 50%</ci>
                    <ci type="logical">There has been a marked reduction in drainage of all fistula(e)
                    from baseline as demonstrated by a reduction in the Fistula Assessment score,
                    together with less induration and patient-reported pain</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="Ocular inflammation - chronic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">The patient has had an initial Special Authority approval for
                    infliximab for chronic ocular inflammation</ci>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has severe uveitis uncontrolled with treatment of
                        steroids and other immunosuppressants with a severe risk of vision loss</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient is 18 years or older and treatment with at least
                            two other immunomodulatory agents has proven ineffective</ci>
                        <ci type="logical">Patient is under 18 years and treatment with methotrexate
                            has proven ineffective or is not tolerated at a therapeutic dose</ci>
                        <ci type="logical">Patient is under 8 years and treatment with steroids or
                            methotrexate has proven ineffective or is not tolerated at a therapeutic
                            dose; or disease requires control to prevent irreversible vision loss
                            prior to achieving a therapeutic dose of methotrexate</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="Ocular inflammation - chronic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">The patient has had a good clinical response following 12 weeks'
                    initial treatment</ci>
                    <ci type="logical">Following each 2 year treatment period, the patient has had a
                    sustained reduction in inflammation (Standardisation of Uveitis Nomenclature
                    (SUN) criteria &lt; ½+ anterior chamber or vitreous cells, absence of active
                    vitreous or retinal lesions, or resolution of uveitic cystoid macular
                    oedema)</ci>
                    <ci type="logical">Following each 2 year treatment period, the patient has a
                    sustained steroid sparing effect, allowing reduction in prednisone to &lt; 10mg
                    daily, or steroid drops less than twice daily if under 18 years old</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="Ocular inflammation - severe">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Patient has had an initial Special Authority approval for
                    infliximab for severe ocular inflammation</ci>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has severe, vision-threatening ocular inflammation
                        requiring rapid control</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Treatment with high-dose steroids (intravenous
                            methylprednisolone) followed by high dose oral steroids has proven
                            ineffective at controlling symptoms</ci>
                        <ci type="logical">Patient developed new inflammatory symptoms while
                            receiving high dose steroids</ci>
                        <ci type="logical">Patient is aged under 8 years and treatment with high
                            dose oral steroids and other immunosuppressants has proven ineffective
                            at controlling symptoms</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="Ocular inflammation - severe">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">The patient has had a good clinical response following 3 initial
                    doses</ci>
                    <ci type="logical">Following each 2 year treatment period, the patient has had a
                    sustained reduction in inflammation (Standardisation of Uveitis Nomenclature
                    (SUN) criteria &lt;½+ anterior chamber or vitreous cells, absence of active
                    vitreous or retinal lesions, or resolution of uveitic cystoid macular
                    oedema)</ci>
                    <ci type="logical"> Following each 2 year treatment period, the patient has a
                    sustained steroid sparing effect, allowing reduction in prednisone to &lt;10mg
                    daily, or steroid drops less than twice daily if under 18 years old</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="ankylosing spondylitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has had an initial Special Authority approval for
                        etanercept for ankylosing spondylitis</ci>
                      <apply>
                        <or/>
                        <ci type="logical">The patient has experienced intolerable side effects</ci>
                        <ci type="logical">The patient has received insufficient benefit to meet the
                            renewal criteria for ankylosing spondylitis</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has a confirmed diagnosis of ankylosing spondylitis
                        for more than six months</ci>
                      <ci type="logical">Patient has low back pain and stiffness that is relieved by
                        exercise but not by rest</ci>
                      <ci type="logical">Patient has bilateral sacroiliitis demonstrated by radiology
                        imaging</ci>
                      <ci type="logical">Patient has not responded adequately to treatment with two or
                        more NSAIDs, while patient was undergoing at least 3 months of a regular
                        exercise regimen for ankylosing spondylitis</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has limitation of motion of the lumbar spine in
                            the sagittal and the frontal planes as determined by the following BASMI
                            measures: a modified Schober's test of less than or equal to 4 cm and
                            lumbar side flexion measurement of less than or equal to 10 cm (mean of
                            left and right)</ci>
                        <ci type="logical">Patient has limitation of chest expansion by at least 2.5
                            cm below the average normal values corrected for age and gender</ci>
                      </apply>
                      <ci type="logical">A BASDAI of at least 6 on a 0-10 scale completed after the 3
                        month exercise trial, but prior to ceasing any previous pharmacological
                        treatment and is no more than 1 month old at the time of application</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="ankylosing spondylitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For applications where treatment has resulted in an improvement in
                BASDAI of 4 or more points from pre-treatment baseline on a 10 point scale, or an
                improvement in BASDAI of 50%, whichever is less</ci>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="Arthritis - oligoarticular course juvenile idiopathic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has had an initial Special Authority approval for
                        etanercept for oligoarticular course juvenile idiopathic arthritis
                        (JIA)</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has experienced intolerable side effects</ci>
                        <ci type="logical">Patient has received insufficient benefit to meet the
                            renewal criteria for oligoarticular course JIA</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">To be used as an adjunct to methotrexate therapy or
                        monotherapy where use of methotrexate is limited by toxicity or
                        intolerance</ci>
                      <ci type="logical">Patient has had oligoarticular course JIA for 6 months
                        duration or longer</ci>
                      <apply>
                        <or/>
                        <ci type="logical">At least 2 active joints with limited range of motion,
                            pain or tenderness after a 3-month trial of methotrexate (at the maximum
                            tolerated dose)</ci>
                        <ci type="logical">Moderate or high disease activity (cJADAS10 score greater
                            than 1.5) with poor prognostic features after a 3-month trial of
                            methotrexate (at the maximum tolerated dose)</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>named specialist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Arthritis - oligoarticular course juvenile idiopathic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Following initial treatment, the patient has at least a 50%
                    decrease in active joint count and an improvement in physician's global
                    assessment from baseline</ci>
                    <ci type="logical">On subsequent reapplications, the patient demonstrates at least a
                    continuing 30% improvement in active joint count and continued improvement in
                    physician's global assessment from baseline</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="Arthritis - polyarticular course juvenile idiopathic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has had an initial Special Authority approval for
                        etanercept for polyarticular course juvenile idiopathic arthritis (JIA)</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has experienced intolerable side effects</ci>
                        <ci type="logical">Patient has received insufficient benefit to meet the
                            renewal criteria for polyarticular course JIA</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">To be used as an adjunct to methotrexate therapy or
                        monotherapy where use of methotrexate is limited by toxicity or
                        intolerance</ci>
                      <ci type="logical">Patient has had polyarticular course JIA for 6 months
                        duration or longer</ci>
                      <apply>
                        <or/>
                        <ci type="logical">At least 5 active joints and at least 3 joints with
                            limited range of motion, pain or tenderness after a 3-month trial of
                            methotrexate (at the maximum tolerated dose)</ci>
                        <ci type="logical">Moderate or high disease activity (cJADAS10 score of at
                            least 2.5) after a 3-month trial of methotrexate (at the maximum
                            tolerated dose)</ci>
                        <ci type="logical">Low disease activity (cJADAS10 score between 1.1 and 2.5)
                            after a 6-month trial of methotrexate</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>named specialist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Arthritis - polyarticular course juvenile idiopathic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Following initial treatment, the patient has at least a 50%
                    decrease in active joint count and an improvement in physician's global
                    assessment from baseline</ci>
                    <ci type="logical">On subsequent reapplications, the patient demonstrates at least a
                    continuing 30% improvement in active joint count and continued improvement in
                    physician's global assessment from baseline</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="Arthritis - psoriatic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has had an initial Special Authority approval for
                        etanercept or secukinumab for psoriatic arthritis</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has experienced intolerable side effects</ci>
                        <ci type="logical">Patient has received insufficient benefit to meet the
                            renewal criteria for psoriatic arthritis</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has had active psoriatic arthritis for six months
                        duration or longer</ci>
                      <ci type="logical">Patient has tried and not responded to at least three months
                        of methotrexate at a maximum tolerated dose (unless contraindicated)</ci>
                      <ci type="logical">Patient has tried and not responded to at least three months
                        of sulfasalazine or leflunomide at maximum tolerated doses (unless
                        contraindicated)</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has persistent symptoms of poorly controlled and
                            active disease in at least 15 swollen joints</ci>
                        <ci type="logical">Patient has persistent symptoms of poorly controlled and
                            active disease in at least four joints from the following: wrist, elbow,
                            knee, ankle, and either shoulder or hip</ci>
                      </apply>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has CRP level greater than 15 mg/L measured no
                            more than one month prior to the date of this application</ci>
                        <ci type="logical">Patient has an elevated ESR greater than 25 mm per
                            hour</ci>
                        <ci type="logical">ESR and CRP not measured as patient is currently
                            receiving prednisone therapy at a dose of greater than 5 mg per day and
                            has done so for more than three months</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Arthritis - psoriatic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Following initial treatment, the patient has at least a 50%
                    decrease in swollen joint count from baseline and a clinically significant
                    response in the opinion of the physician</ci>
                    <ci type="logical">Patient demonstrates at least a continuing 30% improvement in
                    swollen joint count from baseline and a clinically significant response in the
                    opinion of the treating physician</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="Arthritis - rheumatoid">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has had an initial Special Authority approval for
                        etanercept for rheumatoid arthritis</ci>
                      <apply>
                        <or/>
                        <ci type="logical">The patient has experienced intolerable side effects</ci>
                        <ci type="logical">The patient has received insufficient benefit from
                            etanercept to meet the renewal criteria for rheumatoid arthritis</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has had rheumatoid arthritis (either confirmed by
                        radiology imaging, or the patient is cyclic citrullinated peptide (CCP)
                        antibody positive) for six months duration or longer</ci>
                      <ci type="logical">Treatment is to be used as an adjunct to methotrexate therapy
                        or monotherapy where use of methotrexate is limited by toxicity or
                        intolerance</ci>
                      <ci type="logical">Patient has tried and not responded to at least three months
                        of methotrexate at a maximum tolerated dose (unless contraindicated)</ci>
                      <ci type="logical">Patient has tried and not responded to at least three months
                        of methotrexate in combination with sulfasalazine and hydroxychloroquine
                        sulphate at maximum tolerated doses (unless contraindicated)</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has tried and not responded to at least three
                            months of methotrexate in combination with the maximum tolerated dose of
                            ciclosporin</ci>
                        <ci type="logical">Patient has tried and not responded to at least three
                            months of therapy at the maximum tolerated dose of leflunomide alone or
                            in combination with methotrexate</ci>
                      </apply>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has persistent symptoms of poorly controlled and
                            active disease in at least 15 swollen joints</ci>
                        <ci type="logical">Patient has persistent symptoms of poorly controlled and
                            active disease in at least four joints from the following: wrist, elbow,
                            knee, ankle, and either shoulder or hip</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Arthritis - rheumatoid">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Following initial treatment, the patient has at least a 50%
                    decrease in active joint count from baseline and a clinically significant
                    response to treatment in the opinion of the physician</ci>
                    <ci type="logical">On subsequent reapplications, the patient demonstrates at least a
                    continuing 30% improvement in active joint count from baseline and a clinically
                    significant response to treatment in the opinion of the physician</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="Still's disease - adult-onset (AOSD)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has had an initial Special Authority approval for
                        etanercept and/or tocilizumab for (AOSD)</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has experienced intolerable side effects from
                            etanercept and/or tocilizumab</ci>
                        <ci type="logical">Patient has received insufficient benefit from at least a
                            three-month trial of etanercept and/or tocilizumab</ci>
                      </apply>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient diagnosed with AOSD according to the Yamaguchi
                        criteria</ci>
                      <ci type="logical">Patient has tried and not responded to at least 6 months of
                        glucocorticosteroids at a dose of at least 0.5 mg/kg, NSAIDs and
                        methotrexate</ci>
                      <ci type="logical">Patient has persistent symptoms of disabling poorly
                        controlled and active disease</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="ulcerative colitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has active ulcerative colitis</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient's SCCAI score is greater than or equal to 4</ci>
                      <ci type="logical">Patient's PUCAI score is greater than or equal to 20</ci>
                    </apply>
                    <ci type="logical">Patient has tried but had an inadequate response to, or has
                    experienced intolerable side effects from, prior therapy with immunomodulators
                    and systemic corticosteroids</ci>
                    <ci type="logical">Surgery (or further surgery) is considered to be clinically
                    inappropriate</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="ulcerative colitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">The SCCAI score has reduced by 2 points or more from the SCCAI
                    score when the patient was initiated on biologic therapy</ci>
                    <ci type="logical">The PUCAI score has reduced by 10 points or more from the
                    PUCAI score when the patient was initiated on biologic therapy</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="undifferentiated spondyloarthiritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has undifferentiated peripheral spondyloarthritis* with
                    active peripheral joint arthritis in at least four joints from the following:
                    wrist, elbow, knee, ankle, and either shoulder or hip</ci>
                    <ci type="logical">Patient has tried and not responded to at least three months of
                    each of methotrexate, sulphasalazine and leflunomide, at maximum tolerated doses
                    (unless contraindicated)</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has a CRP level greater than 15 mg/L measured no more
                        than one month prior to the date of this application</ci>
                      <ci type="logical">Patient has an ESR greater than 25 mm per hour measured no
                        more than one month prior to the date of this application</ci>
                      <ci type="logical">ESR and CRP not measured as patient is currently receiving
                        prednisone therapy at a dose of greater than 5 mg per day and has done so
                        for more than three months</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="undifferentiated spondyloarthiritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Following initial treatment, the patient has at least a 50%
                    decrease in active joint count from baseline and a clinically significant
                    response to treatment in the opinion of the physician</ci>
                    <ci type="logical">The patient demonstrates at least a continuing 30% improvement in
                    active joint count from baseline and a clinically significant response in the
                    opinion of the treating physician</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="inflammatory bowel arthritis – axial">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has a diagnosis of active ulcerative colitis or active
                    Crohn's disease</ci>
                    <ci type="logical">Patient has axial inflammatory pain for six months or more</ci>
                    <ci type="logical">Patient is unable to take NSAIDs</ci>
                    <ci type="logical">Patient has unequivocal sacroiliitis demonstrated by radiological
                    imaging or MRI</ci>
                    <ci type="logical">Patient has not responded adequately to prior treatment
                    consisting of at least 3 months of an exercise regime supervised by a
                    physiotherapist</ci>
                    <ci type="logical">A BASDAI of at least 6 on a 0-10 scale completed after the 3
                    month exercise trial, but prior to ceasing any previous pharmacological
                    treatment</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="inflammatory bowel arthritis – axial">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Where treatment has resulted in an improvement in
                BASDAI of 4 or more points from pre-treatment baseline on a 10 point scale, or an
                improvement in BASDAI of 50%, whichever is less</ci>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="inflammatory bowel arthritis – peripheral">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has a diagnosis of active ulcerative colitis or active
                    Crohn's disease</ci>
                    <ci type="logical">Patient has active arthritis in at least four joints from the
                    following: hip, knee, ankle, subtalar, tarsus, forefoot, wrist, elbow, shoulder,
                    sternoclavicular</ci>
                    <ci type="logical">Patient has tried and not experienced a response to at least
                    three months of methotrexate, or azathioprine at a maximum tolerated dose
                    (unless contraindicated)</ci>
                    <ci type="logical">Patient has tried and not experienced a response to at least
                    three months of sulphasalazine at a maximum tolerated dose (unless
                    contraindicated)</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has a CRP level greater than 15 mg/L measured no more
                        than one month prior to the date of this application</ci>
                      <ci type="logical">Patient has an ESR greater than 25 mm per hour</ci>
                      <ci type="logical">ESR and CRP not measured as patient is currently receiving
                        prednisone therapy at a dose of greater than 5 mg per day and has done so
                        for more than three months</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="inflammatory bowel arthritis – peripheral">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Following initial treatment, the patient has at least a 50%
                    decrease in active joint count from baseline and a clinically significant
                    response to treatment in the opinion of the physician</ci>
                    <ci type="logical">Patient demonstrates at least a continuing 30% improvement in
                    active joint count from baseline in the opinion of the treating physician</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1940" style="display:none"/>
            <Formulation ID="F251212868425" Rank="4" Units="inj" Weight="40">
              <Name>Inj 40 mg per 0.8 ml prefilled pen</Name>
              <Rule Type="DVLimit" Attribute="Oct-22 to~31~Jul~2026" Value="5"/>
              <Brand ID="B25121286842525" PSS="true">
                <Name>Amgevita</Name>
                <Pack ID="P2631105" Specified="true" nzmt:ctpp_id="50252821000117106">
                  <Quantity>2</Quantity>
                  <Price>375.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212868426" Rank="4" Units="inj" Weight="40">
              <Name>Inj 40 mg per 0.8 ml prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Oct-22 to~31~Jul~2026" Value="5"/>
              <Brand ID="B25121286842625" PSS="true">
                <Name>Amgevita</Name>
                <Pack ID="P2631113" Specified="true" nzmt:ctpp_id="50252771000117100">
                  <Quantity>2</Quantity>
                  <Price>375.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212868427" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg per 0.4 ml prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Oct-22 to~31~Jul~2026" Value="5"/>
              <Brand ID="B25121286842725" PSS="true">
                <Name>Amgevita</Name>
                <Pack ID="P2631121" Specified="true" nzmt:ctpp_id="50252741000117106">
                  <Quantity>1</Quantity>
                  <Price>190.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128689">
            <Name>Gemtuzumab ozogamicin</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1923">
              <Title>
                <range>Gemtuzumab ozogamicin</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has not received prior chemotherapy for this condition</ci>
                    <ci type="logical">Patient has de novo CD33-positive acute myeloid leukaemia</ci>
                    <ci type="logical">Patient does not have acute promyelocytic leukaemia</ci>
                    <ci type="logical">Gemtuzumab ozogamicin will be used in combination with standard anthracycline and cytarabine (AraC)</ci>
                    <ci type="logical">Patient is being treated with curative intent</ci>
                    <ci type="logical">Patient’s disease risk has been assessed by cytogenetic testing to be good or intermediate</ci>
                    <ci type="logical">Patient must be considered eligible for standard intensive remission induction chemotherapy with standard anthracycline and cytarabine (AraC)</ci>
                    <ci type="logical">Gemtuzumab ozogamicin to be funded for one course only (one dose at 3 mg per m² body surface area or up to 2 vials of 5 mg as separate doses)</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Acute myeloid leukaemia excludes acute promyelocytic leukaemia and acute myeloid leukaemia that is secondary to another haematological disorder (eg myelodysplasia or myeloproliferative disorder).</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1923" style="display:none"/>
            <Formulation ID="F251212868925" Rank="4" Units="inj">
              <Name>Inj 5 mg vial</Name>
              <Brand ID="B25121286892525">
                <Name>Mylotarg</Name>
                <Pack ID="P2611678" Specified="true" nzmt:ctpp_id="50174701000117101">
                  <Quantity>1</Quantity>
                  <Price>12973.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128691">
            <Name>Tixagevimab with cilgavimab</Name>
            <Request Form="RS1911" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Tixagevimab with cilgavimab</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Only if patient meets access criteria (as per
                    https://pharmac.govt.nz/Evusheld). Note the supply of treatment is via Pharmac’s
                    approved distribution process. Refer to the Pharmac website for more information
                    about this and stock availability</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1911" style="display:none"/>
            <Formulation ID="F251212869125" Rank="4" Units="inj">
              <Name>Inj 100 mg per ml, 1.5 ml vial with cilgavimab 100 mg per ml,1.5 ml vial</Name>
              <Brand ID="B25121286912525">
                <Name>Evusheld</Name>
                <Pack ID="P2639750" Specified="true" nzmt:ctpp_id="50299311000117109">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128694">
            <Name>Benralizumab</Name>
            <Request Form="RS1920" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Benralizumab</range>
              </Title>
              <Case When="Initial application" Category="Severe eosinophilic asthma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient must be aged 12 years or older</ci>
                    <ci type="logical" class="Indication">Patient must have a diagnosis of severe eosinophilic asthma documented by a respiratory physician or clinical immunologist</ci>
                    <ci type="logical" class="Indication">Conditions that mimic asthma eg. vocal cord dysfunction, central airway obstruction, bronchiolitis etc. have been excluded</ci>
                    <ci type="logical" class="Indication">Patient has a blood eosinophil count of greater than 0.5 × 10^9 cells/L in the last 12 months</ci>
                    <ci type="logical" class="Indication">Patient must be adherent to optimised asthma therapy including inhaled corticosteroids (equivalent to at least 1000 mcg per day of fluticasone propionate) plus long-acting beta-2 agonist, or budesonide/formoterol as part of the anti-inflammatory reliever therapy plus maintenance regimen, unless contraindicated or not tolerated</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient has had at least 4 exacerbations needing systemic corticosteroids in the previous 12 months, where an exacerbation is defined as either documented use of oral corticosteroids for at least 3 days or parenteral corticosteroids</ci>
                      <ci type="logical" class="Indication">Patient has received continuous oral corticosteroids of at least the equivalent of 10 mg per day over the previous 3 months</ci>
                    </apply>
                    <ci type="logical" class="Indication">Treatment is not to be used in combination with subsidised mepolizumab</ci>
                    <ci type="logical" class="Indication">Patient has an Asthma Control Test (ACT) score of 10 or less. Baseline measurements of the patient’s asthma control using the ACT and oral corticosteroid dose must be made at the time of application, and again at around 52 weeks after the first dose to assess response to treatment</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient has not previously received an anti-IL5 biological therapy for their severe eosinophilic asthma</ci>
                      <apply>
                        <and/>
                        <ci type="logical" class="Indication">Patient was refractory or intolerant to previous anti-IL5 biological therapy</ci>
                        <ci type="logical" class="Indication">Patient was not eligible to continue treatment with previous anti-IL5 biological therapy and discontinued within 12 months of commencing treatment</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory physician</Applicant>
                <Applicant>clinical immunologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="Severe eosinophilic asthma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">An increase in the Asthma Control Test (ACT) score of at least 5 from baseline</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Exacerbations have been reduced from baseline by 50% as a result of treatment with benralizumab</ci>
                      <ci type="logical" class="Indication">Reduction in continuous oral corticosteroid use by 50% or by 10 mg/day while maintaining or improving asthma control</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory physician</Applicant>
                <Applicant>clinical immunologist</Applicant>
                <Term Measure="year">2</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1920" style="display:none"/>
            <Formulation ID="F251212869425" Rank="4" Units="inj">
              <Name>Inj 30 mg per ml, 1 ml prefilled pen</Name>
              <Brand ID="B25121286942525">
                <Name>Fasenra</Name>
                <Pack ID="P2638746" Specified="true" nzmt:ctpp_id="50284831000117107">
                  <Quantity>1</Quantity>
                  <Price>3539.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128703">
            <Name>Ustekinumab</Name>
            <Request Form="RS1942" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Ustekinumab</range>
              </Title>
              <Case When="Initial application" Category="Crohn's disease - adults">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">Patient is currently on treatment with
           ustekinumab commenced prior to 1 February 2023 and met all remaining criteria
           (criterion 2) below at the time of commencing treatment</ci>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">Patient has active Crohn's disease</ci>
                      <apply>
                        <or/>
                        <ci type="logical" class="Indication">Patient has had an initial approval
               for prior biologic therapy for Crohn’s disease and has experienced
               intolerable side effects or insufficient benefit to meet renewal
               criteria</ci>
                        <apply>
                          <and/>
                          <ci type="logical" class="Indication">Patient meets the initiation
                 criteria for prior biologic therapies for Crohn’s disease</ci>
                          <ci type="logical" class="Indication">Other biologics for Crohn’s
                 disease are contraindicated</ci>
                        </apply>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Crohn's disease - adults">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical" class="Use">CDAI score has reduced by 100 points, or HBI
            score has reduced by 3 points, from when the patient was initiated on
            biologic therapy</ci>
                      <ci type="logical" class="Use">CDAI score is 150 or less, or HBI is 4 or
            less</ci>
                      <ci type="logical" class="Use">The patient has experienced an adequate response
            to treatment, but CDAI score and/or HBI score cannot be assessed</ci>
                    </apply>
                    <ci type="logical" class="Use">Ustekinumab to be administered at a dose no greater
          than 90 mg every 8 weeks</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="Crohn's disease - children*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">Patient is currently on treatment with
          ustekinumab commenced prior to 1 February 2023 and met all remaining criteria
          (criterion 2) below at the time of commencing treatment</ci>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">Patient has active Crohn's disease</ci>
                      <apply>
                        <or/>
                        <ci type="logical" class="Indication">Patient has had an initial approval
              for prior biologic therapy and has experienced intolerable side effects
              or insufficient benefit to meet renewal criteria</ci>
                        <apply>
                          <and/>
                          <ci type="logical" class="Indication">Patient meets the initiation
                criteria for prior biologic therapies for Crohn’s disease</ci>
                          <ci type="logical" class="Indication">Other biologics for Crohn’s
                disease are contraindicated</ci>
                        </apply>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indication marked with * is an unapproved indication.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="Crohn's disease - children*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical" class="Use">PCDAI score has reduced by 10 points from when
            the patient was initiated on biologic therapy</ci>
                      <ci type="logical" class="Use">PCDAI score is 15 or less</ci>
                      <ci type="logical" class="Use">The patient has experienced an adequate response
            to treatment, but CDAI score cannot be assessed</ci>
                    </apply>
                    <ci type="logical" class="Indication">Ustekinumab to administered at a dose no
          greater than 90 mg every 8 weeks</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indication marked with * is an unapproved indication.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="ulcerative colitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">Patient is currently on treatment with
          ustekinumab commenced prior to 1 February 2023 and met all remaining criteria
          (criterion 2) below at the time of commencing treatment</ci>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">Patient has active ulcerative colitis</ci>
                      <apply>
                        <or/>
                        <ci type="logical" class="Indication">Patient has had an initial approval
              for prior biologic therapy for ulcerative colitis and has experienced
              intolerable side effects or insufficient benefit to meet renewal
              criteria</ci>
                        <apply>
                          <and/>
                          <ci type="logical" class="Indication">Patient meets the initiation criteria for prior biologic therapies for ulcerative colitis</ci>
                          <ci type="logical" class="Indication">Other biologics for ulcerative colitis are contraindicated</ci>
                        </apply>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="ulcerative colitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical" class="Use">The SCCAI score has reduced by 2 points or more from the SCCAI score since initiation on biologic therapy</ci>
                      <ci type="logical" class="Use">PUCAI score has reduced by 10 points or more from the PUCAI score since initiation on biologic therapy*</ci>
                    </apply>
                    <ci type="logical" class="Indication">Ustekinumab will be used at a dose no greater than 90 mg intravenously every 8 weeks</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Criterion marked with * is for an unapproved indication.</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1942" style="display:none"/>
            <Formulation ID="F251212870325" Rank="4" Units="inj">
              <Name>Inj 130 mg vial</Name>
              <Brand ID="B25121287032525">
                <Name>Stelara</Name>
                <Pack ID="P2634619" Specified="true" nzmt:ctpp_id="50233881000117103">
                  <Quantity>1</Quantity>
                  <Price>4162.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212870326" Rank="4" Units="inj">
              <Name>Inj 90 mg per ml, 1 ml prefilled syringe</Name>
              <Brand ID="B25121287032625">
                <Name>Stelara</Name>
                <Pack ID="P2455544" Specified="true" nzmt:ctpp_id="50201311000117106">
                  <Quantity>1</Quantity>
                  <Price>4162.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128704">
            <Name>Vedolizumab</Name>
            <Request Form="RS1943" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Vedolizumab</range>
              </Title>
              <Case When="Initial application" Category="Crohn's disease - adults">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has active Crohn's disease</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Use">Patient has had an initial approval for prior biologic therapy and has experienced intolerable side effects or insufficient benefit to meet renewal criteria (unless contraindicated)</ci>
                      <ci type="logical" class="Use">Patient has a CDAI score of greater than or equal to 300, or HBI score of greater than or equal to 10</ci>
                      <ci type="logical" class="Use">Patient has extensive small intestine disease affecting more than 50 cm of the small intestine</ci>
                      <ci type="logical" class="Use">Patient has evidence of short gut syndrome or would be at risk of short gut syndrome with further bowel resection</ci>
                      <ci type="logical" class="Use">Patient has an ileostomy or colostomy, and has intestinal inflammation</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical" class="Use">Patient has tried but experienced an inadequate response to (including lack of initial response and/or loss of initial response) from prior therapy with immunomodulators and corticosteroids</ci>
                      <ci type="logical" class="Use">Patient has experienced intolerable side effects from immunomodulators and corticosteroids</ci>
                      <ci type="logical" class="Use">Immunomodulators and corticosteroids are contraindicated</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Crohn's disease - adults">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical" class="Use">CDAI score has reduced by 100 points, or HBI score has reduced by 3 points, from when the patient was initiated on biologic therapy</ci>
                      <ci type="logical" class="Use">CDAI score is 150 or less, or HBI is 4 or less</ci>
                      <ci type="logical" class="Use">The patient has experienced an adequate response to treatment, but CDAI score and/or HBI score cannot be assessed</ci>
                    </apply>
                    <ci type="logical" class="Use">Vedolizumab to administered at a dose no greater than 300 mg every 8 weeks</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Initial application" Category="Crohn's disease - children*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Paediatric patient has active Crohn’s disease</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Use">Patient has had an initial approval for prior biologic therapy and has experienced intolerable side effects or insufficient benefit to meet renewal criteria (unless contraindicated)</ci>
                      <ci type="logical" class="Use">Patient has a Paediatric Crohn’s Disease Activity Index (PCDAI) score of greater than or equal to 30</ci>
                      <ci type="logical" class="Use">Patient has extensive small intestine disease</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical" class="Use">Patient has tried but experienced an inadequate response to (including lack of initial response and/or loss of initial response) from prior therapy with immunomodulators and corticosteroids</ci>
                      <ci type="logical" class="Use">Patient has experienced intolerable side effects from immunomodulators and corticosteroids</ci>
                      <ci type="logical" class="Use">Immunomodulators and corticosteroids are contraindicated</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indication marked with * is an unapproved indication.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="Crohn's disease - children*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical" class="Use">PCDAI score has reduced by 10 points from when the patient was initiated on biologic therapy</ci>
                      <ci type="logical" class="Use">PCDAI score is 15 or less</ci>
                      <ci type="logical" class="Use">The patient has experienced an adequate response to treatment, but CDAI score cannot be assessed</ci>
                    </apply>
                    <ci type="logical" class="Indication">Vedolizumab to administered at a dose no greater than 300mg every 8 weeks</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="year">2</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indication marked with * is an unapproved indication.</p>
                </div>
              </Case>
              <Case When="Initial application" Category="ulcerative colitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has active ulcerative colitis</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient has had an initial approval for prior biologic therapy and has experienced intolerable side effects or insufficient benefit to meet renewal criteria (unless contraindicated)</ci>
                      <ci type="logical" class="Indication">Patient has a SCCAI score is greater than or equal to 4</ci>
                      <ci type="logical" class="Indication">Patient’s PUCAI score is greater than or equal to 20*</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient has tried but experienced an inadequate response to (including lack of initial response and/or loss of initial response) from prior therapy with immunomodulators and corticosteroids</ci>
                      <ci type="logical" class="Indication">Patient has experienced intolerable side effects from immunomodulators and corticosteroids</ci>
                      <ci type="logical" class="Indication">Immunomodulators and corticosteroids are contraindicated</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indication marked with * is an unapproved indication.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="ulcerative colitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">The SCCAI score has reduced by 2 points or more from the SCCAI score since initiation on biologic therapy</ci>
                      <ci type="logical" class="Indication">The PUCAI score has reduced by 10 points or more from the PUCAI score since initiation on biologic therapy *</ci>
                    </apply>
                    <ci type="logical" class="Indication">Vedolizumab will be used at a dose no greater than 300 mg intravenously every 8 weeks</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="year">2</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indication marked with * is an unapproved indication.</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1943" style="display:none"/>
            <Formulation ID="F251212870425" Rank="4" Units="inj">
              <Name>Inj 300 mg vial</Name>
              <Brand ID="B25121287042525">
                <Name>Entyvio</Name>
                <Pack ID="P2649144" Specified="true" nzmt:ctpp_id="50276411000117102">
                  <Quantity>1</Quantity>
                  <Price>3313.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128722">
            <Name>Brentuximab vedotin</Name>
            <Request Form="RS2002" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Brentuximab</range>
              </Title>
              <Case When="Initial application" Category="relapsed/refractory Hodgkin lymphoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical" class="Indication">Patient has relapsed/refractory CD30-positive Hodgkin lymphoma after two or more lines of chemotherapy</ci>
                        <ci type="logical" class="Indication">Patient is ineligible for autologous stem cell transplant</ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical" class="Indication">Patient has relapsed/refractory CD30-positive Hodgkin lymphoma</ci>
                        <ci type="logical" class="Indication">Patient has previously undergone autologous stem cell transplant</ci>
                      </apply>
                    </apply>
                    <ci type="logical" class="Indication">Patient has not previously received funded brentuximab vedotin</ci>
                    <ci type="logical" class="Indication">Response to brentuximab vedotin treatment is to be reviewed after a maximum of 6 treatment cycles</ci>
                    <ci type="logical" class="Indication">Brentuximab vedotin to be administered at doses no greater than 1.8 mg/kg every 3 weeks</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="relapsed/refractory Hodgkin lymphoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has achieved a partial or complete response to brentuximab vedotin after 6 treatment cycles</ci>
                    <ci type="logical" class="Indication">Treatment remains clinically appropriate and the patient is benefitting from treatment and treatment is being tolerated</ci>
                    <ci type="logical" class="Indication">Patient is to receive a maximum of 16 total cycles of brentuximab vedotin treatment</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">9</Term>
              </Case>
              <Case When="Initial application" Category="anaplastic large cell lymphoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has relapsed/refractory CD30-positive systemic anaplastic large cell lymphoma</ci>
                    <ci type="logical" class="Indication">Patient has an ECOG performance status of 0-1</ci>
                    <ci type="logical" class="Indication">Patient has not previously received brentuximab vedotin</ci>
                    <ci type="logical" class="Indication">Response to brentuximab vedotin treatment is to be reviewed after a maximum of 6 treatment cycles</ci>
                    <ci type="logical" class="Indication">Brentuximab vedotin to be administered at doses no greater than 1.8 mg/kg every 3 weeks</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">9</Term>
              </Case>
              <Case When="Renewal" Category="anaplastic large cell lymphoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has achieved a partial or complete response to brentuximab vedotin after 6 treatment cycles</ci>
                    <ci type="logical" class="Indication">Treatment remains clinically appropriate and the patient is benefitting from treatment and treatment is being tolerated</ci>
                    <ci type="logical" class="Indication">Patient is to receive a maximum of 16 total cycles of brentuximab vedotin treatment</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">9</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2002" style="display:none"/>
            <Formulation ID="F251212872225" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg vial</Name>
              <Brand ID="B25121287222525">
                <Name>Adcetris</Name>
                <Pack ID="P2649152" Specified="true" nzmt:ctpp_id="50208141000117102">
                  <Quantity>1</Quantity>
                  <Price>5275.18</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512128723">
            <Name>Trastuzumab (Herzuma)</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS2005">
              <Title>
                <range>Trastuzumab (Herzuma)</range>
              </Title>
              <Case When="Initial application" Category="early breast cancer">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The patient has early breast cancer expressing HER-2 IHC 3+ or ISH + (including FISH or other current technology</ci>
                    <ci type="logical" class="Indication">Maximum cumulative dose of 106 mg/kg (12 months' treatment)</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="early breast cancer*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">The patient has metastatic breast cancer expressing HER-2 IHC 3+ or ISH+ (including FISH or other current technology</ci>
                      <ci type="logical" class="Indication">The patient received prior adjuvant trastuzumab treatment for early breast cancer</ci>
                      <apply>
                        <or/>
                        <ci type="logical" class="Indication">The patient has not previously received lapatinib treatment for HER-2 positive metastatic breast cancer</ci>
                        <ci type="logical" class="Indication">The patient discontinued lapatinib within 3 months due to intolerable side effects and the cancer did not progress whilst on lapatinib</ci>
                        <ci type="logical" class="Indication">he cancer has not progressed at any time point during the previous 12 months whilst on trastuzumab</ci>
                      </apply>
                      <apply>
                        <or/>
                        <ci type="logical" class="Indication">Trastuzumab will not be given in combination with pertuzumab</ci>
                        <apply>
                          <and/>
                          <ci type="logical" class="Indication">Trastuzumab to be administered in combination with pertuzumab</ci>
                          <ci type="logical" class="Indication">Patient has not received prior treatment for their metastatic disease and has had a treatment-free interval of at least 12 months between prior
                (neo)adjuvant chemotherapy treatment and diagnosis of metastatic breast cancer</ci>
                          <ci type="logical" class="Indication">The patient has good performance status (ECOG grade 0-1)</ci>
                        </apply>
                      </apply>
                      <ci type="logical" class="Indication">Trastuzumab to be discontinued at disease progression</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">Patient has previously discontinued treatment with trastuzumab in the metastatic setting for reasons other than severe toxicity or disease
            progression</ci>
                      <ci type="logical" class="Indication">Patient has signs of disease progression</ci>
                      <ci type="logical" class="Indication">Disease has not progressed during previous treatment with trastuzumab</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>* For patients with relapsed HER-2 positive disease who have previously received adjuvant trastuzumab for early breast cancer</p>
                </div>
              </Case>
              <Case When="Initial application" Category="metastatic breast cancer">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The patient has metastatic breast cancer expressing HER-2 IHC 3+ or ISH+ (including FISH or other current technology)</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">The patient has not previously received lapatinib treatment for HER-2 positive metastatic breast cancer</ci>
                      <ci type="logical" class="Indication">The patient discontinued lapatinib within 3 months due to intolerable side effects and the cancer did not progress whilst on lapatinib</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Trastuzumab will not be given in combination with pertuzumab</ci>
                      <apply>
                        <and/>
                        <ci type="logical" class="Indication">Trastuzumab to be administered in combination with pertuzumab</ci>
                        <ci type="logical" class="Indication">Patient has not received prior treatment for their metastatic disease and has had a treatment-free interval of at least 12 months between prior
              (neo)adjuvant chemotherapy treatment and diagnosis of metastatic breast cancer</ci>
                        <ci type="logical" class="Indication">The patient has good performance status (ECOG grade 0-1)</ci>
                      </apply>
                    </apply>
                    <ci type="logical" class="Indication">Trastuzumab to be discontinued at disease progression</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="metastatic breast cancer">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">The patient has metastatic breast cancer expressing HER-2 IHC 3+ or ISH+ (including FISH or other current technology)</ci>
                      <ci type="logical" class="Indication">The cancer has not progressed at any time point during the previous 12 months whilst on trastuzumab</ci>
                      <ci type="logical" class="Indication">Trastuzumab to be discontinued at disease progression</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">Patient has previously discontinued treatment with trastuzumab for reasons other than severe toxicity or disease progression</ci>
                      <ci type="logical" class="Indication">Patient has signs of disease progression</ci>
                      <ci type="logical" class="Indication">Disease has not progressed during previous treatment with trastuzumab</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="gastric, gastro-oesophageal junction and oesophageal cancer">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The patient has locally advanced or metastatic gastric, gastro-oesophageal junction or oesophageal cancer expressing HER-2 IHC 2+ FISH+ or IHC3+ (or other
          current technology)</ci>
                    <ci type="logical" class="Indication">Patient has an ECOG score of 0-2</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="gastric, gastro-oesophageal junction and oesophageal cancer">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The cancer has not progressed at any time point during the previous 12 months whilst on trastuzumab</ci>
                    <ci type="logical" class="Indication">Trastuzumab to be discontinued at disease progression</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2005" style="display:none"/>
            <Formulation ID="F251212872325" Rank="10" Units="vial" Weight="150">
              <Name>Inj 150 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~31~May~2027" Value="5"/>
              <Brand ID="B25121287232525" PSS="true">
                <Name>Herzuma</Name>
                <Pack ID="P2670127" Specified="true" nzmt:ctpp_id="50243261000117108">
                  <Quantity>1</Quantity>
                  <Price>100.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212872326" Rank="10" Units="vial" Weight="440">
              <Name>Inj 440 mg vial</Name>
              <Rule Type="DVLimit" Attribute="Jun-24 to~31~May~2027" Value="5"/>
              <Brand ID="B25121287232625" PSS="true">
                <Name>Herzuma</Name>
                <Pack ID="P2670135" Specified="true" nzmt:ctpp_id="50243301000117101">
                  <Quantity>1</Quantity>
                  <Price>293.35</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512129004">
            <Name>Basiliximab</Name>
            <Request Form="RS1203" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Basiliximab</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For use in solid organ transplants</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1203" style="display:none"/>
            <Formulation ID="F251212900401" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg vial</Name>
              <Brand ID="B25121290040101">
                <Name>Simulect</Name>
                <Pack ID="P493279" Specified="true" nzmt:ctpp_id="50092131000117104">
                  <Quantity>1</Quantity>
                  <Price>2560.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512129053">
            <Name>Rituximab (mabthera)</Name>
            <Request Form="RS1785" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Rituximab<instance>Mabthera</instance></range>
              </Title>
              <Case When="Initial application" Category="rheumatoid arthritis - prior TNF inhibitor use">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <and/>
                      <ci type="logical">The patient has had an initial community Special Authority approval for at least one of etanercept and/or adalimumab for rheumatoid arthritis</ci>
                      <apply>
                        <or/>
                        <ci type="logical">The patient has experienced intolerable side effects from a reasonable trial of adalimumab and/or etanercept</ci>
                        <ci type="logical">Following at least a four month trial of adalimumab and/or etanercept, the patient did not meet the renewal criteria for adalimumab and/or etanercept for rheumatoid
              arthritis</ci>
                      </apply>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical">Rituximab to be used as an adjunct to methotrexate or leflunomide therapy</ci>
                      <ci type="logical">Patient is contraindicated to both methotrexate and leflunomide, requiring rituximab monotherapy to be used</ci>
                    </apply>
                    <ci type="logical">Maximum of two 1,000 mg infusions of rituximab given two weeks apart</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Initial application" Category="rheumatoid arthritis - TNF inhibitors contraindicated">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Treatment with a Tumour Necrosis Factor alpha inhibitor is contraindicated</ci>
                    <ci type="logical">Patient has had severe and active erosive rheumatoid arthritis (either confirmed by radiology imaging, or the patient is cyclic citrullinated peptide (CCP) antibody
          positive) for six months duration or longer</ci>
                    <ci type="logical">Patient has tried and not responded to at least three months of oral or parenteral methotrexate at a dose of at least 20 mg weekly or a maximum tolerated dose</ci>
                    <ci type="logical">Patient has tried and not responded to at least three months of oral or parenteral methotrexate in combination with sulfasalazine and hydroxychloroquine sulphate (at maximum
          tolerated doses)</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has tried and not responded to at least three months of oral or parenteral methotrexate in combination with the maximum tolerated dose of cyclosporin</ci>
                      <ci type="logical">Patient has tried and not responded to at least three months of oral or parenteral methotrexate in combination with intramuscular gold</ci>
                      <ci type="logical">Patient has tried and not responded to at least three months of therapy at the maximum tolerated dose of leflunomide alone or in combination with oral or parenteral
            methotrexate</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has persistent symptoms of poorly controlled and active disease in at least 20 swollen, tender joints</ci>
                      <ci type="logical">Patient has persistent symptoms of poorly controlled and active disease in at least four joints from the following: wrist, elbow, knee, ankle, and either shoulder or
            hip</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has a C-reactive protein level greater than 15 mg/L measured no more than one month prior to the date of this application</ci>
                      <ci type="logical">C-reactive protein levels not measured as patient is currently receiving prednisone therapy at a dose of greater than 5 mg per day and has done so for more than three
            months</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical">Rituximab to be used as an adjunct to methotrexate or leflunomide therapy</ci>
                      <ci type="logical">Patient is contraindicated to both methotrexate and leflunomide, requiring rituximab monotherapy to be used</ci>
                    </apply>
                    <ci type="logical">Maximum of two 1,000 mg infusions of rituximab given two weeks apart</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="rheumatoid arthritis - re-treatment in 'partial responders' to rituximab">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">At 4 months following the initial course of rituximab infusions the patient had between a 30% and 50% decrease in active joint count from baseline and a clinically
            significant response to treatment in the opinion of the physician</ci>
                      <ci type="logical">At 4 months following the second course of rituximab infusions the patient had at least a 50% decrease in active joint count from baseline and a clinically significant
            response to treatment in the opinion of the physician</ci>
                      <ci type="logical">At 4 months following the third and subsequent courses of rituximab infusions, the patient demonstrates at least a continuing 30% improvement in active joint count from
            baseline and a clinically significant response to treatment in the opinion of the physician</ci>
                    </apply>
                    <ci type="logical">Rituximab re-treatment not to be given within 6 months of the previous course of treatment</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Rituximab to be used as an adjunct to methotrexate or leflunomide therapy</ci>
                      <ci type="logical">Patient is contraindicated to both methotrexate and leflunomide, requiring rituximab monotherapy to be used</ci>
                    </apply>
                    <ci type="logical">Maximum of two 1,000 mg infusions of rituximab given two weeks apart</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="rheumatoid arthritis - re-treatment in 'responders' to rituximab">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">At 4 months following the initial course of rituximab infusions the patient had at least a 50% decrease in active joint count from baseline and a clinically significant
            response to treatment in the opinion of the physician</ci>
                      <ci type="logical">At 4 months following the second and subsequent courses of rituximab infusions, the patient demonstrates at least a continuing 30% improvement in active joint count from
            baseline and a clinically significant response to treatment in the opinion of the physician</ci>
                    </apply>
                    <ci type="logical">Rituximab re-treatment not to be given within 6 months of the previous course of treatment</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Rituximab to be used as an adjunct to methotrexate or leflunomide therapy</ci>
                      <ci type="logical">Patient is contraindicated to both methotrexate and leflunomide, requiring rituximab monotherapy to be used</ci>
                    </apply>
                    <ci type="logical">Maximum of two 1,000 mg infusions of rituximab given two weeks apart</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">4</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1785" style="display:none"/>
            <Formulation ID="F251212905301" Rank="4" Units="inj" Weight="100">
              <Name>Inj 10 mg per ml, 10 ml vial</Name>
              <Brand ID="B25121290530101">
                <Name>Mabthera</Name>
                <Pack ID="P307785" Specified="true" nzmt:ctpp_id="50069021000117105">
                  <Quantity>2</Quantity>
                  <Price>1075.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212905302" Rank="4" Units="inj" Weight="500">
              <Name>Inj 10 mg per ml, 50 ml vial</Name>
              <Brand ID="B25121290530201">
                <Name>Mabthera</Name>
                <Pack ID="P307831" Specified="true" nzmt:ctpp_id="50069031000117108">
                  <Quantity>1</Quantity>
                  <Price>2688.30</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512129289">
            <Name>Adalimumab (Humira - alternative brand)</Name>
            <Request Form="RS1922" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Adalimumab (Humira - Alternative brand)</range>
              </Title>
              <Case When="Initial application" Category="Behcet’s disease – severe">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from
                        adalimumab (Amgevita) following a minimum of 4 weeks treatment</ci>
                      <ci type="logical">Patient has developed symptoms of loss of disease control
                        following a minimum of 4 weeks treatment with adalimumab (Amgevita) and
                        clinician attributes this loss of disease response to a change in treatment
                        regimen</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has received a maximum of 6 months
                    treatment with Amgevita</ci>
                    <ci type="logical" class="Indication">Patient has previously had a Special Authority
                    approval for the Humira brand of adalimumab for this indication</ci>
                    <ci type="logical" class="Indication">Adalimumab to be administered at doses no
                    greater than 40 mg every 14 days</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Behcet’s disease – severe">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has had a good clinical response to treatment with
                    measurably improved quality of life</ci>
                    <ci type="logical">Adalimumab to be administered at doses no greater than 40 mg
                    every 14 days</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Hidradenitis suppurativa">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from
                        adalimumab (Amgevita) following a minimum of 4 weeks treatment</ci>
                      <ci type="logical">Patient has developed symptoms of loss of disease control
                        following a minimum of 4 weeks treatment with adalimumab (Amgevita) and
                        clinician attributes this loss of disease response to a change in treatment
                        regimen</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has received a maximum of 6 months
                    treatment with Amgevita</ci>
                    <ci type="logical" class="Indication">Patient has previously had a Special Authority
                    approval for the Humira brand of adalimumab for this indication</ci>
                    <ci type="logical" class="Indication">Adalimumab to be administered at doses no
                    greater than 40 mg every 7 days. Fortnightly dosing has been considered</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Applicant Referring="dermatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Hidradenitis suppurativa">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has a reduction in active lesions (e.g. inflammatory
                    nodules, abscesses, draining fistulae) of 25% or more from baseline</ci>
                    <ci type="logical">The patient has a Dermatology Quality of Life Index improvement
                    of 4 or more from baseline</ci>
                    <ci type="logical">Adalimumab is to be administered at doses no greater than 40mg
                    every 7 days. Fortnightly dosing has been considered</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Applicant Referring="dermatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Psoriasis - severe chronic plaque">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from
                        adalimumab (Amgevita) following a minimum of 4 weeks treatment</ci>
                      <ci type="logical">Patient has developed symptoms of loss of disease control
                        following a minimum of 4 weeks treatment with adalimumab (Amgevita) and
                        clinician attributes this loss of disease response to a change in treatment
                        regimen</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has received a maximum of 6 months
                    treatment with Amgevita</ci>
                    <ci type="logical" class="Indication">Patient has previously had a Special Authority
                    approval for the Humira brand of adalimumab for this indication</ci>
                    <ci type="logical" class="Indication">Adalimumab to be administered at doses no
                    greater than 40 mg every 14 days</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Applicant Referring="dermatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Psoriasis - severe chronic plaque">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical">Patient had "whole body" severe chronic plaque psoriasis
                            at the start of treatment</ci>
                        <apply>
                          <or/>
                          <ci type="logical">Following each prior adalimumab treatment course the
                                patient has a PASI score which is reduced by 75% or more, or is
                                sustained at this level, when compared with the pre-adalimumab
                                treatment baseline value</ci>
                          <ci type="logical">Following each prior adalimumab treatment course the
                                patient has a Dermatology Quality of Life Index (DLQI) improvement
                                of 5 or more, when compared with the pre-treatment baseline
                                value</ci>
                        </apply>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">Patient had severe chronic plaque psoriasis of the face,
                            or palm of a hand or sole of a foot at the start of treatment</ci>
                        <apply>
                          <or/>
                          <ci type="logical">Following each prior adalimumab treatment course the
                                patient has a reduction in the PASI symptom subscores for all 3 of
                                erythema, thickness and scaling, to slight or better, or sustained
                                at this level, as compared to the treatment course baseline
                                values</ci>
                          <ci type="logical">Following each prior adalimumab treatment course the
                                patient has a reduction of 75% or more in the skin area affected, or
                                sustained at this level, as compared to the pre-adalimumab treatment
                                baseline value</ci>
                        </apply>
                      </apply>
                    </apply>
                    <ci type="logical">Adalimumab to be administered at doses no greater than 40 mg
                    every 14 days</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Applicant Referring="dermatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Pyoderma gangrenosum">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from
                        adalimumab (Amgevita) following a minimum of 4 weeks treatment</ci>
                      <ci type="logical">Patient has developed symptoms of loss of disease control
                        following a minimum of 4 weeks treatment with adalimumab (Amgevita) and
                        clinician attributes this loss of disease response to a change in treatment
                        regimen</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has received a maximum of 6 months
                    treatment with Amgevita</ci>
                    <ci type="logical" class="Indication">Patient has previously had a Special Authority
                    approval for the Humira brand of adalimumab for this indication</ci>
                    <ci type="logical" class="Indication">A maximum of 8 doses</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Pyoderma gangrenosum">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has demonstrated clinical improvement and continues
                    to require treatment</ci>
                    <ci type="logical">A maximum of 8 doses</ci>
                  </apply>
                </math>
                <Applicant>dermatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Crohn’s disease - adult">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from
                        adalimumab (Amgevita) following a minimum of 4 weeks treatment, and a
                        maximum of 6 months treatment with Amgevita</ci>
                      <ci type="logical">Patient has developed symptoms of loss of disease control
                        following a minimum of 4 weeks treatment, and a maximum of 6 months
                        treatment with Amgevita and clinician attributes this loss of disease
                        response to a change in treatment regimen</ci>
                      <ci type="logical">Patient has Crohn’s and is considered to be at risk of
                        disease destabilisation if there were to be a change to current
                        treatment</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has previously had a Special Authority
                    approval for the Humira brand of adalimumab for this indication</ci>
                    <ci type="logical" class="Indication">Adalimumab to be administered at doses no
                    greater than 40 mg every 14 days</ci>
                  </apply>
                </math>
                <Applicant>gastroenterologist</Applicant>
                <Applicant Referring="gastroenterologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Crohn’s disease - adult">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">CDAI score has reduced by 100 points from the CDAI score when
                        the patient was initiated on adalimumab</ci>
                      <ci type="logical">CDAI score is 150 or less</ci>
                      <ci type="logical">The patient has demonstrated an adequate response to
                        treatment, but CDAI score cannot be assessed</ci>
                    </apply>
                    <ci type="logical">Adalimumab to be administered at doses no greater than 40 mg
                    every 14 days</ci>
                  </apply>
                </math>
                <Applicant>gastroenterologist</Applicant>
                <Applicant Referring="gastroenterologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Crohn’s disease - children">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from
                        adalimumab (Amgevita) following a minimum of 4 weeks treatment, and a
                        maximum of 6 months treatment with Amgevita</ci>
                      <ci type="logical">Patient has developed symptoms of loss of disease control
                        following a minimum of 4 weeks treatment, and a maximum of 6 months
                        treatment with Amgevita and clinician attributes this loss of disease
                        response to a change in treatment regimen</ci>
                      <ci type="logical">Patient has Crohn’s and is considered to be at risk of
                        disease destabilisation if there were to be a change to current
                        treatment</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has previously had a Special Authority
                    approval for the Humira brand of adalimumab for this indication</ci>
                    <ci type="logical" class="Indication">Adalimumab to be administered at doses no
                    greater than 40 mg every 14 days</ci>
                  </apply>
                </math>
                <Applicant>gastroenterologist</Applicant>
                <Applicant Referring="gastroenterologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Crohn’s disease - children">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">PCDAI score has reduced by 10 points from the PCDAI score
                        when the patient was initiated on adalimumab</ci>
                      <ci type="logical">PCDAI score is 15 or less</ci>
                      <ci type="logical">The patient has demonstrated an adequate response to
                        treatment, but PCDAI score cannot be assessed</ci>
                    </apply>
                    <ci type="logical">Adalimumab to be administered at doses no greater than 40 mg
                    every 14 days</ci>
                  </apply>
                </math>
                <Applicant>gastroenterologist</Applicant>
                <Applicant Referring="gastroenterologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Crohn’s disease - fistulising">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from
                        adalimumab (Amgevita) following a minimum of 4 weeks treatment, and a
                        maximum of 6 months treatment with Amgevita</ci>
                      <ci type="logical">Patient has developed symptoms of loss of disease control
                        following a minimum of 4 weeks treatment, and a maximum of 6 months
                        treatment with Amgevita and clinician attributes this loss of disease
                        response to a change in treatment regimen</ci>
                      <ci type="logical">Patient has Crohn’s and is considered to be at risk of
                        disease destabilisation if there were to be a change to current
                        treatment</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has previously had a Special Authority
                    approval for the Humira brand of adalimumab for this indication</ci>
                    <ci type="logical" class="Indication">Adalimumab to be administered at doses no
                    greater than 40 mg every 14 days</ci>
                  </apply>
                </math>
                <Applicant>gastroenterologist</Applicant>
                <Applicant Referring="gastroenterologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Crohn’s disease - fistulising">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The number of open draining fistulae have decreased from
                        baseline by at least 50%</ci>
                      <ci type="logical">There has been a marked reduction in drainage of all
                        fistula(e) from baseline as demonstrated by a reduction in the Fistula
                        Assessment score, together with less induration and patient-reported
                        pain</ci>
                    </apply>
                    <ci type="logical" class="Indication">Adalimumab to be administered at doses no
                    greater than 40 mg every 14 days</ci>
                  </apply>
                </math>
                <Applicant>gastroenterologist</Applicant>
                <Applicant Referring="gastroenterologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Ocular inflammation – chronic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from
                        adalimumab (Amgevita) following a minimum of 4 weeks treatment, and a
                        maximum of 6 months treatment with Amgevita</ci>
                      <ci type="logical">Patient has developed symptoms of loss of disease control
                        following a minimum of 4 weeks treatment with Amgevita, and a maximum of 6
                        months treatment with Amgevita and clinician attributes this loss of disease
                        response to a change in treatment regimen</ci>
                      <ci type="logical">Patient has uveitis and is considered to be at risk of vision
                        loss if they were to change treatment</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has previously had a Special Authority
                    approval for the Humira brand of adalimumab for this indication</ci>
                    <ci type="logical" class="Indication">Adalimumab to be administered at doses no
                    greater than 40 mg every 14 days</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="Ocular inflammation – chronic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has had a good clinical response following 12
                        weeks' initial treatment</ci>
                      <ci type="logical">Following each 12-month treatment period, the patient has had
                        a sustained reduction in inflammation (Standardisation of Uveitis
                        Nomenclature (SUN) criteria &lt; ½+ anterior chamber or vitreous cells,
                        absence of active vitreous or retinal lesions, or resolution of uveitic
                        cystoid macular oedema)</ci>
                      <ci type="logical">Following each 12-month treatment period, the patient has a
                        sustained steroid sparing effect, allowing reduction in prednisone to &lt;
                        10mg daily, or steroid drops less than twice daily if under 18 years
                        old</ci>
                    </apply>
                    <ci type="logical">Adalimumab to be administered at doses no greater than 40 mg
                    every 14 days</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="Ocular inflammation – severe">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from
                        adalimumab (Amgevita) following a minimum of 4 weeks treatment, and a
                        maximum of 6 months treatment with Amgevita</ci>
                      <ci type="logical">Patient has developed symptoms of loss of disease control
                        following a minimum of 4 weeks treatment with Amgevita, and a maximum of 6
                        months treatment with Amgevita and clinician attributes this loss of disease
                        response to a change in treatment regimen</ci>
                      <ci type="logical">Patient has uveitis and is considered to be at risk of vision
                        loss if they were to change treatment</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has previously had a Special Authority
                    approval for the Humira brand of adalimumab for this indication</ci>
                    <ci type="logical" class="Indication">Adalimumab to be administered at doses no
                    greater than 40 mg every 14 days</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="Ocular inflammation – severe">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has had a good clinical response following 3
                        initial doses</ci>
                      <ci type="logical">Following each 12-month treatment period, the patient has had
                        a sustained reduction in inflammation (Standardisation of Uveitis
                        Nomenclature (SUN) criteria &lt;½+ anterior chamber or vitreous cells,
                        absence of active vitreous or retinal lesions, or resolution of uveitic
                        cystoid macular oedema)</ci>
                      <ci type="logical">Following each 12-month treatment period, the patient has a
                        sustained steroid sparing effect, allowing reduction in prednisone to &lt;
                        10mg daily, or steroid drops less than twice daily if under 18 years
                        old</ci>
                    </apply>
                    <ci type="logical">Adalimumab to be administered at doses no greater than 40 mg
                    every 14 days</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Initial application" Category="ankylosing spondylitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from
                        adalimumab (Amgevita) following a minimum of 4 weeks treatment</ci>
                      <ci type="logical">Patient has developed symptoms of loss of disease control
                        following a minimum of 4 weeks treatment with adalimumab (Amgevita)</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has received a maximum of 6 months
                    treatment with Amgevita</ci>
                    <ci type="logical" class="Indication">Patient has previously had a Special Authority
                    approval for the Humira brand of adalimumab for this indication</ci>
                    <ci type="logical" class="Indication">Adalimumab to be administered at doses no
                    greater than 40 mg every 14 days</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="rheumatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="ankylosing spondylitis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Treatment has resulted in an improvement in BASDAI of 4 or more
                    points from pre-treatment baseline on a 10 point scale, or an improvement in
                    BASDAI of 50%, whichever is less</ci>
                    <ci type="logical">Adalimumab to be administered at doses no greater than 40 mg
                    every 14 days</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="rheumatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Arthritis – oligoarticular course juvenile idiopathic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from
                        adalimumab (Amgevita) following a minimum of 4 weeks treatment</ci>
                      <ci type="logical">Patient has developed symptoms of loss of disease control
                        following a minimum of 4 weeks treatment with adalimumab (Amgevita) and
                        clinician attributes this loss of disease response to a change in treatment
                        regimen</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has received a maximum of 6 months
                    treatment with Amgevita</ci>
                    <ci type="logical" class="Indication">Patient has previously had a Special Authority
                    approval for the Humira brand of adalimumab for this indication</ci>
                  </apply>
                </math>
                <Applicant>named specialist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Arthritis – oligoarticular course juvenile idiopathic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For patients that demonstrate at least a continuing 30% improvement
                in active joint count and continued improvement in physician's global assessment
                from baseline</ci>
                </math>
                <Applicant>named specialist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Arthritis - polyarticular course juvenile idiopathic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from
                        adalimumab (Amgevita) following a minimum of 4 weeks treatment</ci>
                      <ci type="logical">Patient has developed symptoms of loss of disease control
                        following a minimum of 4 weeks treatment with adalimumab (Amgevita) and
                        clinician attributes this loss of disease response to a change in treatment
                        regimen</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has received a maximum of 6 months
                    treatment with Amgevita</ci>
                    <ci type="logical" class="Indication">Patient has previously had a Special Authority
                    approval for the Humira brand of adalimumab for this indication</ci>
                  </apply>
                </math>
                <Applicant>named specialist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Arthritis - polyarticular course juvenile idiopathic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For patients that demonstrate at least a continuing 30% improvement
                in active joint count and continued improvement in physician's global assessment
                from baseline</ci>
                </math>
                <Applicant>named specialist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Arthritis - psoriatic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from
                        adalimumab (Amgevita) following a minimum of 4 weeks treatment</ci>
                      <ci type="logical">Patient has developed symptoms of loss of disease control
                        following a minimum of 4 weeks treatment with adalimumab (Amgevita) and
                        clinician attributes this loss of disease response to a change in treatment
                        regimen</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has received a maximum of 6 months
                    treatment with Amgevita</ci>
                    <ci type="logical" class="Indication">Patient has previously had a Special Authority
                    approval for the Humira brand of adalimumab for this indication</ci>
                    <ci type="logical" class="Indication">Adalimumab to be administered at doses no
                    greater than 40 mg every 14 days</ci>
                  </apply>
                </math>
                <Applicant>named specialist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Arthritis - psoriatic">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient demonstrates at least a continuing 30% improvement in
                    active joint count from baseline and a clinically significant response to prior
                    adalimumab treatment in the opinion of the treating physician</ci>
                    <ci type="logical">Adalimumab to be administered at doses no greater than 40 mg
                    every 14 days</ci>
                  </apply>
                </math>
                <Applicant>named specialist</Applicant>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Arthritis – rheumatoid">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from
                        adalimumab (Amgevita) following a minimum of 4 weeks treatment</ci>
                      <ci type="logical">Patient has developed symptoms of loss of disease control
                        following a minimum of 4 weeks treatment with adalimumab (Amgevita) and
                        clinician attributes this loss of disease response to a change in treatment
                        regimen</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has received a maximum of 6 months
                    treatment with Amgevita</ci>
                    <ci type="logical" class="Indication">Patient has previously had a Special Authority
                    approval for the Humira brand of adalimumab for this indication</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Adalimumab to be administered at doses no greater than 40 mg
                        every 14 days</ci>
                      <ci type="logical">Patient cannot take concomitant methotrexate and requires
                        doses of adalimumab higher than 40 mg every 14 days to maintain an adequate
                        response</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="rheumatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Arthritis – rheumatoid">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient demonstrates at least a continuing 30% improvement in
                    active joint count from baseline and a clinically significant response to prior
                    adalimumab treatment in the opinion of the treating physician</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Adalimumab to be administered at doses no greater than 40 mg
                        every 14 days</ci>
                      <ci type="logical">Patient cannot take concomitant methotrexate and requires
                        doses of adalimumab higher than 40 mg every 14 days to maintain an adequate
                        response</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="rheumatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="Still's disease – adult-onset (AOSD)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has experienced intolerable side effects from
                        adalimumab (Amgevita) following a minimum of 4 weeks treatment</ci>
                      <ci type="logical">Patient has developed symptoms of loss of disease control
                        following a minimum of 4 weeks treatment with adalimumab (Amgevita) and
                        clinician attributes this loss of disease response to a change in treatment
                        regimen</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient has received a maximum of 6 months
                    treatment with Amgevita</ci>
                    <ci type="logical" class="Indication">Patient has previously had a Special Authority
                    approval for the Humira brand of adalimumab for this indication</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="rheumatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Still's disease – adult-onset (AOSD)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">the patient has demonstrated a sustained improvement in inflammatory
                markers and functional status</ci>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Applicant Referring="rheumatologist">Practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1922" style="display:none"/>
            <Formulation ID="F251212928929" Rank="4" Units="inj">
              <Name>Inj 20 mg per 0.2 ml prefilled syringe</Name>
              <Brand ID="B25121292892925">
                <Name>Humira</Name>
                <Pack ID="P2635062" Specified="true" nzmt:ctpp_id="50245271000117104">
                  <Quantity>2</Quantity>
                  <Price>1599.96</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212928930" Rank="4" Units="inj">
              <Name>Inj 40 mg per 0.4 ml prefilled syringe</Name>
              <Brand ID="B25121292893025">
                <Name>Humira</Name>
                <Pack ID="P2635038" Specified="true" nzmt:ctpp_id="50231751000117104">
                  <Quantity>2</Quantity>
                  <Price>1599.96</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251212928931" Rank="4" Units="inj" Weight="40">
              <Name>Inj 40 mg per 0.4 ml prefilled pen</Name>
              <Brand ID="B25121292893125">
                <Name>HumiraPen</Name>
                <Pack ID="P2635003" Specified="true" nzmt:ctpp_id="50231791000117108">
                  <Quantity>2</Quantity>
                  <Price>1599.96</Price>
                </Pack>
                <Pack ID="P2635011">
                  <Quantity>2</Quantity>
                  <Price>1599.96</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512129299">
            <Name>Abciximab</Name>
            <Request Form="RS1202" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Abciximab</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">For use in patients with acute coronary syndromes undergoing percutaneous coronary intervention</ci>
                    <ci type="logical">For use in patients undergoing intra-cranial intervention</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1202" style="display:none"/>
            <Formulation ID="F251212929925" Rank="4" Units="inj" Weight="10">
              <Name>Inj 2 mg per ml, 5 ml vial</Name>
              <Brand ID="B25121292992500">
                <Name>Any</Name>
                <Pack ID="P92992500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A251214">
          <Name>Programmed Cell Death-1 (PD-1) Inhibitors</Name>
          <Chemical ID="C2512148594">
            <Name>Nivolumab</Name>
            <Request Form="RS2015" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Nivolumab</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has metastatic or unresectable melanoma (excluding uveal)
                    stage III or IV</ci>
                    <ci type="logical">Baseline measurement of overall tumour burden is documented clinically and radiologically</ci>
                    <ci type="logical">The patient has ECOG performance score of 0-2</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient has not received funded
                        pembrolizumab</ci>
                      <apply>
                        <and/>
                        <ci type="logical" class="Trial">Patient has received an initial Special
                            Authority approval for pembrolizumab and has discontinued pembrolizumab
                            within 12 weeks of starting treatment due to intolerance</ci>
                        <ci type="logical" class="Trial">The cancer did not progress while the
                            patient was on pembrolizumab</ci>
                      </apply>
                    </apply>
                    <ci type="logical">Documentation confirming that the patient has been informed and
                    acknowledges that funded treatment with nivolumab will not be continued if their
                    disease progresses</ci>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="less than 24 months on treatment">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <apply>
                        <or/>
                        <ci type="logical">Patient's disease has had a complete response to
                            treatment</ci>
                        <ci type="logical">Patient's disease has had a partial response to treatment</ci>
                        <ci type="logical">Patient has stable disease</ci>
                      </apply>
                      <ci type="logical">Response to treatment in target lesions has been determined by comparable radiologic assessment following the most recent treatment period</ci>
                      <ci type="logical">The treatment remains clinically appropriate and the patient
                        is benefitting from the treatment</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has previously discontinued treatment with nivolumab
                        for reasons other than severe toxicity or disease progression</ci>
                      <ci type="logical">Patient has signs of disease progression</ci>
                      <ci type="logical">Disease has not progressed during previous treatment with
                        nivolumab</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="more than 24 months on treatment">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has been on treatment for more than 24 months</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <apply>
                          <or/>
                          <ci type="logical">Patient's disease has had a complete response to treatment</ci>
                          <ci type="logical">Patient's disease has had a partial response to treatment</ci>
                          <ci type="logical">Patient has stable disease</ci>
                        </apply>
                        <ci type="logical">Response to treatment in target lesions has been determined by comparable radiologic or clinical assessment following the most recent treatment period</ci>
                        <ci type="logical">The treatment remains clinically appropriate and the patient is benefitting from the treatment</ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">Patient has previously discontinued treatment with nivolumab for reasons other than severe toxicity or disease progression</ci>
                        <ci type="logical">Patient has signs of disease progression</ci>
                        <ci type="logical">Disease has not progressed during previous treatment with nivolumab</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Term Measure="month">4</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2015" style="display:none"/>
            <Formulation ID="F251214859425" Rank="4" Units="inj" Weight="40">
              <Name>Inj 10 mg per ml, 4 ml vial</Name>
              <Brand ID="B25121485942525">
                <Name>Opdivo</Name>
                <Pack ID="P2504138" Specified="true" nzmt:ctpp_id="50229151000117100">
                  <Quantity>1</Quantity>
                  <Price>1051.98</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251214859426" Rank="4" Units="inj" Weight="100">
              <Name>Inj 10 mg per ml, 10 ml vial</Name>
              <Brand ID="B25121485942625">
                <Name>Opdivo</Name>
                <Pack ID="P2504146" Specified="true" nzmt:ctpp_id="50229161000117103">
                  <Quantity>1</Quantity>
                  <Price>2629.96</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512148598">
            <Name>Pembrolizumab</Name>
            <Request Form="RS2056" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Pembrolizumab</range>
              </Title>
              <Case When="Initial application" Category="unresectable or metastatic melanoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has metastatic or unresectable melanoma (excluding uveal)
                    stage III or IV</ci>
                    <ci type="logical">Baseline measurement of overall tumour burden is documented
                    clinically and radiologically</ci>
                    <ci type="logical">The patient has ECOG performance score of 0-2</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has not received funded nivolumab</ci>
                      <apply>
                        <and/>
                        <ci type="logical" class="Trial">Patient has received an initial Special
                            Authority approval for nivolumab and has discontinued nivolumab within
                            12 weeks of starting treatment due to intolerance</ci>
                        <ci type="logical" class="Trial">The cancer did not progress while the
                            patient was on nivolumab</ci>
                      </apply>
                    </apply>
                    <ci type="logical">Documentation confirming that the patient has been informed and
                    acknowledges that funded treatment with pembrolizumab will not be continued if
                    their disease progresses</ci>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="unresectable or metastatic melanoma, less than 24 months on treatment">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <apply>
                        <or/>
                        <ci type="logical">Patient's disease has had a complete response to
                            treatment</ci>
                        <ci type="logical">Patient's disease has had a partial response to
                            treatment</ci>
                        <ci type="logical">Patient has stable disease</ci>
                      </apply>
                      <ci type="logical">Response to treatment in target lesions has been determined
                        by comparable radiologic assessment following the most recent treatment
                        period</ci>
                      <ci type="logical">The treatment remains clinically appropriate and the patient
                        is benefitting from the treatment</ci>
                    </apply>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has previously discontinued treatment with
                        pembrolizumab for reasons other than severe toxicity or disease
                        progression</ci>
                      <ci type="logical">Patient has signs of disease progression</ci>
                      <ci type="logical">Disease has not progressed during previous treatment with
                        pembrolizumab</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="unresectable or metastatic melanoma, more than 24 months on treatment">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has been on treatment for more than 24 months</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <apply>
                          <or/>
                          <ci type="logical">Patient's disease has had a complete response to
                                treatment</ci>
                          <ci type="logical">Patient's disease has had a partial response to
                                treatment</ci>
                          <ci type="logical">Patient has stable disease</ci>
                        </apply>
                        <ci type="logical">Response to treatment in target lesions has been
                            determined by comparable radiologic or clinical assessment following the
                            most recent treatment period</ci>
                        <ci type="logical">The treatment remains clinically appropriate and the
                            patient is benefitting from the treatment</ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">Patient has previously discontinued treatment with
                            pembrolizumab for reasons other than severe toxicity or disease
                            progression</ci>
                        <ci type="logical">Patient has signs of disease progression</ci>
                        <ci type="logical">Disease has not progressed during previous treatment with
                            pembrolizumab</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Initial application" Category="non-small cell lung cancer first-line monotherapy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has locally advanced or metastatic, unresectable,
                    non-small cell lung cancer</ci>
                    <ci type="logical">Patient has not had chemotherapy for their disease in the
                    palliative setting</ci>
                    <ci type="logical">Patient has not received prior funded treatment with an immune
                    checkpoint inhibitor for NSCLC</ci>
                    <ci type="logical">For patients with non-squamous histology there is documentation
                    confirming that the disease does not express activating mutations of EGFR or ALK
                    tyrosine kinase unless not possible to ascertain</ci>
                    <ci type="logical">Pembrolizumab to be used as monotherapy</ci>
                    <apply>
                      <or/>
                      <ci type="logical">There is documentation confirming the disease expresses PD-L1
                        at a level greater than or equal to 50% as determined by a validated test
                        unless not possible to ascertain</ci>
                      <apply>
                        <and/>
                        <ci type="logical" class="Trial">There is documentation confirming the
                            disease expresses PD-L1 at a level greater than or equal to 1% as
                            determined by a validated test unless not possible to ascertain</ci>
                        <ci type="logical" class="Trial">Chemotherapy is determined to be not in the
                            best interest of the patient based on clinician assessment</ci>
                      </apply>
                    </apply>
                    <ci type="logical">Patient has an ECOG 0-2</ci>
                    <ci type="logical">Pembrolizumab to be used at a maximum dose of 200 mg every three
                    weeks (or equivalent) for a maximum of 16 weeks</ci>
                    <ci type="logical">Baseline measurement of overall tumour burden is documented
                    clinically and radiologically</ci>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Applicant Referring="medical oncologist">any relevant practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="non-small cell lung cancer first-line monotherapy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Patient’s disease has had a complete response to
                        treatment</ci>
                      <ci type="logical">Patient’s disease has had a partial response to
                        treatment</ci>
                      <ci type="logical">Patient has stable disease</ci>
                    </apply>
                    <ci type="logical">Response to treatment in target lesions has been determined by
                    comparable radiologic assessment following the most recent treatment period</ci>
                    <ci type="logical">No evidence of disease progression</ci>
                    <ci type="logical">The treatment remains clinically appropriate and patient is
                    benefitting from treatment</ci>
                    <ci type="logical">Pembrolizumab to be used at a maximum dose of 200 mg every three
                    weeks (or equivalent)</ci>
                    <ci type="logical">Treatment with pembrolizumab to cease after a total duration of
                    24 months from commencement (or equivalent of 35 cycles dosed every 3
                    weeks)</ci>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Applicant Referring="medical oncologist">any relevant practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Initial application" Category="non-small cell lung cancer first-line combination therapy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has locally advanced or metastatic, unresectable,
                    non-small cell lung cancer</ci>
                    <ci type="logical">The patient has not had chemotherapy for their disease in the
                    palliative setting</ci>
                    <ci type="logical">Patient has not received prior funded treatment with an immune
                    checkpoint inhibitor for NSCLC</ci>
                    <ci type="logical">For patients with non-squamous histology there is documentation
                    confirming that the disease does not express activating mutations of EGFR or ALK
                    tyrosine kinase unless not possible to ascertain</ci>
                    <ci type="logical">Pembrolizumab to be used in combination with platinum-based
                    chemotherapy</ci>
                    <ci type="logical">Patient has an ECOG 0-2</ci>
                    <ci type="logical">Pembrolizumab to be used at a maximum dose of 200 mg every three
                    weeks (or equivalent) for a maximum of 16 weeks</ci>
                    <ci type="logical">Baseline measurement of overall tumour burden is documented
                    clinically and radiologically</ci>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Applicant Referring="medical oncologist">any relevant practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="non-small cell lung cancer first-line combination therapy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Patient’s disease has had a complete response to
                        treatment</ci>
                      <ci type="logical">Patient’s disease has had a partial response to
                        treatment</ci>
                      <ci type="logical">Patient has stable disease</ci>
                    </apply>
                    <ci type="logical">Response to treatment in target lesions has been determined by
                    comparable radiologic assessment following the most recent treatment period</ci>
                    <ci type="logical">No evidence of disease progression</ci>
                    <ci type="logical">The treatment remains clinically appropriate and patient is
                    benefitting from treatment</ci>
                    <ci type="logical">Pembrolizumab to be used at a maximum dose of 200 mg every three
                    weeks (or equivalent)</ci>
                    <ci type="logical">Treatment with pembrolizumab to cease after a total duration of
                    24 months from commencement (or equivalent of 35 cycles dosed every 3
                    weeks)</ci>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Applicant Referring="medical oncologist">any relevant practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Initial application" Category="breast cancer, advanced">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Patient is currently on treatment with pembrolizumab and met all
                    remaining criteria prior to commencing treatment</ci>
                    <apply>
                      <and/>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has recurrent or de novo unresectable, inoperable
                            locally advanced triple-negative breast cancer (that does not express
                            ER, PR or HER2 IHC3+ or ISH+ [including FISH or other technology])</ci>
                        <ci type="logical">Patient has recurrent or de novo metastatic
                            triple-negative breast cancer (that does not express ER, PR or HER2
                            IHC3+ or ISH+ [including FISH or other technology]</ci>
                      </apply>
                      <ci type="logical">Patient is treated with palliative intent</ci>
                      <ci type="logical">Patient’s cancer has confirmed PD-L1 Combined Positive Score
                        (CPS) is greater than or equal to 10</ci>
                      <ci type="logical">Patient has received no prior systemic therapy in the
                        palliative setting</ci>
                      <ci type="logical">Patient has an ECOG score of 0–2</ci>
                      <ci type="logical">Pembrolizumab is to be used in combination with
                        chemotherapy</ci>
                      <ci type="logical">Baseline measurement of overall tumour burden is documented
                        clinically and radiologically</ci>
                      <ci type="logical">Pembrolizumab is to be used at a maximum dose of 200 mg every
                        three weeks (or equivalent) for a maximum of 16 weeks</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>relevant specialist</Applicant>
                <Applicant Referring="relevant specialist">any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="breast cancer, advanced">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Patient’s disease has had a complete response to
                        treatment</ci>
                      <ci type="logical">Patient’s disease has had a partial response to
                        treatment</ci>
                      <ci type="logical">Patient has stable disease</ci>
                    </apply>
                    <ci type="logical">No evidence of disease progression</ci>
                    <ci type="logical">Response to treatment in target lesions has been determined by a
                    comparable radiologic assessment following the most recent treatment period</ci>
                    <ci type="logical">Pembrolizumab is to be used at a maximum dose of 200 mg every
                    three weeks (or equivalent)</ci>
                    <ci type="logical">Treatment with pembrolizumab is to cease after a total duration
                    of 24 months from commencement (or equivalent of 35 cycles dosed every 3
                    weeks)</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Initial application" Category="head and neck squamous cell carcinoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Patient is currently on treatment with pembrolizumab and met all
                    remaining criteria prior to commencing treatment</ci>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has recurrent or metastatic head and neck squamous
                        cell carcinoma of mucosal origin (excluding nasopharyngeal carcinoma) that
                        is incurable by local therapies</ci>
                      <ci type="logical">Patient has not received prior systemic therapy in the
                        recurrent or metastatic setting</ci>
                      <ci type="logical">Patient has a positive PD-L1 combined positive score (CPS) of
                        greater than or equal to 1</ci>
                      <ci type="logical">Patient has an ECOG performance score of 0-2</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Pembrolizumab to be used in combination with
                            platinum-based chemotherapy</ci>
                        <ci type="logical">Pembrolizumab to be used as monotherapy</ci>
                      </apply>
                      <ci type="logical">Pembrolizumab is to be used at a maximum dose of 200 mg every
                        three weeks (or equivalent) for a maximum of 16 weeks</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>relevant specialist</Applicant>
                <Applicant Referring="relevant specialist">any relevant practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="head and neck squamous cell carcinoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Patient’s disease has had a complete response to
                        treatment</ci>
                      <ci type="logical">Patient’s disease has had a partial response to
                        treatment</ci>
                      <ci type="logical">Patient has stable disease</ci>
                    </apply>
                    <ci type="logical">No evidence of disease progression</ci>
                    <ci type="logical">Pembrolizumab is to be used at a maximum dose of 200 mg every
                    three weeks (or equivalent)</ci>
                    <ci type="logical">Treatment with pembrolizumab is to cease after a total duration
                    of 24 months from commencement (or equivalent of 35 cycles dosed every 3
                    weeks)</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Initial application" Category="MSI-H/dMMR advanced colorectal cancer">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Patient is currently on treatment with pembrolizumab and met all
                    remaining criteria prior to commencing treatment</ci>
                    <apply>
                      <and/>
                      <apply>
                        <or/>
                        <ci type="logical">Patient has deficient mismatch repair (dMMR) or
                            microsatellite instability-high (MSI-H) metastatic colorectal
                            cancer</ci>
                        <ci type="logical">Patient has deficient mismatch repair (dMMR) or
                            microsatellite instability-high (MSI-H) unresectable colorectal
                            cancer</ci>
                      </apply>
                      <ci type="logical">Patient is treated with palliative intent</ci>
                      <ci type="logical">Patient has not previously received funded treatment with
                        pembrolizumab</ci>
                      <ci type="logical">Patient has an ECOG performance score of 0-2</ci>
                      <ci type="logical">Baseline measurement of overall tumour burden is documented
                        clinically and radiologically</ci>
                      <ci type="logical">Pembrolizumab to be used at a maximum dose of 200 mg every
                        three weeks (or equivalent) for a maximum of 16 weeks</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>relevant specialist</Applicant>
                <Applicant Referring="relevant specialist">any relevant practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="MSI-H/dMMR advanced colorectal cancer">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">No evidence of disease progression</ci>
                    <ci type="logical">Pembrolizumab to be used at a maximum dose of 200 mg every three
                    weeks (or equivalent)</ci>
                    <ci type="logical">Treatment with pembrolizumab is to cease after a total duration
                    of 24 months from commencement (or equivalent of 35 cycles dosed every 3
                    weeks)</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Initial application" Category="Urothelial carcinoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Patient is currently on treatment with pembrolizumab and met all
                    remaining criteria prior to commencing treatment</ci>
                    <apply>
                      <and/>
                      <ci type="logical">Patient has inoperable locally advanced (T4) or metastatic
                        urothelial carcinoma</ci>
                      <ci type="logical">Patient has an ECOG performance score of 0-2</ci>
                      <ci type="logical">Patient has documented disease progression following
                        treatment with chemotherapy</ci>
                      <ci type="logical">Pembrolizumab to be used as monotherapy at a maximum dose of
                        200 mg every three weeks (or equivalent) for a maximum of 16 weeks</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>relevant specialist</Applicant>
                <Applicant Referring="relevant specialist">any relevant practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="Urothelial carcinoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Patient’s disease has had a complete response to
                        treatment</ci>
                      <ci type="logical">Patient’s disease has had a partial response to
                        treatment</ci>
                      <ci type="logical">Patient has stable disease</ci>
                    </apply>
                    <ci type="logical">No evidence of disease progression</ci>
                    <ci type="logical">Pembrolizumab is to be used as monotherapy at a maximum dose of
                    200 mg every three weeks (or equivalent)</ci>
                    <ci type="logical">Treatment with pembrolizumab is to cease after a total duration
                    of 24 months from commencement (or equivalent of 35 cycles dosed every 3
                    weeks)</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Initial application" Category="relapsed/refractory Hodgkin lymphoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Patient is currently on treatment with pembrolizumab and met all remaining criteria prior to commencing treatment</ci>
                    <apply>
                      <and/>
                      <apply>
                        <or/>
                        <apply>
                          <and/>
                          <ci type="logical">Patient has relapsed/refractory Hodgkin lymphoma after two or more lines of 
                                chemotherapy</ci>
                          <ci type="logical">Patient is ineligible for autologous stem cell transplant</ci>
                        </apply>
                        <ci type="logical">Patient has relapsed/refractory Hodgkin lymphoma and has previously undergone an autologous stem cell transplant</ci>
                      </apply>
                      <ci type="logical">Patient has not previously received funded pembrolizumab</ci>
                      <ci type="logical">Pembrolizumab to be administered at doses no greater than 200 mg once every 3 weeks</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>relevant specialist</Applicant>
                <Applicant Referring="relevant specialist">any relevant practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="relapsed/refractory Hodgkin lymphoma">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has received a partial or complete response to pembrolizumab</ci>
                    <ci type="logical">Treatment with pembrolizumab is to cease after a total duration of 24 months from commencement (or equivalent of 35 cycles dosed every 3 weeks)</ci>
                  </apply>
                </math>
                <Applicant>any relevant practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2056" style="display:none"/>
            <Formulation ID="F251214859826" Rank="4" Units="inj">
              <Name>Inj 25 mg per ml, 4 ml vial</Name>
              <Brand ID="B25121485982625">
                <Name>Keytruda</Name>
                <Pack ID="P2547996" Specified="true" nzmt:ctpp_id="50231951000117101">
                  <Quantity>1</Quantity>
                  <Price>4680.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512148693">
            <Name>Durvalumab</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1926">
              <Title>
                <range>Durvalumab</range>
              </Title>
              <Case When="Initial application" Category="Non-small cell lung cancer">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has histologically or cytologically documented stage III, locally advanced, unresectable non-small cell lung cancer (NSCLC)</ci>
                    <ci type="logical" class="Indication">Patient has received two or more cycles of platinum-based chemotherapy concurrently with definitive radiation therapy</ci>
                    <ci type="logical" class="Indication">Patient has no disease progression following the second or subsequent cycle of platinum-based chemotherapy with definitive radiation therapy treatment</ci>
                    <ci type="logical" class="Indication">Patient has a ECOG performance status of 0 or 1</ci>
                    <ci type="logical" class="Indication">Patient has completed last radiation dose within 8 weeks of starting treatment with durvalumab</ci>
                    <ci type="logical" class="Indication">Patient must not have received prior PD-1 or PD-L1 inhibitor therapy for this condition</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Durvalumab is to be used at a maximum dose of no greater than 10 mg/kg every 2 weeks</ci>
                      <ci type="logical" class="Indication">Durvalumab is to be used at a flat dose of 1500 mg every 4 weeks</ci>
                    </apply>
                    <ci type="logical" class="Indication">Treatment with durvalumab to cease upon signs of disease progression</ci>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Term Measure="month">3</Term>
              </Case>
              <Case When="Renewal" Category="Non-small cell lung cancer">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">The treatment remains clinically appropriate and the patient is benefitting from treatment</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Durvalumab is to be used at a maximum dose of no greater than 10 mg/kg every 2 weeks</ci>
                      <ci type="logical" class="Indication">Durvalumab is to be used at a flat dose of 1500 mg every 4 weeks</ci>
                    </apply>
                    <ci type="logical" class="Indication">Treatment with durvalumab to cease upon signs of disease progression</ci>
                    <ci type="logical" class="Indication">Total continuous treatment duration must not exceed 12 months</ci>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Term Measure="month">3</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1926" style="display:none"/>
            <Formulation ID="F251214869325" Rank="4" Units="inj">
              <Name>Inj 50 mg per ml, 2.4 ml vial</Name>
              <Brand ID="B25121486932525">
                <Name>Imfinzi</Name>
                <Pack ID="P2578425" Specified="true" nzmt:ctpp_id="50259971000117107">
                  <Quantity>1</Quantity>
                  <Price>1128.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251214869326" Rank="4" Units="inj">
              <Name>Inj 50 mg per ml, 10 ml vial</Name>
              <Brand ID="B25121486932625">
                <Name>Imfinzi</Name>
                <Pack ID="P2578433" Specified="true" nzmt:ctpp_id="50259981000117105">
                  <Quantity>1</Quantity>
                  <Price>4700.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512148713">
            <Name>Atezolizumab</Name>
            <Request Form="RS1986" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Atezolizumab</range>
              </Title>
              <Case When="Initial application" Category="non-small cell lung cancer second line monotherapy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has locally advanced or metastatic non-small cell lung
                    cancer</ci>
                    <ci type="logical">Patient has not received prior funded treatment with an immune
                    checkpoint inhibitor for NSCLC</ci>
                    <ci type="logical">For patients with non-squamous histology there is documentation confirming that the disease does not
                    express activating mutations of EGFR or ALK tyrosine kinase unless not possible
                    to ascertain</ci>
                    <ci type="logical">Patient has an ECOG 0-2</ci>
                    <ci type="logical">Patient has documented disease progression following treatment
                    with at least two cycles of platinum-based chemotherapy</ci>
                    <ci type="logical">Atezolizumab is to be used as monotherapy at a dose of 1200 mg
                    every three weeks (or equivalent) for a maximum of 16 weeks</ci>
                    <ci type="logical">Baseline measurement of overall tumour burden is documented
                    clinically and radiologically</ci>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Applicant Referring="medical oncologist">any relevant practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
              <Case When="Renewal" Category="non-small cell lung cancer second line monotherapy">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Patient’s disease has had a complete response to
                        treatment</ci>
                      <ci type="logical">Patient’s disease has had a partial response to
                        treatment</ci>
                      <ci type="logical">Patient has stable disease</ci>
                    </apply>
                    <ci type="logical">Response to treatment in target lesions has been determined by
                    comparable radiologic assessment following the most recent treatment period</ci>
                    <ci type="logical">No evidence of disease progression</ci>
                    <ci type="logical">The treatment remains clinically appropriate and patient is
                    benefitting from treatment</ci>
                    <ci type="logical">Atezolizumab to be used at a maximum dose of 1200 mg every three
                    weeks (or equivalent)</ci>
                    <ci type="logical">Treatment with atezolizumab to cease after a total duration of 24
                    months from commencement (or equivalent of 35 cycles dosed every 3 weeks)</ci>
                  </apply>
                </math>
                <Applicant>medical oncologist</Applicant>
                <Applicant Referring="medical oncologist">any relevant practitioner</Applicant>
                <Term Measure="month">4</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1986" style="display:none"/>
            <Formulation ID="F251214871325" Rank="4" Units="inj" Weight="60">
              <Name>Inj 60 mg per ml, 20 ml vial</Name>
              <Brand ID="B25121487132525">
                <Name>Tecentriq</Name>
                <Pack ID="P2524953" Specified="true" nzmt:ctpp_id="50237251000117102">
                  <Quantity>1</Quantity>
                  <Price>9503.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A251216">
          <Name>Other Immunosuppressants</Name>
          <Chemical ID="C2512168033">
            <Name>Antithymocyte globulin (rabbit)</Name>
            <Formulation ID="F251216803301" Rank="4" Units="inj" Weight="25">
              <Name>Inj 25 mg vial</Name>
              <Brand ID="B25121680330100">
                <Name>Any</Name>
                <Pack ID="P80330100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512168364">
            <Name>Picibanil</Name>
            <Formulation ID="F251216836401" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mcg vial</Name>
              <Brand ID="B25121683640100">
                <Name>Any</Name>
                <Pack ID="P83640100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512168560">
            <Name>Everolimus</Name>
            <Request Form="RS1811" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Everolimus</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has tuberous sclerosis</ci>
                    <ci type="logical">Patient has progressively enlarging sub-ependymal giant cell astrocytomas (SEGAs) that require treatment</ci>
                  </apply>
                </math>
                <Applicant>neurologist</Applicant>
                <Applicant>oncologist</Applicant>
                <Term Measure="month">3</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Documented evidence of SEGA reduction or stabilisation by MRI within the last 3 months</ci>
                    <ci type="logical">The treatment remains appropriate and the patient is benefiting from treatment</ci>
                    <ci type="logical">Everolimus to be discontinued at progression of SEGAs</ci>
                  </apply>
                </math>
                <Applicant>neurologist</Applicant>
                <Applicant>oncologist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1811" style="display:none"/>
            <Formulation ID="F251216856025" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Brand ID="B25121685602525">
                <Name>Afinitor</Name>
                <Pack ID="P2334860" Specified="true" nzmt:ctpp_id="50120081000117100">
                  <Quantity>30</Quantity>
                  <Price>4555.76</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251216856026" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Brand ID="B25121685602625">
                <Name>Afinitor</Name>
                <Pack ID="P2334879" Specified="true" nzmt:ctpp_id="50120091000117102">
                  <Quantity>30</Quantity>
                  <Price>6512.29</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512169037">
            <Name>Mycophenolate mofetil</Name>
            <Formulation ID="F251216903701" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg vial</Name>
              <Brand ID="B25121690370101">
                <Name>CellCept</Name>
                <Pack ID="P307742" Specified="true" nzmt:ctpp_id="50069001000117102">
                  <Quantity>4</Quantity>
                  <Price>133.33</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251216903702" Rank="2" Units="cap" Weight="250">
              <Name>Cap 250 mg</Name>
              <Brand ID="B25121690370201">
                <Name>CellCept</Name>
                <Pack ID="P350516" Specified="true" nzmt:ctpp_id="50076851000117105">
                  <Quantity>100</Quantity>
                  <Price>35.90</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251216903703" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Brand ID="B25121690370301">
                <Name>CellCept</Name>
                <Pack ID="P2093774" Specified="true" nzmt:ctpp_id="50017601000117101">
                  <Quantity>50</Quantity>
                  <Price>35.90</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251216903725" Rank="3" Units="ml" Weight="5">
              <Name>Powder for oral liq 1 g per 5 ml</Name>
              <Brand ID="B25121690372525">
                <Name>CellCept</Name>
                <Pack ID="P2124912" Specified="true" nzmt:ctpp_id="50022571000117100">
                  <Quantity>165</Quantity>
                  <Price>187.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512169292">
            <Name>Antithymocyte globulin (equine)</Name>
            <Formulation ID="F251216929225" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 5 ml ampoule</Name>
              <Brand ID="B25121692922525">
                <Name>ATGAM</Name>
                <Pack ID="P765651" Specified="true" nzmt:ctpp_id="50110581000117101">
                  <Quantity>5</Quantity>
                  <Price>2774.48</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512169398">
            <Name>Sirolimus</Name>
            <Request Form="RS1991" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Sirolimus</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For rescue therapy for an organ transplant recipient</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Rescue therapy defined as unresponsive to calcineurin inhibitor treatment as defined by
        refractory rejection; or intolerant to calcineurin inhibitor treatment due to any of the
        following:</p>
                  <ul>
                    <li>
                      <p>GFR &lt; 30 ml/min; or</p>
                    </li>
                    <li>
                      <p>Rapidly progressive transplant vasculopathy; or</p>
                    </li>
                    <li>
                      <p>Rapidly progressive obstructive bronchiolitis; or</p>
                    </li>
                    <li>
                      <p>HUS or TTP; or</p>
                    </li>
                    <li>
                      <p>Leukoencepthalopathy; or</p>
                    </li>
                    <li>
                      <p>Significant malignant disease</p>
                    </li>
                  </ul>
                </div>
              </Case>
              <Case When="Initial application" Category="severe non-malignant lymphovascular malformations*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has severe non-malignant lymphovascular
          malformation*</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Malformations are not adequately controlled by
            sclerotherapy and surgery</ci>
                      <ci type="logical" class="Indication">Malformations are widespread/extensive and
            sclerotherapy and surgery are not considered clinically appropriate</ci>
                      <ci type="logical" class="Indication">Sirolimus is to be used to reduce malformation prior
            to consideration of surgery</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patient is being treated by a specialist
          lymphovascular malformation multi-disciplinary team</ci>
                    <ci type="logical" class="Indication">Patient has measurable disease as defined by RECIST
          version 1.1 (see Note)</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="severe non-malignant lymphovascular malformations*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient’s disease has had either a complete response
            or a partial response to treatment, or patient has stable disease according to RECIST
            version 1.1 (see Note)</ci>
                      <ci type="logical" class="Indication">Patient’s disease has stabilised or responded
            clinically and disease response to treatment has been clearly documents in patient
            notes</ci>
                    </apply>
                    <ci type="logical" class="Indication">No evidence of progressive disease</ci>
                    <ci type="logical" class="Indication">The treatment remains clinically appropriate and the
          patient is benefitting from the treatment</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Baseline assessment and disease responses to be assessed according to the Response
        Evaluation Criteria in Solid Tumours (RECIST) version 1.1 (Eisenhauer et al. Eur J Cancer
        2009;45:228-47)</p>
                  <p>Indications marked with * are unapproved indications</p>
                </div>
              </Case>
              <Case When="Initial application" Category="renal angiomyolipoma(s) associated with tuberous sclerosis complex*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has tuberous sclerosis complex*</ci>
                    <ci type="logical" class="Indication">Evidence of renal angiomyolipoma(s) measuring 3 cm or
          greater and that have shown interval growth</ci>
                  </apply>
                </math>
                <Applicant>nephrologist</Applicant>
                <Applicant>urologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="renal angiomyolipoma(s) associated with tuberous sclerosis complex*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Documented evidence of renal angiomyolipoma reduction
          or stability by magnetic resonance imaging (MRI) or ultrasound</ci>
                    <ci type="logical" class="Indication">Demonstrated stabilisation or improvement in renal
          function</ci>
                    <ci type="logical" class="Indication">The patient has not experienced angiomyolipoma
          haemorrhage or significant adverse effects to sirolimus treatment</ci>
                    <ci type="logical" class="Indication">The treatment remains appropriate and the patient is
          benefitting from treatment</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications</p>
                </div>
              </Case>
              <Case When="Initial application" Category="refractory seizures associated with tuberous sclerosis complex*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has epilepsy with a background of documented
          tuberous sclerosis complex*</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical" class="Indication">Vigabatrin has been trialled and has not
              adequately controlled seizures</ci>
                        <ci type="logical" class="Indication">Seizures are not adequately controlled by, or the
              patient has experienced unacceptable side effects from, optimal treatment with at
              least two of the following: sodium valproate, topiramate, levetiracetam,
              carbamazepine, lamotrigine, phenytoin sodium, and lacosamide (see Note)</ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical" class="Indication">Vigabatrin is contraindicated</ci>
                        <ci type="logical" class="Indication">Seizures are not adequately controlled by, or the
              patient has experienced unacceptable side effects from, optimal treatment with at
              least three of the following: sodium valproate, topiramate, levetiracetam,
              carbamazepine, lamotrigine, phenytoin sodium, and lacosamide (see Note)</ci>
                      </apply>
                    </apply>
                    <ci type="logical" class="Indication">Seizures have a significant impact on quality of
          life</ci>
                    <ci type="logical" class="Indication">Patient has been assessed and surgery is considered
          inappropriate for this patient, or the patient has been assessed and would benefit from
          mTOR inhibitor treatment prior to surgery</ci>
                  </apply>
                </math>
                <Applicant>neurologist</Applicant>
                <Term Measure="month">6</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Those of childbearing potential are not required to trial phenytoin sodium, sodium
        valproate, and topiramate. Those who can father children are not required to trial sodium valproate.</p>
                </div>
              </Case>
              <Case When="Renewal" Category="refractory seizures associated with tuberous sclerosis complex*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical" class="Indication">demonstrated significant and sustained improvement in
        seizure rate (e.g. 50% reduction in seizure frequency) or severity and/or patient quality of
        life compared with baseline prior to starting sirolimus treatment</ci>
                </math>
                <Applicant>neurologist</Applicant>
                <Term Measure="month">12</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1991" style="display:none"/>
            <Formulation ID="F251216939825" Rank="1" Units="tab" Weight="1">
              <Name>Tab 1 mg</Name>
              <Brand ID="B25121693982525">
                <Name>Rapamune</Name>
                <Pack ID="P2109638" Specified="true" nzmt:ctpp_id="50019561000117105">
                  <Quantity>100</Quantity>
                  <Price>749.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251216939826" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Brand ID="B25121693982625">
                <Name>Rapamune</Name>
                <Pack ID="P2258218" Specified="true" nzmt:ctpp_id="50040831000117103">
                  <Quantity>100</Quantity>
                  <Price>1499.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251216939827" Rank="3" Units="ml" Weight="1">
              <Name>Oral liq 1 mg per ml</Name>
              <Brand ID="B25121693982725">
                <Name>Rapamune</Name>
                <Pack ID="P2059339" Specified="true" nzmt:ctpp_id="50010601000117102">
                  <Quantity>60</Quantity>
                  <Price>449.99</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512169544">
            <Name>Azathioprine</Name>
            <Formulation ID="F251216954425" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg vial</Name>
              <Brand ID="B25121695442500">
                <Name>Any</Name>
                <Pack ID="P95442500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251216954426" Rank="1" Units="tab" Weight="50">
              <Name>Tab 50 mg</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2025" Value="5"/>
              <Brand ID="B25121695442627" PSS="true">
                <Name>Azamun</Name>
                <Pack ID="P390003" Specified="true" nzmt:ctpp_id="50080791000117104">
                  <Quantity>100</Quantity>
                  <Price>8.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251216954427" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Apr-23 to~2025" Value="5"/>
              <Brand ID="B25121695442725" PSS="true">
                <Name>Azamun</Name>
                <Pack ID="P2465345" Specified="true" nzmt:ctpp_id="50208701000117100">
                  <Quantity>60</Quantity>
                  <Price>7.36</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251216954428" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg vial</Name>
              <Brand ID="B25121695442800">
                <Name>Any</Name>
                <Pack ID="P95442800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512169561">
            <Name>Bacillus calmette-guerin (BCG)</Name>
            <Request Form="RS1206" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Bacillus calmette-guerin (BCG)</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For use in bladder cancer</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1206" style="display:none"/>
            <Formulation ID="F251216956125" Rank="4" Units="inj">
              <Name>Inj 2-8 x 10^8 CFU vial</Name>
              <Brand ID="B25121695612525">
                <Name>OncoTICE</Name>
                <Pack ID="P799629" Specified="true" nzmt:ctpp_id="50117311000117103">
                  <Quantity>1</Quantity>
                  <Price>149.37</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A251218">
          <Name>JAK inhibitors</Name>
          <Chemical ID="C2512188678">
            <Name>Upadacitinib</Name>
            <Request Form="RS1861" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Upadacitinib</range>
              </Title>
              <Case When="Initial application" Category="Rheumatoid Arthritis (patients previously treated with adalimumab or etanercept)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Use">The patient has had an initial Special Authority
                        approval for adalimumab and/or etanercept for rheumatoid arthritis</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">The patient has experienced
                            intolerable side effects from adalimumab and/or etanercept</ci>
                      <ci type="logical" class="Use">The patient has received insufficient benefit
                            from at least a three-month trial of adalimumab and/or etanercept such
                            that they do not meet the renewal criteria for rheumatoid arthritis</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">The patient is seronegative for both
                            anti-cyclic citrullinated peptide (CCP) antibodies and rheumatoid
                            factor</ci>
                      <apply>
                        <and/>
                        <ci type="logical" class="Indication">The patient has been started on
                                rituximab for rheumatoid arthritis in a Health NZ Hospital</ci>
                        <apply>
                          <or/>
                          <ci type="logical" class="Indication">The patient has experienced
                                    intolerable side effects from rituximab</ci>
                          <ci type="logical" class="Use">At four months following the initial
                                    course of rituximab the patient has received insufficient
                                    benefit such that they do not meet the renewal criteria for
                                    rheumatoid arthritis</ci>
                        </apply>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
              <Case When="Renewal" Category="Rheumatoid Arthritis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">Following 6 months' initial treatment, the
                    patient has at least a 50% decrease in active joint count from baseline and a
                    clinically significant response to treatment in the opinion of the
                    physician</ci>
                    <ci type="logical" class="Indication">On subsequent reapplications, the patient
                    demonstrates at least a continuing 30% improvement in active joint count from
                    baseline and a clinically significant response to treatment in the opinion of
                    the physician</ci>
                  </apply>
                </math>
                <Applicant>rheumatologist</Applicant>
                <Term Measure="month">6</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1861" style="display:none"/>
            <Formulation ID="F251218867825" Rank="1" Units="tab" Weight="15">
              <Name>Tab 15 mg</Name>
              <Brand ID="B25121886782525">
                <Name>RINVOQ</Name>
                <Pack ID="P2619415" Specified="true" nzmt:ctpp_id="50260941000117102">
                  <Quantity>28</Quantity>
                  <Price>1271.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2512188683">
            <Name>Baricitinib</Name>
            <Request Form="RS1876" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Baricitinib</range>
              </Title>
              <Case When="Initial application" Category="moderate to severe COVID-19*">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has confirmed (or probable)
                    COVID-19*</ci>
                    <ci type="logical" class="Indication">Oxygen saturation of &lt;92% on room air, or
                    requiring supplemental oxygen</ci>
                    <ci type="logical" class="Indication">Patient is receiving adjunct systemic
                    corticosteroids, or systemic corticosteroids are contraindicated</ci>
                    <ci type="logical" class="Indication">Baricitinib is to be administered at doses no
                    greater than 4 mg daily for up to 14 days</ci>
                    <ci type="logical" class="Indication">Baricitinib is not to be administered in
                    combination with tocilizumab</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="day">14</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>Indications marked with * are unapproved indications.</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1876" style="display:none"/>
            <Formulation ID="F251218868325" Rank="1" Units="tab" Weight="4">
              <Name>Tab 4 mg</Name>
              <Brand ID="B25121886832525">
                <Name>Olumiant</Name>
                <Pack ID="P2631237" Specified="true" nzmt:ctpp_id="50293151000117105">
                  <Quantity>28</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F251218868326" Rank="1" Units="tab" Weight="2">
              <Name>Tab 2 mg</Name>
              <Brand ID="B25121886832625">
                <Name>Olumiant</Name>
                <Pack ID="P2631229" Specified="true" nzmt:ctpp_id="50293141000117108">
                  <Quantity>28</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
    <ATC1 ID="A28">
      <Name>Respiratory System and Allergies</Name>
      <ATC2 ID="A2804">
        <Name>Antiallergy Preparations</Name>
        <ATC3 ID="A280401">
          <Name>Allergic Emergencies</Name>
          <Chemical ID="C2804018577">
            <Name>Icatibant</Name>
            <Request Form="RS1501" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Icatibant</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Supply for anticipated emergency treatment of laryngeal/oro-pharyngeal or severe abdominal attacks of acute hereditary angioedema (HAE) for patients with confirmed diagnosis of C1-esterase inhibitor deficiency</ci>
                    <ci type="logical">The patient has undergone product training and has agreed upon an action plan for self-administration</ci>
                  </apply>
                </math>
                <Applicant>clinical immunologist</Applicant>
                <Applicant>relevant specialist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The treatment remains appropriate and the patient is benefiting from treatment</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">12</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1501" style="display:none"/>
            <Formulation ID="F280401857725" Rank="4" Units="inj" Weight="30">
              <Name>Inj 10 mg per ml, 3 ml prefilled syringe</Name>
              <Brand ID="B28040185772525">
                <Name>Firazyr</Name>
                <Pack ID="P2617560" Specified="true" nzmt:ctpp_id="50221871000117103">
                  <Quantity>1</Quantity>
                  <Price>2668.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2804019264">
            <Name>Adrenaline</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1944">
              <Title>
                <range>Adrenaline</range>
              </Title>
              <Case When="Initial application" Category="anaphylaxis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">Patient has experienced a previous anaphylactic reaction which has resulted in presentation to a hospital or emergency department</ci>
                    <ci type="logical" class="Indication">Patient has been assessed to be at significant
                    risk of anaphylaxis by a relevant practitioner</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1944" style="display:none"/>
            <Formulation ID="F280401926430" Rank="4" Units="inj" Weight="0.15">
              <Name>Inj 0.15 mg per 0.3 ml auto-injector</Name>
              <Rule Type="DVLimit" Attribute="Jul-23 to~2025" Value="5"/>
              <Brand ID="B28040192643025" PSS="true">
                <Name>Epipen Jr</Name>
                <Pack ID="P208191" Specified="true" nzmt:ctpp_id="50013511000117109">
                  <Quantity>1</Quantity>
                  <Price>90.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280401926431" Rank="4" Units="inj" Weight="0.3">
              <Name>Inj 0.3 mg per 0.3 ml auto-injector</Name>
              <Rule Type="DVLimit" Attribute="Jul-23 to~2025" Value="5"/>
              <Brand ID="B28040192643125" PSS="true">
                <Name>Epipen</Name>
                <Pack ID="P223972" Specified="true" nzmt:ctpp_id="50038111000117102">
                  <Quantity>1</Quantity>
                  <Price>90.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A280404">
          <Name>Allergy Desensitisation</Name>
          <Chemical ID="C2804048045">
            <Name>Bee venom</Name>
            <Request Form="RS1117" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Bee venom</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">RAST or skin test positive</ci>
                    <ci type="logical">Patient has had severe generalised reaction to the sensitising agent</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1117" style="display:none"/>
            <Formulation ID="F280404804502" Rank="4" Units="inj" Weight="550">
              <Name>Inj 550 mcg vial with diluent</Name>
              <Brand ID="B28040480450200">
                <Name>Any</Name>
                <Pack ID="P80450200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280404804525" Rank="4" Units="inj">
              <Name>Maintenance kit - 6 vials 120 mcg freeze dried venom, with diluent</Name>
              <Brand ID="B28040480452500">
                <Name>Any</Name>
                <Pack ID="P80452500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280404804526" Rank="10" Units="pack">
              <Name>Initiation Kit - 5 vials freeze dried venom with diluent</Name>
              <Brand ID="B28040480452625">
                <Name>VENOX</Name>
                <Pack ID="P2596822" Specified="true" nzmt:ctpp_id="50282931000117106">
                  <Quantity>1</Quantity>
                  <Price>305.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280404804527" Rank="10" Units="pack">
              <Name>Maintenance Kit - 1 vial freeze dried venom with diluent</Name>
              <Brand ID="B28040480452725">
                <Name>VENOX</Name>
                <Pack ID="P2596814" Specified="true" nzmt:ctpp_id="50282941000117103">
                  <Quantity>1</Quantity>
                  <Price>305.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2804048341">
            <Name>Paper wasp venom</Name>
            <Request Form="RS1118" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Paper wasp venom</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">RAST or skin test positive</ci>
                    <ci type="logical">Patient has had severe generalised reaction to the sensitising agent</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1118" style="display:none"/>
            <Formulation ID="F280404834101" Rank="4" Units="inj" Weight="550">
              <Name>Inj 550 mcg vial with diluent</Name>
              <Brand ID="B28040483410100">
                <Name>Any</Name>
                <Pack ID="P83410100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280404834125" Rank="4" Units="inj">
              <Name>Treatment kit - 6 vials 120 mcg freeze dried venom, with diluent</Name>
              <Brand ID="B28040483412500">
                <Name>Any</Name>
                <Pack ID="P83412500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2804048500">
            <Name>Yellow jacket wasp venom</Name>
            <Request Form="RS1119" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Yellow jacket wasp venom</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">RAST or skin test positive</ci>
                    <ci type="logical">Patient has had severe generalised reaction to the sensitising agent</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1119" style="display:none"/>
            <Formulation ID="F280404850001" Rank="4" Units="inj" Weight="550">
              <Name>Inj 550 mcg vial with diluent</Name>
              <Brand ID="B28040485000100">
                <Name>Any</Name>
                <Pack ID="P85000100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280404850025" Rank="4" Units="inj">
              <Name>Treatment kit - 6 vials 120 mcg freeze dried venom, with diluent</Name>
              <Brand ID="B28040485002500">
                <Name>Any</Name>
                <Pack ID="P85002500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A280408">
          <Name>Allergy Prophylactics</Name>
          <Chemical ID="C2804088427">
            <Name>Sodium cromoglicate</Name>
            <Formulation ID="F280408842703" Rank="6" Units="dose">
              <Name>Nasal spray 4%</Name>
              <Brand ID="B28040884270300">
                <Name>Any</Name>
                <Pack ID="P84270300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2804089137">
            <Name>Budesonide</Name>
            <Formulation ID="F280408913725" Rank="6" Units="dose" Weight="50">
              <Name>Nasal spray 50 mcg per dose</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B28040891372526" PSS="true">
                <Name>SteroClear</Name>
                <Pack ID="P2541149" Specified="true" nzmt:ctpp_id="50250101000117109">
                  <Quantity>200</Quantity>
                  <Price>2.59</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280408913726" Rank="6" Units="dose" Weight="100">
              <Name>Nasal spray 100 mcg per dose</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B28040891372626" PSS="true">
                <Name>SteroClear</Name>
                <Pack ID="P2541068" Specified="true" nzmt:ctpp_id="50250111000117107">
                  <Quantity>200</Quantity>
                  <Price>2.89</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2804089201">
            <Name>Ipratropium bromide</Name>
            <Formulation ID="F280408920102" Rank="3" Units="ml">
              <Name>Aqueous nasal spray 0.03%</Name>
              <Brand ID="B28040892010225">
                <Name>Univent</Name>
                <Pack ID="P2372908" Specified="true" nzmt:ctpp_id="50122511000117104">
                  <Quantity>15</Quantity>
                  <Price>5.23</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2804089679">
            <Name>Fluticasone propionate</Name>
            <Formulation ID="F280408967925" Rank="6" Units="dose">
              <Name>Nasal spray 50 mcg per dose</Name>
              <Brand ID="B28040896792525">
                <Name>Flixonase Hayfever &amp; Allergy</Name>
                <Pack ID="P2407000" Specified="true" nzmt:ctpp_id="50157831000117105">
                  <Quantity>120</Quantity>
                  <Price>1.98</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A280412">
          <Name>Antihistamines</Name>
          <Chemical ID="C2804128092">
            <Name>Chlorpheniramine maleate</Name>
            <Formulation ID="F280412809201" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B28041280920100">
                <Name>Any</Name>
                <Pack ID="P80920100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280412809202" Rank="3" Units="ml">
              <Name>Oral liq 0.4 mg per ml</Name>
              <Brand ID="B28041280920200">
                <Name>Any</Name>
                <Pack ID="P80920200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2804128120">
            <Name>Cyproheptadine hydrochloride</Name>
            <Formulation ID="F280412812001" Rank="1" Units="tab" Weight="4">
              <Name>Tab 4 mg</Name>
              <Brand ID="B28041281200100">
                <Name>Any</Name>
                <Pack ID="P81200100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2804128187">
            <Name>Fexofenadine hydrochloride</Name>
            <Formulation ID="F280412818701" Rank="1" Units="tab" Weight="120">
              <Name>Tab 120 mg</Name>
              <Brand ID="B28041281870100">
                <Name>Any</Name>
                <Pack ID="P81870100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280412818702" Rank="1" Units="tab" Weight="180">
              <Name>Tab 180 mg</Name>
              <Brand ID="B28041281870200">
                <Name>Any</Name>
                <Pack ID="P81870200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280412818703" Rank="1" Units="tab" Weight="60">
              <Name>Tab 60 mg</Name>
              <Brand ID="B28041281870300">
                <Name>Any</Name>
                <Pack ID="P81870300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2804129278">
            <Name>Promethazine hydrochloride</Name>
            <Formulation ID="F280412927825" Rank="4" Units="inj" Weight="50">
              <Name>Inj 25 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B28041292782525">
                <Name>Hospira</Name>
                <Pack ID="P722952" Specified="true" nzmt:ctpp_id="50105791000117100">
                  <Quantity>5</Quantity>
                  <Price>21.09</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280412927826" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Sep-22 to~2025" Value="5"/>
              <Brand ID="B28041292782625" PSS="true">
                <Name>Allersoothe</Name>
                <Pack ID="P2238098" Specified="true" nzmt:ctpp_id="50037941000117100">
                  <Quantity>50</Quantity>
                  <Price>1.39</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280412927827" Rank="1" Units="tab" Weight="25">
              <Name>Tab 25 mg</Name>
              <Rule Type="DVLimit" Attribute="Sep-22 to~2025" Value="5"/>
              <Brand ID="B28041292782725" PSS="true">
                <Name>Allersoothe</Name>
                <Pack ID="P2238128" Specified="true" nzmt:ctpp_id="50037961000117101">
                  <Quantity>50</Quantity>
                  <Price>1.58</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280412927828" Rank="3" Units="ml">
              <Name>Oral liq 1 mg per ml</Name>
              <Brand ID="B28041292782826">
                <Name>Allersoothe</Name>
                <Pack ID="P2404281" Specified="true" nzmt:ctpp_id="50147151000117107">
                  <Quantity>100</Quantity>
                  <Price>3.39</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2804129290">
            <Name>Cetirizine hydrochloride</Name>
            <Formulation ID="F280412929025" Rank="3" Units="ml" Weight="1">
              <Name>Oral liq 1 mg per ml</Name>
              <Brand ID="B28041292902527">
                <Name>Histaclear</Name>
                <Pack ID="P2461625" Specified="true" nzmt:ctpp_id="50202791000117107">
                  <Quantity>200</Quantity>
                  <Price>2.84</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280412929026" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Sep-23 to~2026" Value="5"/>
              <Brand ID="B28041292902626" PSS="true">
                <Name>Zista</Name>
                <Pack ID="P2500728" Specified="true" nzmt:ctpp_id="50205841000117104">
                  <Quantity>100</Quantity>
                  <Price>1.71</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2804129390">
            <Name>Loratadine</Name>
            <Formulation ID="F280412939025" Rank="3" Units="ml">
              <Name>Oral liq 1 mg per ml</Name>
              <Brand ID="B28041293902527">
                <Name>Haylor Syrup</Name>
                <Pack ID="P2605678" Specified="true" nzmt:ctpp_id="50282461000117107">
                  <Quantity>100</Quantity>
                  <Price>1.43</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280412939026" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Feb-23 to~2025" Value="5"/>
              <Brand ID="B28041293902626" PSS="true">
                <Name>Lorafix</Name>
                <Pack ID="P2443996" Specified="true" nzmt:ctpp_id="50147201000117100">
                  <Quantity>100</Quantity>
                  <Price>1.78</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2808">
        <Name>Anticholinergic Agents</Name>
        <ATC3 ID="A280804">
          <Name>Anticholinergic Agents</Name>
          <Chemical ID="C2808049201">
            <Name>Ipratropium bromide</Name>
            <Formulation ID="F280804920101" Rank="6" Units="dose">
              <Name>Aerosol inhaler 20 mcg per dose</Name>
              <Brand ID="B28080492010100">
                <Name>Any</Name>
                <Pack ID="P92010100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280804920125" Rank="8" Units="neb" Weight="250">
              <Name>Nebuliser soln 250 mcg per ml, 1 ml ampoule</Name>
              <Brand ID="B28080492012500">
                <Name>Any</Name>
                <Pack ID="P92012500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280804920126" Rank="8" Units="neb" Weight="500">
              <Name>Nebuliser soln 250 mcg per ml, 2 ml ampoule</Name>
              <Brand ID="B28080492012626">
                <Name>Univent</Name>
                <Pack ID="P2154307" Specified="true" nzmt:ctpp_id="50026441000117109">
                  <Quantity>20</Quantity>
                  <Price>11.73</Price>
                </Pack>
              </Brand>
              <Brand ID="B28080492012627">
                <Name>Ipratropium IVAX</Name>
                <Pack ID="P2680815" Specified="true" nzmt:ctpp_id="50335231000117106">
                  <Quantity>20</Quantity>
                  <Price>11.73</Price>
                </Pack>
              </Brand>
              <Brand ID="B28080492012628">
                <Name>Pharmascience</Name>
                <Pack ID="P2687070" Specified="true" nzmt:ctpp_id="50338111000117101">
                  <Quantity>10</Quantity>
                  <Price>5.86</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A280808">
          <Name>Anticholinergic Agents with Beta-Adrenoceptor Agonists</Name>
          <Chemical ID="C2808089438">
            <Name>Salbutamol with ipratropium bromide</Name>
            <Formulation ID="F280808943801" Rank="6" Units="dose">
              <Name>Aerosol inhaler 100 mcg with ipratropium bromide 20 mcg per dose</Name>
              <Brand ID="B28080894380100">
                <Name>Any</Name>
                <Pack ID="P94380100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280808943826" Rank="8" Units="neb">
              <Name>Nebuliser soln 2.5 mg with ipratropium bromide 0.5 mg per 2.5 ml ampoule</Name>
              <Brand ID="B28080894382625">
                <Name>Duolin</Name>
                <Pack ID="P2039281" Specified="true" nzmt:ctpp_id="50007571000117109">
                  <Quantity>20</Quantity>
                  <Price>11.04</Price>
                </Pack>
              </Brand>
              <Brand ID="B28080894382626">
                <Name>Duolin Cipla</Name>
                <Pack ID="P2680807" Specified="true" nzmt:ctpp_id="50335241000117103">
                  <Quantity>20</Quantity>
                  <Price>11.04</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A280812">
          <Name>Long-Acting Muscarinic Agents</Name>
          <Chemical ID="C2808128561">
            <Name>Glycopyrronium</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: inhaled glycopyrronium treatment must not be used if the patient is also receiving treatment with subsidised tiotropium or umeclidinium.</p>
            </div>
            <Formulation ID="F280812856125" Rank="6" Units="dose">
              <Name>Powder for inhalation 50 mcg per dose</Name>
              <Brand ID="B28081285612525">
                <Name>Seebri Breezhaler</Name>
                <Pack ID="P2465949" Specified="true" nzmt:ctpp_id="50209791000117100">
                  <Quantity>30</Quantity>
                  <Price>61.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2808128581">
            <Name>Umeclidinium</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: Umeclidinium must not be used if the patient is also receiving treatment with subsidised inhaled glycopyrronium or tiotropium bromide.</p>
            </div>
            <Formulation ID="F280812858125" Rank="6" Units="dose" Weight="62">
              <Name>Powder for inhalation 62.5 mcg per dose</Name>
              <Brand ID="B28081285812525">
                <Name>Incruse Ellipta</Name>
                <Pack ID="P2494280" Specified="true" nzmt:ctpp_id="50208191000117109">
                  <Quantity>30</Quantity>
                  <Price>61.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2808129164">
            <Name>Tiotropium bromide</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Note: tiotropium treatment must not be used if the patient is also receiving treatment with subsidised inhaled glycopyrronium  or umeclidinium.</p>
            </div>
            <Formulation ID="F280812916425" Rank="6" Units="dose" Weight="18">
              <Name>Powder for inhalation 18 mcg per dose</Name>
              <Brand ID="B28081291642525">
                <Name>Spiriva</Name>
                <Pack ID="P2115468" Specified="true" nzmt:ctpp_id="50020441000117106">
                  <Quantity>30</Quantity>
                  <Price>50.37</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F280812916426" Rank="6" Units="dose" Weight="2">
              <Name>Soln for inhalation 2.5 mcg per dose</Name>
              <Brand ID="B28081291642625">
                <Name>Spiriva Respimat</Name>
                <Pack ID="P2494019" Specified="true" nzmt:ctpp_id="50227671000117105">
                  <Quantity>60</Quantity>
                  <Price>50.37</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A280816">
          <Name>Long-Acting Muscarinic Antagonists with Long-Acting Beta-Adrenoceptor Agonists</Name>
          <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
            <p>Note: Combination long acting muscarinic antagonist and long acting beta-2 agonist must not be used if the patient is also receiving treatment with a combination inhaled corticosteroid and long acting beta-2 agonist.</p>
          </div>
          <Request Form="RS1518" To="HealthPAC" For="Subsidy">
            <Title>
              <range>Long-acting muscarinic antagonists with long-acting beta-adrenoceptor agonists</range>
            </Title>
            <Case When="Initial application">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <and/>
                  <ci type="logical">Patient has been stabilised on a long acting muscarinic antagonist</ci>
                  <ci type="logical">The prescriber considers that the patient would receive additional benefit from switching to a combination product</ci>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="year">2</Term>
            </Case>
            <Case When="Renewal">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <and/>
                  <ci type="logical">Patient is compliant with the medication</ci>
                  <ci type="logical">Patient has experienced improved COPD symptom control (prescriber determined)</ci>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="year">2</Term>
            </Case>
          </Request>
          <html:div class="Restricted" xlink:href="RS1518" style="display:none"/>
          <Chemical ID="C2808168582">
            <Name>Glycopyrronium with indacaterol</Name>
            <Formulation ID="F280816858225" Rank="6" Units="dose" Weight="160">
              <Name>Powder for Inhalation 50 mcg with indacaterol 110 mcg</Name>
              <Brand ID="B28081685822525">
                <Name>Ultibro Breezhaler</Name>
                <Pack ID="P2495562" Specified="true" nzmt:ctpp_id="50215691000117105">
                  <Quantity>30</Quantity>
                  <Price>81.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2808168583">
            <Name>Tiotropium bromide with olodaterol</Name>
            <Formulation ID="F280816858325" Rank="6" Units="dose">
              <Name>Soln for inhalation 2.5 mcg with olodaterol 2.5 mcg</Name>
              <Brand ID="B28081685832525">
                <Name>Spiolto Respimat</Name>
                <Pack ID="P2494027" Specified="true" nzmt:ctpp_id="50207051000117103">
                  <Quantity>60</Quantity>
                  <Price>81.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2808168584">
            <Name>Umeclidinium with vilanterol</Name>
            <Formulation ID="F280816858425" Rank="6" Units="dose" Weight="87">
              <Name>Powder for inhalation 62.5 mcg with vilanterol 25 mcg</Name>
              <Brand ID="B28081685842525">
                <Name>Anoro Ellipta</Name>
                <Pack ID="P2494272" Specified="true" nzmt:ctpp_id="50169371000117102">
                  <Quantity>30</Quantity>
                  <Price>77.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A280818">
          <Name>Inhaled Corticosteroid with Long-Acting Muscarinic Antagonist and Beta Agonist</Name>
          <Chemical ID="C2808188738">
            <Name>Fluticasone furoate with umeclidinium and vilanterol</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS2028">
              <Title>
                <range>Fluticasone furoate with umeclidinium and vilanterol</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has a diagnosis of COPD confirmed by spirometry or spirometry has been attempted and technically acceptable results are not possible</ci>
                    <apply>
                      <or/>
                      <apply>
                        <and/>
                        <ci type="logical" class="Indication">Patient is currently receiving an inhaled corticosteroid with long acting beta-2 agonist (ICS/LABA) or a long acting muscarinic antagonist with long acting beta-2 agonist (LAMA/LABA)</ci>
                        <apply>
                          <or/>
                          <mi class="heading">Clinical criteria:</mi>
                          <ci type="logical" class="Indication">Patient has a COPD Assessment Test (CAT) score greater than 10</ci>
                          <ci type="logical" class="Indication">Patient has had 2 or more exacerbations in the previous 12 months</ci>
                          <ci type="logical" class="Indication">Patient has had one exacerbation requiring hospitalisation in the previous 12 months</ci>
                          <ci type="logical" class="Indication">Patient has had an eosinophil count greater than or equal to 0.3 x 10ˆ9 cells/L in the previous 12 months</ci>
                        </apply>
                      </apply>
                      <ci type="logical" class="Indication">Patient is currently receiving multiple inhaler triple therapy (inhaled corticosteroid with long acting muscarinic antagonist and long acting beta-2 agonist – ICS/LAMA/LABA) and met at least one of the clinical criteria above prior to commencing multiple inhaler triple therapy</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2028" style="display:none"/>
            <Formulation ID="F280818873825" Rank="6" Units="dose">
              <Name>Powder for inhalation fluticasone furoate 100 mcg with umeclidinium 62.5 mcg and vilanterol 25 mcg</Name>
              <Brand ID="B28081887382525">
                <Name>Trelegy Ellipta</Name>
                <Pack ID="P2674904" Specified="true" nzmt:ctpp_id="50251201000117109">
                  <Quantity>30</Quantity>
                  <Price>104.24</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2810">
        <Name>Antifibrotics</Name>
        <ATC3 ID="A281001">
          <Name>Antifibrotics</Name>
          <Chemical ID="C2810018605">
            <Name>Pirfenidone</Name>
            <Request Form="RS1814" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Pirfenidone</range>
              </Title>
              <Case When="Initial application" Category="idiopathic pulmonary fibrosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has been diagnosed with idiopathic pulmonary fibrosis by a multidisciplinary team including a radiologist</ci>
                    <ci type="logical">Forced vital capacity is between 50% and 90% predicted</ci>
                    <ci type="logical">Pirfenidone is to be discontinued at disease progression (See Notes)</ci>
                    <ci type="logical">Pirfenidone is not to be used in combination with subsidised nintedanib</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has not previously received treatment with nintedanib</ci>
                      <ci type="logical">Patient has previously received nintedanib, but discontinued nintedanib within 12 weeks due to intolerance</ci>
                      <ci type="logical">Patient has previously received nintedanib, but the patient’s disease has not progressed (disease progression defined as 10% or more decline in predicted FVC
                        within any 12 month period since starting treatment with nintedanib)</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="idiopathic pulmonary fibrosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Treatment remains clinically appropriate and patient is benefitting from and tolerating treatment</ci>
                    <ci type="logical">Pirfenidone is not to be used in combination with subsidised nintedanib</ci>
                    <ci type="logical">Pirfenidone is to be discontinued at disease progression (See Note)</ci>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>disease progression is defined as a decline in percent predicted FVC of 10% or more within any 12 month period.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1814" style="display:none"/>
            <Formulation ID="F281001860526" Rank="1" Units="tab">
              <Name>Tab 801 mg</Name>
              <Brand ID="B28100186052625">
                <Name>Esbriet</Name>
                <Pack ID="P2575833" Specified="true" nzmt:ctpp_id="50240021000117104">
                  <Quantity>90</Quantity>
                  <Price>3645.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F281001860527" Rank="1" Units="tab">
              <Name>Tab 267 mg</Name>
              <Brand ID="B28100186052725">
                <Name>Esbriet</Name>
                <Pack ID="P2602156" Specified="true" nzmt:ctpp_id="50240031000117101">
                  <Quantity>90</Quantity>
                  <Price>1215.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2810018633">
            <Name>Nintedanib</Name>
            <Request Form="RS1813" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Nintedanib</range>
              </Title>
              <Case When="Initial application" Category="idiopathic pulmonary fibrosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has been diagnosed with idiopathic pulmonary fibrosis by a multidisciplinary team including a radiologist</ci>
                    <ci type="logical">Forced vital capacity is between 50% and 90% predicted</ci>
                    <ci type="logical">Nintedanib is to be discontinued at disease progression (See Note)</ci>
                    <ci type="logical">Nintedanib is not to be used in combination with subsidised pirfenidone</ci>
                    <apply>
                      <or/>
                      <ci type="logical">The patient has not previously received treatment with pirfenidone</ci>
                      <ci type="logical">Patient has previously received pirfenidone, but discontinued pirfenidone within 12 weeks due to intolerance</ci>
                      <ci type="logical">Patient has previously received pirfenidone, but the patient’s disease has not progressed (disease progression defined as 10% or more decline in predicted FVC within any 12 month period since starting treatment with pirfenidone)</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="idiopathic pulmonary fibrosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Treatment remains clinically appropriate and patient is benefitting from and tolerating treatment</ci>
                    <ci type="logical">Nintedanib is not to be used in combination with subsidised pirfenidone</ci>
                    <ci type="logical">Nintedanib is to be discontinued at disease progression (See Note)</ci>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>disease progression is defined as a decline in percent predicted FVC of 10% or more within any 12 month period.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1813" style="display:none"/>
            <Formulation ID="F281001863325" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Brand ID="B28100186332525">
                <Name>Ofev</Name>
                <Pack ID="P2553694" Specified="true" nzmt:ctpp_id="50212751000117101">
                  <Quantity>60</Quantity>
                  <Price>2554.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F281001863326" Rank="2" Units="cap" Weight="150">
              <Name>Cap 150 mg</Name>
              <Brand ID="B28100186332625">
                <Name>Ofev</Name>
                <Pack ID="P2553708" Specified="true" nzmt:ctpp_id="50213141000117109">
                  <Quantity>60</Quantity>
                  <Price>3870.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2812">
        <Name>Beta-Adrenoceptor Agonists</Name>
        <ATC3 ID="A281204">
          <Name>Beta-Adrenoceptor Agonists</Name>
          <Chemical ID="C2812048458">
            <Name>Terbutaline sulphate</Name>
            <Formulation ID="F281204845801" Rank="4" Units="inj" Weight="0.5">
              <Name>Inj 0.5 mg per ml, 1 ml ampoule</Name>
              <Brand ID="B28120484580100">
                <Name>Any</Name>
                <Pack ID="P84580100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F281204845802" Rank="3" Units="g">
              <Name>Powder for inhalation 250 mcg per dose</Name>
              <Brand ID="B28120484580200">
                <Name>Any</Name>
                <Pack ID="P84580200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F281204845825" Rank="6" Units="dose">
              <Name>Powder for inhalation, 200 mcg per dose (equivalent to 250 mcg metered dose), breath activated</Name>
              <Brand ID="B28120484582525">
                <Name>Bricanyl Turbuhaler</Name>
                <Pack ID="P2578417" Specified="true" nzmt:ctpp_id="50264521000117109">
                  <Quantity>120</Quantity>
                  <Price>22.20</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2812049056">
            <Name>Salbutamol</Name>
            <Formulation ID="F281204905601" Rank="6" Units="dose" Weight="100">
              <Name>Aerosol inhaler, 100 mcg per dose</Name>
              <Brand ID="B28120490560101">
                <Name>Ventolin</Name>
                <Pack ID="P2026414" Specified="true" nzmt:ctpp_id="50005221000117100">
                  <Quantity>200</Quantity>
                  <Price>6.80</Price>
                </Pack>
              </Brand>
              <Brand ID="B28120490560126">
                <Name>SalAir</Name>
                <Pack ID="P2404516" Specified="true" nzmt:ctpp_id="50226901000117107">
                  <Quantity>200</Quantity>
                  <Price>3.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F281204905602" Rank="4" Units="inj" Weight="5">
              <Name>Inj 1 mg per ml, 5 ml ampoule</Name>
              <Brand ID="B28120490560200">
                <Name>Any</Name>
                <Pack ID="P90560200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F281204905603" Rank="4" Units="inj" Weight="0.5">
              <Name>Inj 500 mcg per ml, 1 ml ampoule</Name>
              <Brand ID="B28120490560300">
                <Name>Any</Name>
                <Pack ID="P90560300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F281204905626" Rank="8" Units="neb" Weight="2.5">
              <Name>Nebuliser soln 1 mg per ml, 2.5 ml ampoule</Name>
              <Brand ID="B28120490562625">
                <Name>Asthalin</Name>
                <Pack ID="P2154315" Specified="true" nzmt:ctpp_id="50026451000117106">
                  <Quantity>20</Quantity>
                  <Price>8.96</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F281204905627" Rank="8" Units="neb" Weight="5">
              <Name>Nebuliser soln 2 mg per ml, 2.5 ml ampoule</Name>
              <Brand ID="B28120490562725">
                <Name>Asthalin</Name>
                <Pack ID="P2154323" Specified="true" nzmt:ctpp_id="50026461000117108">
                  <Quantity>20</Quantity>
                  <Price>9.43</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F281204905628" Rank="3" Units="ml" Weight="10">
              <Name>Oral liq 400 mcg per ml</Name>
              <Brand ID="B28120490562827">
                <Name>Ventolin</Name>
                <Pack ID="P2140543" Specified="true" nzmt:ctpp_id="50024241000117100">
                  <Quantity>150</Quantity>
                  <Price>40.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2820">
        <Name>Decongestants</Name>
        <ATC3 ID="A282004">
          <Name>Decongestants</Name>
          <Chemical ID="C2820048337">
            <Name>Oxymetazoline hydrochloride</Name>
            <Formulation ID="F282004833701" Rank="3" Units="ml">
              <Name>Aqueous nasal spray 0.25 mg per ml</Name>
              <Brand ID="B28200483370100">
                <Name>Any</Name>
                <Pack ID="P83370100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282004833702" Rank="3" Units="ml">
              <Name>Aqueous nasal spray 0.5 mg per ml</Name>
              <Brand ID="B28200483370200">
                <Name>Any</Name>
                <Pack ID="P83370200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2820048399">
            <Name>Pseudoephedrine hydrochloride</Name>
            <Formulation ID="F282004839901" Rank="1" Units="tab" Weight="60">
              <Name>Tab 60 mg</Name>
              <Brand ID="B28200483990100">
                <Name>Any</Name>
                <Pack ID="P83990100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2820048423">
            <Name>Sodium chloride with sodium bicarbonate</Name>
            <Formulation ID="F282004842301" Rank="3" Units="ml">
              <Name>Soln for nasal irrigation</Name>
              <Brand ID="B28200484230100">
                <Name>Any</Name>
                <Pack ID="P84230100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2820048499">
            <Name>Xylometazoline hydrochloride</Name>
            <Formulation ID="F282004849901" Rank="3" Units="ml">
              <Name>Aqueous nasal spray 0.05%</Name>
              <Brand ID="B28200484990100">
                <Name>Any</Name>
                <Pack ID="P84990100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282004849902" Rank="3" Units="ml">
              <Name>Aqueous nasal spray 0.1%</Name>
              <Brand ID="B28200484990200">
                <Name>Any</Name>
                <Pack ID="P84990200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282004849903" Rank="6" Units="dose">
              <Name>Nasal drops 0.05%</Name>
              <Brand ID="B28200484990300">
                <Name>Any</Name>
                <Pack ID="P84990300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282004849904" Rank="6" Units="dose">
              <Name>Nasal drops 0.1%</Name>
              <Brand ID="B28200484990400">
                <Name>Any</Name>
                <Pack ID="P84990400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2820049058">
            <Name>Sodium chloride</Name>
            <Formulation ID="F282004905803" Rank="3" Units="ml">
              <Name>Aqueous nasal spray isotonic</Name>
              <Brand ID="B28200490580300">
                <Name>Any</Name>
                <Pack ID="P90580300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2824">
        <Name>Inhaled Corticosteroids</Name>
        <ATC3 ID="A282404">
          <Name>Inhaled Corticosteroids</Name>
          <Chemical ID="C2824049133">
            <Name>Beclomethasone dipropionate</Name>
            <Formulation ID="F282404913327" Rank="6" Units="dose" Weight="50">
              <Name>Aerosol inhaler 50 mcg per dose</Name>
              <Brand ID="B28240491332725">
                <Name>Beclazone 50</Name>
                <Pack ID="P2326159" Specified="true" nzmt:ctpp_id="50049091000117102">
                  <Quantity>200</Quantity>
                  <Price>8.54</Price>
                </Pack>
              </Brand>
              <Brand ID="B28240491332726">
                <Name>Qvar</Name>
                <Pack ID="P2023873" Specified="true" nzmt:ctpp_id="50004821000117100">
                  <Quantity>200</Quantity>
                  <Price>14.01</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282404913328" Rank="6" Units="dose" Weight="100">
              <Name>Aerosol inhaler 100 mcg per dose</Name>
              <Brand ID="B28240491332825">
                <Name>Beclazone 100</Name>
                <Pack ID="P2326167" Specified="true" nzmt:ctpp_id="50049101000117106">
                  <Quantity>200</Quantity>
                  <Price>12.50</Price>
                </Pack>
              </Brand>
              <Brand ID="B28240491332826">
                <Name>Qvar</Name>
                <Pack ID="P2023857" Specified="true" nzmt:ctpp_id="50004801000117108">
                  <Quantity>200</Quantity>
                  <Price>17.52</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282404913329" Rank="6" Units="dose" Weight="250">
              <Name>Aerosol inhaler 250 mcg per dose</Name>
              <Brand ID="B28240491332925">
                <Name>Beclazone 250</Name>
                <Pack ID="P2326175" Specified="true" nzmt:ctpp_id="50049111000117109">
                  <Quantity>200</Quantity>
                  <Price>22.67</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2824049137">
            <Name>Budesonide</Name>
            <Formulation ID="F282404913702" Rank="4" Units="amp" Weight="500">
              <Name>Nebuliser soln 250 mcg per ml, 2 ml ampoule</Name>
              <Brand ID="B28240491370200">
                <Name>Any</Name>
                <Pack ID="P91370200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282404913703" Rank="4" Units="amp" Weight="1000">
              <Name>Nebuliser soln 500 mcg per ml, 2 ml ampoule</Name>
              <Brand ID="B28240491370300">
                <Name>Any</Name>
                <Pack ID="P91370300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282404913704" Rank="6" Units="dose" Weight="100">
              <Name>Powder for inhalation 100 mcg per dose</Name>
              <Brand ID="B28240491370400">
                <Name>Any</Name>
                <Pack ID="P91370400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282404913727" Rank="6" Units="dose" Weight="200">
              <Name>Powder for inhalation 200 mcg per dose</Name>
              <Brand ID="B28240491372700">
                <Name>Any</Name>
                <Pack ID="P91372700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282404913728" Rank="6" Units="dose" Weight="400">
              <Name>Powder for inhalation 400 mcg per dose</Name>
              <Brand ID="B28240491372800">
                <Name>Any</Name>
                <Pack ID="P91372800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2824049502">
            <Name>Fluticasone</Name>
            <Formulation ID="F282404950225" Rank="6" Units="dose" Weight="50">
              <Name>Aerosol inhaler 50 mcg per dose</Name>
              <Brand ID="B28240495022525">
                <Name>Flixotide</Name>
                <Pack ID="P2004887" Specified="true" nzmt:ctpp_id="50000431000117108">
                  <Quantity>120</Quantity>
                  <Price>7.19</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282404950226" Rank="6" Units="dose" Weight="125">
              <Name>Aerosol inhaler 125 mcg per dose</Name>
              <Brand ID="B28240495022625">
                <Name>Flixotide</Name>
                <Pack ID="P472859" Specified="true" nzmt:ctpp_id="50089161000117100">
                  <Quantity>120</Quantity>
                  <Price>13.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282404950227" Rank="6" Units="dose" Weight="250">
              <Name>Aerosol inhaler 250 mcg per dose</Name>
              <Brand ID="B28240495022725">
                <Name>Flixotide</Name>
                <Pack ID="P472867" Specified="true" nzmt:ctpp_id="50089171000117105">
                  <Quantity>120</Quantity>
                  <Price>24.62</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282404950228" Rank="6" Units="dose" Weight="50">
              <Name>Powder for inhalation 50 mcg per dose</Name>
              <Brand ID="B28240495022825">
                <Name>Flixotide Accuhaler</Name>
                <Pack ID="P402958" Specified="true" nzmt:ctpp_id="50082201000117103">
                  <Quantity>60</Quantity>
                  <Price>8.61</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282404950229" Rank="6" Units="dose" Weight="100">
              <Name>Powder for inhalation 100 mcg per dose</Name>
              <Brand ID="B28240495022925">
                <Name>Flixotide Accuhaler</Name>
                <Pack ID="P402974" Specified="true" nzmt:ctpp_id="50082211000117100">
                  <Quantity>60</Quantity>
                  <Price>7.81</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282404950230" Rank="6" Units="dose" Weight="250">
              <Name>Powder for inhalation 250 mcg per dose</Name>
              <Brand ID="B28240495023025">
                <Name>Flixotide Accuhaler</Name>
                <Pack ID="P402990" Specified="true" nzmt:ctpp_id="50082221000117106">
                  <Quantity>60</Quantity>
                  <Price>11.93</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2828">
        <Name>Leukotriene Receptor Antagonists</Name>
        <ATC3 ID="A282804">
          <Name>Leukotriene Receptor Antagonists</Name>
          <Chemical ID="C2828049656">
            <Name>Montelukast</Name>
            <Formulation ID="F282804965625" Rank="1" Units="tab" Weight="5">
              <Name>Tab 5 mg</Name>
              <Rule Type="DVLimit" Attribute="Jul-23 to~2025" Value="5"/>
              <Brand ID="B28280496562528" PSS="true">
                <Name>Montelukast Viatris</Name>
                <Pack ID="P2643626" Specified="true" nzmt:ctpp_id="50295191000117100">
                  <Quantity>28</Quantity>
                  <Price>3.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282804965626" Rank="1" Units="tab" Weight="4">
              <Name>Tab 4 mg</Name>
              <Rule Type="DVLimit" Attribute="Sep-23 to~2025" Value="5"/>
              <Brand ID="B28280496562628" PSS="true">
                <Name>Montelukast Viatris</Name>
                <Pack ID="P2643618" Specified="true" nzmt:ctpp_id="50295171000117101">
                  <Quantity>28</Quantity>
                  <Price>3.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F282804965627" Rank="1" Units="tab" Weight="10">
              <Name>Tab 10 mg</Name>
              <Rule Type="DVLimit" Attribute="Sep-23 to~2025" Value="5"/>
              <Brand ID="B28280496562728" PSS="true">
                <Name>Montelukast Viatris</Name>
                <Pack ID="P2643634" Specified="true" nzmt:ctpp_id="50295211000117104">
                  <Quantity>28</Quantity>
                  <Price>2.90</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2832">
        <Name>Long-Acting Beta-Adrenoceptor Agonists</Name>
        <ATC3 ID="A283202">
          <Name>Long-Acting Beta-Adrenoceptor Agonists</Name>
          <Chemical ID="C2832028164">
            <Name>Eformoterol fumarate</Name>
            <Formulation ID="F283202816401" Rank="3" Units="g" Weight="12">
              <Name>Powder for inhalation 12 mcg per dose</Name>
              <Brand ID="B28320281640100">
                <Name>Any</Name>
                <Pack ID="P81640100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2832028565">
            <Name>Indacaterol</Name>
            <Formulation ID="F283202856525" Rank="6" Units="dose">
              <Name>Powder for inhalation 150 mcg per dose</Name>
              <Brand ID="B28320285652525">
                <Name>Onbrez Breezhaler</Name>
                <Pack ID="P2465922" Specified="true" nzmt:ctpp_id="50186981000117109">
                  <Quantity>30</Quantity>
                  <Price>61.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F283202856526" Rank="6" Units="dose">
              <Name>Powder for inhalation 300 mcg per dose</Name>
              <Brand ID="B28320285652625">
                <Name>Onbrez Breezhaler</Name>
                <Pack ID="P2465930" Specified="true" nzmt:ctpp_id="50187001000117101">
                  <Quantity>30</Quantity>
                  <Price>61.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2832028635">
            <Name>Eformoterol fumarate dihydrate</Name>
            <Formulation ID="F283202863525" Rank="6" Units="dose">
              <Name>Powder for inhalation 4.5 mcg per dose, breath activated (equivalent to eformoterol fumarate 6 mcg metered dose)</Name>
              <Brand ID="B28320286352500">
                <Name>Any</Name>
                <Pack ID="P86352500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2832029286">
            <Name>Salmeterol</Name>
            <Formulation ID="F283202928625" Rank="6" Units="dose">
              <Name>Powder for inhalation 50 mcg per dose</Name>
              <Brand ID="B28320292862525">
                <Name>Serevent Accuhaler</Name>
                <Pack ID="P479489" Specified="true" nzmt:ctpp_id="50090411000117102">
                  <Quantity>60</Quantity>
                  <Price>26.25</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F283202928626" Rank="6" Units="dose">
              <Name>Aerosol inhaler 25 mcg per dose</Name>
              <Brand ID="B28320292862625">
                <Name>Serevent</Name>
                <Pack ID="P2243903" Specified="true" nzmt:ctpp_id="50038641000117108">
                  <Quantity>120</Quantity>
                  <Price>26.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A283204">
          <Name>Inhaled Corticosteroids with Long-Acting Beta-Adrenoceptor Agonists</Name>
          <Chemical ID="C2832048069">
            <Name>Budesonide with eformoterol</Name>
            <Formulation ID="F283204806901" Rank="6" Units="dose">
              <Name>Aerosol inhaler 100 mcg with eformoterol fumarate 6 mcg</Name>
              <Brand ID="B28320480690100">
                <Name>Any</Name>
                <Pack ID="P80690100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F283204806902" Rank="6" Units="dose">
              <Name>Aerosol inhaler 200 mcg with eformoterol fumarate 6 mcg</Name>
              <Brand ID="B28320480690200">
                <Name>Any</Name>
                <Pack ID="P80690200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F283204806903" Rank="3" Units="g">
              <Name>Powder for inhalation 100 mcg with eformoterol fumarate 6 mcg</Name>
              <Brand ID="B28320480690300">
                <Name>Any</Name>
                <Pack ID="P80690300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F283204806904" Rank="6" Units="dose">
              <Name>Powder for inhalation 200 mcg with eformoterol fumarate 6 mcg</Name>
              <Brand ID="B28320480690425">
                <Name>Symbicort Turbuhaler</Name>
                <Pack ID="P2035960" Specified="true" nzmt:ctpp_id="50007061000117107">
                  <Quantity>120</Quantity>
                  <Price>33.74</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F283204806905" Rank="6" Units="dose">
              <Name>Powder for inhalation 400 mcg with eformoterol fumarate 12 mcg</Name>
              <Brand ID="B28320480690525">
                <Name>Symbicort Turbuhaler</Name>
                <Pack ID="P2228009" Specified="true" nzmt:ctpp_id="50036661000117108">
                  <Quantity>60</Quantity>
                  <Price>33.74</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F283204806925" Rank="6" Units="dose">
              <Name>Powder for inhalation 160 mcg with 4.5 mcg eformoterol fumarate per dose (equivalent to 200 mcg budesonide with 6 mcg eformoterol fumarate metered dose)</Name>
              <Brand ID="B28320480692525">
                <Name>DuoResp Spiromax</Name>
                <Pack ID="P2576031" Specified="true" nzmt:ctpp_id="50251641000117109">
                  <Quantity>120</Quantity>
                  <Price>41.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F283204806926" Rank="6" Units="dose">
              <Name>Powder for inhalation 320 mcg with 9 mcg eformoterol fumarate per dose (equivalent to 400 mcg budesonide with 12 mcg eformoterol fumarate metered dose)</Name>
              <Brand ID="B28320480692625">
                <Name>DuoResp Spiromax</Name>
                <Pack ID="P2576058" Specified="true" nzmt:ctpp_id="50251761000117101">
                  <Quantity>120</Quantity>
                  <Price>82.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2832048585">
            <Name>Fluticasone furoate with vilanterol</Name>
            <Formulation ID="F283204858525" Rank="6" Units="dose" Weight="125">
              <Name>Powder for inhalation 100 mcg with vilanterol 25 mcg</Name>
              <Brand ID="B28320485852525">
                <Name>Breo Ellipta</Name>
                <Pack ID="P2494299" Specified="true" nzmt:ctpp_id="50226721000117101">
                  <Quantity>30</Quantity>
                  <Price>44.08</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2832049315">
            <Name>Fluticasone with salmeterol</Name>
            <Formulation ID="F283204931525" Rank="6" Units="dose" Weight="50">
              <Name>Aerosol inhaler 50 mcg with salmeterol 25 mcg</Name>
              <Brand ID="B28320493152525">
                <Name>Seretide</Name>
                <Pack ID="P2120194" Specified="true" nzmt:ctpp_id="50021661000117101">
                  <Quantity>120</Quantity>
                  <Price>25.79</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F283204931526" Rank="6" Units="dose" Weight="125">
              <Name>Aerosol inhaler 125 mcg with salmeterol 25 mcg</Name>
              <Brand ID="B28320493152625">
                <Name>Seretide</Name>
                <Pack ID="P2120208" Specified="true" nzmt:ctpp_id="50021671000117106">
                  <Quantity>120</Quantity>
                  <Price>32.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F283204931527" Rank="6" Units="dose" Weight="100">
              <Name>Powder for inhalation 100 mcg with salmeterol 50 mcg</Name>
              <Brand ID="B28320493152725">
                <Name>Seretide Accuhaler</Name>
                <Pack ID="P2120216" Specified="true" nzmt:ctpp_id="50021681000117109">
                  <Quantity>60</Quantity>
                  <Price>33.74</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F283204931528" Rank="6" Units="dose" Weight="250">
              <Name>Powder for inhalation 250 mcg with salmeterol 50 mcg</Name>
              <Brand ID="B28320493152825">
                <Name>Seretide Accuhaler</Name>
                <Pack ID="P2120224" Specified="true" nzmt:ctpp_id="50021691000117107">
                  <Quantity>60</Quantity>
                  <Price>44.08</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2840">
        <Name>Methylxanthines</Name>
        <ATC3 ID="A284004">
          <Name>Methylxanthines</Name>
          <Chemical ID="C2840048461">
            <Name>Theophylline</Name>
            <Formulation ID="F284004846101" Rank="3" Units="ml">
              <Name>Oral liq 80 mg per 15 ml</Name>
              <Brand ID="B28400484610125">
                <Name>Nuelin</Name>
                <Pack ID="P255092" Specified="true" nzmt:ctpp_id="50054831000117108">
                  <Quantity>500</Quantity>
                  <Price>17.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F284004846102" Rank="1" Units="tab">
              <Name>Tab long-acting 250 mg</Name>
              <Brand ID="B28400484610225">
                <Name>Nuelin-SR</Name>
                <Pack ID="P255149" Specified="true" nzmt:ctpp_id="50054871000117106">
                  <Quantity>100</Quantity>
                  <Price>24.90</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2840049139">
            <Name>Caffeine citrate</Name>
            <Formulation ID="F284004913901" Rank="3" Units="ml">
              <Name>Oral liq 20 mg per ml (caffeine 10 mg per ml)</Name>
              <Brand ID="B28400491390125">
                <Name>Biomed</Name>
                <Pack ID="P461253" Specified="true" nzmt:ctpp_id="50087561000117103">
                  <Quantity>25</Quantity>
                  <Price>16.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F284004913925" Rank="4" Units="inj" Weight="25">
              <Name>Inj 20 mg per ml (caffeine 10 mg per ml), 2.5 ml ampoule</Name>
              <Brand ID="B28400491392525">
                <Name>Biomed</Name>
                <Pack ID="P2157934" Specified="true" nzmt:ctpp_id="50027051000117101">
                  <Quantity>5</Quantity>
                  <Price>66.40</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2840049266">
            <Name>Aminophylline</Name>
            <Formulation ID="F284004926601" Rank="4" Units="inj" Weight="25">
              <Name>Inj 25 mg per ml, 10 ml ampoule</Name>
              <Brand ID="B28400492660125">
                <Name>DBL Aminophylline</Name>
                <Pack ID="P333956" Specified="true" nzmt:ctpp_id="50074201000117103">
                  <Quantity>5</Quantity>
                  <Price>180.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2844">
        <Name>Mucolytics and Expectorants</Name>
        <ATC3 ID="A284404">
          <Name>Mucolytics and Expectorants</Name>
          <Chemical ID="C2844048666">
            <Name>Ivacaftor</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1818">
              <Title>
                <range>Ivacaftor</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has been diagnosed with cystic
                    fibrosis</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient must have G551D mutation in the
                        cystic fibrosis transmembrane conductance regulator (CFTR) gene on at least
                        1 allele</ci>
                      <ci type="logical" class="Indication">Patient must have other gating (class III)
                        mutation (G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N and S549R) in
                        the CFTR gene on at least 1 allele</ci>
                    </apply>
                    <ci type="logical" class="Indication">Patients must have a sweat chloride value of
                    at least 60 mmol/L by quantitative pilocarpine iontophoresis or by Macroduct
                    sweat collection system</ci>
                    <ci type="logical" class="Indication">Treatment with ivacaftor must be given
                    concomitantly with standard therapy for this condition</ci>
                    <ci type="logical" class="Indication">Patient must not have an acute upper or lower
                    respiratory infection, pulmonary exacerbation, or changes in therapy (including
                    antibiotics) for pulmonary disease in the last 4 weeks prior to commencing
                    treatment with ivacaftor</ci>
                    <ci type="logical" class="Indication">The dose of ivacaftor will not exceed one
                    tablet or one sachet twice daily</ci>
                    <ci type="logical" class="Indication">Applicant has experience and expertise in the
                    management of cystic fibrosis</ci>
                  </apply>
                </math>
                <Applicant>respiratory specialist</Applicant>
                <Applicant>paediatrician</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1818" style="display:none"/>
            <Formulation ID="F284404866625" Rank="1" Units="tab" Weight="150">
              <Name>Tab 150 mg</Name>
              <Brand ID="B28440486662525">
                <Name>Kalydeco</Name>
                <Pack ID="P2586118" Specified="true" nzmt:ctpp_id="50177711000117106">
                  <Quantity>56</Quantity>
                  <Price>29386.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F284404866626" Rank="10" Units="ea" Weight="50">
              <Name>Oral granules 50 mg, sachet</Name>
              <Brand ID="B28440486662625">
                <Name>Kalydeco</Name>
                <Pack ID="P2586134" Specified="true" nzmt:ctpp_id="50274751000117104">
                  <Quantity>56</Quantity>
                  <Price>29386.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F284404866627" Rank="10" Units="ea" Weight="75">
              <Name>Oral granules 75 mg, sachet</Name>
              <Brand ID="B28440486662725">
                <Name>Kalydeco</Name>
                <Pack ID="P2586126" Specified="true" nzmt:ctpp_id="50274761000117102">
                  <Quantity>56</Quantity>
                  <Price>29386.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2844048712">
            <Name>Elexacaftor with tezacaftor, ivacaftor and ivacaftor</Name>
            <Request Form="RS1950" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Elexacaftor with tezacaftor, ivacaftor and ivacaftor</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical" class="Indication">Patient has been diagnosed with cystic fibrosis</ci>
                    <ci type="logical" class="Indication">Patient is 6 years of age or older</ci>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient has two cystic fibrosis-causing mutations in the cystic fibrosis transmembrane regulator (CFTR) gene (one from each parental
                        allele)</ci>
                      <ci type="logical" class="Indication">Patient has a sweat chloride value of at least 60 mmol/L by quantitative pilocarpine iontophoresis or by Macroduct sweat collection
                        system</ci>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Patient has a heterozygous or homozygous F508del mutation</ci>
                      <ci type="logical" class="Indication">Patient has a G551D mutation or other mutation responsive in vitro to elexacaftor/tezacaftor/ivacaftor (see note a)</ci>
                    </apply>
                    <ci type="logical" class="Indication">The treatment must be the sole funded CFTR modulator therapy for this condition</ci>
                    <ci type="logical" class="Indication">Treatment with elexacaftor/tezacaftor/ivacaftor must be given concomitantly with standard therapy for this condition</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <ol style="list-style-type: lower-alpha">
                    <li>
                      <p>Eligible mutations are listed in the Food and Drug Administration (FDA) Trikafta prescribing information</p>
                      <p>
                        <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212273s004lbl.pdf"> https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212273s004lbl.pdf</a>
                      </p>
                    </li>
                  </ol>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1950" style="display:none"/>
            <Formulation ID="F284404871225" Rank="1" Units="tab" Weight="50">
              <Name>Tab elexacaftor 50 mg with tezacaftor 25 mg, ivacaftor 37.5 mg (56) and ivacaftor 75 mg (28)</Name>
              <Brand ID="B28440487122525">
                <Name>Trikafta</Name>
                <Pack ID="P2649748" Specified="true" nzmt:ctpp_id="50287441000117105">
                  <Quantity>84</Quantity>
                  <Price>27647.39</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F284404871226" Rank="1" Units="tab" Weight="100">
              <Name>Tab elexacaftor 100 mg with tezacaftor 50 mg, ivacaftor 75 mg (56) and ivacaftor 150 mg (28)</Name>
              <Brand ID="B28440487122625">
                <Name>Trikafta</Name>
                <Pack ID="P2611694" Specified="true" nzmt:ctpp_id="50287431000117102">
                  <Quantity>84</Quantity>
                  <Price>27647.39</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2844049058">
            <Name>Sodium chloride</Name>
            <Formulation ID="F284404905836" Rank="3" Units="ml">
              <Name>Nebuliser soln 7%, 90 ml bottle</Name>
              <Brand ID="B28440490583625">
                <Name>Biomed</Name>
                <Pack ID="P2378701" Specified="true" nzmt:ctpp_id="50121531000117102">
                  <Quantity>90</Quantity>
                  <Price>24.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2844049645">
            <Name>Dornase alfa</Name>
            <Request Form="RS1787" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Dornase alfa</range>
              </Title>
              <Case When="Initial application" Category="cystic fibrosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has a confirmed diagnosis of cystic fibrosis</ci>
                    <ci type="logical">Patient has previously undergone a trial with, or is currently being treated with, hypertonic saline</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has required one or more hospital inpatient respiratory admissions in the previous 12 month period</ci>
                      <ci type="logical">Patient has had 3 exacerbations due to CF, requiring oral or intravenous (IV) antibiotics in in the previous 12 month period</ci>
                      <ci type="logical">Patient has had 1 exacerbation due to CF, requiring oral or IV antibiotics in the previous 12 month period and a Brasfield score of &lt;22/25</ci>
                      <ci type="logical">Patient has a diagnosis of allergic bronchopulmonary aspergillosis (ABPA)</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>respiratory physician</Applicant>
                <Applicant>paediatrician</Applicant>
                <Term Measure="month">12</Term>
              </Case>
              <Case When="Renewal" Category="cystic fibrosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">The treatment remains appropriate and the patient continues to benefit from treatment</ci>
                </math>
                <Applicant>respiratory physician</Applicant>
                <Applicant>paediatrician</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="significant mucus production">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is an in-patient</ci>
                    <ci type="logical">The mucus production cannot be cleared by first line chest techniques</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="week">4</Term>
              </Case>
              <Case When="Initial application" Category="pleural emphyema">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is an in-patient</ci>
                    <ci type="logical">Patient diagnoses with pleural emphyema</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="day">3</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1787" style="display:none"/>
            <Formulation ID="F284404964525" Rank="4" Units="inj" Weight="1">
              <Name>Nebuliser soln 2.5 mg per 2.5 ml ampoule</Name>
              <Brand ID="B28440496452525">
                <Name>Pulmozyme</Name>
                <Pack ID="P239070" Specified="true" nzmt:ctpp_id="50051371000117101">
                  <Quantity>6</Quantity>
                  <Price>250.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2848">
        <Name>Pulmonary Surfactants</Name>
        <ATC3 ID="A284804">
          <Name>Pulmonary Surfactants</Name>
          <Chemical ID="C2848049005">
            <Name>Beractant</Name>
            <Formulation ID="F284804900501" Rank="4" Units="inj" Weight="25">
              <Name>Soln 200 mg per 8 ml vial</Name>
              <Brand ID="B28480490050100">
                <Name>Any</Name>
                <Pack ID="P90050100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C2848049415">
            <Name>Poractant alfa</Name>
            <Formulation ID="F284804941525" Rank="4" Units="inj" Weight="120">
              <Name>Soln 120 mg per 1.5 ml vial</Name>
              <Brand ID="B28480494152525">
                <Name>Curosurf</Name>
                <Pack ID="P2184559" Specified="true" nzmt:ctpp_id="50030251000117105">
                  <Quantity>1</Quantity>
                  <Price>425.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F284804941526" Rank="4" Units="inj" Weight="240">
              <Name>Soln 240 mg per 3 ml vial</Name>
              <Brand ID="B28480494152625">
                <Name>Curosurf</Name>
                <Pack ID="P2184567" Specified="true" nzmt:ctpp_id="50030261000117107">
                  <Quantity>1</Quantity>
                  <Price>695.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2852">
        <Name>Respiratory Stimulants</Name>
        <ATC3 ID="A285204">
          <Name>Respiratory Stimulants</Name>
          <Chemical ID="C2852048159">
            <Name>Doxapram</Name>
            <Formulation ID="F285204815901" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg per ml, 5 ml vial</Name>
              <Brand ID="B28520481590100">
                <Name>Any</Name>
                <Pack ID="P81590100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A2856">
        <Name>Sclerosing Agents</Name>
        <ATC3 ID="A285604">
          <Name>Sclerosing Agents</Name>
          <Chemical ID="C2856048453">
            <Name>Talc</Name>
            <Formulation ID="F285604845301" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B28560484530100">
                <Name>Any</Name>
                <Pack ID="P84530100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F285604845302" Rank="3" Units="ml">
              <Name>Soln (slurry) 100 mg per ml, 50 ml</Name>
              <Brand ID="B28560484530200">
                <Name>Any</Name>
                <Pack ID="P84530200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
    <ATC1 ID="A31">
      <Name>Sensory Organs</Name>
      <ATC2 ID="A3104">
        <Name>Anti-Infective Preparations</Name>
        <ATC3 ID="A310404">
          <Name>Antibacterials</Name>
          <Chemical ID="C3104048194">
            <Name>Framycetin sulphate</Name>
            <Formulation ID="F310404819401" Rank="3" Units="ml">
              <Name>Ear/eye drops 0.5%</Name>
              <Brand ID="B31040481940100">
                <Name>Any</Name>
                <Pack ID="P81940100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3104048396">
            <Name>Propamidine isethionate</Name>
            <Formulation ID="F310404839601" Rank="3" Units="ml">
              <Name>Eye drops 0.1%</Name>
              <Brand ID="B31040483960100">
                <Name>Any</Name>
                <Pack ID="P83960100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3104048451">
            <Name>Sulphacetamide sodium</Name>
            <Formulation ID="F310404845101" Rank="3" Units="ml">
              <Name>Eye drops 10%</Name>
              <Brand ID="B31040484510100">
                <Name>Any</Name>
                <Pack ID="P84510100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3104049117">
            <Name>Gentamicin sulphate</Name>
            <Formulation ID="F310404911702" Rank="3" Units="ml">
              <Name>Eye drops 0.3%</Name>
              <Brand ID="B31040491170200">
                <Name>Any</Name>
                <Pack ID="P91170200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3104049148">
            <Name>Chloramphenicol</Name>
            <Formulation ID="F310404914801" Rank="3" Units="ml">
              <Name>Ear drops 0.5%</Name>
              <Brand ID="B31040491480100">
                <Name>Any</Name>
                <Pack ID="P91480100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F310404914802" Rank="3" Units="ml">
              <Name>Eye drops 0.5%, single dose</Name>
              <Brand ID="B31040491480200">
                <Name>Any</Name>
                <Pack ID="P91480200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F310404914825" Rank="3" Units="ml">
              <Name>Eye drops 0.5%</Name>
              <Rule Type="DVLimit" Attribute="Sep-23 to~2025" Value="5"/>
              <Brand ID="B31040491482525" PSS="true">
                <Name>Chlorsig</Name>
                <Pack ID="P335142" Specified="true" nzmt:ctpp_id="50074271000117107">
                  <Quantity>10</Quantity>
                  <Price>1.45</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F310404914826" Rank="3" Units="g">
              <Name>Eye oint 1%</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B31040491482626" PSS="true">
                <Name>Devatis</Name>
                <Pack ID="P2576902" Specified="true" nzmt:ctpp_id="50267541000117109">
                  <Quantity>5</Quantity>
                  <Price>1.09</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3104049151">
            <Name>Ciprofloxacin</Name>
            <Formulation ID="F310404915101" Rank="3" Units="ml">
              <Name>Eye drops 0.3%</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B31040491510125" PSS="true">
                <Name>Ciprofloxacin Teva</Name>
                <Pack ID="P2539144" Specified="true" nzmt:ctpp_id="50252581000117107">
                  <Quantity>5</Quantity>
                  <Price>10.85</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3104049195">
            <Name>Sodium fusidate  [Fusidic acid]</Name>
            <Formulation ID="F310404919526" Rank="3" Units="g">
              <Name>Eye drops 1%</Name>
              <Brand ID="B31040491952625">
                <Name>Fucithalmic</Name>
                <Pack ID="P716634" Specified="true" nzmt:ctpp_id="50105131000117100">
                  <Quantity>5</Quantity>
                  <Price>5.29</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3104049280">
            <Name>Tobramycin</Name>
            <Formulation ID="F310404928026" Rank="3" Units="g" Weight="3.5">
              <Name>Eye oint 0.3%</Name>
              <Brand ID="B31040492802625">
                <Name>Tobrex</Name>
                <Pack ID="P331767" Specified="true" nzmt:ctpp_id="50073531000117109">
                  <Quantity>3.5</Quantity>
                  <Price>10.45</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F310404928027" Rank="3" Units="ml">
              <Name>Eye drops 0.3%</Name>
              <Brand ID="B31040492802725">
                <Name>Tobrex</Name>
                <Pack ID="P308390" Specified="true" nzmt:ctpp_id="50069141000117101">
                  <Quantity>5</Quantity>
                  <Price>11.48</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A310408">
          <Name>Antifungals</Name>
          <Chemical ID="C3104088312">
            <Name>Natamycin</Name>
            <Formulation ID="F310408831201" Rank="3" Units="ml">
              <Name>Eye drops 5%</Name>
              <Brand ID="B31040883120100">
                <Name>Any</Name>
                <Pack ID="P83120100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A310412">
          <Name>Antivirals</Name>
          <Chemical ID="C3104129123">
            <Name>Aciclovir</Name>
            <Formulation ID="F310412912301" Rank="3" Units="g">
              <Name>Eye oint 3%</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B31041291230125" PSS="true">
                <Name>ViruPOS</Name>
                <Pack ID="P2490803" Specified="true" nzmt:ctpp_id="50232991000117103">
                  <Quantity>4.5</Quantity>
                  <Price>15.89</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A310416">
          <Name>Combination Preparations</Name>
          <Chemical ID="C3104168130">
            <Name>Dexamethasone with framycetin and gramicidin</Name>
            <Formulation ID="F310416813001" Rank="3" Units="ml">
              <Name>Ear/eye drops 500 mcg with framycetin sulphate 5 mg and gramicidin 50 mcg per ml</Name>
              <Brand ID="B31041681300100">
                <Name>Any</Name>
                <Pack ID="P81300100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3104168131">
            <Name>Dexamethasone with neomycin sulphate and polymyxin B sulphate</Name>
            <Formulation ID="F310416813101" Rank="3" Units="ml">
              <Name>Eye drops 0.1% with neomycin sulphate 0.35% and polymyxin b sulphate 6,000 u per ml</Name>
              <Brand ID="B31041681310125">
                <Name>Maxitrol</Name>
                <Pack ID="P207454" Specified="true" nzmt:ctpp_id="50012341000117109">
                  <Quantity>5</Quantity>
                  <Price>4.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F310416813102" Rank="3" Units="g">
              <Name>Eye oint 0.1% with neomycin sulphate 0.35% and polymyxin b sulphate 6,000 u per g</Name>
              <Brand ID="B31041681310225">
                <Name>Maxitrol</Name>
                <Pack ID="P207381" Specified="true" nzmt:ctpp_id="50012301000117107">
                  <Quantity>3.5</Quantity>
                  <Price>5.39</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3104168132">
            <Name>Dexamethasone with tobramycin</Name>
            <Formulation ID="F310416813201" Rank="3" Units="ml">
              <Name>Eye drops 0.1% with tobramycin 0.3%</Name>
              <Brand ID="B31041681320125">
                <Name>Tobradex</Name>
                <Pack ID="P722499" Specified="true" nzmt:ctpp_id="50105731000117104">
                  <Quantity>5</Quantity>
                  <Price>12.64</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3104168189">
            <Name>Flumetasone pivalate with clioquinol</Name>
            <Formulation ID="F310416818901" Rank="3" Units="ml">
              <Name>Ear drops 0.02% with clioquinol 1%</Name>
              <Brand ID="B31041681890100">
                <Name>Any</Name>
                <Pack ID="P81890100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3104168219">
            <Name>Ciprofloxacin with hydrocortisone</Name>
            <Formulation ID="F310416821901" Rank="3" Units="ml">
              <Name>Ear drops ciprofloxacin 0.2% with 1% hydrocortisone</Name>
              <Brand ID="B31041682190125">
                <Name>Ciproxin HC Otic</Name>
                <Pack ID="P433691" Specified="true" nzmt:ctpp_id="50085131000117105">
                  <Quantity>10</Quantity>
                  <Price>16.30</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3104169351">
            <Name>Triamcinolone acetonide with gramicidin, neomycin and nystatin</Name>
            <Formulation ID="F310416935125" Rank="3" Units="ml">
              <Name>Ear drops 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 mcg per g</Name>
              <Brand ID="B31041693512525">
                <Name>Kenacomb</Name>
                <Pack ID="P253634" Specified="true" nzmt:ctpp_id="50053971000117104">
                  <Quantity>7.5</Quantity>
                  <Price>5.16</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A3108">
        <Name>Anti-Inflammatory Preparations</Name>
        <ATC3 ID="A310804">
          <Name>Corticosteroids</Name>
          <Chemical ID="C3108048385">
            <Name>Prednisolone acetate</Name>
            <Formulation ID="F310804838501" Rank="3" Units="ml">
              <Name>Eye drops 0.12%</Name>
              <Brand ID="B31080483850100">
                <Name>Any</Name>
                <Pack ID="P83850100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F310804838502" Rank="3" Units="ml">
              <Name>Eye drops 1%</Name>
              <Brand ID="B31080483850225">
                <Name>Prednisolone- AFT</Name>
                <Pack ID="P2501511" Specified="true" nzmt:ctpp_id="50227681000117108">
                  <Quantity>10</Quantity>
                  <Price>6.92</Price>
                </Pack>
              </Brand>
              <Brand ID="B31080483850226">
                <Name>Pred Forte</Name>
                <Pack ID="P260533" Specified="true" nzmt:ctpp_id="50057171000117109">
                  <Quantity>5</Quantity>
                  <Price>7.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3108049191">
            <Name>Fluorometholone</Name>
            <Formulation ID="F310804919125" Rank="3" Units="ml">
              <Name>Eye drops 0.1%</Name>
              <Brand ID="B31080491912526">
                <Name>FML</Name>
                <Pack ID="P264415" Specified="true" nzmt:ctpp_id="50058651000117106">
                  <Quantity>5</Quantity>
                  <Price>3.09</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3108049211">
            <Name>Prednisolone sodium phosphate</Name>
            <Formulation ID="F310804921101" Rank="6" Units="dose">
              <Name>Eye drops 0.5%, single dose (preservative free)</Name>
              <Brand ID="B31080492110125">
                <Name>Minims Prednisolone</Name>
                <Pack ID="P307475" Specified="true" nzmt:ctpp_id="50068881000117105">
                  <Quantity>20</Quantity>
                  <Price>43.26</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3108049243">
            <Name>Dexamethasone</Name>
            <Formulation ID="F310804924326" Rank="3" Units="ml">
              <Name>Eye drops 0.1%</Name>
              <Brand ID="B31080492432625">
                <Name>Maxidex</Name>
                <Pack ID="P207446" Specified="true" nzmt:ctpp_id="50012331000117101">
                  <Quantity>5</Quantity>
                  <Price>4.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F310804924327" Rank="3" Units="g" Weight="3.5">
              <Name>Eye oint 0.1%</Name>
              <Brand ID="B31080492432725">
                <Name>Maxidex</Name>
                <Pack ID="P207373" Specified="true" nzmt:ctpp_id="50012291000117106">
                  <Quantity>3.5</Quantity>
                  <Price>5.86</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F310804924331" Rank="10" Units="each" Weight="700">
              <Name>Ocular implant 700 mcg</Name>
              <Request Form="RS1606" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Dexamethasone</range>
                </Title>
                <Case When="Initial application" Category="Diabetic macular oedema">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">Patients have diabetic macular oedema with pseudophakic lens</ci>
                      <ci type="logical" class="Indication">Patient has reduced visual acuity of between 6/9 – 6/48 with functional awareness of reduction in vision</ci>
                      <apply>
                        <or/>
                        <ci type="logical" class="Indication">Patient’s disease has progressed despite 3 injections with bevacizumab</ci>
                        <ci type="logical" class="Indication">Patient is unsuitable or contraindicated to treatment with anti-VEGF agents</ci>
                      </apply>
                      <ci type="logical" class="Indication">Dexamethasone implants are to be administered not more frequently than once every 4 months into each eye, and up to a maximum of 3 implants per eye per year</ci>
                    </apply>
                  </math>
                  <Applicant>ophthalmologist</Applicant>
                  <Term Measure="month">12</Term>
                </Case>
                <Case When="Renewal" Category="Diabetic macular oedema">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">Patient’s vision is stable or has improved (prescriber determined)</ci>
                      <ci type="logical" class="Indication">Dexamethasone implants are to be administered not more frequently than once every 4 months into each eye, and up to a maximum of 3 implants per eye per year</ci>
                    </apply>
                  </math>
                  <Applicant>ophthalmologist</Applicant>
                  <Term Measure="month">12</Term>
                </Case>
                <Case When="Initial application" Category="Women of child bearing age with diabetic macular oedema">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">Patients have diabetic macular oedema</ci>
                      <ci type="logical" class="Indication">Patient has reduced visual acuity of between 6/9 – 6/48 with functional awareness of reduction in vision</ci>
                      <ci type="logical" class="Indication">Patient is of child bearing potential and has not yet completed a family</ci>
                      <ci type="logical" class="Indication">Dexamethasone implants are to be administered not more frequently than once every 4 months into each eye, and up to a maximum of 3 implants per eye per year</ci>
                    </apply>
                  </math>
                  <Applicant>ophthalmologist</Applicant>
                  <Term Measure="month">12</Term>
                </Case>
                <Case When="Renewal" Category="Women of child bearing age with diabetic macular oedema">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <and/>
                      <ci type="logical" class="Indication">Patient’s vision is stable or has improved (prescriber determined)</ci>
                      <ci type="logical" class="Indication">Patient is of child bearing potential and has not yet completed a family</ci>
                      <ci type="logical" class="Indication">Dexamethasone implants are to be administered not more frequently than once every 4 months into each eye, and up to a maximum of 3 implants per eye per year</ci>
                    </apply>
                  </math>
                  <Applicant>ophthalmologist</Applicant>
                  <Term Measure="month">12</Term>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1606" style="display:none"/>
              <Brand ID="B31080492433125">
                <Name>Ozurdex</Name>
                <Pack ID="P2529610" Specified="true" nzmt:ctpp_id="50246951000117109">
                  <Quantity>1</Quantity>
                  <Price>1444.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A310808">
          <Name>Non-Steroidal Anti-Inflammatory Drugs</Name>
          <Chemical ID="C3108088250">
            <Name>Ketorolac  trometamol</Name>
            <Formulation ID="F310808825001" Rank="3" Units="ml">
              <Name>Eye drops 0.5%</Name>
              <Brand ID="B31080882500100">
                <Name>Any</Name>
                <Pack ID="P82500100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3108088663">
            <Name>Nepafenac</Name>
            <Formulation ID="F310808866325" Rank="3" Units="ml">
              <Name>Eye drops 0.3%</Name>
              <Brand ID="B31080886632500">
                <Name>Any</Name>
                <Pack ID="P86632500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3108089177">
            <Name>Diclofenac sodium</Name>
            <Formulation ID="F310808917725" Rank="3" Units="ml">
              <Name>Eye drops 0.1%</Name>
              <Brand ID="B31080891772525" ToBeDelisted="2024-12-01">
                <Name>Voltaren Ophtha</Name>
                <Pack ID="P781851" Specified="true" nzmt:ctpp_id="50113641000117102">
                  <Quantity>5</Quantity>
                  <Price>8.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A3112">
        <Name>Decongestants and Antiallergics</Name>
        <ATC3 ID="A311204">
          <Name>Antiallergic Preparations</Name>
          <Chemical ID="C3112048254">
            <Name>Levocabastine</Name>
            <Formulation ID="F311204825401" Rank="3" Units="ml">
              <Name>Eye drops 0.05%</Name>
              <Brand ID="B31120482540100">
                <Name>Any</Name>
                <Pack ID="P82540100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3112048266">
            <Name>Lodoxamide</Name>
            <Formulation ID="F311204826601" Rank="3" Units="ml">
              <Name>Eye drops 0.1%</Name>
              <Brand ID="B31120482660125">
                <Name>Lomide</Name>
                <Pack ID="P424544" Specified="true" nzmt:ctpp_id="50084301000117102">
                  <Quantity>10</Quantity>
                  <Price>8.71</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3112048330">
            <Name>Olopatadine</Name>
            <Formulation ID="F311204833001" Rank="3" Units="ml">
              <Name>Eye drops 0.1%</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B31120483300126" PSS="true">
                <Name>Olopatadine Teva</Name>
                <Pack ID="P2588048" Specified="true" nzmt:ctpp_id="50247531000117106">
                  <Quantity>5</Quantity>
                  <Price>2.17</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3112048427">
            <Name>Sodium cromoglicate</Name>
            <Formulation ID="F311204842702" Rank="3" Units="ml">
              <Name>Eye drops 2%</Name>
              <Rule Type="DVLimit" Attribute="Mar-23 to~2025" Value="5"/>
              <Brand ID="B31120484270226" PSS="true">
                <Name>Allerfix</Name>
                <Pack ID="P2645416" Specified="true" nzmt:ctpp_id="50306321000117102">
                  <Quantity>10</Quantity>
                  <Price>2.62</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A311208">
          <Name>Decongestants</Name>
          <Chemical ID="C3112089592">
            <Name>Naphazoline hydrochloride</Name>
            <Formulation ID="F311208959225" Rank="3" Units="ml">
              <Name>Eye drops 0.1%</Name>
              <Rule Type="DVLimit" Attribute="Jan-25 to~2027" Value="5"/>
              <Brand ID="B31120895922525" ToBeDelisted="2025-01-01">
                <Name>Naphcon Forte</Name>
                <Pack ID="P211265" Specified="true" nzmt:ctpp_id="50019891000117101">
                  <Quantity>15</Quantity>
                  <Price>4.15</Price>
                </Pack>
              </Brand>
              <Brand ID="B31120895922526" PSS="true">
                <Name>Albalon</Name>
                <Pack ID="P200182" Specified="true" nzmt:ctpp_id="50000211000117100">
                  <Quantity>15</Quantity>
                  <Price>5.65</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A3116">
        <Name>Diagnostic and Surgical Preparations</Name>
        <ATC3 ID="A311604">
          <Name>Diagnostic Dyes</Name>
          <Chemical ID="C3116048190">
            <Name>Fluorescein sodium with lignocaine hydrochloride</Name>
            <Formulation ID="F311604819001" Rank="3" Units="ml">
              <Name>Eye drops 0.25% with lignocaine hydrochloride 4%, single dose</Name>
              <Brand ID="B31160481900100">
                <Name>Any</Name>
                <Pack ID="P81900100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3116048265">
            <Name>Lissamine green</Name>
            <Formulation ID="F311604826501" Rank="10" Units="strip">
              <Name>Ophthalmic strips 1.5 mg</Name>
              <Brand ID="B31160482650100">
                <Name>Any</Name>
                <Pack ID="P82650100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3116048409">
            <Name>Rose bengal sodium</Name>
            <Formulation ID="F311604840901" Rank="10" Units="strip">
              <Name>Ophthalmic strips 1%</Name>
              <Brand ID="B31160484090100">
                <Name>Any</Name>
                <Pack ID="P84090100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3116049553">
            <Name>Fluorescein sodium</Name>
            <Formulation ID="F311604955301" Rank="3" Units="ml">
              <Name>Eye drops 2%, single dose</Name>
              <Brand ID="B31160495530100">
                <Name>Any</Name>
                <Pack ID="P95530100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F311604955302" Rank="10" Units="strip">
              <Name>Ophthalmic strips 1 mg</Name>
              <Brand ID="B31160495530200">
                <Name>Any</Name>
                <Pack ID="P95530200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F311604955325" Rank="4" Units="inj">
              <Name>Inj 10%, 5 ml vial</Name>
              <Brand ID="B31160495532525">
                <Name>Fluorescite</Name>
                <Pack ID="P702862" Specified="true" nzmt:ctpp_id="50103631000117107">
                  <Quantity>12</Quantity>
                  <Price>125.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A311608">
          <Name>Irrigation Solutions</Name>
          <Chemical ID="C3116088074">
            <Name>Mixed salt solution for eye irrigation</Name>
            <Formulation ID="F311608807401" Rank="3" Units="ml" Weight="15">
              <Name>Eye irrigation solution calcium chloride 0.048% with magnesium chloride 0.03%, potassium chloride 0.075%, sodium acetate 0.39%, sodium chloride 0.64%  and sodium citrate 0.17%, 15 ml dropper bottle</Name>
              <Brand ID="B31160880740125">
                <Name>Balanced Salt Solution</Name>
                <Pack ID="P200913" Specified="true" nzmt:ctpp_id="50000951000117107">
                  <Quantity>15</Quantity>
                  <Price>5.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F311608807402" Rank="3" Units="ml" Weight="250">
              <Name>Eye irrigation solution calcium chloride 0.048% with magnesium chloride 0.03%, potassium chloride 0.075%, sodium acetate 0.39%, sodium chloride 0.64% and sodium citrate 0.17%, 250 ml</Name>
              <Brand ID="B31160880740200">
                <Name>e.g. Balanced Salt Solution</Name>
                <Pack ID="P80740200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F311608807403" Rank="3" Units="ml" Weight="500">
              <Name>Eye irrigation solution calcium chloride 0.048% with magnesium chloride 0.03%, potassium chloride 0.075%, sodium acetate 0.39%, sodium chloride 0.64% and sodium citrate 0.17%, 500 ml bottle</Name>
              <Brand ID="B31160880740325">
                <Name>Balanced Salt Solution</Name>
                <Pack ID="P286850" Specified="true" nzmt:ctpp_id="50064711000117100">
                  <Quantity>500</Quantity>
                  <Price>10.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F311608807425" Rank="3" Units="ml" Weight="500">
              <Name>Eye irrigation solution calcium chloride 0.048% with magnesium chloride 0.03%, potassium chloride 0.075%, sodium acetate 0.39%, sodium chloride 0.64% and sodium citrate 0.17%, 500 ml bag</Name>
              <Brand ID="B31160880742500">
                <Name>e.g. Balanced Salt Solution</Name>
                <Pack ID="P80742500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A311612">
          <Name>Ocular Anaesthetics</Name>
          <Chemical ID="C3116128336">
            <Name>Oxybuprocaine hydrochloride</Name>
            <Formulation ID="F311612833601" Rank="3" Units="ml">
              <Name>Eye drops 0.4%, single dose</Name>
              <Brand ID="B31161283360100">
                <Name>Any</Name>
                <Pack ID="P83360100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3116128460">
            <Name>Tetracaine [Amethocaine] hydrochloride</Name>
            <Formulation ID="F311612846001" Rank="3" Units="ml">
              <Name>Eye drops 0.5%, single dose</Name>
              <Brand ID="B31161284600100">
                <Name>Any</Name>
                <Pack ID="P84600100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F311612846002" Rank="3" Units="ml">
              <Name>Eye drops 1%, single dose</Name>
              <Brand ID="B31161284600200">
                <Name>Any</Name>
                <Pack ID="P84600200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3116128542">
            <Name>Proxymetacaine hydrochloride</Name>
            <Formulation ID="F311612854225" Rank="3" Units="ml">
              <Name>Eye drops 0.5%</Name>
              <Brand ID="B31161285422500">
                <Name>Any</Name>
                <Pack ID="P85422500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A311616">
          <Name>Viscoelastic Substances</Name>
          <Chemical ID="C3116168429">
            <Name>Sodium hyaluronate [Hyaluronic acid] with chondroitin sulphate</Name>
            <Formulation ID="F311616842901" Rank="4" Units="inj" Weight="30">
              <Name>Inj 30 mg per ml with chondroitin sulphate 40 mg per ml, 0.35 ml syringe and inj 10 mg sodium hyaluronate [hyaluronic acid] per ml, 0.4 ml syringe</Name>
              <Brand ID="B31161684290125">
                <Name>Duovisc</Name>
                <Pack ID="P2099292" Specified="true" nzmt:ctpp_id="50018311000117107">
                  <Quantity>1</Quantity>
                  <Price>64.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F311616842902" Rank="4" Units="inj" Weight="30">
              <Name>Inj 30 mg per ml with chondroitin sulphate 40 mg per ml, 0.5 ml syringe and inj 10 mg sodium hyaluronate [hyaluronic acid] per ml, 0.55 ml syringe</Name>
              <Brand ID="B31161684290225">
                <Name>Duovisc</Name>
                <Pack ID="P2177544" Specified="true" nzmt:ctpp_id="50015511000117105">
                  <Quantity>1</Quantity>
                  <Price>74.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F311616842903" Rank="4" Units="inj" Weight="30">
              <Name>Inj 30 mg per ml with chondroitin sulphate 40 mg per ml, 0.75 ml syringe</Name>
              <Brand ID="B31161684290325">
                <Name>Viscoat</Name>
                <Pack ID="P2195364" Specified="true" nzmt:ctpp_id="50031271000117107">
                  <Quantity>1</Quantity>
                  <Price>67.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3116169170">
            <Name>Sodium hyaluronate [Hyaluronic acid]</Name>
            <Formulation ID="F311616917002" Rank="4" Units="inj" Weight="23">
              <Name>Inj 23 mg per ml, 0.6 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B31161691700225" PSS="true">
                <Name>Healon 5</Name>
                <Pack ID="P346721" Specified="true" nzmt:ctpp_id="50076091000117108">
                  <Quantity>1</Quantity>
                  <Price>60.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F311616917025" Rank="10" Units="syr">
              <Name>Inj 10 mg per ml, 0.85 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B31161691702525" PSS="true">
                <Name>Healon</Name>
                <Pack ID="P470619" Specified="true" nzmt:ctpp_id="50088511000117100">
                  <Quantity>1</Quantity>
                  <Price>28.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F311616917028" Rank="4" Units="inj">
              <Name>Inj 14 mg per ml, 0.85 ml syringe</Name>
              <Brand ID="B31161691702825">
                <Name>Healon GV</Name>
                <Pack ID="P2271591" Specified="true" nzmt:ctpp_id="50042561000117107">
                  <Quantity>1</Quantity>
                  <Price>50.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F311616917029" Rank="4" Units="inj" Weight="18">
              <Name>Inj 18 mg per ml, 0.85 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-22 to~2025" Value="5"/>
              <Brand ID="B31161691702925" PSS="true">
                <Name>Healon GV Pro</Name>
                <Pack ID="P2618540" Specified="true" nzmt:ctpp_id="50290111000117101">
                  <Quantity>1</Quantity>
                  <Price>50.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3116169471">
            <Name>Hypromellose</Name>
            <Formulation ID="F311616947101" Rank="4" Units="inj">
              <Name>Inj 2%, 1 ml syringe</Name>
              <Brand ID="B31161694710100">
                <Name>Any</Name>
                <Pack ID="P94710100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F311616947102" Rank="4" Units="inj">
              <Name>Inj 2%, 2 ml syringe</Name>
              <Brand ID="B31161694710200">
                <Name>Any</Name>
                <Pack ID="P94710200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A311620">
          <Name>Other</Name>
          <Chemical ID="C3116208153">
            <Name>Disodium edetate</Name>
            <Formulation ID="F311620815301" Rank="4" Units="inj" Weight="15000">
              <Name>Inj 150 mg per ml, 100 ml vial</Name>
              <Brand ID="B31162081530100">
                <Name>Any</Name>
                <Pack ID="P81530100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F311620815302" Rank="4" Units="inj" Weight="3000">
              <Name>Inj 150 mg per ml, 20 ml ampoule</Name>
              <Brand ID="B31162081530200">
                <Name>Any</Name>
                <Pack ID="P81530200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F311620815303" Rank="4" Units="inj" Weight="3000">
              <Name>Inj 150 mg per ml, 20 ml vial</Name>
              <Brand ID="B31162081530300">
                <Name>Any</Name>
                <Pack ID="P81530300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3116208543">
            <Name>Riboflavin 5-phosphate</Name>
            <Formulation ID="F311620854325" Rank="4" Units="inj">
              <Name>Inj 0.1%</Name>
              <Brand ID="B31162085432500">
                <Name>Any</Name>
                <Pack ID="P85432500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F311620854326" Rank="4" Units="inj">
              <Name>Inj 0.1% plus 20% dextran T500</Name>
              <Brand ID="B31162085432600">
                <Name>Any</Name>
                <Pack ID="P85432600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F311620854327" Rank="3" Units="ml">
              <Name>Soln trans epithelial riboflavin</Name>
              <Brand ID="B31162085432700">
                <Name>Any</Name>
                <Pack ID="P85432700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A3120">
        <Name>Glaucoma Preparations</Name>
        <ATC3 ID="A312004">
          <Name>Beta Blockers</Name>
          <Chemical ID="C3120048056">
            <Name>Betaxolol</Name>
            <Formulation ID="F312004805601" Rank="3" Units="ml">
              <Name>Eye drops 0.25%</Name>
              <Brand ID="B31200480560125" ToBeDelisted="2025-12-01">
                <Name>Betoptic S</Name>
                <Pack ID="P214558" Specified="true" nzmt:ctpp_id="50025131000117100">
                  <Quantity>5</Quantity>
                  <Price>11.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312004805602" Rank="3" Units="ml">
              <Name>Eye drops 0.5%</Name>
              <Brand ID="B31200480560225" ToBeDelisted="2025-12-01">
                <Name>Betoptic</Name>
                <Pack ID="P535982" Specified="true" nzmt:ctpp_id="50094921000117105">
                  <Quantity>5</Quantity>
                  <Price>7.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3120048473">
            <Name>Timolol</Name>
            <Formulation ID="F312004847301" Rank="3" Units="ml">
              <Name>Eye drops 0.25%</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B31200484730125" PSS="true">
                <Name>Arrow-Timolol</Name>
                <Pack ID="P2390663" Specified="true" nzmt:ctpp_id="50125551000117109">
                  <Quantity>5</Quantity>
                  <Price>2.42</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312004847303" Rank="3" Units="ml">
              <Name>Eye drops 0.5%</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B31200484730325" PSS="true">
                <Name>Arrow-Timolol</Name>
                <Pack ID="P2390655" Specified="true" nzmt:ctpp_id="50125561000117106">
                  <Quantity>5</Quantity>
                  <Price>2.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312004847304" Rank="3" Units="ml">
              <Name>Eye drops 0.5%, gel forming</Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
                <p>For continuation only</p>
              </div>
              <Brand ID="B31200484730400">
                <Name>Any</Name>
                <Pack ID="P84730400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A312008">
          <Name>Carbonic Anhydrase Inhibitors</Name>
          <Chemical ID="C3120088067">
            <Name>Brinzolamide</Name>
            <Formulation ID="F312008806701" Rank="3" Units="ml">
              <Name>Eye drops 1%</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B31200880670125" PSS="true">
                <Name>Azopt</Name>
                <Pack ID="P2117061" Specified="true" nzmt:ctpp_id="50020791000117106">
                  <Quantity>5</Quantity>
                  <Price>5.11</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3120088158">
            <Name>Dorzolamide</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Restricted" style="display:inline">
              <p>For continuation only</p>
            </div>
            <Formulation ID="F312008815801" Rank="3" Units="ml">
              <Name>Eye drops 2%</Name>
              <Brand ID="B31200881580100">
                <Name>Any</Name>
                <Pack ID="P81580100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3120089447">
            <Name>Acetazolamide</Name>
            <Formulation ID="F312008944701" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg</Name>
              <Brand ID="B31200894470100">
                <Name>Any</Name>
                <Pack ID="P94470100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312008944725" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg</Name>
              <Brand ID="B31200894472525">
                <Name>Diamox</Name>
                <Pack ID="P2164795" Specified="true" nzmt:ctpp_id="50027581000117104">
                  <Quantity>100</Quantity>
                  <Price>17.03</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3120089501">
            <Name>Dorzolamide with timolol</Name>
            <Formulation ID="F312008950125" Rank="3" Units="ml">
              <Name>Eye drops 2% with timolol 0.5%</Name>
              <Rule Type="DVLimit" Attribute="Feb-25 to~2027" Value="5"/>
              <Brand ID="B31200895012527" PSS="true">
                <Name>Dortimopt</Name>
                <Pack ID="P2398354" Specified="true" nzmt:ctpp_id="50255151000117104">
                  <Quantity>5</Quantity>
                  <Price>3.58</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A312012">
          <Name>Miotics</Name>
          <Chemical ID="C3120128004">
            <Name>Acetylcholine chloride</Name>
            <Formulation ID="F312012800401" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mg vial with diluent</Name>
              <Brand ID="B31201280040100">
                <Name>Any</Name>
                <Pack ID="P80040100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3120128365">
            <Name>Pilocarpine hydrochloride</Name>
            <Formulation ID="F312012836501" Rank="3" Units="ml">
              <Name>Eye drops 1%</Name>
              <Brand ID="B31201283650125">
                <Name>Isopto Carpine</Name>
                <Pack ID="P252514" Specified="true" nzmt:ctpp_id="50053381000117102">
                  <Quantity>15</Quantity>
                  <Price>4.26</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312012836502" Rank="3" Units="ml">
              <Name>Eye drops 2%</Name>
              <Brand ID="B31201283650225">
                <Name>Isopto Carpine</Name>
                <Pack ID="P252522" Specified="true" nzmt:ctpp_id="50053391000117104">
                  <Quantity>15</Quantity>
                  <Price>5.35</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312012836525" Rank="3" Units="ml">
              <Name>Eye drops 4%</Name>
              <Brand ID="B31201283652525">
                <Name>Isopto Carpine</Name>
                <Pack ID="P252549" Specified="true" nzmt:ctpp_id="50053411000117104">
                  <Quantity>15</Quantity>
                  <Price>7.99</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3120128366">
            <Name>Pilocarpine nitrate</Name>
            <Formulation ID="F312012836603" Rank="3" Units="ml">
              <Name>Eye drops 2%, single dose</Name>
              <Brand ID="B31201283660300">
                <Name>Any</Name>
                <Pack ID="P83660100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3120128645">
            <Name>Carbachol</Name>
            <Formulation ID="F312012864525" Rank="4" Units="inj" Weight="150">
              <Name>Inj 150 mcg vial</Name>
              <Brand ID="B31201286452500">
                <Name>Any</Name>
                <Pack ID="P86452500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A312016">
          <Name>Prostaglandin Analogues</Name>
          <Chemical ID="C3120168058">
            <Name>Bimatoprost</Name>
            <Formulation ID="F312016805801" Rank="3" Units="ml">
              <Name>Eye drops 0.03%</Name>
              <Rule Type="DVLimit" Attribute="Jan-25 to~2027" Value="5"/>
              <Brand ID="B31201680580126" ToBeDelisted="2025-01-01">
                <Name>Bimatoprost Multichem</Name>
                <Pack ID="P2545128" Specified="true" nzmt:ctpp_id="50229761000117104">
                  <Quantity>3</Quantity>
                  <Price>5.95</Price>
                </Pack>
              </Brand>
              <Brand ID="B31201680580127" PSS="true">
                <Name>Lumigan</Name>
                <Pack ID="P2109220" Specified="true" nzmt:ctpp_id="50019511000117107">
                  <Quantity>3</Quantity>
                  <Price>5.15</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3120168476">
            <Name>Travoprost</Name>
            <Formulation ID="F312016847601" Rank="3" Units="ml">
              <Name>Eye drops 0.004%</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B31201684760126" PSS="true">
                <Name>Travatan</Name>
                <Pack ID="P2550091" Specified="true" nzmt:ctpp_id="50024921000117104">
                  <Quantity>2.5</Quantity>
                  <Price>6.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3120168667">
            <Name>Latanoprost with timolol</Name>
            <Formulation ID="F312016866725" Rank="3" Units="ml">
              <Name>Eye drops 0.005% with timolol 0.5%</Name>
              <Rule Type="DVLimit" Attribute="Mar-24 to~2026" Value="5"/>
              <Brand ID="B31201686672525" PSS="true">
                <Name>Arrow - Lattim</Name>
                <Pack ID="P2597861" Specified="true" nzmt:ctpp_id="50159261000117107">
                  <Quantity>2.5</Quantity>
                  <Price>4.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3120169653">
            <Name>Latanoprost</Name>
            <Formulation ID="F312016965325" Rank="3" Units="ml">
              <Name>Eye drops 0.005%</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B31201696532526" PSS="true">
                <Name>Teva</Name>
                <Pack ID="P2553139" Specified="true" nzmt:ctpp_id="50246471000117108">
                  <Quantity>2.5</Quantity>
                  <Price>2.08</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A312020">
          <Name>Sympathomimetics</Name>
          <Chemical ID="C3120208034">
            <Name>Apraclonidine</Name>
            <Formulation ID="F312020803401" Rank="3" Units="ml">
              <Name>Eye drops 0.5%</Name>
              <Brand ID="B31202080340125">
                <Name>Iopidine</Name>
                <Pack ID="P296295" Specified="true" nzmt:ctpp_id="50066161000117105">
                  <Quantity>5</Quantity>
                  <Price>19.77</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3120208066">
            <Name>Brimonidine tartrate with timolol maleate</Name>
            <Formulation ID="F312020806601" Rank="3" Units="ml">
              <Name>Eye drops 0.2% with timolol 0.5%</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B31202080660125" PSS="true">
                <Name>Combigan</Name>
                <Pack ID="P2203502" Specified="true" nzmt:ctpp_id="50032171000117106">
                  <Quantity>5</Quantity>
                  <Price>7.13</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3120209429">
            <Name>Brimonidine tartrate</Name>
            <Formulation ID="F312020942925" Rank="3" Units="ml">
              <Name>Eye drops 0.2%</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B31202094292526" PSS="true">
                <Name>Arrow-Brimonidine</Name>
                <Pack ID="P2396513" Specified="true" nzmt:ctpp_id="50127571000117109">
                  <Quantity>5</Quantity>
                  <Price>5.16</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A3124">
        <Name>Mydriatics and Cycloplegics</Name>
        <ATC3 ID="A312404">
          <Name>Anticholinergic Agents</Name>
          <Chemical ID="C3124048118">
            <Name>Cyclopentolate hydrochloride</Name>
            <Formulation ID="F312404811801" Rank="3" Units="ml">
              <Name>Eye drops 0.5%, single dose</Name>
              <Brand ID="B31240481180100">
                <Name>Any</Name>
                <Pack ID="P81180100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312404811802" Rank="3" Units="ml">
              <Name>Eye drops 1%</Name>
              <Brand ID="B31240481180225">
                <Name>Cyclogyl</Name>
                <Pack ID="P203351" Specified="true" nzmt:ctpp_id="50006351000117105">
                  <Quantity>15</Quantity>
                  <Price>8.76</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312404811803" Rank="3" Units="ml">
              <Name>Eye drops 1%, single dose</Name>
              <Brand ID="B31240481180300">
                <Name>Any</Name>
                <Pack ID="P81180300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3124049003">
            <Name>Atropine sulphate</Name>
            <Formulation ID="F312404900301" Rank="3" Units="ml">
              <Name>Eye drops 0.5%</Name>
              <Brand ID="B31240490030100">
                <Name>Any</Name>
                <Pack ID="P90030100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312404900302" Rank="3" Units="ml">
              <Name>Eye drops 1%, single dose</Name>
              <Brand ID="B31240490030200">
                <Name>Any</Name>
                <Pack ID="P90030200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312404900325" Rank="3" Units="ml" Weight="1">
              <Name>Eye drops 1%</Name>
              <Rule Type="DVLimit" Attribute="Feb-24 to~2026" Value="5"/>
              <Brand ID="B31240490032525" PSS="true">
                <Name>Atropt</Name>
                <Pack ID="P200905" Specified="true" nzmt:ctpp_id="50000941000117105">
                  <Quantity>15</Quantity>
                  <Price>18.27</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3124049600">
            <Name>Tropicamide</Name>
            <Formulation ID="F312404960001" Rank="3" Units="ml">
              <Name>Eye drops 0.5%, single dose</Name>
              <Brand ID="B31240496000100">
                <Name>Any</Name>
                <Pack ID="P96000100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312404960002" Rank="3" Units="ml">
              <Name>Eye drops 1%, single dose</Name>
              <Brand ID="B31240496000200">
                <Name>Any</Name>
                <Pack ID="P96000200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312404960025" Rank="3" Units="ml">
              <Name>Eye drops 0.5%</Name>
              <Brand ID="B31240496002525">
                <Name>Mydriacyl</Name>
                <Pack ID="P253995" Specified="true" nzmt:ctpp_id="50054201000117101">
                  <Quantity>15</Quantity>
                  <Price>7.15</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312404960026" Rank="3" Units="ml">
              <Name>Eye drops 1%</Name>
              <Brand ID="B31240496002625">
                <Name>Mydriacyl</Name>
                <Pack ID="P254002" Specified="true" nzmt:ctpp_id="50054211000117103">
                  <Quantity>15</Quantity>
                  <Price>8.66</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A312408">
          <Name>Sympathomimetics</Name>
          <Chemical ID="C3124089225">
            <Name>Phenylephrine hydrochloride</Name>
            <Formulation ID="F312408922501" Rank="3" Units="ml" Weight="10">
              <Name>Eye drops 10%, single dose</Name>
              <Brand ID="B31240892250100">
                <Name>Any</Name>
                <Pack ID="P92250100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312408922502" Rank="3" Units="ml" Weight="2.5">
              <Name>Eye drops 2.5%, single dose</Name>
              <Brand ID="B31240892250200">
                <Name>Any</Name>
                <Pack ID="P92250200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A3128">
        <Name>Ocular Lubricants</Name>
        <ATC3 ID="A312804">
          <Name>Ocular Lubricants</Name>
          <Chemical ID="C3128048079">
            <Name>Carbomer</Name>
            <Formulation ID="F312804807901" Rank="10" Units="strip">
              <Name>Ophthalmic gel 0.2%</Name>
              <Brand ID="B31280480790100">
                <Name>Any</Name>
                <Pack ID="P80790100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312804807902" Rank="10" Units="conta">
              <Name>Ophthalmic gel 0.3%, single dose</Name>
              <Brand ID="B31280480790225" ToBeDelisted="2025-07-01">
                <Name>Poly Gel</Name>
                <Pack ID="P2181827" Specified="true" nzmt:ctpp_id="50029801000117102">
                  <Quantity>30</Quantity>
                  <Price>8.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3128048082">
            <Name>Carmellose sodium with pectin and gelatine</Name>
            <Formulation ID="F312804808201" Rank="3" Units="ml">
              <Name>Eye drops 0.5%</Name>
              <Brand ID="B31280480820100">
                <Name>Any</Name>
                <Pack ID="P80820100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312804808202" Rank="3" Units="ml">
              <Name>Eye drops 0.5%, single dose</Name>
              <Brand ID="B31280480820200">
                <Name>Any</Name>
                <Pack ID="P80820200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312804808203" Rank="3" Units="ml">
              <Name>Eye drops 1%</Name>
              <Brand ID="B31280480820300">
                <Name>Any</Name>
                <Pack ID="P80820300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312804808204" Rank="3" Units="ml">
              <Name>Eye drops 1%, single dose</Name>
              <Brand ID="B31280480820400">
                <Name>Any</Name>
                <Pack ID="P80820400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3128048223">
            <Name>Hypromellose with dextran</Name>
            <Formulation ID="F312804822301" Rank="3" Units="ml">
              <Name>Eye drops 0.3% with dextran 0.1%</Name>
              <Brand ID="B31280482230125">
                <Name>Poly-Tears</Name>
                <Pack ID="P229075" Specified="true" nzmt:ctpp_id="50044621000117109">
                  <Quantity>15</Quantity>
                  <Price>2.30</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312804822302" Rank="3" Units="ml">
              <Name>Eye drops 0.3% with dextran 0.1%, single dose</Name>
              <Brand ID="B31280482230200">
                <Name>Any</Name>
                <Pack ID="P82230200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3128048342">
            <Name>Paraffin liquid with wool fat</Name>
            <Formulation ID="F312804834201" Rank="3" Units="g">
              <Name>Eye oint 3% with wool fat 3%</Name>
              <Brand ID="B31280483420125">
                <Name>Poly-Visc</Name>
                <Pack ID="P2035812" Specified="true" nzmt:ctpp_id="50007031000117100">
                  <Quantity>3.5</Quantity>
                  <Price>3.63</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3128048374">
            <Name>Polyvinyl alcohol with povidone</Name>
            <Formulation ID="F312804837401" Rank="3" Units="ml">
              <Name>Eye drops 1.4% with povidone 0.6%, single dose</Name>
              <Brand ID="B31280483740100">
                <Name>Any</Name>
                <Pack ID="P83740100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3128048517">
            <Name>Retinol Palmitate</Name>
            <Formulation ID="F312804851725" Rank="3" Units="g">
              <Name>Oint 138 mcg per g</Name>
              <Brand ID="B31280485172525">
                <Name>VitA-POS</Name>
                <Pack ID="P2396246" Specified="true" nzmt:ctpp_id="50176251000117100">
                  <Quantity>5</Quantity>
                  <Price>3.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3128048524">
            <Name>Polyethylene glycol 400 and propylene glycol</Name>
            <Formulation ID="F312804852425" Rank="10" Units="vial">
              <Name>Eye drops 0.4% with propylene glycol 0.3% preservative free, single dose</Name>
              <Brand ID="B31280485242525">
                <Name>Systane Unit Dose</Name>
                <Pack ID="P2640120" Specified="true" nzmt:ctpp_id="50290361000117100">
                  <Quantity>30</Quantity>
                  <Price>10.78</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F312804852426" Rank="3" Units="ml" Weight="10">
              <Name>Eye drops 0.4% with propylene glycol 0.3%, 10 ml bottle</Name>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Note: Only for use in compounding an eye drop formulation </p>
              </div>
              <Brand ID="B31280485242600">
                <Name>Any</Name>
                <Pack ID="P85242600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3128049170">
            <Name>Sodium hyaluronate [Hyaluronic acid]</Name>
            <Formulation ID="F312804917027" Rank="3" Units="ml">
              <Name>Eye drops 1 mg per ml</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B31280491702725" PSS="true">
                <Name>Hylo-Fresh</Name>
                <Pack ID="P2608162" Specified="true" nzmt:ctpp_id="50137101000117107">
                  <Quantity>10</Quantity>
                  <Price>13.58</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3128049471">
            <Name>Hypromellose</Name>
            <Formulation ID="F312804947125" Rank="3" Units="ml">
              <Name>Eye drops 0.5%</Name>
              <Brand ID="B31280494712525">
                <Name>Methopt</Name>
                <Pack ID="P2603608" Specified="true" nzmt:ctpp_id="50012351000117106">
                  <Quantity>15</Quantity>
                  <Price>19.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3128049556">
            <Name>Paraffin liquid with soft white paraffin</Name>
            <Formulation ID="F312804955601" Rank="3" Units="ml">
              <Name>Eye oint 42.5% with soft white paraffin 57.3%</Name>
              <Brand ID="B31280495560100">
                <Name>Any</Name>
                <Pack ID="P95560100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A3132">
        <Name>Other Otological Preparations</Name>
        <ATC3 ID="A313204">
          <Name>Other Otological Preparations</Name>
          <Chemical ID="C3132048003">
            <Name>Acetic acid with propylene glycol</Name>
            <Formulation ID="F313204800301" Rank="3" Units="ml">
              <Name>Ear drops 2.3% with propylene glycol 2.8%</Name>
              <Brand ID="B31320480030100">
                <Name>Any</Name>
                <Pack ID="P80030100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3132049530">
            <Name>Docusate sodium</Name>
            <Formulation ID="F313204953001" Rank="3" Units="ml">
              <Name>Ear drops 0.5%</Name>
              <Brand ID="B31320495300100">
                <Name>Any</Name>
                <Pack ID="P95300100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
    <ATC1 ID="A35">
      <Name>Various</Name>
      <ATC2 ID="A3504">
        <Name>Agents Used in the Treatment of Poisonings</Name>
        <ATC3 ID="A350404">
          <Name>Antidotes</Name>
          <Chemical ID="C3504048031">
            <Name>Amyl nitrite</Name>
            <Formulation ID="F350404803101" Rank="3" Units="ml">
              <Name>Liq 98% in 3 ml capsule</Name>
              <Brand ID="B35040480310100">
                <Name>Any</Name>
                <Pack ID="P80310100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504048140">
            <Name>Digoxin immune Fab</Name>
            <Formulation ID="F350404814001" Rank="4" Units="inj" Weight="38">
              <Name>Inj 38 mg vial</Name>
              <Brand ID="B35040481400100">
                <Name>Any</Name>
                <Pack ID="P81400100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350404814002" Rank="4" Units="inj" Weight="40">
              <Name>Inj 40 mg vial</Name>
              <Brand ID="B35040481400200">
                <Name>Any</Name>
                <Pack ID="P81400200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504048171">
            <Name>Ethanol with glucose</Name>
            <Formulation ID="F350404817101" Rank="4" Units="inj">
              <Name>Inj 10% with glucose 5%, 500 ml bottle</Name>
              <Brand ID="B35040481710100">
                <Name>Any</Name>
                <Pack ID="P81710100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504048172">
            <Name>Ethanol, dehydrated</Name>
            <Formulation ID="F350404817201" Rank="4" Units="inj">
              <Name>Inj 100%, 5 ml ampoule</Name>
              <Brand ID="B35040481720100">
                <Name>Any</Name>
                <Pack ID="P81720100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350404817225" Rank="4" Units="inj">
              <Name>Inj 96%</Name>
              <Brand ID="B35040481722500">
                <Name>Any</Name>
                <Pack ID="P81722500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504048382">
            <Name>Pralidoxime iodide</Name>
            <Formulation ID="F350404838201" Rank="4" Units="inj" Weight="25">
              <Name>Inj 25 mg per ml, 20 ml ampoule</Name>
              <Brand ID="B35040483820100">
                <Name>Any</Name>
                <Pack ID="P83820100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504048432">
            <Name>Sodium nitrite</Name>
            <Formulation ID="F350404843201" Rank="4" Units="inj" Weight="30">
              <Name>Inj 30 mg per ml, 10 ml ampoule</Name>
              <Brand ID="B35040484320100">
                <Name>Any</Name>
                <Pack ID="P84320100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504048438">
            <Name>Sodium thiosulfate</Name>
            <Formulation ID="F350404843801" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 mg per ml, 10 ml vial</Name>
              <Brand ID="B35040484380100">
                <Name>Any</Name>
                <Pack ID="P84380100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350404843802" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg per ml, 10 ml vial</Name>
              <Brand ID="B35040484380200">
                <Name>Any</Name>
                <Pack ID="P84380200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350404843825" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg per ml, 20 ml ampoule</Name>
              <Brand ID="B35040484382500">
                <Name>Any</Name>
                <Pack ID="P84382500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350404843826" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 mg per ml. 50 ml vial</Name>
              <Brand ID="B35040484382600">
                <Name>Any</Name>
                <Pack ID="P84382600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350404843827" Rank="4" Units="inj">
              <Name>Inj 250 mg per ml, 100 ml vial</Name>
              <Brand ID="B35040484382700">
                <Name>Any</Name>
                <Pack ID="P84382700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504048442">
            <Name>Soya oil</Name>
            <Formulation ID="F350404844201" Rank="4" Units="inj">
              <Name>Inj 20%, 500 ml bag</Name>
              <Brand ID="B35040484420100">
                <Name>Any</Name>
                <Pack ID="P84420100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350404844202" Rank="4" Units="inj">
              <Name>Inj 20%, 500 ml bottle</Name>
              <Brand ID="B35040484420200">
                <Name>Any</Name>
                <Pack ID="P84420200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504048518">
            <Name>Ethanol</Name>
            <Formulation ID="F350404851825" Rank="3" Units="ml">
              <Name>Liq 96%</Name>
              <Brand ID="B35040485182500">
                <Name>Any</Name>
                <Pack ID="P85182500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504048734">
            <Name>Pralidoxime chloride</Name>
            <Formulation ID="F350404873425" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 g vial</Name>
              <Brand ID="B35040487342500">
                <Name>Any</Name>
                <Pack ID="P87342500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504049021">
            <Name>Flumazenil</Name>
            <Formulation ID="F350404902101" Rank="4" Units="inj" Weight="0.1">
              <Name>Inj 0.1 mg per ml, 5 ml ampoule</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B35040490210125" ToBeDelisted="2024-12-01">
                <Name>Hameln</Name>
                <Pack ID="P2558904" Specified="true" nzmt:ctpp_id="50221631000117100">
                  <Quantity>10</Quantity>
                  <Price>110.12</Price>
                </Pack>
              </Brand>
              <Brand ID="B35040490210126" PSS="true">
                <Name>Flumazenil-Baxter</Name>
                <Pack ID="P2599481" Specified="true" nzmt:ctpp_id="50267171000117106">
                  <Quantity>5</Quantity>
                  <Price>44.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504049232">
            <Name>Naloxone hydrochloride</Name>
            <Formulation ID="F350404923225" Rank="4" Units="inj" Weight="400">
              <Name>Inj 400 mcg per ml, 1 ml ampoule</Name>
              <Brand ID="B35040492322526">
                <Name>Hameln</Name>
                <Pack ID="P2634090" Specified="true" nzmt:ctpp_id="50220971000117101">
                  <Quantity>10</Quantity>
                  <Price>35.26</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504049284">
            <Name>Hydroxocobalamin</Name>
            <Formulation ID="F350404928401" Rank="4" Units="inj" Weight="2.5">
              <Name>Inj 2.5 g vial</Name>
              <Brand ID="B35040492840100">
                <Name>Any</Name>
                <Pack ID="P92840100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350404928425" Rank="4" Units="inj">
              <Name>Inj 5 g vial</Name>
              <Brand ID="B35040492842500">
                <Name>Any</Name>
                <Pack ID="P92842500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504049476">
            <Name>Acetylcysteine</Name>
            <Formulation ID="F350404947601" Rank="1" Units="tab">
              <Name>Tab eff 200 mg</Name>
              <Brand ID="B35040494760100">
                <Name>Any</Name>
                <Pack ID="P94760100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350404947625" Rank="4" Units="inj" Weight="2000">
              <Name>Inj 200 mg per ml, 10 ml ampoule</Name>
              <Brand ID="B35040494762527">
                <Name>Martindale Pharma</Name>
                <Pack ID="P2634864" Specified="true" nzmt:ctpp_id="50048471000117104">
                  <Quantity>10</Quantity>
                  <Price>52.88</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A350408">
          <Name>Antitoxins</Name>
          <Chemical ID="C3504088064">
            <Name>Botulism antitoxin</Name>
            <Formulation ID="F350408806401" Rank="4" Units="inj" Weight="250">
              <Name>Inj 250 ml vial</Name>
              <Brand ID="B35040880640100">
                <Name>Any</Name>
                <Pack ID="P80640100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504088149">
            <Name>Diphtheria antitoxin</Name>
            <Formulation ID="F350408814901" Rank="4" Units="inj" Weight="10000">
              <Name>Inj 10,000 iu vial</Name>
              <Brand ID="B35040881490100">
                <Name>Any</Name>
                <Pack ID="P81490100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A350412">
          <Name>Antivenoms</Name>
          <Chemical ID="C3504128406">
            <Name>Red back spider antivenom</Name>
            <Formulation ID="F350412840601" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 u vial</Name>
              <Brand ID="B35041284060100">
                <Name>Any</Name>
                <Pack ID="P84060100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504128416">
            <Name>Snake antivenom</Name>
            <Formulation ID="F350412841601" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 ml vial</Name>
              <Brand ID="B35041284160100">
                <Name>Any</Name>
                <Pack ID="P84160100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A350416">
          <Name>Removal and Elimination</Name>
          <Chemical ID="C3504168136">
            <Name>Dicobalt edetate</Name>
            <Formulation ID="F350416813601" Rank="4" Units="inj" Weight="15">
              <Name>Inj 15 mg per ml, 20 ml ampoule</Name>
              <Brand ID="B35041681360100">
                <Name>Any</Name>
                <Pack ID="P81360100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504168142">
            <Name>Dimercaprol</Name>
            <Formulation ID="F350416814201" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 2 ml ampoule</Name>
              <Brand ID="B35041681420100">
                <Name>Any</Name>
                <Pack ID="P81420100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504168143">
            <Name>Dimercaptosuccinic acid</Name>
            <Formulation ID="F350416814301" Rank="2" Units="cap" Weight="100">
              <Name>Cap 100 mg</Name>
              <Brand ID="B35041681430100">
                <Name>e.g. PCNZ, Optimus Healthcare, Chemet</Name>
                <Pack ID="P81430100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350416814325" Rank="2" Units="cap" Weight="200">
              <Name>Cap 200 mg</Name>
              <Brand ID="B35041681432500">
                <Name>e.g. PCNZ, Optimus Healthcare, Chemet</Name>
                <Pack ID="P81432500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504168421">
            <Name>Sodium calcium edetate</Name>
            <Formulation ID="F350416842101" Rank="4" Units="inj" Weight="200">
              <Name>Inj 200 mg per ml, 2.5 ml ampoule</Name>
              <Brand ID="B35041684210100">
                <Name>Any</Name>
                <Pack ID="P84210100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350416842102" Rank="4" Units="inj" Weight="200">
              <Name>Inj 200 mg per ml, 5 ml ampoule</Name>
              <Brand ID="B35041684210200">
                <Name>Any</Name>
                <Pack ID="P84210200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350416842125" Rank="4" Units="inj">
              <Name>Inj 50 mg per ml, 10 ml ampoule</Name>
              <Brand ID="B35041684212500">
                <Name>Any</Name>
                <Pack ID="P84212500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504168562">
            <Name>Deferasirox</Name>
            <Request Form="RS1444" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Deferasirox</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has been diagnosed with chronic iron overload due to congenital inherited anaemia</ci>
                    <ci type="logical">Deferasirox is to be given at a daily dose not exceeding 40 mg/kg/day</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Treatment with maximum tolerated doses of deferiprone monotherapy or deferiprone and desferrioxamine combination therapy
                        have proven ineffective as measured by serum ferritin levels, liver or cardiac MRI T2*</ci>
                      <ci type="logical">Treatment with deferiprone has resulted in severe persistent vomiting or diarrhoea</ci>
                      <ci type="logical">Treatment with deferiprone has resulted in arthritis</ci>
                      <ci type="logical">Treatment with deferiprone is contraindicated due to a history of agranulocytosis (defined as an absolute neutrophil count (ANC) of &lt; 0.5 cells per µL) or recurrent episodes (greater than 2 episodes) of moderate neutropenia (ANC 0.5 - 1.0 cells per µL)</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="year">2</Term>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">For the first renewal following 2 years of therapy, the treatment has been tolerated and has resulted in clinical improvement in all
                    three parameters namely serum ferritin, cardiac MRI T2* and liver MRI T2* levels</ci>
                    <ci type="logical">For subsequent renewals, the treatment has been tolerated and has resulted in clinical stability or continued improvement in all
                    three parameters namely serum ferritin, cardiac MRI T2* and liver MRI T2* levels. </ci>
                  </apply>
                </math>
                <Applicant>haematologist</Applicant>
                <Term Measure="year">2</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1444" style="display:none"/>
            <Formulation ID="F350416856225" Rank="1" Units="tab" Weight="125">
              <Name>Tab 125 mg dispersible</Name>
              <Brand ID="B35041685622525">
                <Name>Exjade</Name>
                <Pack ID="P2234769" Specified="true" nzmt:ctpp_id="50037341000117104">
                  <Quantity>28</Quantity>
                  <Price>276.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350416856226" Rank="1" Units="tab" Weight="250">
              <Name>Tab 250 mg dispersible</Name>
              <Brand ID="B35041685622625">
                <Name>Exjade</Name>
                <Pack ID="P2234777" Specified="true" nzmt:ctpp_id="50037351000117102">
                  <Quantity>28</Quantity>
                  <Price>552.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350416856227" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg dispersible</Name>
              <Brand ID="B35041685622725">
                <Name>Exjade</Name>
                <Pack ID="P2234750" Specified="true" nzmt:ctpp_id="50037331000117107">
                  <Quantity>28</Quantity>
                  <Price>1105.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504169174">
            <Name>Desferrioxamine mesilate</Name>
            <Formulation ID="F350416917425" Rank="4" Units="inj" Weight="500">
              <Name>Inj 500 mg vial</Name>
              <Brand ID="B35041691742525">
                <Name>DBL Desferrioxamine Mesylate for Inj BP</Name>
                <Pack ID="P461598" Specified="true" nzmt:ctpp_id="50087711000117106">
                  <Quantity>10</Quantity>
                  <Price>151.31</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504169354">
            <Name>Charcoal</Name>
            <Formulation ID="F350416935401" Rank="3" Units="ml">
              <Name>Oral liq 200 mg per ml</Name>
              <Brand ID="B35041693540125">
                <Name>Carbasorb-X</Name>
                <Pack ID="P2189186" Specified="true" nzmt:ctpp_id="50030711000117101">
                  <Quantity>250</Quantity>
                  <Price>43.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3504169557">
            <Name>Deferiprone</Name>
            <Request Form="RS1445" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Deferiprone</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Patient has been diagnosed with chronic iron overload due to congenital inherited anaemia or acquired red cell aplasia</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1445" style="display:none"/>
            <Formulation ID="F350416955725" Rank="1" Units="tab" Weight="500">
              <Name>Tab 500 mg</Name>
              <Brand ID="B35041695572525">
                <Name>Ferriprox</Name>
                <Pack ID="P2369532" Specified="true" nzmt:ctpp_id="50119731000117100">
                  <Quantity>100</Quantity>
                  <Price>533.17</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350416955726" Rank="3" Units="ml">
              <Name>Oral liq 100 mg per ml</Name>
              <Brand ID="B35041695572625">
                <Name>Ferriprox</Name>
                <Pack ID="P2369524" Specified="true" nzmt:ctpp_id="50119741000117108">
                  <Quantity>250</Quantity>
                  <Price>266.59</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A3508">
        <Name>Antiseptics and Disinfectants</Name>
        <ATC3 ID="A350804">
          <Name>Antiseptics and Disinfectants</Name>
          <Chemical ID="C3508048381">
            <Name>Povidone-iodine with ethanol</Name>
            <Formulation ID="F350804838101" Rank="3" Units="ml">
              <Name>Soln 10% with ethanol 30%</Name>
              <Brand ID="B35080483810100">
                <Name>Any</Name>
                <Pack ID="P83810100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350804838102" Rank="3" Units="ml">
              <Name>Soln 10% with ethanol 70%</Name>
              <Brand ID="B35080483810200">
                <Name>Any</Name>
                <Pack ID="P83810200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3508048430">
            <Name>Sodium hypochlorite</Name>
            <Formulation ID="F350804843001" Rank="3" Units="ml">
              <Name>Soln</Name>
              <Brand ID="B35080484300100">
                <Name>Any</Name>
                <Pack ID="P84300100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3508049150">
            <Name>Chlorhexidine</Name>
            <Formulation ID="F350804915006" Rank="3" Units="ml">
              <Name>Soln 5%</Name>
              <Brand ID="B35080491500625">
                <Name>healthE</Name>
                <Pack ID="P2326574" Specified="true" nzmt:ctpp_id="50190521000117104">
                  <Quantity>500</Quantity>
                  <Price>15.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350804915031" Rank="3" Units="ml">
              <Name>Soln 4%</Name>
              <Brand ID="B35080491503100">
                <Name>Any</Name>
                <Pack ID="P91503100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350804915032" Rank="3" Units="ml">
              <Name>Soln 0.1%</Name>
              <Brand ID="B35080491503200">
                <Name>Any</Name>
                <Pack ID="P91503200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3508049410">
            <Name>Povidone-iodine</Name>
            <Formulation ID="F350804941001" Rank="10" Units="ea">
              <Name>Pad 10%</Name>
              <Brand ID="B35080494100100">
                <Name>Any</Name>
                <Pack ID="P94100100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350804941002" Rank="3" Units="ml">
              <Name>Soln 5%</Name>
              <Brand ID="B35080494100200">
                <Name>Any</Name>
                <Pack ID="P94100200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350804941003" Rank="3" Units="ml">
              <Name>Soln 7.5%</Name>
              <Brand ID="B35080494100300">
                <Name>Any</Name>
                <Pack ID="P94100300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350804941004" Rank="10" Units="ea">
              <Name>Swab set 10%</Name>
              <Brand ID="B35080494100400">
                <Name>Any</Name>
                <Pack ID="P94100400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350804941026" Rank="3" Units="ml">
              <Name>Soln 10%</Name>
              <Brand ID="B35080494102626">
                <Name>Riodine</Name>
                <Pack ID="P777447" Specified="true" nzmt:ctpp_id="50112821000117101">
                  <Quantity>100</Quantity>
                  <Price>4.99</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350804941027" Rank="3" Units="g">
              <Name>Oint 10%</Name>
              <Brand ID="B35080494102725">
                <Name>Betadine</Name>
                <Pack ID="P2159252" Specified="true" nzmt:ctpp_id="50027161000117100">
                  <Quantity>65</Quantity>
                  <Price>7.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350804941028" Rank="1" Units="tab">
              <Name>Vaginal tab 200 mg</Name>
              <Request Form="RS1354" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Povidone-iodine - Vaginal tab 200 mg</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">Rectal administration pre-prostate biopsy</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1354" style="display:none"/>
              <Brand ID="B35080494102800">
                <Name>Any</Name>
                <Pack ID="P94102800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350804941029" Rank="3" Units="ml" Weight="10">
              <Name>Soln 10%,</Name>
              <Brand ID="B35080494102925">
                <Name>Riodine</Name>
                <Pack ID="P994812" Specified="true" nzmt:ctpp_id="50119611000117103">
                  <Quantity>500</Quantity>
                  <Price>6.99</Price>
                </Pack>
                <Pack ID="P2013304" Specified="true" nzmt:ctpp_id="50001851000117109">
                  <Quantity>15</Quantity>
                  <Price>3.83</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3508049509">
            <Name>Chlorhexidine with cetrimide</Name>
            <Formulation ID="F350804950901" Rank="3" Units="g">
              <Name>Crm 0.1% with cetrimide 0.5%</Name>
              <Brand ID="B35080495090100">
                <Name>Any</Name>
                <Pack ID="P95090100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350804950902" Rank="3" Units="ml">
              <Name>Foaming soln 0.5% with cetrimide 0.5%</Name>
              <Brand ID="B35080495090200">
                <Name>Any</Name>
                <Pack ID="P95090200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3508049539">
            <Name>Chlorhexidine with ethanol</Name>
            <Formulation ID="F350804953933" Rank="10" Units="pack" Weight="12.5">
              <Name>Soln 0.5% with ethanol 70%, non-staining (pink) 25 ml</Name>
              <Brand ID="B35080495393325">
                <Name>healthE</Name>
                <Pack ID="P2326590" Specified="true" nzmt:ctpp_id="50190541000117109">
                  <Quantity>1</Quantity>
                  <Price>1.55</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350804953936" Rank="3" Units="ml">
              <Name>Soln 0.5% with ethanol 70%</Name>
              <Brand ID="B35080495393600">
                <Name>Any</Name>
                <Pack ID="P95393600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F350804953937" Rank="3" Units="ml">
              <Name>Soln 2% with ethanol 70%</Name>
              <Brand ID="B35080495393700">
                <Name>Any</Name>
                <Pack ID="P95393700" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3508049540">
            <Name>Iodine with ethanol</Name>
            <Formulation ID="F350804954026" Rank="3" Units="ml">
              <Name>Soln 1% with ethanol 70%</Name>
              <Brand ID="B35080495402600">
                <Name>Any</Name>
                <Pack ID="P95402600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3508049541">
            <Name>Isopropyl alcohol</Name>
            <Formulation ID="F350804954125" Rank="10" Units="btl">
              <Name>Soln 70%, 500 ml</Name>
              <Brand ID="B35080495412525">
                <Name>healthE</Name>
                <Pack ID="P2326647" Specified="true" nzmt:ctpp_id="50190621000117100">
                  <Quantity>1</Quantity>
                  <Price>5.65</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A3512">
        <Name>Contrast Media</Name>
        <ATC3 ID="A351204">
          <Name>Iodinated X-ray Contrast Media</Name>
          <Chemical ID="C3512048241">
            <Name>Iodised oil</Name>
            <Formulation ID="F351204824101" Rank="4" Units="inj" Weight="480">
              <Name>Inj 38% w/w (480 mg per ml), 10 ml ampoule</Name>
              <Brand ID="B35120482410125">
                <Name>Lipiodol Ultra Fluid</Name>
                <Pack ID="P2459582" Specified="true" nzmt:ctpp_id="50056771000117107">
                  <Quantity>1</Quantity>
                  <Price>410.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3512049357">
            <Name>Iodixanol</Name>
            <Formulation ID="F351204935725" Rank="4" Units="inj" Weight="270.05">
              <Name>Inj 270 mg per ml (iodine equivalent), 50 ml bottle</Name>
              <Brand ID="B35120493572525">
                <Name>Visipaque</Name>
                <Pack ID="P2242370" Specified="true" nzmt:ctpp_id="50038291000117103">
                  <Quantity>10</Quantity>
                  <Price>260.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351204935726" Rank="4" Units="inj" Weight="270.1">
              <Name>Inj 270 mg per ml (iodine equivalent), 100 ml bottle</Name>
              <Brand ID="B35120493572625">
                <Name>Visipaque</Name>
                <Pack ID="P2242389" Specified="true" nzmt:ctpp_id="50038301000117102">
                  <Quantity>10</Quantity>
                  <Price>480.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351204935727" Rank="4" Units="inj" Weight="320.05">
              <Name>Inj 320 mg per ml (iodine equivalent), 50 ml bottle</Name>
              <Brand ID="B35120493572725">
                <Name>Visipaque</Name>
                <Pack ID="P2242397" Specified="true" nzmt:ctpp_id="50038311000117104">
                  <Quantity>10</Quantity>
                  <Price>260.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351204935728" Rank="4" Units="inj" Weight="320.1">
              <Name>Inj 320 mg per ml (iodine equivalent), 100 ml bottle</Name>
              <Brand ID="B35120493572825">
                <Name>Visipaque</Name>
                <Pack ID="P2242400" Specified="true" nzmt:ctpp_id="50038321000117105">
                  <Quantity>10</Quantity>
                  <Price>480.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351204935729" Rank="4" Units="inj" Weight="320.2">
              <Name>Inj 320 mg per ml (iodine equivalent), 200 ml bottle</Name>
              <Brand ID="B35120493572925">
                <Name>Visipaque</Name>
                <Pack ID="P2333902" Specified="true" nzmt:ctpp_id="50155841000117105">
                  <Quantity>10</Quantity>
                  <Price>950.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3512049358">
            <Name>Iohexol</Name>
            <Formulation ID="F351204935825" Rank="4" Units="inj" Weight="240.05">
              <Name>Inj 240 mg per ml (iodine equivalent), 50 ml bottle</Name>
              <Brand ID="B35120493582525">
                <Name>Omnipaque</Name>
                <Pack ID="P777803" Specified="true" nzmt:ctpp_id="50112921000117108">
                  <Quantity>10</Quantity>
                  <Price>94.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351204935826" Rank="4" Units="inj" Weight="300.02">
              <Name>Inj 300 mg per ml (iodine equivalent), 20 ml bottle</Name>
              <Brand ID="B35120493582625">
                <Name>Omnipaque</Name>
                <Pack ID="P2376563" Specified="true" nzmt:ctpp_id="50121691000117104">
                  <Quantity>10</Quantity>
                  <Price>89.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351204935827" Rank="4" Units="inj" Weight="300.05">
              <Name>Inj 300 mg per ml (iodine equivalent), 50 ml bottle</Name>
              <Brand ID="B35120493582725">
                <Name>Omnipaque</Name>
                <Pack ID="P398470" Specified="true" nzmt:ctpp_id="50081821000117101">
                  <Quantity>10</Quantity>
                  <Price>96.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351204935828" Rank="4" Units="inj" Weight="300.1">
              <Name>Inj 300 mg per ml (iodine equivalent), 100 ml bottle</Name>
              <Brand ID="B35120493582825">
                <Name>Omnipaque</Name>
                <Pack ID="P777846" Specified="true" nzmt:ctpp_id="50112951000117101">
                  <Quantity>10</Quantity>
                  <Price>166.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351204935831" Rank="4" Units="inj" Weight="350.05">
              <Name>Inj 350 mg per ml (iodine equivalent), 50 ml bottle</Name>
              <Brand ID="B35120493583125">
                <Name>Omnipaque</Name>
                <Pack ID="P398519" Specified="true" nzmt:ctpp_id="50081831000117103">
                  <Quantity>10</Quantity>
                  <Price>98.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351204935832" Rank="4" Units="inj" Weight="350.08">
              <Name>Inj 350 mg per ml (iodine equivalent), 75 ml bottle</Name>
              <Brand ID="B35120493583225">
                <Name>Omnipaque</Name>
                <Pack ID="P2668505" Specified="true" nzmt:ctpp_id="50071421000117108">
                  <Quantity>10</Quantity>
                  <Price>130.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351204935833" Rank="4" Units="inj" Weight="350.1">
              <Name>Inj 350 mg per ml (iodine equivalent), 100 ml bottle</Name>
              <Brand ID="B35120493583325">
                <Name>Omnipaque</Name>
                <Pack ID="P777862" Specified="true" nzmt:ctpp_id="50112971000117109">
                  <Quantity>10</Quantity>
                  <Price>170.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351204935834" Rank="4" Units="inj" Weight="350.2">
              <Name>Inj 350 mg per ml (iodine equivalent), 200 ml bottle</Name>
              <Brand ID="B35120493583425">
                <Name>Omnipaque</Name>
                <Pack ID="P2450399" Specified="true" nzmt:ctpp_id="50071361000117108">
                  <Quantity>10</Quantity>
                  <Price>330.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351204935835" Rank="4" Units="inj" Weight="350.5">
              <Name>Inj 350 mg per ml, 500 ml bottle</Name>
              <Brand ID="B35120493583525">
                <Name>Omnipaque</Name>
                <Pack ID="P2630974" Specified="true" nzmt:ctpp_id="50151841000117108">
                  <Quantity>6</Quantity>
                  <Price>515.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3512049360">
            <Name>Diatrizoate meglumine with sodium amidotrizoate</Name>
            <Formulation ID="F351204936001" Rank="10" Units="btl" Weight="146">
              <Name>Inj 260 mg with sodium amidotrizoate 40 mg per ml, 250 ml bottle</Name>
              <Brand ID="B35120493600126">
                <Name>Urografin</Name>
                <Pack ID="P328359" Specified="true" nzmt:ctpp_id="50072821000117104">
                  <Quantity>1</Quantity>
                  <Price>120.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351204936026" Rank="3" Units="ml" Weight="100">
              <Name>Oral liq 660 mg per ml with sodium amidotrizoate 100 mg per ml, 100 ml bottle</Name>
              <Brand ID="B35120493602625">
                <Name>Gastrografin</Name>
                <Pack ID="P2345579" Specified="true" nzmt:ctpp_id="50050221000117104">
                  <Quantity>100</Quantity>
                  <Price>30.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351204936027" Rank="3" Units="ml" Weight="100">
              <Name>Oral liquid 660 mg per ml with sodium amidotrizoate 100 mg per ml, 100 ml bottle</Name>
              <Brand ID="B35120493602725">
                <Name>Gastrografin S29</Name>
                <Pack ID="P2669102" Specified="true" nzmt:ctpp_id="50324341000117109">
                  <Quantity>10</Quantity>
                  <Price>399.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B35120493602726">
                <Name>Gastrografin Ger</Name>
                <Pack ID="P2670038" Specified="true" nzmt:ctpp_id="50325521000117108">
                  <Quantity>10</Quantity>
                  <Price>496.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3512049362">
            <Name>Diatrizoate sodium</Name>
            <Formulation ID="F351204936225" Rank="2" Units="sach">
              <Name>Oral liq 370 mg per ml, 10 ml sachet</Name>
              <Brand ID="B35120493622525">
                <Name>Ioscan</Name>
                <Pack ID="P2243881" Specified="true">
                  <Quantity>50</Quantity>
                  <Price>156.12</Price>
                </Pack>
                <Pack ID="P2495686" nzmt:ctpp_id="50038631000117100">
                  <Quantity>50</Quantity>
                  <Price>156.12</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A351208">
          <Name>Non-iodinated X-ray Contrast Media</Name>
          <Chemical ID="C3512088102">
            <Name>Citric acid with sodium bicarbonate</Name>
            <Formulation ID="F351208810201" Rank="3" Units="g">
              <Name>Powder 382.2 mg per g with sodium bicarbonate 551.3 mg per g, 4 g sachet</Name>
              <Brand ID="B35120881020100">
                <Name>e.g. E-Z-GAS II</Name>
                <Pack ID="P81020100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3512088566">
            <Name>Barium sulphate with sodium bicarbonate</Name>
            <Formulation ID="F351208856625" Rank="2" Units="sach">
              <Name>Grans eff 382.2 mg per g with sodium bicarbonate 551.3 mg per g, 4 g sachet</Name>
              <Brand ID="B35120885662525">
                <Name>E-Z-Gas II</Name>
                <Pack ID="P2469200" Specified="true" nzmt:ctpp_id="50202311000117100">
                  <Quantity>50</Quantity>
                  <Price>90.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3512089550">
            <Name>Barium sulphate</Name>
            <Formulation ID="F351208955027" Rank="10" Units="pack" Weight="1">
              <Name>Oral liq 1 mg per ml (0.1% w/v, 0.1% w/w), 450 ml bottle</Name>
              <Brand ID="B35120895502726">
                <Name>Neulumex</Name>
                <Pack ID="P2683075" Specified="true" nzmt:ctpp_id="50336831000117101">
                  <Quantity>1</Quantity>
                  <Price>15.95</Price>
                </Pack>
                <Pack ID="P2683083" Specified="true" nzmt:ctpp_id="50336851000117106">
                  <Quantity>12</Quantity>
                  <Price>191.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351208955029" Rank="10" Units="pack" Weight="400">
              <Name>Oral liq 400 mg per ml (40% w/v, 30% w/w), 20 ml bottle</Name>
              <Brand ID="B35120895502925">
                <Name>Tagitol V</Name>
                <Pack ID="P2469138" Specified="true" nzmt:ctpp_id="50212891000117101">
                  <Quantity>3</Quantity>
                  <Price>52.35</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351208955030" Rank="3" Units="ml" Weight="400">
              <Name>Oral liq 400 mg per ml (40% w/v), bottle</Name>
              <Brand ID="B35120895503025">
                <Name>Varibar - Nectar</Name>
                <Pack ID="P2469146" Specified="true" nzmt:ctpp_id="50212821000117103">
                  <Quantity>240</Quantity>
                  <Price>38.40</Price>
                </Pack>
              </Brand>
              <Brand ID="B35120895503026">
                <Name>Varibar - Honey</Name>
                <Pack ID="P2469154" Specified="true" nzmt:ctpp_id="50212831000117100">
                  <Quantity>250</Quantity>
                  <Price>189.15</Price>
                </Pack>
              </Brand>
              <Brand ID="B35120895503027">
                <Name>Varibar - Pudding</Name>
                <Pack ID="P2469162" Specified="true" nzmt:ctpp_id="50212841000117108">
                  <Quantity>230</Quantity>
                  <Price>159.05</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351208955033" Rank="3" Units="g" Weight="400">
              <Name>Oral liq 400 mg per ml (40% w/v, 30% w/w), bottle</Name>
              <Brand ID="B35120895503325">
                <Name>Varibar - Thin Liquid</Name>
                <Pack ID="P2469170" Specified="true" nzmt:ctpp_id="50212851000117105">
                  <Quantity>148</Quantity>
                  <Price>17.39</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351208955039" Rank="10" Units="btl" Weight="960">
              <Name>Grans for oral liq 960 mg per g (96% w/w), 176 g bottle</Name>
              <Brand ID="B35120895503925">
                <Name>Vanilla SilQ MD</Name>
                <Pack ID="P2665913" Specified="true" nzmt:ctpp_id="50322561000117109">
                  <Quantity>24</Quantity>
                  <Price>530.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351208955040" Rank="10" Units="btl" Weight="980">
              <Name>Grans for oral liq 980 mg per g (98% w/w), 310 g bottle</Name>
              <Brand ID="B35120895504025">
                <Name>Vanilla SilQ HD</Name>
                <Pack ID="P2665921" Specified="true" nzmt:ctpp_id="50322571000117104">
                  <Quantity>24</Quantity>
                  <Price>490.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351208955041" Rank="10" Units="pack">
              <Name>Oral liq 20.9 mg per ml (2.1% w/v, 2% w/w), 450 ml bottle</Name>
              <Brand ID="B35120895504125">
                <Name>Readi-CAT 2</Name>
                <Pack ID="P2683067" Specified="true" nzmt:ctpp_id="50336821000117104">
                  <Quantity>12</Quantity>
                  <Price>97.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A351212">
          <Name>Paramagnetic Contrast Media</Name>
          <Chemical ID="C3512128198">
            <Name>Gadoteric acid</Name>
            <Formulation ID="F351212819801" Rank="4" Units="inj" Weight="0.5">
              <Name>Inj 279.32 mg per ml (0.5 mmol per ml), 10 ml bottle</Name>
              <Brand ID="B35121281980125">
                <Name>Dotarem</Name>
                <Pack ID="P2459515" Specified="true" nzmt:ctpp_id="50146331000117103">
                  <Quantity>1</Quantity>
                  <Price>14.30</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351212819802" Rank="4" Units="inj" Weight="0.5">
              <Name>Inj 279.32 mg per ml (0.5 mmol per ml), 20 ml bottle</Name>
              <Brand ID="B35121281980225">
                <Name>Dotarem</Name>
                <Pack ID="P2459531" Specified="true" nzmt:ctpp_id="50146351000117108">
                  <Quantity>1</Quantity>
                  <Price>28.90</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351212819803" Rank="4" Units="inj" Weight="0.5">
              <Name>Inj 279.32 mg per ml (0.5 mmol per ml), 5 ml bottle</Name>
              <Brand ID="B35121281980325">
                <Name>Dotarem</Name>
                <Pack ID="P2459507" Specified="true" nzmt:ctpp_id="50156531000117105">
                  <Quantity>1</Quantity>
                  <Price>9.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351212819825" Rank="4" Units="inj">
              <Name>Inj 279.32 mg per ml (0.5 mmol per ml), 10 ml prefilled syringe</Name>
              <Brand ID="B35121281982525">
                <Name>Dotarem</Name>
                <Pack ID="P2613204" Specified="true" nzmt:ctpp_id="50278381000117101">
                  <Quantity>10</Quantity>
                  <Price>172.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351212819826" Rank="4" Units="inj">
              <Name>Inj 279.32 mg per ml (0.5 mmol per ml), 20 ml prefilled syringe</Name>
              <Brand ID="B35121281982625">
                <Name>Dotarem</Name>
                <Pack ID="P2613220" Specified="true" nzmt:ctpp_id="50278401000117101">
                  <Quantity>10</Quantity>
                  <Price>344.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351212819827" Rank="4" Units="inj">
              <Name>Inj 279.32 mg per ml (0.5 mmol per ml), 15 ml prefilled syringe</Name>
              <Brand ID="B35121281982725">
                <Name>Dotarem</Name>
                <Pack ID="P2613212" Specified="true" nzmt:ctpp_id="50278391000117103">
                  <Quantity>10</Quantity>
                  <Price>258.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351212819828" Rank="4" Units="inj">
              <Name>Inj 279.32 mg per ml (0.5 mmol per ml), 15 ml bottle</Name>
              <Brand ID="B35121281982825">
                <Name>Dotarem</Name>
                <Pack ID="P2459523" Specified="true" nzmt:ctpp_id="50146341000117106">
                  <Quantity>1</Quantity>
                  <Price>25.35</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351212819829" Rank="4" Units="inj">
              <Name>Inj 279.30 mg per ml, 10 ml prefilled syringe</Name>
              <Brand ID="B35121281982900">
                <Name>e.g. Clariscan</Name>
                <Pack ID="P81982900" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351212819830" Rank="4" Units="inj">
              <Name>Inj 279.30 mg per ml, 15 ml prefilled syringe</Name>
              <Brand ID="B35121281983000">
                <Name>e.g. Clariscan</Name>
                <Pack ID="P81983000" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351212819831" Rank="4" Units="inj">
              <Name>Inj 279.30 mg per ml, 5 ml vial</Name>
              <Brand ID="B35121281983100">
                <Name>e.g. Clariscan</Name>
                <Pack ID="P81983100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351212819832" Rank="4" Units="inj">
              <Name>Inj 279.30 mg per ml, 10 ml vial</Name>
              <Brand ID="B35121281983200">
                <Name>e.g. Clariscan</Name>
                <Pack ID="P81983200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351212819833" Rank="4" Units="inj">
              <Name>Inj 279.30 mg per ml, 20 ml vial</Name>
              <Brand ID="B35121281983300">
                <Name>e.g. Clariscan</Name>
                <Pack ID="P81983300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3512128199">
            <Name>Gadoxetate disodium</Name>
            <Formulation ID="F351212819901" Rank="4" Units="inj" Weight="181">
              <Name>Inj 181.43 mg per ml (equivalent to 0.25 mmol per ml), 10 ml prefilled syringe</Name>
              <Brand ID="B35121281990125">
                <Name>Primovist</Name>
                <Pack ID="P2400987" Specified="true" nzmt:ctpp_id="50130971000117101">
                  <Quantity>1</Quantity>
                  <Price>300.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3512128549">
            <Name>Meglumine iotroxate</Name>
            <Formulation ID="F351212854925" Rank="3" Units="ml" Weight="105">
              <Name>Inj 105 mg per ml, 100 ml bottle</Name>
              <Brand ID="B35121285492525">
                <Name>Biliscopin</Name>
                <Pack ID="P797634" Specified="true" nzmt:ctpp_id="50116801000117108">
                  <Quantity>100</Quantity>
                  <Price>169.15</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3512129361">
            <Name>Meglumine gadopentetate</Name>
            <Formulation ID="F351212936125" Rank="4" Units="inj" Weight="469">
              <Name>Inj 469 mg per ml, 10 ml prefilled syringe</Name>
              <Brand ID="B35121293612525">
                <Name>Magnevist</Name>
                <Pack ID="P368806" Specified="true" nzmt:ctpp_id="50206101000117100">
                  <Quantity>5</Quantity>
                  <Price>95.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351212936127" Rank="4" Units="inj" Weight="469">
              <Name>Inj 469 mg per ml, 10 ml vial</Name>
              <Brand ID="B35121293612725">
                <Name>Magnevist</Name>
                <Pack ID="P2343339" Specified="true" nzmt:ctpp_id="50206111000117102">
                  <Quantity>10</Quantity>
                  <Price>185.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3512129515">
            <Name>Gadobutrol</Name>
            <Formulation ID="F351212951501" Rank="4" Units="inj" Weight="1">
              <Name>Inj 1 mmol per ml, 15 ml vial</Name>
              <Brand ID="B35121295150100">
                <Name>Any</Name>
                <Pack ID="P95150100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351212951525" Rank="4" Units="inj" Weight="7.5">
              <Name>Inj 604.72 mg per ml (equivalent to 1 mmol per ml), 7.5 ml prefilled syringe</Name>
              <Brand ID="B35121295152525">
                <Name>Gadovist 1.0</Name>
                <Pack ID="P2056402" Specified="true" nzmt:ctpp_id="50224891000117100">
                  <Quantity>5</Quantity>
                  <Price>189.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351212951526" Rank="4" Units="inj" Weight="15">
              <Name>Inj 604.72 mg per ml (equivalent to 1 mmol per ml), 15 ml prefilled syringe</Name>
              <Brand ID="B35121295152625">
                <Name>Gadovist 1.0</Name>
                <Pack ID="P2056399" Specified="true" nzmt:ctpp_id="50224921000117109">
                  <Quantity>10</Quantity>
                  <Price>735.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351212951527" Rank="4" Units="inj" Weight="5">
              <Name>Inj 604.72 mg per ml (equivalent to 1 mmol per ml), 5 ml prefilled syringe</Name>
              <Brand ID="B35121295152725">
                <Name>Gadovist 1.0</Name>
                <Pack ID="P2484420" Specified="true" nzmt:ctpp_id="50224881000117103">
                  <Quantity>5</Quantity>
                  <Price>126.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A351216">
          <Name>Ultrasound Contrast Media</Name>
          <Chemical ID="C3512168528">
            <Name>Perflutren</Name>
            <Formulation ID="F351216852825" Rank="4" Units="inj">
              <Name>Inj 1.1 mg per ml, 1.5 ml vial</Name>
              <Brand ID="B35121685282525">
                <Name>Definity</Name>
                <Pack ID="P2461935" Specified="true" nzmt:ctpp_id="50174491000117104">
                  <Quantity>4</Quantity>
                  <Price>720.00</Price>
                </Pack>
                <Pack ID="P2461943" Specified="true" nzmt:ctpp_id="50206141000117103">
                  <Quantity>1</Quantity>
                  <Price>180.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A3516">
        <Name>Diagnostic Agents</Name>
        <ATC3 ID="A351604">
          <Name>Diagnostic Agents</Name>
          <Chemical ID="C3516048036">
            <Name>Arginine</Name>
            <Formulation ID="F351604803601" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 mg per ml, 300 ml bottle</Name>
              <Brand ID="B35160480360100">
                <Name>Any</Name>
                <Pack ID="P80360100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351604803602" Rank="4" Units="inj" Weight="50">
              <Name>Inj 50 mg per ml, 500 ml bottle</Name>
              <Brand ID="B35160480360200">
                <Name>Any</Name>
                <Pack ID="P80360200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3516048216">
            <Name>Histamine acid phosphate</Name>
            <Formulation ID="F351604821601" Rank="4" Units="amp">
              <Name>Nebuliser soln 0.6%, 10 ml vial</Name>
              <Brand ID="B35160482160100">
                <Name>Any</Name>
                <Pack ID="P82160100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351604821602" Rank="4" Units="amp">
              <Name>Nebuliser soln 2.5%, 10 ml vial</Name>
              <Brand ID="B35160482160200">
                <Name>Any</Name>
                <Pack ID="P82160200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351604821603" Rank="4" Units="amp">
              <Name>Nebuliser soln 5%, 10 ml vial</Name>
              <Brand ID="B35160482160300">
                <Name>Any</Name>
                <Pack ID="P82160300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3516048411">
            <Name>Secretin pentahydrochloride</Name>
            <Formulation ID="F351604841101" Rank="4" Units="inj" Weight="100">
              <Name>Inj 100 u ampoule</Name>
              <Brand ID="B35160484110100">
                <Name>Any</Name>
                <Pack ID="P84110100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351604841125" Rank="4" Units="inj">
              <Name>Inj 80 u vial</Name>
              <Brand ID="B35160484112500">
                <Name>Any</Name>
                <Pack ID="P84112500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351604841126" Rank="4" Units="inj">
              <Name>Inj 100 u vial</Name>
              <Brand ID="B35160484112600">
                <Name>Any</Name>
                <Pack ID="P84112600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3516048537">
            <Name>Sincalide</Name>
            <Formulation ID="F351604853725" Rank="4" Units="inj">
              <Name>Inj 5 mcg per vial</Name>
              <Brand ID="B35160485372500">
                <Name>Any</Name>
                <Pack ID="P85372500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3516048538">
            <Name>Methacholine chloride</Name>
            <Formulation ID="F351604853825" Rank="10" Units="mg">
              <Name>Powder 100 mg</Name>
              <Brand ID="B35160485382500">
                <Name>Any</Name>
                <Pack ID="P85382500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3516049324">
            <Name>Mannitol</Name>
            <Formulation ID="F351604932428" Rank="3" Units="g">
              <Name>Powder for inhalation</Name>
              <Brand ID="B35160493242800">
                <Name>e.g. Aridol</Name>
                <Pack ID="P93242800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A351608">
          <Name>Diagnostic Dyes</Name>
          <Chemical ID="C3516088062">
            <Name>Bonney's blue dye</Name>
            <Formulation ID="F351608806201" Rank="3" Units="ml">
              <Name>Soln</Name>
              <Brand ID="B35160880620100">
                <Name>Any</Name>
                <Pack ID="P80620100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3516088225">
            <Name>Indigo carmine</Name>
            <Formulation ID="F351608822501" Rank="4" Units="inj" Weight="4">
              <Name>Inj 4 mg per ml, 5 ml ampoule</Name>
              <Brand ID="B35160882250100">
                <Name>Any</Name>
                <Pack ID="P82250100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351608822502" Rank="4" Units="inj" Weight="8">
              <Name>Inj 8 mg per ml, 5 ml ampoule</Name>
              <Brand ID="B35160882250200">
                <Name>Any</Name>
                <Pack ID="P82250200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3516088227">
            <Name>Indocyanine green</Name>
            <Formulation ID="F351608822701" Rank="4" Units="inj" Weight="25">
              <Name>Inj 25 mg vial</Name>
              <Brand ID="B35160882270100">
                <Name>Any</Name>
                <Pack ID="P82270100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3516088297">
            <Name>Methylthioninium chloride [Methylene blue]</Name>
            <Formulation ID="F351608829703" Rank="4" Units="inj" Weight="50">
              <Name>Inj 5 mg per ml, 10 ml ampoule</Name>
              <Brand ID="B35160882970325">
                <Name>Proveblue</Name>
                <Pack ID="P2513293" Specified="true" nzmt:ctpp_id="50245601000117106">
                  <Quantity>5</Quantity>
                  <Price>240.35</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3516088345">
            <Name>Patent blue V</Name>
            <Formulation ID="F351608834501" Rank="4" Units="inj">
              <Name>Inj 2.5%, 2 ml ampoule</Name>
              <Brand ID="B35160883450125">
                <Name>Obex Medical</Name>
                <Pack ID="P2459590" Specified="true" nzmt:ctpp_id="50206971000117107">
                  <Quantity>5</Quantity>
                  <Price>440.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F351608834525" Rank="4" Units="inj">
              <Name>Inj 2.5%, 5 ml prefilled syringe</Name>
              <Brand ID="B35160883452525">
                <Name>InterPharma</Name>
                <Pack ID="P2574330" Specified="true" nzmt:ctpp_id="50273151000117101">
                  <Quantity>5</Quantity>
                  <Price>420.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A3520">
        <Name>Irrigation Solutions</Name>
        <ATC3 ID="A352004">
          <Name>Irrigation Solutions</Name>
          <Chemical ID="C3520049058">
            <Name>Sodium chloride</Name>
            <Formulation ID="F352004905810" Rank="4" Units="inj" Weight="1000">
              <Name>Irrigation soln 0.9%, 1,000 ml bottle</Name>
              <Brand ID="B35200490581025">
                <Name>Baxter Sodium Chloride 0.9%</Name>
                <Pack ID="P2541645" Specified="true" nzmt:ctpp_id="50253261000117106">
                  <Quantity>10</Quantity>
                  <Price>16.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F352004905834" Rank="4" Units="inj" Weight="30">
              <Name>Irrigation soln 0.9%, 30 ml ampoule</Name>
              <Brand ID="B35200490583426">
                <Name>InterPharma</Name>
                <Pack ID="P2541777" Specified="true" nzmt:ctpp_id="50255941000117104">
                  <Quantity>20</Quantity>
                  <Price>12.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F352004905847" Rank="10" Units="btl">
              <Name>Irrigation soln 0.9%, 250 ml bottle</Name>
              <Brand ID="B35200490584725">
                <Name>Fresenius Kabi</Name>
                <Pack ID="P2510839" Specified="true" nzmt:ctpp_id="50255391000117105">
                  <Quantity>12</Quantity>
                  <Price>21.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F352004905848" Rank="4" Units="inj">
              <Name>Irrigation soln 0.9%, 3,000 ml bag</Name>
              <Brand ID="B35200490584825">
                <Name>B Braun</Name>
                <Pack ID="P2543702" Specified="true" nzmt:ctpp_id="50255491000117102">
                  <Quantity>4</Quantity>
                  <Price>54.40</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3520049331">
            <Name>Water</Name>
            <Formulation ID="F352004933104" Rank="4" Units="inj" Weight="1000">
              <Name>Irrigation soln, 1,000 ml bottle</Name>
              <Brand ID="B35200493310425">
                <Name>Baxter Water for Irrigation</Name>
                <Pack ID="P2541653" Specified="true" nzmt:ctpp_id="50253271000117101">
                  <Quantity>10</Quantity>
                  <Price>18.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F352004933130" Rank="10" Units="btl">
              <Name>Irrigation soln, 250 ml bottle</Name>
              <Brand ID="B35200493313025">
                <Name>Fresenius Kabi</Name>
                <Pack ID="P2510804" Specified="true" nzmt:ctpp_id="50255381000117107">
                  <Quantity>12</Quantity>
                  <Price>21.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F352004933131" Rank="4" Units="inj">
              <Name>Irrigation soln, 3,000 ml bag</Name>
              <Brand ID="B35200493313125">
                <Name>B Braun</Name>
                <Pack ID="P2543710" Specified="true" nzmt:ctpp_id="50255501000117108">
                  <Quantity>4</Quantity>
                  <Price>57.74</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3520049509">
            <Name>Chlorhexidine with cetrimide</Name>
            <Formulation ID="F352004950903" Rank="4" Units="inj" Weight="15">
              <Name>Irrigation soln 0.015% with cetrimide 0.15%, 100 ml bottle</Name>
              <Brand ID="B35200495090300">
                <Name>Any</Name>
                <Pack ID="P95090300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F352004950904" Rank="4" Units="inj" Weight="15">
              <Name>Irrigation soln 0.015% with cetrimide 0.15%, 30 ml ampoule</Name>
              <Brand ID="B35200495090425">
                <Name>Pfizer</Name>
                <Pack ID="P697745" Specified="true" nzmt:ctpp_id="50102741000117103">
                  <Quantity>30</Quantity>
                  <Price>29.76</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F352004950925" Rank="3" Units="ml" Weight="15">
              <Name>Irrigation soln 0.015% with cetrimide 0.15%, 500 ml bottle</Name>
              <Request Form="RS1683" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Chlorhexidine with cetrimide</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <and/>
                      <ci type="logical">Patient has burns that are greater than 30% of total body surface area (BSA)</ci>
                      <ci type="logical">For use in the perioperative preparation and cleansing of large burn areas requiring debridement/skin grafting</ci>
                      <ci type="logical">The use of 30 ml ampoules is impractical due to the size of the area to be covered</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="month">3</Term>
                </Case>
                <Case When="Renewal">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">The treatment remains appropriate for the patient and the patient is benefiting from the treatment</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="month">3</Term>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1683" style="display:none"/>
              <Brand ID="B35200495092500">
                <Name>Any</Name>
                <Pack ID="P95092500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                  <Multiple>1</Multiple>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3520049510">
            <Name>Glycine</Name>
            <Formulation ID="F352004951025" Rank="4" Units="inj">
              <Name>Irrigation soln 1.5%, 3,000 ml bag</Name>
              <Brand ID="B35200495102525">
                <Name>B Braun</Name>
                <Pack ID="P2543729" Specified="true" nzmt:ctpp_id="50255471000117103">
                  <Quantity>4</Quantity>
                  <Price>33.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A3524">
        <Name>Surgical Preparations</Name>
        <ATC3 ID="A352402">
          <Name>Surgical Preparations</Name>
          <Chemical ID="C3524028060">
            <Name>Bismuth subnitrate and iodoform paraffin</Name>
            <Formulation ID="F352402806001" Rank="3" Units="g">
              <Name>Paste</Name>
              <Brand ID="B35240280600100">
                <Name>Any</Name>
                <Pack ID="P80600100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3524028145">
            <Name>Dimethyl sulfoxide</Name>
            <Formulation ID="F352402814501" Rank="3" Units="ml" Weight="50">
              <Name>Soln 50%</Name>
              <Brand ID="B35240281450100">
                <Name>Any</Name>
                <Pack ID="P81450100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F352402814525" Rank="3" Units="ml" Weight="99">
              <Name>Soln 99%</Name>
              <Brand ID="B35240281452500">
                <Name>Any</Name>
                <Pack ID="P81452500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3524028357">
            <Name>Phenol</Name>
            <Formulation ID="F352402835701" Rank="4" Units="inj">
              <Name>Inj 6%, 10 ml ampoule</Name>
              <Brand ID="B35240283570100">
                <Name>Any</Name>
                <Pack ID="P83570100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3524028358">
            <Name>Phenol with ioxaglic acid</Name>
            <Formulation ID="F352402835801" Rank="4" Units="inj">
              <Name>Inj 12%, 10 ml ampoule</Name>
              <Brand ID="B35240283580100">
                <Name>Any</Name>
                <Pack ID="P83580100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3524028486">
            <Name>Trometamol</Name>
            <Formulation ID="F352402848601" Rank="4" Units="inj" Weight="36">
              <Name>Inj 36 mg per ml, 500 ml bottle</Name>
              <Brand ID="B35240284860100">
                <Name>Any</Name>
                <Pack ID="P84860100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3524028695">
            <Name>Sodium hydroxide</Name>
            <Formulation ID="F352402869525" Rank="3" Units="ml">
              <Name>Soln 10%</Name>
              <Brand ID="B35240286952500">
                <Name>Any</Name>
                <Pack ID="P86952500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A352404">
          <Name>Cardioplegia Solutions</Name>
          <Chemical ID="C3524048165">
            <Name>Electrolytes</Name>
            <Formulation ID="F352404816501" Rank="4" Units="inj" Weight="110">
              <Name>Inj 110 mmol/l sodium, 16 mmol/l potassium, 1.2 mmol/l calcium, 16 mmol/l magnesium and 160 mmol/l chloride, 1,000 ml bag</Name>
              <Brand ID="B35240481650100">
                <Name>e.g. Cardioplegia Solution AHB7832</Name>
                <Pack ID="P81650100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F352404816502" Rank="4" Units="inj" Weight="143">
              <Name>Inj 143 mmol/l sodium, 16 mmol/l potassium, 16 mmol/l magnesium and 1.2 mmol/l calcium, 1,000 ml bag</Name>
              <Brand ID="B35240481650200">
                <Name>e.g. Cardioplegia Electrolyte Solution</Name>
                <Pack ID="P81650200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F352404816503" Rank="4" Units="inj">
              <Name>Inj aspartic acid 10.43 mg per ml, citric acid 0.22476 mg per ml, glutamic acid 11.53 mg per ml, sodium phosphate 0.1725 mg per ml, potassium chloride 2.15211 mg per ml, sodium citrate 1.80768 mg per ml, sodium hydroxide 6.31 mg per ml and trometamol 11.2369 mg per ml, 364 ml bag</Name>
              <Brand ID="B35240481650300">
                <Name>e.g. Cardioplegia Enriched Paed. Soln.</Name>
                <Pack ID="P81650300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F352404816504" Rank="4" Units="inj">
              <Name>Inj aspartic acid 8.481 mg per ml, citric acid 0.8188 mg per ml, glutamic acid 9.375 mg per ml, sodium phosphate 0.6285 mg per ml, potassium chloride 2.5 mg per ml, sodium citrate 6.585 mg per ml, sodium hydroxide 5.133 mg per ml and trometamol 9.097 mg per ml, 527 ml bag</Name>
              <Brand ID="B35240481650400">
                <Name>e.g. Cardioplegia Enriched Solution</Name>
                <Pack ID="P81650400" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F352404816505" Rank="4" Units="inj">
              <Name>Inj citric acid 0.07973 mg per ml, sodium phosphate 0.06119 mg per ml, potassium chloride 2.181 mg per ml, sodium chloride 1.788 mg ml, sodium citrate 0.6412 mg per ml and trometamol 5.9 mg per ml, 523 ml bag</Name>
              <Brand ID="B35240481650500">
                <Name>e.g. Cardioplegia Base Solution</Name>
                <Pack ID="P81650500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F352404816525" Rank="4" Units="inj">
              <Name>Inj 15 mmol/l sodium chloride, 9 mmol/l potassium chloride, 1 mmol/l potassium hydrogen 2-ketoglutarate, 4 mmol/l magnesium chloride, 18 mmol/l histidine hydrochloride, 180 mmol/l histidine, 2 mmol/l tryptophan, 30 mmol/l mannitol, 0.015 mmol/l calcium chloride, 1,000 ml bag</Name>
              <Brand ID="B35240481652500">
                <Name>e.g. Custodiol-HTK</Name>
                <Pack ID="P81652500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3524048308">
            <Name>Monosodium glutamate with sodium aspartate</Name>
            <Formulation ID="F352404830801" Rank="4" Units="inj" Weight="42.68">
              <Name>Inj 42.68 mg with sodium aspartate 39.48 mg per ml, 250 ml bottle</Name>
              <Brand ID="B35240483080100">
                <Name>Any</Name>
                <Pack ID="P83080100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3524048536">
            <Name>Monosodium l-aspartate</Name>
            <Formulation ID="F352404853625" Rank="4" Units="inj">
              <Name>Inj 14 mmol per 10 ml, 10 ml</Name>
              <Brand ID="B35240485362500">
                <Name>Any</Name>
                <Pack ID="P85362500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A352408">
          <Name>Cold Storage Solutions</Name>
          <Chemical ID="C3524088440">
            <Name>Sodium with potassium</Name>
            <Formulation ID="F352408844001" Rank="4" Units="inj" Weight="29">
              <Name>Inj 29 mmol/l with potassium 125 mmol/l, 1,000 ml bag</Name>
              <Brand ID="B35240884400100">
                <Name>Any</Name>
                <Pack ID="P84400100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
    <ATC1 ID="A38">
      <Name>Extemporaneously Compounded Preparations</Name>
      <ATC2 ID="A3804">
        <Name>Extemporaneously Compounded Preparations</Name>
        <ATC3 ID="A380404">
          <Name>Extemporaneously Compounded Preparations</Name>
          <Chemical ID="C3804048001">
            <Name>Acetic acid</Name>
            <Formulation ID="F380404800101" Rank="3" Units="ml">
              <Name>Liq</Name>
              <Brand ID="B38040480010100">
                <Name>Any</Name>
                <Pack ID="P80010100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048014">
            <Name>Alum</Name>
            <Formulation ID="F380404801401" Rank="3" Units="g">
              <Name>Powder BP</Name>
              <Brand ID="B38040480140100">
                <Name>Any</Name>
                <Pack ID="P80140100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048035">
            <Name>Arachis oil [Peanut oil]</Name>
            <Formulation ID="F380404803501" Rank="3" Units="ml">
              <Name>Liq</Name>
              <Brand ID="B38040480350100">
                <Name>Any</Name>
                <Pack ID="P80350100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048046">
            <Name>Benzoin</Name>
            <Formulation ID="F380404804601" Rank="3" Units="ml">
              <Name>Tincture compound BP</Name>
              <Brand ID="B38040480460100">
                <Name>Any</Name>
                <Pack ID="P80460100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048059">
            <Name>Bismuth subgallate</Name>
            <Formulation ID="F380404805901" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040480590100">
                <Name>Any</Name>
                <Pack ID="P80590100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048063">
            <Name>Boric acid</Name>
            <Formulation ID="F380404806301" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040480630100">
                <Name>Any</Name>
                <Pack ID="P80630100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048081">
            <Name>Carboxymethylcellulose</Name>
            <Formulation ID="F380404808102" Rank="3" Units="ml">
              <Name>Soln 1.5%</Name>
              <Brand ID="B38040480810200">
                <Name>Any</Name>
                <Pack ID="P80810200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048087">
            <Name>Cetrimide</Name>
            <Formulation ID="F380404808701" Rank="3" Units="ml">
              <Name>Soln 40%</Name>
              <Brand ID="B38040480870100">
                <Name>Any</Name>
                <Pack ID="P80870100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048090">
            <Name>Chloroform</Name>
            <Formulation ID="F380404809001" Rank="3" Units="ml">
              <Name>Liq BP</Name>
              <Brand ID="B38040480900100">
                <Name>Any</Name>
                <Pack ID="P80900100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048100">
            <Name>Citric acid</Name>
            <Formulation ID="F380404810001" Rank="3" Units="g">
              <Name>Powder BP</Name>
              <Brand ID="B38040481000100">
                <Name>Any</Name>
                <Pack ID="P81000100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048106">
            <Name>Clove oil</Name>
            <Formulation ID="F380404810601" Rank="3" Units="ml">
              <Name>Liq</Name>
              <Brand ID="B38040481060100">
                <Name>Any</Name>
                <Pack ID="P81060100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048107">
            <Name>Coal tar</Name>
            <Formulation ID="F380404810701" Rank="3" Units="ml">
              <Name>Soln BP</Name>
              <Brand ID="B38040481070125">
                <Name>Midwest</Name>
                <Pack ID="P2361671" Specified="true" nzmt:ctpp_id="50051021000117100">
                  <Quantity>200</Quantity>
                  <Price>36.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048111">
            <Name>Collodion  flexible</Name>
            <Formulation ID="F380404811101" Rank="3" Units="ml">
              <Name>Liq</Name>
              <Brand ID="B38040481110100">
                <Name>Any</Name>
                <Pack ID="P81110100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048114">
            <Name>Compound hydroxybenzoate</Name>
            <Formulation ID="F380404811401" Rank="3" Units="ml">
              <Name>Soln</Name>
              <Brand ID="B38040481140125">
                <Name>Midwest</Name>
                <Pack ID="P2460149" Specified="true" nzmt:ctpp_id="50205381000117104">
                  <Quantity>100</Quantity>
                  <Price>30.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048122">
            <Name>Cysteamine hydrochloride</Name>
            <Formulation ID="F380404812201" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040481220100">
                <Name>Any</Name>
                <Pack ID="P81220100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048154">
            <Name>Disodium hydrogen phosphate with sodium dihydrogen phosphate</Name>
            <Formulation ID="F380404815401" Rank="4" Units="inj" Weight="37.46">
              <Name>Inj 37.46 mg with sodium dihydrogen phosphate 47.7 mg in 1.5 ml ampoule</Name>
              <Brand ID="B38040481540100">
                <Name>Any</Name>
                <Pack ID="P81540100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048156">
            <Name>Dithranol</Name>
            <Formulation ID="F380404815601" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040481560100">
                <Name>Any</Name>
                <Pack ID="P81560100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048252">
            <Name>Lactose</Name>
            <Formulation ID="F380404825201" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040482520100">
                <Name>Any</Name>
                <Pack ID="P82520100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048274">
            <Name>Magnesium hydroxide</Name>
            <Formulation ID="F380404827401" Rank="3" Units="g">
              <Name>Paste</Name>
              <Brand ID="B38040482740100">
                <Name>Any</Name>
                <Pack ID="P82740100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048290">
            <Name>Menthol</Name>
            <Formulation ID="F380404829001" Rank="3" Units="g">
              <Name>Crystals</Name>
              <Brand ID="B38040482900100">
                <Name>Any</Name>
                <Pack ID="P82900100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048329">
            <Name>Olive oil</Name>
            <Formulation ID="F380404832901" Rank="3" Units="ml">
              <Name>Liq</Name>
              <Brand ID="B38040483290100">
                <Name>Any</Name>
                <Pack ID="P83290100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048356">
            <Name>Phenobarbitone sodium</Name>
            <Formulation ID="F380404835601" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040483560100">
                <Name>Any</Name>
                <Pack ID="P83560100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048357">
            <Name>Phenol</Name>
            <Formulation ID="F380404835702" Rank="3" Units="ml">
              <Name>Liq</Name>
              <Brand ID="B38040483570200">
                <Name>Any</Name>
                <Pack ID="P83570200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048366">
            <Name>Pilocarpine nitrate</Name>
            <Formulation ID="F380404836602" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040483660200">
                <Name>Any</Name>
                <Pack ID="P83660200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048373">
            <Name>Polyhexamethylene biguanide</Name>
            <Formulation ID="F380404837301" Rank="3" Units="ml">
              <Name>Liq</Name>
              <Brand ID="B38040483730100">
                <Name>Any</Name>
                <Pack ID="P83730100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048380">
            <Name>Povidone K30</Name>
            <Formulation ID="F380404838001" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040483800100">
                <Name>Any</Name>
                <Pack ID="P83800100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048414">
            <Name>Silver nitrate</Name>
            <Formulation ID="F380404841401" Rank="3" Units="g">
              <Name>Crystals</Name>
              <Brand ID="B38040484140100">
                <Name>Any</Name>
                <Pack ID="P84140100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048424">
            <Name>Sodium citrate</Name>
            <Formulation ID="F380404842402" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040484240200">
                <Name>Any</Name>
                <Pack ID="P84240200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048431">
            <Name>Sodium metabisulfite</Name>
            <Formulation ID="F380404843101" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040484310100">
                <Name>Any</Name>
                <Pack ID="P84310100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048444">
            <Name>Starch</Name>
            <Formulation ID="F380404844401" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040484440100">
                <Name>Any</Name>
                <Pack ID="P84440100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048477">
            <Name>Tri-sodium citrate</Name>
            <Formulation ID="F380404847701" Rank="3" Units="g">
              <Name>Crystals</Name>
              <Brand ID="B38040484770100">
                <Name>Any</Name>
                <Pack ID="P84770100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048481">
            <Name>Trichloracetic acid</Name>
            <Formulation ID="F380404848101" Rank="2" Units="sach">
              <Name>Grans</Name>
              <Brand ID="B38040484810100">
                <Name>Any</Name>
                <Pack ID="P84810100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048488">
            <Name>Urea</Name>
            <Formulation ID="F380404848802" Rank="3" Units="g">
              <Name>Powder BP</Name>
              <Brand ID="B38040484880200">
                <Name>Any</Name>
                <Pack ID="P84880200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048497">
            <Name>Wool fat</Name>
            <Formulation ID="F380404849702" Rank="3" Units="g">
              <Name>Oint, anhydrous</Name>
              <Brand ID="B38040484970200">
                <Name>Any</Name>
                <Pack ID="P84970200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048498">
            <Name>Xanthan</Name>
            <Formulation ID="F380404849801" Rank="10" Units="piece">
              <Name>Gum 1%</Name>
              <Brand ID="B38040484980100">
                <Name>Any</Name>
                <Pack ID="P84980100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048503">
            <Name>Zinc oxide</Name>
            <Formulation ID="F380404850301" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040485030100">
                <Name>Any</Name>
                <Pack ID="P85030100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804048567">
            <Name>Theobroma oil</Name>
            <Formulation ID="F380404856725" Rank="3" Units="g">
              <Name>Oint</Name>
              <Brand ID="B38040485672500">
                <Name>Any</Name>
                <Pack ID="P85672500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049119">
            <Name>Hydrocortisone</Name>
            <Formulation ID="F380404911927" Rank="3" Units="g" Weight="25">
              <Name>Powder</Name>
              <Brand ID="B38040491192725">
                <Name>ABM</Name>
                <Pack ID="P2322420" Specified="true" nzmt:ctpp_id="50048881000117104">
                  <Quantity>25</Quantity>
                  <Price>49.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049169">
            <Name>Codeine phosphate</Name>
            <Formulation ID="F380404916901" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040491690100">
                <Name>Any</Name>
                <Pack ID="P91690100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049246">
            <Name>Methadone hydrochloride</Name>
            <Formulation ID="F380404924602" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040492460200">
                <Name>Any</Name>
                <Pack ID="P92460200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049259">
            <Name>Sodium bicarbonate</Name>
            <Formulation ID="F380404925925" Rank="3" Units="g">
              <Name>Powder BP</Name>
              <Brand ID="B38040492592527">
                <Name>Midwest</Name>
                <Pack ID="P2032880" Specified="true" nzmt:ctpp_id="50121131000117109">
                  <Quantity>500</Quantity>
                  <Price>10.05</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049321">
            <Name>Glucose [Dextrose]</Name>
            <Formulation ID="F380404932111" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040493211100">
                <Name>Any</Name>
                <Pack ID="P93211100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049387">
            <Name>Glycerol</Name>
            <Formulation ID="F380404938726" Rank="3" Units="ml">
              <Name>Liq</Name>
              <Brand ID="B38040493872626">
                <Name>healthE Glycerol BP Liquid</Name>
                <Pack ID="P2341026" Specified="true" nzmt:ctpp_id="50212951000117103">
                  <Quantity>500</Quantity>
                  <Price>3.23</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049399">
            <Name>Syrup</Name>
            <Formulation ID="F380404939925" Rank="3" Units="ml">
              <Name>Liq (pharmaceutical grade)</Name>
              <Brand ID="B38040493992525">
                <Name>Midwest</Name>
                <Pack ID="P2572346" Specified="true" nzmt:ctpp_id="50267161000117101">
                  <Quantity>500</Quantity>
                  <Price>14.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049420">
            <Name>Methyl hydroxybenzoate</Name>
            <Formulation ID="F380404942025" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040494202526">
                <Name>Midwest</Name>
                <Pack ID="P2018853" Specified="true" nzmt:ctpp_id="50121141000117101">
                  <Quantity>25</Quantity>
                  <Price>8.98</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049421">
            <Name>Methylcellulose</Name>
            <Formulation ID="F380404942125" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040494212526">
                <Name>Midwest</Name>
                <Pack ID="P2121131" Specified="true" nzmt:ctpp_id="50021981000117103">
                  <Quantity>100</Quantity>
                  <Price>36.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F380404942126" Rank="3" Units="ml">
              <Name>Suspension</Name>
              <Brand ID="B38040494212625">
                <Name>Ora-Plus</Name>
                <Pack ID="P2377233" Specified="true" nzmt:ctpp_id="50014601000117109">
                  <Quantity>473</Quantity>
                  <Price>30.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049423">
            <Name>Salicylic acid</Name>
            <Formulation ID="F380404942325" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040494232500">
                <Name>Any</Name>
                <Pack ID="P94232500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049424">
            <Name>Sulphur</Name>
            <Formulation ID="F380404942401" Rank="3" Units="g">
              <Name>Sublimed</Name>
              <Brand ID="B38040494240100">
                <Name>Any</Name>
                <Pack ID="P94240100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F380404942425" Rank="3" Units="g">
              <Name>Precipitated</Name>
              <Brand ID="B38040494242500">
                <Name>Any</Name>
                <Pack ID="P94242500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049495">
            <Name>Paraffin</Name>
            <Formulation ID="F380404949502" Rank="3" Units="ml">
              <Name>Liq</Name>
              <Brand ID="B38040494950200">
                <Name>Any</Name>
                <Pack ID="P94950200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049538">
            <Name>Chlorhexidine gluconate</Name>
            <Formulation ID="F380404953828" Rank="10" Units="sol">
              <Name>Soln 20 %</Name>
              <Brand ID="B38040495382800">
                <Name>Any</Name>
                <Pack ID="P95382800" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049543">
            <Name>Ascorbic acid</Name>
            <Formulation ID="F380404954301" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B38040495430100">
                <Name>Any</Name>
                <Pack ID="P95430100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049571">
            <Name>Glycerin with sucrose</Name>
            <Formulation ID="F380404957125" Rank="3" Units="ml">
              <Name>Suspension</Name>
              <Brand ID="B38040495712525">
                <Name>Ora-Sweet</Name>
                <Pack ID="P2377241" Specified="true" nzmt:ctpp_id="50121171000117107">
                  <Quantity>473</Quantity>
                  <Price>30.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049572">
            <Name>Glycerin with sodium saccharin</Name>
            <Formulation ID="F380404957225" Rank="3" Units="ml">
              <Name>Suspension</Name>
              <Brand ID="B38040495722525">
                <Name>Ora-Sweet SF</Name>
                <Pack ID="P2377268" Specified="true" nzmt:ctpp_id="50014611000117107">
                  <Quantity>473</Quantity>
                  <Price>30.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049573">
            <Name>Methylcellulose with glycerin and sucrose</Name>
            <Formulation ID="F380404957325" Rank="3" Units="ml">
              <Name>Suspension</Name>
              <Brand ID="B38040495732525">
                <Name>Ora-Blend</Name>
                <Pack ID="P2377217" Specified="true" nzmt:ctpp_id="50121151000117104">
                  <Quantity>473</Quantity>
                  <Price>30.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C3804049574">
            <Name>Methylcellulose with glycerin and sodium saccharin</Name>
            <Formulation ID="F380404957425" Rank="3" Units="ml">
              <Name>Suspension</Name>
              <Brand ID="B38040495742525">
                <Name>Ora-Blend SF</Name>
                <Pack ID="P2377225" Specified="true" nzmt:ctpp_id="50121161000117102">
                  <Quantity>473</Quantity>
                  <Price>30.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
    <ATC1 ID="A42">
      <Name>Special Foods</Name>
      <ATC2 ID="A4204">
        <Name>Food Modules</Name>
        <ATC3 ID="A420404">
          <Name>Carbohydrate</Name>
          <Request Form="RS1467" To="HealthPAC" For="Subsidy">
            <Title>
              <range>Carbohydrate</range>
            </Title>
            <Case When="Initial application" Category="Use as an additive">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <or/>
                  <ci type="logical">Cystic fibrosis</ci>
                  <ci type="logical">Chronic kidney disease</ci>
                  <ci type="logical">Cancer in children</ci>
                  <ci type="logical">Cancers affecting alimentary tract where there are malabsorption problems in patients over the age of 20 years</ci>
                  <ci type="logical">Faltering growth in an infant/child</ci>
                  <ci type="logical">Bronchopulmonary dysplasia</ci>
                  <ci type="logical">Premature and post premature infant</ci>
                  <ci type="logical">Inborn errors of metabolism</ci>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
            <Case When="Initial application" Category="Use as a module">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <ci type="logical">For use as a component in a modular formula made from at least one nutrient module and at least one further product listed in Section D of the Pharmaceutical Schedule or breast milk</ci>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Patients are required to meet any Special Authority criteria associated with all of the products used in the modular formula.</p>
              </div>
            </Case>
          </Request>
          <html:div class="Restricted" xlink:href="RS1467" style="display:none"/>
          <Chemical ID="C4204048078">
            <Name>Carbohydrate supplement</Name>
            <Formulation ID="F420404807825" Rank="3" Units="g">
              <Name>Powder 96 g carbohydrate per 100 g, can</Name>
              <Brand ID="B42040480782525">
                <Name>Polycal</Name>
                <Pack ID="P408050" Specified="true" nzmt:ctpp_id="50082711000117108">
                  <Quantity>400</Quantity>
                  <Price>6.72</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A420408">
          <Name>Fat</Name>
          <Request Form="RS1468" To="HealthPAC" For="Subsidy">
            <Title>
              <range>Fat</range>
            </Title>
            <Case When="Initial application" Category="Use as an additive">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <or/>
                  <ci type="logical">Patient has inborn errors of metabolism</ci>
                  <ci type="logical">Faltering growth in an infant/child</ci>
                  <ci type="logical">Bronchopulmonary dysplasia</ci>
                  <ci type="logical">Fat malabsorption</ci>
                  <ci type="logical">Lymphangiectasia</ci>
                  <ci type="logical">Short bowel syndrome</ci>
                  <ci type="logical">Infants with necrotising enterocolitis</ci>
                  <ci type="logical">Biliary atresia</ci>
                  <ci type="logical">For use in a ketogenic diet</ci>
                  <ci type="logical">Chyle leak</ci>
                  <ci type="logical">Ascites</ci>
                  <ci type="logical">Patient has increased energy requirements, and for whom dietary measures have not been successful</ci>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
            <Case When="Initial application" Category="Use as a module">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <ci type="logical">For use as a component in a modular formula made from at least one nutrient module and at least one further product listed in Section D of the Pharmaceutical Schedule or breast milk. </ci>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Patients are required to meet any Special Authority criteria associated with all of the products used in the modular formula.</p>
              </div>
            </Case>
          </Request>
          <html:div class="Restricted" xlink:href="RS1468" style="display:none"/>
          <Chemical ID="C4204088267">
            <Name>Long-chain triglyceride supplement</Name>
            <Formulation ID="F420408826725" Rank="3" Units="ml">
              <Name>Liquid 50 g fat per 100 ml, bottle</Name>
              <Brand ID="B42040882672525">
                <Name>Calogen (neutral)</Name>
                <Pack ID="P2222051" Specified="true" nzmt:ctpp_id="50035211000117103">
                  <Quantity>500</Quantity>
                  <Price>38.44</Price>
                </Pack>
                <Pack ID="P2253933" Specified="true" nzmt:ctpp_id="50040291000117100">
                  <Quantity>200</Quantity>
                  <Price>15.38</Price>
                </Pack>
              </Brand>
              <Brand ID="B42040882672526">
                <Name>Calogen (strawberry)</Name>
                <Pack ID="P2253941" Specified="true" nzmt:ctpp_id="50040301000117104">
                  <Quantity>200</Quantity>
                  <Price>15.38</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4204088281">
            <Name>Medium-chain triglyceride supplement</Name>
            <Formulation ID="F420408828101" Rank="10" Units="btl">
              <Name>Liquid 50 g fat per 100 ml, 250 ml bottle</Name>
              <Brand ID="B42040882810125">
                <Name>Liquigen</Name>
                <Pack ID="P2441241" Specified="true" nzmt:ctpp_id="50176621000117109">
                  <Quantity>4</Quantity>
                  <Price>143.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F420408828125" Rank="3" Units="ml">
              <Name>Liquid 95 g fat per 100 ml, bottle</Name>
              <Brand ID="B42040882812525">
                <Name>MCT Oil</Name>
                <Pack ID="P413933" Specified="true" nzmt:ctpp_id="50083321000117108">
                  <Quantity>500</Quantity>
                  <Price>37.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4204088495">
            <Name>Walnut oil</Name>
            <Formulation ID="F420408849501" Rank="3" Units="ml">
              <Name>Liq</Name>
              <Brand ID="B42040884950100">
                <Name>Any</Name>
                <Pack ID="P84950100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A420416">
          <Name>Protein</Name>
          <Request Form="RS1469" To="HealthPAC" For="Subsidy">
            <Title>
              <range>Protein</range>
            </Title>
            <Case When="Initial application" Category="Use as an additive">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <or/>
                  <ci type="logical">Protein losing enteropathy</ci>
                  <ci type="logical">High protein needs</ci>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
            <Case When="Initial application" Category="Use as a module">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <ci type="logical">For use as a component in a modular formula made from at least one nutrient module and at least one further product listed in Section D of the Pharmaceutical Schedule or
        breast milk. </ci>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Patients are required to meet any Special Authority criteria associated with all of the products used in the modular formula.</p>
              </div>
            </Case>
          </Request>
          <html:div class="Restricted" xlink:href="RS1469" style="display:none"/>
          <Chemical ID="C4204169617">
            <Name>Protein supplement</Name>
            <Formulation ID="F420416961701" Rank="3" Units="g">
              <Name>Powder 6 g protein per 7 g, can</Name>
              <Brand ID="B42041696170101">
                <Name>Resource Beneprotein</Name>
                <Pack ID="P2264471" Specified="true" nzmt:ctpp_id="50041681000117106">
                  <Quantity>227</Quantity>
                  <Price>8.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F420416961702" Rank="3" Units="g">
              <Name>Powder 5 g protein, 0.67 g carbohydrate and 0.6 g fat per 6.6 g, 275 g can</Name>
              <Brand ID="B42041696170200">
                <Name>Any</Name>
                <Pack ID="P96170200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F420416961725" Rank="3" Units="g">
              <Name>Powder 89 g protein, less than 1.5 g carbohydrate and 2 g fat per 100 g, can</Name>
              <Brand ID="B42041696172525">
                <Name>Protifar</Name>
                <Pack ID="P279269" Specified="true" nzmt:ctpp_id="50062081000117102">
                  <Quantity>225</Quantity>
                  <Price>13.82</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A420420">
          <Name>Other Supplements</Name>
          <Chemical ID="C4204208065">
            <Name>Human milk fortifier</Name>
            <Formulation ID="F420420806501" Rank="3" Units="g">
              <Name>Powder 0.2 g protein, 0.7 g carbohydrate and 0.02 g fat per 1 g sachet</Name>
              <Brand ID="B42042080650100">
                <Name>e.g. FM 85</Name>
                <Pack ID="P80650100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F420420806525" Rank="2" Units="sach">
              <Name>Powder 0.325 g protein, 0.37 g carbohydrate and 0.175 g fat per 1 g sachet</Name>
              <Brand ID="B42042080652525">
                <Name>Human Milk Fortifier</Name>
                <Pack ID="P2678470" Specified="true" nzmt:ctpp_id="50332491000117100">
                  <Quantity>50</Quantity>
                  <Price>33.48</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4204208077">
            <Name>Carbohydrate and fat supplement</Name>
            <Request Form="RS1212" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Carbohydrate and fat supplement</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Infant or child aged four years or under</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Cystic fibrosis</ci>
                      <ci type="logical">Cancer in children</ci>
                      <ci type="logical">Faltering growth</ci>
                      <ci type="logical">Bronchopulmonary dysplasia</ci>
                      <ci type="logical">Premature and post premature infants</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1212" style="display:none"/>
            <Formulation ID="F420420807725" Rank="3" Units="g">
              <Name>Powder 72.7 g carbohydrate and 22.3 g fat per 100 g, can</Name>
              <Brand ID="B42042080772525">
                <Name>Duocal Super Soluble Powder</Name>
                <Pack ID="P727113" Specified="true" nzmt:ctpp_id="50106371000117109">
                  <Quantity>400</Quantity>
                  <Price>71.77</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A4208">
        <Name>Food/Fluid Thickeners</Name>
        <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
          <h4>NOTE:</h4>
          <p>While pre-thickened drinks and supplements have not been included in Section H, Health NZ Hospitals may continue to use such products for patients with dysphagia, provided that:</p>
          <ul>
            <li>
              <p>use was established prior to 1 July 2013; and</p>
            </li>
            <li>
              <p>the product has not been specifically considered and excluded by Pharmac; and</p>
            </li>
            <li>
              <p>use of the product conforms to any applicable indication restrictions for similar products that are listed in Section H (for example, use of thickened high protein products should be in line with the restriction for high protein oral feed in Section H).</p>
            </li>
          </ul>
          <p>Pharmac intends to make a further decision in relation to pre-thickened drinks and supplements in the future, and will notify of any change to this situation.</p>
        </div>
        <ATC3 ID="A420804">
          <Name>Food/Fluid Thickeners</Name>
          <Chemical ID="C4208048084">
            <Name>Carob bean gum with maize starch and maltodextrin</Name>
            <Formulation ID="F420804808401" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B42080480840125">
                <Name>Aptamil Feed Thickener</Name>
                <Pack ID="P2432129" Specified="true" nzmt:ctpp_id="50262481000117102">
                  <Quantity>380</Quantity>
                  <Price>24.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4208048208">
            <Name>Guar gum</Name>
            <Formulation ID="F420804820801" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B42080482080100">
                <Name>e.g. Guarcol</Name>
                <Pack ID="P82080100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4208048275">
            <Name>Maize starch</Name>
            <Formulation ID="F420804827501" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B42080482750125">
                <Name>Nutilis</Name>
                <Pack ID="P2400456" Specified="true" nzmt:ctpp_id="50199671000117109">
                  <Quantity>300</Quantity>
                  <Price>8.29</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4208048277">
            <Name>Maltodextrin with xanthan gum</Name>
            <Formulation ID="F420804827701" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B42080482770100">
                <Name>e.g. Instant Thick</Name>
                <Pack ID="P82770100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4208048278">
            <Name>Maltodextrin with xanthan gum and ascorbic acid</Name>
            <Formulation ID="F420804827801" Rank="3" Units="g">
              <Name>Powder</Name>
              <Brand ID="B42080482780100">
                <Name>e.g. Easy Thick</Name>
                <Pack ID="P82780100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A4212">
        <Name>Metabolic Products</Name>
        <Request Form="RS2047" To="HealthPAC" For="Subsidy">
          <Title>
            <range>Metabolic Products</range>
          </Title>
          <Case When="Initial application">
            <math xmlns="http://www.w3.org/1998/Math/MathML">
              <apply>
                <or/>
                <ci type="logical">For the dietary management of inherited metabolic disease</ci>
                <ci type="logical">Patient has adrenoleukodystrophy</ci>
              </apply>
            </math>
            <Applicant>medical practitioner</Applicant>
            <Term Measure="patient's lifetime"/>
          </Case>
        </Request>
        <html:div class="Restricted" xlink:href="RS2047" style="display:none"/>
        <ATC3 ID="A421204">
          <Name>Supplements for Glutaric Aciduria Type 1</Name>
          <Chemical ID="C4212048022">
            <Name>Amino acid formula (without lysine and low tryptophan)</Name>
            <Formulation ID="F421204802201" Rank="3" Units="g">
              <Name>Powder 13.1 g protein, 49.5 g carbohydrate, 23 g fat and 5.3 g fibre per 100 g, 400 g can</Name>
              <Brand ID="B42120480220100">
                <Name>e.g. GA1 Anamix Infant</Name>
                <Pack ID="P80220100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421204802202" Rank="3" Units="g">
              <Name>Powder 25 g protein and 51 g carbohydrate per 100 g, 500 g can</Name>
              <Brand ID="B42120480220200">
                <Name>e.g. XLYS Low TRY Maxamaid</Name>
                <Pack ID="P80220200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4212048724">
            <Name>Amino acid formula (without lysine)</Name>
            <Formulation ID="F421204872425" Rank="2" Units="sach">
              <Name>Powder, 5 g protein, 5.3 g carbohydrate, 0.2 g fat per 12.5 g sachet</Name>
              <Brand ID="B42120487242525">
                <Name>GA Explore 5</Name>
                <Pack ID="P2668521" Specified="true" nzmt:ctpp_id="50328281000117102">
                  <Quantity>30</Quantity>
                  <Price>349.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421204872427" Rank="3" Units="g">
              <Name>Powder, 13.1 g protein, 50.1 g carbohydrate, 23 g fat and 3.7 g fibre per 100 g, 400 g can</Name>
              <Brand ID="B42120487242725">
                <Name>GA1 Anamix Infant</Name>
                <Pack ID="P2400480" Specified="true" nzmt:ctpp_id="50129561000117108">
                  <Quantity>400</Quantity>
                  <Price>260.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421204872428" Rank="2" Units="sach">
              <Name>Powder (neutral) 5 g protein, 5.4 g carbohydrate, 2.3 g fat and 2 g fibre per 18 g sachet</Name>
              <Brand ID="B42120487242825">
                <Name>GA1 Anamix Junior</Name>
                <Pack ID="P2498820" Specified="true" nzmt:ctpp_id="50332531000117100">
                  <Quantity>30</Quantity>
                  <Price>750.30</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421208">
          <Name>Supplements for Homocystinuria</Name>
          <Chemical ID="C4212088023">
            <Name>Amino acid formula (without methionine)</Name>
            <Formulation ID="F421208802325" Rank="2" Units="sach">
              <Name>Powder, 5 g protein, 5.3 g carbohydrate, 0.2 g fat per 12.5 g sachet</Name>
              <Brand ID="B42120880232525">
                <Name>HCU Explore 5</Name>
                <Pack ID="P2668548" Specified="true" nzmt:ctpp_id="50328231000117103">
                  <Quantity>30</Quantity>
                  <Price>349.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421208802326" Rank="2" Units="sach">
              <Name>Powder, 15 g protein, 3.5 g carbohydrate, 0.55 g fat per 25 g sachet</Name>
              <Brand ID="B42120880232625">
                <Name>HCU Express 15</Name>
                <Pack ID="P2668556" Specified="true" nzmt:ctpp_id="50328271000117100">
                  <Quantity>30</Quantity>
                  <Price>1048.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421208802327" Rank="3" Units="g">
              <Name>Powder (unflavoured) 13.1 g protein, 49.5 g carbohydrate, 23 g fat and 5.3 g fibre per 100 g, 400 g can</Name>
              <Brand ID="B42120880232725">
                <Name>HCU Anamix Infant</Name>
                <Pack ID="P2682982" Specified="true" nzmt:ctpp_id="50199791000117100">
                  <Quantity>400</Quantity>
                  <Price>260.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421208802328" Rank="2" Units="sach">
              <Name>Powder (neutral), 10 g protein, 11.5 g carbohydrate and 4.5 g fat per 36 g sachet</Name>
              <Brand ID="B42120880232825">
                <Name>HCU Anamix Junior</Name>
                <Pack ID="P2682990" Specified="true" nzmt:ctpp_id="50337411000117105">
                  <Quantity>30</Quantity>
                  <Price>750.30</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421208802329" Rank="10" Units="btl">
              <Name>Liquid (orange), 8 g protein, 7 g carbohydrate, 3.8 g fat and 0.25 g fibre per 100 ml, 125 ml bottle</Name>
              <Brand ID="B42120880232925">
                <Name>HCU Anamix Junior LQ</Name>
                <Pack ID="P2683008" Specified="true" nzmt:ctpp_id="50337421000117104">
                  <Quantity>36</Quantity>
                  <Price>941.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421208802330" Rank="10" Units="btl">
              <Name>Liquid (juicy berries), 20 g protein, 9.3 g carbohydrate, 0.44 g fat and 0.44 g fibre per 125 ml bottle</Name>
              <Brand ID="B42120880233025">
                <Name>HCU Lophlex LQ</Name>
                <Pack ID="P2592096" Specified="true" nzmt:ctpp_id="50337431000117101">
                  <Quantity>30</Quantity>
                  <Price>1684.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421208802331" Rank="3" Units="g">
              <Name>Powder (neutral) 39 g protein and 34 g carbohydrate per 100 g, 500 g can</Name>
              <Brand ID="B42120880233125">
                <Name>XMET Maxamum</Name>
                <Pack ID="P949027" Specified="true" nzmt:ctpp_id="50118251000117107">
                  <Quantity>500</Quantity>
                  <Price>480.42</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421216">
          <Name>Supplements for MSUD and Short chain enoyl coA hydratase deficiency</Name>
          <Chemical ID="C4212168019">
            <Name>Amino acid formula (without isoleucine, leucine and valine)</Name>
            <Formulation ID="F421216801925" Rank="2" Units="sach">
              <Name>Powder, 5 g protein, 5.3 g carbohydrate, 0.2 g fat per 12.5 g sachet</Name>
              <Brand ID="B42121680192525">
                <Name>MSUD Explore 5</Name>
                <Pack ID="P2668580" Specified="true" nzmt:ctpp_id="50328261000117105">
                  <Quantity>30</Quantity>
                  <Price>349.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421216801926" Rank="2" Units="sach">
              <Name>Powder, 15 g protein, 3.5 g carbohydrate, 0.6 g fat per 25 g sachet</Name>
              <Brand ID="B42121680192625">
                <Name>MSUD Express 15</Name>
                <Pack ID="P2668599" Specified="true" nzmt:ctpp_id="50328221000117101">
                  <Quantity>30</Quantity>
                  <Price>1048.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421216801927" Rank="3" Units="g">
              <Name>Powder (unflavoured) 13.1 g protein, 49.5 g carbohydrate, 23 g fat and 5.3 g fibre per 100 g, 400 g can</Name>
              <Brand ID="B42121680192725">
                <Name>MSUD Anamix Infant</Name>
                <Pack ID="P2184257" Specified="true" nzmt:ctpp_id="50199881000117106">
                  <Quantity>400</Quantity>
                  <Price>260.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421216801928" Rank="2" Units="sach">
              <Name>Powder (neutral) 10 g protein, 11.5 g carbohydrate and 4.5 g fat per 36 g sachet</Name>
              <Brand ID="B42121680192825">
                <Name>MSUD Anamix Junior</Name>
                <Pack ID="P2528649" Specified="true" nzmt:ctpp_id="50319341000117103">
                  <Quantity>30</Quantity>
                  <Price>750.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421216801929" Rank="10" Units="btl">
              <Name>Liquid (orange) 8 g protein, 7 g carbohydrate, 3.8 g fat and 0.25 g fibre per 100 ml, 125 ml bottle</Name>
              <Brand ID="B42121680192925">
                <Name>MSUD Anamix Junior LQ</Name>
                <Pack ID="P2637413" Specified="true" nzmt:ctpp_id="50337391000117105">
                  <Quantity>36</Quantity>
                  <Price>941.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421216801930" Rank="10" Units="btl">
              <Name>Liquid (juicy berries), 20 g protein, 8.8 g carbohydrate, 0.44 g fat and 0.5 g fibre per 125 ml pouch</Name>
              <Brand ID="B42121680193025">
                <Name>MSUD Lophlex LQ 20</Name>
                <Pack ID="P2683016" Specified="true" nzmt:ctpp_id="50337401000117107">
                  <Quantity>30</Quantity>
                  <Price>1684.80</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421216801931" Rank="3" Units="g">
              <Name>Powder (orange) 39 g protein and 34 g carbohydrate per 100 g, 500 g can</Name>
              <Brand ID="B42121680193125">
                <Name>MSUD Maxamum</Name>
                <Pack ID="P469564" Specified="true" nzmt:ctpp_id="50088441000117102">
                  <Quantity>500</Quantity>
                  <Price>454.71</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421216801932" Rank="3" Units="g">
              <Name>Powder (unflavoured) 39 g protein and 34 g carbohydrate per 100 g, 500 g can</Name>
              <Brand ID="B42121680193225">
                <Name>MSUD Maxamum</Name>
                <Pack ID="P2010364" Specified="true" nzmt:ctpp_id="50001191000117108">
                  <Quantity>500</Quantity>
                  <Price>454.71</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421220">
          <Name>Supplements for Phenylketonuria</Name>
          <Chemical ID="C4212208717">
            <Name>Glycomacropeptide and amino acid contains some phenylalanine</Name>
            <Formulation ID="F421220871725" Rank="2" Units="sach">
              <Name>Powder 20 g protein, 4.9 g carbohydrate per 33.4 g sachet</Name>
              <Brand ID="B42122087172525">
                <Name>PKU GMPro Ultra Lemonade</Name>
                <Pack ID="P2657201" Specified="true" nzmt:ctpp_id="50315281000117102">
                  <Quantity>30</Quantity>
                  <Price>936.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B42122087172526">
                <Name>PKU GMPro Ultra Vanilla</Name>
                <Pack ID="P2682931" Specified="true" nzmt:ctpp_id="50337351000117101">
                  <Quantity>30</Quantity>
                  <Price>936.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220871726" Rank="2" Units="sach">
              <Name>Powder 20 g protein, 6.3 g carbohydrate per 35 g sachet</Name>
              <Brand ID="B42122087172625">
                <Name>PKU sphere20 Vanilla</Name>
                <Pack ID="P2659808" Specified="true" nzmt:ctpp_id="50318851000117104">
                  <Quantity>30</Quantity>
                  <Price>930.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B42122087172626">
                <Name>PKU sphere20 Red Berry</Name>
                <Pack ID="P2659794" Specified="true" nzmt:ctpp_id="50318841000117101">
                  <Quantity>30</Quantity>
                  <Price>930.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B42122087172627">
                <Name>PKU sphere20 Chocolate</Name>
                <Pack ID="P2659778" Specified="true" nzmt:ctpp_id="50318861000117102">
                  <Quantity>30</Quantity>
                  <Price>930.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220871727" Rank="2" Units="sach">
              <Name>Powder 20 g protein, 6.0 g carbohydrate per 35 g sachet</Name>
              <Brand ID="B42122087172725">
                <Name>PKU sphere20 Lemon</Name>
                <Pack ID="P2659786" Specified="true" nzmt:ctpp_id="50318881000117105">
                  <Quantity>30</Quantity>
                  <Price>930.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220871728" Rank="2" Units="sach">
              <Name>Powder 20 g protein, 6.7 g carbohydrate per 35 g sachet</Name>
              <Brand ID="B42122087172825">
                <Name>PKU sphere20 Banana</Name>
                <Pack ID="P2659751" Specified="true" nzmt:ctpp_id="50318871000117107">
                  <Quantity>30</Quantity>
                  <Price>930.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220871729" Rank="2" Units="sach">
              <Name>Powder 20 g protein, 1.7 g carbohydrate per 32 g sachet</Name>
              <Brand ID="B42122087172925">
                <Name>PKU Build 20 Chocolate</Name>
                <Pack ID="P2663368" Specified="true" nzmt:ctpp_id="50335921000117102">
                  <Quantity>30</Quantity>
                  <Price>898.56</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220871730" Rank="2" Units="sach">
              <Name>Powder (neutral), 15 g protein, 15 g carbohydrate, 4.5 g fat per 40 g sachet</Name>
              <Brand ID="B42122087173025">
                <Name>Glytactin Bettermilk</Name>
                <Pack ID="P2672081" Specified="true" nzmt:ctpp_id="50335961000117106">
                  <Quantity>30</Quantity>
                  <Price>673.92</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220871731" Rank="10" Units="pack">
              <Name>Liquid (original), 15 g protein, 22 g carbohydrate, 5.3 g fat per 250 ml, carton</Name>
              <Brand ID="B42122087173125">
                <Name>PKU Glytactin RTD 15</Name>
                <Pack ID="P2672049" Specified="true" nzmt:ctpp_id="50328511000117109">
                  <Quantity>30</Quantity>
                  <Price>684.45</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220871732" Rank="10" Units="pack">
              <Name>Liquid (vanilla), 15 g protein, 3.3 g carbohydrate, 4.6 g fat per 250 ml, carton</Name>
              <Brand ID="B42122087173225">
                <Name>PKU Glytactin RTD 15 Lite</Name>
                <Pack ID="P2672065" Specified="true" nzmt:ctpp_id="50328531000117100">
                  <Quantity>30</Quantity>
                  <Price>684.45</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220871733" Rank="10" Units="pack">
              <Name>Liquid (chocolate), 15 g protein, 22 g carbohydrate, 5.3 g fat per 250 ml, carton</Name>
              <Brand ID="B42122087173325">
                <Name>PKU Glytactin RTD 15</Name>
                <Pack ID="P2672057" Specified="true" nzmt:ctpp_id="50328501000117106">
                  <Quantity>30</Quantity>
                  <Price>684.45</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220871734" Rank="2" Units="sach">
              <Name>Powder (Neutral), 10 g protein, 0.5 g carbohydrate, 0.6 g fat per 15 g sachet</Name>
              <Brand ID="B42122087173425">
                <Name>PKU Build 10</Name>
                <Pack ID="P2672030" Specified="true" nzmt:ctpp_id="50335911000117108">
                  <Quantity>30</Quantity>
                  <Price>449.28</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220871735" Rank="10" Units="pack">
              <Name>Liquid (Coffee Mocha), 15 g protein, 3.1 g carbohydrate, 4.6 g fat 250 ml, carton</Name>
              <Brand ID="B42122087173525">
                <Name>PKU Glytactin RTD 15 Lite</Name>
                <Pack ID="P2672073" Specified="true" nzmt:ctpp_id="50328521000117103">
                  <Quantity>30</Quantity>
                  <Price>684.45</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220871736" Rank="2" Units="sach">
              <Name>Powder 20 g protein, 1.7 g carbohydrate per 31 g sachet</Name>
              <Brand ID="B42122087173627">
                <Name>PKU Build 20 Raspberry Lemonade</Name>
                <Pack ID="P2663392" Specified="true" nzmt:ctpp_id="50335931000117104">
                  <Quantity>30</Quantity>
                  <Price>898.56</Price>
                </Pack>
              </Brand>
              <Brand ID="B42122087173628">
                <Name>PKU Build 20 Smooth</Name>
                <Pack ID="P2663384" Specified="true" nzmt:ctpp_id="50335941000117107">
                  <Quantity>30</Quantity>
                  <Price>898.56</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220871737" Rank="2" Units="sach">
              <Name>Powder 20 g protein, 1.7 g carbohydrate per 33 g sachet</Name>
              <Brand ID="B42122087173726">
                <Name>PKU Build 20 Vanilla</Name>
                <Pack ID="P2663376" Specified="true" nzmt:ctpp_id="50335951000117109">
                  <Quantity>30</Quantity>
                  <Price>898.56</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220871738" Rank="2" Units="sach">
              <Name>Powder (unflavoured) 10 g protein, 4 g carbohydrate per 12.5 g sachet</Name>
              <Brand ID="B42122087173825">
                <Name>PKU GMPro Mix-In</Name>
                <Pack ID="P2682958" Specified="true" nzmt:ctpp_id="50337361000117104">
                  <Quantity>30</Quantity>
                  <Price>468.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220871739" Rank="10" Units="pack">
              <Name>Liquid (neutral),10 g protein, 8.5 g carbohydrate per 250 ml carton</Name>
              <Brand ID="B42122087173925">
                <Name>PKU GMPro LQ</Name>
                <Pack ID="P2682974" Specified="true" nzmt:ctpp_id="50337371000117109">
                  <Quantity>18</Quantity>
                  <Price>280.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4212209631">
            <Name>Amino acid formula (without phenylalanine)</Name>
            <Formulation ID="F421220963105" Rank="10" Units="btl">
              <Name>Liquid 6.7 g protein, 5.1 g carbohydrate and 2 g fat per 100 ml, 250 ml carton</Name>
              <Brand ID="B42122096310525">
                <Name>Easiphen Liquid</Name>
                <Pack ID="P2450828" Specified="true" nzmt:ctpp_id="50200241000117107">
                  <Quantity>18</Quantity>
                  <Price>540.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963110" Rank="1" Units="tab" Weight="833">
              <Name>Tab 8.33 mg</Name>
              <Brand ID="B42122096311025">
                <Name>Phlexy 10</Name>
                <Pack ID="P2198460" Specified="true" nzmt:ctpp_id="50031731000117104">
                  <Quantity>75</Quantity>
                  <Price>99.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963127" Rank="3" Units="ml">
              <Name>Liquid 8 g protein, 7 g carbohydrate, 3.8 g fat and 0.25 g fibre per 100 ml, bottle</Name>
              <Brand ID="B42122096312725">
                <Name>PKU Anamix Junior LQ (Unflavoured)</Name>
                <Pack ID="P2400510" Specified="true" nzmt:ctpp_id="50129551000117106">
                  <Quantity>125</Quantity>
                  <Price>13.10</Price>
                </Pack>
              </Brand>
              <Brand ID="B42122096312726">
                <Name>PKU Anamix Junior LQ (Orange)</Name>
                <Pack ID="P2400502" Specified="true" nzmt:ctpp_id="50129541000117109">
                  <Quantity>125</Quantity>
                  <Price>13.10</Price>
                </Pack>
              </Brand>
              <Brand ID="B42122096312727">
                <Name>PKU Anamix Junior LQ (Berry)</Name>
                <Pack ID="P2400499" Specified="true" nzmt:ctpp_id="50129531000117101">
                  <Quantity>125</Quantity>
                  <Price>13.10</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963131" Rank="10" Units="pot">
              <Name>Semi-solid 18.3 g protein, 18.5 g carbohydrate and 0.92 g fibre per 100 g, 109 g pot</Name>
              <Brand ID="B42122096313125">
                <Name>PKU Lophlex Sensations 20 (berries)</Name>
                <Pack ID="P2528606" Specified="true" nzmt:ctpp_id="50253021000117109">
                  <Quantity>36</Quantity>
                  <Price>1123.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963134" Rank="3" Units="g">
              <Name>Powder 13.1 g protein, 50.1 g carbohydrate, 23 g fat and 5.3 g fibre per 100 g, 400 g can</Name>
              <Brand ID="B42122096313425">
                <Name>PKU Anamix Infant</Name>
                <Pack ID="P2595923" Specified="true" nzmt:ctpp_id="50283931000117101">
                  <Quantity>400</Quantity>
                  <Price>174.72</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963135" Rank="2" Units="sach">
              <Name>Powder (Berry), 5.0 g protein, 14 g carbohydrate, 0 g fat per 20 g sachet</Name>
              <Brand ID="B42122096313525">
                <Name>PKU Restore Powder</Name>
                <Pack ID="P2672103" Specified="true" nzmt:ctpp_id="50328561000117107">
                  <Quantity>60</Quantity>
                  <Price>449.28</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963136" Rank="2" Units="sach">
              <Name>Powder (Orange), 5.0 g protein, 14 g carbohydrate, 0 g fat per 20 g sachet</Name>
              <Brand ID="B42122096313625">
                <Name>PKU Restore Powder</Name>
                <Pack ID="P2672480" Specified="true" nzmt:ctpp_id="50328571000117102">
                  <Quantity>60</Quantity>
                  <Price>449.28</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963138" Rank="2" Units="sach">
              <Name>Powder (Neutral), 5.0 g protein, 5.2 g carbohydrate, 0.2 g fat per 12.5 g sachet</Name>
              <Brand ID="B42122096313825">
                <Name>PKU Explore 5</Name>
                <Pack ID="P2668602" Specified="true" nzmt:ctpp_id="50328451000117109">
                  <Quantity>30</Quantity>
                  <Price>220.88</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963139" Rank="2" Units="sach">
              <Name>Powder (Orange), 10 g protein, 9.8 g carbohydrate, 0.4 g fat per 25 g sachet</Name>
              <Brand ID="B42122096313925">
                <Name>PKU Explore 10</Name>
                <Pack ID="P2668610" Specified="true" nzmt:ctpp_id="50328441000117107">
                  <Quantity>30</Quantity>
                  <Price>441.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963140" Rank="2" Units="sach">
              <Name>Powder (Raspberry), 10 g protein, 9.8 g carbohydrate, 0.4 g fat per 25 g sachet</Name>
              <Brand ID="B42122096314025">
                <Name>PKU Explore 10</Name>
                <Pack ID="P2668629" Specified="true" nzmt:ctpp_id="50328431000117104">
                  <Quantity>30</Quantity>
                  <Price>441.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963141" Rank="2" Units="sach">
              <Name>Powder (Neutral), 20 g protein, 4.8 g carbohydrate, 0.8 g fat per 34 g sachet</Name>
              <Brand ID="B42122096314125">
                <Name>PKU Express 20</Name>
                <Pack ID="P2668661" Specified="true" nzmt:ctpp_id="50328391000117108">
                  <Quantity>30</Quantity>
                  <Price>883.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963142" Rank="2" Units="sach">
              <Name>Powder (Orange), 20 g protein, 3.9 g carbohydrate, 0.8 g fat per 34 g sachet</Name>
              <Brand ID="B42122096314225">
                <Name>PKU Express 20</Name>
                <Pack ID="P2668645" Specified="true" nzmt:ctpp_id="50328411000117108">
                  <Quantity>30</Quantity>
                  <Price>883.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963143" Rank="2" Units="sach">
              <Name>Powder (Lemon), 20 g protein, 3.9 g carbohydrate, 0.8 g fat per 34 g sachet</Name>
              <Brand ID="B42122096314325">
                <Name>PKU Express 20</Name>
                <Pack ID="P2668637" Specified="true" nzmt:ctpp_id="50328421000117102">
                  <Quantity>30</Quantity>
                  <Price>883.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963144" Rank="2" Units="sach">
              <Name>Powder (Tropical), 20 g protein, 3.9 g carbohydrate, 0.8 g fat per 34 g sachet</Name>
              <Brand ID="B42122096314425">
                <Name>PKU Express 20</Name>
                <Pack ID="P2668653" Specified="true" nzmt:ctpp_id="50328401000117105">
                  <Quantity>30</Quantity>
                  <Price>883.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963145" Rank="2" Units="sach">
              <Name>Powder (unflavoured), 5 g protein, 4.8 g carbohydrate per 12.5 g sachets</Name>
              <Brand ID="B42122096314525">
                <Name>PKU First Spoon</Name>
                <Pack ID="P2682966" Specified="true" nzmt:ctpp_id="50305931000117108">
                  <Quantity>30</Quantity>
                  <Price>234.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963146" Rank="2" Units="sach">
              <Name>Powder (neutral) 20 g protein, 3.8 g carbohydrate and 0.23 g fibre per 28 g sachet</Name>
              <Brand ID="B42122096314625">
                <Name>PKU Lophlex Powder</Name>
                <Pack ID="P2642999" Specified="true" nzmt:ctpp_id="50304431000117103">
                  <Quantity>30</Quantity>
                  <Price>936.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963147" Rank="2" Units="sach">
              <Name>Powder (berry) 20 g protein, 3.8 g carbohydrate and 0.23 g fibre per 28 g sachet</Name>
              <Brand ID="B42122096314725">
                <Name>PKU Lophlex Powder</Name>
                <Pack ID="P2593882" Specified="true" nzmt:ctpp_id="50293611000117102">
                  <Quantity>30</Quantity>
                  <Price>936.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963148" Rank="2" Units="sach">
              <Name>Powder (orange) 20 g protein, 3.8 g carbohydrate and 0.23 g fibre per 28 g sachet</Name>
              <Brand ID="B42122096314825">
                <Name>PKU Lophlex Powder</Name>
                <Pack ID="P2593890" Specified="true" nzmt:ctpp_id="50293601000117100">
                  <Quantity>30</Quantity>
                  <Price>936.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963149" Rank="10" Units="btl">
              <Name>Liquid (juicy berries) 16 g protein, 7 g carbohydrate and 0.4 g fibre per 100 ml, 62.5 ml bottle</Name>
              <Brand ID="B42122096314925">
                <Name>PKU Lophlex LQ 10</Name>
                <Pack ID="P2470586" Specified="true" nzmt:ctpp_id="50338141000117102">
                  <Quantity>60</Quantity>
                  <Price>939.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963150" Rank="10" Units="btl">
              <Name>Liquid (juicy tropical) 16 g protein, 7 g carbohydrate and 0.4 g fibre per 100 ml, 125 ml bottle</Name>
              <Brand ID="B42122096315025">
                <Name>PKU Lophlex LQ 20</Name>
                <Pack ID="P2528592" Specified="true" nzmt:ctpp_id="50338151000117100">
                  <Quantity>30</Quantity>
                  <Price>936.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963151" Rank="10" Units="btl">
              <Name>Liquid (juicy berries) 20 g protein, 8.8 g carbohydrate and 0.34 g fibre per 100 ml, 125 ml bottle</Name>
              <Brand ID="B42122096315125">
                <Name>PKU Lophlex LQ 20</Name>
                <Pack ID="P2470535" Specified="true" nzmt:ctpp_id="50338161000117103">
                  <Quantity>30</Quantity>
                  <Price>936.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963152" Rank="10" Units="btl">
              <Name>Liquid (juicy orange) 20 g protein, 8.8 g carbohydrate and 0.34 g fibre per 100 ml, 125 ml bottle</Name>
              <Brand ID="B42122096315225">
                <Name>PKU Lophlex LQ 20</Name>
                <Pack ID="P2470543" Specified="true" nzmt:ctpp_id="50338171000117108">
                  <Quantity>30</Quantity>
                  <Price>936.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963153" Rank="3" Units="g">
              <Name>Powder (unflavoured) 39 g protein and 34 g carbohydrate per 100 g, 500 g can</Name>
              <Brand ID="B42122096315325">
                <Name>XP Maxamum</Name>
                <Pack ID="P459828" Specified="true" nzmt:ctpp_id="50087441000117103">
                  <Quantity>500</Quantity>
                  <Price>320.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963154" Rank="3" Units="g">
              <Name>Powder (orange) 39 g protein and 34 g carbohydrate per 100 g, 500 g can</Name>
              <Brand ID="B42122096315425">
                <Name>XP Maxamum</Name>
                <Pack ID="P212059" Specified="true" nzmt:ctpp_id="50021821000117109">
                  <Quantity>500</Quantity>
                  <Price>320.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963155" Rank="2" Units="sach">
              <Name>Powder (neutral) 36 g protein, 32 g carbohydrate and 12.5 g fat per 100 g, 36 g sachet</Name>
              <Brand ID="B42122096315525">
                <Name>PKU Anamix Junior</Name>
                <Pack ID="P2642980" Specified="true" nzmt:ctpp_id="50304441000117106">
                  <Quantity>30</Quantity>
                  <Price>393.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963156" Rank="2" Units="sach">
              <Name>Powder (vanilla) 36 g protein, 32 g carbohydrate and 12.5 g fat per 100 g, 36 g sachet</Name>
              <Brand ID="B42122096315625">
                <Name>PKU Anamix Junior</Name>
                <Pack ID="P2556162" Specified="true" nzmt:ctpp_id="50304811000117105">
                  <Quantity>30</Quantity>
                  <Price>393.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963157" Rank="2" Units="sach">
              <Name>Powder (chocolate) 36 g protein, 32 g carbohydrate and 12.5 g fat per 100 g, 36 g sachet</Name>
              <Brand ID="B42122096315725">
                <Name>PKU Anamix Junior</Name>
                <Pack ID="P2556154" Specified="true" nzmt:ctpp_id="50304791000117106">
                  <Quantity>30</Quantity>
                  <Price>393.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963158" Rank="2" Units="sach">
              <Name>Powder (orange) 36 g protein, 32 g carbohydrate and 12.5 g fat per 100 g, 36 g sachet</Name>
              <Brand ID="B42122096315825">
                <Name>PKU Anamix Junior</Name>
                <Pack ID="P2609657" Specified="true" nzmt:ctpp_id="50304801000117107">
                  <Quantity>30</Quantity>
                  <Price>393.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421220963159" Rank="10" Units="pack">
              <Name>Powder (Neutral), 14.3 g protein, 25 g fat per 100 g, 400 g can</Name>
              <Brand ID="B42122096315925">
                <Name>PKU Start</Name>
                <Pack ID="P2689391" Specified="true" nzmt:ctpp_id="50339871000117108">
                  <Quantity>4</Quantity>
                  <Price>715.16</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421226">
          <Name>Protein Free Supplements</Name>
          <Chemical ID="C4212268747">
            <Name>Protein free supplement containing carbohydrate, fat with added vitamins and minerals</Name>
            <Formulation ID="F421226874725" Rank="3" Units="g">
              <Name>Powder (neutral) nil added protein and 67 g carbohydrate per 100 g, 400 g can</Name>
              <Brand ID="B42122687472525">
                <Name>Energivit</Name>
                <Pack ID="P2000628" Specified="true" nzmt:ctpp_id="50000091000117102">
                  <Quantity>400</Quantity>
                  <Price>49.29</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421228">
          <Name>Supplements for Tyrosinaemia</Name>
          <Chemical ID="C4212288024">
            <Name>Amino acid formula (without phenylalanine and tyrosine)</Name>
            <Formulation ID="F421228802402" Rank="3" Units="g">
              <Name>Powder 13.1 g protein, 49.5 g carbohydrate, 23 g fat and 5.3 g fibre per 100 g, 400 g can</Name>
              <Brand ID="B42122880240225">
                <Name>TYR Anamix Infant</Name>
                <Pack ID="P2405342" Specified="true" nzmt:ctpp_id="50329331000117100">
                  <Quantity>400</Quantity>
                  <Price>260.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421228802425" Rank="2" Units="sach">
              <Name>Powder (neutral), 5 g protein, 5.3 g carbohydrate, 0.2 g fat per 12.5 g sachet</Name>
              <Brand ID="B42122880242525">
                <Name>TYR Explore 5</Name>
                <Pack ID="P2668696" Specified="true" nzmt:ctpp_id="50328291000117104">
                  <Quantity>30</Quantity>
                  <Price>349.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421228802426" Rank="2" Units="sach">
              <Name>Powder (neutral) 36 g protein, 32 g carbohydrate and 12.5 g fat per 100 g, 36 g sachet</Name>
              <Brand ID="B42122880242625">
                <Name>TYR Anamix Junior</Name>
                <Pack ID="P2482444" Specified="true" nzmt:ctpp_id="50329321000117103">
                  <Quantity>30</Quantity>
                  <Price>471.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421228802427" Rank="10" Units="btl">
              <Name>Liquid (orange) 8 g protein, 7 g carbohydrate, 3.8 g fat and 0.25 g fibre per 100 ml, 125 ml bottle</Name>
              <Brand ID="B42122880242725">
                <Name>TYR Anamix Junior LQ</Name>
                <Pack ID="P2683024" Specified="true" nzmt:ctpp_id="50337381000117107">
                  <Quantity>36</Quantity>
                  <Price>941.40</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421228802428" Rank="10" Units="pack">
              <Name>Liquid (juicy berries), 20 g protein,8.8 g carbohydrate, 0.44 g fat and 0.5 g fibre per 125 ml pouch</Name>
              <Brand ID="B42122880242825">
                <Name>TYR Lophlex LQ 20</Name>
                <Pack ID="P2610906" Specified="true" nzmt:ctpp_id="50287381000117108">
                  <Quantity>30</Quantity>
                  <Price>1684.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4212288725">
            <Name>Glycomacropeptide and amino acid contains some tyrosine and phenylalanine</Name>
            <Formulation ID="F421228872525" Rank="2" Units="sach">
              <Name>Powder (Red Berry), 20 g protein, 6.3 carbohydrate, 1.6 g fat per 35 g sachet</Name>
              <Brand ID="B42122887252525">
                <Name>TYR Sphere 20</Name>
                <Pack ID="P2668726" Specified="true" nzmt:ctpp_id="50317301000117109">
                  <Quantity>30</Quantity>
                  <Price>1398.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421228872526" Rank="2" Units="sach">
              <Name>Powder (Vanilla), 20 g protein, 6.0 g carbohydrate, 1.6 g fat per 35 g sachet</Name>
              <Brand ID="B42122887252625">
                <Name>TYR Sphere 20</Name>
                <Pack ID="P2668734" Specified="true" nzmt:ctpp_id="50328591000117101">
                  <Quantity>30</Quantity>
                  <Price>1398.60</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421236">
          <Name>X-Linked Adrenoleukodystrophy Products</Name>
          <Chemical ID="C4212368204">
            <Name>Glycerol trierucate</Name>
            <Formulation ID="F421236820401" Rank="3" Units="ml">
              <Name>Liquid, 1,000 ml bottle</Name>
              <Brand ID="B42123682040100">
                <Name>Any</Name>
                <Pack ID="P82040100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4212368205">
            <Name>Glycerol trioleate</Name>
            <Formulation ID="F421236820525" Rank="3" Units="ml">
              <Name>Liquid, bottle</Name>
              <Brand ID="B42123682052525">
                <Name>GTO Oil</Name>
                <Pack ID="P2126567" Specified="true" nzmt:ctpp_id="50200921000117108">
                  <Quantity>500</Quantity>
                  <Price>131.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421238">
          <Name>Supplements for Glycogen Storage Disease</Name>
          <Chemical ID="C4212388727">
            <Name>High amylopectin corn-starch</Name>
            <Formulation ID="F421238872725" Rank="2" Units="sach">
              <Name>Powder 0 g protein, 53 g carbohydrate, 0 g fat per 60 g sachet</Name>
              <Brand ID="B42123887272525">
                <Name>Glycosade</Name>
                <Pack ID="P2456834" Specified="true" nzmt:ctpp_id="50326571000117103">
                  <Quantity>30</Quantity>
                  <Price>241.62</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421240">
          <Name>Supplements for Organic Acidaemias</Name>
          <Chemical ID="C4212408020">
            <Name>Amino acid formula (without isoleucine, methionine, threonine and valine)</Name>
            <Formulation ID="F421240802025" Rank="3" Units="g">
              <Name>Powder 13.1 g protein, 50.1 g carbohydrate, 23 g fat and 5.3 g fibre per 100 g, 400 g can</Name>
              <Brand ID="B42124080202525">
                <Name>MMA/PA Anamix Infant</Name>
                <Pack ID="P2386313" Specified="true" nzmt:ctpp_id="50200591000117102">
                  <Quantity>400</Quantity>
                  <Price>260.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4212408726">
            <Name>Amino acid formula (without methionine, threonine and valine)</Name>
            <Formulation ID="F421240872625" Rank="2" Units="sach">
              <Name>Powder, 5 g protein, 5.3 g carbohydrate, 0.2 g fat per 12.5 g sachet</Name>
              <Brand ID="B42124087262525">
                <Name>MMA/PA Explore 5</Name>
                <Pack ID="P2668564" Specified="true" nzmt:ctpp_id="50328241000117106">
                  <Quantity>30</Quantity>
                  <Price>349.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421240872626" Rank="2" Units="sach">
              <Name>Powder, 15 g protein, 3.4 g carbohydrate, 0.05 g fat per 25 g sachet</Name>
              <Brand ID="B42124087262625">
                <Name>MMA/PA Express 15</Name>
                <Pack ID="P2668572" Specified="true" nzmt:ctpp_id="50328251000117108">
                  <Quantity>30</Quantity>
                  <Price>1048.95</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421240872627" Rank="2" Units="sach">
              <Name>Powder (neutral), 5 g protein, 5.4 g carbohydrate, 2.3 g fat and 2.0 g fibre per 18 g sachet</Name>
              <Brand ID="B42124087262725">
                <Name>MMA/PA Anamix Junior</Name>
                <Pack ID="P2498812" Specified="true" nzmt:ctpp_id="50337441000117109">
                  <Quantity>30</Quantity>
                  <Price>750.30</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421242">
          <Name>Single Dose Amino Acids</Name>
          <Chemical ID="C4212428036">
            <Name>Arginine</Name>
            <Formulation ID="F421242803630" Rank="2" Units="sach">
              <Name>Powder 1.7 g protein, 1.9 g carbohydrate per 4 g sachet</Name>
              <Brand ID="B42124280363025">
                <Name>Arginine2000</Name>
                <Pack ID="P2668750" Specified="true" nzmt:ctpp_id="50302871000117108">
                  <Quantity>30</Quantity>
                  <Price>211.45</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4212428728">
            <Name>Phenylalanine</Name>
            <Formulation ID="F421242872825" Rank="2" Units="sach">
              <Name>Powder 0.04 g protein, 3.8 g carbohydrate per 4 g sachet</Name>
              <Brand ID="B42124287282525">
                <Name>Phenylalanine50</Name>
                <Pack ID="P2474557" Specified="true" nzmt:ctpp_id="50326501000117107">
                  <Quantity>30</Quantity>
                  <Price>141.05</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4212428729">
            <Name>Valine</Name>
            <Formulation ID="F421242872925" Rank="2" Units="sach">
              <Name>Powder 0.04 g protein, 3.8 g carbohydrate per 4 g sachet</Name>
              <Brand ID="B42124287292525">
                <Name>Valine50</Name>
                <Pack ID="P2514079" Specified="true" nzmt:ctpp_id="50327661000117107">
                  <Quantity>30</Quantity>
                  <Price>141.05</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4212428730">
            <Name>Isoleucine</Name>
            <Formulation ID="F421242873025" Rank="2" Units="sach">
              <Name>Powder 0.04 g protein, 3.8 g carbohydrate per 4 g sachet</Name>
              <Brand ID="B42124287302525">
                <Name>Isoleucine50</Name>
                <Pack ID="P2514060" Specified="true" nzmt:ctpp_id="50326031000117107">
                  <Quantity>30</Quantity>
                  <Price>141.05</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4212428731">
            <Name>Leucine</Name>
            <Formulation ID="F421242873125" Rank="2" Units="sach">
              <Name>Powder 0.08 g protein, 3.7 g carbohydrate per 4 g sachet</Name>
              <Brand ID="B42124287312525">
                <Name>Leucine100</Name>
                <Pack ID="P2622572" Specified="true" nzmt:ctpp_id="50292431000117101">
                  <Quantity>30</Quantity>
                  <Price>141.05</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4212428732">
            <Name>Tyrosine</Name>
            <Formulation ID="F421242873225" Rank="2" Units="sach">
              <Name>Powder 0.8 g protein, 2.9 g carbohydrate per 4 g sachet</Name>
              <Brand ID="B42124287322525">
                <Name>Tyrosine1000</Name>
                <Pack ID="P2668742" Specified="true" nzmt:ctpp_id="50328371000117107">
                  <Quantity>30</Quantity>
                  <Price>211.45</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4212428733">
            <Name>Citrulline</Name>
            <Formulation ID="F421242873325" Rank="2" Units="sach">
              <Name>Powder 0.8 g protein, 2.9 g carbohydrate per 4 g sachet</Name>
              <Brand ID="B42124287332525">
                <Name>Citrulline1000</Name>
                <Pack ID="P2632330" Specified="true" nzmt:ctpp_id="50297711000117103">
                  <Quantity>30</Quantity>
                  <Price>211.45</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421244">
          <Name>Other Fat Modified Products</Name>
          <Chemical ID="C4212448746">
            <Name>Elemental feed with high medium chain triglycerides</Name>
            <Formulation ID="F421244874625" Rank="2" Units="sach">
              <Name>Powder (neutral), 12.5 g protein, 60 g carbohydrate and 16.4 g fat per 100 g sachet</Name>
              <Brand ID="B42124487462525">
                <Name>Emsogen</Name>
                <Pack ID="P2508419" Specified="true" nzmt:ctpp_id="50337451000117106">
                  <Quantity>10</Quantity>
                  <Price>47.01</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421248">
          <Name>Essential Amino Acids</Name>
          <Chemical ID="C4212488745">
            <Name>Essential amino acid formula</Name>
            <Formulation ID="F421248874525" Rank="3" Units="g">
              <Name>Powder (neutral) 79 g protein per 100 g, 200 g can</Name>
              <Brand ID="B42124887452525">
                <Name>Essential Amino Acid Mix</Name>
                <Pack ID="P2389053" Specified="true" nzmt:ctpp_id="50200901000117100">
                  <Quantity>200</Quantity>
                  <Price>313.73</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A4216">
        <Name>Specialised Formulas</Name>
        <ATC3 ID="A421604">
          <Name>Diabetic Products</Name>
          <Request Form="RS1215" To="HealthPAC" For="Subsidy">
            <Title>
              <range>Diabetic Products</range>
            </Title>
            <Case When="Initial application">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <or/>
                  <ci type="logical">For patients with type I or type II diabetes suffering weight loss and malnutrition that requires nutritional support</ci>
                  <ci type="logical">For patients with pancreatic insufficiency</ci>
                  <ci type="logical">For patients who have, or are expected to, eat little or nothing for 5 days</ci>
                  <ci type="logical">For patients who have a poor absorptive capacity and/or high nutrient losses and/or increased nutritional needs from causes such as catabolism</ci>
                  <ci type="logical">For use pre- and post-surgery</ci>
                  <ci type="logical">For patients being tube-fed</ci>
                  <ci type="logical">For tube-feeding as a transition from intravenous nutrition</ci>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
          </Request>
          <html:div class="Restricted" xlink:href="RS1215" style="display:none"/>
          <Chemical ID="C4216048741">
            <Name>Diabetic oral feed 1 kcal/ml</Name>
            <Formulation ID="F421604874125" Rank="3" Units="ml">
              <Name>Liquid 4.9 g protein, 11.7 g carbohydrate, 3.8 g fat and 2 g fibre per 100 ml, 200 ml bottle</Name>
              <Brand ID="B42160487412525">
                <Name>Diasip (strawberry)</Name>
                <Pack ID="P2224437" Specified="true" nzmt:ctpp_id="50035741000117105">
                  <Quantity>200</Quantity>
                  <Price>2.25</Price>
                </Pack>
              </Brand>
              <Brand ID="B42160487412526">
                <Name>Diasip (vanilla)</Name>
                <Pack ID="P2224429" Specified="true" nzmt:ctpp_id="50035731000117102">
                  <Quantity>200</Quantity>
                  <Price>2.25</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216049604">
            <Name>Low-GI oral feed 1 kcal/ml</Name>
            <Formulation ID="F421604960426" Rank="3" Units="ml">
              <Name>Liquid 7 g protein, 10.9 g carbohydrate, 2.7 g fat and 2 g fibre per 100 ml, bottle</Name>
              <Brand ID="B42160496042625">
                <Name>Nutren Diabetes (Vanilla)</Name>
                <Pack ID="P2605570" Specified="true" nzmt:ctpp_id="50286361000117102">
                  <Quantity>200</Quantity>
                  <Price>2.10</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216049605">
            <Name>Low-GI enteral feed 1 kcal/ml</Name>
            <Formulation ID="F421604960525" Rank="3" Units="ml">
              <Name>Liquid 5 g protein, 9.6 g carbohydrate and 5.4 g fat per 100 ml, 500 ml bottle</Name>
              <Brand ID="B42160496052525">
                <Name>Glucerna Select</Name>
                <Pack ID="P2605651" Specified="true" nzmt:ctpp_id="50285691000117108">
                  <Quantity>500</Quantity>
                  <Price>4.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421604960526" Rank="10" Units="btl">
              <Name>Liquid 4.3 g protein, 11.3 g carbohydrate and 4.2 g fat per 100 ml, 1,000 ml bottle</Name>
              <Brand ID="B42160496052600">
                <Name>e.g. Nutrison Advanced Diason</Name>
                <Pack ID="P96052600" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421608">
          <Name>Elemental and Semi-Elemental Products</Name>
          <Request Form="RS1216" To="HealthPAC" For="Subsidy">
            <Title>
              <range>Elemental and Semi-Elemental Products</range>
            </Title>
            <Case When="Initial application">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <or/>
                  <ci type="logical">Malabsorption</ci>
                  <ci type="logical">Short bowel syndrome</ci>
                  <ci type="logical">Enterocutaneous fistulas</ci>
                  <ci type="logical">Eosinophilic enteritis (including oesophagitis)</ci>
                  <ci type="logical">Inflammatory bowel disease</ci>
                  <ci type="logical">Acute pancreatitis where standard feeds are not tolerated</ci>
                  <ci type="logical">Patients with multiple food allergies requiring enteral feeding</ci>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
          </Request>
          <html:div class="Restricted" xlink:href="RS1216" style="display:none"/>
          <Chemical ID="C4216088025">
            <Name>Amino acid oral feed</Name>
            <Formulation ID="F421608802525" Rank="3" Units="g">
              <Name>Powder 11 g protein, 62 g carbohydrate and 1 g fat per sachet</Name>
              <Brand ID="B42160880252525">
                <Name>Vivonex TEN</Name>
                <Pack ID="P2494450" Specified="true" nzmt:ctpp_id="50232281000117105">
                  <Quantity>80</Quantity>
                  <Price>4.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216088026">
            <Name>Amino acid oral feed 0.8 kcal/ml</Name>
            <Formulation ID="F421608802601" Rank="10" Units="btl">
              <Name>Liquid 2.5 g protein, 11 g carbohydrate and 3.5 g fat per 100 ml, 250 ml carton</Name>
              <Brand ID="B42160880260125">
                <Name>Elemental 028 Extra (grapefruit)</Name>
                <Pack ID="P2450771" Specified="true" nzmt:ctpp_id="50196941000117101">
                  <Quantity>18</Quantity>
                  <Price>179.46</Price>
                </Pack>
              </Brand>
              <Brand ID="B42160880260126">
                <Name>Elemental 028 Extra (pineapple &amp; orange)</Name>
                <Pack ID="P2450801" Specified="true" nzmt:ctpp_id="50196951000117104">
                  <Quantity>18</Quantity>
                  <Price>179.46</Price>
                </Pack>
              </Brand>
              <Brand ID="B42160880260127">
                <Name>Elemental 028 Extra (summer fruits)</Name>
                <Pack ID="P2450798" Specified="true" nzmt:ctpp_id="50196931000117109">
                  <Quantity>18</Quantity>
                  <Price>179.46</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216088351">
            <Name>Peptide-based enteral feed 1 kcal/ml</Name>
            <Formulation ID="F421608835127" Rank="3" Units="ml">
              <Name>Liquid 4 g protein, 17.7 g carbohydrate and 1.7 g fat per 100 ml, bottle</Name>
              <Brand ID="B42160883512725">
                <Name>Nutrison Advanced Peptisorb</Name>
                <Pack ID="P2665433" Specified="true" nzmt:ctpp_id="50323711000117108">
                  <Quantity>500</Quantity>
                  <Price>7.47</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216088352">
            <Name>Peptide-based oral feed</Name>
            <Formulation ID="F421608835202" Rank="3" Units="g">
              <Name>Powder 13.7 g protein, 62.9 g carbohydrate and 17.5 g fat per 100 g, 400 g can</Name>
              <Brand ID="B42160883520200">
                <Name>e.g. Peptamen Junior</Name>
                <Pack ID="P83520200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421608835203" Rank="3" Units="g">
              <Name>Powder 13.8 g protein, 59 g carbohydrate and 18 g fat per 100 g, 400 g can</Name>
              <Brand ID="B42160883520300">
                <Name>e.g. MCT Pepdite; MCT Pepdite 1+</Name>
                <Pack ID="P83520300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216088608">
            <Name>Peptide-based enteral feed 1.5 kcal/ml</Name>
            <Formulation ID="F421608860825" Rank="3" Units="ml">
              <Name> Liquid 6.75 g protein, 18.4 g carbohydrate and 5.5 g fat per 100 ml, bottle</Name>
              <Brand ID="B42160886082525">
                <Name>Vital</Name>
                <Pack ID="P2492989" Specified="true" nzmt:ctpp_id="50228681000117107">
                  <Quantity>1000</Quantity>
                  <Price>22.39</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216089611">
            <Name>Peptide-based oral feed 1 kcal/ml</Name>
            <Formulation ID="F421608961101" Rank="3" Units="ml">
              <Name>Liquid 5 g protein, 16 g carbohydrate and 1.69 g fat per 100 ml, carton</Name>
              <Brand ID="B42160896110125">
                <Name>Peptamen OS 1.0 (Vanilla)</Name>
                <Pack ID="P2082942" Specified="true" nzmt:ctpp_id="50200941000117103">
                  <Quantity>237</Quantity>
                  <Price>4.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421612">
          <Name>Fat Modified Products</Name>
          <Chemical ID="C4216128182">
            <Name>Fat-modified feed</Name>
            <Request Form="RS1470" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Fat-modified feed</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Patient has metabolic disorders of fat metabolism</ci>
                    <ci type="logical">Patient has a chyle leak</ci>
                    <ci type="logical">Modified as a modular feed, made from at least one nutrient module and at least one further product listed in Section D of the Pharmaceutical Schedule, for adults</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Patients are required to meet any Special Authority criteria associated with all of the products used in the modular formula. </p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1470" style="display:none"/>
            <Formulation ID="F421612818227" Rank="3" Units="g">
              <Name>Powder 12.8 g protein, 68.6 g carbohydrate and 12.9 g fat per 100 g,  can</Name>
              <Brand ID="B42161281822725">
                <Name>Monogen</Name>
                <Pack ID="P2601443" Specified="true" nzmt:ctpp_id="50285751000117107">
                  <Quantity>400</Quantity>
                  <Price>62.90</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421616">
          <Name>Hepatic Products</Name>
          <Request Form="RS1217" To="HealthPAC" For="Subsidy">
            <Title>
              <range>Hepatic Products</range>
            </Title>
            <Case When="Initial application">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <ci type="logical">For children (up to 18 years) who require a liver transplant</ci>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
          </Request>
          <html:div class="Restricted" xlink:href="RS1217" style="display:none"/>
          <Chemical ID="C4216169678">
            <Name>Hepatic oral feed</Name>
            <Formulation ID="F421616967826" Rank="3" Units="g">
              <Name>Powder 12 g protein, 56 g carbohydrate and 22 g fat per 100 g, can</Name>
              <Brand ID="B42161696782625">
                <Name>Heparon Junior</Name>
                <Pack ID="P2615568" Specified="true" nzmt:ctpp_id="50289761000117107">
                  <Quantity>400</Quantity>
                  <Price>93.97</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421620">
          <Name>High Calorie Products</Name>
          <Request Form="RS1317" To="HealthPAC" For="Subsidy">
            <Title>
              <range>High Calorie Products</range>
            </Title>
            <Case When="Initial application">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <or/>
                  <ci type="logical">Patient is fluid volume or rate restricted</ci>
                  <ci type="logical">Patient requires low electrolyte</ci>
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Cystic fibrosis</ci>
                      <ci type="logical">Any condition causing malabsorption</ci>
                      <ci type="logical">Faltering growth in an infant/child</ci>
                      <ci type="logical">Increased nutritional requirements</ci>
                    </apply>
                    <ci type="logical">Patient has substantially increased metabolic requirements</ci>
                  </apply>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
          </Request>
          <html:div class="Restricted" xlink:href="RS1317" style="display:none"/>
          <Chemical ID="C4216208710">
            <Name>Peptide-based enteral feed 1kcal/ml</Name>
            <Formulation ID="F421620871025" Rank="3" Units="ml">
              <Name>Liquid 4.5 g protein, 14.3 g carbohydrate and 2.8 g fat per 100 ml, bag</Name>
              <Brand ID="B42162087102525">
                <Name>Survimed OPD</Name>
                <Pack ID="P2651769" Specified="true" nzmt:ctpp_id="50308911000117108">
                  <Quantity>500</Quantity>
                  <Price>9.60</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216209614">
            <Name>Oral feed 2 kcal/ml</Name>
            <Formulation ID="F421620961425" Rank="3" Units="ml">
              <Name>Liquid 8.4 g protein, 22.4 g carbohydrate, 8.9 g fat and 0.8 g fibre per 100 ml, bottle</Name>
              <Brand ID="B42162096142525">
                <Name>Two Cal HN</Name>
                <Pack ID="P2443228" Specified="true" nzmt:ctpp_id="50287971000117106">
                  <Quantity>200</Quantity>
                  <Price>2.34</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216209633">
            <Name>Enteral Feed 2 kcal/ml</Name>
            <Formulation ID="F421620963301" Rank="3" Units="ml">
              <Name>Liquid 7.5 g protein, 20 g carbohydrate and 10 g fat per 100 ml, bottle</Name>
              <Brand ID="B42162096330125">
                <Name>Nutrison Concentrated</Name>
                <Pack ID="P2572966" Specified="true" nzmt:ctpp_id="50270261000117103">
                  <Quantity>500</Quantity>
                  <Price>6.82</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421620963302" Rank="3" Units="ml">
              <Name>Liquid 8.4 g protein, 21.9 g carbohydrate, 9.1 g fat and 0.5 g fibre per 100 ml, bottle</Name>
              <Brand ID="B42162096330226">
                <Name>Ensure Two Cal HN RTH</Name>
                <Pack ID="P2614162" Specified="true" nzmt:ctpp_id="50289061000117109">
                  <Quantity>1000</Quantity>
                  <Price>13.64</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421620963325" Rank="3" Units="ml">
              <Name>Liquid 10 g protein, 17.5 g carbohydrate and 10 g fat per 100 ml, bag</Name>
              <Brand ID="B42162096332525">
                <Name>Fresubin 2kcal HP</Name>
                <Pack ID="P2651696" Specified="true" nzmt:ctpp_id="50308851000117102">
                  <Quantity>500</Quantity>
                  <Price>6.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421624">
          <Name>High Protein Products</Name>
          <Chemical ID="C4216248214">
            <Name>High protein enteral feed 1.28 kcal/ml</Name>
            <Request Form="RS1327" To="HealthPAC" For="Subsidy">
              <Title>
                <range>High protein enteral feed</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has a high protein requirement</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has liver disease</ci>
                      <ci type="logical">Patient is obese (BMI &gt; 30) and is undergoing surgery</ci>
                      <ci type="logical">Patient is fluid restricted</ci>
                      <ci type="logical">Patient's needs cannot be more appropriately met using high calorie product</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1327" style="display:none"/>
            <Formulation ID="F421624821426" Rank="3" Units="ml">
              <Name>Liquid 6.3 g protein, 14.1 g carbohydrate, 4.9 g fat and 1.5 g fibre per 100 ml, bottle</Name>
              <Brand ID="B42162482142625">
                <Name>Nutrison Protein Plus Multi Fibre</Name>
                <Pack ID="P2148986" Specified="true" nzmt:ctpp_id="50025681000117107">
                  <Quantity>1000</Quantity>
                  <Price>12.54</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216248507">
            <Name>High protein enteral feed 1.25 kcal/ml</Name>
            <Request Form="RS1327" To="HealthPAC" For="Subsidy">
              <Title>
                <range>High protein enteral feed</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has a high protein requirement</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has liver disease</ci>
                      <ci type="logical">Patient is obese (BMI &gt; 30) and is undergoing surgery</ci>
                      <ci type="logical">Patient is fluid restricted</ci>
                      <ci type="logical">Patient's needs cannot be more appropriately met using high calorie product</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1327" style="display:none"/>
            <Formulation ID="F421624850725" Rank="3" Units="ml">
              <Name>Liquid 6.3 g protein, 14.2 g carbohydrate and 4.9 g fat per 100 ml, bottle</Name>
              <Brand ID="B42162485072525">
                <Name>Nutrison Protein Plus</Name>
                <Pack ID="P2572974" Specified="true" nzmt:ctpp_id="50269181000117103">
                  <Quantity>1000</Quantity>
                  <Price>12.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216248659">
            <Name>High protein enteral feed 1.26 kcal/ml</Name>
            <Request Form="RS1327" To="HealthPAC" For="Subsidy">
              <Title>
                <range>High protein enteral feed</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has a high protein requirement</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has liver disease</ci>
                      <ci type="logical">Patient is obese (BMI &gt; 30) and is undergoing surgery</ci>
                      <ci type="logical">Patient is fluid restricted</ci>
                      <ci type="logical">Patient's needs cannot be more appropriately met using high calorie product</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1327" style="display:none"/>
            <Formulation ID="F421624865925" Rank="3" Units="ml">
              <Name>Liquid 10 g protein, 10.4 g carbohydrate and 4.9 g fat per 100 ml, bottle</Name>
              <Brand ID="B42162486592525">
                <Name>Nutrison Protein Intense</Name>
                <Pack ID="P2572990" Specified="true" nzmt:ctpp_id="50280041000117100">
                  <Quantity>500</Quantity>
                  <Price>8.67</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216248709">
            <Name>High protein enteral feed 1.2 kcal/ml</Name>
            <Request Form="RS1327" To="HealthPAC" For="Subsidy">
              <Title>
                <range>High protein enteral feed</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">The patient has a high protein requirement</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Patient has liver disease</ci>
                      <ci type="logical">Patient is obese (BMI &gt; 30) and is undergoing surgery</ci>
                      <ci type="logical">Patient is fluid restricted</ci>
                      <ci type="logical">Patient's needs cannot be more appropriately met using high calorie product</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1327" style="display:none"/>
            <Formulation ID="F421624870925" Rank="3" Units="ml">
              <Name>Liquid 10 g protein, 12.9 g carbohydrate and 3.2 g fat and 0.64 g fibre per 100 ml, bag</Name>
              <Brand ID="B42162487092525">
                <Name>Fresubin Intensive</Name>
                <Pack ID="P2651750" Specified="true" nzmt:ctpp_id="50308881000117108">
                  <Quantity>500</Quantity>
                  <Price>9.60</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421628">
          <Name>Infant Formulas</Name>
          <Chemical ID="C4216288179">
            <Name>Extensively hydrolysed formula</Name>
            <Request Form="RS1502" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Extensively hydrolysed formula</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <apply>
                      <and/>
                      <ci type="logical">Cows' milk formula is inappropriate due to severe intolerance or allergy to its protein content</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Soy milk formula has been reasonably trialled without resolution of symptoms</ci>
                        <ci type="logical">Soy milk formula is considered clinically inappropriate or contraindicated</ci>
                      </apply>
                    </apply>
                    <ci type="logical">Severe malabsorption</ci>
                    <ci type="logical">Short bowel syndrome</ci>
                    <ci type="logical">Intractable diarrhoea</ci>
                    <ci type="logical">Biliary atresia</ci>
                    <ci type="logical">Cholestatic liver diseases causing malsorption</ci>
                    <ci type="logical">Cystic fibrosis</ci>
                    <ci type="logical">Proven fat malabsorption</ci>
                    <ci type="logical">Severe intestinal motility disorders causing significant malabsorption</ci>
                    <ci type="logical">Intestinal failure</ci>
                    <ci type="logical">For step down from Amino Acid Formula</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>A reasonable trial is defined as a 2-4 week trial, or signs of an immediate IgE mediated allergic reaction.</p>
                </div>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">An assessment as to whether the infant can be transitioned to a cows' milk protein or soy infant formula has been undertaken</ci>
                    <ci type="logical">The outcome of the assessment is that the infant continues to require an extensively hydrolysed infant formula</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1502" style="display:none"/>
            <Formulation ID="F421628817925" Rank="3" Units="g">
              <Name>Powder 1.6 g protein, 7.5 g carbohydrate and 3.1 g fat per 100 ml, 900 g can</Name>
              <Brand ID="B42162881792526">
                <Name>Allerpro Syneo 1</Name>
                <Pack ID="P2641283" Specified="true" nzmt:ctpp_id="50303891000117100">
                  <Quantity>900</Quantity>
                  <Price>36.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421628817926" Rank="3" Units="g">
              <Name>Powder 1.6 g protein, 7.8 g carbohydrate and 3.2 g fat per 100 ml, 900 g can</Name>
              <Brand ID="B42162881792626">
                <Name>Allerpro Syneo 2</Name>
                <Pack ID="P2641291" Specified="true" nzmt:ctpp_id="50303901000117101">
                  <Quantity>900</Quantity>
                  <Price>36.20</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421628817928" Rank="3" Units="g">
              <Name>Powder 14 g protein, 53.4 g carbohydrate and 27.3 g fat per 100 g, can</Name>
              <Brand ID="B42162881792825">
                <Name>Pepti-Junior</Name>
                <Pack ID="P2641305" Specified="true" nzmt:ctpp_id="50004861000117109">
                  <Quantity>450</Quantity>
                  <Price>18.10</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216288195">
            <Name>Fructose-based formula</Name>
            <Formulation ID="F421628819501" Rank="3" Units="g">
              <Name>Powder 14.6 g protein, 49.7 g carbohydrate and 30.8 g fat per 100 g, 400 g can</Name>
              <Brand ID="B42162881950100">
                <Name>e.g. Galactomin 19</Name>
                <Pack ID="P81950100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216288253">
            <Name>Lactose-free formula</Name>
            <Formulation ID="F421628825301" Rank="3" Units="g">
              <Name>Powder 1.5 g protein, 7.2 g carbohydrate and 3.6 g fat per 100 ml, 900 g can</Name>
              <Brand ID="B42162882530100">
                <Name>e.g. S26 Lactose Free</Name>
                <Pack ID="P82530100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421628825302" Rank="3" Units="g">
              <Name>Powder 1.3 g protein, 7.3 g carbohydrate and 3.5 g fat per 100 ml, 900 g can</Name>
              <Brand ID="B42162882530200">
                <Name>e.g. Karicare Aptamil Gold De-Lact</Name>
                <Pack ID="P82530200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216288271">
            <Name>Low-calcium formula</Name>
            <Formulation ID="F421628827126" Rank="3" Units="g">
              <Name>Powder 14.6 g protein, 55.2 g carbohydrate and 25.8 g fat per 100 g, can</Name>
              <Brand ID="B42162882712625" ToBeDelisted="2025-03-01">
                <Name>Locasol</Name>
                <Pack ID="P2601451" Specified="true" nzmt:ctpp_id="50285741000117105">
                  <Quantity>400</Quantity>
                  <Price>46.18</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421628827127" Rank="3" Units="g">
              <Name>Powder 14.8 g protein, 53.7 g carbohydrate and 26.7 g fat per 100 g and tuna fish oil (DHA), can</Name>
              <Brand ID="B42162882712725">
                <Name>Locasol</Name>
                <Pack ID="P2684721" Specified="true" nzmt:ctpp_id="50338051000117104">
                  <Quantity>400</Quantity>
                  <Price>46.18</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216288387">
            <Name>Preterm formula</Name>
            <Request Form="RS1224" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Preterm formula</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For infants born before 33 weeks' gestation or weighing less than 1.5 kg at birth</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1224" style="display:none"/>
            <Formulation ID="F421628838701" Rank="3" Units="ml">
              <Name>Liquid 2.2 g protein, 8.4 g carbohydrate and 4.4 g fat per 100 ml, bottle</Name>
              <Brand ID="B42162883870100">
                <Name>S26 LBW Gold RTF</Name>
                <Pack ID="P222011" Specified="true" nzmt:ctpp_id="50034911000117108">
                  <Quantity>100</Quantity>
                  <Price>0.75</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421628838702" Rank="10" Units="btl">
              <Name>Liquid 2.3 g protein, 8.6 g carbohydrate and 4.2 g fat per 100 ml, 90 ml bottle</Name>
              <Brand ID="B42162883870200">
                <Name>e.g. Pre Nan Gold RTF</Name>
                <Pack ID="P83870200" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421628838703" Rank="10" Units="btl">
              <Name>Liquid 2.6 g protein, 8.4 g carbohydrate and 3.9 g fat per 100 ml, 70 ml bottle</Name>
              <Brand ID="B42162883870300">
                <Name>e.g. Karicare Aptamil Gold+Preterm</Name>
                <Pack ID="P83870300" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216288463">
            <Name>Thickened formula</Name>
            <Formulation ID="F421628846301" Rank="3" Units="g">
              <Name>Powder 1.8 g protein, 8.1 g carbohydrate and 3.3 g fat per 100 ml, 900 g can</Name>
              <Brand ID="B42162884630100">
                <Name>e.g. Karicare Aptamil Thickened AR</Name>
                <Pack ID="P84630100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216288617">
            <Name>Paediatric oral/enteral feed 1 kcal/ml</Name>
            <Request Form="RS1614" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Paediatric oral/enteral feed 1 kcal/ml</range>
              </Title>
              <Case When="Initial application" Category="Fluid restricted or volume intolerance with faltering growth">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">The patient is fluid restricted or volume intolerant</ci>
                      <ci type="logical">The patient has increased nutritional requirements due to faltering growth</ci>
                    </apply>
                    <ci type="logical">Patient is under 18 months old and weighs less than 8kg</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>‘Volume intolerant’ patients are those who are unable to tolerate an adequate volume of infant formula to achieve expected growth rate. These patients should have first trialled
                appropriate clinical alternative treatments, such as concentrating, fortifying and adjusting the frequency of feeding.</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1614" style="display:none"/>
            <Formulation ID="F421628861725" Rank="3" Units="ml">
              <Name>Liquid 2.6 g protein, 10.3 g carbohydrate, 5.4 g fat and 0.6 g fibre per 100 ml, bottle</Name>
              <Brand ID="B42162886172525">
                <Name>Infatrini</Name>
                <Pack ID="P2537923" Specified="true" nzmt:ctpp_id="50251101000117101">
                  <Quantity>125</Quantity>
                  <Price>2.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216288657">
            <Name>Enteral liquid peptide formula</Name>
            <Request Form="RS1775" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Enteral liquid peptide formula</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has impaired gastrointestinal function and either cannot tolerate polymeric feeds, or polymeric feeds are unsuitable</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Severe malabsorption</ci>
                      <ci type="logical">Short bowel syndrome</ci>
                      <ci type="logical">Intractable diarrhoea</ci>
                      <ci type="logical">Biliary atresia</ci>
                      <ci type="logical">Cholestatic liver diseases causing malabsorption</ci>
                      <ci type="logical">Cystic fibrosis</ci>
                      <ci type="logical">Proven fat malabsorption</ci>
                      <ci type="logical">Severe intestinal motility disorders causing significant malabsorption</ci>
                      <ci type="logical">Intestinal failure</ci>
                      <apply>
                        <and/>
                        <ci type="logical">The patient is currently receiving funded amino acid formula</ci>
                        <ci type="logical">The patient is to be trialled on, or transitioned to, an enteral liquid peptide formula</ci>
                      </apply>
                    </apply>
                    <apply>
                      <or/>
                      <ci type="logical">A semi-elemental or partially hydrolysed powdered feed has been reasonably trialled and considered unsuitable</ci>
                      <ci type="logical">For step down from intravenous nutrition</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>A reasonable trial is defined as a 2-4 week trial.</p>
                </div>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">An assessment as to whether the patient can be transitioned to a cows milk protein or soy infant formula or extensively hydrolysed formula has been undertaken</ci>
                    <ci type="logical">The outcome of the assessment is that the patient continues to require an enteral liquid peptide formula</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1775" style="display:none"/>
            <Formulation ID="F421628865726" Rank="3" Units="ml">
              <Name>Liquid 4.2 g protein, 18.6 g carbohydrate and 6.58 g fat per 100 ml</Name>
              <Brand ID="B42162886572625">
                <Name>Nutrini Peptisorb Energy</Name>
                <Pack ID="P2594897" Specified="true" nzmt:ctpp_id="50280611000117107">
                  <Quantity>500</Quantity>
                  <Price>18.66</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216289602">
            <Name>Amino acid formula</Name>
            <Request Form="RS1867" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Amino acid formula</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Extensively hydrolysed formula has been reasonably trialled for
                    2-4 weeks and is inappropriate due to documented severe intolerance or allergy
                    or malabsorption</ci>
                    <ci type="logical">History of anaphylaxis to cows' milk protein formula or dairy
                    products</ci>
                    <ci type="logical">Eosinophilic oesophagitis</ci>
                    <ci type="logical">Ultra-short gut</ci>
                    <ci type="logical">Severe Immune deficiency</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Renewal">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">An assessment as to whether the infant can be transitioned to a
                    cows' milk protein, soy, or extensively hydrolysed infant formula has been
                    undertaken</ci>
                    <ci type="logical">The outcome of the assessment is that the infant continues to
                    require an amino acid infant formula</ci>
                    <ci type="logical">Amino acid formula is required for a nutritional deficit</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="patients who are currently funded under RS1502 or SA1557">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient has a valid initiation or renewal approval for
                    extensively hydrolysed formula (RS1502)</ci>
                    <ci type="logical">Patient is unable to source funded Aptamil powder at this
                    time</ci>
                    <ci type="logical">The approval only applies to funded dispensings of Neocate Gold
                    and Neocate Syneo</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="month">3</Term>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>This criteria is short term funding to cover an out-of-stock situation on some
                extensively hydrolysed formula powder funded under Hospital Restriction RS1502.
                There is no continuation criteria under this criterion.</p>
                </div>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1867" style="display:none"/>
            <Formulation ID="F421628960201" Rank="3" Units="g">
              <Name>Powder 1.95 g protein, 8.1 g carbohydrate and 3.5 g fat per 100 ml, 400 g can</Name>
              <Brand ID="B42162896020100">
                <Name>e.g. Neocate</Name>
                <Pack ID="P96020100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421628960203" Rank="3" Units="g">
              <Name>Powder 13.5 g protein, 52 g carbohydrate and 24.5 g fat per 100 g, can</Name>
              <Brand ID="B42162896020325">
                <Name>Neocate Gold (Unflavoured)</Name>
                <Pack ID="P2400464" Specified="true" nzmt:ctpp_id="50129631000117102">
                  <Quantity>400</Quantity>
                  <Price>55.61</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421628960206" Rank="3" Units="g">
              <Name>Powder 2.2 g protein, 7.8 g carbohydrate and  3.4 g fat per 100 ml, can</Name>
              <Brand ID="B42162896020625">
                <Name>Elecare LCP (Unflavoured)</Name>
                <Pack ID="P2372541" Specified="true" nzmt:ctpp_id="50288031000117105">
                  <Quantity>400</Quantity>
                  <Price>65.72</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421628960207" Rank="3" Units="g">
              <Name>Powder 2.2 g protein, 7.8 g carbohydrate and 3.4 g fat per 100 ml, can</Name>
              <Brand ID="B42162896020725">
                <Name>Elecare (Unflavoured)</Name>
                <Pack ID="P2372568" Specified="true" nzmt:ctpp_id="50288021000117107">
                  <Quantity>400</Quantity>
                  <Price>65.72</Price>
                </Pack>
              </Brand>
              <Brand ID="B42162896020726">
                <Name>Elecare (Vanilla)</Name>
                <Pack ID="P2372533" Specified="true" nzmt:ctpp_id="50288041000117102">
                  <Quantity>400</Quantity>
                  <Price>65.72</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421628960225" Rank="3" Units="g">
              <Name>Powder 15 g protein, 56 g carbohydrate and 20 g fat per 100 g, can</Name>
              <Brand ID="B42162896022525">
                <Name>Alfamino Junior</Name>
                <Pack ID="P2634848" Specified="true" nzmt:ctpp_id="50237861000117101">
                  <Quantity>400</Quantity>
                  <Price>43.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421628960228" Rank="3" Units="g">
              <Name>Powder 14.8 g protein, 51.4 g carbohydrate and 23 g fat per 100 g, can</Name>
              <Brand ID="B42162896022825">
                <Name>Neocate Junior Vanilla</Name>
                <Pack ID="P2573008" Specified="true" nzmt:ctpp_id="50268981000117108">
                  <Quantity>400</Quantity>
                  <Price>55.61</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421628960229" Rank="3" Units="g">
              <Name>Powder 13.3 g protein, 57 g carbohydrate and 24.6 g fat per 100 g, can</Name>
              <Brand ID="B42162896022925">
                <Name>Alfamino</Name>
                <Pack ID="P2632187" nzmt:ctpp_id="50290391000117106">
                  <Quantity>400</Quantity>
                  <Price>43.60</Price>
                </Pack>
                <Pack ID="P2657953" Specified="true">
                  <Quantity>400</Quantity>
                  <Price>43.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421628960230" Rank="3" Units="g">
              <Name>Powder 13.3 g protein, 56 g carbohydrate and 22 g fat per 100 g, can</Name>
              <Brand ID="B42162896023025">
                <Name>Neocate Junior Unflavoured</Name>
                <Pack ID="P2530252" Specified="true" nzmt:ctpp_id="50248181000117102">
                  <Quantity>400</Quantity>
                  <Price>55.61</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421628960231" Rank="3" Units="g">
              <Name>Powder 13 g protein, 49 g carbohydrate and 23 g fat per 100 g, can</Name>
              <Brand ID="B42162896023125">
                <Name>Neocate SYNEO</Name>
                <Pack ID="P2555271" nzmt:ctpp_id="50259261000117109">
                  <Quantity>400</Quantity>
                  <Price>55.61</Price>
                </Pack>
                <Pack ID="P2587955">
                  <Quantity>400</Quantity>
                  <Price>55.61</Price>
                </Pack>
                <Pack ID="P2684713" Specified="true" nzmt:ctpp_id="50276781000117101">
                  <Quantity>400</Quantity>
                  <Price>55.61</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421632">
          <Name>Ketogenic Diet Products</Name>
          <Chemical ID="C4216329634">
            <Name>High fat formula</Name>
            <Request Form="RS1225" To="HealthPAC" For="Subsidy">
              <Title>
                <range>High fat formula</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For patients with intractable epilepsy, pyruvate dehydrogenase deficiency or glucose transported type-1 deficiency and other conditions requiring a ketogenic diet</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1225" style="display:none"/>
            <Formulation ID="F421632963425" Rank="3" Units="g">
              <Name>Powder 15.4 g protein, 7.2 g carbohydrate and 68.6 g fat per 100 g, can</Name>
              <Brand ID="B42163296342525">
                <Name>Ketocal 3:1 (Unflavoured)</Name>
                <Pack ID="P2610590" Specified="true" nzmt:ctpp_id="50291281000117106">
                  <Quantity>300</Quantity>
                  <Price>36.92</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421632963426" Rank="3" Units="g">
              <Name>Powder 14.3 g protein, 2.8 g carbohydrate and 69.2 g fat per 100 g, can</Name>
              <Brand ID="B42163296342625">
                <Name>Ketocal 4:1 (Unflavoured)</Name>
                <Pack ID="P2639378" Specified="true" nzmt:ctpp_id="50303911000117103">
                  <Quantity>300</Quantity>
                  <Price>36.92</Price>
                </Pack>
              </Brand>
              <Brand ID="B42163296342626">
                <Name>Ketocal 4:1 (Vanilla)</Name>
                <Pack ID="P2639386" Specified="true" nzmt:ctpp_id="50303921000117109">
                  <Quantity>300</Quantity>
                  <Price>36.92</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421636">
          <Name>Paediatric Products</Name>
          <Request Form="RS1473" To="HealthPAC" For="Subsidy">
            <Title>
              <range>Paediatric Products</range>
            </Title>
            <Case When="Initial application">
              <math xmlns="http://www.w3.org/1998/Math/MathML">
                <apply>
                  <and/>
                  <ci type="logical">Child is aged one to ten years</ci>
                  <apply>
                    <or/>
                    <ci type="logical">The child is being fed via a tube or a tube is to be inserted for the purposes of feeding</ci>
                    <ci type="logical">Any condition causing malabsorption</ci>
                    <ci type="logical">Faltering growth in an infant/child</ci>
                    <ci type="logical">Increased nutritional requirements</ci>
                    <ci type="logical">The child is being transitioned from TPN or tube feeding to oral feeding</ci>
                    <ci type="logical">The child has eaten, or is expected to eat, little or nothing for 3 days</ci>
                  </apply>
                </apply>
              </math>
              <Applicant>medical practitioner</Applicant>
              <Term Measure="patient's lifetime"/>
            </Case>
          </Request>
          <html:div class="Restricted" xlink:href="RS1473" style="display:none"/>
          <Chemical ID="C4216368339">
            <Name>Paediatric oral feed 1.5 kcal/ml</Name>
            <Formulation ID="F421636833925" Rank="3" Units="ml">
              <Name>Liquid 4.2 g protein, 16.7 g carbohydrate and 7.5 g fat per 100 ml, 500 ml bottle</Name>
              <Brand ID="B42163683392525">
                <Name>Pediasure Plus</Name>
                <Pack ID="P2372649" Specified="true" nzmt:ctpp_id="50297101000117100">
                  <Quantity>500</Quantity>
                  <Price>8.67</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421636833926" Rank="3" Units="ml">
              <Name>Liquid 3.4 g protein, 18.8 g carbohydrate and 6.8 g fat per 100 ml, bottle</Name>
              <Brand ID="B42163683392625">
                <Name>Fortini (Strawberry)</Name>
                <Pack ID="P2224496" Specified="true" nzmt:ctpp_id="50035801000117102">
                  <Quantity>200</Quantity>
                  <Price>1.90</Price>
                </Pack>
              </Brand>
              <Brand ID="B42163683392626">
                <Name>Fortini (Vanilla)</Name>
                <Pack ID="P2224488" Specified="true" nzmt:ctpp_id="50035791000117103">
                  <Quantity>200</Quantity>
                  <Price>1.90</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421636833927" Rank="3" Units="ml">
              <Name>Liquid 4.0 g protein, 18.8 g carbohydrate, 6.8 g fat and 1.5 g fibre per 100 ml, bottle</Name>
              <Brand ID="B42163683392725">
                <Name>Fortini Multi Fibre (Chocolate)</Name>
                <Pack ID="P2224461" Specified="true" nzmt:ctpp_id="50287261000117108">
                  <Quantity>200</Quantity>
                  <Price>1.90</Price>
                </Pack>
              </Brand>
              <Brand ID="B42163683392726">
                <Name>Fortini Multi Fibre (Strawberry)</Name>
                <Pack ID="P2224453" Specified="true" nzmt:ctpp_id="50287281000117100">
                  <Quantity>200</Quantity>
                  <Price>1.90</Price>
                </Pack>
              </Brand>
              <Brand ID="B42163683392727">
                <Name>Fortini Multi Fibre (Unflavoured)</Name>
                <Pack ID="P2558394" Specified="true" nzmt:ctpp_id="50287291000117102">
                  <Quantity>200</Quantity>
                  <Price>1.90</Price>
                </Pack>
              </Brand>
              <Brand ID="B42163683392728">
                <Name>Fortini Multi Fibre (Vanilla)</Name>
                <Pack ID="P2224445" Specified="true" nzmt:ctpp_id="50287271000117103">
                  <Quantity>200</Quantity>
                  <Price>1.90</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216368705">
            <Name>Paediatric enteral feed with fibre 1 kcal/ml</Name>
            <Formulation ID="F421636870525" Rank="3" Units="ml">
              <Name>Liquid 2.5 g protein, 12.1 g carbohydrate, 4.5g fat and 0.8 g fibre per 100 ml</Name>
              <Brand ID="B42163687052525">
                <Name>Frebini Original Fibre</Name>
                <Pack ID="P2651785" Specified="true" nzmt:ctpp_id="50308831000117107">
                  <Quantity>500</Quantity>
                  <Price>7.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216368706">
            <Name>Paediatric enteral feed with fibre 1.5 kcal/ml</Name>
            <Formulation ID="F421636870625" Rank="3" Units="ml">
              <Name>Liquid 3.8 g protein, 18.1 g carbohydrate, 6.7 g fat and 1.1 g fibre per 100 ml</Name>
              <Brand ID="B42163687062525">
                <Name>Frebini Energy Fibre</Name>
                <Pack ID="P2651807" Specified="true" nzmt:ctpp_id="50308791000117102">
                  <Quantity>500</Quantity>
                  <Price>7.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216369615">
            <Name>Paediatric enteral feed 1 kcal/ml</Name>
            <Formulation ID="F421636961501" Rank="3" Units="ml">
              <Name>Liquid 2.8 g protein, 11.2 g carbohydrate and 5 g fat per 100 ml, bag</Name>
              <Brand ID="B42163696150101">
                <Name>Pediasure RTH</Name>
                <Pack ID="P367958" Specified="true" nzmt:ctpp_id="50288011000117101">
                  <Quantity>500</Quantity>
                  <Price>3.32</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421636961526" Rank="3" Units="ml">
              <Name>Liquid 2.5 g protein, 12.5 g carbohydrate and 4.4 g fat per 100 ml</Name>
              <Brand ID="B42163696152625">
                <Name>Frebini Original</Name>
                <Pack ID="P2651777" Specified="true" nzmt:ctpp_id="50308841000117104">
                  <Quantity>500</Quantity>
                  <Price>6.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421636961527" Rank="3" Units="ml">
              <Name>Liquid 2.7 g protein, 12.3 g carbohydrate and 4.4 g fat per 100 ml, bottle</Name>
              <Brand ID="B42163696152725">
                <Name>Nutrini RTH</Name>
                <Pack ID="P2632918" Specified="true" nzmt:ctpp_id="50307181000117102">
                  <Quantity>500</Quantity>
                  <Price>4.69</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216369616">
            <Name>Paediatric oral feed 1 kcal/ml</Name>
            <Formulation ID="F421636961625" Rank="3" Units="ml">
              <Name>Liquid 2.8 g protein, 11.2 g carbohydrate and 5 g fat per 100 ml, bottle</Name>
              <Brand ID="B42163696162525">
                <Name>Pediasure (Chocolate)</Name>
                <Pack ID="P2444852" Specified="true" nzmt:ctpp_id="50287201000117107">
                  <Quantity>200</Quantity>
                  <Price>1.33</Price>
                </Pack>
              </Brand>
              <Brand ID="B42163696162526">
                <Name>Pediasure (Strawberry)</Name>
                <Pack ID="P2444860" Specified="true" nzmt:ctpp_id="50287211000117105">
                  <Quantity>200</Quantity>
                  <Price>1.33</Price>
                </Pack>
              </Brand>
              <Brand ID="B42163696162527">
                <Name>Pediasure (Vanilla)</Name>
                <Pack ID="P2444844" Specified="true" nzmt:ctpp_id="50287221000117104">
                  <Quantity>200</Quantity>
                  <Price>1.33</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421636961626" Rank="3" Units="ml">
              <Name>Liquid 2.8 g protein, 11.2 g carbohydrate and 5 g fat per 100 ml, can</Name>
              <Brand ID="B42163696162625">
                <Name>Pediasure (Vanilla)</Name>
                <Pack ID="P2444879" Specified="true" nzmt:ctpp_id="50287251000117106">
                  <Quantity>250</Quantity>
                  <Price>1.66</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216369636">
            <Name>Paediatric enteral feed 0.76 kcal/ml</Name>
            <Formulation ID="F421636963625" Rank="3" Units="ml">
              <Name>Liquid 2.5 g protein, 12.5 g carbohydrate, 3.3 g fat and 0.7 g fibre per 100 ml, bag</Name>
              <Brand ID="B42163696362525">
                <Name>Nutrini Low Energy Multifibre RTH</Name>
                <Pack ID="P2565234" Specified="true" nzmt:ctpp_id="50267281000117103">
                  <Quantity>500</Quantity>
                  <Price>6.27</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216369637">
            <Name>Paediatric enteral feed 1.5 kcal/ml</Name>
            <Formulation ID="F421636963726" Rank="3" Units="ml">
              <Name>Liquid 4.1 g protein, 18.5 g carbohydrate, 6.7 g fat and 0.8 g fibre per 100 ml, bottle</Name>
              <Brand ID="B42163696372625">
                <Name>Nutrini Energy Multi Fibre</Name>
                <Pack ID="P2632934" Specified="true" nzmt:ctpp_id="50298961000117103">
                  <Quantity>500</Quantity>
                  <Price>7.14</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421636963728" Rank="3" Units="ml">
              <Name>Liquid 3.8 g protein, 18.7 g carbohydrate and 6.7 g fat per 100 ml</Name>
              <Brand ID="B42163696372825">
                <Name>Frebini Energy</Name>
                <Pack ID="P2651793" Specified="true" nzmt:ctpp_id="50308801000117101">
                  <Quantity>500</Quantity>
                  <Price>6.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421636963729" Rank="3" Units="ml">
              <Name>Liquid 4.1 g protein, 18.5 g carbohydrate and 6.7 g fat per 100 ml, bottle</Name>
              <Brand ID="B42163696372925">
                <Name>Nutrini Energy RTH</Name>
                <Pack ID="P2632926" Specified="true" nzmt:ctpp_id="50298951000117100">
                  <Quantity>500</Quantity>
                  <Price>7.46</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421640">
          <Name>Renal Products</Name>
          <Chemical ID="C4216408270">
            <Name>Low electrolyte oral feed</Name>
            <Request Form="RS1227" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Low electrolyte oral feed</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For children (up to 18 years) with acute or chronic kidney disease</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1227" style="display:none"/>
            <Formulation ID="F421640827026" Rank="3" Units="g">
              <Name>Powder 7.5 g protein, 57.6 g carbohydrate and 25.9 g fat per 100 g, can</Name>
              <Brand ID="B42164082702625">
                <Name>Kindergen</Name>
                <Pack ID="P2601427" Specified="true" nzmt:ctpp_id="50284971000117101">
                  <Quantity>400</Quantity>
                  <Price>64.26</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216408547">
            <Name>Low electrolyte oral feed 1.8 kcal/ml</Name>
            <Formulation ID="F421640854725" Rank="3" Units="ml">
              <Name>Liquid 8 g protein, 14.74 g carbohydrate, 9.77 g fat and 1.26 g fibre per 100 ml, carton</Name>
              <Request Form="RS1228" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Low electrolyte oral feed</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">For patients with acute or chronic kidney disease</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS1228" style="display:none"/>
              <Brand ID="B42164085472525">
                <Name>Nepro HP (Vanilla)</Name>
                <Pack ID="P2457741" Specified="true" nzmt:ctpp_id="50205421000117107">
                  <Quantity>220</Quantity>
                  <Price>3.31</Price>
                </Pack>
              </Brand>
              <Brand ID="B42164085472526">
                <Name>Nepro HP (Strawberry)</Name>
                <Pack ID="P2457768" Specified="true" nzmt:ctpp_id="50205411000117101">
                  <Quantity>220</Quantity>
                  <Price>3.31</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216409618">
            <Name>Low electrolyte oral feed 2 kcal/ml</Name>
            <Request Form="RS1228" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Low electrolyte oral feed</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For patients with acute or chronic kidney disease</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1228" style="display:none"/>
            <Formulation ID="F421640961801" Rank="10" Units="btl">
              <Name>Liquid 3 g protein, 25.5 g carbohydrate and 9.6 g fat per 100 ml, 237 ml bottle</Name>
              <Brand ID="B42164096180100">
                <Name>Any</Name>
                <Pack ID="P96180100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421640961804" Rank="10" Units="btl">
              <Name>Liquid 7.5 g protein, 20 g carbohydrate and 10 g fat per 100 ml, 125 ml carton</Name>
              <Brand ID="B42164096180425">
                <Name>Renilon 7.5 (apricot)</Name>
                <Pack ID="P2439379" Specified="true" nzmt:ctpp_id="50176611000117103">
                  <Quantity>4</Quantity>
                  <Price>13.72</Price>
                </Pack>
              </Brand>
              <Brand ID="B42164096180426">
                <Name>Renilon 7.5 (caramel)</Name>
                <Pack ID="P2439387" Specified="true" nzmt:ctpp_id="50176601000117101">
                  <Quantity>4</Quantity>
                  <Price>13.72</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F421640961825" Rank="10" Units="btl">
              <Name>Liquid 9.1 g protein, 19 g carbohydrate and 10 g fat per 100 ml, 200 ml bottle</Name>
              <Brand ID="B42164096182525">
                <Name>Novasource Renal (Vanilla)</Name>
                <Pack ID="P2632195" Specified="true" nzmt:ctpp_id="50297701000117101">
                  <Quantity>4</Quantity>
                  <Multiple>1</Multiple>
                  <Price>13.24</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
        <ATC3 ID="A421648">
          <Name>Surgical Products</Name>
          <Chemical ID="C4216488550">
            <Name>Preoperative carbohydrate feed 0.5 kcal/ml</Name>
            <Request Form="RS1415" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Preoperative carbohydrate feed 0.5 kcal/ml</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Maximum of 400 ml as part of an Enhanced Recovery After Surgery (ERAS) protocol 2 to 3 hours before major abdominal surgery</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1415" style="display:none"/>
            <Formulation ID="F421648855025" Rank="10" Units="pack">
              <Name>Oral liq 0 g protein, 12.6 g carbohydrate and 0 g fat per 100 ml, 200 ml bottle</Name>
              <Brand ID="B42164885502525">
                <Name>preOp</Name>
                <Pack ID="P2441268" Specified="true" nzmt:ctpp_id="50208181000117106">
                  <Quantity>4</Quantity>
                  <Price>8.64</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4216489620">
            <Name>High arginine oral feed 1.4 kcal/ml</Name>
            <Request Form="RS1231" To="HealthPAC" For="Subsidy">
              <Title>
                <range>High arginine oral feed 1.4 kcal/ml</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Three packs per day for 5 to 7 days prior to major gastrointestinal, head or neck surgery</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1231" style="display:none"/>
            <Formulation ID="F421648962026" Rank="10" Units="pack">
              <Name>Liquid 10.4 g protein, 8 g carbohydrate, 4.4 g fat and 0 g fibre per 100 ml, 250 ml carton</Name>
              <Brand ID="B42164896202625">
                <Name>Impact Advanced Recovery</Name>
                <Pack ID="P2633019" Specified="true" nzmt:ctpp_id="50298811000117106">
                  <Quantity>10</Quantity>
                  <Multiple>1</Multiple>
                  <Price>56.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A4220">
        <Name>Standard Feeds</Name>
        <Request Form="RS1214" To="HealthPAC" For="Subsidy">
          <Title>
            <range>Standard Feeds</range>
          </Title>
          <Case When="Initial application">
            <math xmlns="http://www.w3.org/1998/Math/MathML">
              <apply>
                <or/>
                <mi class="heading">For patients with malnutrition, defined as any of the following:</mi>
                <apply>
                  <or/>
                  <ci type="logical">BMI &lt; 18.5</ci>
                  <ci type="logical">Greater than 10% weight loss in the last 3-6 months</ci>
                  <ci type="logical">BMI &lt; 20 with greater than 5% weight loss in the last 3-6 months</ci>
                </apply>
                <ci type="logical">For patients who have, or are expected to, eat little or nothing for 5 days</ci>
                <ci type="logical">For patients who have a poor absorptive capacity and/or high nutrient losses and/or increased nutritional needs from causes such as catabolism</ci>
                <ci type="logical">For use pre- and post-surgery</ci>
                <ci type="logical">For patients being tube-fed</ci>
                <ci type="logical">For tube-feeding as a transition from intravenous nutrition</ci>
                <ci type="logical">For any other condition that meets the community Special Authority criteria</ci>
              </apply>
            </math>
            <Applicant>medical practitioner</Applicant>
            <Term Measure="patient's lifetime"/>
          </Case>
        </Request>
        <html:div class="Restricted" xlink:href="RS1214" style="display:none"/>
        <ATC3 ID="A422004">
          <Name>Standard Feeds</Name>
          <Chemical ID="C4220048167">
            <Name>Enteral feed 1.2 kcal/ml</Name>
            <Formulation ID="F422004816701" Rank="10" Units="btl">
              <Name>Liquid 5.55 g protein, 15.1 g carbohydrate, 3.93 g fat and 2 g fibre per 100 ml, 1,000 ml bag</Name>
              <Brand ID="B42200481670125">
                <Name>Jevity Plus RTH</Name>
                <Pack ID="P2217120" Specified="true" nzmt:ctpp_id="50287931000117108">
                  <Quantity>1000</Quantity>
                  <Price>7.87</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4220048332">
            <Name>Oral feed 1 kcal/ml</Name>
            <Formulation ID="F422004833201" Rank="10" Units="btl">
              <Name>Liquid 3.8 g protein, 23 g carbohydrate and 12.7 g fibre per 100 ml, 237 ml carton</Name>
              <Brand ID="B42200483320100">
                <Name>e.g. Resource Fruit Beverage</Name>
                <Pack ID="P83320100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4220048600">
            <Name>Enteral feed with fibre 0.83 kcal/ml</Name>
            <Formulation ID="F422004860025" Rank="3" Units="ml">
              <Name>Liquid 5.5 g protein, 8.8 g carbohydrate, 2.5 g fat and 1.5 g fibre per 100 ml, bottle</Name>
              <Brand ID="B42200486002525">
                <Name>Nutrison 800 Complete Multi Fibre</Name>
                <Pack ID="P2572982" Specified="true" nzmt:ctpp_id="50271881000117104">
                  <Quantity>1000</Quantity>
                  <Price>9.05</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4220048685">
            <Name>High protein oral feed 2.4 kcal/ml</Name>
            <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
              <p>Only to be used for patients currently on or would be using Fortisip or Fortisip Multi Fibre</p>
            </div>
            <Formulation ID="F422004868525" Rank="10" Units="btl">
              <Name>Liquid 14.6 g protein, 25.3 g carbohydrate and 9.6 g fat per 100 ml, 125 ml bottle</Name>
              <Brand ID="B42200486852500" ToBeDelisted="2024-12-01">
                <Name>e.g. Fortisip Compact Protein</Name>
                <Pack ID="P86852500" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4220048707">
            <Name>Enteral feed with fibre 1 kcal/ml</Name>
            <Formulation ID="F422004870725" Rank="3" Units="ml">
              <Name>Liquid 3.8 g protein, 13.0 g carbohydrate, 3.4 g fat and 1.5 g fibre per 100 ml, bag</Name>
              <Brand ID="B42200487072525">
                <Name>Fresubin Original Fibre</Name>
                <Pack ID="P2651726" Specified="true" nzmt:ctpp_id="50308891000117106">
                  <Quantity>1000</Quantity>
                  <Price>7.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4220048708">
            <Name>Enteral feed with fibre 1.5 kcal/ml</Name>
            <Formulation ID="F422004870825" Rank="3" Units="ml">
              <Name>Liquid 7.5 g protein, 16.2 g carbohydrate, 5.8 g fat and 1.5 g fibre per 100 ml, bag</Name>
              <Brand ID="B42200487082525">
                <Name>Fresubin HP Energy Fibre</Name>
                <Pack ID="P2651742" Specified="true" nzmt:ctpp_id="50308861000117100">
                  <Quantity>1000</Quantity>
                  <Price>9.80</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4220049606">
            <Name>Enteral feed 1 kcal/ml</Name>
            <Formulation ID="F422004960607" Rank="3" Units="ml">
              <Name>Liquid 4 g protein, 13.6 g carbohydrate and 3.4 g fat per 100 ml, bottle</Name>
              <Brand ID="B42200496060725">
                <Name>Osmolite RTH</Name>
                <Pack ID="P2217155" Specified="true" nzmt:ctpp_id="50034541000117101">
                  <Quantity>1000</Quantity>
                  <Price>6.56</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F422004960610" Rank="3" Units="ml">
              <Name>Liquid 4 g protein, 14.1 g carbohydrate, 3.47 g fat and 1.76 g fibre per 100 ml, bottle</Name>
              <Brand ID="B42200496061025">
                <Name>Jevity RTH</Name>
                <Pack ID="P2217147" Specified="true" nzmt:ctpp_id="50034531000117109">
                  <Quantity>1000</Quantity>
                  <Price>6.56</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F422004960627" Rank="3" Units="ml">
              <Name>Liquid 3.8 g protein, 13.8 g carbohydrate and 3.4 g fat per 100 ml, bag</Name>
              <Brand ID="B42200496062725">
                <Name>Fresubin Original</Name>
                <Pack ID="P2651734" Specified="true" nzmt:ctpp_id="50308901000117105">
                  <Quantity>1000</Quantity>
                  <Price>6.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F422004960628" Rank="3" Units="ml">
              <Name>Liquid 4 g protein, 12.3 g carbohydrate and 3.9 g fat per 100 ml,  bottle</Name>
              <Brand ID="B42200496062825">
                <Name>Nutrison RTH</Name>
                <Pack ID="P2632969" Specified="true" nzmt:ctpp_id="50298831000117102">
                  <Quantity>1000</Quantity>
                  <Price>6.90</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F422004960629" Rank="3" Units="ml">
              <Name>Liquid 4 g protein, 12.3 g carbohydrate, 3.9 g fat and 1.5 g fibre per 100 ml, bottle</Name>
              <Brand ID="B42200496062925">
                <Name>Nutrison Multi Fibre</Name>
                <Pack ID="P2632993" Specified="true" nzmt:ctpp_id="50298881000117101">
                  <Quantity>1000</Quantity>
                  <Price>7.21</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4220049612">
            <Name>Oral feed with fibre 1.5 kcal/ml</Name>
            <Formulation ID="F422004961201" Rank="3" Units="ml">
              <Name>Liquid 6 g protein, 18.4 g carbohydrate, 5.8 g fat and 2.3 g fibre per 100 ml, 200 ml bottle</Name>
              <Brand ID="B42200496120125">
                <Name>Fortisip Multi Fibre (vanilla)</Name>
                <Pack ID="P2224410" Specified="true" nzmt:ctpp_id="50035721000117100">
                  <Quantity>200</Quantity>
                  <Price>1.76</Price>
                </Pack>
              </Brand>
              <Brand ID="B42200496120126">
                <Name>Fortisip Multi Fibre (chocolate)</Name>
                <Pack ID="P2224399" Specified="true" nzmt:ctpp_id="50035701000117108">
                  <Quantity>200</Quantity>
                  <Price>1.76</Price>
                </Pack>
              </Brand>
              <Brand ID="B42200496120127">
                <Name>Fortisip Multi Fibre (strawberry)</Name>
                <Pack ID="P2224402" Specified="true" nzmt:ctpp_id="50035711000117106">
                  <Quantity>200</Quantity>
                  <Price>1.76</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4220049613">
            <Name>Oral feed 1.5 kcal/ml</Name>
            <Formulation ID="F422004961301" Rank="3" Units="ml">
              <Name>Liquid 4 g protein and 33.5 g carbohydrate per 100 ml, 200 ml bottle</Name>
              <Brand ID="B42200496130125">
                <Name>Fortijuice (Orange)</Name>
                <Pack ID="P2224534" Specified="true" nzmt:ctpp_id="50035831000117108">
                  <Quantity>200</Quantity>
                  <Price>3.30</Price>
                </Pack>
              </Brand>
              <Brand ID="B42200496130126">
                <Name>Fortijuice (Apple)</Name>
                <Pack ID="P2224518" Specified="true" nzmt:ctpp_id="50035811000117104">
                  <Quantity>200</Quantity>
                  <Price>3.30</Price>
                </Pack>
              </Brand>
              <Brand ID="B42200496130127">
                <Name>Fortijuice (Strawberry)</Name>
                <Pack ID="P2224526" Specified="true" nzmt:ctpp_id="50035821000117105">
                  <Quantity>200</Quantity>
                  <Price>3.30</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F422004961302" Rank="3" Units="ml">
              <Name>Liquid 5.5 g protein, 21.1 g carbohydrate and 4.81 g fat per 100 ml, can</Name>
              <Brand ID="B42200496130227">
                <Name>Ensure Plus (Vanilla)</Name>
                <Pack ID="P308455" Specified="true" nzmt:ctpp_id="50069151000117104">
                  <Quantity>237</Quantity>
                  <Price>1.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F422004961303" Rank="10" Units="btl">
              <Name>Liquid 6 g protein, 18.4 g carbohydrate and 5.8 g fat per 100 ml, 200 ml bottle</Name>
              <Brand ID="B42200496130325">
                <Name>Fortisip (banana)</Name>
                <Pack ID="P2220857" Specified="true" nzmt:ctpp_id="50035141000117106">
                  <Quantity>200</Quantity>
                  <Price>1.76</Price>
                </Pack>
              </Brand>
              <Brand ID="B42200496130326">
                <Name>Fortisip (strawberry)</Name>
                <Pack ID="P2220849" Specified="true" nzmt:ctpp_id="50035131000117103">
                  <Quantity>200</Quantity>
                  <Price>1.76</Price>
                </Pack>
              </Brand>
              <Brand ID="B42200496130327">
                <Name>Fortisip (chocolate)</Name>
                <Pack ID="P2220830" Specified="true" nzmt:ctpp_id="50035121000117101">
                  <Quantity>200</Quantity>
                  <Price>1.76</Price>
                </Pack>
              </Brand>
              <Brand ID="B42200496130328">
                <Name>Fortisip (vanilla)</Name>
                <Pack ID="P2220822" Specified="true" nzmt:ctpp_id="50035111000117107">
                  <Quantity>200</Quantity>
                  <Price>1.76</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F422004961305" Rank="3" Units="ml">
              <Name>Liquid 6.25 g protein, 20.2 g carbohydrate and 4.92 g fat per 100 ml, carton</Name>
              <Brand ID="B42200496130525" ToBeDelisted="2025-04-01">
                <Name>Ensure Plus (Banana)</Name>
                <Pack ID="P234885" Specified="true" nzmt:ctpp_id="50050371000117105">
                  <Quantity>200</Quantity>
                  <Price>1.56</Price>
                </Pack>
              </Brand>
              <Brand ID="B42200496130526" ToBeDelisted="2025-04-01">
                <Name>Ensure Plus (Chocolate)</Name>
                <Pack ID="P234680" Specified="true" nzmt:ctpp_id="50050251000117106">
                  <Quantity>200</Quantity>
                  <Price>1.56</Price>
                </Pack>
              </Brand>
              <Brand ID="B42200496130527" ToBeDelisted="2025-04-01">
                <Name>Ensure Plus (Fruit of the Forest)</Name>
                <Pack ID="P234893" Specified="true" nzmt:ctpp_id="50050381000117108">
                  <Quantity>200</Quantity>
                  <Price>1.56</Price>
                </Pack>
              </Brand>
              <Brand ID="B42200496130528" ToBeDelisted="2025-04-01">
                <Name>Ensure Plus (Vanilla)</Name>
                <Pack ID="P234672" Specified="true" nzmt:ctpp_id="50050241000117109">
                  <Quantity>200</Quantity>
                  <Price>1.56</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F422004961325" Rank="3" Units="ml">
              <Name>Liquid 6.25 g protein, 20.2 g carbohydrate and 4.92 g fat per 100 ml, bottle</Name>
              <Brand ID="B42200496132525">
                <Name>Ensure Plus (Banana)</Name>
                <Pack ID="P2688808" Specified="true" nzmt:ctpp_id="50340361000117102">
                  <Quantity>200</Quantity>
                  <Price>1.56</Price>
                </Pack>
              </Brand>
              <Brand ID="B42200496132526">
                <Name>Ensure Plus (Chocolate)</Name>
                <Pack ID="P2688786" Specified="true" nzmt:ctpp_id="50340351000117104">
                  <Quantity>200</Quantity>
                  <Price>1.56</Price>
                </Pack>
              </Brand>
              <Brand ID="B42200496132527">
                <Name>Ensure Plus (Fruit of the Forest)</Name>
                <Pack ID="P2688816" Specified="true" nzmt:ctpp_id="50340371000117107">
                  <Quantity>200</Quantity>
                  <Price>1.56</Price>
                </Pack>
              </Brand>
              <Brand ID="B42200496132528">
                <Name>Ensure Plus (Vanilla)</Name>
                <Pack ID="P2688794" Specified="true" nzmt:ctpp_id="50340381000117105">
                  <Quantity>200</Quantity>
                  <Price>1.56</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4220049619">
            <Name>Oral feed</Name>
            <Formulation ID="F422004961903" Rank="3" Units="g">
              <Name>Powder 23 g protein, 65 g carbohydrate and 2.5 g fat per 100 g, can</Name>
              <Brand ID="B42200496190325">
                <Name>Sustagen Hospital Formula (Chocolate)</Name>
                <Pack ID="P2538997" Specified="true" nzmt:ctpp_id="50227111000117105">
                  <Quantity>840</Quantity>
                  <Price>14.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B42200496190326">
                <Name>Sustagen Hospital Formula (Vanilla)</Name>
                <Pack ID="P2539004" Specified="true" nzmt:ctpp_id="50227121000117104">
                  <Quantity>840</Quantity>
                  <Price>14.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F422004961926" Rank="3" Units="g">
              <Name>Powder 15.9 g protein, 57.4 g carbohydrate and 14 g fat per 100 g, can</Name>
              <Brand ID="B42200496192625">
                <Name>Ensure (Chocolate)</Name>
                <Pack ID="P2504324" Specified="true" nzmt:ctpp_id="50287981000117109">
                  <Quantity>850</Quantity>
                  <Price>26.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B42200496192626">
                <Name>Ensure (Vanilla)</Name>
                <Pack ID="P2504316" Specified="true" nzmt:ctpp_id="50287991000117107">
                  <Quantity>850</Quantity>
                  <Price>26.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4220049632">
            <Name>Enteral Feed 1.5 kcal/ml</Name>
            <Formulation ID="F422004963203" Rank="3" Units="ml">
              <Name>Liquid 6.25 g protein, 20 g carbohydrate and 5 g fat per 100 ml, can</Name>
              <Brand ID="B42200496320325">
                <Name>Ensure Plus HN</Name>
                <Pack ID="P2372665" Specified="true" nzmt:ctpp_id="50201411000117103">
                  <Quantity>250</Quantity>
                  <Price>2.17</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F422004963204" Rank="3" Units="ml">
              <Name>Liquid 6.27 g protein, 20.4 g carbohydrate and 4.9 g fat per 100 ml, bag</Name>
              <Brand ID="B42200496320425">
                <Name>Ensure Plus HN RTH</Name>
                <Pack ID="P2217171" Specified="true" nzmt:ctpp_id="50287961000117101">
                  <Quantity>1000</Quantity>
                  <Price>8.68</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F422004963205" Rank="3" Units="ml">
              <Name>Liquid 6.38 g protein, 21.1 g carbohydrate, 4.9 g fat and 1.2 g fibre per 100 ml, bag</Name>
              <Brand ID="B42200496320525">
                <Name>Jevity HiCal RTH</Name>
                <Pack ID="P2217139" Specified="true" nzmt:ctpp_id="50287951000117103">
                  <Quantity>1000</Quantity>
                  <Price>8.68</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F422004963226" Rank="3" Units="ml">
              <Name>Liquid 6 g protein, 18.3 g carbohydrate and 5.8 g fat per 100 ml, bottle</Name>
              <Brand ID="B42200496322625">
                <Name>Nutrison Energy</Name>
                <Pack ID="P2632950" Specified="true" nzmt:ctpp_id="50298821000117100">
                  <Quantity>1000</Quantity>
                  <Price>9.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F422004963228" Rank="3" Units="ml">
              <Name>Liquid 7.5 g protein, 17 g carbohydrate and 5.8 g fat per 100 ml, bag</Name>
              <Brand ID="B42200496322825">
                <Name>Fresubin HP Energy</Name>
                <Pack ID="P2651718" Specified="true" nzmt:ctpp_id="50308871000117105">
                  <Quantity>1000</Quantity>
                  <Price>9.60</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F422004963229" Rank="3" Units="ml">
              <Name>Liquid 6 g protein, 18.4 g carbohydrate, 5.8 g fat and 1.5 g fibre per 100 ml, bottle</Name>
              <Brand ID="B42200496322925">
                <Name>Nutrison Energy Multi Fibre</Name>
                <Pack ID="P2632985" Specified="true" nzmt:ctpp_id="50298861000117109">
                  <Quantity>1000</Quantity>
                  <Price>8.68</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
    <ATC1 ID="A45">
      <Name>Vaccines</Name>
      <ATC2 ID="A4504">
        <Name>Bacterial and Viral Vaccines</Name>
        <ATC3 ID="A450404">
          <Name>Bacterial and Viral Vaccines</Name>
          <Chemical ID="C4504048151">
            <Name>Diphtheria, tetanus, pertussis and polio vaccine</Name>
            <Request Form="RS1387" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Diphtheria, tetanus, pertussis and polio vaccine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">A single dose for children up to the age of 7 who have completed primary immunisation</ci>
                    <ci type="logical">A course of up to four vaccines is funded for catch up programmes for children (to the age of 10 years) to complete full primary immunisation</ci>
                    <ci type="logical">An additional four doses (as appropriate) are funded for (re-)immunisation for patients post HSCT, or chemotherapy; pre- or post splenectomy; pre- or post solid
                    organ transplant, renal dialysis and other severely immunosuppressive regimens</ci>
                    <ci type="logical">Five doses will be funded for children requiring solid organ transplantation</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Please refer to the Immunisation Handbook for appropriate schedule for catch up programmes</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1387" style="display:none"/>
            <Formulation ID="F450404815101" Rank="4" Units="inj" Weight="30">
              <Name>Inj 30 IU diphtheria toxoid with 30IU tetanus toxoid, 25 mcg pertussis toxoid, 25 mcg pertussis filamentous haemagglutinin, 8 mcg pertactin and 80 D-antigen units poliomyelitis virus in 0.5 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B45040481510125" PSS="true">
                <Name>Infanrix IPV</Name>
                <Pack ID="P2086417" Specified="true" nzmt:ctpp_id="50014751000117100">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4504048152">
            <Name>Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type B vaccine</Name>
            <Request Form="RS2051" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type B vaccine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Up to four doses for children under the age of 10 years for primary
          immunisation</ci>
                    <ci type="logical">An additional four doses (as appropriate) for (re-)immunisation of
          children under the age of 18 years post haematopoietic stem cell transplantation</ci>
                    <ci type="logical">An additional four doses (as appropriate) for (re-)immunisation of
          children under the age of 10 years who are post chemotherapy; pre or post splenectomy;
          undergoing renal dialysis and other severely immunosuppressive regimens</ci>
                    <ci type="logical">Up to five doses for children under the age of 10 years receiving
          solid organ transplantation</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>A course of up-to four vaccines is funded for catch up programmes for children (up to and
      under the age of 10 years) to complete full primary immunisation. Please refer to the
      Immunisation Handbook for the appropriate schedule for catch up programmes.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS2051" style="display:none"/>
            <Formulation ID="F450404815201" Rank="4" Units="inj" Weight="30">
              <Name>Inj 30IU diphtheria with 40IU tetanus and 25mcg pertussis toxoids, 25mcg pertussis filamentous haemagglutinin, 8mcg pertactin, 80D-AgU polio virus, 10mcg hepatitis B antigen 10mcg H. influenzae type b with tetanus toxoid 20-40mcg in 0.5ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B45040481520125" PSS="true">
                <Name>Infanrix-hexa</Name>
                <Pack ID="P2459396" Specified="true" nzmt:ctpp_id="50129661000117109">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A4508">
        <Name>Bacterial Vaccines</Name>
        <ATC3 ID="A450804">
          <Name>Bacterial Vaccines</Name>
          <Chemical ID="C4508048044">
            <Name>Bacillus calmette-guerin vaccine</Name>
            <Request Form="RS1233" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Bacillus calmette-guerin vaccine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <mi class="heading">For infants at increased risk of tuberculosis defined as:</mi>
                    <ci type="logical">Living in a house or family with a person with current or past history of TB</ci>
                    <ci type="logical">Having one or more household members or carers who within the last 5 years lived in a country with a rate of TB &gt; or equal to 40 per 100,000 for 6 months or
                    longer</ci>
                    <ci type="logical">During their first 5 years will be living 3 months or longer in a country with a rate of TB &gt; or equal to 40 per 100,000</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>A list of countries with high rates of TB are available at http://www.health.govt.nz/tuberculosis (Search for Downloads) or www.bcgatlas.org/index.php</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1233" style="display:none"/>
            <Formulation ID="F450804804425" Rank="4" Units="inj">
              <Name>Inj Mycobacterium bovis BCG (Bacillus Calmette-Guerin), Danish strain 1331, live attenuated, vial with diluent</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B45080480442525" PSS="true">
                <Name>BCG Vaccine AJV</Name>
                <Pack ID="P2461854" Specified="true" nzmt:ctpp_id="50298481000117103">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4508048150">
            <Name>Diphtheria, tetanus and pertussis vaccine</Name>
            <Request Form="RS1790" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Diphtheria, tetanus and pertussis vaccine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">A single dose for pregnant women in the
                    second or third trimester of each pregnancy; or</ci>
                    <ci type="logical" class="Indication">A single dose for parents or primary
                    caregivers of infants admitted to a Neonatal Intensive Care Unit or Specialist
                    Care Baby Unit for more than 3 days, who had not been exposed to maternal
                    vaccination at least 14 days prior to birth; or</ci>
                    <ci type="logical" class="Indication">A course of up to four doses is funded for
                    children from age 7 up the age of 18 years inclusive to complete full primary
                    immunisation</ci>
                    <ci type="logical" class="Indication">An additional four doses (as appropriate) are
                    funded for (re-)immunisation for patients post haematopoietic stem cell
                    transplantation or chemotherapy; pre or post splenectomy; pre- or post solid
                    organ transplant, renal dialysis and other severely immunosuppressive
                    regimens</ci>
                    <ci type="logical" class="Indication">A single dose for vaccination of patients aged from 65 years old</ci>
                    <ci type="logical" class="Indication">A single dose for vaccination of patients aged from 45 years old who have not had 4 previous tetanus doses</ci>
                    <ci type="logical" class="Indication">For vaccination of previously unimmunised or partially immunised patients</ci>
                    <ci type="logical" class="Indication">For revaccination following immunosuppression</ci>
                    <ci type="logical" class="Indication">For boosting of patients with tetanus-prone wounds</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Please refer to the Immunisation Handbook for the appropriate schedule for catch up programmes.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1790" style="display:none"/>
            <Formulation ID="F450804815001" Rank="4" Units="inj" Weight="2">
              <Name>Inj 2 IU diphtheria toxoid with 20 IU tetanus toxoid, 8 mcg pertussis toxoid, 8 mcg pertussis filamentous haemagglutinin and 2.5 mcg pertactin in 0.5 ml prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B45080481500125" PSS="true">
                <Name>Boostrix</Name>
                <Pack ID="P2459418" Specified="true" nzmt:ctpp_id="50158241000117100">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4508048210">
            <Name>Haemophilus influenzae type B vaccine</Name>
            <Request Form="RS1520" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Haemophilus influenzae type B vaccine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">For primary vaccination in children</ci>
                    <ci type="logical">An additional dose (as appropriate) is funded for (re-)immunisation for patients post haematopoietic stem cell transplantation, or chemotherapy; functional asplenic; pre or post splenectomy; pre- or post solid organ transplant, pre- or post cochlear implants, renal dialysis and other severely immunosuppressive regimens</ci>
                    <ci type="logical">For use in testing for primary immunodeficiency diseases, on the recommendation of an internal medicine physician or paediatrician</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">1</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1520" style="display:none"/>
            <Formulation ID="F450804821001" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mcg vial with diluent syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2026" Value="5"/>
              <Brand ID="B45080482100125" PSS="true">
                <Name>Act-HIB</Name>
                <Pack ID="P2404699" Specified="true" nzmt:ctpp_id="50135021000117109">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F450804821025" Rank="4" Units="inj">
              <Name>Haemophilus Influenzae type B polysaccharide 10 mcg conjugated to tetanus toxoid as carrier protein 20-40 mcg; prefilled syringe plus vial 0.5 ml</Name>
              <Brand ID="B45080482102525" ToBeDelisted="2024-12-01">
                <Name>Hiberix</Name>
                <Pack ID="P2087758" Specified="true" nzmt:ctpp_id="50015851000117108">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4508048287">
            <Name>Meningococcal (A, C, Y and W-135) conjugate vaccine</Name>
            <Formulation ID="F450804828725" Rank="4" Units="inj">
              <Name>Inj 10 mcg of each meningococcal polysaccharide conjugated to a total of approximately 55 mcg of tetanus toxoid carrier per 0.5 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Request Form="RS2019" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Meningococcal (A, C, Y and W-135) conjugate vaccine</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <apply>
                        <or/>
                        <ci type="logical">Up to three doses and a booster every five years for patients
                        pre- and post splenectomy and for patients with HIV, complement deficiency
                        (acquired or inherited), functional or anatomic asplenia or pre or post
                        solid organ transplant</ci>
                        <ci type="logical">One dose for close contacts of meningococcal cases of any
                        group</ci>
                        <ci type="logical">One dose for person who has previously had meningococcal
                        disease of any group</ci>
                        <ci type="logical">A maximum of two doses for bone marrow transplant
                        patients</ci>
                        <ci type="logical">A maximum of two doses for person pre and
                        post-immunosuppression*</ci>
                      </apply>
                      <apply>
                        <and/>
                        <ci type="logical">Person is aged between 13 and 25 years, inclusive</ci>
                        <apply>
                          <or/>
                          <ci type="logical">One dose for individuals who are entering within the next
                        three months, or in their first year of living in boarding school hostels,
                        tertiary education halls of residence, military barracks, or prisons</ci>
                          <ci type="logical">One dose for individuals who turn 13 years of age while living in boarding school hostels</ci>
                        </apply>
                      </apply>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>children under seven years of age require two doses 8 weeks apart, a booster dose three
            years after the primary series and then five yearly.</p>
                  <p>*Immunosuppression due to steroid or other immunosuppressive therapy must be for a period
            of greater than 28 days.</p>
                </div>
              </Request>
              <html:div class="Restricted" xlink:href="RS2019" style="display:none"/>
              <Brand ID="B45080482872525" PSS="true">
                <Name>MenQuadfi</Name>
                <Pack ID="P2649012" Specified="true" nzmt:ctpp_id="50296211000117108">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F450804828726" Rank="4" Units="inj">
              <Name>Inj 5 mcg of each meningococcal polysaccharide conjugated to a total of approximately 44 mcg of tetanus toxoid carrier in 0.5 ml vial</Name>
              <Request Form="RS2037" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Meningococcal (A, C, Y and W-135) conjugate vaccine</range>
                </Title>
                <Case When="Initial application" Category="Children under 12 months of age">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical">A maximum of three doses (dependant on age at first dose) for
                    patients pre- and post- splenectomy and for patients with functional or anatomic
                    asplenia, HIV, complement deficiency (acquired or inherited), or pre- or post-
                    solid organ transplant</ci>
                      <ci type="logical">A maximum of three doses (dependant on age at first dose) for
                    close contacts of meningococcal cases of any group</ci>
                      <ci type="logical">A maximum of three doses (dependant on age at first dose) for
                    child who has previously had meningococcal disease of any group</ci>
                      <ci type="logical">A maximum of three doses (dependant on age at first dose) for
                    bone marrow transplant patients</ci>
                      <ci type="logical">A maximum of three doses (dependant on age at first dose) for
                    child pre- and post-immunosuppression*</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>infants from 6 weeks to less than 6 months of age require a 2+1 schedule, infants from 6
            months to less than 12 months of age require a 1+1 schedule. Refer to the Immunisation
            Handbook for recommended booster schedules with meningococcal ACWY vaccine.</p>
                  <p>*Immunosuppression due to steroid or other immunosuppressive therapy must be for a period
            of greater than 28 days.</p>
                </div>
              </Request>
              <html:div class="Restricted" xlink:href="RS2037" style="display:none"/>
              <Brand ID="B45080482872625">
                <Name>Nimenrix</Name>
                <Pack ID="P2506971" Specified="true" nzmt:ctpp_id="50183821000117109">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4508048289">
            <Name>Meningococcal C conjugate vaccine</Name>
            <Request Form="RS1935" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Meningococcal C conjugate vaccine</range>
              </Title>
              <Case When="Initial application" Category="Children under 12 months of age">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Up to three doses for patients pre- and post splenectomy and for
                    patients with HIV, complement deficiency (acquired or inherited), functional or
                    anatomic asplenia or pre or post solid organ transplant</ci>
                    <ci type="logical">Two doses for close contacts of meningococcal cases of any group</ci>
                    <ci type="logical">Two doses for child who has previously had meningococcal disease of any group</ci>
                    <ci type="logical">A maximum of two doses for bone marrow transplant patients</ci>
                    <ci type="logical">A maximum of two doses for child pre- and
                    post-immunosuppression*</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>children under 12 months of age require two doses 8 weeks apart. Refer to the
            Immunisation Handbook for recommended booster schedules with meningococcal ACWY vaccine.</p>
                <p>*Immunosuppression due to steroid or other immunosuppressive therapy must be for a period
            of greater than 28 days.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1935" style="display:none"/>
            <Formulation ID="F450804828901" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mcg in 0.5 ml syringe</Name>
              <Brand ID="B45080482890125" ToBeDelisted="2024-12-01">
                <Name>Neisvac-C</Name>
                <Pack ID="P2461919" Specified="true" nzmt:ctpp_id="50163811000117101">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4508048369">
            <Name>Pneumococcal (PCV13) conjugate vaccine</Name>
            <Request Form="RS1936" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Pneumococcal (PCV13) conjugate vaccine</range>
              </Title>
              <Case When="Initial application" Category="Primary course for previously unvaccinated children aged under 5 years">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">A primary course of three doses for previously unvaccinated children
                up to the age of 59 months inclusive</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">3</Term>
              </Case>
              <Case When="Initial application" Category="High risk individuals who have received PCV10">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Two doses are funded for high risk individuals (over the age of 12
                months and under 18 years) who have previously received two doses of the primary
                course of PCV10</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">2</Term>
              </Case>
              <Case When="Initial application" Category="High risk children aged under 5 years">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Up to an additional four doses (as appropriate) are funded for
                    the (re)immunisation of high-risk children aged under 5 years</ci>
                    <apply>
                      <or/>
                      <ci type="logical">on immunosuppressive therapy or radiation therapy, vaccinate
                        when there is expected to be a sufficient immune response</ci>
                      <ci type="logical">primary immune deficiencies</ci>
                      <ci type="logical">HIV infection</ci>
                      <ci type="logical">renal failure, or nephrotic syndrome</ci>
                      <ci type="logical">are immune-suppressed following organ transplantation
                        (including haematopoietic stem cell transplant)</ci>
                      <ci type="logical">cochlear implants or intracranial shunts</ci>
                      <ci type="logical">cerebrospinal fluid leaks</ci>
                      <ci type="logical">receiving corticosteroid therapy for more than two weeks, and
                        who are on an equivalent daily dosage of prednisone of 2 mg/kg per day or
                        greater, or children who weigh more than 10 kg on a total daily dosage of 20
                        mg or greater</ci>
                      <ci type="logical">chronic pulmonary disease (including asthma treated with
                        high-dose corticosteroid therapy)</ci>
                      <ci type="logical">pre term infants, born before 28 weeks gestation</ci>
                      <ci type="logical">cardiac disease, with cyanosis or failure</ci>
                      <ci type="logical">diabetes</ci>
                      <ci type="logical">Down syndrome</ci>
                      <ci type="logical">who are pre-or post-splenectomy, or with functional
                        asplenia</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">4</Term>
              </Case>
              <Case When="Initial application" Category="High risk individuals 5 years and over">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Up to an additional four doses (as appropriate) are funded for the
                (re-)immunisation of individuals 5 years and over with HIV, pre or post
                haematopoietic stem cell transplantation, or chemotherapy; pre- or post splenectomy;
                functional asplenia, pre- or post- solid organ transplant, renal dialysis,
                complement deficiency (acquired or inherited), cochlear implants, intracranial
                shunts, cerebrospinal fluid leaks or primary immunodeficiency</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">4</Term>
              </Case>
              <Case When="Initial application" Category="Testing for primary immunodeficiency diseases">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For use in testing for primary immunodeficiency diseases, on the
                recommendation of an internal medicine physician or paediatrician</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Please refer to the Immunisation Handbook for the appropriate schedule for catch up
            programmes</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1936" style="display:none"/>
            <Formulation ID="F450804836901" Rank="4" Units="inj" Weight="30.8">
              <Name>Inj 30.8 mcg of pneumococcal polysaccharide serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in 0.5 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B45080483690125" PSS="true">
                <Name>Prevenar 13</Name>
                <Pack ID="P2383047" Specified="true" nzmt:ctpp_id="50123821000117103">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
                <Pack ID="P2451085" Specified="true" nzmt:ctpp_id="50195241000117103">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4508048370">
            <Name>Pneumococcal (PPV23) polysaccharide vaccine</Name>
            <Request Form="RS1587" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Pneumococcal (PPV23) polysaccharide vaccine</range>
              </Title>
              <Case When="Initial application" Category="High risk patients">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For patients with HIV, for patients post haematopoietic stem cell
                    transplant, or chemotherapy; pre- or post-splenectomy; or with functional
                    asplenia, pre- or post-solid organ transplant, renal dialysis, complement
                    deficiency (acquired or inherited), cochlear implants, or primary
                    immunodeficiency</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">3</Term>
              </Case>
              <Case When="Initial application" Category="High risk children">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Patient is a child under 18 years for (re-)immunisation</ci>
                    <apply>
                      <or/>
                      <ci type="logical">On immunosuppressive therapy or radiation therapy, vaccinate when there is expected to be a sufficient immune response</ci>
                      <ci type="logical">With primary immune deficiencies</ci>
                      <ci type="logical">With HIV infection</ci>
                      <ci type="logical">With renal failure, or nephrotic syndrome</ci>
                      <ci type="logical">Who are immune-suppressed following organ transplantation (including haematopoietic stem cell transplant)</ci>
                      <ci type="logical">With cochlear implants or intracranial shunts</ci>
                      <ci type="logical">With cerebrospinal fluid leaks</ci>
                      <ci type="logical">Receiving corticosteroid therapy for more than two weeks, and who are on an equivalent daily dosage of prednisone of 2 mg/kg per day or greater, or children who weigh more than 10 kg on a total daily dosage of 20 mg or greater</ci>
                      <ci type="logical">With chronic pulmonary disease (including asthma treated with high-dose corticosteroid therapy)</ci>
                      <ci type="logical">Pre term infants, born before 28 weeks gestation</ci>
                      <ci type="logical">With cardiac disease, with cyanosis or failure</ci>
                      <ci type="logical">With diabetes</ci>
                      <ci type="logical">With Down syndrome</ci>
                      <ci type="logical">Who are pre-or post-splenectomy, or with functional asplenia</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">2</Term>
              </Case>
              <Case When="Initial application" Category="Testing for primary immunodeficiency diseases">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For use in testing for primary immunodeficiency diseases, on the recommendation of an internal medicine physician or paediatrician</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1587" style="display:none"/>
            <Formulation ID="F450804837025" Rank="4" Units="inj">
              <Name>Inj 575 mcg in 0.5 ml prefilled syringe (25 mcg of each 23 pneumococcal serotype)</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B45080483702525" PSS="true">
                <Name>Pneumovax 23</Name>
                <Pack ID="P2478838" Specified="true" nzmt:ctpp_id="50222761000117109">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4508048410">
            <Name>Salmonella typhi vaccine</Name>
            <Request Form="RS1243" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Salmonella typhi vaccine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">For use during typhoid fever outbreaks</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1243" style="display:none"/>
            <Formulation ID="F450804841001" Rank="4" Units="inj" Weight="25">
              <Name>Inj 25 mcg in 0.5 ml syringe</Name>
              <Brand ID="B45080484100100">
                <Name>Any</Name>
                <Pack ID="P84100100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4508048674">
            <Name>Meningococcal B multicomponent vaccine</Name>
            <Request Form="RS2020" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Meningococcal B multicomponent vaccine</range>
              </Title>
              <Case When="Initial application" Category="Primary immunisation for children up to 12 months of age">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Three doses for children up to 12 months of age (inclusive) for
                    primary immunisation</ci>
                    <ci type="logical">Up to three doses (dependent on age at first dose) for a catch-up
                    programme for children from 13 months to 59 months of age (inclusive) for
                    primary immunisation, from 1 March 2023 to 31 August 2025</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">3</Term>
              </Case>
              <Case When="Initial application" Category="Person is one year of age or over">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">up to two doses and a booster every five years for patients pre-
                    and post-splenectomy and for patients with functional or anatomic asplenia, HIV,
                    complement deficiency (acquired or inherited), or pre- or post-solid organ
                    transplant</ci>
                    <ci type="logical">up to two doses for close contacts of meningococcal cases of any
                    group</ci>
                    <ci type="logical">up to two doses for person who has previously had meningococcal
                    disease of any group</ci>
                    <ci type="logical">up to two doses for bone marrow transplant patients</ci>
                    <ci type="logical">up to two doses for person pre- and post-immunosuppression* </ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Person is aged between 13 and 25 years (inclusive)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">Person is aged between 13 and 25 years (inclusive)</ci>
                    <apply>
                      <or/>
                      <ci type="logical">Two doses for individuals who are entering within the next
                        three months, or in their first year of living in boarding school hostels,
                        tertiary education halls of residence, military barracks, Youth Justice residences, or prisons</ci>
                      <ci type="logical">Two doses for individuals who turn 13 years of age while living in
                        boarding school hostels</ci>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">2</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>*Immunosuppression due to corticosteroid or other immunosuppressive therapy must be for a
            period of greater than 28 days.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS2020" style="display:none"/>
            <Formulation ID="F450804867425" Rank="4" Units="inj">
              <Name>Inj 175 mcg per 0.5 ml prefilled syringe</Name>
              <Brand ID="B45080486742525">
                <Name>Bexsero</Name>
                <Pack ID="P2556251" nzmt:ctpp_id="50247291000117107">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
                <Pack ID="P2669668" Specified="true" nzmt:ctpp_id="50247281000117109">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
                <Pack ID="P2671948" Specified="true" nzmt:ctpp_id="50308971000117101">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A4512">
        <Name>Viral Vaccines</Name>
        <ATC3 ID="A451204">
          <Name>Viral Vaccines</Name>
          <Chemical ID="C4512048211">
            <Name>Hepatitis A vaccine</Name>
            <Request Form="RS1638" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Hepatitis A vaccine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Two vaccinations for use in transplant patients</ci>
                    <ci type="logical">Two vaccinations for use in children with chronic liver disease</ci>
                    <ci type="logical">One dose of vaccine for close contacts of known hepatitis A cases</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1638" style="display:none"/>
            <Formulation ID="F451204821101" Rank="4" Units="inj" Weight="1440">
              <Name>Inj 1440 ELISA units in 1 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B45120482110125" PSS="true">
                <Name>Havrix 1440</Name>
                <Pack ID="P2061937" Specified="true" nzmt:ctpp_id="50062911000117108">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F451204821102" Rank="4" Units="inj" Weight="720">
              <Name>Inj 720 ELISA units in 0.5 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B45120482110225" PSS="true">
                <Name>Havrix Junior</Name>
                <Pack ID="P793582" Specified="true" nzmt:ctpp_id="50116211000117107">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4512048212">
            <Name>Hepatitis B recombinant vaccine</Name>
            <Formulation ID="F451204821226" Rank="4" Units="inj" Weight="20">
              <Name>Inj 20 mcg per 1 ml prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Request Form="RS2050" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Hepatitis B recombinant vaccine</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical">For household or sexual contacts of known acute hepatitis B patients or hepatitis B carriers</ci>
                      <ci type="logical">For children born to mothers who are hepatitis B surface antigen (HBsAg) positive</ci>
                      <ci type="logical">For children up to and under the age of 18 years inclusive who are considered not to have achieved a positive serology and require additional vaccination or require
                    a primary course of vaccination</ci>
                      <ci type="logical">For HIV positive patients</ci>
                      <ci type="logical">For hepatitis C positive patients</ci>
                      <ci type="logical">For patients following non-consensual sexual intercourse</ci>
                      <ci type="logical">For patients prior to planned immunosuppression for greater than 28 days</ci>
                      <ci type="logical">For patients following immunosuppression</ci>
                      <ci type="logical">For solid organ transplant patients</ci>
                      <ci type="logical">For post-haematopoietic stem cell transplant (HSCT) patients</ci>
                      <ci type="logical">Following needle stick injury</ci>
                      <ci type="logical">For dialysis patients</ci>
                      <ci type="logical">For liver or kidney transplant patients</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS2050" style="display:none"/>
              <Brand ID="B45120482122625" PSS="true">
                <Name>Engerix-B</Name>
                <Pack ID="P2534533" Specified="true" nzmt:ctpp_id="50152361000117107">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F451204821227" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mcg per 0.5 ml prefilled syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Request Form="RS2049" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Hepatitis B recombinant vaccine</range>
                </Title>
                <Case When="Initial application">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical">For household or sexual contacts of known acute hepatitis B patients or hepatitis B carriers</ci>
                      <ci type="logical">For children born to mothers who are hepatitis B surface antigen (HBsAg) positive</ci>
                      <ci type="logical">For children up to and under the age of 18 years inclusive who are considered not to have achieved a positive serology and require additional vaccination or require a primary course of vaccination</ci>
                      <ci type="logical">For HIV positive patients</ci>
                      <ci type="logical">For hepatitis C positive patients</ci>
                      <ci type="logical">For patients following non-consensual sexual intercourse</ci>
                      <ci type="logical">For patients prior to planned immunosuppression for greater than 28 days</ci>
                      <ci type="logical">For patients following immunosuppression</ci>
                      <ci type="logical">For solid organ transplant patients</ci>
                      <ci type="logical">For post-haematopoietic stem cell transplant (HSCT) patients</ci>
                      <ci type="logical">Following needle stick injury</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS2049" style="display:none"/>
              <Brand ID="B45120482122725" PSS="true">
                <Name>Engerix-B</Name>
                <Pack ID="P2601044" Specified="true" nzmt:ctpp_id="50201081000117104">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4512048229">
            <Name>Influenza vaccine</Name>
            <Formulation ID="F451204822925" Rank="4" Units="inj" Weight="60">
              <Name>Inj 60 mcg in 0.5 ml syringe (quadrivalent vaccine)</Name>
              <Request Form="RS2013" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Influenza vaccine Inj 60 mcg in 0.5 ml syringe (quadrivalent vaccine)</range>
                </Title>
                <Case When="Initial application" Category="People over 65">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical" class="Indication">The patient is 65 years of age or over</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
                <Case When="Initial application" Category="cardiovascular disease">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Ischaemic heart disease</ci>
                      <ci type="logical" class="Indication">Congestive heart failure</ci>
                      <ci type="logical" class="Indication">Rheumatic heart disease</ci>
                      <ci type="logical" class="Indication">Congenital heart disease</ci>
                      <ci type="logical" class="Indication">Cerebro-vascular disease</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                  <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                    <p>hypertension and/or dyslipidaemia without evidence of end-organ disease is excluded
                from funding.</p>
                  </div>
                </Case>
                <Case When="Initial application" Category="chronic respiratory disease">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">Asthma, if on a regular preventative
                    therapy</ci>
                      <ci type="logical" class="Indication">Other chronic respiratory disease with
                    impaired lung function</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                  <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                    <p>asthma not requiring regular preventative therapy is excluded from funding.</p>
                  </div>
                </Case>
                <Case When="Initial application" Category="Other conditions">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <apply>
                        <or/>
                        <ci type="logical" class="Indication">Diabetes</ci>
                        <ci type="logical" class="Indication">chronic renal disease</ci>
                        <ci type="logical" class="Indication">Any cancer, excluding basal and squamous
                        skin cancers if not invasive</ci>
                        <ci type="logical" class="Indication">Autoimmune disease</ci>
                        <ci type="logical" class="Indication">Immune suppression or immune
                        deficiency</ci>
                        <ci type="logical" class="Indication">HIV</ci>
                        <ci type="logical" class="Indication">Transplant recipient</ci>
                        <ci type="logical" class="Indication">Neuromuscular and CNS diseases/
                        disorders</ci>
                        <ci type="logical" class="Indication">Haemoglobinopathies</ci>
                        <ci type="logical" class="Indication">Is a child on long term aspirin</ci>
                        <ci type="logical" class="Indication">Has a cochlear implant</ci>
                        <ci type="logical" class="Indication">Errors of metabolism at risk of major
                        metabolic decompensation</ci>
                        <ci type="logical" class="Indication">Pre and post splenectomy</ci>
                        <ci type="logical" class="Indication">Down syndrome</ci>
                        <ci type="logical" class="Indication">Is pregnant</ci>
                        <ci type="logical" class="Indication">Is a child 4 years of age or under (inclusive) 
                        who has been hospitalised for respiratory illness or has a history of
                        significant respiratory illness</ci>
                      </apply>
                      <ci type="logical" class="Indication">Patients in a long-stay inpatient mental
                    health care unit or who are compulsorily detained long-term in a forensic unit
                    within a Public Hospital</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
                <Case When="Initial application" Category="Serious mental health conditions or addiction">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical" class="Indication">schizophrenia</ci>
                      <ci type="logical" class="Indication">major depressive disorder</ci>
                      <ci type="logical" class="Indication">bipolar disorder</ci>
                      <ci type="logical" class="Indication">schizoaffective disorder</ci>
                      <ci type="logical" class="Indication">person is currently accessing secondary or tertiary mental health and addiction services</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS2013" style="display:none"/>
              <Brand ID="B45120482292531">
                <Name>Influvac Tetra (2024 formulation)</Name>
                <Pack ID="P2670143" Specified="true" nzmt:ctpp_id="50328191000117106">
                  <Quantity>10</Quantity>
                  <Price>120.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4512048280">
            <Name>Measles, mumps and rubella vaccine</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS1487">
              <Title>
                <range>Measles, mumps and rubella vaccine</range>
              </Title>
              <Case When="Initial application" Category="first dose prior to 12 months">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">For primary vaccination in children</ci>
                    <ci type="logical" class="Indication">For revaccination following immunosuppression</ci>
                    <ci type="logical" class="Indication">For any individual susceptible to measles, mumps or rubella</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">3</Term>
              </Case>
              <Case When="Initial application" Category="first dose after 12 months">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical" class="Indication">For primary vaccination in children</ci>
                    <ci type="logical" class="Indication">For revaccination following immunosuppression</ci>
                    <ci type="logical" class="Indication">For any individual susceptible to measles, mumps or rubella</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">2</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Please refer to the Immunisation Handbook for appropriate schedule for catch up programmes.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1487" style="display:none"/>
            <Formulation ID="F451204828025" Rank="4" Units="inj">
              <Name>Injection, measles virus 1,000 CCID50, mumps virus 5,012 CCID50, Rubella virus 1,000 CCID50; prefilled syringe/ampoule of diluent 0.5 ml</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B45120482802525" PSS="true">
                <Name>Priorix</Name>
                <Pack ID="P2509369" Specified="true" nzmt:ctpp_id="50199491000117107">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4512048372">
            <Name>Poliomyelitis vaccine</Name>
            <Request Form="RS1398" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Poliomyelitis vaccine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">For partially vaccinated or previously unvaccinated individuals</ci>
                    <ci type="logical">For revaccination following immunosuppression</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">3</Term>
              </Case>
              <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                <p>Please refer to the Immunisation Handbook for the appropriate schedule for catch up programmes.</p>
              </div>
            </Request>
            <html:div class="Restricted" xlink:href="RS1398" style="display:none"/>
            <Formulation ID="F451204837201" Rank="4" Units="inj" Weight="80">
              <Name>Inj 80 D-antigen units in 0.5 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B45120483720125" PSS="true">
                <Name>IPOL</Name>
                <Pack ID="P216909" Specified="true" nzmt:ctpp_id="50329341000117108">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4512048403">
            <Name>Rabies vaccine</Name>
            <Formulation ID="F451204840301" Rank="4" Units="inj" Weight="2.5">
              <Name>Inj 2.5 IU vial with diluent</Name>
              <Brand ID="B45120484030100">
                <Name>Any</Name>
                <Pack ID="P84030100" Specified="true" CBS="true">
                  <Quantity>0</Quantity>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4512048490">
            <Name>Varicella vaccine [Chickenpox vaccine]</Name>
            <Formulation ID="F451204849002" Rank="4" Units="inj" Weight="2000">
              <Name>Inj 2000 PFU prefilled syringe plus vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Request Form="RS1591" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Varicella vaccine [Chickenpox vaccine]</range>
                </Title>
                <Case When="Initial application" Category="primary vaccinations">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical">Any infant born on or after 1 April 2016</ci>
                      <ci type="logical">For previously unvaccinated children turning 11 years old on or
                    after 1 July 2017, who have not previously had a varicella infection
                    (chickenpox)</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="dose">1</Term>
                </Case>
                <Case When="Initial application" Category="other conditions">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <apply>
                        <or/>
                        <mi class="heading">for non-immune patients:</mi>
                        <ci type="logical">With chronic liver disease who may in future be candidates
                        for transplantation</ci>
                        <ci type="logical">With deteriorating renal function before transplantation</ci>
                        <ci type="logical">Prior to solid organ transplant</ci>
                        <ci type="logical">Prior to any elective immunosuppression*</ci>
                        <ci type="logical">For post exposure prophylaxis who are immune competent
                        inpatients</ci>
                      </apply>
                      <ci type="logical">For patients at least 2 years after bone marrow transplantation,
                    on advice of their specialist</ci>
                      <ci type="logical">For patients at least 6 months after completion of chemotherapy,
                    on advice of their specialist</ci>
                      <ci type="logical">For HIV positive patients non immune to varicella with mild or
                    moderate immunosuppression on advice of HIV specialist</ci>
                      <ci type="logical">For patients with inborn errors of metabolism at risk of major
                    metabolic decompensation, with no clinical history of varicella</ci>
                      <ci type="logical">For household contacts of paediatric patients who are
                    immunocompromised, or undergoing a procedure leading to immune compromise where
                    the household contact has no clinical history of varicella</ci>
                      <ci type="logical">For household contacts of adult patients who have no clinical
                    history of varicella and who are severely immunocompromised or undergoing a
                    procedure leading to immune compromise where the household contact has no
                    clinical history of varicella</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="dose">2</Term>
                </Case>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>* immunosuppression due to steroid or other immunosuppressive therapy must be for a
            treatment period of greater than 28 days</p>
                </div>
              </Request>
              <html:div class="Restricted" xlink:href="RS1591" style="display:none"/>
              <Brand ID="B45120484900225" PSS="true">
                <Name>Varilrix</Name>
                <Pack ID="P2678950" Specified="true" nzmt:ctpp_id="50121731000117105">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F451204849025" Rank="4" Units="inj">
              <Name>Inj 1350 PFU prefiiled syringe</Name>
              <Request Form="RS1591" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>Varicella vaccine [Chickenpox vaccine]</range>
                </Title>
                <Case When="Initial application" Category="primary vaccinations">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical">Any infant born on or after 1 April 2016</ci>
                      <ci type="logical">For previously unvaccinated children turning 11 years old on or
                    after 1 July 2017, who have not previously had a varicella infection
                    (chickenpox)</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="dose">1</Term>
                </Case>
                <Case When="Initial application" Category="other conditions">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <apply>
                        <or/>
                        <mi class="heading">for non-immune patients:</mi>
                        <ci type="logical">With chronic liver disease who may in future be candidates
                        for transplantation</ci>
                        <ci type="logical">With deteriorating renal function before transplantation</ci>
                        <ci type="logical">Prior to solid organ transplant</ci>
                        <ci type="logical">Prior to any elective immunosuppression*</ci>
                        <ci type="logical">For post exposure prophylaxis who are immune competent
                        inpatients</ci>
                      </apply>
                      <ci type="logical">For patients at least 2 years after bone marrow transplantation,
                    on advice of their specialist</ci>
                      <ci type="logical">For patients at least 6 months after completion of chemotherapy,
                    on advice of their specialist</ci>
                      <ci type="logical">For HIV positive patients non immune to varicella with mild or
                    moderate immunosuppression on advice of HIV specialist</ci>
                      <ci type="logical">For patients with inborn errors of metabolism at risk of major
                    metabolic decompensation, with no clinical history of varicella</ci>
                      <ci type="logical">For household contacts of paediatric patients who are
                    immunocompromised, or undergoing a procedure leading to immune compromise where
                    the household contact has no clinical history of varicella</ci>
                      <ci type="logical">For household contacts of adult patients who have no clinical
                    history of varicella and who are severely immunocompromised or undergoing a
                    procedure leading to immune compromise where the household contact has no
                    clinical history of varicella</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="dose">2</Term>
                </Case>
                <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
                  <p>* immunosuppression due to steroid or other immunosuppressive therapy must be for a
            treatment period of greater than 28 days</p>
                </div>
              </Request>
              <html:div class="Restricted" xlink:href="RS1591" style="display:none"/>
              <Brand ID="B45120484902525" ToBeDelisted="2024-12-01">
                <Name>Varivax</Name>
                <Pack ID="P2173085" Specified="true" nzmt:ctpp_id="50029001000117105">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
                <Pack ID="P2593793" Specified="true" nzmt:ctpp_id="50157131000117100">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4512048606">
            <Name>Human papillomavirus (6, 11, 16, 18, 31, 33, 45, 52 and 58) vaccine [HPV]</Name>
            <Request To="HealthPAC" For="Subsidy" Form="RS2038">
              <Title>
                <range>Human papillomavirus (6, 11, 16, 18, 31, 33, 45, 52 and 58) vaccine [HPV]</range>
              </Title>
              <Case When="Initial application" Category="Children aged 14 years and under">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <ci type="logical">Children aged 14 years and under</ci>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">2</Term>
              </Case>
              <Case When="Initial application" Category="other conditions">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Up to 3 doses for people aged 15 to 26 years inclusive</ci>
                    <apply>
                      <and/>
                      <ci type="logical">People aged 9 to 26 years inclusive</ci>
                      <apply>
                        <or/>
                        <ci type="logical">Up to 3 doses for confirmed HIV infection</ci>
                        <ci type="logical">Up to 3 doses people with a transplant (including stem cell)</ci>
                        <ci type="logical">Up to 4 doses for Post chemotherapy</ci>
                      </apply>
                    </apply>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
              <Case When="Initial application" Category="Recurrent Respiratory Papillomatosis">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <apply>
                      <or/>
                      <ci type="logical">Maximum of two doses for children aged 14 years and under</ci>
                      <ci type="logical">Maximum of three doses for people aged 15 years and over</ci>
                    </apply>
                    <ci type="logical">The person has recurrent respiratory papillomatosis</ci>
                    <ci type="logical">The person has not previously had an HPV vaccine</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="patient's lifetime"/>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2038" style="display:none"/>
            <Formulation ID="F451204860625" Rank="4" Units="inj" Weight="270">
              <Name>Inj 270 mcg in 0.5 ml syringe</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B45120486062525" PSS="true">
                <Name>Gardasil 9</Name>
                <Pack ID="P2506254" Specified="true" nzmt:ctpp_id="50225581000117100">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4512048611">
            <Name>Rotavirus oral vaccine</Name>
            <Request Form="RS1590" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Rotavirus oral vaccine</range>
              </Title>
              <Case When="Initial application">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <and/>
                    <ci type="logical">First dose to be administered in infants aged under 14 weeks of age</ci>
                    <ci type="logical">No vaccination being administered to children aged 24 weeks or over</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">2</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS1590" style="display:none"/>
            <Formulation ID="F451204861125" Rank="4" Units="inj">
              <Name>Oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, prefilled oral applicator</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B45120486112525" PSS="true">
                <Name>Rotarix</Name>
                <Pack ID="P2509415" Specified="true" nzmt:ctpp_id="50187811000117107">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F451204861126" Rank="9" Units="tube">
              <Name>Oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, squeezable tube</Name>
              <Brand ID="B45120486112625">
                <Name>Rotarix</Name>
                <Pack ID="P2650290" Specified="true" nzmt:ctpp_id="50308961000117106">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4512048620">
            <Name>Varicella zoster vaccine [Shingles vaccine]</Name>
            <Request Form="RS2039" To="HealthPAC" For="Subsidy">
              <Title>
                <range>Varicella zoster vaccine [shingles vaccine]</range>
              </Title>
              <Case When="Initial application" Category="people aged 18 years and over (Shingrix)">
                <math xmlns="http://www.w3.org/1998/Math/MathML">
                  <apply>
                    <or/>
                    <ci type="logical">Pre- and post-haematopoietic stem cell transplant or cellular
                    therapy</ci>
                    <ci type="logical">Pre- or post-solid organ transplant</ci>
                    <ci type="logical">Haematological malignancies</ci>
                    <ci type="logical">People living with poorly controlled HIV infection</ci>
                    <ci type="logical">Planned or receiving disease modifying anti-rheumatic drugs
                    (DMARDs – targeted synthetic, biologic, or conventional synthetic) for
                    polymyalgia rheumatica, systemic lupus erythematosus or rheumatoid
                    arthritis</ci>
                    <ci type="logical">End stage kidney disease (CKD 4 or 5);</ci>
                    <ci type="logical">Primary immunodeficiency</ci>
                  </apply>
                </math>
                <Applicant>medical practitioner</Applicant>
                <Term Measure="dose">2</Term>
              </Case>
            </Request>
            <html:div class="Restricted" xlink:href="RS2039" style="display:none"/>
            <Formulation ID="F451204862026" Rank="4" Units="inj">
              <Name>Inj 50 mcg per 0.5 ml vial plus vial</Name>
              <Brand ID="B45120486202625">
                <Name>Shingrix</Name>
                <Pack ID="P2631687" Specified="true" nzmt:ctpp_id="50256931000117102">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
                <Pack ID="P2671921" Specified="true" nzmt:ctpp_id="50256941000117105">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C4512048742">
            <Name>COVID-19 vaccine</Name>
            <Formulation ID="F451204874225" Rank="4" Units="inj" Weight="30">
              <Name>Inj 30 mcg raxtozinameran per 0.3 ml, 2.25 ml vial; adult vaccine, dark grey cap </Name>
              <Request Form="RS2036" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>COVID-19 vaccine</range>
                </Title>
                <Case When="Initial application" Category="initial dose">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical">One dose for previously unvaccinated people aged 12-15 years old</ci>
                      <ci type="logical">Up to three doses for immunocompromised people aged 12-15 years old</ci>
                      <ci type="logical">Up to two doses for previously unvaccinated people 16-29 years old</ci>
                      <ci type="logical">Up to four doses for people aged 16-29 at high risk of severe illness</ci>
                      <ci type="logical">One dose for previously unvaccinated people aged 30 and older</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
                <Case When="Initial application" Category="additional dose">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">One additional dose every 6 months for people aged 30 years and over, additional dose is given at least 6 months after last dose</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
                <Case When="Renewal" Category="additional dose">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">One additional dose every 6 months for people aged 30 years and over, additional dose is given at least 6 months after last dose</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS2036" style="display:none"/>
              <Brand ID="B45120487422525">
                <Name>Comirnaty Omicron (XBB.1.5)</Name>
                <Pack ID="P2682311" Specified="true" nzmt:ctpp_id="50323341000117106">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F451204874226" Rank="4" Units="inj" Weight="30">
              <Name>Inj 30 mcg raxtozinameran per 0.3 ml, 0.48 ml vial; adult vaccine, light grey cap </Name>
              <Request Form="RS2040" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>COVID-19 vaccine</range>
                </Title>
                <Case When="Initial application" Category="initial dose">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical">One dose for previously unvaccinated people aged 12-15 years old</ci>
                      <ci type="logical">Up to three doses for immunocompromised people aged 12-15 years old</ci>
                      <ci type="logical">Up to two doses for previously unvaccinated people 16-29 years old</ci>
                      <ci type="logical">Up to four doses for people aged 16-29 at high risk of severe illness</ci>
                      <ci type="logical">One dose for previously unvaccinated people aged 30 and older</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
                <Case When="Initial application" Category="additional dose">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">One additional dose every 6 months for people aged 30 years and over, additional dose is given at least 6 months after last dose</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
                <Case When="Renewal" Category="additional dose">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">One additional dose every 6 months for people aged 30 years and over, additional dose is given at least 6 months after last dose</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS2040" style="display:none"/>
              <Brand ID="B45120487422625">
                <Name>Comirnaty Omicron (XBB.1.5)</Name>
                <Pack ID="P2682338" Specified="true" nzmt:ctpp_id="50323371000117100">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F451204874227" Rank="4" Units="inj" Weight="10">
              <Name>Inj 10 mcg raxtozinameran per 0.3 ml, 0.48 ml vial; paediatric vaccine, light blue cap </Name>
              <Request Form="RS2041" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>COVID-19 vaccine</range>
                </Title>
                <Case When="Initial application" Category="initial dose">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <apply>
                      <or/>
                      <ci type="logical">One dose for previously unvaccinated children aged 5-11 years old</ci>
                      <ci type="logical">Up to three doses for immunocompromised children aged 5-11 years old</ci>
                    </apply>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS2041" style="display:none"/>
              <Brand ID="B45120487422725">
                <Name>Comirnaty Omicron (XBB.1.5)</Name>
                <Pack ID="P2682346" Specified="true" nzmt:ctpp_id="50323441000117100">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F451204874228" Rank="4" Units="inj" Weight="3">
              <Name>Inj 3 mcg raxtozinameran per 0.2 ml, 0.4 ml vial; infant vaccine, maroon cap </Name>
              <Request Form="RS2042" To="HealthPAC" For="Subsidy">
                <Title>
                  <range>COVID-19 vaccine</range>
                </Title>
                <Case When="Initial application" Category="initial dose">
                  <math xmlns="http://www.w3.org/1998/Math/MathML">
                    <ci type="logical">Up to three doses for previously unvaccinated children aged 6
                    months – 4 years at high risk of severe illness</ci>
                  </math>
                  <Applicant>medical practitioner</Applicant>
                  <Term Measure="patient's lifetime"/>
                </Case>
              </Request>
              <html:div class="Restricted" xlink:href="RS2042" style="display:none"/>
              <Brand ID="B45120487422825">
                <Name>Comirnaty Omicron XBB.1.5</Name>
                <Pack ID="P2682354" Specified="true" nzmt:ctpp_id="50323501000117101">
                  <Quantity>10</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
      <ATC2 ID="A4516">
        <Name>Diagnostic Agents</Name>
        <ATC3 ID="A451604">
          <Name>Diagnostic Agents</Name>
          <Chemical ID="C4516048612">
            <Name>Tuberculin PPD [Mantoux] test</Name>
            <Formulation ID="F451604861225" Rank="4" Units="inj">
              <Name>Inj 5 TU per 0.1 ml, 1 ml vial</Name>
              <Rule Type="DVLimit" Attribute="Dec-24 to~2027" Value="5"/>
              <Brand ID="B45160486122525" PSS="true">
                <Name>Tubersol</Name>
                <Pack ID="P703338" Specified="true" nzmt:ctpp_id="50103681000117108">
                  <Quantity>1</Quantity>
                  <Price>0.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
    <ATC1 ID="A50">
      <Name>Part III - OPTIONAL PHARMACEUTICALS</Name>
      <ATC2 ID="A5004">
        <Name>Optional Pharmaceuticals</Name>
        <div xmlns="http://www.w3.org/1999/xhtml" class="Note">
          <h4>NOTE:</h4>
          <p>In addition to the products expressly listed here in Part III: Optional Pharmaceuticals, a range of hospital medical devices are listed in an addendum to Part III which is available at <a href="http://schedule.pharmac.govt.nz">schedule.pharmac.govt.nz</a>. The Optional Pharmaceuticals listed in the
    addendum are deemed to be listed in Part III, and the Rules of the Pharmaceutical Schedule applying to products listed in Part III apply to them.</p>
        </div>
        <ATC3 ID="A500404">
          <Name>Optional Pharmaceuticals</Name>
          <Chemical ID="C5004048386">
            <Name>Pregnancy test - hCG urine</Name>
            <Formulation ID="F500404838601" Rank="10" Units="test">
              <Name>Cassette</Name>
              <Rule Type="DVLimit" Attribute="Mar-25 to~2027" Value="5"/>
              <Brand ID="B50040483860127" ToBeDelisted="2025-03-01">
                <Name>Smith BioMed Rapid Pregnancy Test</Name>
                <Pack ID="P2544873" Specified="true" nzmt:ctpp_id="50255581000117101">
                  <Quantity>40</Quantity>
                  <Price>12.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B50040483860128" PSS="true">
                <Name>David One Step Cassette Pregnancy Test</Name>
                <Pack ID="P2602318" Specified="true" nzmt:ctpp_id="50283781000117102">
                  <Quantity>40</Quantity>
                  <Price>16.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C5004048618">
            <Name>Blood ketone diagnostic test strip</Name>
            <Formulation ID="F500404861825" Rank="10" Units="strip">
              <Name>Test strips</Name>
              <Brand ID="B50040486182525">
                <Name>KetoSens</Name>
                <Pack ID="P2535432" Specified="true" nzmt:ctpp_id="50250981000117104">
                  <Quantity>10</Quantity>
                  <Price>15.50</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C5004048619">
            <Name>Dual blood glucose and blood ketone diagnostic test meter</Name>
            <Formulation ID="F500404861925" Rank="10" Units="pack">
              <Name>Meter with 50 lancets, a lancing device, and 10 blood glucose diagnostic test strips</Name>
              <Brand ID="B50040486192525">
                <Name>CareSens Dual</Name>
                <Pack ID="P2535408" Specified="true" nzmt:ctpp_id="50250991000117101">
                  <Quantity>1</Quantity>
                  <Price>20.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C5004049481">
            <Name>Blood glucose diagnostic test strip</Name>
            <Formulation ID="F500404948125" Rank="10" Units="test">
              <Name>Blood glucose test strips</Name>
              <Brand ID="B50040494812528">
                <Name>CareSens N</Name>
                <Pack ID="P2403153" Specified="true" nzmt:ctpp_id="50143491000117101">
                  <Quantity>50</Quantity>
                  <Price>10.56</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F500404948127" Rank="10" Units="test">
              <Name>Test strips</Name>
              <Brand ID="B50040494812725">
                <Name>CareSens PRO</Name>
                <Pack ID="P2535424" Specified="true" nzmt:ctpp_id="50250971000117102">
                  <Quantity>50</Quantity>
                  <Price>10.56</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C5004049482">
            <Name>Blood glucose diagnostic test meter</Name>
            <Formulation ID="F500404948226" Rank="10" Units="meter">
              <Name>1 meter with 50 lancets, a lancing device, and 10 diagnostic test strips</Name>
              <Brand ID="B50040494822626">
                <Name>Caresens N</Name>
                <Pack ID="P2403137" Specified="true" nzmt:ctpp_id="50143391000117109">
                  <Quantity>1</Quantity>
                  <Price>10.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B50040494822627">
                <Name>Caresens N POP</Name>
                <Pack ID="P2403145" Specified="true" nzmt:ctpp_id="50143401000117106">
                  <Quantity>1</Quantity>
                  <Price>10.00</Price>
                </Pack>
              </Brand>
              <Brand ID="B50040494822628">
                <Name>CareSens N Premier</Name>
                <Pack ID="P2535416" Specified="true" nzmt:ctpp_id="50250961000117107">
                  <Quantity>1</Quantity>
                  <Price>20.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C5004049488">
            <Name>Spacer device</Name>
            <Formulation ID="F500404948825" Rank="10" Units="dev" Weight="1">
              <Name>800 ml</Name>
              <Brand ID="B50040494882525">
                <Name>Volumatic</Name>
                <Pack ID="P529613" Specified="true" nzmt:ctpp_id="50094511000117107">
                  <Quantity>1</Quantity>
                  <Price>6.50</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F500404948827" Rank="10" Units="dev">
              <Name>220 ml (single patient)</Name>
              <Brand ID="B50040494882725">
                <Name>e-chamber Turbo</Name>
                <Pack ID="P2490072" Specified="true" nzmt:ctpp_id="50227481000117105">
                  <Quantity>1</Quantity>
                  <Price>3.65</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F500404948828" Rank="10" Units="dev">
              <Name>510 ml (single patient)</Name>
              <Brand ID="B50040494882825">
                <Name>e-chamber La Grande</Name>
                <Pack ID="P2490080" Specified="true" nzmt:ctpp_id="50227491000117108">
                  <Quantity>1</Quantity>
                  <Price>5.95</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C5004049628">
            <Name>Mask for spacer device</Name>
            <Formulation ID="F500404962826" Rank="10" Units="dev">
              <Name>Small</Name>
              <Brand ID="B50040496282625">
                <Name>e-chamber Mask</Name>
                <Pack ID="P2490099" Specified="true" nzmt:ctpp_id="50227461000117102">
                  <Quantity>1</Quantity>
                  <Price>2.70</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C5004049629">
            <Name>Peak flow meter</Name>
            <Formulation ID="F500404962925" Rank="10" Units="meter">
              <Name>Low Range</Name>
              <Brand ID="B50040496292526">
                <Name>Mini-Wright AFS Low Range</Name>
                <Pack ID="P2489945" Specified="true" nzmt:ctpp_id="50227471000117107">
                  <Quantity>1</Quantity>
                  <Price>9.54</Price>
                </Pack>
              </Brand>
            </Formulation>
            <Formulation ID="F500404962926" Rank="10" Units="meter">
              <Name>Normal Range</Name>
              <Brand ID="B50040496292626">
                <Name>Mini-Wright Standard</Name>
                <Pack ID="P2489953" Specified="true" nzmt:ctpp_id="50030591000117103">
                  <Quantity>1</Quantity>
                  <Price>9.54</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
          <Chemical ID="C5004049648">
            <Name>Sodium nitroprusside</Name>
            <Formulation ID="F500404964825" Rank="10" Units="strip">
              <Name>Test strip</Name>
              <Brand ID="B50040496482526">
                <Name>Ketostix</Name>
                <Pack ID="P2185121" Specified="true" nzmt:ctpp_id="50030361000117104">
                  <Quantity>50</Quantity>
                  <Price>22.00</Price>
                </Pack>
              </Brand>
            </Formulation>
          </Chemical>
        </ATC3>
      </ATC2>
    </ATC1>
  </Section>
</Schedule>
